archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,8.7323e-05,1.5121,1.2774,1,1
1,GO BLEB ASSEMBLY,7.889e-07,1.4154,1.2967,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,7.2111e-07,1.1931,1.0766,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00017186,1.1881,0.97101,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,3.9926e-07,1.1602,1.0594,1,1
1,GO MEMBRANE RAFT ASSEMBLY,9.7801e-06,1.1516,1.4723,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,2.0833e-05,1.1041,0.87048,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00092958,1.0756,0.91874,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.5427e-07,1.054,0.88242,1,1
1,GO NEUTROPHIL HOMEOSTASIS,1.8521e-05,1.0288,0.89941,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,2.1831e-07,1.0287,0.87582,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.4044e-06,1.0272,0.99016,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,2.3975e-07,1.0272,1.025,1,1
1,GO RESPONSE TO INTERFERON ALPHA,5.7413e-06,1.0105,1.0296,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.0779e-06,1.006,0.9373,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,3.1888e-05,0.98795,0.76324,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00026903,0.96203,0.74567,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.2505e-07,0.93424,0.77973,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.6228e-06,0.93268,0.8887,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.8301e-05,0.93074,0.85933,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,4.0073e-05,0.9304,0.83103,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,6.8936e-07,0.92222,0.96416,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,1.1267e-06,0.91845,0.90223,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00020448,0.90973,0.73687,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.4346e-05,0.90403,0.82123,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.9873e-07,0.903,0.88563,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00013917,0.8915,0.82544,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,0.00019079,0.8802,0.68253,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,4.3763e-07,0.87942,0.80176,1,1
1,GO MEMBRANE RAFT ORGANIZATION,3.8583e-05,0.87229,0.8721,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,5.0683e-06,0.83498,0.82186,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.4674e-06,0.83091,0.78046,1,1
1,GO CD40 SIGNALING PATHWAY,1.725e-07,0.82693,0.76011,1,1
1,GO RESPONSE TO INTERFERON BETA,8.3127e-06,0.81918,0.90214,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,2.8077e-06,0.81777,0.75506,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,4.6597e-05,0.81651,0.69178,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,7.2111e-07,0.80446,0.66319,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,1.1964e-05,0.80417,0.72165,1,1
1,GO ZYMOGEN INHIBITION,1.071e-07,0.80339,0.85053,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,7.2111e-07,0.80137,0.7,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00013433,0.79871,0.74509,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00012074,0.79101,0.68983,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.8958e-07,0.79033,0.77634,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.2308e-06,0.78385,0.75693,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00010092,0.76685,0.59985,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00016023,0.76678,0.62869,1,1
1,GO ENDODERM FORMATION,1.1964e-05,0.76072,0.70836,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00037661,0.75905,0.58424,1,1
1,GO DNA DEAMINATION,2.9532e-05,0.75553,0.61416,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.4674e-06,0.75166,0.77794,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,1.4674e-06,0.74902,0.81395,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,5.4977e-07,0.74703,0.73549,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.6414e-07,0.74649,0.75446,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.2862e-06,0.74437,0.67726,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,3.3132e-05,0.74281,0.63718,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,4.3218e-05,0.72759,0.63625,1,1
1,GO MUCUS SECRETION,0.00040247,0.72579,0.60867,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.0784e-06,0.72061,0.64324,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.5759e-05,0.71514,0.58832,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.1663e-05,0.71419,0.91332,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00045924,0.71383,0.54104,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,1.0604e-05,0.71065,0.74473,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,0.00017186,0.70915,0.54064,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,1.1493e-05,0.70704,0.59162,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,4.5813e-07,0.70682,0.68871,1,1
1,GO TROPHOBLAST CELL MIGRATION,9.7801e-06,0.70407,0.77659,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,3.9926e-07,0.69817,0.60266,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.9301e-06,0.69595,0.67261,1,1
1,GO HEMIDESMOSOME ASSEMBLY,6.2786e-05,0.69294,0.72488,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,5.508e-06,0.69023,0.67938,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.0779e-06,0.68838,0.62379,1,1
1,GO LATERAL MESODERM DEVELOPMENT,2.1702e-06,0.67902,0.61586,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00098941,0.67234,0.53411,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,3.9926e-07,0.67082,0.65571,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.0604e-05,0.66014,0.49041,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,8.7323e-05,0.65756,0.57068,1,1
1,GO BONE TRABECULA FORMATION,0.0028141,0.65454,0.6288,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,1.104e-05,0.65376,0.60852,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,4.8612e-06,0.65302,0.62531,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.0033e-05,0.64921,0.62016,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,7.2111e-07,0.6465,0.67909,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,6.5896e-07,0.64612,0.63657,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.6455e-05,0.64567,0.68469,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,9.389e-05,0.64536,0.60463,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00010092,0.6445,0.51858,1,1
1,GO HIPPO SIGNALING,2.3418e-05,0.64208,0.54027,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,4.1617e-05,0.6418,0.73205,1,1
1,GO EPIBOLY,9.7801e-06,0.6395,0.69259,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.7801e-06,0.63677,0.61319,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.7806e-05,0.63569,0.57191,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,1.7118e-05,0.6355,0.53575,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,5.8301e-05,0.63484,0.5715,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,3.17e-07,0.63026,0.70817,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,3.17e-07,0.62907,0.58968,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.4039e-05,0.62864,0.52162,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,3.6228e-06,0.62853,0.59511,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.5774e-06,0.62295,0.56637,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.8084e-07,0.6183,0.65122,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.1802e-07,0.61556,0.58084,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.02166,0.61252,0.61273,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.6603e-06,0.61142,0.67184,1,1
1,GO GAP JUNCTION ASSEMBLY,4.3218e-05,0.61055,0.53712,1,1
1,GO PIGMENT GRANULE MATURATION,9.0179e-06,0.60856,0.50042,1,1
1,GO ENDODERM DEVELOPMENT,1.2454e-05,0.60721,0.56636,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00012512,0.6071,0.49628,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,3.8583e-05,0.6059,0.63161,1,1
1,GO BIOLOGICAL PHASE,0.00031859,0.60413,0.56618,1,1
1,GO VASCULOGENESIS,4.7955e-07,0.60346,0.57724,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,4.8612e-06,0.60153,0.53939,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00014935,0.60118,0.59684,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,2.2524e-05,0.60018,0.47611,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.349e-05,0.59943,0.6373,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,1.0311e-06,0.59784,0.73939,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,3.9926e-07,0.59627,0.54906,1,1
1,GO CYTOLYSIS,3.5759e-05,0.59555,0.45524,1,1
1,GO LIVER REGENERATION,3.6228e-06,0.59534,0.53234,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.4039e-05,0.5935,0.55081,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.00024286,0.59333,0.63591,1,1
1,GO REGULATION OF PINOCYTOSIS,5.9841e-06,0.59209,0.64928,1,1
1,GO COLLAGEN METABOLIC PROCESS,2.2524e-05,0.58733,0.53184,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,5.2837e-06,0.58629,0.59452,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,3.6228e-06,0.58625,0.52284,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00022676,0.58608,0.48727,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.00010845,0.58552,0.50876,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00050664,0.58453,0.5176,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00012512,0.58437,0.50578,1,1
1,GO HEME METABOLIC PROCESS,6.0198e-07,0.58415,0.55693,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,5.0683e-06,0.58373,0.59064,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.2658e-06,0.58278,0.5419,1,1
1,GO NOTOCHORD DEVELOPMENT,7.3528e-06,0.58159,0.61194,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.5308e-05,0.57931,0.63549,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.00081984,0.57908,0.46344,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.4039e-05,0.57699,0.58567,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,4.3218e-05,0.57696,0.46072,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00012964,0.57539,0.59002,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.1267e-06,0.57534,0.4746,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,5.2139e-05,0.57087,0.60097,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,0.00019753,0.57021,0.37795,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,5.8301e-05,0.56806,0.69538,1,1
1,GO APOPTOTIC CELL CLEARANCE,9.3916e-06,0.56783,0.61245,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,0.00012074,0.56622,0.5091,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,4.0073e-05,0.56455,0.55776,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,5.4121e-05,0.56287,0.49853,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,9.3916e-06,0.56236,0.77833,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,6.2367e-06,0.5601,0.53492,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,7.9801e-06,0.55959,0.49632,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0012662,0.55846,0.34912,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00029782,0.55702,0.48569,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.349e-05,0.55675,0.47485,1,1
1,GO PLASMINOGEN ACTIVATION,0.00028792,0.55099,0.55501,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00052342,0.5507,0.43059,1,1
1,GO TYPE 2 IMMUNE RESPONSE,8.6584e-06,0.5506,0.55008,1,1
1,GO RESPONSE TO ANGIOTENSIN,2.0829e-07,0.55057,0.51393,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00090094,0.55036,0.47567,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.00030804,0.54974,0.63041,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0018173,0.54808,0.39732,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,0.00013917,0.5478,0.54242,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00019753,0.5469,0.43328,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.1192e-05,0.54627,0.5204,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.4205e-05,0.54509,0.51787,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0014299,0.54251,0.43717,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00012512,0.54227,0.49257,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00019079,0.54162,0.44737,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,0.00040247,0.54015,0.51411,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.5308e-05,0.53991,0.50846,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,9.0179e-06,0.53793,0.50424,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,3.3132e-05,0.53723,0.5058,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,3.4421e-05,0.53714,0.4824,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,8.1192e-05,0.53489,0.47909,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.9904e-06,0.53474,0.51633,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,4.2876e-06,0.53405,0.6194,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.5759e-05,0.53245,0.39705,1,1
1,GO COLLAGEN CATABOLIC PROCESS,3.1888e-05,0.53243,0.53773,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00055855,0.53142,0.46256,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,3.8583e-05,0.53071,0.55837,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00016595,0.53002,0.48161,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00012512,0.52934,0.62693,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,3.7791e-06,0.52924,0.47707,1,1
1,GO RESPONSE TO TYPE I INTERFERON,0.00017186,0.52911,0.58247,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,6.5149e-05,0.5289,0.56024,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,0.00029782,0.52766,0.4139,1,1
1,GO VAGINA DEVELOPMENT,4.3218e-05,0.5274,0.55374,1,1
1,GO AMYLOID BETA CLEARANCE,7.547e-05,0.52732,0.41108,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00049035,0.52599,0.36389,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.004408,0.52542,0.56802,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,1.5201e-05,0.52439,0.45816,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.027188,0.52405,0.31025,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,3.3132e-05,0.52259,0.46778,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.1904e-06,0.52137,0.47507,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0042883,0.52061,0.36377,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,1.9904e-06,0.51976,0.59229,1,1
1,GO STORE OPERATED CALCIUM ENTRY,3.1888e-05,0.51969,0.39953,1,1
1,GO RESPONSE TO X RAY,2.7578e-07,0.51895,0.50807,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.9926e-07,0.51749,0.4636,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,3.0264e-07,0.51677,0.61463,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00029782,0.51364,0.50326,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,0.00022676,0.51359,0.48612,1,1
1,GO VIRAL GENOME REPLICATION,2.7343e-05,0.5126,0.40636,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0014738,0.5123,0.36545,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00045924,0.51214,0.4427,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.7118e-05,0.51143,0.50264,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00044439,0.51112,0.48649,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,3.7791e-06,0.51085,0.47974,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.015574,0.51001,0.31739,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.8251e-06,0.50763,0.46321,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,4.1802e-07,0.50727,0.49925,1,1
1,GO TOLERANCE INDUCTION,0.0011199,0.50715,0.42034,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00038934,0.50603,0.40192,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0013457,0.50574,0.43951,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00026903,0.50552,0.47625,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,3.1904e-06,0.50319,0.43335,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.4334e-07,0.5007,0.61605,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.4692e-06,0.49918,0.47136,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.2862e-06,0.49818,0.43976,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.3916e-06,0.49796,0.46015,1,1
1,GO LEUKOCYTE AGGREGATION,0.0012662,0.49735,0.48529,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00054072,0.49624,0.35161,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.4609e-05,0.49568,0.40283,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.6455e-05,0.49361,0.59041,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.1617e-05,0.49314,0.40101,1,1
1,GO MATURATION OF SSU RRNA,9.0551e-05,0.4915,0.36467,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,2.0833e-05,0.48967,0.42784,1,1
1,GO RETINAL METABOLIC PROCESS,0.0060989,0.48923,0.33401,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,3.4728e-06,0.48603,0.43018,1,1
1,GO SALIVARY GLAND DEVELOPMENT,0.00050664,0.48541,0.45904,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,3.6228e-06,0.48527,0.54284,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0032441,0.48516,0.39929,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.00034072,0.48473,0.36074,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00027832,0.48419,0.46919,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.1617e-05,0.48377,0.3915,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.0047853,0.483,0.27418,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,9.3916e-06,0.48235,0.40073,1,1
1,GO RECEPTOR CATABOLIC PROCESS,8.2505e-07,0.48233,0.45714,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00044439,0.48233,0.36066,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,7.6603e-06,0.47956,0.56525,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,9.7801e-06,0.47891,0.4414,1,1
1,GO ENTRY INTO HOST,2.9301e-06,0.47861,0.53104,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,8.628e-07,0.4783,0.49095,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,9.0221e-07,0.47824,0.54145,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00090094,0.47813,0.40376,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0022332,0.47781,0.34788,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.00038934,0.47718,0.40778,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00063551,0.47626,0.40032,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.019283,0.47608,0.3564,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010092,0.47511,0.42865,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,5.9841e-06,0.47487,0.4688,1,1
1,GO HAIR FOLLICLE MATURATION,0.0011199,0.4746,0.33329,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.00013433,0.47445,0.56187,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,5.7413e-06,0.47436,0.43255,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,2.2524e-05,0.47395,0.35358,1,1
1,GO PINOCYTOSIS,4.3763e-07,0.47321,0.6138,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,3.6228e-06,0.47275,0.47175,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00092958,0.4724,0.34317,1,1
1,GO REGULATION OF TRANSPOSITION,0.00074557,0.47114,0.42421,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017796,0.47112,0.38646,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,9.3916e-06,0.47109,0.48614,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,5.7413e-06,0.47004,0.41467,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.5427e-07,0.46997,0.44826,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00084609,0.46959,0.5178,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00032948,0.46759,0.55347,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,6.7596e-05,0.46682,0.41295,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,2.8418e-05,0.46674,0.45041,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0031536,0.46592,0.3599,1,1
1,GO HYALURONAN METABOLIC PROCESS,0.00057693,0.4653,0.41293,1,1
1,GO MATURATION OF LSU RRNA,3.4421e-05,0.46526,0.43546,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,5.0226e-05,0.46466,0.45385,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00023468,0.46432,0.40627,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00041602,0.46362,0.53531,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0033369,0.46336,0.3715,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,2.9301e-06,0.46315,0.40489,1,1
1,GO BLOOD VESSEL REMODELING,0.00038934,0.46169,0.38287,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.0226e-05,0.46006,0.3728,1,1
1,GO VASCULAR TRANSPORT,0.010773,0.45944,0.48247,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,2.0784e-06,0.45851,0.53559,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,5.986e-08,0.45798,0.57621,1,1
1,GO VIRAL RNA GENOME REPLICATION,1.7806e-05,0.45743,0.39811,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.0184e-05,0.45741,0.42617,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,6.2786e-05,0.45732,0.49397,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.0013872,0.45708,0.37524,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,6.8936e-07,0.45701,0.42799,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00010462,0.45558,0.3937,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,5.0226e-05,0.45501,0.40837,1,1
1,GO PROTEASOME ASSEMBLY,9.7801e-06,0.45437,0.36929,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,3.9418e-06,0.45382,0.42082,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00035231,0.45355,0.36823,1,1
1,GO LYMPHANGIOGENESIS,2.6307e-05,0.45312,0.43197,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00010845,0.45309,0.566,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0037331,0.45272,0.31321,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,5.8301e-05,0.4525,0.3613,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,7.547e-05,0.45187,0.35253,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.02068,0.45146,0.27093,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.00013917,0.45014,0.44052,1,1
1,GO ZYMOGEN ACTIVATION,0.00013433,0.4498,0.46531,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.1888e-05,0.44959,0.41967,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,4.8379e-05,0.44939,0.37433,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.001662,0.4477,0.4105,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,2.4346e-05,0.44693,0.39313,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0042883,0.44665,0.35545,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,1.2862e-06,0.44643,0.44712,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.8521e-05,0.44636,0.35093,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,7.0571e-06,0.44634,0.36313,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,5.2837e-06,0.44554,0.47337,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0016129,0.44472,0.4285,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,7.6603e-06,0.44429,0.35908,1,1
1,GO T CELL MEDIATED IMMUNITY,1.6455e-05,0.44399,0.44019,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.9418e-06,0.44195,0.44942,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,4.1112e-06,0.44187,0.36826,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.0099891,0.44142,0.42713,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,8.3127e-06,0.44108,0.52002,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,3.4728e-06,0.43986,0.45943,1,1
1,GO CELLULAR RESPONSE TO IRON ION,0.00065623,0.43798,0.44836,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00069957,0.43773,0.3929,1,1
1,GO DEFENSE RESPONSE TO VIRUS,5.0226e-05,0.43748,0.38821,1,1
1,GO REGULATION OF MYOBLAST FUSION,2.8418e-05,0.43551,0.5295,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,3.1888e-05,0.4354,0.3623,1,1
1,GO CYTOKINE METABOLIC PROCESS,5.7413e-06,0.43528,0.38692,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00011241,0.43489,0.35804,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.7118e-05,0.43475,0.38092,1,1
1,GO TYPE I INTERFERON PRODUCTION,2.6307e-05,0.43431,0.32374,1,1
1,GO PROTEIN ACTIVATION CASCADE,6.0504e-05,0.43358,0.33842,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,4.6597e-05,0.43259,0.42029,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,2.5308e-05,0.43222,0.45964,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,3.0576e-06,0.43197,0.42723,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.00020448,0.43182,0.46406,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,8.4205e-05,0.43172,0.40175,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00052342,0.4317,0.59067,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00041602,0.43066,0.588,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.1702e-06,0.43063,0.41276,1,1
1,GO PLATELET AGGREGATION,3.9418e-06,0.42999,0.36779,1,1
1,GO RESPONSE TO HYPEROXIA,0.0010206,0.42895,0.3871,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00029782,0.42878,0.35594,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.6307e-05,0.42834,0.46916,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,3.0689e-05,0.42819,0.38271,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00072223,0.42792,0.3295,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,1.1267e-06,0.42778,0.48554,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,3.3287e-06,0.42704,0.51867,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.022165,0.42704,0.34952,1,1
1,GO RIBOSOME ASSEMBLY,0.00024286,0.42689,0.3497,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00059588,0.42516,0.36825,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00017186,0.42445,0.37402,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00024286,0.42438,0.42738,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.1904e-06,0.42407,0.49715,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,2.5308e-05,0.42354,0.39264,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,6.5896e-07,0.42324,0.39679,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,2.9532e-05,0.42319,0.41115,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00035231,0.42266,0.36727,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,5.6174e-05,0.42213,0.35591,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00034072,0.42118,0.48596,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.6228e-06,0.42029,0.47223,1,1
1,GO RIG I SIGNALING PATHWAY,1.2308e-06,0.42013,0.42217,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0007696,0.41998,0.32896,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,3.17e-07,0.41976,0.37884,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,2.1702e-06,0.41965,0.3618,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00030804,0.41962,0.42806,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,9.0179e-06,0.41924,0.44085,1,1
1,GO RESPONSE TO INTERFERON GAMMA,6.7596e-05,0.41907,0.4504,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.013e-05,0.4188,0.37173,1,1
1,GO ENAMEL MINERALIZATION,0.0023671,0.4175,0.39553,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,6.4994e-06,0.41743,0.35322,1,1
1,GO INTERLEUKIN 1 PRODUCTION,6.5149e-05,0.41731,0.42745,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,0.0029794,0.41636,0.35585,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.8521e-05,0.41634,0.37541,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.0604e-05,0.4163,0.49943,1,1
1,GO NIK NF KAPPAB SIGNALING,2.3975e-07,0.41583,0.41891,1,1
1,GO RESPONSE TO INTERLEUKIN 12,1.2862e-06,0.41524,0.40942,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.0033e-05,0.41479,0.39851,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,3.7145e-05,0.41397,0.43676,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,6.2786e-05,0.41374,0.32954,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010462,0.41326,0.32554,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,6.4994e-06,0.41222,0.37462,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.4609e-05,0.41215,0.37737,1,1
1,GO VIRAL TRANSLATION,8.3127e-06,0.41209,0.40113,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.00017796,0.41167,0.38638,1,1
1,GO INTERFERON BETA PRODUCTION,0.00028792,0.41142,0.29094,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00044439,0.41112,0.3662,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00026903,0.41096,0.31868,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.5308e-05,0.41019,0.38181,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.1702e-06,0.40973,0.36644,1,1
1,GO PEPTIDE CROSS LINKING,0.00014418,0.40915,0.41479,1,1
1,GO RESPONSE TO SALT STRESS,5.8301e-05,0.40877,0.33836,1,1
1,GO REGULATION OF MRNA BINDING,3.5759e-05,0.40814,0.35005,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00014418,0.40814,0.42286,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,9.0179e-06,0.40786,0.36058,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00031859,0.40708,0.40465,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,2.3654e-06,0.40661,0.45676,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.3528e-06,0.40585,0.37122,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.017549,0.40564,0.25729,1,1
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00074557,0.40549,0.38426,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.014138,0.40547,0.24713,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,2.8077e-06,0.40446,0.39325,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00012964,0.40416,0.39912,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0007696,0.40416,0.4134,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0060989,0.40414,0.38711,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0075304,0.4034,0.2807,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,2.3654e-06,0.40325,0.50001,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,8.1192e-05,0.40277,0.31562,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00025131,0.40267,0.37434,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,5.7413e-06,0.40259,0.36302,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.0194e-07,0.40247,0.44664,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00049035,0.40197,0.37879,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00011241,0.4013,0.32563,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00012512,0.40103,0.32796,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.0829e-07,0.40024,0.37577,1,1
1,GO INTERLEUKIN 8 PRODUCTION,1.104e-05,0.40007,0.38686,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0017641,0.39942,0.35823,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,0.00026903,0.39886,0.5765,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,6.2985e-07,0.39783,0.39293,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,5.9841e-06,0.39555,0.39463,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00050664,0.39517,0.37929,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,1.6455e-05,0.39374,0.33596,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00020448,0.39326,0.39399,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00353,0.39324,0.29497,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00020448,0.39213,0.33452,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,3.5759e-05,0.39202,0.44151,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00034072,0.39137,0.33879,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00059588,0.38996,0.33874,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00017796,0.38981,0.41786,1,1
1,GO I KAPPAB PHOSPHORYLATION,0.00019079,0.38911,0.27387,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.6455e-05,0.38812,0.35451,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.3287e-06,0.38802,0.38266,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00014418,0.38793,0.44647,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.3654e-06,0.38731,0.35839,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,9.7801e-06,0.38699,0.38555,1,1
1,GO ARGININE METABOLIC PROCESS,0.0006154,0.38692,0.35517,1,1
1,GO ANIMAL ORGAN REGENERATION,4.0073e-05,0.38657,0.41983,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.3441e-06,0.38657,0.36958,1,1
1,GO RESPONSE TO ESTROGEN,9.0221e-07,0.38605,0.38119,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,0.00095906,0.38584,0.50672,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.5331e-06,0.38382,0.37193,1,1
1,GO ERBB2 SIGNALING PATHWAY,3.5759e-05,0.38381,0.32344,1,1
1,GO IMMATURE T CELL PROLIFERATION,0.00010092,0.3835,0.43102,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,9.389e-05,0.38349,0.43474,1,1
1,GO T CELL APOPTOTIC PROCESS,2.6902e-06,0.3831,0.35687,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.6228e-06,0.38288,0.35237,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.6597e-05,0.38263,0.32527,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00019079,0.38245,0.35777,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,2.2879e-07,0.38216,0.36336,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00035231,0.38197,0.31249,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.2754e-05,0.38189,0.33714,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0024367,0.38078,0.33635,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,2.4692e-06,0.38061,0.32855,1,1
1,GO MATURATION OF 5 8S RRNA,0.00013433,0.38036,0.3235,1,1
1,GO EMBRYO IMPLANTATION,1.349e-05,0.38029,0.45298,1,1
1,GO AORTIC VALVE DEVELOPMENT,0.00047456,0.38022,0.38993,1,1
1,GO VIRAL LIFE CYCLE,1.6015e-06,0.37964,0.38751,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,8.7323e-05,0.3792,0.38873,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,0.00026003,0.37907,0.37146,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,3.4772e-07,0.3785,0.49066,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.7343e-05,0.37758,0.40848,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,6.5149e-05,0.37717,0.37394,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,4.4712e-06,0.37702,0.35211,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0081404,0.37698,0.29958,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,0.00014935,0.37681,0.34428,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.0010206,0.37609,0.29272,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0014299,0.37539,0.33708,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0025817,0.37515,0.39316,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,9.3916e-06,0.37484,0.35914,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,3.8583e-05,0.37424,0.32326,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00010845,0.37407,0.34837,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00018427,0.37329,0.3228,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.4346e-05,0.37311,0.36972,1,1
1,GO MUSCLE FILAMENT SLIDING,0.00081984,0.37288,0.28691,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,2.7343e-05,0.3719,0.32281,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,8.4205e-05,0.37172,0.35973,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.5331e-06,0.37093,0.34489,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,3.5759e-05,0.37033,0.41627,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,2.5774e-06,0.37029,0.3434,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.7806e-05,0.36936,0.32184,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0013457,0.36913,0.38082,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,8.7323e-05,0.36896,0.40233,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.1663e-05,0.36874,0.343,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,7.9801e-06,0.36865,0.31596,1,1
1,GO NECROTIC CELL DEATH,4.1112e-06,0.36814,0.44593,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00081984,0.36799,0.28299,1,1
1,GO PENTOSE METABOLIC PROCESS,0.00024286,0.36797,0.33323,1,1
1,GO COPPER ION HOMEOSTASIS,3.4728e-06,0.3673,0.48764,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0056288,0.36694,0.26514,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00055855,0.36672,0.37102,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.001191,0.36662,0.35455,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0015189,0.36644,0.36814,1,1
1,GO SNRNA PROCESSING,0.0022992,0.36635,0.54944,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.1888e-05,0.366,0.33115,1,1
1,GO MEMBRANE INVAGINATION,0.00012964,0.36568,0.2944,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00025131,0.36564,0.37206,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.8612e-06,0.36556,0.37817,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,2.6307e-05,0.36524,0.36146,1,1
1,GO NCRNA PROCESSING,5.0226e-05,0.36512,0.27569,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00022676,0.36469,0.31645,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00041602,0.36445,0.33006,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00021909,0.36311,0.33094,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0033369,0.36296,0.36455,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,7.8282e-05,0.36261,0.31856,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0010206,0.36223,0.3005,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,1.5816e-05,0.36166,0.52746,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,0.0017123,0.36132,0.29715,1,1
1,GO CRISTAE FORMATION,0.0029794,0.36054,0.24261,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,9.7801e-06,0.35955,0.32196,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.0040578,0.35893,0.25076,1,1
1,GO INTERACTION WITH HOST,2.0784e-06,0.3588,0.39129,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,2.1663e-05,0.35848,0.30594,1,1
1,GO TRANSLATIONAL TERMINATION,6.2786e-05,0.35841,0.28834,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0001165,0.35821,0.26886,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,5.4121e-05,0.35803,0.35521,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.8077e-06,0.35759,0.34389,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0028141,0.35747,0.30386,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.4421e-05,0.3573,0.36868,1,1
1,GO BONE GROWTH,0.0022332,0.35588,0.32952,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0022332,0.35573,0.36319,1,1
1,GO RIBOSOME BIOGENESIS,0.00014935,0.35553,0.28966,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,4.5813e-07,0.35527,0.37973,1,1
1,GO REGULATION OF STEROL TRANSPORT,0.00010462,0.35505,0.30199,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,2.9301e-06,0.35458,0.30137,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00074557,0.35432,0.26522,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,4.0073e-05,0.35427,0.33647,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0001547,0.35415,0.29796,1,1
1,GO REGULATION OF GASTRULATION,1.4609e-05,0.35369,0.3503,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.0027346,0.35364,0.27771,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.010773,0.35323,0.2807,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.036164,0.35251,0.22252,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.018836,0.35247,0.42294,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,7.013e-05,0.35211,0.41758,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.00014418,0.35194,0.40083,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00013433,0.35188,0.36577,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,4.1112e-06,0.35119,0.33568,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0046564,0.35108,0.28961,1,1
1,GO RESPONSE TO MANGANESE ION,1.349e-05,0.35094,0.35314,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00041602,0.35078,0.30303,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,3.4728e-06,0.35069,0.32548,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00017186,0.34928,0.33639,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,6.7728e-06,0.34904,0.31672,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00044439,0.34868,0.31277,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,7.0571e-06,0.348,0.3209,1,1
1,GO ERAD PATHWAY,2.6307e-05,0.348,0.26441,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00022676,0.3478,0.3283,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0013457,0.34769,0.37874,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.7343e-05,0.34748,0.33947,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00022676,0.34716,0.37858,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00032948,0.34693,0.36141,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00057693,0.34661,0.28937,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0007696,0.34653,0.28703,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0007696,0.34483,0.29646,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,3.4421e-05,0.34481,0.28857,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0021689,0.34378,0.28291,1,1
1,GO NCRNA 3 END PROCESSING,0.0028957,0.34296,0.3773,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,0.00012074,0.34295,0.38174,1,1
1,GO RRNA METABOLIC PROCESS,0.00019079,0.34139,0.26919,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.00020448,0.34056,0.45438,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00044439,0.34004,0.31269,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.02268,0.33993,0.25443,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00353,0.33988,0.26277,1,1
1,GO VIRAL GENE EXPRESSION,2.3418e-05,0.33947,0.34981,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00052342,0.33933,0.31933,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.0226e-05,0.33897,0.29616,1,1
1,GO RESPONSE TO PROGESTERONE,0.0087944,0.33875,0.26684,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00028792,0.3383,0.34277,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,2.1663e-05,0.33744,0.26722,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00010092,0.33723,0.26503,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.2962e-05,0.33704,0.37509,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.011904,0.33682,0.22492,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00052342,0.33578,0.33275,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0013054,0.33571,0.34067,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.00042998,0.33543,0.3076,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0049174,0.33518,0.36148,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.2524e-05,0.33491,0.29627,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00014418,0.33477,0.37042,1,1
1,GO REGULATION OF PHAGOCYTOSIS,8.7323e-05,0.33447,0.33081,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.2524e-05,0.33393,0.30867,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0036303,0.33352,0.30341,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,5.4121e-05,0.33269,0.29134,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.038561,0.33189,0.32434,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00017796,0.33137,0.38507,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00026903,0.33127,0.30421,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0046564,0.33107,0.27857,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,6.7596e-05,0.33074,0.36454,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.014138,0.33058,0.24751,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,0.0021689,0.33052,0.33501,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.024288,0.33037,0.21746,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0014299,0.32954,0.31256,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00019079,0.32929,0.30411,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.007729,0.32892,0.30623,1,1
1,GO RESPONSE TO VIRUS,4.1617e-05,0.32885,0.32696,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0025083,0.32858,0.34465,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0029794,0.32832,0.29623,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00027832,0.32795,0.288,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,3.7145e-05,0.32793,0.46488,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00072223,0.32793,0.30609,1,1
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.038561,0.3275,0.27293,1,1
1,GO INTERLEUKIN 17 PRODUCTION,2.5308e-05,0.32749,0.43152,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.2454e-05,0.32743,0.44722,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,5.2533e-07,0.32728,0.33682,1,1
1,GO PIGMENT ACCUMULATION,0.00047456,0.32724,0.27417,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.011326,0.32617,0.36068,1,1
1,GO PRIMARY MIRNA PROCESSING,0.00014418,0.32507,0.35988,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,1.5201e-05,0.32507,0.30294,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.2454e-05,0.3245,0.40936,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00035231,0.32398,0.39674,1,1
1,GO B CELL MEDIATED IMMUNITY,5.2139e-05,0.32382,0.29005,1,1
1,GO SNRNA METABOLIC PROCESS,0.00084609,0.32355,0.44013,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,3.8583e-05,0.32338,0.31049,1,1
1,GO MESODERM MORPHOGENESIS,2.0833e-05,0.32325,0.30431,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0018173,0.32281,0.281,1,1
1,GO RNA 5 END PROCESSING,0.00012074,0.3228,0.29727,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.8077e-06,0.32273,0.38344,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00052342,0.32248,0.30335,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.4878e-05,0.32225,0.4387,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.4728e-06,0.32181,0.31898,1,1
1,GO TRANSLATIONAL INITIATION,0.00032948,0.32166,0.29504,1,1
1,GO PEPTIDE CATABOLIC PROCESS,0.00026003,0.32074,0.24963,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.0050528,0.31971,0.30666,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0006154,0.31962,0.24848,1,1
1,GO CELL REDOX HOMEOSTASIS,1.5201e-05,0.31955,0.293,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00012964,0.3194,0.33488,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0010859,0.31924,0.21539,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0016129,0.3189,0.37544,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00020448,0.31884,0.37135,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,8.2505e-07,0.31874,0.33074,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0064317,0.31867,0.54113,1,1
1,GO SPROUTING ANGIOGENESIS,2.4346e-05,0.31812,0.33445,1,1
1,GO CYTOKINETIC PROCESS,2.0833e-05,0.31726,0.2949,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.004408,0.31722,0.28121,1,1
1,GO GASTRULATION,3.7145e-05,0.31715,0.29991,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.00012074,0.31694,0.26127,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.0012662,0.31683,0.22138,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.004408,0.31647,0.28927,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,9.0551e-05,0.3159,0.27924,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010462,0.31513,0.25221,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.5816e-05,0.31461,0.31204,1,1
1,GO NCRNA METABOLIC PROCESS,7.8282e-05,0.31443,0.24528,1,1
1,GO INNATE IMMUNE RESPONSE,7.013e-05,0.31441,0.24956,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.00038934,0.31441,0.38643,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,0.00021167,0.31386,0.33291,1,1
1,GO VESICLE CARGO LOADING,2.2524e-05,0.31358,0.29499,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0018173,0.31351,0.26164,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.547e-05,0.31346,0.25566,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0025083,0.31324,0.28291,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00050664,0.31311,0.29786,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,4.6623e-06,0.31228,0.28167,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00065623,0.3114,0.45373,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.001662,0.31045,0.32096,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.023205,0.30976,0.27112,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.0025083,0.30964,0.24157,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.8583e-05,0.3094,0.34669,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.011612,0.30928,0.23967,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.2524e-05,0.30918,0.27956,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.00014418,0.30892,0.25946,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.00010845,0.30888,0.25345,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00028792,0.30883,0.24502,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,5.2533e-07,0.30854,0.31614,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.00026003,0.30834,0.24685,1,1
1,GO ACUTE PHASE RESPONSE,0.0046564,0.30828,0.27178,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0051916,0.30801,0.27816,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,9.0551e-05,0.308,0.26331,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0018173,0.30708,0.28575,1,1
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00014935,0.30708,0.26973,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00010845,0.30679,0.25632,1,1
1,GO TRNA 5 LEADER REMOVAL,3.8583e-05,0.30644,0.35312,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,6.5149e-05,0.30635,0.27563,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,1.8521e-05,0.30552,0.29674,1,1
1,GO RESPONSE TO INTERLEUKIN 1,5.0683e-06,0.3052,0.32859,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00042998,0.30503,0.26317,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00018427,0.30483,0.30812,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00050664,0.30448,0.30629,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,9.7346e-05,0.30439,0.36198,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00012074,0.30412,0.25615,1,1
1,GO ACTIN FILAMENT SEVERING,0.001228,0.30394,0.40041,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00012074,0.30376,0.32865,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0094949,0.30363,0.27101,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00050664,0.30351,0.27449,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.014486,0.30285,0.20609,1,1
1,GO MULTI ORGANISM LOCALIZATION,1.2971e-07,0.30285,0.39001,1,1
1,GO PIGMENT METABOLIC PROCESS,2.0033e-05,0.3028,0.26404,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.010506,0.3027,0.21381,1,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.0057817,0.30262,0.278,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9532e-05,0.30225,0.32978,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,6.8936e-07,0.30217,0.35077,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0051916,0.30214,0.30739,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0014738,0.30213,0.31581,1,1
1,GO FOCAL ADHESION ASSEMBLY,0.0012662,0.30173,0.30657,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0028141,0.3015,0.25417,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0047853,0.30123,0.17569,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.031059,0.30122,0.26901,1,1
1,GO MACROPHAGE MIGRATION,5.9841e-06,0.30081,0.35095,1,1
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.001662,0.30016,0.30508,1,1
1,GO T CELL CYTOKINE PRODUCTION,4.3218e-05,0.29996,0.38592,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0010859,0.29948,0.32924,1,1
1,GO RRNA MODIFICATION,0.0014738,0.2993,0.21884,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.0041716,0.2991,0.34759,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00065623,0.29882,0.26223,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0040578,0.2987,0.34746,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.00024286,0.29837,0.36513,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,7.3528e-06,0.29831,0.29938,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.012203,0.29821,0.17609,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0001547,0.29803,0.29255,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00072223,0.29798,0.17057,1,1
1,GO HISTONE PHOSPHORYLATION,8.4205e-05,0.29794,0.25743,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,6.7596e-05,0.29777,0.28859,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0028141,0.29765,0.31681,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0029794,0.29761,0.28193,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,6.2367e-06,0.29746,0.33508,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,7.013e-05,0.29734,0.31639,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001191,0.29678,0.2407,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.5759e-05,0.29675,0.34083,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,6.2786e-05,0.29644,0.30952,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0010859,0.29638,0.23484,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00021167,0.29619,0.39117,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0024367,0.29589,0.29909,1,1
1,GO RESPONSE TO CADMIUM ION,0.045624,0.29579,0.18426,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0025083,0.29549,0.53188,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.1112e-06,0.29518,0.42888,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.0022992,0.29502,0.32524,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.2862e-06,0.29489,0.25796,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0066042,0.29484,0.25761,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,8.6584e-06,0.2948,0.26939,1,1
1,GO SELECTIVE AUTOPHAGY,1.5331e-06,0.29472,0.29246,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,1.1493e-05,0.2947,0.30103,1,1
1,GO REGULATION OF CELL AGING,2.8077e-06,0.29407,0.30189,1,1
1,GO SPERM EGG RECOGNITION,0.00029782,0.29368,0.22464,1,1
1,GO INTERACTION WITH SYMBIONT,2.8418e-05,0.29237,0.287,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,6.2367e-06,0.29192,0.31479,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00019079,0.29186,0.28694,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0013054,0.2918,0.28579,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00014418,0.29172,0.2407,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.036948,0.29156,0.31848,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0069616,0.29116,0.22936,1,1
1,GO MYOBLAST DIFFERENTIATION,1.0604e-05,0.29037,0.29841,1,1
1,GO REGENERATION,0.00012964,0.29036,0.24367,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,4.6623e-06,0.29035,0.29085,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00084609,0.29,0.22326,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00010462,0.28993,0.29747,1,1
1,GO HYPOTONIC RESPONSE,0.011326,0.2899,0.24357,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00011241,0.28949,0.28513,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0028957,0.28943,0.22622,1,1
1,GO NATURAL KILLER CELL ACTIVATION,6.2786e-05,0.28942,0.29297,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00010092,0.28934,0.40886,1,1
1,GO MYOBLAST MIGRATION,0.0025083,0.28919,0.43669,1,1
1,GO TRACHEA MORPHOGENESIS,0.0010206,0.28909,0.27175,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,0.00063551,0.28899,0.32352,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00052342,0.28892,0.22939,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00017796,0.28882,0.24901,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,1.2308e-06,0.28881,0.27728,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.041967,0.28867,0.248,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.036164,0.28801,0.25868,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,5.2837e-06,0.28801,0.29963,1,1
1,GO PODOSOME ASSEMBLY,0.00011241,0.28791,0.36568,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.012508,0.2878,0.1751,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00045924,0.28773,0.32644,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00010462,0.28752,0.25008,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.7806e-05,0.2873,0.32018,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,2.1702e-06,0.28707,0.25932,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00020448,0.28706,0.26047,1,1
1,GO SYMBIOTIC PROCESS,6.5896e-07,0.28705,0.26923,1,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.046579,0.28694,0.2399,1,1
1,GO CELLULAR RESPONSE TO VIRUS,1.4039e-05,0.28692,0.28818,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00067758,0.2867,0.24568,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00052342,0.28621,0.2522,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0027346,0.28592,0.23685,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.025414,0.28563,0.2444,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.030383,0.28545,0.19204,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,4.8612e-06,0.28518,0.26569,1,1
1,GO FIBROBLAST MIGRATION,0.0011549,0.28499,0.3211,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00049035,0.28496,0.23877,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00016595,0.28439,0.29912,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6623e-06,0.28424,0.3219,1,1
1,GO RNA CATABOLIC PROCESS,1.6015e-06,0.28421,0.25595,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00034072,0.28389,0.28781,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0046564,0.28369,0.2214,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00098941,0.28362,0.19606,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.010245,0.28353,0.18457,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,6.0504e-05,0.28284,0.2696,1,1
1,GO SEQUESTERING OF METAL ION,0.00022676,0.28268,0.2643,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0018173,0.28266,0.28321,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00018427,0.28262,0.25392,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00019079,0.28222,0.2125,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,7.013e-05,0.2822,0.251,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0019282,0.28217,0.31563,1,1
1,GO DECIDUALIZATION,0.02268,0.28206,0.2696,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,2.0833e-05,0.28176,0.34063,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.00052342,0.28086,0.22749,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.3132e-05,0.2806,0.34485,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.011326,0.28033,0.15719,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0001165,0.28031,0.21405,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00010462,0.2802,0.36064,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.004408,0.28009,0.27466,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00092958,0.28,0.22674,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,7.2754e-05,0.27984,0.335,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,0.00014418,0.27967,0.24451,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0013054,0.27944,0.25233,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,5.508e-06,0.27927,0.39524,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.27904,0.28622,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00074557,0.27893,0.29621,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00065623,0.27882,0.22822,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00045924,0.27864,0.28288,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0021689,0.27844,0.21577,1,1
1,GO CELL CELL RECOGNITION,9.7801e-06,0.27838,0.26528,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.0045306,0.27822,0.21205,1,1
1,GO TISSUE REGENERATION,0.00079435,0.2781,0.25002,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.007729,0.27803,0.27382,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00016595,0.27775,0.25053,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.016734,0.27773,0.23361,1,1
1,GO CHEMOKINE PRODUCTION,0.0026572,0.27751,0.23796,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.9263e-05,0.27713,0.26704,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,9.0179e-06,0.27674,0.25307,1,1
1,GO OSTEOCLAST DEVELOPMENT,0.00040247,0.27659,0.34234,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0087944,0.27632,0.21745,1,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.013139,0.27617,0.19782,1,1
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0024367,0.27583,0.20836,1,1
1,GO CELL SUBSTRATE ADHESION,0.00013433,0.27574,0.32014,1,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.010245,0.27563,0.19721,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.5816e-05,0.27514,0.3028,1,1
1,GO TRABECULA FORMATION,0.0090226,0.27477,0.32916,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00021167,0.27467,0.24795,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0010528,0.27428,0.25829,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,6.2786e-05,0.27378,0.21379,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.025994,0.27261,0.18775,1,1
1,GO TRANSLATIONAL ELONGATION,0.0001165,0.27257,0.2405,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00036427,0.27188,0.19954,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0013872,0.27176,0.26353,1,1
1,GO COPPER ION TRANSPORT,0.00012074,0.27168,0.27025,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0012662,0.27146,0.31599,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,0.0001547,0.27126,0.31324,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,1.0779e-06,0.27113,0.27373,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00011241,0.27099,0.22309,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0019282,0.27078,0.31979,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00074557,0.27069,0.35797,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00081984,0.27055,0.2151,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.5816e-05,0.27044,0.22588,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0057817,0.27001,0.22661,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,9.0551e-05,0.27,0.34114,1,1
1,GO PLATELET MORPHOGENESIS,7.013e-05,0.2699,0.25906,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0017123,0.26964,0.24138,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0064317,0.26942,0.21992,1,1
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0023671,0.26937,0.20747,1,1
1,GO STEROL IMPORT,0.00079435,0.26923,0.41577,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.0045306,0.26889,0.22862,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00035231,0.2683,0.30615,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.4421e-05,0.26793,0.30464,1,1
1,GO RESPONSE TO IONIZING RADIATION,5.0683e-06,0.26769,0.22465,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0079323,0.26768,0.17334,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.00087311,0.26757,0.21686,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.4609e-05,0.26755,0.24747,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.00036427,0.26721,0.2327,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,6.7596e-05,0.26714,0.31185,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0064317,0.26694,0.18668,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0025083,0.26675,0.23569,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.0028957,0.26641,0.26407,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00067758,0.26616,0.31827,1,1
1,GO REGULATION OF RNA BINDING,6.5149e-05,0.26612,0.25969,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0013457,0.26583,0.37106,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00022676,0.26537,0.24313,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,9.7346e-05,0.26485,0.23966,1,1
1,GO HISTONE H4 DEACETYLATION,0.0045306,0.26479,0.23682,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00057693,0.26476,0.24249,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.0779e-06,0.26469,0.28323,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00026003,0.26455,0.22406,1,1
1,GO IRON ION HOMEOSTASIS,1.9263e-05,0.26454,0.24204,1,1
1,GO MRNA TRANSCRIPTION,2.8418e-05,0.26419,0.346,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.016734,0.26414,0.20663,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0018173,0.26363,0.34518,1,1
1,GO RESPONSE TO REDOX STATE,0.022165,0.2635,0.21226,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.5308e-05,0.26346,0.36826,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00081984,0.26343,0.22354,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00095906,0.26309,0.22372,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,3.4421e-05,0.26308,0.32659,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00081984,0.26304,0.19504,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.0094949,0.26303,0.2776,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,4.6597e-05,0.26289,0.19563,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00069957,0.2628,0.23501,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00034072,0.26233,0.40224,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00031859,0.26192,0.21101,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.004408,0.26141,0.28939,1,1
1,GO NADP METABOLIC PROCESS,0.010773,0.26127,0.20448,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.03245,0.2611,0.23159,1,1
1,GO AUTOPHAGOSOME MATURATION,0.00017796,0.26096,0.24687,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0013457,0.26095,0.27483,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00026003,0.26077,0.27893,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.02068,0.26068,0.32553,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00052342,0.25986,0.21344,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0013872,0.25984,0.25755,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.00045924,0.25943,0.3593,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.014841,0.25898,0.18167,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.010773,0.25877,0.22113,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00067758,0.25865,0.21537,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00040247,0.25864,0.18181,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0085714,0.25832,0.22524,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0062634,0.25817,0.25752,1,1
1,GO TRNA 5 END PROCESSING,8.1192e-05,0.25778,0.30413,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.014486,0.25728,0.38889,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,0.00013917,0.25695,0.21925,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.0047853,0.25662,0.20962,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00069957,0.25642,0.2321,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.03245,0.25634,0.19199,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,5.0226e-05,0.2563,0.21597,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00072223,0.25587,0.28085,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00013917,0.25568,0.23287,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.03939,0.25513,0.26456,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.4421e-05,0.25504,0.25303,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,2.8418e-05,0.25431,0.23518,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0053338,0.25426,0.28137,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00040247,0.25369,0.1943,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.029068,0.25341,0.19035,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.0604e-05,0.25329,0.26672,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,4.2876e-06,0.25286,0.21214,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.9418e-06,0.25279,0.2203,1,1
1,GO PROTEIN FOLDING,0.0032441,0.25176,0.18179,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.00029782,0.25165,0.23794,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.0013054,0.2516,0.23534,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.9263e-05,0.25145,0.31643,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.036948,0.25089,0.16533,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0014738,0.25077,0.20898,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.3218e-05,0.25055,0.2701,1,1
1,GO RESPONSE TO CYTOKINE,4.3218e-05,0.25042,0.27147,1,1
1,GO MEMBRANE DISASSEMBLY,0.027803,0.25026,0.21685,1,1
1,GO PLATELET ACTIVATION,0.00049035,0.24983,0.22251,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00098941,0.24972,0.19934,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0013054,0.2497,0.1754,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00353,0.24942,0.19847,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.017969,0.24926,0.24529,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,3.5759e-05,0.24925,0.2426,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.011904,0.24921,0.25308,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.00079435,0.24901,0.30337,1,1
1,GO TRNA METHYLATION,0.00024286,0.24895,0.22438,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0087944,0.24872,0.21765,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.0683e-06,0.24866,0.25779,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00011241,0.24849,0.22507,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00028792,0.24835,0.23246,1,1
1,GO FATTY ACID BETA OXIDATION,0.0025083,0.24817,0.21023,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0029794,0.24791,0.29656,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.2454e-05,0.24791,0.29425,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0079323,0.24761,0.24744,1,1
1,GO MITOPHAGY,9.7346e-05,0.24745,0.24782,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0018173,0.24701,0.24113,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0007696,0.24698,0.20294,1,1
1,GO TRNA PROCESSING,0.00047456,0.2469,0.18144,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.001986,0.24682,0.25286,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.3418e-05,0.24665,0.33805,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.047551,0.2466,0.18179,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,6.5149e-05,0.24627,0.21123,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00026903,0.24621,0.40407,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0041716,0.2461,0.21005,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.029068,0.24603,0.33736,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.349e-05,0.24559,0.21804,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,5.8301e-05,0.24548,0.23967,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00049035,0.24505,0.38836,1,1
1,GO METANEPHROS DEVELOPMENT,0.00014935,0.245,0.22233,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00030804,0.24468,0.18995,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00022676,0.24459,0.25139,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0010206,0.24457,0.2337,1,1
1,GO MUSCLE CELL PROLIFERATION,3.8583e-05,0.24455,0.26073,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.029719,0.24436,0.29815,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.0001165,0.24436,0.2496,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,8.7323e-05,0.24432,0.22148,1,1
1,GO RNA DESTABILIZATION,8.1192e-05,0.24431,0.22225,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.029719,0.24429,0.15649,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.02166,0.24402,0.19259,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,2.9532e-05,0.24374,0.23223,1,1
1,GO VASCULATURE DEVELOPMENT,0.00010092,0.24367,0.25431,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.0001165,0.24349,0.21683,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0031536,0.24281,0.22708,1,1
1,GO ASTROCYTE ACTIVATION,0.0085714,0.24249,0.26238,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0032441,0.24249,0.20362,1,1
1,GO RESPONSE TO GAMMA RADIATION,4.4878e-05,0.24248,0.21214,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0064317,0.24188,0.21611,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00013917,0.24163,0.24703,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00049035,0.24144,0.18548,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,0.00010462,0.24138,0.26014,1,1
1,GO DNA DEALKYLATION,0.0025083,0.24137,0.22803,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,0.00021909,0.24136,0.24276,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0017641,0.24102,0.32778,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00018427,0.24102,0.28326,1,1
1,GO TONGUE MORPHOGENESIS,0.038561,0.24098,0.25813,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,3.7145e-05,0.2406,0.23154,1,1
1,GO REGULATION OF ORGAN GROWTH,1.104e-05,0.24039,0.25823,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.00028792,0.24,0.17836,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00052342,0.23988,0.20023,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0022332,0.23979,0.23846,1,1
1,GO PHAGOCYTOSIS,2.2524e-05,0.23925,0.28826,1,1
1,GO POSITIVE REGULATION OF COAGULATION,0.0073363,0.23845,0.25654,1,1
1,GO NEPHRON TUBULE FORMATION,0.033166,0.23827,0.23854,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0007696,0.23763,0.22703,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.011047,0.23749,0.21386,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.01282,0.23741,0.1962,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.001662,0.23732,0.24924,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00024286,0.23699,0.33959,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.018398,0.23667,0.27949,1,1
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0011549,0.23658,0.24658,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.4712e-06,0.23637,0.20976,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00059588,0.23619,0.33256,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.033894,0.23608,0.15266,1,1
1,GO NUCLEOSIDE SALVAGE,0.0075304,0.23576,0.39315,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00042998,0.23541,0.26977,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00067758,0.2354,0.24148,1,1
1,GO CHOLESTEROL EFFLUX,0.0011199,0.23526,0.2219,1,1
1,GO RESPONSE TO LEPTIN,0.027803,0.23484,0.17814,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00049035,0.23423,0.36125,1,1
1,GO REGULATION OF GENE SILENCING,4.4712e-06,0.2341,0.2345,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0087944,0.23395,0.25128,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.02166,0.23377,0.23884,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0031536,0.23373,0.21367,1,1
1,GO MESODERM DEVELOPMENT,7.8282e-05,0.23369,0.18643,1,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0025083,0.23364,0.18281,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00021167,0.23303,0.23508,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.0014738,0.23279,0.21005,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00021167,0.23262,0.29818,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,9.7346e-05,0.23253,0.19718,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.8583e-05,0.23227,0.28285,1,1
1,GO RESPONSE TO CORTICOSTEROID,0.0017641,0.23224,0.20195,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.0024367,0.23217,0.22579,1,1
1,GO VIRION ASSEMBLY,4.0073e-05,0.23214,0.20991,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,6.2367e-06,0.232,0.19864,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0016129,0.23199,0.23835,1,1
1,GO AXIS ELONGATION,0.011612,0.23132,0.20925,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00067758,0.23077,0.19744,1,1
1,GO RNA MODIFICATION,0.00012964,0.23061,0.18902,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0017641,0.23052,0.28332,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0042883,0.23048,0.25386,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.029068,0.2297,0.19076,1,1
1,GO RNA 3 END PROCESSING,9.0551e-05,0.22955,0.19551,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.031059,0.22915,0.13324,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.02068,0.2291,0.14685,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.014841,0.22887,0.27572,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0083534,0.22849,0.18279,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.00026903,0.22824,0.26694,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,7.8282e-05,0.22821,0.18525,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.011326,0.22807,0.22446,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,5.0226e-05,0.22807,0.22907,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0051916,0.22801,0.16725,1,1
1,GO PEPTIDE METABOLIC PROCESS,1.2962e-05,0.22794,0.19896,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00069957,0.22792,0.23503,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.013465,0.22789,0.26544,1,1
1,GO CERAMIDE TRANSPORT,0.013798,0.22783,0.23329,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.017969,0.22769,0.22581,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,9.0179e-06,0.22761,0.23047,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.011904,0.22756,0.1948,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0090226,0.22751,0.14636,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00098941,0.22751,0.19469,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,5.6174e-05,0.22728,0.26795,1,1
1,GO RNA POLYADENYLATION,0.00029782,0.22693,0.1778,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.011326,0.22693,0.15988,1,1
1,GO T CELL MIGRATION,0.0024367,0.22646,0.23275,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0014738,0.22612,0.24698,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0029794,0.22598,0.19315,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0022332,0.22594,0.24368,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,2.7343e-05,0.2257,0.28471,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.010506,0.2253,0.36154,1,1
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.03939,0.2252,0.18369,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0010859,0.22506,0.29195,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00087311,0.22467,0.30764,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0025083,0.22425,0.19063,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.1964e-05,0.22392,0.24416,1,1
1,GO T CELL CHEMOTAXIS,0.00023468,0.22383,0.22772,1,1
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.045624,0.22366,0.17362,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00095906,0.22362,0.19699,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.025994,0.22358,0.16946,1,1
1,GO CHONDROCYTE DIFFERENTIATION,0.00087311,0.22355,0.25535,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,5.2139e-05,0.22326,0.22816,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00081984,0.22294,0.21593,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00059588,0.22265,0.20145,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.001228,0.22263,0.24626,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.0025817,0.22208,0.17362,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0010859,0.22159,0.17404,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00013433,0.22142,0.20376,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0071468,0.22126,0.16264,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.3218e-05,0.22106,0.19636,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.013798,0.22105,0.25566,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.001191,0.22105,0.25331,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,9.7346e-05,0.22078,0.17863,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0079323,0.22044,0.21006,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00047456,0.21998,0.17923,1,1
1,GO OVULATION,0.029719,0.21987,0.24759,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0046564,0.21909,0.20043,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0041716,0.21901,0.2218,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.0031536,0.21805,0.24288,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0042883,0.2177,0.23196,1,1
1,GO TRNA METABOLIC PROCESS,0.00092958,0.21758,0.1713,1,1
1,GO HISTONE H2B UBIQUITINATION,0.0010859,0.21753,0.18054,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,4.0073e-05,0.21731,0.2188,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.019739,0.21706,0.13987,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.016339,0.21699,0.23305,1,1
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0021689,0.21655,0.18537,1,1
1,GO PLASMA MEMBRANE FUSION,0.038561,0.21637,0.18604,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00055855,0.21597,0.24373,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.031059,0.21595,0.2523,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00050664,0.21583,0.19415,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00013433,0.21578,0.2357,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.0085714,0.21565,0.14756,1,1
1,GO LYMPHOCYTE MIGRATION,0.0036303,0.21563,0.17783,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0012662,0.21533,0.21485,1,1
1,GO VESICLE TARGETING,9.0551e-05,0.21491,0.21606,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0022992,0.21456,0.20341,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.0024367,0.21427,0.17936,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00012964,0.21391,0.23239,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0083534,0.21379,0.18787,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0025083,0.21352,0.16801,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.02268,0.21336,0.15972,1,1
1,GO RRNA METHYLATION,0.02068,0.213,0.13833,1,1
1,GO TRNA MODIFICATION,0.00087311,0.21222,0.17432,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.017969,0.21218,0.18157,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,8.4205e-05,0.21213,0.23321,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00084609,0.21196,0.17653,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0039469,0.21168,0.17946,1,1
1,GO RESPONSE TO RETINOIC ACID,0.0013872,0.21128,0.1883,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,6.2367e-06,0.21113,0.22291,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,6.2786e-05,0.21094,0.17007,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.001872,0.21078,0.19515,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0051916,0.21014,0.21399,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.03939,0.2101,0.1343,1,1
1,GO RUFFLE ORGANIZATION,0.00049035,0.21008,0.16896,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0036303,0.21008,0.18662,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,4.6597e-05,0.21002,0.20531,1,1
1,GO REGULATION OF IMMUNE RESPONSE,0.00012074,0.20963,0.1947,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00037661,0.20907,0.18054,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.00090094,0.20902,0.21061,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.043763,0.20859,0.17521,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.014138,0.20852,0.15867,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.00050664,0.20838,0.2202,1,1
1,GO RESPONSE TO DSRNA,0.00020448,0.2082,0.30648,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0028957,0.20736,0.2873,1,1
1,GO BODY FLUID SECRETION,0.00026003,0.20724,0.21223,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.044685,0.20707,0.14707,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.001872,0.2069,0.19399,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.4728e-06,0.20677,0.19052,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,3.7145e-05,0.20632,0.1972,1,1
1,GO OSTEOCLAST DIFFERENTIATION,0.00025131,0.20608,0.18491,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0097392,0.20588,0.17321,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0049174,0.20588,0.18847,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0062634,0.20582,0.22953,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,2.3418e-05,0.20553,0.21665,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0099891,0.20534,0.16932,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.011904,0.20495,0.22643,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.0016129,0.20472,0.25549,1,1
1,GO CELLULAR RESPONSE TO ATP,0.00017186,0.20426,0.21767,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.0042883,0.20357,0.18547,1,1
1,GO MIDBODY ABSCISSION,0.0026572,0.2034,0.21377,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,1.349e-05,0.20279,0.17382,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0012662,0.20275,0.23426,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0029794,0.20271,0.20361,1,1
1,GO STRESS FIBER ASSEMBLY,0.0028141,0.20259,0.19794,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00079435,0.20228,0.15712,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.011326,0.20215,0.19307,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.010773,0.20199,0.23598,1,1
1,GO NUCLEAR EXPORT,9.0179e-06,0.20099,0.18942,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00024286,0.20093,0.24628,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00014935,0.20073,0.19602,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0037331,0.20046,0.18697,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00034072,0.20039,0.22491,1,1
1,GO GENITALIA MORPHOGENESIS,0.036164,0.20029,0.19198,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0039469,0.20028,0.2721,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.0001165,0.20019,0.22614,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00052342,0.20005,0.21182,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,5.0226e-05,0.19935,0.20845,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00054072,0.19931,0.25376,1,1
1,GO RNA LOCALIZATION,0.00019753,0.19872,0.17885,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.001986,0.19867,0.19727,1,1
1,GO REGULATION OF HEMOPOIESIS,4.0073e-05,0.19814,0.18912,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,4.3218e-05,0.19803,0.20469,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00072223,0.19791,0.19223,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.019739,0.19781,0.1865,1,1
1,GO RNA METHYLATION,0.00049035,0.19755,0.18085,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.014138,0.19748,0.15508,1,1
1,GO REGULATION OF URINE VOLUME,0.0030654,0.19708,0.19915,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,5.0226e-05,0.19683,0.1986,1,1
1,GO LACTATION,0.0034322,0.1965,0.19238,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.0054795,0.19596,0.1396,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0067808,0.19587,0.17803,1,1
1,GO TONGUE DEVELOPMENT,0.018398,0.19584,0.20545,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.036948,0.19555,0.14824,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00057693,0.19522,0.1701,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,7.8282e-05,0.19521,0.17127,1,1
1,GO MYELOID CELL HOMEOSTASIS,0.00014935,0.19516,0.18628,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.0013457,0.19504,0.14242,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.9263e-05,0.19501,0.18968,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,3.3132e-05,0.19492,0.20955,1,1
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0045306,0.19429,0.21035,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.016734,0.19377,0.18143,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00063551,0.19376,0.21489,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.024288,0.1933,0.10685,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0001165,0.19304,0.18022,1,1
1,GO RNA INTERFERENCE,0.025414,0.19302,0.17157,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0045306,0.19291,0.13831,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00013433,0.19256,0.21236,1,1
1,GO MITOTIC CYTOKINESIS,0.007729,0.19225,0.15498,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0011199,0.19181,0.22747,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0018173,0.19172,0.14958,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,8.3127e-06,0.19162,0.201,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.019739,0.19104,0.17425,1,1
1,GO ORGANELLE INHERITANCE,0.0010206,0.19036,0.17848,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.0071468,0.19033,0.23091,1,1
1,GO CELL AGING,6.2367e-06,0.19015,0.2108,1,1
1,GO PROTEIN DENEDDYLATION,0.040234,0.18983,0.12338,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0085714,0.18975,0.26929,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00012074,0.18969,0.17852,1,1
1,GO ELECTRON TRANSPORT CHAIN,0.001662,0.18921,0.13859,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00084609,0.18884,0.19295,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.012508,0.18873,0.16258,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.037747,0.18866,0.15735,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00016595,0.18833,0.17509,1,1
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.041967,0.18741,0.16122,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00027832,0.1872,0.17047,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0094949,0.18715,0.12199,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00019079,0.18695,0.20536,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00028792,0.18678,0.1998,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00050664,0.18678,0.17459,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0011549,0.18676,0.17221,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0049174,0.1863,0.1686,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0047853,0.18623,0.16783,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00081984,0.18622,0.24604,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00025131,0.18551,0.17285,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0011199,0.18542,0.21398,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.00092958,0.18497,0.15357,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0042883,0.1849,0.19852,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,4.8379e-05,0.18486,0.16195,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00021909,0.18473,0.18114,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00067758,0.18427,0.22334,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,4.0073e-05,0.18418,0.20227,1,1
1,GO VACUOLAR ACIDIFICATION,0.017137,0.18411,0.1549,1,1
1,GO REGULATION OF HEART GROWTH,0.0011549,0.1837,0.19485,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0050528,0.18365,0.18106,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0075304,0.18334,0.16621,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00092958,0.18319,0.14603,1,1
1,GO CARTILAGE DEVELOPMENT,0.0032441,0.18265,0.20508,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,6.0504e-05,0.18213,0.17467,1,1
1,GO GOLGI VESICLE BUDDING,0.0006154,0.18208,0.17306,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.5774e-06,0.18157,0.17648,1,1
1,GO CENTRIOLE ASSEMBLY,0.0045306,0.1811,0.12464,1,1
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.027188,0.18109,0.22431,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.03245,0.18075,0.18035,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0039469,0.18074,0.22662,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0062634,0.18033,0.22415,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0028957,0.18006,0.16001,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0014299,0.17994,0.25563,1,1
1,GO RNA CAPPING,9.7346e-05,0.17984,0.17231,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00026003,0.17948,0.15684,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0021689,0.1794,0.16625,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.00026003,0.17924,0.17391,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00026903,0.17907,0.19117,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0028141,0.17879,0.14699,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.03939,0.1785,0.21582,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00090094,0.1784,0.14403,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.010245,0.17824,0.16189,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,3.4728e-06,0.1769,0.16851,1,1
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.012508,0.17678,0.15212,1,1
1,GO RNA PROCESSING,0.00026903,0.17656,0.1497,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,3.4421e-05,0.17626,0.19546,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.0042883,0.17615,0.18698,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.0075304,0.17593,0.21072,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0083534,0.17535,0.16581,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,2.9532e-05,0.17522,0.17455,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,5.8301e-05,0.17459,0.18435,1,1
1,GO PROTEIN TARGETING,0.00041602,0.17441,0.15855,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.0032441,0.17437,0.14872,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.001191,0.17413,0.16361,1,1
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.019739,0.17334,0.15364,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0022992,0.17318,0.12531,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00067758,0.17275,0.15828,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00024286,0.17203,0.15328,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,1.2454e-05,0.17177,0.20627,1,1
1,GO PROTEIN IMPORT,6.7596e-05,0.1717,0.15154,1,1
1,GO PROTEIN NEDDYLATION,0.0029794,0.1714,0.17124,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018427,0.17104,0.16302,1,1
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.014138,0.17088,0.1261,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0026572,0.1707,0.13882,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,0.00019753,0.17062,0.14768,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0014738,0.17034,0.17843,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.037747,0.16977,0.11694,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.010773,0.1692,0.23229,1,1
1,GO DE NOVO PROTEIN FOLDING,0.036164,0.16867,0.13321,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.043763,0.16805,0.14453,1,1
1,GO IMPORT INTO NUCLEUS,0.00026903,0.16798,0.12344,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00032948,0.1677,0.19436,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.004408,0.16705,0.17952,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.029719,0.16695,0.1382,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.5816e-05,0.16693,0.15452,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.0062634,0.1667,0.14116,1,1
1,GO REGULATION OF MITOPHAGY,0.012508,0.16635,0.1894,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00055855,0.16596,0.17218,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.019283,0.16565,0.15814,1,1
1,GO COPII COATED VESICLE BUDDING,0.001228,0.16531,0.17553,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00079435,0.16525,0.16786,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0030654,0.16511,0.19466,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0028141,0.16487,0.18409,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00065623,0.1648,0.16662,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.015203,0.16464,0.22004,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0057817,0.16395,0.13555,1,1
1,GO NUCLEAR TRANSPORT,3.8583e-05,0.16387,0.13606,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,6.7596e-05,0.1632,0.14,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.0007696,0.16313,0.16151,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00044439,0.16298,0.18409,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.03939,0.16267,0.10693,1,1
1,GO MYELOID CELL DIFFERENTIATION,0.00010845,0.16177,0.1584,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0075304,0.16174,0.098848,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0073363,0.16164,0.13595,1,1
1,GO SPINDLE LOCALIZATION,0.007729,0.16145,0.11819,1,1
1,GO RESPONSE TO STEROID HORMONE,0.0069616,0.16142,0.13181,1,1
1,GO MAINTENANCE OF LOCATION,8.1192e-05,0.16139,0.1647,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,3.3132e-05,0.16106,0.15159,1,1
1,GO TUBE MORPHOGENESIS,0.0010859,0.16096,0.17318,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.0018173,0.16089,0.13617,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.011904,0.16069,0.16482,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.013465,0.16029,0.14523,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0053338,0.16028,0.24338,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.0011199,0.16017,0.18779,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00087311,0.15974,0.16928,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0022992,0.15973,0.14286,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0032441,0.15969,0.28425,1,1
1,GO GLOMERULUS DEVELOPMENT,0.0012662,0.15944,0.2842,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,2.4692e-06,0.15927,0.15215,1,1
1,GO REGULATION OF RESPONSE TO STRESS,0.00042998,0.15876,0.13656,1,1
1,GO RNA STABILIZATION,0.017549,0.15833,0.13386,1,1
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.040234,0.15787,0.12989,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.015203,0.15756,0.11938,1,1
1,GO PROTEIN POLYUBIQUITINATION,2.0833e-05,0.15752,0.14519,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0038387,0.15732,0.11847,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00069957,0.15728,0.17937,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,9.389e-05,0.15693,0.20487,1,1
1,GO MRNA TRANSPORT,0.00013433,0.15679,0.16946,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00038934,0.15671,0.13118,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.027803,0.1565,0.092265,1,1
1,GO HISTONE DEACETYLATION,0.001191,0.15572,0.12142,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0020453,0.15561,0.12826,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0010528,0.15513,0.12676,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0010206,0.15501,0.13526,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.035393,0.15481,0.10105,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00027832,0.15415,0.143,1,1
1,GO VACUOLE ORGANIZATION,0.0026572,0.15413,0.1182,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,2.4692e-06,0.15365,0.15978,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00012074,0.15364,0.15383,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0054795,0.1532,0.27496,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.00047456,0.153,0.18694,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.013798,0.15291,0.14073,1,1
1,GO TELOMERE ORGANIZATION,0.00095906,0.15251,0.12157,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00035231,0.15213,0.16199,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0087944,0.1519,0.20736,1,1
1,GO RESPONSE TO ATP,0.0075304,0.1518,0.12078,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,2.5308e-05,0.15167,0.17907,1,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.036164,0.15088,0.13635,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.025994,0.15085,0.16364,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.033894,0.14962,0.1466,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.011326,0.14962,0.10546,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0010859,0.14961,0.15806,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0024367,0.14949,0.24871,1,1
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.031748,0.14937,0.14383,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0038387,0.14935,0.15572,1,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.021165,0.14916,0.14433,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0094949,0.14897,0.103,1,1
1,GO FACE DEVELOPMENT,0.0028141,0.14861,0.19622,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.0071468,0.14778,0.29658,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,3.3132e-05,0.14777,0.14059,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.033166,0.14705,0.16477,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00012964,0.14654,0.14161,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0060989,0.14597,0.18282,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.010245,0.14558,0.15826,1,1
1,GO NEURAL TUBE FORMATION,0.02166,0.14497,0.12711,1,1
1,GO GOLGI VESICLE TRANSPORT,0.00012074,0.14457,0.14644,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0013457,0.1445,0.11899,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0001165,0.14448,0.13449,1,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.025994,0.14396,0.17219,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00029782,0.14395,0.12167,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.0087944,0.14379,0.14828,1,1
1,GO POSITIVE REGULATION OF BINDING,0.0025083,0.1436,0.12926,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,9.3916e-06,0.1434,0.15456,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00042998,0.1427,0.15572,1,1
1,GO RESPONSE TO UV,0.0028141,0.1427,0.10717,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.020205,0.14254,0.13634,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,8.1192e-05,0.14231,0.18957,1,1
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.017137,0.14196,0.12604,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.013465,0.14195,0.24061,1,1
1,GO HEART VALVE DEVELOPMENT,0.03245,0.14185,0.16907,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,2.7343e-05,0.14162,0.13501,1,1
1,GO TRANSLESION SYNTHESIS,0.001228,0.14159,0.15343,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.014138,0.14151,0.087884,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0094949,0.14075,0.13829,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.013465,0.14069,0.14027,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.014486,0.14014,0.12113,1,1
1,GO GENE SILENCING,8.4205e-05,0.14012,0.12021,1,1
1,GO POSTREPLICATION REPAIR,0.0010206,0.13961,0.13073,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.025414,0.13914,0.12163,1,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.024288,0.13903,0.093791,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.0021689,0.13765,0.10208,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.014841,0.13688,0.17062,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00012512,0.13681,0.23153,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0094949,0.13654,0.12757,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,1.7118e-05,0.13643,0.15162,1,1
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.017137,0.13643,0.088587,1,1
1,GO DNA BIOSYNTHETIC PROCESS,3.4728e-06,0.13617,0.1511,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.027188,0.13605,0.07987,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.012203,0.13541,0.17841,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0081404,0.13527,0.10817,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0073363,0.13511,0.11679,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0020453,0.13483,0.13492,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.001872,0.13474,0.13465,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,5.4121e-05,0.13404,0.14249,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0010206,0.13378,0.12809,1,1
1,GO STEM CELL DIFFERENTIATION,0.00021909,0.13358,0.1436,1,1
1,GO REGULATION OF CATABOLIC PROCESS,1.8521e-05,0.13357,0.13861,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.024288,0.13319,0.10074,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0087944,0.13164,0.12679,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.00020448,0.13088,0.12701,1,1
1,GO GENITALIA DEVELOPMENT,0.030383,0.13028,0.092207,1,1
1,GO SPHINGOID METABOLIC PROCESS,0.031059,0.1301,0.10135,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0007696,0.13002,0.12392,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0013872,0.12993,0.13188,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0021689,0.12979,0.1621,1,1
1,GO BONE DEVELOPMENT,0.0081404,0.12896,0.14562,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.001191,0.12876,0.12224,1,1
1,GO CELLULAR SENESCENCE,0.0013054,0.12839,0.1364,1,1
1,GO MITOTIC RECOMBINATION,0.012203,0.12789,0.16484,1,1
1,GO CELLULAR RESPIRATION,0.0053338,0.12788,0.12734,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.00049035,0.12781,0.12545,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0040578,0.12706,0.16407,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.014486,0.1269,0.12813,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0060989,0.12659,0.14078,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0054795,0.12564,0.10969,1,1
1,GO BASE EXCISION REPAIR,0.0057817,0.1256,0.15406,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00074557,0.1253,0.16681,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0010528,0.12504,0.11799,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.037747,0.1249,0.17906,1,1
1,GO PROTEIN CATABOLIC PROCESS,0.00012512,0.12485,0.11987,1,1
1,GO MRNA CLEAVAGE,0.00040247,0.12428,0.1369,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0054795,0.12407,0.083867,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0094949,0.12393,0.16319,1,1
1,GO RECEPTOR RECYCLING,0.031748,0.12386,0.10932,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00036427,0.12359,0.14964,1,1
1,GO OXIDATIVE PHOSPHORYLATION,0.015203,0.12338,0.13094,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.001191,0.12304,0.10228,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.018836,0.12242,0.11521,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.027803,0.1221,0.10138,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001662,0.12207,0.16185,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.0064317,0.12098,0.083541,1,1
1,GO REGULATION OF HISTONE DEACETYLATION,0.045624,0.12055,0.12465,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.00012512,0.11984,0.12637,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.013139,0.11871,0.11116,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00037661,0.11775,0.11321,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.022165,0.11742,0.15597,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.0504e-05,0.11725,0.12535,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00092958,0.11502,0.13663,1,1
1,GO BLASTOCYST GROWTH,0.035393,0.11494,0.18576,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.004408,0.11479,0.12264,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.035393,0.11471,0.13295,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00032948,0.11401,0.1311,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.020205,0.11368,0.10757,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.023741,0.11223,0.092723,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00057693,0.11155,0.10246,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.00353,0.1108,0.095781,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.010506,0.11079,0.10361,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.019283,0.11068,0.083958,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0059384,0.11053,0.11015,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.010245,0.11019,0.16814,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0030654,0.10974,0.092492,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0085714,0.10955,0.12456,1,1
1,GO MRNA 3 END PROCESSING,0.0059384,0.10938,0.11083,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0031536,0.1087,0.1543,1,1
1,GO CELLULAR RESPONSE TO UV,0.012508,0.10852,0.10064,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00010462,0.10835,0.13299,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.010245,0.10833,0.12553,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0056288,0.10832,0.087484,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.0015189,0.10803,0.087313,1,1
1,GO REGULATION OF AUTOPHAGY,0.0021062,0.10667,0.10389,1,1
1,GO REGULATION OF BINDING,0.011047,0.10665,0.10249,1,1
1,GO MACROAUTOPHAGY,0.00014418,0.1055,0.12369,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014841,0.10491,0.084573,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0079323,0.10475,0.093413,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0050528,0.10466,0.0789,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.024846,0.10445,0.14516,1,1
1,GO REGULATION OF DNA REPAIR,0.015574,0.10232,0.076375,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0059384,0.10186,0.080179,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0099891,0.10141,0.16523,1,1
1,GO MITOTIC CELL CYCLE,0.010773,0.099976,0.072399,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.03939,0.09936,0.07518,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.044685,0.098875,0.093699,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.037747,0.09817,0.078389,1,1
1,GO RUFFLE ASSEMBLY,0.027803,0.096832,0.09938,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.0024367,0.096372,0.087638,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0025817,0.094846,0.13206,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.007729,0.093582,0.060508,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00017796,0.093352,0.11998,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00050664,0.093265,0.086388,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0018173,0.092091,0.11755,1,1
1,GO FEMALE GAMETE GENERATION,0.031059,0.092027,0.065696,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.00031859,0.091191,0.09351,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00019753,0.090965,0.082361,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.0049174,0.089026,0.071318,1,1
1,GO ORGANELLE DISASSEMBLY,0.0023671,0.08854,0.10581,1,1
1,GO CELL CYCLE PROCESS,0.029068,0.088378,0.053367,1,1
1,GO TUBE FORMATION,0.040234,0.08837,0.08933,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0010206,0.087704,0.074723,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.0075304,0.086614,0.093026,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0016129,0.085809,0.10819,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0062634,0.085464,0.082348,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.015574,0.083701,0.11785,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.014841,0.083249,0.09418,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0064317,0.083163,0.061761,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00059588,0.083088,0.076833,1,1
1,GO CELL DIVISION,0.03245,0.082775,0.06183,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00041602,0.082616,0.084617,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.026586,0.079624,0.062326,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.0017123,0.079391,0.073978,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.036164,0.077628,0.081665,1,1
1,GO MITOCHONDRION ORGANIZATION,0.00084609,0.076636,0.084473,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.010773,0.074853,0.074688,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.015953,0.074327,0.063945,1,1
1,GO DNA MODIFICATION,0.024846,0.071979,0.081702,1,1
1,GO DNA METABOLIC PROCESS,0.0011549,0.071189,0.07488,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00035231,0.068261,0.10134,1,1
1,GO CELL CYCLE,0.042857,0.065067,0.042154,1,1
1,GO HEART DEVELOPMENT,0.041967,0.063923,0.091431,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.047551,0.063781,0.063116,1,1
1,GO REGULATION OF CELL CYCLE,0.038561,0.06374,0.044157,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.029719,0.059605,0.057371,1,1
1,GO DNA RECOMBINATION,0.044685,0.051405,0.065609,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00054072,0.74461,0.63256,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,2.4692e-06,0.70446,0.57911,1,0
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0014738,0.63087,0.5589,1,0
1,GO T CELL MEDIATED CYTOTOXICITY,9.389e-05,0.61912,0.53846,1,0
1,GO FIBRINOLYSIS,7.547e-05,0.60008,0.70716,1,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00041602,0.58163,0.50595,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,9.0179e-06,0.5619,0.65569,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00084609,0.56141,0.62308,1,0
1,GO T CELL EXTRAVASATION,0.0015189,0.52332,0.50208,1,0
1,GO REGULATION OF FIBRINOLYSIS,0.00042998,0.52059,0.53782,1,0
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00013917,0.47865,0.47927,1,0
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0031536,0.47736,0.38187,1,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0021689,0.4632,0.37238,1,0
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00057693,0.45896,0.45603,1,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,6.0504e-05,0.45883,0.41748,1,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,8.4205e-05,0.44055,0.45072,1,0
1,GO GERMINAL CENTER FORMATION,0.0010859,0.4368,0.384,1,0
1,GO MACROPHAGE PROLIFERATION,0.0062634,0.43278,0.36303,1,0
1,GO RESPONSE TO INTERLEUKIN 18,0.0099891,0.41576,0.48531,1,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.0226e-05,0.40756,0.41093,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0022332,0.4043,0.29505,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0013054,0.40127,0.40053,1,0
1,GO PROSTANOID METABOLIC PROCESS,1.9263e-05,0.39358,0.43689,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0011199,0.39027,0.36933,1,0
1,GO DETECTION OF BIOTIC STIMULUS,0.00024286,0.3837,0.37892,1,0
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.001986,0.37801,0.32317,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0040578,0.37379,0.44235,1,0
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.001662,0.36988,0.31056,1,0
1,GO PSEUDOURIDINE SYNTHESIS,0.00090094,0.36682,0.31319,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014935,0.36516,0.35806,1,0
1,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0001165,0.36193,0.42342,1,0
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0025083,0.35953,0.30589,1,0
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,2.2524e-05,0.35909,0.46237,1,0
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00030804,0.35576,0.36196,1,0
1,GO INTERLEUKIN 13 PRODUCTION,0.0013457,0.35173,0.4081,1,0
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0021689,0.35135,0.41345,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00041602,0.33619,0.35823,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.011326,0.32783,0.19479,1,0
1,GO NADPH REGENERATION,0.00026903,0.31827,0.3257,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.041967,0.3181,0.27284,1,0
1,GO PROTEIN DEGLYCOSYLATION,0.0016129,0.31014,0.26345,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.029719,0.30919,0.17727,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.0689e-05,0.30885,0.5399,1,0
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.0551e-05,0.30883,0.31261,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0060989,0.30866,0.32986,1,0
1,GO REGULATION OF ANOIKIS,0.019739,0.30642,0.2323,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010859,0.3037,0.24892,1,0
1,GO PLATELET DEGRANULATION,0.00059588,0.29984,0.36074,1,0
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0053338,0.29767,0.26758,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0001547,0.297,0.34249,1,0
1,GO NEGATIVE REGULATION OF WOUND HEALING,0.00032948,0.29675,0.3652,1,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0013872,0.29622,0.23519,1,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0054795,0.29541,0.30368,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0047853,0.29479,0.26426,1,0
1,GO CARDIOLIPIN METABOLIC PROCESS,0.0015189,0.29408,0.22357,1,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.035393,0.29088,0.24349,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00038934,0.28927,0.25725,1,0
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0049174,0.28836,0.2411,1,0
1,GO PROTEIN HYDROXYLATION,0.0090226,0.2873,0.34725,1,0
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0013054,0.28525,0.21493,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00049035,0.28517,0.23988,1,0
1,GO RESPONSE TO PROTOZOAN,0.0006154,0.28426,0.28145,1,0
1,GO SYNCYTIUM FORMATION,0.00013917,0.28425,0.30443,1,0
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0010528,0.28424,0.26903,1,0
1,GO MACROPHAGE DIFFERENTIATION,2.6307e-05,0.2823,0.34638,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0017641,0.28221,0.3221,1,0
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,8.4205e-05,0.2817,0.23937,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.00079435,0.27973,0.28153,1,0
1,GO GALACTOSE METABOLIC PROCESS,0.016339,0.27887,0.22768,1,0
1,GO ACUTE INFLAMMATORY RESPONSE,0.00037661,0.27829,0.30654,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,9.0551e-05,0.27473,0.24978,1,0
1,GO GLYCINE METABOLIC PROCESS,0.016339,0.27364,0.21702,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0001165,0.27211,0.33264,1,0
1,GO MUSCLE CELL MIGRATION,0.013465,0.26857,0.22074,1,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0022332,0.26761,0.33632,1,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0085714,0.26723,0.18717,1,0
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,4.8379e-05,0.26643,0.32287,1,0
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0051916,0.26479,0.20538,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0038387,0.26242,0.31681,1,0
1,GO RESPONSE TO THYROID HORMONE,0.0060989,0.26171,0.22682,1,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,8.7323e-05,0.26129,0.27481,1,0
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00092958,0.26101,0.21812,1,0
1,GO FIBROBLAST PROLIFERATION,0.0006154,0.2578,0.25309,1,0
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,4.8379e-05,0.25738,0.3045,1,0
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0015189,0.25718,0.25246,1,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.00059588,0.25712,0.32869,1,0
1,GO AMP METABOLIC PROCESS,0.045624,0.2554,0.23967,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.031748,0.25521,0.18621,1,0
1,GO LEUKOCYTE CELL CELL ADHESION,0.00032948,0.2551,0.21551,1,0
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.5759e-05,0.2549,0.28289,1,0
1,GO GLIAL CELL ACTIVATION,0.0037331,0.25417,0.27622,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00016023,0.25411,0.24449,1,0
1,GO WOUND HEALING,0.00030804,0.25366,0.2739,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0075304,0.25307,0.16761,1,0
1,GO SMOOTH MUSCLE CELL PROLIFERATION,7.013e-05,0.25301,0.30347,1,0
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0051916,0.25216,0.16642,1,0
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,6.2786e-05,0.25063,0.28777,1,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00098941,0.2504,0.24832,1,0
1,GO MYOBLAST FUSION,0.00028792,0.24902,0.32011,1,0
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,5.0226e-05,0.24798,0.30701,1,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.018398,0.24739,0.18473,1,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0062634,0.24659,0.33015,1,0
1,GO REGULATION OF WOUND HEALING,0.0015653,0.24629,0.26351,1,0
1,GO IMMUNE EFFECTOR PROCESS,4.0073e-05,0.24623,0.26233,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00027832,0.24615,0.21882,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00072223,0.24604,0.24842,1,0
1,GO ERK1 AND ERK2 CASCADE,5.0226e-05,0.24481,0.22913,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0027346,0.24464,0.32817,1,0
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.6174e-05,0.24399,0.29014,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00041602,0.24346,0.26072,1,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.035393,0.24318,0.18645,1,0
1,GO REGULATION OF CELL MATRIX ADHESION,0.00067758,0.24301,0.29818,1,0
1,GO COAGULATION,0.00019753,0.24278,0.2551,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00030804,0.24248,0.25577,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015189,0.24212,0.2599,1,0
1,GO ALPHA BETA T CELL ACTIVATION,0.00036427,0.24163,0.22531,1,0
1,GO DETECTION OF OTHER ORGANISM,0.018398,0.23997,0.24874,1,0
1,GO LEUKOCYTE MEDIATED IMMUNITY,5.4121e-05,0.23988,0.27103,1,0
1,GO MACROPHAGE APOPTOTIC PROCESS,0.00049035,0.23972,0.38748,1,0
1,GO GLUTATHIONE METABOLIC PROCESS,0.001228,0.23909,0.24753,1,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.0041716,0.239,0.22493,1,0
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0025083,0.23895,0.18603,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0017123,0.23862,0.25966,1,0
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00081984,0.23832,0.21636,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0042883,0.23802,0.20842,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0040578,0.23797,0.18209,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION,0.00025131,0.2375,0.25936,1,0
1,GO COMPLEMENT ACTIVATION,0.001872,0.23679,0.21393,1,0
1,GO DENDRITIC CELL DIFFERENTIATION,0.03245,0.23615,0.23859,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.03939,0.23573,0.17747,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.018398,0.23531,0.25911,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00040247,0.23433,0.21821,1,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00040247,0.23353,0.34956,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00092958,0.23332,0.22118,1,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.035393,0.23323,0.3537,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0057817,0.23224,0.23592,1,0
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.547e-05,0.23166,0.29848,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0023671,0.22996,0.25486,1,0
1,GO LIPID OXIDATION,0.013465,0.22948,0.15287,1,0
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00031859,0.22927,0.32716,1,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00059588,0.22918,0.2339,1,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0083534,0.2286,0.20689,1,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00021167,0.2283,0.21692,1,0
1,GO FOAM CELL DIFFERENTIATION,0.0033369,0.22665,0.22661,1,0
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0085714,0.22511,0.18402,1,0
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00011241,0.22466,0.34263,1,0
1,GO RESPONSE TO BIOTIC STIMULUS,8.7323e-05,0.22386,0.21852,1,0
1,GO REGULATION OF LIGASE ACTIVITY,0.029719,0.2238,0.18771,1,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.02166,0.22379,0.23967,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00010462,0.22361,0.24939,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00052342,0.2233,0.31792,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00035231,0.22286,0.21457,1,0
1,GO LIPID STORAGE,0.00037661,0.22264,0.23901,1,0
1,GO AMINO ACID ACTIVATION,0.009256,0.222,0.19044,1,0
1,GO TRACHEA DEVELOPMENT,0.011047,0.22186,0.21717,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0033369,0.22158,0.22509,1,0
1,GO GRANULOCYTE MIGRATION,0.00090094,0.22146,0.25304,1,0
1,GO MACROPHAGE CHEMOTAXIS,6.0504e-05,0.22063,0.33394,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0041716,0.2199,0.16717,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.011904,0.21936,0.17888,1,0
1,GO CYTOKINE PRODUCTION,9.7346e-05,0.21896,0.23716,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.029719,0.21886,0.1442,1,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.013798,0.2188,0.20837,1,0
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00032948,0.21825,0.24114,1,0
1,GO RESPONSE TO WOUNDING,0.00038934,0.21768,0.22332,1,0
1,GO ETHER METABOLIC PROCESS,0.015574,0.21754,0.20327,1,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0010528,0.2168,0.23276,1,0
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.017137,0.21656,0.21415,1,0
1,GO ETHANOL METABOLIC PROCESS,0.013465,0.21647,0.237,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.018398,0.21551,0.14728,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0034322,0.21498,0.17441,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,0.0027346,0.21433,0.2164,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00084609,0.21373,0.21053,1,0
1,GO P38MAPK CASCADE,0.00029782,0.21368,0.30195,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.021165,0.21362,0.14523,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0017641,0.21234,0.1632,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0094949,0.21229,0.18127,1,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00032948,0.21226,0.20557,1,0
1,GO STEROL TRANSPORT,0.0028957,0.21224,0.17861,1,0
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.014841,0.2115,0.28049,1,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.016734,0.21025,0.21864,1,0
1,GO SUPEROXIDE ANION GENERATION,0.024846,0.21014,0.19588,1,0
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0097392,0.20943,0.19606,1,0
1,GO ENDOTHELIAL CELL MIGRATION,0.00013433,0.20875,0.29042,1,0
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00020448,0.20775,0.20857,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0083534,0.20773,0.20771,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.019739,0.20748,0.16268,1,0
1,GO TISSUE REMODELING,0.0036303,0.20719,0.21469,1,0
1,GO REGULATION OF PROTEOLYSIS,0.00030804,0.20708,0.16861,1,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0010528,0.20651,0.17233,1,0
1,GO AMEBOIDAL TYPE CELL MIGRATION,0.00022676,0.2063,0.22559,1,0
1,GO T CELL ACTIVATION,0.00035231,0.20287,0.19261,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0011199,0.20257,0.19411,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0042883,0.20217,0.1547,1,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0025817,0.20152,0.23087,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0023671,0.20136,0.16802,1,0
1,GO PROTEIN KINASE B SIGNALING,0.00095906,0.2005,0.17217,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00029782,0.20037,0.20831,1,0
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.020205,0.20027,0.18125,1,0
1,GO RESPONSE TO INTERLEUKIN 4,0.0007696,0.19955,0.18534,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.013798,0.19905,0.26643,1,0
1,GO REGULATION OF VASCULATURE DEVELOPMENT,7.013e-05,0.19893,0.26459,1,0
1,GO MYELOID LEUKOCYTE ACTIVATION,0.00019079,0.19841,0.26608,1,0
1,GO RESPONSE TO BACTERIUM,0.00019079,0.19839,0.2286,1,0
1,GO REGULATION OF DEFENSE RESPONSE,0.00031859,0.19803,0.18729,1,0
1,GO CELLULAR DEFENSE RESPONSE,0.025414,0.1975,0.22945,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.0047853,0.19748,0.15025,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0087944,0.19739,0.19616,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.030383,0.19738,0.12987,1,0
1,GO REGULATION OF PLATELET ACTIVATION,0.037747,0.19693,0.1619,1,0
1,GO INTEGRIN ACTIVATION,0.0067808,0.19621,0.1839,1,0
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0034322,0.195,0.16559,1,0
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00019079,0.19439,0.18984,1,0
1,GO KERATINOCYTE MIGRATION,0.0039469,0.1942,0.24033,1,0
1,GO ALDITOL METABOLIC PROCESS,0.0010859,0.19398,0.2326,1,0
1,GO RRNA TRANSCRIPTION,0.004408,0.19385,0.1931,1,0
1,GO INTERMEMBRANE LIPID TRANSFER,0.0015189,0.19359,0.1665,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0034322,0.19318,0.1575,1,0
1,GO LEUKOCYTE PROLIFERATION,0.0054795,0.19297,0.15387,1,0
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0014738,0.19203,0.15457,1,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.02068,0.1919,0.18094,1,0
1,GO LYMPHOCYTE ACTIVATION,0.00041602,0.19155,0.1706,1,0
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.001986,0.19051,0.16693,1,0
1,GO REGULATION OF CELL ACTIVATION,0.00074557,0.1903,0.17326,1,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.047551,0.19003,0.15433,1,0
1,GO REGULATION OF TOLERANCE INDUCTION,0.038561,0.18967,0.22415,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,4.0073e-05,0.18952,0.23203,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.023741,0.18903,0.20748,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.001662,0.18892,0.19955,1,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0030654,0.18853,0.2642,1,0
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00034072,0.18798,0.18358,1,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0021689,0.18779,0.1752,1,0
1,GO CELL ACTIVATION,0.00014935,0.18702,0.20986,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.025994,0.18619,0.19545,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.025414,0.18606,0.11089,1,0
1,GO REGULATION OF PROTON TRANSPORT,0.0059384,0.18451,0.19446,1,0
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0020453,0.18409,0.20287,1,0
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00050664,0.18277,0.16447,1,0
1,GO PROTEIN MATURATION,0.00079435,0.18244,0.13691,1,0
1,GO SUPEROXIDE METABOLIC PROCESS,0.041967,0.18242,0.113,1,0
1,GO LEUKOCYTE MIGRATION,0.01282,0.18165,0.16307,1,0
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0011549,0.18141,0.15429,1,0
1,GO DEFENSE RESPONSE,0.00038934,0.18123,0.19325,1,0
1,GO TRNA WOBBLE BASE MODIFICATION,0.0081404,0.18043,0.16618,1,0
1,GO CELL CHEMOTAXIS,0.0090226,0.18035,0.17673,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.031059,0.18029,0.17795,1,0
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00010845,0.17996,0.26701,1,0
1,GO REGULATION OF CELL KILLING,0.02268,0.17871,0.16017,1,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.012203,0.17826,0.27103,1,0
1,GO PROTEIN PROCESSING,0.0022332,0.17809,0.16858,1,0
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.023205,0.17781,0.17449,1,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,4.8379e-05,0.17738,0.19454,1,0
1,GO RESPONSE TO ISCHEMIA,0.00027832,0.17656,0.19861,1,0
1,GO RETINOL METABOLIC PROCESS,0.0094949,0.17599,0.17112,1,0
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00054072,0.17595,0.20518,1,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00090094,0.17536,0.1692,1,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.026586,0.17507,0.38372,1,0
1,GO SULFUR COMPOUND METABOLIC PROCESS,0.00049035,0.17441,0.15687,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.025994,0.17393,0.13935,1,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.013798,0.17379,0.14941,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0033369,0.17302,0.16894,1,0
1,GO TISSUE MIGRATION,0.00017796,0.17112,0.26086,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.024846,0.17104,0.17168,1,0
1,GO RESPONSE TO KETONE,0.029719,0.17048,0.098825,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00041602,0.17001,0.18516,1,0
1,GO FATTY ACID CATABOLIC PROCESS,0.025994,0.16998,0.12367,1,0
1,GO INFLAMMATORY RESPONSE,0.00084609,0.16989,0.20692,1,0
1,GO REGULATION OF B CELL ACTIVATION,0.018398,0.16982,0.10211,1,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.03245,0.16923,0.14523,1,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.007729,0.16917,0.34893,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.011904,0.16907,0.16974,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0010859,0.16866,0.24503,1,0
1,GO T CELL DIFFERENTIATION,0.0036303,0.16865,0.13371,1,0
1,GO TRNA TRANSPORT,0.0073363,0.16849,0.1673,1,0
1,GO CHONDROCYTE DEVELOPMENT,0.014486,0.16835,0.274,1,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.033894,0.16829,0.13103,1,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.017137,0.16827,0.30009,1,0
1,GO L PHENYLALANINE METABOLIC PROCESS,0.044685,0.16822,0.12435,1,0
1,GO APOPTOTIC SIGNALING PATHWAY,0.0025083,0.16818,0.14052,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.02843,0.16775,0.10769,1,0
1,GO REGULATION OF CELL ADHESION,0.0099891,0.16752,0.15036,1,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.03245,0.16674,0.11743,1,0
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0028957,0.1666,0.209,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0081404,0.16638,0.12974,1,0
1,GO POSITIVE CHEMOTAXIS,0.02843,0.16606,0.18974,1,0
1,GO SEQUESTERING OF TRIGLYCERIDE,0.02268,0.16573,0.26253,1,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0087944,0.16533,0.16127,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00090094,0.16426,0.32444,1,0
1,GO LEUKOCYTE HOMEOSTASIS,0.00065623,0.16363,0.17564,1,0
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0059384,0.16297,0.22907,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.018836,0.16263,0.12014,1,0
1,GO ERBB SIGNALING PATHWAY,0.00036427,0.16237,0.22761,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.015203,0.16176,0.20027,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.029068,0.16166,0.1758,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.018836,0.16146,0.1574,1,0
1,GO ORGANIC ACID CATABOLIC PROCESS,0.011904,0.16138,0.14015,1,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.013465,0.16135,0.13631,1,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00040247,0.16123,0.15115,1,0
1,GO REGULATION OF T CELL ACTIVATION,0.001662,0.16111,0.16529,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0010206,0.16045,0.15758,1,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0006154,0.15998,0.14348,1,0
1,GO CELL KILLING,0.022165,0.15996,0.1245,1,0
1,GO BONE REMODELING,0.0094949,0.15888,0.16313,1,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00059588,0.15832,0.27049,1,0
1,GO CHYLOMICRON ASSEMBLY,0.017549,0.1558,0.18371,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.0016129,0.15514,0.12603,1,0
1,GO REGULATION OF VASOCONSTRICTION,0.00353,0.15513,0.20491,1,0
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0060989,0.15449,0.18195,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.0059384,0.15425,0.14247,1,0
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,8.1192e-05,0.15403,0.15207,1,0
1,GO REGULATION OF CELL CELL ADHESION,0.0064317,0.15398,0.1351,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.012508,0.15379,0.14329,1,0
1,GO CELLULAR RESPONSE TO LIPID,0.0011549,0.15342,0.16371,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.047551,0.15304,0.20191,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0060989,0.15293,0.13445,1,0
1,GO REGULATION OF BODY FLUID LEVELS,0.0025817,0.15268,0.16279,1,0
1,GO REGULATION OF LIPID STORAGE,0.0014299,0.15219,0.22854,1,0
1,GO LEUKOCYTE DIFFERENTIATION,0.00074557,0.15198,0.1527,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.033166,0.15179,0.21047,1,0
1,GO FATTY ACID METABOLIC PROCESS,0.0097392,0.15153,0.10522,1,0
1,GO B CELL ACTIVATION,0.0031536,0.15151,0.11869,1,0
1,GO AGING,0.00065623,0.15139,0.14768,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.011326,0.15046,0.11615,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.046579,0.14997,0.14297,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0094949,0.14993,0.13444,1,0
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00034072,0.14958,0.13186,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0034322,0.14901,0.15152,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00013917,0.14892,0.2307,1,0
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.007729,0.14685,0.13611,1,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.035393,0.14643,0.23118,1,0
1,GO PEPTIDYL ARGININE MODIFICATION,0.0022332,0.14636,0.12991,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.0014299,0.14618,0.13167,1,0
1,GO RRNA 3 END PROCESSING,0.014486,0.14614,0.13889,1,0
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.024846,0.14541,0.11952,1,0
1,GO PROTEOLYSIS,0.00040247,0.14407,0.11529,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.010245,0.14324,0.12277,1,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.026586,0.14312,0.1917,1,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.027188,0.14309,0.11626,1,0
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0018173,0.14231,0.14039,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00353,0.14143,0.10003,1,0
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0037331,0.14052,0.11097,1,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.024288,0.13914,0.12283,1,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.016339,0.13745,0.13082,1,0
1,GO REGULATION OF ENDOCYTOSIS,0.015574,0.13709,0.10431,1,0
1,GO REGULATION OF CELL DEATH,0.0013457,0.13702,0.11041,1,0
1,GO ENDOSOME ORGANIZATION,0.00095906,0.13664,0.14257,1,0
1,GO CELLULAR EXTRAVASATION,0.0066042,0.13649,0.16671,1,0
1,GO RESPONSE TO LIPID,0.0073363,0.13589,0.12628,1,0
1,GO BONE RESORPTION,0.017969,0.13578,0.12072,1,0
1,GO MRNA METABOLIC PROCESS,9.7346e-05,0.13486,0.1435,1,0
1,GO ENDOCRINE PROCESS,0.0057817,0.13485,0.14995,1,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.023741,0.1338,0.10015,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.001986,0.13369,0.15122,1,0
1,GO POSITIVE REGULATION OF CELL DEATH,0.0073363,0.13368,0.10255,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0010206,0.13283,0.12094,1,0
1,GO REGULATION OF LIPID TRANSPORT,0.0040578,0.13271,0.11981,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.023741,0.13249,0.093279,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0017641,0.13242,0.12747,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.034637,0.13238,0.1902,1,0
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.017137,0.13121,0.16484,1,0
1,GO REGULATION OF PROTEIN BINDING,0.0022992,0.13114,0.13058,1,0
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.0024367,0.13106,0.14635,1,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.041967,0.13057,0.20693,1,0
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,7.8282e-05,0.13044,0.16586,1,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.014841,0.13042,0.12272,1,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.018836,0.13034,0.17665,1,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0032441,0.12881,0.12315,1,0
1,GO AEROBIC RESPIRATION,0.027803,0.12857,0.10128,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.012203,0.12847,0.14917,1,0
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.015574,0.12803,0.10629,1,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.02166,0.12799,0.11501,1,0
1,GO MUSCLE ATROPHY,0.037747,0.12787,0.23168,1,0
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0027346,0.12764,0.14476,1,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.031748,0.1276,0.1785,1,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.0038387,0.12613,0.11533,1,0
1,GO ORGANIC ACID METABOLIC PROCESS,0.0039469,0.12601,0.10208,1,0
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0056288,0.1259,0.12274,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.026586,0.12549,0.10533,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.027803,0.12455,0.087196,1,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0073363,0.12408,0.17622,1,0
1,GO TRANSITION METAL ION TRANSPORT,0.001872,0.12388,0.089362,1,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00021167,0.1237,0.1433,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0049174,0.1235,0.17277,1,0
1,GO APOPTOTIC PROCESS,0.0013054,0.1235,0.10358,1,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.0069616,0.12281,0.15896,1,0
1,GO OXIDATION REDUCTION PROCESS,0.0085714,0.12231,0.094915,1,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0079323,0.1223,0.19841,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0028957,0.12205,0.11114,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.018398,0.1217,0.12579,1,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0062634,0.12129,0.10609,1,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0053338,0.12072,0.12341,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0045306,0.12063,0.083777,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,0.0099891,0.12,0.10411,1,0
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0057817,0.11864,0.12186,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0090226,0.11813,0.14356,1,0
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00063551,0.118,0.12391,1,0
1,GO LIPID CATABOLIC PROCESS,0.030383,0.11721,0.072852,1,0
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0013872,0.11694,0.12622,1,0
1,GO REGULATION OF HYDROLASE ACTIVITY,0.027803,0.11498,0.075112,1,0
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0045306,0.11427,0.1015,1,0
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.015574,0.11388,0.094744,1,0
1,GO REGULATION OF VACUOLE ORGANIZATION,0.027188,0.11372,0.12102,1,0
1,GO AMINE METABOLIC PROCESS,0.038561,0.11325,0.087308,1,0
1,GO RESPONSE TO HEAT,0.00045924,0.11293,0.15393,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0039469,0.11224,0.12014,1,0
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00065623,0.11169,0.10389,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.041093,0.11105,0.091275,1,0
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.11089,0.1216,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0017123,0.11088,0.13309,1,0
1,GO ESTROGEN METABOLIC PROCESS,0.036948,0.11086,0.10675,1,0
1,GO RESPONSE TO CHEMOKINE,0.041093,0.11034,0.16041,1,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.02843,0.11018,0.0928,1,0
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.02843,0.11014,0.10969,1,0
1,GO PEROXISOMAL TRANSPORT,0.0056288,0.10931,0.17141,1,0
1,GO PROTEIN STABILIZATION,0.013139,0.1058,0.093043,1,0
1,GO CELLULAR RESPONSE TO HEAT,0.0045306,0.10578,0.13136,1,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.001662,0.10561,0.099306,1,0
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0017123,0.10557,0.17515,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.029719,0.10536,0.22766,1,0
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.033894,0.10441,0.083317,1,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.017969,0.10386,0.11617,1,0
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.036948,0.10377,0.062885,1,0
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0021689,0.10224,0.11355,1,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.001662,0.10207,0.11006,1,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.026586,0.10093,0.079528,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.047551,0.10071,0.13145,1,0
1,GO VIRAL BUDDING,0.0066042,0.10026,0.13711,1,0
1,GO B CELL DIFFERENTIATION,0.047551,0.099961,0.091955,1,0
1,GO PEROXISOME ORGANIZATION,0.0049174,0.09993,0.16269,1,0
1,GO REGULATION OF MAPK CASCADE,0.0046564,0.099893,0.12114,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0030654,0.099847,0.10399,1,0
1,GO RNA SURVEILLANCE,0.015953,0.099305,0.13998,1,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.030383,0.097929,0.10148,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.010773,0.097786,0.11274,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.042857,0.096926,0.064656,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.043763,0.096689,0.07843,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0050528,0.095423,0.092171,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.012203,0.095383,0.080397,1,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0083534,0.093448,0.080894,1,0
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0039469,0.093358,0.1119,1,0
1,GO NUCLEOTIDE EXCISION REPAIR,0.0013054,0.092945,0.11888,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0054795,0.091827,0.081792,1,0
1,GO HORMONE METABOLIC PROCESS,0.043763,0.091664,0.072642,1,0
1,GO GOLGI ORGANIZATION,0.022165,0.090956,0.082923,1,0
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0071468,0.090875,0.094342,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.037747,0.090494,0.066168,1,0
1,GO FLUID TRANSPORT,0.036164,0.08976,0.09836,1,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0069616,0.089534,0.08556,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.020205,0.088975,0.12655,1,0
1,GO RESPONSE TO ABIOTIC STIMULUS,0.037747,0.088866,0.067061,1,0
1,GO REGULATION OF PROTEIN STABILITY,0.0067808,0.088294,0.085149,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.011612,0.088046,0.073913,1,0
1,GO RESPONSE TO PEPTIDE,0.031059,0.087436,0.067232,1,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.024846,0.087178,0.066398,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0059384,0.08712,0.095554,1,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.02268,0.087037,0.12768,1,0
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0054795,0.08671,0.12235,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.010773,0.085725,0.074745,1,0
1,GO EXOCYTOSIS,0.013798,0.085608,0.10358,1,0
1,GO T CELL LINEAGE COMMITMENT,0.03939,0.084698,0.12178,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.043763,0.08389,0.10868,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.010245,0.082912,0.086738,1,0
1,GO LIPID METABOLIC PROCESS,0.030383,0.081536,0.062439,1,0
1,GO NEGATIVE REGULATION OF SIGNALING,0.012508,0.081282,0.079292,1,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.022165,0.081117,0.075377,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.0099891,0.081033,0.067009,1,0
1,GO REGULATION OF PHOSPHORYLATION,0.0099891,0.08072,0.085708,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00081984,0.080189,0.14632,1,0
1,GO RESPONSE TO HORMONE,0.034637,0.080122,0.069275,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.033894,0.080047,0.093674,1,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.045624,0.07976,0.067506,1,0
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.017549,0.079148,0.070507,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0033369,0.07907,0.12462,1,0
1,GO ENDOCYTOSIS,0.029719,0.078831,0.086679,1,0
1,GO MEMBRANE ORGANIZATION,0.023741,0.078068,0.072889,1,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.016339,0.077444,0.078792,1,0
1,GO SULFATE TRANSPORT,0.024288,0.077033,0.089101,1,0
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.020205,0.075244,0.069441,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.040234,0.074622,0.055982,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,0.047551,0.072369,0.056168,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.012203,0.070026,0.098435,1,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.023205,0.066613,0.064344,1,0
1,GO POLYOL METABOLIC PROCESS,0.029719,0.064593,0.076541,1,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.033166,0.063351,0.062709,1,0
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.035393,0.060539,0.094546,1,0
1,GO IRON ION TRANSPORT,0.03245,0.056981,0.072531,1,0
1,GO INTRACELLULAR TRANSPORT,0.013798,0.056172,0.051916,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0054795,0.054857,0.074195,1,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.033894,0.052784,0.099024,1,0
1,GO MITOCHONDRIAL TRANSPORT,0.029068,0.051881,0.063018,1,0
1,GO REGULATION OF MACROAUTOPHAGY,0.024288,0.048796,0.088782,1,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.045624,0.047968,0.058925,1,0
1,GO ORGANIC ANION TRANSPORT,0.047551,-0.03965,-0.077283,1,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.036948,-0.041878,-0.083017,1,0
1,GO ANION TRANSPORT,0.024846,-0.043565,-0.079527,1,0
1,GO INORGANIC ANION TRANSPORT,0.035393,-0.054397,-0.080236,1,0
1,GO PROTEIN ACETYLATION,0.0097392,-0.061301,-0.090649,1,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.029068,-0.062489,-0.10314,1,0
1,GO RESPONSE TO CARBOHYDRATE,0.024288,-0.072078,-0.076293,1,0
1,GO ORGANIC ACID TRANSPORT,0.0042883,-0.072733,-0.1051,1,0
1,GO RESPONSE TO MONOSACCHARIDE,0.0040578,-0.074106,-0.10004,1,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.045624,-0.076217,-0.06749,1,0
1,GO CALCIUM MEDIATED SIGNALING,0.023741,-0.078613,-0.076589,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.0097392,-0.079721,-0.091427,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.010773,-0.081957,-0.1019,1,0
1,GO VESICLE LOCALIZATION,0.0073363,-0.082139,-0.081342,1,0
1,GO TRANSMEMBRANE TRANSPORT,0.0034322,-0.087343,-0.087082,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.022165,-0.09042,-0.14337,1,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.045624,-0.090561,-0.07439,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.031748,-0.091047,-0.091426,1,0
1,GO FEAR RESPONSE,0.0059384,-0.093152,-0.16436,1,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.033894,-0.096373,-0.11215,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0073363,-0.098147,-0.1294,1,0
1,GO HISTONE H3 K9 MODIFICATION,0.012508,-0.099046,-0.12742,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.011612,-0.099452,-0.12209,1,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.02166,-0.10091,-0.11069,1,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.024846,-0.10499,-0.092695,1,0
1,GO OOCYTE DIFFERENTIATION,0.0087944,-0.10505,-0.12589,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00019079,-0.10585,-0.14759,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0041716,-0.1059,-0.10959,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.00040247,-0.10706,-0.13827,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.034637,-0.10787,-0.14252,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.00036427,-0.11212,-0.17088,1,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.047551,-0.1126,-0.14007,1,0
1,GO DETECTION OF STIMULUS,0.00012964,-0.11386,-0.1191,1,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.036948,-0.11465,-0.1353,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00016595,-0.11603,-0.17319,1,0
1,GO CIRCULATORY SYSTEM PROCESS,0.015953,-0.11752,-0.089765,1,0
1,GO REGULATION OF HORMONE LEVELS,0.00047456,-0.11789,-0.15705,1,0
1,GO RESPONSE TO CALCIUM ION,0.044685,-0.11813,-0.10526,1,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.011612,-0.12062,-0.12032,1,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.026586,-0.12097,-0.13643,1,0
1,GO PEPTIDE SECRETION,0.00019079,-0.12425,-0.14333,1,0
1,GO REGULATION OF FERTILIZATION,0.036164,-0.12461,-0.15105,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0045306,-0.12487,-0.14318,1,0
1,GO SOMITE DEVELOPMENT,0.0025817,-0.12501,-0.15077,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00353,-0.1251,-0.12622,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.043763,-0.12555,-0.10983,1,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.021165,-0.12563,-0.20346,1,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.033166,-0.12712,-0.14889,1,0
1,GO HISTONE METHYLATION,0.0022332,-0.1288,-0.13212,1,0
1,GO ION TRANSPORT,0.00013917,-0.12881,-0.12717,1,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.011047,-0.12928,-0.20959,1,0
1,GO REGULATION OF ANION TRANSPORT,0.00038934,-0.12951,-0.16977,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0073363,-0.13003,-0.20528,1,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0097392,-0.13103,-0.14569,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0027346,-0.13314,-0.16787,1,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.045624,-0.13378,-0.15018,1,0
1,GO RESPONSE TO ETHER,0.042857,-0.13433,-0.16743,1,0
1,GO PEPTIDYL LYSINE METHYLATION,0.0073363,-0.13449,-0.13264,1,0
1,GO METAL ION TRANSPORT,0.00020448,-0.13536,-0.13145,1,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.016734,-0.13542,-0.15295,1,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.013139,-0.13559,-0.13138,1,0
1,GO RESPONSE TO FUNGUS,0.029719,-0.13641,-0.14231,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.00044439,-0.13863,-0.13347,1,0
1,GO WATER HOMEOSTASIS,0.013139,-0.13962,-0.1429,1,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0050528,-0.13975,-0.24304,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.030383,-0.1412,-0.3449,1,0
1,GO REGULATION OF GLUCOSE IMPORT,0.004408,-0.14158,-0.1551,1,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.0041716,-0.14175,-0.16915,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.00018427,-0.14479,-0.14861,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.00072223,-0.14502,-0.14384,1,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.010506,-0.14739,-0.19553,1,0
1,GO CELL FATE COMMITMENT,0.0019282,-0.14886,-0.15748,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.0017641,-0.15008,-0.17568,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.013465,-0.15065,-0.1599,1,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.017969,-0.15208,-0.10861,1,0
1,GO REGULATION OF HISTONE METHYLATION,0.00353,-0.15361,-0.13758,1,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.027803,-0.15461,-0.17674,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.0069616,-0.15584,-0.27069,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,7.2754e-05,-0.15833,-0.14409,1,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0027346,-0.1587,-0.25388,1,0
1,GO CATION TRANSPORT,2.0033e-05,-0.1589,-0.15682,1,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.043763,-0.16065,-0.181,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00067758,-0.16081,-0.13774,1,0
1,GO CELL MATURATION,2.6307e-05,-0.16162,-0.17004,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.00047456,-0.16216,-0.19601,1,0
1,GO PROTEIN METHYLATION,0.001872,-0.16261,-0.13588,1,0
1,GO LIPID DROPLET ORGANIZATION,0.025414,-0.16294,-0.12852,1,0
1,GO SENSORY PERCEPTION,2.2524e-05,-0.16388,-0.15131,1,0
1,GO HISTONE H4 ACETYLATION,0.00021909,-0.1661,-0.1704,1,0
1,GO HISTONE H3 K9 METHYLATION,0.00050664,-0.16688,-0.18296,1,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.040234,-0.16733,-0.11913,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.011612,-0.16769,-0.18007,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0045306,-0.16796,-0.17137,1,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.03245,-0.16881,-0.23053,1,0
1,GO HISTONE H4 K16 ACETYLATION,0.00027832,-0.16885,-0.26202,1,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.018836,-0.17029,-0.13465,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.040234,-0.17127,-0.11802,1,0
1,GO ACID SECRETION,0.0010528,-0.17314,-0.18435,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00012074,-0.17512,-0.18355,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00023468,-0.17517,-0.20156,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0016129,-0.1759,-0.18064,1,0
1,GO REGULATION OF SECRETION,1.5331e-06,-0.17623,-0.18467,1,0
1,GO PHAGOSOME ACIDIFICATION,0.011326,-0.17895,-0.16268,1,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0036303,-0.1795,-0.20296,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,3.4421e-05,-0.17953,-0.15859,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,2.8418e-05,-0.17966,-0.16269,1,0
1,GO CHLORIDE TRANSPORT,0.00010845,-0.18174,-0.17129,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,4.8379e-05,-0.18743,-0.20676,1,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.031748,-0.18764,-0.16919,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,8.7323e-05,-0.18964,-0.19508,1,0
1,GO CALCIUM ION IMPORT,0.0010206,-0.18989,-0.18936,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.016734,-0.19154,-0.18724,1,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.044685,-0.19342,-0.11715,1,0
1,GO DIGESTION,0.015574,-0.19629,-0.14502,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,3.3132e-05,-0.1966,-0.1855,1,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0026572,-0.19671,-0.16187,1,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.024288,-0.19702,-0.1825,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00014935,-0.19857,-0.19462,1,0
1,GO HISTONE H3 K4 METHYLATION,0.004408,-0.19911,-0.2087,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.017137,-0.19985,-0.17411,1,0
1,GO ORGANIC CATION TRANSPORT,2.0033e-05,-0.20569,-0.26145,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00044439,-0.20596,-0.27044,1,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.040234,-0.20826,-0.21044,1,0
1,GO HAIR CELL DIFFERENTIATION,0.0028141,-0.20932,-0.2728,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00021909,-0.21153,-0.2118,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0041716,-0.21182,-0.22544,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.001228,-0.21191,-0.25136,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,3.7145e-05,-0.21642,-0.22184,1,0
1,GO LIPID TRANSLOCATION,0.0051916,-0.21695,-0.19019,1,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.036164,-0.21742,-0.22081,1,0
1,GO FORELIMB MORPHOGENESIS,0.019283,-0.2181,-0.18323,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.0050528,-0.2194,-0.20238,1,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.0056288,-0.21994,-0.28041,1,0
1,GO REGULATION OF CELL MATURATION,0.010506,-0.22172,-0.16965,1,0
1,GO DENDRITE SELF AVOIDANCE,0.024846,-0.22382,-0.19865,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00072223,-0.22418,-0.33747,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0094949,-0.22439,-0.24131,1,0
1,GO REGULATION OF HORMONE SECRETION,6.8936e-07,-0.22532,-0.25788,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.013798,-0.22621,-0.23285,1,0
1,GO RESPONSE TO ALKALOID,6.2985e-07,-0.22689,-0.24802,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00010092,-0.23119,-0.24445,1,0
1,GO SHORT TERM MEMORY,0.014486,-0.23365,-0.29086,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0013054,-0.23368,-0.2244,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00074557,-0.23783,-0.33665,1,0
1,GO BILE ACID METABOLIC PROCESS,0.0079323,-0.2389,-0.18638,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00037661,-0.24299,-0.23782,1,0
1,GO SPINAL CORD DEVELOPMENT,9.389e-05,-0.24452,-0.28234,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,6.4994e-06,-0.24584,-0.28562,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,6.0504e-05,-0.24662,-0.25196,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0085714,-0.24711,-0.25906,1,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00030804,-0.24789,-0.25653,1,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.017969,-0.24817,-0.22744,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00047456,-0.24956,-0.30712,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.0001165,-0.2501,-0.23018,1,0
1,GO HORMONE TRANSPORT,2.7578e-07,-0.25276,-0.27804,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.019739,-0.25625,-0.24441,1,0
1,GO CELL FATE SPECIFICATION,0.00098941,-0.25759,-0.31189,1,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0011199,-0.25889,-0.2738,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00081984,-0.25944,-0.27251,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.010245,-0.25972,-0.21571,1,0
1,GO AMINO ACID TRANSPORT,1.7474e-06,-0.26093,-0.26519,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,5.753e-07,-0.2614,-0.29293,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,9.3916e-06,-0.2622,-0.23966,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,1.4039e-05,-0.26457,-0.22305,1,0
1,GO FEEDING BEHAVIOR,1.4674e-06,-0.26638,-0.26597,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.0032441,-0.26678,-0.21956,1,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.0013872,-0.2674,-0.23112,1,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.012508,-0.26854,-0.21325,1,0
1,GO REPRODUCTIVE BEHAVIOR,2.9532e-05,-0.27003,-0.29287,1,0
1,GO INSEMINATION,0.02843,-0.27193,-0.18539,1,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0034322,-0.27373,-0.24883,1,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012508,-0.28425,-0.30235,1,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,1.6455e-05,-0.28481,-0.24356,1,0
1,GO SODIUM ION HOMEOSTASIS,1.9904e-06,-0.28586,-0.32272,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00353,-0.28643,-0.29938,1,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.0021062,-0.28671,-0.2797,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,9.7346e-05,-0.28826,-0.39977,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00035231,-0.28919,-0.2659,1,0
1,GO GLYCINE TRANSPORT,0.0067808,-0.29059,-0.31942,1,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.010245,-0.29069,-0.33622,1,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.036164,-0.29514,-0.25318,1,0
1,GO REGULATION OF HEART RATE,4.8379e-05,-0.29709,-0.26248,1,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0075304,-0.2987,-0.2889,1,0
1,GO REGULATION OF INSULIN SECRETION,5.2533e-07,-0.29958,-0.30443,1,0
1,GO ENERGY HOMEOSTASIS,0.0067808,-0.30069,-0.23696,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.045624,-0.30274,-0.21441,1,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.0027346,-0.30425,-0.24301,1,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0025817,-0.30662,-0.25244,1,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0025817,-0.30769,-0.27291,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,3.1904e-06,-0.31232,-0.29922,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00029782,-0.31278,-0.37138,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,3.4772e-07,-0.31811,-0.33781,1,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,3.8583e-05,-0.31822,-0.3067,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.0050528,-0.32124,-0.3262,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.0010206,-0.32165,-0.2874,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,7.2756e-08,-0.32193,-0.31945,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.00036427,-0.32315,-0.34845,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0017123,-0.32494,-0.309,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00010092,-0.32504,-0.29746,1,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.035393,-0.32673,-0.22197,1,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.017549,-0.32674,-0.30448,1,0
1,GO HISTONE H4 K5 ACETYLATION,1.104e-05,-0.32763,-0.32428,1,0
1,GO RELAXATION OF MUSCLE,0.00041602,-0.32929,-0.31292,1,0
1,GO INSULIN SECRETION,2.1831e-07,-0.33008,-0.32749,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.7413e-06,-0.33155,-0.35303,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,1.1237e-07,-0.3316,-0.36172,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00040247,-0.332,-0.36816,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,2.2879e-07,-0.33216,-0.33673,1,0
1,GO POTASSIUM ION HOMEOSTASIS,3.9418e-06,-0.33354,-0.3287,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,8.7323e-05,-0.33663,-0.31978,1,0
1,GO PEPTIDE HORMONE SECRETION,5.6999e-08,-0.33809,-0.33813,1,0
1,GO NOREPINEPHRINE SECRETION,6.7728e-06,-0.33854,-0.38485,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00074557,-0.34299,-0.30901,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,5.2139e-05,-0.34408,-0.34179,1,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,5.4121e-05,-0.35207,-0.37422,1,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0026572,-0.35566,-0.31882,1,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.017549,-0.35669,-0.22773,1,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.010245,-0.35835,-0.28483,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,5.2139e-05,-0.36004,-0.32401,1,0
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.017137,-0.37498,-0.41746,1,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,3.8583e-05,-0.37617,-0.4639,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.00016595,-0.37748,-0.30955,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.1776e-06,-0.37916,-0.37094,1,0
1,GO NOREPINEPHRINE TRANSPORT,4.6597e-05,-0.38281,-0.33178,1,0
1,GO MALE SEX DETERMINATION,0.0021062,-0.38452,-0.33445,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.00026003,-0.38636,-0.34013,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,7.2754e-05,-0.38957,-0.38113,1,0
1,GO APICAL PROTEIN LOCALIZATION,0.017549,-0.3924,-0.28102,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,3.4728e-06,-0.39569,-0.62341,1,0
1,GO RESPONSE TO DIETARY EXCESS,2.4346e-05,-0.40026,-0.45344,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,3.0576e-06,-0.40284,-0.42446,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,9.7346e-05,-0.4045,-0.48048,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.0007696,-0.4046,-0.37567,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00010092,-0.40553,-0.42561,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.001872,-0.40602,-0.3184,1,0
1,GO FAT CELL PROLIFERATION,0.00010845,-0.40618,-0.38596,1,0
1,GO FOREBRAIN REGIONALIZATION,0.00020448,-0.40746,-0.38049,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,9.3916e-06,-0.40927,-0.42687,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,2.5308e-05,-0.41131,-0.3804,1,0
1,GO SOMATIC STEM CELL DIVISION,0.043763,-0.4124,-0.26484,1,0
1,GO MRNA SPLICE SITE SELECTION,1.0779e-06,-0.41507,-0.40671,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0022332,-0.41776,-0.42615,1,0
1,GO N GLYCAN PROCESSING,4.6597e-05,-0.41834,-0.4001,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,9.8628e-07,-0.41905,-0.47441,1,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,5.8301e-05,-0.41906,-0.58247,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,1.4674e-06,-0.42006,-0.39685,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,6.2985e-07,-0.42301,-0.40923,1,0
1,GO PITUITARY GLAND DEVELOPMENT,9.3916e-06,-0.42356,-0.45469,1,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,3.8583e-05,-0.44178,-0.36673,1,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,3.3202e-07,-0.44206,-0.46126,1,0
1,GO CATECHOLAMINE UPTAKE,3.1888e-05,-0.44421,-0.41222,1,0
1,GO DIENCEPHALON DEVELOPMENT,9.8628e-07,-0.45163,-0.4275,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,5.986e-08,-0.45325,-0.4705,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.00010462,-0.45495,-0.53408,1,0
1,GO TOXIN METABOLIC PROCESS,0.0011199,-0.45713,-0.34824,1,0
1,GO LIMB BUD FORMATION,0.044685,-0.46115,-0.32354,1,0
1,GO SUCKLING BEHAVIOR,2.4346e-05,-0.46444,-0.46331,1,0
1,GO OPTIC NERVE DEVELOPMENT,3.4421e-05,-0.46456,-0.45323,1,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00035231,-0.46871,-0.40621,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,3.3287e-06,-0.47285,-0.44279,1,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,6.5896e-07,-0.47722,-0.44773,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,2.0033e-05,-0.47828,-0.40038,1,0
1,GO EXOCYTIC PROCESS,2.8496e-08,-0.48015,-0.48779,1,0
1,GO CARDIOBLAST PROLIFERATION,0.009256,-0.48986,-0.4123,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0013457,-0.50121,-0.52844,1,0
1,GO RESPONSE TO INSECTICIDE,3.0576e-06,-0.50395,-0.49304,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,1.1964e-05,-0.5056,-0.47814,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00042998,-0.51162,-0.34163,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00084609,-0.52099,-0.39404,1,0
1,GO SIALYLATION,8.3127e-06,-0.53251,-0.50717,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.011904,-0.53443,-0.32126,1,0
1,GO SPINAL CORD PATTERNING,1.0604e-05,-0.54838,-0.55558,1,0
1,GO REGULATION OF NEURON MATURATION,0.0042883,-0.55274,-0.43975,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,1.6015e-06,-0.56091,-0.54478,1,0
1,GO RESPONSE TO L GLUTAMATE,4.4712e-06,-0.56195,-0.59915,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,7.8282e-05,-0.56394,-0.49228,1,0
1,GO DOPAMINE METABOLIC PROCESS,5.6999e-08,-0.57283,-0.61284,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,4.0073e-05,-0.57489,-0.42424,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00045924,-0.58527,-0.41741,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,1.2862e-06,-0.59011,-0.52418,1,0
1,GO REFLEX,5.2533e-07,-0.59214,-0.64902,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00010462,-0.59963,-0.56136,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.3605e-07,-0.59978,-0.62069,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.0033e-05,-0.60134,-0.60256,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,5.986e-08,-0.62089,-0.59038,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,7.0571e-06,-0.62277,-0.78105,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,5.2139e-05,-0.62291,-0.54488,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,5.4977e-07,-0.64183,-0.6917,1,0
1,GO NEURON FATE COMMITMENT,5.753e-07,-0.66533,-0.7044,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,4.2876e-06,-0.67883,-0.6235,1,0
1,GO RESPONSE TO HISTAMINE,4.1802e-07,-0.68527,-0.72412,1,0
1,GO RESPONSE TO LITHIUM ION,1.9904e-06,-0.70196,-0.63034,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,5.6999e-08,-0.72267,-0.69049,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,1.1788e-07,-0.73148,-0.80868,1,0
1,GO THALAMUS DEVELOPMENT,3.0264e-07,-0.73371,-0.67974,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,8.8325e-08,-0.73533,-0.71359,1,0
1,GO SYNAPSE MATURATION,1.071e-07,-0.77632,-0.88806,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,4.2424e-08,-0.77944,-0.79631,1,0
1,GO AMINE TRANSPORT,2.4515e-08,-0.78766,-0.72056,1,0
1,GO MONOAMINE TRANSPORT,2.8496e-08,-0.80048,-0.76417,1,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.3202e-07,-0.80721,-0.81975,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.4044e-06,-0.81962,-0.76412,1,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,3.0264e-07,-0.82744,-0.88371,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,9.7275e-08,-0.83692,-0.7667,1,0
1,GO INNERVATION,6.93e-08,-0.84412,-0.83639,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,6.93e-08,-0.84821,-0.89375,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,2.6902e-06,-0.85528,-0.80595,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,2.2879e-07,-0.86294,-0.84694,1,0
1,GO NEURON FATE SPECIFICATION,6.8936e-07,-0.86658,-0.9452,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,3.3287e-06,-0.86705,-0.76717,1,0
1,GO DOPAMINE TRANSPORT,4.9191e-08,-0.94843,-0.88391,1,0
1,GO SYNAPTIC VESICLE PRIMING,2.1077e-08,-0.95648,-0.97839,1,0
1,GO CATECHOLAMINE SECRETION,3.8423e-08,-0.98425,-0.92761,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,3.1491e-08,-1.0472,-1.0489,1,0
1,GO SYNAPTIC VESICLE MATURATION,4.2876e-06,-1.0972,-0.92462,1,0
1,GO GANGLION DEVELOPMENT,3.6563e-08,-1.1058,-1.0332,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.479e-08,-1.1513,-1.1293,1,0
1,GO REGULATION OF DOPAMINE SECRETION,4.9191e-08,-1.1655,-1.0922,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,2.9301e-06,-1.4084,-1.2081,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,2.5778e-08,-1.7372,-1.7921,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.077957,0.3986,0.24147,0,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.068167,0.39475,0.27844,0,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.088862,0.34202,0.22371,0,1
1,GO PROTEIN OXIDATION,0.065563,0.33122,0.28669,0,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.12049,0.31055,0.14963,0,1
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.054842,0.26917,0.25023,0,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.060602,0.25765,0.19909,0,1
1,GO FOREBRAIN MORPHOGENESIS,0.070855,0.2568,0.15568,0,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.11636,0.25322,0.24276,0,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.057089,0.23911,0.15874,0,1
1,GO MITRAL VALVE DEVELOPMENT,0.057089,0.23888,0.22764,0,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.05824,0.23549,0.20148,0,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.17934,0.23495,0.10576,0,1
1,GO LAMELLIPODIUM MORPHOGENESIS,0.12908,0.23425,0.1935,0,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.19393,0.23396,0.1257,0,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.11636,0.2304,0.17445,0,1
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.1028,0.22947,0.16781,0,1
1,GO PHOSPHOLIPID EFFLUX,0.48678,0.22294,0.15503,0,1
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.11434,0.22174,0.23557,0,1
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.1028,0.21965,0.13395,0,1
1,GO NEURAL CREST CELL MIGRATION,0.070855,0.21198,0.16526,0,1
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.11039,0.20768,0.087441,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.1028,0.20656,0.11284,0,1
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.05161,0.20576,0.12544,0,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.13583,0.19854,0.10502,0,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.093897,0.19484,0.26791,0,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.10096,0.19344,0.13346,0,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.12049,0.1911,0.14092,0,1
1,GO DENDRITIC CELL MIGRATION,0.15264,0.18871,0.15228,0,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.26847,0.18636,0.072173,0,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.23589,0.1821,0.12766,0,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.079444,0.17921,0.12431,0,1
1,GO RESPONSE TO LEAD ION,0.079444,0.17736,0.12177,0,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.050569,0.17494,0.2009,0,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.061812,0.17339,0.1001,0,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.061812,0.17085,0.26168,0,1
1,GO CYTOPLASM ORGANIZATION,0.22235,0.17008,0.11261,0,1
1,GO PIRNA METABOLIC PROCESS,0.099158,0.16841,0.19271,0,1
1,GO HINDLIMB MORPHOGENESIS,0.24288,0.16595,0.090261,0,1
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.070855,0.16471,0.081943,0,1
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.05824,0.16303,0.15769,0,1
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.29992,0.15873,0.060387,0,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.088862,0.15801,0.17222,0,1
1,GO DNA DEMETHYLATION,0.21579,0.15801,0.12304,0,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.095625,0.15723,0.13496,0,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.061812,0.15428,0.14598,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.12473,0.15337,0.10505,0,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.11235,0.15291,0.18823,0,1
1,GO PEPTIDYL ARGININE METHYLATION,0.055956,0.15035,0.12023,0,1
1,GO MAINTENANCE OF CELL NUMBER,0.099158,0.14971,0.09022,0,1
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.20621,0.14703,0.14417,0,1
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.05161,0.14566,0.14476,0,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.076492,0.14498,0.18241,0,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.092194,0.14374,0.083442,0,1
1,GO CORPUS CALLOSUM DEVELOPMENT,0.15015,0.14349,0.11035,0,1
1,GO UV DAMAGE EXCISION REPAIR,0.19695,0.14161,0.064644,0,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.05824,0.13963,0.097845,0,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.049546,0.13954,0.10771,0,1
1,GO REGULATION OF MYELINATION,0.05824,0.1394,0.10497,0,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.23937,0.1392,0.10446,0,1
1,GO NEURAL TUBE PATTERNING,0.090515,0.13837,0.10721,0,1
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.27611,0.1383,0.1359,0,1
1,GO MEMBRANE BIOGENESIS,0.12473,0.13645,0.13899,0,1
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.15773,0.13549,0.10275,0,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.079444,0.13135,0.079212,0,1
1,GO HEXOSE CATABOLIC PROCESS,0.16559,0.1286,0.053767,0,1
1,GO BODY MORPHOGENESIS,0.0695,0.12859,0.10851,0,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.27227,0.12781,0.062507,0,1
1,GO LEFT RIGHT PATTERN FORMATION,0.04854,0.12722,0.1573,0,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.12908,0.12551,0.082774,0,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.10096,0.12467,0.14405,0,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.04854,0.12251,0.091562,0,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.05161,0.12127,0.10074,0,1
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.085627,0.12114,0.10243,0,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0695,0.11945,0.11601,0,1
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.15015,0.11573,0.11937,0,1
1,GO REGULATION OF T CELL MIGRATION,0.10654,0.11534,0.10716,0,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.099158,0.1138,0.067901,0,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.14526,0.11296,0.082562,0,1
1,GO METAPHASE PLATE CONGRESSION,0.0695,0.11002,0.082677,0,1
1,GO NUCLEUS ORGANIZATION,0.063042,0.10908,0.08752,0,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.063042,0.10883,0.08025,0,1
1,GO CYTOKINESIS,0.070855,0.10602,0.070118,0,1
1,GO ACTIN FILAMENT ORGANIZATION,0.073629,0.10515,0.08,0,1
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.068167,0.10502,0.096259,0,1
1,GO MESENCHYME MORPHOGENESIS,0.12049,0.10471,0.19123,0,1
1,GO PROTEIN REFOLDING,0.16032,0.10368,0.11262,0,1
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.066855,0.10145,0.056603,0,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.2,0.1002,0.047329,0,1
1,GO CHROMOSOME LOCALIZATION,0.13814,0.097955,0.081763,0,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.4598,0.097899,0.039114,0,1
1,GO OOCYTE MATURATION,0.42347,0.097724,0.008392,0,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.20621,0.097647,0.13688,0,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.087232,0.095575,0.094371,0,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.19095,0.093787,0.11564,0,1
1,GO SPINDLE ORGANIZATION,0.31653,0.091972,0.042542,0,1
1,GO POSITIVE REGULATION OF MYELINATION,0.25001,0.091914,0.096514,0,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.090515,0.09053,0.068119,0,1
1,GO EMBRYONIC MORPHOGENESIS,0.0695,0.089893,0.070732,0,1
1,GO EPITHELIAL TUBE FORMATION,0.093897,0.089452,0.078993,0,1
1,GO HEART TRABECULA FORMATION,0.49227,0.087119,0.10576,0,1
1,GO ERYTHROCYTE DEVELOPMENT,0.057089,0.084779,0.1121,0,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.15264,0.084016,0.06488,0,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.14048,0.079326,0.056853,0,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.052669,0.077702,0.071799,0,1
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36991,0.077045,0.068719,0,1
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.96163,0.076434,0.064074,0,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.12049,0.07592,0.14482,0,1
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.34256,0.074248,0.021744,0,1
1,GO HISTONE EXCHANGE,0.29586,0.073192,0.05517,0,1
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.47049,0.072355,-0.0071616,0,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15517,0.069717,0.050006,0,1
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.25363,0.064721,0.047305,0,1
1,GO REGULATION OF CELL DIVISION,0.13583,0.064538,0.047754,0,1
1,GO MITOTIC NUCLEAR DIVISION,0.073629,0.064163,0.061044,0,1
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.20621,0.064017,0.03498,0,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.087232,0.061591,0.039955,0,1
1,GO DNA CONFORMATION CHANGE,0.16828,0.06145,0.036996,0,1
1,GO DNA INTEGRITY CHECKPOINT,0.095625,0.059533,0.044943,0,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.061812,0.059341,0.076369,0,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.20937,0.058888,0.080933,0,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.05161,0.057891,0.070663,0,1
1,GO REGULATION OF DNA REPLICATION,0.063042,0.057889,0.055165,0,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.10096,0.057106,0.072798,0,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.16032,0.056697,0.082165,0,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.69707,0.05661,0.0065726,0,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.16032,0.05634,0.055717,0,1
1,GO CELL CYCLE CHECKPOINT,0.05824,0.056315,0.044733,0,1
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.22235,0.053945,0.079761,0,1
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.27227,0.052947,0.083917,0,1
1,GO ORGANELLE FISSION,0.13814,0.04987,0.052533,0,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.084046,0.049839,0.072486,0,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.12908,0.049102,0.057436,0,1
1,GO CHROMOSOME SEGREGATION,0.1028,0.04808,0.052889,0,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.11841,0.045137,0.045803,0,1
1,GO HISTONE H3 ACETYLATION,0.66501,0.044558,0.0029345,0,1
1,GO RECOMBINATIONAL REPAIR,0.67776,0.040644,0.022939,0,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.38408,0.040112,0.018592,0,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.095625,0.039069,0.058194,0,1
1,GO ORGANELLE ASSEMBLY,0.47588,0.028233,0.018528,0,1
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.31232,0.02357,0.023909,0,1
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.32938,0.022111,0.01602,0,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.040234,0.55414,0.29023,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.4609e-05,0.53066,0.58298,0,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,9.389e-05,0.4852,0.61701,0,0
1,GO ETHER BIOSYNTHETIC PROCESS,0.00041602,0.47239,0.44121,0,0
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00057693,0.46949,0.46805,0,0
1,GO ETHANOL OXIDATION,0.011904,0.46201,0.40675,0,0
1,GO SKIN MORPHOGENESIS,0.0015189,0.45496,0.53138,0,0
1,GO IMMUNE RESPONSE TO TUMOR CELL,0.00016595,0.44634,0.42704,0,0
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.6455e-05,0.43459,0.60733,0,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.0001547,0.41804,0.43072,0,0
1,GO ELASTIC FIBER ASSEMBLY,0.030383,0.40723,0.50693,0,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.001191,0.40421,0.3132,0,0
1,GO REGULATION OF HIPPO SIGNALING,0.02166,0.39267,0.23851,0,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.013465,0.38316,0.37082,0,0
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.035393,0.38137,0.24805,0,0
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0060989,0.34818,0.39779,0,0
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.022165,0.34296,0.20501,0,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00098941,0.34043,0.33838,0,0
1,GO REGULATION OF COAGULATION,0.00047456,0.33967,0.36019,0,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,6.5149e-05,0.32641,0.42734,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00069957,0.32141,0.29885,0,0
1,GO BASEMENT MEMBRANE ASSEMBLY,0.017969,0.31615,0.34403,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.075049,0.3143,0.16939,0,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.087232,0.30677,0.23554,0,0
1,GO FOREGUT MORPHOGENESIS,0.001228,0.30573,0.33247,0,0
1,GO PORE COMPLEX ASSEMBLY,0.00027832,0.30551,0.24478,0,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.05824,0.30232,0.31208,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00040247,0.30003,0.28606,0,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.014841,0.29922,0.34588,0,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.25729,0.29852,0.16503,0,0
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00057693,0.29763,0.27853,0,0
1,GO PROTEIN TARGETING TO LYSOSOME,0.016339,0.29265,0.22706,0,0
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00022676,0.2901,0.25378,0,0
1,GO PHAGOCYTOSIS RECOGNITION,0.0021689,0.28992,0.43417,0,0
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.053746,0.28814,0.22265,0,0
1,GO REGULATION OF LIPASE ACTIVITY,5.8301e-05,0.28725,0.24953,0,0
1,GO GLAND MORPHOGENESIS,0.00074557,0.2857,0.29572,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0039469,0.28535,0.25528,0,0
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0087944,0.28248,0.32913,0,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0028957,0.28136,0.28166,0,0
1,GO FIBROBLAST ACTIVATION,0.00057693,0.27951,0.29228,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0079323,0.27946,0.27141,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.084046,0.27628,0.18548,0,0
1,GO REPLICATIVE SENESCENCE,0.041093,0.27474,0.28758,0,0
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0069616,0.27361,0.30006,0,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.28785,0.27164,0.14825,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.13355,0.27036,0.19194,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.14526,0.2689,0.13672,0,0
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.25363,0.26587,0.17763,0,0
1,GO GTP METABOLIC PROCESS,0.00021909,0.26495,0.29925,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.099158,0.26481,0.18069,0,0
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0075304,0.26369,0.22751,0,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.033894,0.26362,0.13966,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0075304,0.25869,0.2277,0,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,8.1192e-05,0.25682,0.32118,0,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.059411,0.25648,0.22089,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00067758,0.25555,0.39055,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.10845,0.25515,0.16199,0,0
1,GO TRANSPOSITION,0.11235,0.255,0.15282,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.079444,0.2549,0.26734,0,0
1,GO EOSINOPHIL MIGRATION,0.041967,0.25414,0.272,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00057693,0.25212,0.32116,0,0
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0020453,0.25191,0.38734,0,0
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0014738,0.25166,0.27003,0,0
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00013433,0.24919,0.24322,0,0
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,4.1617e-05,0.24918,0.27314,0,0
1,GO ASYMMETRIC CELL DIVISION,0.0023671,0.24661,0.2331,0,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.054842,0.24599,0.32242,0,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00095906,0.24462,0.25646,0,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.019739,0.24388,0.21679,0,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0075304,0.24263,0.21918,0,0
1,GO ACTIVATION OF MAPKK ACTIVITY,0.00018427,0.24246,0.26835,0,0
1,GO LUNG MORPHOGENESIS,0.0064317,0.24172,0.21033,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.4978,0.24125,0.084947,0,0
1,GO NUCLEOTIDE SALVAGE,0.066855,0.24086,0.25465,0,0
1,GO PROSTATE GLAND DEVELOPMENT,0.001986,0.24038,0.25067,0,0
1,GO CHONDROCYTE PROLIFERATION,0.013465,0.23997,0.32164,0,0
1,GO CELL MATRIX ADHESION,0.00084609,0.23679,0.26961,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.016339,0.23534,0.23658,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0060989,0.2347,0.1993,0,0
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0026572,0.23408,0.36626,0,0
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.043763,0.2339,0.25877,0,0
1,GO MYOBLAST PROLIFERATION,0.099158,0.2331,0.12135,0,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.079444,0.22858,0.14193,0,0
1,GO DNA LIGATION,0.0031536,0.22828,0.22589,0,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0030654,0.2279,0.24726,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.034637,0.2254,0.17851,0,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.21256,0.22507,0.15,0,0
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0016129,0.22396,0.21261,0,0
1,GO REGULATION OF VASCULOGENESIS,0.016339,0.22229,0.29196,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.050569,0.22109,0.26394,0,0
1,GO HOMOTYPIC CELL CELL ADHESION,0.0019282,0.22029,0.23538,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.029719,0.22001,0.28023,0,0
1,GO EPOXYGENASE P450 PATHWAY,0.037747,0.21991,0.16348,0,0
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0057817,0.21934,0.21513,0,0
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012203,0.21856,0.21204,0,0
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.001872,0.21834,0.17244,0,0
1,GO NEGATIVE T CELL SELECTION,0.045624,0.21832,0.17388,0,0
1,GO OSTEOBLAST DIFFERENTIATION,0.0013457,0.21736,0.21951,0,0
1,GO URETER DEVELOPMENT,0.0059384,0.21691,0.27819,0,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.040234,0.21611,0.20634,0,0
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0022992,0.2157,0.29632,0,0
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0007696,0.21472,0.19235,0,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.093897,0.21418,0.1345,0,0
1,GO LIPID IMPORT INTO CELL,0.055956,0.21365,0.17537,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.1028,0.21327,0.31932,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.17934,0.21298,0.13392,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.009256,0.21155,0.30917,0,0
1,GO PROSTATIC BUD FORMATION,0.077957,0.20995,0.22703,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.049546,0.2093,0.21029,0,0
1,GO HEPARIN METABOLIC PROCESS,0.099158,0.20893,0.21692,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.064293,0.20818,0.17818,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.099158,0.20808,0.10487,0,0
1,GO CELL JUNCTION DISASSEMBLY,0.18508,0.2079,0.090766,0,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.0042883,0.20594,0.16137,0,0
1,GO TOOTH MINERALIZATION,0.041093,0.2058,0.20425,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.21905,0.20562,0.18313,0,0
1,GO GRANULOCYTE CHEMOTAXIS,0.011612,0.2054,0.22266,0,0
1,GO PLACENTA DEVELOPMENT,0.0025817,0.20505,0.17494,0,0
1,GO HYPEROSMOTIC RESPONSE,0.026586,0.20443,0.17192,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.014486,0.2033,0.11501,0,0
1,GO STEROID ESTERIFICATION,0.11039,0.20225,0.1437,0,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0049174,0.20191,0.20401,0,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.40349,0.20035,0.10526,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.087232,0.2003,0.27773,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.099158,0.19944,0.21149,0,0
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.092194,0.19782,0.098616,0,0
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.0060989,0.19748,0.21245,0,0
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0053338,0.19691,0.17049,0,0
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00059588,0.1955,0.1866,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.049546,0.19475,0.16097,0,0
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.046579,0.19436,0.30258,0,0
1,GO AMINE CATABOLIC PROCESS,0.040234,0.19408,0.19269,0,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.060602,0.19389,0.19049,0,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.057089,0.19349,0.15135,0,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.036948,0.19334,0.15542,0,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.077957,0.19308,0.1608,0,0
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.027188,0.19235,0.18312,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.13583,0.1918,0.11624,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.70355,0.19162,0.13677,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.11636,0.19152,0.12342,0,0
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.13583,0.19145,0.20442,0,0
1,GO AMINOGLYCAN METABOLIC PROCESS,0.0029794,0.19143,0.21696,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.055956,0.18941,0.10386,0,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.20621,0.18871,0.21362,0,0
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00095906,0.18806,0.17253,0,0
1,GO REGULATION OF HEART MORPHOGENESIS,0.054842,0.18774,0.20614,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.075049,0.18614,0.20462,0,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.013139,0.18473,0.18386,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.076492,0.18467,0.13525,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.04854,0.18349,0.16107,0,0
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.017969,0.18256,0.12948,0,0
1,GO REGULATION OF BONE DEVELOPMENT,0.0027346,0.18233,0.22108,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0087944,0.18231,0.25489,0,0
1,GO ANOIKIS,0.14769,0.18169,0.11252,0,0
1,GO BONE MORPHOGENESIS,0.0087944,0.18159,0.18494,0,0
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0034322,0.1811,0.20342,0,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.25729,0.18091,0.10979,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.010506,0.18035,0.18284,0,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00013433,0.1795,0.19367,0,0
1,GO T CELL PROLIFERATION,0.0026572,0.17897,0.18097,0,0
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.033894,0.17885,0.13847,0,0
1,GO CARNITINE METABOLIC PROCESS,0.080955,0.17869,0.19782,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.084046,0.17813,0.19032,0,0
1,GO TOXIN TRANSPORT,0.02166,0.17796,0.12749,0,0
1,GO INTERLEUKIN 5 PRODUCTION,0.066855,0.17765,0.20732,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.068167,0.17736,0.24195,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.11434,0.1764,0.18138,0,0
1,GO ALPHA BETA T CELL PROLIFERATION,0.12049,0.1763,0.17462,0,0
1,GO PROTEIN AUTOPROCESSING,0.053746,0.1761,0.10057,0,0
1,GO DETOXIFICATION,0.007729,0.17533,0.16401,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.013139,0.1751,0.21278,0,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0059384,0.17506,0.12931,0,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0015189,0.17411,0.19332,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.12049,0.17372,0.076012,0,0
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00016595,0.17348,0.17509,0,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.063042,0.17311,0.19857,0,0
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0054795,0.1723,0.22489,0,0
1,GO TRANSEPITHELIAL TRANSPORT,0.0040578,0.17223,0.1553,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.57857,0.17193,0.057627,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.41842,0.17131,0.11306,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.33812,0.17074,0.027063,0,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0050528,0.17057,0.14862,0,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.22905,0.17027,0.15071,0,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0057817,0.16981,0.13664,0,0
1,GO CARNITINE SHUTTLE,0.05161,0.16936,0.14859,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.22905,0.16926,0.11799,0,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.024846,0.16864,0.14343,0,0
1,GO AMELOGENESIS,0.05824,0.16861,0.1704,0,0
1,GO VACUOLAR TRANSPORT,0.0034322,0.1682,0.1266,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0094949,0.16807,0.16198,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.022165,0.16789,0.19088,0,0
1,GO IMP METABOLIC PROCESS,0.18219,0.16767,0.12372,0,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.19695,0.16747,0.13882,0,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0054795,0.16718,0.14212,0,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.084046,0.16699,0.10085,0,0
1,GO NUCLEUS LOCALIZATION,0.10845,0.16695,0.10562,0,0
1,GO LAMELLIPODIUM ORGANIZATION,0.00067758,0.16612,0.2036,0,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.46512,0.16597,0.051967,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.047551,0.16537,0.22473,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.023741,0.16504,0.14322,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.099158,0.16397,0.18046,0,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.055956,0.16395,0.29869,0,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.30815,0.16332,0.17212,0,0
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.39858,0.16258,0.075139,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00087311,0.16207,0.14438,0,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.001872,0.16207,0.14264,0,0
1,GO MESENCHYME DEVELOPMENT,0.0045306,0.16159,0.16454,0,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.014841,0.16128,0.15243,0,0
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.060602,0.16106,0.34159,0,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.025994,0.16073,0.36778,0,0
1,GO OXYGEN TRANSPORT,0.68418,0.16052,0.037545,0,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0036303,0.16002,0.1749,0,0
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.061812,0.15996,0.23815,0,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0028141,0.15995,0.16818,0,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.087232,0.15989,0.35095,0,0
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.2839,0.1592,0.090265,0,0
1,GO LYSOSOMAL TRANSPORT,0.0062634,0.15823,0.13446,0,0
1,GO REGULATION OF CALCIUM ION IMPORT,0.031748,0.15798,0.1315,0,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.075049,0.15671,0.099377,0,0
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.065563,0.15649,0.15067,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.25729,0.15627,0.045358,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.043763,0.15579,0.14482,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.023205,0.15577,0.15452,0,0
1,GO ANION HOMEOSTASIS,0.087232,0.15547,0.093864,0,0
1,GO SMOOTH MUSCLE CELL MIGRATION,0.068167,0.15515,0.17755,0,0
1,GO FATTY ACID HOMEOSTASIS,0.22905,0.15487,0.085793,0,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.15264,0.15365,0.24006,0,0
1,GO BLASTOCYST FORMATION,0.0021062,0.15349,0.15302,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.097379,0.1527,0.15301,0,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0090226,0.15257,0.15282,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.40843,0.15227,0.041812,0,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.025994,0.15213,0.13878,0,0
1,GO FUCOSE METABOLIC PROCESS,0.12259,0.15131,0.10971,0,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.076492,0.15071,0.14808,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.015574,0.1507,0.1789,0,0
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.019739,0.15044,0.19312,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.03245,0.15021,0.28744,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.32506,0.15012,0.059667,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.024846,0.15001,0.19129,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.059411,0.14935,0.16388,0,0
1,GO LAMELLIPODIUM ASSEMBLY,0.0028141,0.14892,0.16326,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.15773,0.14852,0.1259,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.011904,0.148,0.1952,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.1313,0.1479,0.068275,0,0
1,GO REGULATION OF BIOMINERALIZATION,0.061812,0.14774,0.15712,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.2,0.14772,0.082848,0,0
1,GO OSSIFICATION,0.016734,0.14685,0.14473,0,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.013465,0.14682,0.15281,0,0
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.055956,0.1464,0.17043,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.16828,0.14619,0.3036,0,0
1,GO NEUTROPHIL MIGRATION,0.054842,0.14577,0.18266,0,0
1,GO GOLGI LOCALIZATION,0.32938,0.14502,0.09367,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.016339,0.14495,0.17346,0,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0051916,0.14488,0.13355,0,0
1,GO TRANSCYTOSIS,0.049546,0.14396,0.12521,0,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.19393,0.14357,0.08112,0,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.14285,0.14331,0.096234,0,0
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0067808,0.14306,0.17118,0,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.0014738,0.14297,0.13446,0,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.31653,0.14295,0.10836,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.14285,0.14261,0.13651,0,0
1,GO RESPONSE TO ANTIBIOTIC,0.0073363,0.142,0.12479,0,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.065563,0.142,0.11919,0,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.010773,0.14188,0.21489,0,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.070855,0.14186,0.1435,0,0
1,GO RESPONSE TO UV C,0.014841,0.14159,0.17583,0,0
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.10845,0.14132,0.16363,0,0
1,GO RENAL FILTRATION,0.11636,0.14114,0.15775,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.29586,0.14088,0.15039,0,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.050569,0.1408,0.088302,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.25729,0.14069,0.056247,0,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.087232,0.14065,0.17681,0,0
1,GO REGULATION OF HAIR CYCLE,0.21579,0.14064,0.079787,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.090515,0.14036,0.13727,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.40349,0.14003,0.13272,0,0
1,GO POSITIVE REGULATION OF CELL SIZE,0.085627,0.13998,0.18099,0,0
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.054842,0.13989,0.10465,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.20309,0.13986,0.03376,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.12689,0.13972,0.10176,0,0
1,GO ERYTHROCYTE MATURATION,0.012203,0.13963,0.21688,0,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.034637,0.13951,0.10437,0,0
1,GO MIDGUT DEVELOPMENT,0.50896,0.13942,0.077878,0,0
1,GO RESPONSE TO DRUG,0.090515,0.13912,0.073723,0,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.049546,0.13888,0.1446,0,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.013798,0.13865,0.11152,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.017969,0.13839,0.13829,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.83713,0.13815,0.04389,0,0
1,GO SECRETION BY TISSUE,0.073629,0.13811,0.15482,0,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.0013872,0.13806,0.15589,0,0
1,GO ISOPRENOID METABOLIC PROCESS,0.16828,0.13773,0.074437,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.023741,0.13771,0.12613,0,0
1,GO ANIMAL ORGAN FORMATION,0.065563,0.13688,0.13511,0,0
1,GO REGULATION OF TISSUE REMODELING,0.095625,0.13683,0.077868,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.090515,0.13659,0.12297,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.26471,0.1363,0.034913,0,0
1,GO STEROL HOMEOSTASIS,0.10465,0.1357,0.066335,0,0
1,GO XENOBIOTIC TRANSPORT,0.063042,0.13563,0.1531,0,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.12689,0.13526,0.06172,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.073629,0.13463,0.066702,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.010773,0.1338,0.14338,0,0
1,GO EOSINOPHIL CHEMOTAXIS,0.23937,0.13337,0.21825,0,0
1,GO REGULATION OF T CELL CHEMOTAXIS,0.036948,0.13316,0.16223,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.30402,0.13289,0.068888,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.44924,0.13255,0.035295,0,0
1,GO EPITHELIAL CELL PROLIFERATION,0.017137,0.13195,0.12532,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.087232,0.13109,0.1863,0,0
1,GO REGULATION OF CHEMOTAXIS,0.018836,0.13062,0.11769,0,0
1,GO RESPONSE TO VITAMIN A,0.20309,0.13041,0.078586,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.26847,0.13038,0.059863,0,0
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0028141,0.13018,0.14807,0,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0013054,0.13015,0.10366,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.19695,0.1297,0.090316,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.040234,0.1293,0.14605,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.40843,0.1291,0.050608,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.4598,0.129,0.057082,0,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.046579,0.12877,0.11263,0,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010773,0.12811,0.14349,0,0
1,GO PULMONARY VALVE MORPHOGENESIS,0.13814,0.12713,0.32994,0,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.14285,0.1269,0.11422,0,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0073363,0.12679,0.12336,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.53742,0.12662,0.039798,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.53742,0.12625,0.077243,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.15015,0.12596,0.10258,0,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.021165,0.12584,0.09145,0,0
1,GO AMYLOID BETA FORMATION,0.30402,0.12573,0.070941,0,0
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.23937,0.12529,0.06985,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.038561,0.12507,0.1263,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.36526,0.12498,0.084185,0,0
1,GO RNA DECAPPING,0.0049174,0.12496,0.14916,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.26847,0.12493,0.11205,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.024288,0.1244,0.12585,0,0
1,GO RESPONSE TO INTERLEUKIN 6,0.19695,0.1244,0.084358,0,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.037747,0.12418,0.16299,0,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.14526,0.12333,0.084114,0,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.036948,0.12304,0.12585,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.017549,0.12289,0.13704,0,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.13355,0.12277,0.090423,0,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.010506,0.12251,0.09612,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.12259,0.12219,0.14887,0,0
1,GO LIPID MODIFICATION,0.027188,0.12189,0.090111,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.89215,0.12161,-0.016587,0,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.19095,0.12153,0.065558,0,0
1,GO PROTEIN KINASE C SIGNALING,0.56666,0.12136,-0.0076508,0,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.11434,0.12126,0.10881,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.11841,0.12103,0.14177,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.19095,0.12093,0.1139,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.40843,0.12071,0.12629,0,0
1,GO AMYLOID FIBRIL FORMATION,0.22905,0.12069,0.14047,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.19393,0.12067,0.10022,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.14285,0.12055,0.054848,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.17374,0.1204,0.080545,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.16294,0.12014,0.10129,0,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.31653,0.12007,0.06582,0,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0036303,0.11959,0.15801,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.12049,0.11942,0.16051,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.090515,0.11937,0.18511,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.29992,0.11936,0.14606,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.39371,0.11872,0.13263,0,0
1,GO REGULATION OF OSSIFICATION,0.025994,0.11837,0.14221,0,0
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.066855,0.11826,0.094613,0,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.054842,0.11814,0.081411,0,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.44402,0.11812,0.097451,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.40349,0.11811,0.040274,0,0
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.053746,0.11801,0.09631,0,0
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.24643,0.11794,0.072728,0,0
1,GO B CELL PROLIFERATION,0.53167,0.11791,0.010423,0,0
1,GO NAD METABOLIC PROCESS,0.18508,0.11777,0.098202,0,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.16294,0.11758,0.07188,0,0
1,GO LIVER MORPHOGENESIS,0.12689,0.11754,0.13971,0,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.049546,0.1175,0.070956,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.075049,0.11733,0.10493,0,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.23245,0.11719,0.11878,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.10654,0.11699,0.11461,0,0
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.010773,0.11678,0.17083,0,0
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.31232,0.11652,0.089058,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.18219,0.1164,0.19766,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.63354,0.116,-0.093794,0,0
1,GO TISSUE MORPHOGENESIS,0.0031536,0.11597,0.12441,0,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0066042,0.11568,0.12589,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.17934,0.11567,0.13219,0,0
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.035393,0.11487,0.13076,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.20309,0.1142,0.075889,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.63354,0.11386,0.0047277,0,0
1,GO L GLUTAMATE IMPORT,0.090515,0.11381,0.14838,0,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.1313,0.11376,0.14454,0,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.066855,0.11358,0.12303,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.12259,0.11304,0.094621,0,0
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.44402,0.11283,0.046595,0,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.0028957,0.1128,0.15107,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.59059,0.11264,0.09416,0,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.02843,0.11231,0.11946,0,0
1,GO DRUG METABOLIC PROCESS,0.19393,0.11231,0.037842,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.061812,0.11214,0.087557,0,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.36526,0.11175,0.15268,0,0
1,GO LIPID LOCALIZATION,0.05824,0.11159,0.062059,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.67776,0.1115,0.019495,0,0
1,GO MUSCLE ADAPTATION,0.14285,0.11125,0.067372,0,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.065563,0.11125,0.090064,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.057089,0.11111,0.089147,0,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.32506,0.11088,0.098466,0,0
1,GO ASTROCYTE DIFFERENTIATION,0.020205,0.11073,0.14403,0,0
1,GO REGULATION OF PROTEIN SUMOYLATION,0.10096,0.11062,0.12141,0,0
1,GO LEUKOCYTE CHEMOTAXIS,0.11039,0.1106,0.13008,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.36991,0.11045,0.074708,0,0
1,GO PLASMA MEMBRANE ORGANIZATION,0.079444,0.11022,0.084473,0,0
1,GO NEURAL CREST CELL DIFFERENTIATION,0.23589,0.11007,0.10358,0,0
1,GO UV PROTECTION,0.4545,0.11007,0.081092,0,0
1,GO CELLULAR PIGMENTATION,0.11039,0.10983,0.07092,0,0
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.14526,0.10981,0.15529,0,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.026586,0.1098,0.10798,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.4598,0.10974,0.094227,0,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.10654,0.10942,0.11674,0,0
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.25001,0.10937,0.085691,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0099891,0.10932,0.11327,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.70355,0.10919,0.034263,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.39371,0.10889,0.075819,0,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.055956,0.10888,0.12999,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.44402,0.10827,0.042893,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.15015,0.10817,0.15305,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.41842,0.10794,0.031933,0,0
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.025994,0.10782,0.12113,0,0
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00084609,0.10756,0.13462,0,0
1,GO MIRNA METABOLIC PROCESS,0.010245,0.10722,0.12689,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.23589,0.10708,0.10195,0,0
1,GO LIPID HOMEOSTASIS,0.1028,0.10705,0.045257,0,0
1,GO GLIAL CELL MIGRATION,0.16559,0.10696,0.097923,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0034322,0.10688,0.11243,0,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.16294,0.10682,0.085958,0,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.88523,0.10674,-0.05957,0,0
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0094949,0.10655,0.14413,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.69061,0.10644,0.045025,0,0
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00047456,0.1062,0.10416,0,0
1,GO TUBE DEVELOPMENT,0.009256,0.10599,0.12101,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.093897,0.10576,0.17161,0,0
1,GO OXALATE TRANSPORT,0.22235,0.10567,0.052502,0,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.14048,0.10535,0.09601,0,0
1,GO CENTRIOLE CENTRIOLE COHESION,0.031748,0.10523,0.14387,0,0
1,GO PERICARDIUM DEVELOPMENT,0.023741,0.1051,0.17418,0,0
1,GO VITAMIN D METABOLIC PROCESS,0.25001,0.10499,0.12572,0,0
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.20309,0.10492,0.18176,0,0
1,GO KINETOCHORE ASSEMBLY,0.16559,0.10447,0.11346,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.58456,0.104,0.040999,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.04854,0.10385,0.12481,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.4598,0.10379,0.074194,0,0
1,GO AMYLOID BETA METABOLIC PROCESS,0.33373,0.10362,0.05731,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.070855,0.10346,0.087733,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.061812,0.10344,0.080453,0,0
1,GO HISTONE ARGININE METHYLATION,0.26098,0.10344,0.060904,0,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.12689,0.10311,0.049419,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.055956,0.10305,0.090669,0,0
1,GO FAT CELL DIFFERENTIATION,0.087232,0.10288,0.064195,0,0
1,GO OVULATION CYCLE PROCESS,0.35153,0.10287,0.058892,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.060602,0.10284,0.17438,0,0
1,GO GLIAL CELL DEVELOPMENT,0.41341,0.10283,0.02892,0,0
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.023205,0.10272,0.14369,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.40349,0.10267,0.056781,0,0
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.17934,0.10262,0.090495,0,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.52594,0.10251,0.064952,0,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.04854,0.10224,0.057062,0,0
1,GO LIPID DIGESTION,0.44924,0.10149,0.024485,0,0
1,GO REGULATION OF RECEPTOR BINDING,0.065563,0.1014,0.25198,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.12049,0.10135,0.12729,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.15015,0.10111,0.11904,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.072231,0.10099,0.12446,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.15264,0.10073,0.12655,0,0
1,GO REGULATION OF BONE MINERALIZATION,0.10654,0.10064,0.1508,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.14526,0.10062,0.0888,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.5726,0.1004,0.0605,0,0
1,GO GONADOTROPIN SECRETION,0.13814,0.10039,0.16662,0,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.13583,0.10028,0.13638,0,0
1,GO ALCOHOL METABOLIC PROCESS,0.057089,0.10003,0.065035,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.15264,0.099359,0.11272,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.099158,0.098981,0.06826,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.37932,0.098895,0.071396,0,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.22905,0.098619,0.084458,0,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.044685,0.098571,0.080246,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.12908,0.098552,0.17459,0,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.33812,0.098392,0.064337,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.35153,0.098194,0.052173,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.14526,0.098159,0.073004,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17374,0.098147,0.056131,0,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.17099,0.097964,0.12143,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.088862,0.097866,0.070582,0,0
1,GO RESPONSE TO PH,0.12689,0.097757,0.12467,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.11434,0.097663,0.12368,0,0
1,GO HEAD MORPHOGENESIS,0.043763,0.09765,0.16368,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.015203,0.097422,0.16856,0,0
1,GO NEPHRON DEVELOPMENT,0.031748,0.097375,0.13245,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.082489,0.097307,0.17754,0,0
1,GO PROTEIN SUMOYLATION,0.075049,0.097258,0.068642,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.23589,0.097206,0.073907,0,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.057089,0.096924,0.15556,0,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.082489,0.096691,0.13368,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.33812,0.096612,0.086595,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.12908,0.096224,0.11096,0,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.013139,0.095801,0.11101,0,0
1,GO RNA EXPORT FROM NUCLEUS,0.014841,0.095706,0.10717,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.13355,0.095333,0.04135,0,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.052669,0.095194,0.11841,0,0
1,GO MYOTUBE DIFFERENTIATION,0.031748,0.094963,0.11916,0,0
1,GO GOLGI RIBBON FORMATION,0.20937,0.094949,0.087675,0,0
1,GO GAS TRANSPORT,0.29586,0.094851,0.098973,0,0
1,GO MANGANESE ION TRANSPORT,0.25001,0.094835,0.084513,0,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.084046,0.09425,0.13755,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.75615,0.094148,-0.0056427,0,0
1,GO B CELL APOPTOTIC PROCESS,0.52594,0.093761,0.025346,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.20937,0.093741,0.097666,0,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.51459,0.093724,0.029778,0,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.093897,0.093378,0.10595,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.19695,0.093319,0.11975,0,0
1,GO COCHLEA MORPHOGENESIS,0.69707,0.093287,-0.014563,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.15517,0.092981,0.10161,0,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.12908,0.092849,0.0695,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.26847,0.092783,0.040407,0,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.017969,0.092602,0.072901,0,0
1,GO NEUROINFLAMMATORY RESPONSE,0.23245,0.092389,0.14404,0,0
1,GO REPLACEMENT OSSIFICATION,0.070855,0.092248,0.16977,0,0
1,GO RESPONSE TO GROWTH FACTOR,0.016339,0.092111,0.11194,0,0
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.21256,0.092078,0.067144,0,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.36064,0.091602,0.052397,0,0
1,GO RESPONSE TO NUTRIENT,0.41842,0.091502,0.042269,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.81668,0.091295,0.027761,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.67137,0.090847,-0.0068832,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.41842,0.090835,0.073541,0,0
1,GO REGULATION OF CHROMOSOME SEPARATION,0.02268,0.090682,0.129,0,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.22568,0.090624,0.096477,0,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.066855,0.090563,0.10733,0,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.055956,0.090169,0.37625,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.23937,0.08995,0.10036,0,0
1,GO MYELIN MAINTENANCE,0.41842,0.089713,0.06229,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.72313,0.089501,0.088878,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.23589,0.089257,0.035954,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.56666,0.089244,0.041492,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0021689,0.089227,0.093206,0,0
1,GO LYTIC VACUOLE ORGANIZATION,0.61497,0.088952,0.003331,0,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.7495,0.088922,0.0066319,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.64605,0.088799,0.008731,0,0
1,GO RESPONSE TO TUMOR CELL,0.10654,0.088675,0.12808,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.05161,0.088606,0.070521,0,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.012508,0.088465,0.091666,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.060602,0.088235,0.062239,0,0
1,GO DIOL METABOLIC PROCESS,0.32938,0.088059,0.044173,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.67776,0.087698,-0.012882,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.22905,0.087515,0.087991,0,0
1,GO RESPONSE TO VITAMIN,0.65234,0.087443,0.036043,0,0
1,GO PROTEIN DEMANNOSYLATION,0.11841,0.086525,0.11526,0,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00063551,0.086291,0.099441,0,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.31232,0.086246,0.051807,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.41842,0.085861,0.03633,0,0
1,GO MICROVILLUS ASSEMBLY,0.43883,0.085634,0.033377,0,0
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.011326,0.085294,0.058323,0,0
1,GO ORGAN GROWTH,0.0090226,0.085118,0.13347,0,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.049546,0.084939,0.061309,0,0
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.072231,0.084878,0.13309,0,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.025994,0.084843,0.082003,0,0
1,GO COENZYME A METABOLIC PROCESS,0.40843,0.084763,0.062312,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.044685,0.083992,0.13905,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.63354,0.083294,0.038778,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.89907,0.083121,0.031277,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.50337,0.083022,0.035711,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.25363,0.082897,0.071079,0,0
1,GO REGULATION OF GLIAL CELL MIGRATION,0.14526,0.082844,0.10446,0,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.05824,0.082175,0.070306,0,0
1,GO MRNA EXPORT FROM NUCLEUS,0.02843,0.082166,0.085553,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.11434,0.081978,0.1182,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.19393,0.081684,0.091699,0,0
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.079444,0.081659,0.14469,0,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.15264,0.081642,0.061706,0,0
1,GO DNA GEOMETRIC CHANGE,0.04854,0.08162,0.086951,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.12908,0.08151,0.069432,0,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.093897,0.081417,0.099682,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.60272,0.0814,0.059374,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.36064,0.081307,0.03878,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.32938,0.080938,0.14786,0,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.14526,0.08093,0.058784,0,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.070855,0.080863,0.061925,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.71658,0.080782,0.067385,0,0
1,GO MACROPHAGE ACTIVATION,0.18508,0.080018,0.11104,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.15015,0.079923,0.098564,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.099158,0.079793,0.085204,0,0
1,GO REGULATION OF ATP METABOLIC PROCESS,0.12908,0.079168,0.054838,0,0
1,GO FATTY ACID TRANSPORT,0.099158,0.079145,0.064404,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.44402,0.079059,0.0048561,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.67137,0.079034,0.067406,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.092194,0.078764,0.057488,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.17374,0.078475,0.063535,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.26847,0.078385,0.07776,0,0
1,GO TERPENOID METABOLIC PROCESS,0.40843,0.078365,0.046098,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.85082,0.078319,-0.011432,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17653,0.078259,0.049064,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.20937,0.078037,0.077621,0,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.25363,0.077965,0.086744,0,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.13355,0.077889,0.057249,0,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.047551,0.077648,0.070214,0,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.22905,0.077582,0.13068,0,0
1,GO STEROID METABOLIC PROCESS,0.21905,0.077547,0.025394,0,0
1,GO NCRNA CATABOLIC PROCESS,0.15015,0.077512,0.10644,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.74288,0.077484,0.034573,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.43883,0.077396,0.053594,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.21905,0.077243,0.052289,0,0
1,GO RESPONSE TO GONADOTROPIN,0.16828,0.077209,0.12175,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.65866,0.077141,0.10256,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.082489,0.077115,0.12451,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.077957,0.077036,0.062476,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.44924,0.076941,0.034688,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.20937,0.07679,0.043007,0,0
1,GO ZINC ION HOMEOSTASIS,0.47049,0.076758,0.12561,0,0
1,GO AORTA DEVELOPMENT,0.12473,0.07674,0.16847,0,0
1,GO CELLULAR RESPONSE TO KETONE,0.37932,0.076654,0.028268,0,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.15015,0.076622,0.06889,0,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.021165,0.076609,0.076922,0,0
1,GO MALE SEX DIFFERENTIATION,0.14048,0.076574,0.069654,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.26098,0.076345,0.094824,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.67776,0.076068,0.014926,0,0
1,GO NEURAL CREST FORMATION,0.83713,0.075967,-0.016933,0,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.072231,0.075937,0.092546,0,0
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.26847,0.075931,0.041656,0,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.027803,0.075809,0.082642,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.2839,0.075755,0.055467,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.05161,0.075747,0.0784,0,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.20309,0.075576,0.080863,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.41341,0.075392,0.043094,0,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.011047,0.075382,0.12081,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.19393,0.075176,0.066364,0,0
1,GO VESICLE ORGANIZATION,0.097379,0.075109,0.045959,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.80312,0.075097,0.012092,0,0
1,GO POSITIVE REGULATION OF DNA BINDING,0.46512,0.074507,0.047831,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.095625,0.074471,0.087986,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.03939,0.074288,0.12628,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.54903,0.074143,0.093185,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.59664,0.0741,0.016884,0,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.053746,0.073966,0.075381,0,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.16294,0.073817,0.085758,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.18508,0.073675,0.10045,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.40349,0.073471,0.020959,0,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.26098,0.073459,0.068483,0,0
1,GO RESPONSE TO PEPTIDE HORMONE,0.052669,0.073238,0.057774,0,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.27227,0.073184,0.065481,0,0
1,GO BIOLOGICAL ADHESION,0.11235,0.073046,0.073027,0,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.53742,0.073016,0.019155,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.12689,0.072574,0.10055,0,0
1,GO RESPIRATORY BURST,0.64605,0.072495,0.01901,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.46512,0.072214,0.081796,0,0
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.21256,0.072179,0.069845,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.17934,0.072153,0.084402,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.11434,0.072017,0.14211,0,0
1,GO GMP METABOLIC PROCESS,0.57857,0.071907,0.017119,0,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.10845,0.071856,0.075053,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.30815,0.071716,0.067386,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.50896,0.071634,0.047444,0,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.16032,0.071499,0.059579,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.26847,0.071422,0.038798,0,0
1,GO ATP METABOLIC PROCESS,0.04854,0.071083,0.067696,0,0
1,GO HISTONE DEUBIQUITINATION,0.30402,0.071015,0.04068,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.2839,0.070983,0.09483,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.15773,0.070765,0.14114,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.22568,0.070703,0.097745,0,0
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.060602,0.070468,0.04997,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.83713,0.07035,0.0043962,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.014486,0.06994,0.086668,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.42855,0.06956,0.1186,0,0
1,GO ESTABLISHMENT OF CELL POLARITY,0.2,0.069559,0.049133,0,0
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.10845,0.069487,0.11741,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.43883,0.06936,0.061092,0,0
1,GO RESPONSE TO IRON ION,0.15015,0.069339,0.092496,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.4978,0.069053,0.021933,0,0
1,GO THIOESTER METABOLIC PROCESS,0.25363,0.069052,0.062605,0,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.34702,0.068946,0.03441,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.17374,0.068865,0.060264,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.93377,0.068712,-0.0054287,0,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.11434,0.068691,0.12762,0,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.11039,0.068667,0.055062,0,0
1,GO OVULATION CYCLE,0.23245,0.068509,0.089693,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.049546,0.068479,0.086512,0,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.12259,0.068394,0.045443,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.78962,0.068318,0.017875,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.29184,0.06805,0.067849,0,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.47588,0.067969,0.067571,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.43883,0.067837,0.23343,0,0
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.14048,0.067603,0.12725,0,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.024288,0.067509,0.10362,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.89215,0.067423,-0.023133,0,0
1,GO PROTEIN TETRAMERIZATION,0.15015,0.067371,0.051034,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.11434,0.067277,0.067069,0,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.48131,0.067266,0.026346,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.053746,0.066812,0.060318,0,0
1,GO HUMORAL IMMUNE RESPONSE,0.092194,0.066761,0.067326,0,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.14769,0.066541,0.056204,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.56075,0.066419,0.067708,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.31232,0.066417,0.046323,0,0
1,GO EXTRACELLULAR TRANSPORT,0.52025,0.066342,0.044001,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.66501,0.066286,0.02047,0,0
1,GO PROTEIN DESTABILIZATION,0.21256,0.065932,0.053228,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.9686,0.065843,-0.015806,0,0
1,GO TRANSFERRIN TRANSPORT,0.25001,0.065836,0.039865,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.097379,0.06579,0.12957,0,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.050569,0.065757,0.053586,0,0
1,GO AMMONIUM TRANSPORT,0.097379,0.065542,0.13664,0,0
1,GO INTERLEUKIN 6 PRODUCTION,0.28785,0.065418,0.081241,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.27227,0.065135,0.086279,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.12259,0.065067,0.10486,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.72969,0.065051,0.078181,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.57857,0.064914,0.026541,0,0
1,GO TRABECULA MORPHOGENESIS,0.064293,0.064758,0.15692,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.42347,0.064446,0.18228,0,0
1,GO RESPONSE TO COPPER ION,0.26847,0.064379,0.12836,0,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.079444,0.064287,0.044818,0,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.14526,0.063779,0.050429,0,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.25001,0.063639,0.11487,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.095625,0.063551,0.042847,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.43883,0.06345,0.10461,0,0
1,GO CELL MOTILITY,0.10845,0.06341,0.061222,0,0
1,GO MAMMARY GLAND DEVELOPMENT,0.18508,0.063394,0.077062,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.21579,0.063244,0.069399,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.5726,0.063234,-0.00037927,0,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.076492,0.06294,0.1148,0,0
1,GO TISSUE HOMEOSTASIS,0.19393,0.062816,0.042346,0,0
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.4545,0.062698,0.070674,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.56075,0.06253,0.039897,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.2,0.062473,0.10338,0,0
1,GO ARTERY DEVELOPMENT,0.024288,0.062426,0.19675,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.36526,0.062225,0.10016,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.64605,0.062146,0.025965,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.89907,0.062038,-0.017919,0,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.97557,0.061814,0.091985,0,0
1,GO CELL CYCLE ARREST,0.16828,0.06167,0.039209,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.072231,0.061522,0.036401,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.27999,0.061495,0.091919,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.26471,0.061298,0.1143,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.79636,0.061172,0.0071944,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.40843,0.061156,0.041302,0,0
1,GO EPITHELIUM DEVELOPMENT,0.17099,0.060936,0.047232,0,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.1313,0.060905,0.053428,0,0
1,GO FOLIC ACID METABOLIC PROCESS,0.28785,0.060766,0.046781,0,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.053746,0.06067,0.1405,0,0
1,GO FEVER GENERATION,0.87144,0.060594,0.083308,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.40843,0.060584,0.082217,0,0
1,GO STEROL METABOLIC PROCESS,0.60272,0.060435,0.0092808,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.13583,0.060198,0.039779,0,0
1,GO SPINDLE ASSEMBLY,0.43367,0.060175,0.021759,0,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.1313,0.060159,0.061921,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.39371,0.060093,0.03897,0,0
1,GO REGULATION OF MESODERM DEVELOPMENT,0.50337,0.060069,0.11305,0,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.014138,0.060064,0.16788,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.55487,0.059957,0.028679,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.64605,0.059843,0.018053,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.13583,0.059798,0.068842,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.36526,0.059732,0.035701,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.11434,0.059721,0.057017,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.077957,0.059695,0.090282,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.44402,0.059543,0.038499,0,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.40349,0.059461,0.029799,0,0
1,GO REGULATION OF TUBE SIZE,0.24643,0.059309,0.065206,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.36991,0.05929,0.095969,0,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.070855,0.059271,0.063999,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.73628,0.05927,0.0040903,0,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.24643,0.059214,0.099444,0,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.21579,0.058885,0.062679,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.38408,0.058649,0.073481,0,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.33812,0.058516,0.04453,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.13355,0.058509,0.05281,0,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.05824,0.058396,0.076602,0,0
1,GO REGULATION OF DNA BINDING,0.39858,0.05827,0.030488,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.62113,0.058249,0.0089961,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.29992,0.05823,0.026237,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.44402,0.058036,0.036348,0,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.5726,0.057936,0.06158,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.97557,0.057845,0.11576,0,0
1,GO REGULATION OF PROTEIN TARGETING,0.32077,0.057624,0.035357,0,0
1,GO CARDIOCYTE DIFFERENTIATION,0.12049,0.057503,0.098232,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.37932,0.057469,0.022336,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.79636,0.057445,0.0386,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.92682,0.057425,-0.031429,0,0
1,GO RESPONSE TO STEROL,0.31653,0.057303,0.061484,0,0
1,GO NEGATIVE REGULATION OF BINDING,0.085627,0.057237,0.063985,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.4598,0.056986,0.022288,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.62113,0.056703,0.016415,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.16559,0.056659,0.056439,0,0
1,GO CELL CELL ADHESION,0.48678,0.056643,0.02731,0,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.44924,0.056636,0.078002,0,0
1,GO DNA CATABOLIC PROCESS,0.11636,0.056617,0.047888,0,0
1,GO DNA REPAIR,0.011612,0.056532,0.063001,0,0
1,GO PROSTAGLANDIN SECRETION,0.072231,0.056519,0.13235,0,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.082489,0.056398,0.055639,0,0
1,GO P BODY ASSEMBLY,0.59664,0.056302,0.015488,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.33373,0.056023,0.13031,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.42347,0.055846,0.035496,0,0
1,GO VIRAL LATENCY,0.9686,0.055831,-0.0045077,0,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.39371,0.055821,0.049521,0,0
1,GO ODONTOGENESIS,0.17099,0.055814,0.097517,0,0
1,GO MACROMOLECULE DEACYLATION,0.10654,0.055667,0.053737,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.23245,0.055285,0.056763,0,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.62732,0.055154,0.025379,0,0
1,GO NADH METABOLIC PROCESS,0.39858,0.055143,0.057199,0,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.17099,0.054847,0.036243,0,0
1,GO INOSITOL METABOLIC PROCESS,0.53167,0.054556,0.029228,0,0
1,GO CHROMOSOME CONDENSATION,0.049546,0.054258,0.091708,0,0
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.16828,0.054186,0.050673,0,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.1028,0.05399,0.059207,0,0
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.052669,0.053912,0.076765,0,0
1,GO RESPONSE TO ACIDIC PH,0.47588,0.0539,0.038563,0,0
1,GO HEART GROWTH,0.11039,0.053854,0.091209,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.87833,0.053589,0.03148,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.29184,0.05351,0.052605,0,0
1,GO REGULATION OF AMYLOID BETA FORMATION,0.36526,0.05337,0.06769,0,0
1,GO RESPONSE TO RADIATION,0.12259,0.053309,0.020932,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.21579,0.052936,0.02963,0,0
1,GO DNA METHYLATION,0.70355,0.052655,-0.0017135,0,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.20621,0.052607,0.076249,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.40349,0.052035,0.069508,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.56075,0.051963,0.082771,0,0
1,GO REGULATION OF MUSCLE ADAPTATION,0.64605,0.051694,0.014273,0,0
1,GO REGULATION OF CELL SHAPE,0.1028,0.051665,0.098882,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.39858,0.051395,0.078106,0,0
1,GO POSITIVE REGULATION OF CELL DIVISION,0.56666,0.051367,0.057199,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.27227,0.051353,0.13264,0,0
1,GO KETONE CATABOLIC PROCESS,0.67137,0.051304,-0.055173,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.036948,0.051299,0.086022,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.34702,0.051208,0.050504,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.053746,0.051142,0.085686,0,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.70355,0.051098,0.011257,0,0
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.052669,0.051054,0.089488,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.3746,0.050907,0.061817,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.19393,0.050844,0.076067,0,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.32938,0.050807,0.11124,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.62113,0.050769,0.039271,0,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.22905,0.050597,0.027342,0,0
1,GO NEGATIVE REGULATION OF GROWTH,0.37932,0.050453,0.032656,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.56666,0.050143,0.069482,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.54903,0.05,0.065044,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.10654,0.049836,0.039343,0,0
1,GO CHROMATIN DISASSEMBLY,0.88523,0.049754,-0.018609,0,0
1,GO DNA REPLICATION INITIATION,0.5726,0.049697,0.0067559,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.23245,0.049442,0.078112,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.30815,0.04939,0.065162,0,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.087232,0.049389,0.048258,0,0
1,GO ENDOSOMAL TRANSPORT,0.053746,0.049128,0.055359,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.26098,0.048978,0.073112,0,0
1,GO RESPONSE TO STEROL DEPLETION,1,0.048757,-0.024128,0,0
1,GO JNK CASCADE,0.26471,0.048701,0.03214,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.25001,0.048647,0.094979,0,0
1,GO CHROMOSOME SEPARATION,0.046579,0.04863,0.099312,0,0
1,GO NEUTROPHIL CHEMOTAXIS,0.4978,0.048621,0.13234,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.59664,0.048417,0.037797,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.24643,0.048339,0.083475,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.5726,0.048181,0.075921,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.10845,0.048181,0.063338,0,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.56075,0.048177,0.038399,0,0
1,GO VITAMIN METABOLIC PROCESS,0.11235,0.048156,0.057749,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.30815,0.047863,0.082698,0,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.14285,0.047796,0.073657,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.15517,0.047779,0.053579,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.35153,0.047639,0.027677,0,0
1,GO NUCLEAR MIGRATION,0.65866,0.047507,0.025713,0,0
1,GO HISTONE H3 DEACETYLATION,0.38408,0.047461,0.051959,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.29586,0.047205,0.046694,0,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.15264,0.047171,0.11504,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.50896,0.047166,0.047613,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.31653,0.0471,0.033167,0,0
1,GO SKIN DEVELOPMENT,0.26471,0.047054,0.062655,0,0
1,GO REGULATION OF CYTOKINESIS,0.44402,0.047043,0.023987,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.62113,0.047019,0.042554,0,0
1,GO MRNA PROCESSING,0.27999,0.047,0.029358,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.33812,0.046992,0.049797,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.070855,0.046942,0.040283,0,0
1,GO LYMPH NODE DEVELOPMENT,0.61497,0.046715,0.07596,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.53167,0.046432,0.14318,0,0
1,GO ARTERY MORPHOGENESIS,0.40843,0.045882,0.14434,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.53167,0.045824,0.03936,0,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.71006,0.045658,0.016599,0,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.031059,0.045601,0.10754,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.9686,0.045542,-0.0052493,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.89215,0.045492,-0.0046941,0,0
1,GO PHOTOPERIODISM,0.30815,0.045431,0.021681,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.21905,0.045387,0.033758,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.47588,0.045363,0.051599,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.60883,0.045201,0.037227,0,0
1,GO CELL CELL SIGNALING BY WNT,0.1028,0.045058,0.066518,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.3746,0.045012,0.023317,0,0
1,GO CARDIAC CHAMBER DEVELOPMENT,0.17934,0.04488,0.080483,0,0
1,GO RESPONSE TO INSULIN,0.47588,0.04469,0.010237,0,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.29184,0.044629,0.059991,0,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.14048,0.044607,0.14012,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.27611,0.044557,0.033853,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.75615,0.044512,0.019715,0,0
1,GO THYROID GLAND DEVELOPMENT,0.59059,0.044418,0.062243,0,0
1,GO MULTI ORGANISM PROCESS,0.21905,0.044353,0.019498,0,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.25001,0.044337,0.072584,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.21905,0.044312,0.045081,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.85082,0.044161,-0.046839,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.66501,0.044148,0.016516,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.36064,0.043887,0.062256,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.4598,0.043712,0.08487,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.76281,0.043599,0.0052906,0,0
1,GO MICROVILLUS ORGANIZATION,0.29184,0.042972,-0.12239,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.80989,0.042959,0.019846,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.91293,0.042884,-0.025158,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.72969,0.042781,0.0046677,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.36991,0.042752,0.03718,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.42347,0.042707,0.056641,0,0
1,GO SNRNA TRANSCRIPTION,0.025994,0.042433,0.068205,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.74288,0.04231,0.017088,0,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.22235,0.042124,0.021964,0,0
1,GO OSTEOBLAST PROLIFERATION,0.59059,0.042074,0.084947,0,0
1,GO HISTONE H2A ACETYLATION,0.54903,0.042006,0.020463,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.57857,0.041933,-0.0054119,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.72969,0.041848,0.002369,0,0
1,GO POSITIVE REGULATION OF URINE VOLUME,0.44402,0.041802,0.10181,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.63354,0.041788,0.066274,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.29184,0.041623,0.036471,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.44924,0.041559,0.02795,0,0
1,GO HOMEOSTATIC PROCESS,0.68418,0.041523,-5.4429e-05,0,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.05161,0.041453,0.038987,0,0
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.39858,0.041286,0.031922,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.89215,0.041251,-0.0052011,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.51459,0.041182,0.04764,0,0
1,GO NEUROBLAST DIVISION,0.60272,0.040898,0.030427,0,0
1,GO INTRACELLULAR LIPID TRANSPORT,0.32506,0.040674,0.058526,0,0
1,GO RESPONSE TO ALCOHOL,0.57857,0.04056,0.024057,0,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.59059,0.040437,0.015612,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.74288,0.0404,0.036979,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.29184,0.040223,0.078751,0,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.19393,0.040049,0.038034,0,0
1,GO SPECIFICATION OF SYMMETRY,0.32077,0.040005,0.036106,0,0
1,GO MUSCLE ORGAN DEVELOPMENT,0.079444,0.039935,0.069315,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.34702,0.039891,0.042819,0,0
1,GO RESPONSE TO ZINC ION,0.40349,0.03988,0.086164,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.35607,0.039879,0.020855,0,0
1,GO POSITIVE REGULATION OF SIGNALING,0.17653,0.039844,0.033887,0,0
1,GO CENTROSOME DUPLICATION,0.19695,0.039399,0.055087,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.47588,0.039338,0.040801,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.40843,0.039006,0.044014,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.4598,0.03898,0.076762,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.59059,0.038977,-0.039156,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.41341,0.038862,0.042942,0,0
1,GO PRE MIRNA PROCESSING,0.80312,0.038828,0.0069024,0,0
1,GO NCRNA TRANSCRIPTION,0.13583,0.038825,0.057939,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.69707,0.038777,0.003402,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.94073,0.038662,-4.6369e-05,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.21905,0.03862,0.080214,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.89215,0.038602,-0.0079513,0,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.46512,0.038542,0.038553,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.67137,0.03854,0.008637,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0695,0.038424,0.083003,0,0
1,GO ACTIN FILAMENT BASED PROCESS,0.21256,0.038119,0.051491,0,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.18508,0.037646,0.067167,0,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.17934,0.037635,0.046166,0,0
1,GO RNA SPLICING,0.25363,0.037617,0.028134,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.63978,0.037397,0.00030294,0,0
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.28785,0.037202,0.069254,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.27999,0.03683,0.05535,0,0
1,GO EMBRYO DEVELOPMENT,0.31653,0.036722,0.032248,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.61497,0.036684,-0.07814,0,0
1,GO ACTIN NUCLEATION,0.32506,0.036577,0.012498,0,0
1,GO STEM CELL DIVISION,0.49227,0.036463,0.062773,0,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.27227,0.036279,0.036372,0,0
1,GO SULFATION,0.71006,0.036169,0.027379,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.89215,0.036134,-0.024693,0,0
1,GO LOCOMOTOR RHYTHM,0.80989,0.036037,0.023898,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.46512,0.035794,0.062801,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.48678,0.035723,0.037569,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.91293,0.035458,-0.027594,0,0
1,GO REPRODUCTION,0.52025,0.035366,0.0048839,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.21905,0.034862,0.055029,0,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.10096,0.034851,0.054886,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.13355,0.034831,0.035324,0,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.50337,0.034797,0.026666,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.93377,0.034792,-0.019419,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.91293,0.034492,-0.034431,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.85082,0.034053,-0.00083585,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.76281,0.033958,-0.11671,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.50896,0.033894,0.077356,0,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.32506,0.033845,0.032771,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.39858,0.033773,0.031629,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.83713,0.033668,0.0075247,0,0
1,GO MYELOID CELL DEVELOPMENT,0.32506,0.033632,0.044633,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.71006,0.033587,0.081431,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.063042,0.03355,0.06129,0,0
1,GO VITAMIN TRANSPORT,0.42855,0.033508,0.031338,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.21256,0.03332,0.039002,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.30815,0.033175,0.033823,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.62732,0.032916,0.0032626,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.44924,0.032767,0.049177,0,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.43883,0.032605,0.031179,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.71006,0.032526,0.027388,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.85768,0.032487,0.0013542,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.46512,0.032413,0.056685,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.59059,0.032355,0.041721,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.25729,0.032325,0.033406,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.69061,0.032295,-0.033612,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.69707,0.032135,0.0084603,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.87144,0.032082,0.00049222,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.69061,0.031988,0.0026269,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.48678,0.03191,0.028682,0,0
1,GO REGULATION OF GTPASE ACTIVITY,0.53167,0.031882,0.021504,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.66501,0.031357,0.029695,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.55487,0.031349,0.0089128,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.78289,0.031228,-0.050146,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.83713,0.031143,0.012464,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.59059,0.030814,0.011053,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.21256,0.030684,0.045645,0,0
1,GO PROTEIN TRIMERIZATION,0.71006,0.030527,0.028994,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.59664,0.030508,0.010357,0,0
1,GO REGULATION OF CELL SIZE,0.73628,0.030508,-0.034599,0,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.21579,0.030496,0.031776,0,0
1,GO MUSCLE HYPERTROPHY,0.87833,0.030311,0.0013239,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.84397,0.030252,0.051162,0,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.8303,0.030142,0.032458,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.3746,0.030118,0.10272,0,0
1,GO HISTONE UBIQUITINATION,0.47588,0.030082,0.031228,0,0
1,GO RESPONSE TO UV B,0.80989,0.030039,0.046887,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.64605,0.029976,0.040913,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.11841,0.029815,0.059784,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.59059,0.029715,0.031552,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.89907,0.029646,-0.014713,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.39371,0.029336,0.028866,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.87144,0.029247,-0.049373,0,0
1,GO LACTATE METABOLIC PROCESS,0.26098,0.029039,0.080814,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.53167,0.028898,0.043729,0,0
1,GO DISTAL TUBULE DEVELOPMENT,0.36526,0.028873,0.17005,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.95466,0.028795,-0.00013999,0,0
1,GO PROTEIN POLYMERIZATION,0.56075,0.028788,0.017515,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.50896,0.028782,0.026797,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.92682,0.028781,0.0097874,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.34702,0.028455,0.034031,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.89215,0.028373,-0.0069931,0,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.37932,0.028324,0.077021,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.59059,0.028321,-0.051785,0,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.36064,0.028226,0.027286,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.4545,0.028175,0.066213,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.13355,0.028149,0.098768,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.94769,0.028081,-0.030484,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.32506,0.02784,0.024779,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.69707,0.027818,0.015865,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.71658,0.027811,0.037318,0,0
1,GO CELLULAR RESPONSE TO PH,0.88523,0.027798,0.02308,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.38888,0.02776,0.057444,0,0
1,GO THYMIC T CELL SELECTION,0.84397,0.027747,0.0056005,0,0
1,GO SECRETION,0.21579,0.02769,0.032388,0,0
1,GO MRNA MODIFICATION,0.60272,0.027591,0.037276,0,0
1,GO HEART MORPHOGENESIS,0.15517,0.027577,0.080283,0,0
1,GO SMOOTHENED SIGNALING PATHWAY,0.32506,0.027571,0.045913,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.89215,0.027447,0.012234,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.41341,0.027415,0.067019,0,0
1,GO ENDOTHELIUM DEVELOPMENT,0.99651,0.027321,-0.011531,0,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.188,0.027317,0.0497,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.60272,0.027211,0.023005,0,0
1,GO NEURON PROJECTION REGENERATION,0.9686,0.027195,-0.015548,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.65866,0.027192,0.032547,0,0
1,GO GLYCOSYLATION,0.73628,0.027161,-0.024218,0,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.7495,0.027094,0.071936,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.41842,0.026993,0.02817,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.41842,0.026987,0.030028,0,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.30402,0.026974,0.030013,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.67137,0.026853,-0.024926,0,0
1,GO ENSHEATHMENT OF NEURONS,0.91987,0.026781,-0.010637,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.37932,0.026733,0.050421,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.5726,0.026671,0.021461,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.74288,0.026237,0.024648,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.4978,0.026207,0.033281,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.58456,0.02608,0.017314,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.38888,0.025986,0.022084,0,0
1,GO NEGATIVE REGULATION OF TRANSPORT,0.32506,0.02593,0.033998,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.89215,0.025867,-0.028279,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.32506,0.025835,0.025228,0,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.80989,0.025745,0.0072196,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.76281,0.025688,0.038182,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.18219,0.025572,0.057767,0,0
1,GO RENAL ABSORPTION,0.62113,0.025513,0.045844,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.34702,0.025494,0.09691,0,0
1,GO HISTONE H3 K27 METHYLATION,0.95466,0.025459,-0.0020194,0,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.44924,0.025277,0.019103,0,0
1,GO MISMATCH REPAIR,0.88523,0.025048,0.0046311,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.91987,0.025011,-0.004366,0,0
1,GO ANIMAL ORGAN MORPHOGENESIS,0.42347,0.024917,0.035552,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.53742,0.024388,0.0060333,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.47049,0.024374,0.031643,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.78289,0.024289,0.014931,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.62732,0.024229,0.016533,0,0
1,GO RESPONSE TO ACTIVITY,0.55487,0.024097,0.012649,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.48131,0.024001,0.062313,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.85768,0.023842,0.011516,0,0
1,GO INTRACELLULAR STEROL TRANSPORT,0.92682,0.023695,-0.015806,0,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.13814,0.023676,0.1706,0,0
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.47588,0.023573,0.052075,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.65234,0.023449,-0.040336,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.91293,0.023372,-0.0096151,0,0
1,GO RECEPTOR INTERNALIZATION,0.39858,0.023323,0.04325,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.5726,0.023311,0.01551,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.4978,0.023289,0.01703,0,0
1,GO METHIONINE METABOLIC PROCESS,0.85768,0.02327,-0.038395,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.8303,0.023235,-0.0024688,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.3746,0.023073,0.066179,0,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.23245,0.022939,0.042937,0,0
1,GO TELOMERE CAPPING,0.80989,0.022819,0.0062346,0,0
1,GO RESPONSE TO ESTRADIOL,0.20309,0.022799,0.057439,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.42347,0.022731,0.029349,0,0
1,GO CHOLESTEROL STORAGE,0.84397,0.022673,0.032669,0,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.21579,0.022572,0.029811,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.54321,0.022398,0.027586,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.69707,0.022309,-0.021445,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.94073,0.021917,-0.0090835,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,0.72313,0.021265,-3.2246e-05,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.50337,0.021115,0.11459,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.41842,0.020967,0.061397,0,0
1,GO HEART TRABECULA MORPHOGENESIS,0.48131,0.020944,0.06001,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.77618,0.020535,-0.043365,0,0
1,GO METAL ION HOMEOSTASIS,0.67776,0.020519,0.011947,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.89215,0.020338,0.022176,0,0
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.75615,0.020306,-0.0053023,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.44402,0.020205,0.061503,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.68418,0.020045,0.023007,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.67776,0.019982,0.030989,0,0
1,GO FUCOSYLATION,0.95466,0.019925,-0.001339,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.71658,0.019916,0.037571,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.7495,0.01988,0.0034978,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.35153,0.01978,0.033818,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.58456,0.019774,0.031378,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.72969,0.019721,-0.032,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.22235,0.019546,0.056819,0,0
1,GO CAMP METABOLIC PROCESS,0.59059,0.019544,0.093865,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.41341,0.01945,0.024735,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.33812,0.019375,0.026628,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.48678,0.019199,0.015856,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.70355,0.0191,-0.070142,0,0
1,GO HISTONE MONOUBIQUITINATION,0.52594,0.018931,0.033516,0,0
1,GO SKELETAL SYSTEM DEVELOPMENT,0.13355,0.018854,0.087722,0,0
1,GO NEGATIVE CHEMOTAXIS,0.50896,0.018832,0.040865,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.53742,0.018654,0.033675,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.76948,0.018625,0.0036132,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.72969,0.018624,-0.0010501,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.87833,0.01833,-0.035812,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.52594,0.018115,0.04043,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.60883,0.018029,-0.037341,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.69707,0.017764,-0.00049504,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.61497,0.017668,0.042909,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.54321,0.017633,0.037258,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.91293,0.017615,-0.013979,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.87833,0.01758,-0.018365,0,0
1,GO SISTER CHROMATID SEGREGATION,0.43883,0.017576,0.02132,0,0
1,GO CYTOSOLIC TRANSPORT,0.40843,0.017442,0.034519,0,0
1,GO NODAL SIGNALING PATHWAY,0.62113,0.017259,0.033199,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.71006,0.017253,0.064994,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.27999,0.017127,0.052482,0,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.25729,0.016466,0.16635,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.78962,0.01637,0.026188,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.38408,0.016351,0.069152,0,0
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.79636,0.016278,-0.038061,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.29586,0.016268,0.014241,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.41842,0.016236,0.017256,0,0
1,GO CYTOKINE SECRETION,0.87833,0.016221,0.027941,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.91293,0.016185,-0.0035621,0,0
1,GO CELLULAR RESPONSE TO DRUG,0.099158,0.016115,0.091645,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.71658,0.015958,0.02814,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.89215,0.015885,0.0096173,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.86455,0.01549,0.00011569,0,0
1,GO LYSINE METABOLIC PROCESS,0.59664,0.015408,0.058695,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.60883,0.015389,0.043063,0,0
1,GO LIPID PHOSPHORYLATION,0.56075,0.014905,0.027267,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.31653,0.01459,0.15239,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.65234,0.014275,-0.042309,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.88523,0.014254,-0.012594,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.71658,0.014248,-0.070391,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.39858,0.014047,0.061936,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.54903,0.014033,0.065335,0,0
1,GO ION HOMEOSTASIS,0.87833,0.013989,0.002359,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.66501,0.013363,0.090063,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.71658,0.013204,-0.10243,0,0
1,GO EPIDERMIS DEVELOPMENT,0.67137,0.013151,0.025062,0,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.41341,0.013061,0.057851,0,0
1,GO GROWTH,0.55487,0.013043,0.010284,0,0
1,GO MITOCHONDRIAL FUSION,0.62113,0.01292,0.013289,0,0
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.42855,0.012763,0.068253,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.80989,0.012742,-0.01387,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.98953,0.012157,-0.036616,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.98953,0.012151,0.012651,0,0
1,GO CHROMOSOME ORGANIZATION,0.64605,0.012067,0.0082413,0,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.18219,0.01199,0.045545,0,0
1,GO ACTIVATED T CELL PROLIFERATION,0.55487,0.011659,0.032657,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.26847,0.011611,-0.12056,0,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.72969,0.011538,0.023394,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.94073,0.011485,-0.005947,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.62113,0.011265,0.037543,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.53167,0.011242,0.0096832,0,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.47049,0.011227,0.067628,0,0
1,GO BLASTODERM SEGMENTATION,0.50337,0.011208,0.10365,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.92682,0.011175,0.002122,0,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.48678,0.011135,0.0186,0,0
1,GO REGULATION OF BONE REMODELING,0.9686,0.01108,-0.0053754,0,0
1,GO DNA REPLICATION,0.36991,0.010977,0.013309,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.63354,0.010914,-0.031293,0,0
1,GO ZINC ION TRANSPORT,0.28785,0.010762,0.066982,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.56075,0.010659,0.015344,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.50337,0.010583,0.054326,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.62732,0.010559,0.01395,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.95466,0.010548,-0.013379,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.56075,0.010496,0.068559,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.83713,0.010352,0.0042764,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.93377,0.010168,-0.012529,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.83713,0.010005,-0.054475,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.82348,0.0099572,0.0029378,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.80312,0.0098229,0.024323,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.95466,0.0098084,0.0050193,0,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.36991,0.0096902,0.1469,0,0
1,GO AORTA MORPHOGENESIS,0.92682,0.0096129,0.10475,0,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.53742,0.0095524,0.013366,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.63354,0.0095137,0.017962,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.27999,0.0092718,0.14074,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.82348,0.0089561,0.015006,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.52594,0.0088834,0.038117,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.81668,0.0087368,-0.043521,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.31653,0.008734,0.09323,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.76948,0.0087181,-0.044179,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.80312,0.0083471,0.0077206,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.87833,0.0083381,0.021294,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.94073,0.0082632,-0.055821,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.78962,0.0082356,0.0063393,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.71006,0.0081392,-0.010696,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.74288,0.0079758,-0.01501,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.64605,0.0079007,0.015767,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.79636,0.0076571,0.041343,0,0
1,GO ORGAN INDUCTION,0.21905,0.0072145,0.095466,0,0
1,GO ADAPTIVE THERMOGENESIS,0.63354,0.0071635,-0.029143,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.65234,0.0071624,0.020306,0,0
1,GO L SERINE METABOLIC PROCESS,0.63354,0.0067769,0.029367,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.99651,0.0066901,-0.0061212,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.60272,0.006474,-0.045733,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.69707,0.0062774,-0.011424,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.48131,0.0061204,-0.039596,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.72313,0.0059997,-0.028019,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.68418,0.0059004,-0.017166,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.36064,0.0058593,0.038981,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.65866,0.0057878,0.024235,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.83713,0.00576,0.012878,0,0
1,GO SARCOMERE ORGANIZATION,0.97557,0.0057011,0.030673,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.8303,0.0056857,-0.030925,0,0
1,GO STRESS GRANULE ASSEMBLY,0.4545,0.0056795,-0.04679,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.69061,0.0056082,-0.032855,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.67137,0.0055483,-0.0039712,0,0
1,GO B CELL HOMEOSTASIS,0.62113,0.0051746,0.02113,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.82348,0.0051197,-0.007441,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.61497,0.0050277,0.036519,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.67137,0.0047756,0.009521,0,0
1,GO REGULATION OF GROWTH,0.68418,0.0047398,0.0072458,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.55487,0.0046874,0.0092414,0,0
1,GO SNORNA METABOLIC PROCESS,0.67776,0.0046267,0.0012512,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.43367,0.0044379,-0.080926,0,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.65866,0.0044312,-0.10716,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.79636,0.0044088,0.0098357,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.92682,0.0043921,0.042923,0,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.76948,0.0042774,0.004974,0,0
1,GO DNA REPLICATION CHECKPOINT,0.89215,0.0041734,-0.018756,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.50896,0.0041688,-0.047989,0,0
1,GO MRNA METHYLATION,0.93377,0.004158,0.01123,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.89907,0.0041331,-0.0028674,0,0
1,GO MEMBRANE FUSION,0.99651,0.0039003,-0.014885,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.91293,0.003673,-0.017625,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.96163,0.0036567,0.028968,0,0
1,GO MUSCLE CELL DIFFERENTIATION,0.56075,0.0035238,0.043045,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.21905,0.0034959,0.17833,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.76948,0.0033953,0.012605,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.98255,0.0033143,-0.019759,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.74288,0.003092,-0.013079,0,0
1,GO APPENDAGE DEVELOPMENT,0.73628,0.0030334,-0.019928,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.85768,0.002955,-0.01144,0,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.4545,0.0027369,0.027506,0,0
1,GO RESPONSE TO SALT,0.8303,0.0024165,-0.051488,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.91293,0.0024112,-0.013314,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.76948,0.0022511,-0.029357,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.50896,0.0022479,-0.078908,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.86455,0.0022222,0.0047512,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.89907,0.001847,-0.016787,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.83713,0.0017959,-0.013055,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.61497,0.001487,-0.02847,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.91987,0.0013861,-0.013273,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.77618,0.0011646,0.019162,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.64605,0.0011268,-0.034401,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.62113,0.00095888,0.0090115,0,0
1,GO RESPONSE TO ACID CHEMICAL,0.60883,0.00082831,0.023196,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.98255,0.00071729,-0.0056977,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.63978,0.00068242,0.032607,0,0
1,GO TOR SIGNALING,0.72969,0.00058249,-0.010784,0,0
1,GO TAXIS,0.71006,0.00055706,0.0015465,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.46512,0.00033211,-0.034426,0,0
1,GO CYTOSKELETON ORGANIZATION,0.85768,0.0003025,0.0051807,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.4598,0.00023964,0.089644,0,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.52594,0.00011649,-0.041278,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.78289,0.00011423,-0.028022,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.40843,-0.00065729,-0.083316,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.65234,-0.00074357,-0.021741,0,0
1,GO GLAND DEVELOPMENT,0.63354,-0.00078003,0.018152,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,1,-0.00081968,0.020203,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.96163,-0.00093799,0.0033586,0,0
1,GO DNA PACKAGING,0.9686,-0.0010755,-0.014885,0,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.87833,-0.0011175,0.0044342,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.61497,-0.0011197,0.016619,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.7495,-0.0012035,-0.026744,0,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.59664,-0.0012403,0.078556,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.96163,-0.0013098,0.0070947,0,0
1,GO ATP TRANSPORT,0.96163,-0.0014282,-0.0094252,0,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.72969,-0.0015399,-0.031022,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.23589,-0.0017501,0.085055,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.73628,-0.0018557,-0.029366,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.88523,-0.0021318,0.012233,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.60883,-0.0021347,0.020725,0,0
1,GO REPLICATION FORK PROCESSING,0.72313,-0.0022801,0.032716,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.99651,-0.0022908,-0.0028313,0,0
1,GO MOLTING CYCLE,0.81668,-0.0023157,-0.0053038,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.94073,-0.0023557,-0.0048693,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.80312,-0.002362,-0.024009,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.65866,-0.0024518,0.058092,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.57857,-0.0025897,0.059546,0,0
1,GO CELL VOLUME HOMEOSTASIS,0.71006,-0.0026385,0.015797,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.80989,-0.0030207,0.020409,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.4545,-0.003062,0.069423,0,0
1,GO METHYLATION,0.83713,-0.0031648,-0.010228,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.97557,-0.0032135,-9.3124e-05,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.69061,-0.003231,-0.018881,0,0
1,GO HISTONE H2A UBIQUITINATION,0.97557,-0.0033038,0.00048365,0,0
1,GO BONE CELL DEVELOPMENT,0.98255,-0.0037316,0.0059874,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.52025,-0.0039871,-0.033478,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.86455,-0.0040201,0.01511,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.92682,-0.0040953,-0.00095666,0,0
1,GO ENDOCYTIC RECYCLING,0.40349,-0.004168,0.033655,0,0
1,GO RESPONSE TO WATER,0.61497,-0.004231,-0.055721,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.3746,-0.0044206,-0.064188,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.97557,-0.0044833,-0.012689,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.94769,-0.0046601,-0.043176,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.88523,-0.0047837,-0.024911,0,0
1,GO NUCLEOSOME ORGANIZATION,0.60883,-0.0048712,-0.035534,0,0
1,GO RESPONSE TO AMYLOID BETA,0.92682,-0.0050477,0.016195,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.54321,-0.0051855,-0.034527,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.51459,-0.0052741,0.091648,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.83713,-0.0053518,-0.021353,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.96163,-0.0053929,-0.0097729,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.59059,-0.0055247,-0.028231,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.72969,-0.0057069,0.081484,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.81668,-0.0059612,-0.0061536,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.89907,-0.005991,0.027254,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.92682,-0.0060184,0.046981,0,0
1,GO RESPONSE TO COLD,0.37932,-0.0061696,-0.085974,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.72313,-0.0061778,0.030539,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.38408,-0.0061873,-0.10026,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.91987,-0.0064268,-0.018778,0,0
1,GO MITOTIC CELL CYCLE ARREST,0.69061,-0.0065746,0.035662,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.80312,-0.0065943,-0.063286,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.69707,-0.0066986,-0.03514,0,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.69707,-0.0067193,0.030768,0,0
1,GO SNORNA 3 END PROCESSING,0.76281,-0.0068445,-0.0085327,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.99651,-0.0071297,-0.00047999,0,0
1,GO CELLULAR HOMEOSTASIS,0.54903,-0.0071592,0.013926,0,0
1,GO MANNOSYLATION,0.76281,-0.0074733,-0.0033768,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.91987,-0.0075429,0.011393,0,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.91293,-0.0079302,-0.004348,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.85768,-0.008039,-0.0043067,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.99651,-0.0082558,0.010558,0,0
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.43883,-0.0083404,0.061939,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.87833,-0.0085277,-0.019499,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.65866,-0.0085606,0.16939,0,0
1,GO MITOCHONDRIAL FISSION,0.9686,-0.0086275,0.00070532,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.87144,-0.0086654,-0.024193,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.82348,-0.008722,0.023924,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.35607,-0.0087254,-0.087847,0,0
1,GO NUCLEOTIDE TRANSPORT,0.51459,-0.0089596,-0.051979,0,0
1,GO RESPONSE TO BMP,0.76281,-0.0091751,0.017963,0,0
1,GO O GLYCAN PROCESSING,0.79636,-0.0093573,-0.039821,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.54321,-0.0095445,-0.076784,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.4978,-0.0097058,0.11151,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.51459,-0.0098373,-0.03841,0,0
1,GO CHEMICAL HOMEOSTASIS,0.2839,-0.010283,-0.041855,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.66501,-0.010309,-0.051286,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.78962,-0.010521,-0.032146,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.43367,-0.010547,0.080694,0,0
1,GO RESPONSE TO INACTIVITY,0.62113,-0.01094,-0.052087,0,0
1,GO PROSTATE GLAND GROWTH,0.78962,-0.010952,0.080498,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.21579,-0.01103,-0.084476,0,0
1,GO ARACHIDONIC ACID SECRETION,0.39858,-0.011108,-0.093449,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.84397,-0.011151,-0.01523,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.90599,-0.011315,0.011235,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.89215,-0.011327,-0.041871,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.87144,-0.011351,-0.011969,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.59664,-0.01138,0.03656,0,0
1,GO COVALENT CHROMATIN MODIFICATION,0.37932,-0.011477,-0.035262,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.56075,-0.011482,-0.067829,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.72313,-0.011534,-0.033242,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.89907,-0.011553,0.0023409,0,0
1,GO NUCLEOSOME ASSEMBLY,0.38888,-0.01162,-0.061336,0,0
1,GO DNA STRAND ELONGATION,0.20309,-0.011679,-0.10245,0,0
1,GO MICROTUBULE ANCHORING,0.72969,-0.012188,-0.0061366,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.82348,-0.012236,-0.013119,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.29184,-0.012303,-0.057604,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.59059,-0.012422,-0.022276,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.63354,-0.012522,-0.028837,0,0
1,GO HISTAMINE TRANSPORT,0.95466,-0.012581,-0.017079,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.4545,-0.012776,0.073422,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.49227,-0.012915,-0.11115,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.88523,-0.012935,-0.015188,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.79636,-0.012951,0.0081587,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.72313,-0.013116,-0.039401,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.64605,-0.013147,-0.037648,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.4598,-0.013576,0.027963,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.92682,-0.013929,-0.022825,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.89907,-0.014131,0.0095855,0,0
1,GO BIOMINERALIZATION,0.63354,-0.014146,0.064035,0,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.87833,-0.014184,0.024145,0,0
1,GO NEPHRON MORPHOGENESIS,0.56075,-0.014495,0.044605,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.66501,-0.014569,0.022245,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.98953,-0.014805,0.00026277,0,0
1,GO REGULATION OF RNA SPLICING,0.34702,-0.014811,-0.048082,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.97557,-0.014961,-0.0010089,0,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.25001,-0.015167,-0.095839,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.67137,-0.015594,-0.023262,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.58456,-0.015929,-0.079757,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.54321,-0.015995,-0.022886,0,0
1,GO HEART VALVE FORMATION,0.78962,-0.016185,-0.027254,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.67776,-0.016203,-0.043772,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.97557,-0.016259,0.0010916,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.90599,-0.016404,-0.016235,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.55487,-0.016473,-0.021569,0,0
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.91293,-0.016816,-0.034503,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.63354,-0.016889,-0.028321,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.74288,-0.01692,-0.010778,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.9686,-0.016949,0.035612,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.78289,-0.016959,-0.009682,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.88523,-0.01728,0.0028556,0,0
1,GO CARBOHYDRATE TRANSPORT,0.53167,-0.017469,-0.041377,0,0
1,GO REGULATION OF CELLULAR PH,0.91293,-0.017565,-0.011484,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.95466,-0.017739,0.008309,0,0
1,GO QUINONE METABOLIC PROCESS,0.65866,-0.017886,-0.021136,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.66501,-0.018345,0.078184,0,0
1,GO MIDBRAIN DEVELOPMENT,0.89215,-0.01888,0.017856,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.53742,-0.018979,0.062982,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.67137,-0.019088,-0.021785,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.50896,-0.019175,-0.078055,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.52025,-0.019194,0.061495,0,0
1,GO SEX DIFFERENTIATION,0.75615,-0.019303,-0.018603,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.77618,-0.01974,-0.0051279,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.44402,-0.01992,-0.048315,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.29992,-0.02013,-0.038825,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.59059,-0.020514,-0.04902,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.12908,-0.020708,-0.048418,0,0
1,GO TRNA CATABOLIC PROCESS,0.41341,-0.020749,0.1231,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.16559,-0.020756,-0.06395,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.96163,-0.020804,-0.0065715,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.97557,-0.020838,0.016343,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.64605,-0.020925,-0.011835,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.29992,-0.021056,-0.068032,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.89907,-0.021119,-0.0039088,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.94073,-0.021188,-0.0018494,0,0
1,GO ACETYL COA METABOLIC PROCESS,0.96163,-0.021277,-0.0087084,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.9686,-0.021346,-0.012854,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.74288,-0.021477,-0.0042461,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.64605,-0.021517,-0.055903,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.94073,-0.021532,0.0052526,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.60883,-0.021581,-0.016686,0,0
1,GO RESPONSE TO CAMP,0.97557,-0.021851,0.020262,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.63354,-0.02217,-0.035567,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.27227,-0.022192,-0.069889,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.32506,-0.022224,-0.029943,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.50896,-0.022322,-0.017785,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.29184,-0.022408,-0.043208,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.58456,-0.022777,-0.06239,0,0
1,GO REGULATION OF MRNA PROCESSING,0.4598,-0.022994,-0.041844,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.99651,-0.023021,-0.042415,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.62732,-0.023156,-0.020599,0,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.78289,-0.023216,-0.083016,0,0
1,GO GASTRIC ACID SECRETION,0.97557,-0.023226,0.017469,0,0
1,GO LIPID EXPORT FROM CELL,0.85082,-0.023226,0.0063689,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.52594,-0.02325,-0.029669,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.74288,-0.023284,-0.021871,0,0
1,GO GLIAL CELL PROLIFERATION,0.77618,-0.023571,0.016658,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.26847,-0.023734,-0.056065,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.40843,-0.023737,-0.051217,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.67776,-0.024082,-0.020022,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.65866,-0.024282,-0.0050453,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.72313,-0.024443,0.0078641,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.2839,-0.024483,-0.055498,0,0
1,GO FERTILIZATION,0.87144,-0.024696,-0.0079709,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.84397,-0.024778,0.059902,0,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.70355,-0.025054,0.040914,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.7495,-0.025107,-0.043689,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.63978,-0.025166,-0.028082,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.39371,-0.025293,-0.052278,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.36064,-0.025614,-0.034384,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.4545,-0.025723,-0.039847,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.72969,-0.025755,0.066949,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.35153,-0.025968,-0.026805,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.80312,-0.025991,-0.0074887,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.78962,-0.02615,-0.020519,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.52025,-0.026187,-0.0062933,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.36991,-0.026346,-0.03397,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.46512,-0.026492,-0.12179,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.74288,-0.026512,-0.022938,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.94073,-0.027031,0.018475,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.56075,-0.027128,0.067894,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.94073,-0.027145,0.018637,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.92682,-0.027274,-0.0032061,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.64605,-0.027555,-0.018593,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.97557,-0.027632,-0.0096738,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.8303,-0.027796,0.0053211,0,0
1,GO DEVELOPMENTAL GROWTH,0.31653,-0.02788,-0.03762,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.12908,-0.028286,-0.058606,0,0
1,GO SPLEEN DEVELOPMENT,0.84397,-0.028422,0.0015167,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.69707,-0.028552,0.033409,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.95466,-0.028692,-0.001335,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.24288,-0.028757,-0.1427,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.63354,-0.028854,-0.029081,0,0
1,GO KINETOCHORE ORGANIZATION,0.62732,-0.028871,0.029262,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.84397,-0.029044,-0.012059,0,0
1,GO ENDOCARDIAL CUSHION FORMATION,0.53742,-0.029416,0.073166,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.98953,-0.029495,-0.0055964,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.71006,-0.029595,-0.016181,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.94073,-0.029937,-0.0027485,0,0
1,GO DRUG CATABOLIC PROCESS,0.71658,-0.029948,-0.027884,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.30815,-0.03001,-0.061958,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.35153,-0.030055,-0.06936,0,0
1,GO HISTAMINE SECRETION,0.62732,-0.030177,0.039543,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.20937,-0.030278,-0.06699,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.74288,-0.030475,0.0064839,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.85768,-0.03048,-0.0063492,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.86455,-0.030481,-0.012909,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.17653,-0.03063,-0.10958,0,0
1,GO SECONDARY METABOLIC PROCESS,0.72313,-0.030768,-0.063143,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.69061,-0.030924,-0.010296,0,0
1,GO STEROID HORMONE SECRETION,0.8303,-0.031057,-0.031145,0,0
1,GO SEXUAL REPRODUCTION,0.29184,-0.031115,-0.034545,0,0
1,GO APPENDAGE MORPHOGENESIS,0.43367,-0.03115,-0.054501,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.31232,-0.031215,-0.072802,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.26471,-0.031377,-0.082441,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.92682,-0.031508,-0.0026192,0,0
1,GO AMINO ACID IMPORT,0.64605,-0.031528,-0.036428,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.27227,-0.031685,-0.037651,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.94073,-0.031724,0.0049292,0,0
1,GO RETINA HOMEOSTASIS,0.36526,-0.031748,-0.04978,0,0
1,GO MYELIN ASSEMBLY,0.98953,-0.031764,0.002297,0,0
1,GO CELL PROJECTION ASSEMBLY,0.86455,-0.03188,-0.002621,0,0
1,GO GLIOGENESIS,0.4545,-0.031936,-0.033992,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.51459,-0.031958,-0.0895,0,0
1,GO LYSOSOME LOCALIZATION,0.35153,-0.032155,-0.041771,0,0
1,GO STEM CELL PROLIFERATION,0.42347,-0.032641,-0.059845,0,0
1,GO REGULATION OF PH,0.71006,-0.03273,-0.024189,0,0
1,GO PLASMA MEMBRANE REPAIR,0.54321,-0.03299,-0.20488,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.42347,-0.033019,-0.02955,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.32938,-0.03308,-0.03187,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.56075,-0.033155,-0.072198,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.87833,-0.033242,0.036035,0,0
1,GO T CELL SELECTION,0.91293,-0.033423,0.023878,0,0
1,GO BLASTOCYST DEVELOPMENT,0.3746,-0.034196,-0.030628,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.94769,-0.034244,0.018038,0,0
1,GO PIGMENTATION,0.44402,-0.034285,-0.024306,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.83713,-0.034314,-0.013202,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.17934,-0.034404,-0.030465,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.49227,-0.034426,-0.025887,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.24643,-0.034513,-0.13759,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.75615,-0.0347,-0.0010509,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.54903,-0.034782,-0.023389,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.58456,-0.034782,-0.061283,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.57857,-0.034795,-0.071548,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.65234,-0.034813,-0.011426,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.97557,-0.034868,0.0072437,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.25001,-0.034933,-0.070166,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.87833,-0.035803,0.0074943,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.65866,-0.035901,-0.022386,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.65866,-0.035976,-0.0078595,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.43883,-0.036289,-0.024241,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.43367,-0.036645,-0.098602,0,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,0.93377,-0.036699,-0.0052429,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.68418,-0.036902,-0.0027387,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.56666,-0.037007,-0.029485,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.60883,-0.037109,-0.017153,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.5726,-0.037211,0.066999,0,0
1,GO GDP METABOLIC PROCESS,0.20309,-0.03734,-0.16555,0,0
1,GO RESPONSE TO FATTY ACID,0.42347,-0.037439,-0.034825,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.72969,-0.037509,0.0023719,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.89907,-0.037535,-0.021839,0,0
1,GO GLUCOSE IMPORT,0.21579,-0.037545,-0.072574,0,0
1,GO ALANINE TRANSPORT,0.26847,-0.037741,-0.11585,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.42855,-0.037777,-0.045725,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.78289,-0.037791,-0.0019397,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.60883,-0.037978,-0.029005,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.33373,-0.038128,-0.06821,0,0
1,GO MUSCLE SYSTEM PROCESS,0.54321,-0.038171,-0.017597,0,0
1,GO RESPONSE TO GLUCAGON,0.21256,-0.03818,-0.069184,0,0
1,GO SINGLE FERTILIZATION,0.20937,-0.038231,-0.050349,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.21579,-0.038302,-0.079984,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.23937,-0.038338,-0.040087,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.34702,-0.038433,-0.10144,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.56666,-0.038515,-0.009351,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.33373,-0.038547,-0.10707,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.47588,-0.038609,-0.067453,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.67137,-0.038846,-0.023247,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.89215,-0.038971,0.018431,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.17099,-0.03907,-0.070879,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.23589,-0.039195,-0.083278,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.77618,-0.03929,0.020864,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.59664,-0.039457,-0.020403,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.80312,-0.039536,-0.0081175,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.42347,-0.039663,-0.022833,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.65234,-0.03999,-0.023925,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,1,-0.04031,0.0129,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.052669,-0.040589,-0.074221,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.1028,-0.040672,-0.058788,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.85082,-0.040686,-0.012398,0,0
1,GO CELL CYCLE DNA REPLICATION,0.19095,-0.041107,-0.087297,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.35607,-0.041442,-0.11551,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.32077,-0.041512,-0.055418,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.38888,-0.041669,-0.058328,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.97557,-0.041707,-0.014017,0,0
1,GO CENTROSOME SEPARATION,0.97557,-0.041736,0.014443,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.95466,-0.041782,-0.0026651,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.53742,-0.041791,-0.034942,0,0
1,GO CHROMATIN ORGANIZATION,0.20309,-0.041857,-0.04446,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.25729,-0.042151,-0.049365,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.29586,-0.042322,-0.040804,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.14285,-0.042606,-0.045896,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.19393,-0.04268,-0.082224,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.12049,-0.042849,-0.065394,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.26098,-0.04302,-0.12246,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.57857,-0.043026,-0.041151,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.26471,-0.043242,-0.070353,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.82348,-0.043935,-0.015327,0,0
1,GO GAMETE GENERATION,0.34256,-0.043939,-0.030458,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.8303,-0.044009,0.002774,0,0
1,GO PROTEIN MANNOSYLATION,0.47049,-0.044049,-0.04768,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.4598,-0.04416,-0.049294,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.35153,-0.044561,-0.043597,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.23245,-0.044603,-0.076607,0,0
1,GO MICROTUBULE NUCLEATION,0.32506,-0.045052,-0.052475,0,0
1,GO MESONEPHROS DEVELOPMENT,0.99651,-0.04523,0.014249,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.86455,-0.045464,-0.018618,0,0
1,GO MEIOTIC CELL CYCLE,0.54903,-0.045525,-0.00066613,0,0
1,GO RESPONSE TO ETHANOL,0.29586,-0.045589,-0.042351,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.86455,-0.045606,0.046902,0,0
1,GO CELL GROWTH,0.2,-0.045662,-0.0433,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.057089,-0.045836,-0.084315,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.39371,-0.045914,-0.081908,0,0
1,GO DEPHOSPHORYLATION,0.11039,-0.046054,-0.049809,0,0
1,GO MALE MEIOSIS I,0.70355,-0.046327,-0.01836,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.17934,-0.046467,-0.12886,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.19095,-0.046605,-0.030311,0,0
1,GO SPERM CAPACITATION,0.23937,-0.046736,-0.095523,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.21579,-0.046973,-0.13024,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.46512,-0.047119,-0.034379,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.085627,-0.047414,-0.10827,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.10465,-0.047447,-0.048871,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.87833,-0.047624,0.056856,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.63354,-0.047852,-0.03028,0,0
1,GO WATER TRANSPORT,0.11636,-0.048059,-0.094755,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.4598,-0.048113,-0.051838,0,0
1,GO ORGANELLE LOCALIZATION,0.036948,-0.048182,-0.05504,0,0
1,GO PENILE ERECTION,0.27227,-0.048603,-0.09721,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.84397,-0.048629,0.021788,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.41842,-0.048903,-0.051753,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.41842,-0.048919,-0.064429,0,0
1,GO PRO B CELL DIFFERENTIATION,0.95466,-0.049453,-0.014475,0,0
1,GO OOGENESIS,0.026586,-0.049615,-0.094992,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.95466,-0.04973,0.011366,0,0
1,GO PHOSPHATE ION TRANSPORT,0.20937,-0.050037,-0.05922,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.99651,-0.050187,0.02645,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.47049,-0.050254,-0.064969,0,0
1,GO MALE GAMETE GENERATION,0.12908,-0.050375,-0.043847,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.42347,-0.050503,-0.075411,0,0
1,GO POSITIVE T CELL SELECTION,0.98255,-0.050708,0.044164,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.26471,-0.050785,-0.042258,0,0
1,GO CONVERGENT EXTENSION,0.67137,-0.050948,-0.05694,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.85768,-0.051146,-0.0025779,0,0
1,GO DRINKING BEHAVIOR,0.26098,-0.051287,-0.11762,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.61497,-0.051298,-0.01497,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.28785,-0.05174,-0.044774,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.34702,-0.051764,-0.052631,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.92682,-0.051899,0.025408,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.46512,-0.052564,-0.052127,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.26471,-0.052592,-0.066191,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.49227,-0.052617,-0.044409,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.71658,-0.05273,-0.027056,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.55487,-0.052789,-0.030862,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.87144,-0.052843,0.0088809,0,0
1,GO MUSCLE CONTRACTION,0.31653,-0.053052,-0.033661,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.30815,-0.053061,-0.058622,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.32077,-0.053239,-0.063104,0,0
1,GO STEROID CATABOLIC PROCESS,0.74288,-0.053569,-0.028791,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.061812,-0.053633,-0.08262,0,0
1,GO EXIT FROM MITOSIS,0.38888,-0.053883,-0.034351,0,0
1,GO BICARBONATE TRANSPORT,0.61497,-0.053903,-0.042733,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.017137,-0.054022,-0.10789,0,0
1,GO RESPONSE TO STARVATION,0.15773,-0.054272,-0.06716,0,0
1,GO AUTOPHAGIC CELL DEATH,0.58456,-0.054549,-0.037216,0,0
1,GO DOSAGE COMPENSATION,0.68418,-0.054625,-0.026591,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.69061,-0.054858,-0.019413,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.7495,-0.054872,-0.03804,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.4598,-0.055385,-0.016293,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.16294,-0.055385,-0.060737,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.18219,-0.055394,-0.087391,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.085627,-0.05565,-0.099458,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.36064,-0.055937,-0.047558,0,0
1,GO DIET INDUCED THERMOGENESIS,0.23245,-0.056006,-0.10795,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.12259,-0.056197,-0.11214,0,0
1,GO AXON EXTENSION,0.21905,-0.056545,-0.090313,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.11434,-0.057149,-0.10816,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.12908,-0.057288,-0.069794,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.075049,-0.057695,-0.085705,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.84397,-0.057879,0.0056327,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.099158,-0.05798,-0.16177,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.12689,-0.058199,-0.10004,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.34256,-0.058317,-0.04163,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.26098,-0.058423,-0.084353,0,0
1,GO T CELL HOMEOSTASIS,0.052669,-0.05849,-0.086156,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.25363,-0.058577,-0.056507,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.20937,-0.058692,-0.059087,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.020205,-0.059049,-0.098104,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.52025,-0.059131,-0.029938,0,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.78962,-0.059187,0.0058427,0,0
1,GO RRNA CATABOLIC PROCESS,0.88523,-0.059213,-0.011908,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.60272,-0.059438,-0.070221,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.33812,-0.059601,-0.058119,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.30402,-0.060112,-0.088358,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.42347,-0.06037,-0.041882,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.32506,-0.060584,-0.044304,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.47588,-0.06067,-0.019595,0,0
1,GO NEURON DEATH,0.017137,-0.060838,-0.074693,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.35153,-0.060884,-0.076139,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.92682,-0.061118,0.018597,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.80312,-0.061264,0.018416,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.072231,-0.061533,-0.18004,0,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.031748,-0.061624,-0.11184,0,0
1,GO METANEPHROS MORPHOGENESIS,0.41341,-0.061992,-0.080949,0,0
1,GO ER OVERLOAD RESPONSE,0.97557,-0.062297,-0.0039749,0,0
1,GO CHROMATIN REMODELING,0.21256,-0.062473,-0.077538,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.17099,-0.062555,-0.060387,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.35153,-0.062748,-0.051664,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.48678,-0.062813,-0.010251,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.24288,-0.062914,-0.082689,0,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.088862,-0.062927,-0.083006,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.67137,-0.063047,-0.025762,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.02166,-0.063666,-0.086508,0,0
1,GO REGULATION OF CELL CYCLE ARREST,0.053746,-0.063993,-0.068646,0,0
1,GO REGULATION OF ODONTOGENESIS,0.49227,-0.064309,-0.05853,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.44402,-0.064487,-0.092022,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.060602,-0.064492,-0.077526,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.67776,-0.06457,0.029044,0,0
1,GO ECTODERM DEVELOPMENT,0.052669,-0.064637,-0.10577,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.36991,-0.064867,-0.040487,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.38888,-0.065004,-0.045266,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.85082,-0.065865,-0.0031409,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.068167,-0.06592,-0.11432,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.56666,-0.066035,-0.061756,0,0
1,GO SPERM MOTILITY,0.033894,-0.066903,-0.10673,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.3746,-0.066954,-0.099543,0,0
1,GO RESPONSE TO METAL ION,0.25001,-0.067214,-0.045666,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.11434,-0.067416,-0.17478,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.4598,-0.06778,-0.021562,0,0
1,GO PRENYLATION,0.35153,-0.068035,-0.087914,0,0
1,GO REGULATION OF DNA METHYLATION,0.99651,-0.068081,0.010941,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.11039,-0.06819,-0.098037,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.65866,-0.068709,-0.015755,0,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.75615,-0.068839,-0.09268,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.57857,-0.068998,-0.050779,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.088862,-0.069345,-0.11275,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.05161,-0.069458,-0.075372,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.15773,-0.069737,-0.097581,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.084046,-0.069843,-0.066109,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.10096,-0.06994,-0.095581,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.27227,-0.069959,-0.092035,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.43883,-0.070304,-0.058143,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.2,-0.070328,-0.070523,0,0
1,GO BONE MINERALIZATION,0.50896,-0.070731,0.01711,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.12259,-0.070788,-0.07481,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.19393,-0.070874,-0.10854,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.042857,-0.070934,-0.079245,0,0
1,GO PANCREATIC JUICE SECRETION,0.38888,-0.071049,0.0054597,0,0
1,GO DEVELOPMENTAL INDUCTION,0.21905,-0.071052,-0.084501,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.64605,-0.071345,-0.0010155,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.72313,-0.071398,0.099543,0,0
1,GO DEMETHYLATION,0.17934,-0.071444,-0.038451,0,0
1,GO REGULATION OF GTP BINDING,0.61497,-0.071547,0.068239,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.19393,-0.071711,-0.093291,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.92682,-0.072136,-0.00078004,0,0
1,GO MEMBRANE DOCKING,0.023741,-0.072479,-0.082904,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.91987,-0.072491,-0.034872,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.4598,-0.072524,-0.017841,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.46512,-0.072592,-0.035475,0,0
1,GO SISTER CHROMATID COHESION,0.40843,-0.072679,-0.069407,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.60272,-0.072739,-0.015536,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.3746,-0.073166,-0.076436,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.36526,-0.073261,-0.081448,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.53167,-0.073706,-0.053196,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.084046,-0.074545,-0.079975,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.39858,-0.074548,-0.066199,0,0
1,GO REGULATION OF ACTIN NUCLEATION,0.16828,-0.074608,-0.089884,0,0
1,GO SEGMENTATION,0.13814,-0.074612,-0.076419,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.16559,-0.074809,-0.1568,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.26847,-0.074816,-0.12126,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.065563,-0.075391,-0.10352,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.14769,-0.075613,-0.087428,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.42855,-0.075704,-0.091366,0,0
1,GO MAST CELL ACTIVATION,0.090515,-0.075819,-0.12564,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.25001,-0.075979,-0.09447,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.88523,-0.076214,-0.0069508,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.11434,-0.076343,-0.13886,0,0
1,GO ORGANELLE FUSION,0.10096,-0.076723,-0.077141,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.36991,-0.076737,-0.10634,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.23937,-0.077231,-0.099208,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.3746,-0.07762,-0.050541,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.57857,-0.078287,-0.049591,0,0
1,GO REGULATION OF TRANSPORT,0.0034322,-0.078517,-0.084392,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.072231,-0.07863,-0.093935,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.2,-0.078745,-0.074223,0,0
1,GO REGULATION OF TOR SIGNALING,0.16828,-0.079197,-0.047265,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.60272,-0.079261,0.00093969,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.87833,-0.079617,0.020508,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.29586,-0.079805,-0.064575,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.080955,-0.080374,-0.12417,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.16559,-0.080641,-0.035904,0,0
1,GO POLYOL CATABOLIC PROCESS,0.10096,-0.080871,-0.10341,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.58456,-0.081208,-0.025881,0,0
1,GO REGULATION OF AXON GUIDANCE,0.4598,-0.081332,-0.077223,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.67137,-0.081683,-0.030066,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.62732,-0.082078,-0.087085,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.084046,-0.082348,-0.17088,0,0
1,GO BONE MATURATION,0.34256,-0.082357,-0.094598,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.21905,-0.082653,-0.045755,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.053746,-0.083027,-0.14868,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.61497,-0.08332,-0.029921,0,0
1,GO L AMINO ACID TRANSPORT,0.20309,-0.083583,-0.083749,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.3746,-0.083642,-0.076321,0,0
1,GO CELL JUNCTION ASSEMBLY,0.11235,-0.083981,-0.068353,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.29992,-0.084177,-0.050868,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.24288,-0.084219,-0.063566,0,0
1,GO RESPONSE TO AXON INJURY,0.18508,-0.084239,-0.091063,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.22905,-0.084424,-0.04265,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.19095,-0.084827,-0.065307,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.12908,-0.084851,-0.17997,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.43883,-0.084859,-0.12892,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.28785,-0.084996,-0.07685,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.87833,-0.085336,-0.0035815,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.97557,-0.085692,0.0040266,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.50337,-0.085739,-0.051484,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.84397,-0.08608,0.02316,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.4978,-0.086271,-0.0063128,0,0
1,GO PHAGOSOME MATURATION,0.33373,-0.086704,-0.059141,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.042857,-0.086716,-0.084339,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.28785,-0.086901,-0.069896,0,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.0022332,-0.086914,-0.10281,0,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.14526,-0.086956,-0.17609,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.27999,-0.087031,-0.064405,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.12473,-0.087341,-0.061745,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.065563,-0.087596,-0.11322,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.37932,-0.087604,-0.058015,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.11841,-0.087695,-0.078084,0,0
1,GO RHYTHMIC PROCESS,0.0064317,-0.087755,-0.079386,0,0
1,GO MAGNESIUM ION TRANSPORT,0.21579,-0.087865,-0.075614,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.13814,-0.087875,-0.11119,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.046579,-0.087916,-0.10917,0,0
1,GO HISTONE H3 K36 METHYLATION,0.092194,-0.087989,-0.11968,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0057817,-0.088587,-0.10196,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.079444,-0.088725,-0.10686,0,0
1,GO EAR MORPHOGENESIS,0.054842,-0.089167,-0.11592,0,0
1,GO TORC1 SIGNALING,0.090515,-0.089743,-0.068025,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.015574,-0.090021,-0.096575,0,0
1,GO RENAL SYSTEM PROCESS,0.2839,-0.090364,-0.056919,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.59059,-0.090493,-0.032653,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.31653,-0.090784,-0.081316,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.065563,-0.090789,-0.15451,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.26098,-0.091016,-0.09956,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.32938,-0.09115,-0.023694,0,0
1,GO PH REDUCTION,0.065563,-0.091786,-0.083846,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.0059384,-0.092363,-0.10727,0,0
1,GO RESPONSE TO EPINEPHRINE,0.23589,-0.092488,-0.14242,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.31232,-0.092672,-0.078743,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.17653,-0.092687,-0.096487,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.47588,-0.092719,-0.0055047,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.4598,-0.0932,-0.075974,0,0
1,GO MUSCLE ORGAN MORPHOGENESIS,0.90599,-0.093375,0.038069,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.16559,-0.093553,-0.052929,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.11636,-0.09362,-0.047241,0,0
1,GO KIDNEY MORPHOGENESIS,0.46512,-0.093772,-0.035765,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.024288,-0.093851,-0.090433,0,0
1,GO VASODILATION,0.35153,-0.094248,-0.11149,0,0
1,GO EXPLORATION BEHAVIOR,0.076492,-0.094317,-0.2356,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.064293,-0.094395,-0.13193,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.23245,-0.094462,-0.098998,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.14048,-0.094564,-0.094385,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0024367,-0.094619,-0.15812,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.15264,-0.094739,-0.085584,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.35607,-0.094892,-0.028885,0,0
1,GO PHOTOTRANSDUCTION,0.02068,-0.094953,-0.11797,0,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.013798,-0.095003,-0.1259,0,0
1,GO PROTEIN ACYLATION,0.00022676,-0.095026,-0.1108,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.23589,-0.095186,-0.05477,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.066855,-0.095227,-0.093545,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0097392,-0.095723,-0.12967,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.18219,-0.095894,-0.058709,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.13355,-0.096039,-0.091237,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.099158,-0.097234,-0.21102,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.0031536,-0.097366,-0.1415,0,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0064317,-0.097792,-0.21181,0,0
1,GO ESTROUS CYCLE,0.51459,-0.098024,-0.059771,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.11636,-0.098269,-0.075751,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.1028,-0.098312,-0.093741,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.082489,-0.098329,-0.15835,0,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.34702,-0.09861,-0.091164,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.47588,-0.098974,-0.027362,0,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.05161,-0.099015,-0.1006,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.1028,-0.099156,-0.07557,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.04854,-0.099247,-0.13339,0,0
1,GO MICROTUBULE BASED PROCESS,0.02268,-0.099374,-0.082511,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.015953,-0.099382,-0.10452,0,0
1,GO CELL MORPHOGENESIS,0.0023671,-0.099444,-0.12797,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.31232,-0.09952,-0.040992,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.25729,-0.099749,-0.071291,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.59664,-0.099803,-0.052897,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.023741,-0.099841,-0.12915,0,0
1,GO RECEPTOR CLUSTERING,0.022165,-0.099931,-0.16832,0,0
1,GO EXCRETION,0.11039,-0.10046,-0.07273,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.92682,-0.10147,0.0095086,0,0
1,GO RHYTHMIC BEHAVIOR,0.053746,-0.10173,-0.13244,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.14285,-0.10268,-0.082597,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.65866,-0.10268,-0.015792,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.050569,-0.10284,-0.083843,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.59059,-0.10348,-0.050592,0,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.027803,-0.10368,-0.14208,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.077957,-0.10396,-0.10971,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.099158,-0.10402,-0.11132,0,0
1,GO CORNIFICATION,0.50337,-0.10419,-0.08431,0,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.063042,-0.10421,-0.074753,0,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.22905,-0.10485,0.053651,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.48131,-0.10538,-0.08775,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.043763,-0.10568,-0.11343,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.9686,-0.10572,0.064321,0,0
1,GO PROTEIN DEMETHYLATION,0.034637,-0.10625,-0.15177,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.053746,-0.1063,-0.10519,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.049546,-0.10642,-0.16164,0,0
1,GO CELL RECOGNITION,0.055956,-0.10719,-0.084496,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.041967,-0.10726,-0.069185,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.50337,-0.10866,-0.031988,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.064293,-0.10894,-0.12175,0,0
1,GO CIRCADIAN RHYTHM,0.00011241,-0.10932,-0.13164,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.30815,-0.10947,-0.046213,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.035393,-0.10955,-0.13695,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.038561,-0.10977,-0.10359,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.43883,-0.10999,-0.043488,0,0
1,GO ADULT FEEDING BEHAVIOR,0.033166,-0.11069,-0.17149,0,0
1,GO MYOFIBRIL ASSEMBLY,0.42855,-0.1117,0.0080174,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.016339,-0.11176,-0.10381,0,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.12049,-0.11217,-0.033484,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.009256,-0.11241,-0.13524,0,0
1,GO HEART INDUCTION,0.78962,-0.11318,-0.043403,0,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.009256,-0.1134,-0.077786,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.070855,-0.11344,-0.11625,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.11841,-0.11361,-0.047209,0,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.13814,-0.11388,-0.18602,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.39371,-0.11398,-0.084434,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.10654,-0.11407,-0.12072,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0027346,-0.11463,-0.1147,0,0
1,GO CILIUM ORGANIZATION,0.037747,-0.1148,-0.079168,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.32506,-0.11517,-0.050617,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.068167,-0.11534,-0.12025,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.22905,-0.11543,-0.088361,0,0
1,GO NEURON APOPTOTIC PROCESS,0.0001547,-0.11549,-0.13167,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.031059,-0.11557,-0.1719,0,0
1,GO HORMONE CATABOLIC PROCESS,0.22568,-0.11588,-0.13125,0,0
1,GO CILIUM MOVEMENT,0.022165,-0.11589,-0.11115,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.092194,-0.11621,-0.20574,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0087944,-0.11624,-0.15409,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.23245,-0.11644,-0.068424,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.16294,-0.11652,-0.063146,0,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.16828,-0.11687,-0.08202,0,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.21256,-0.11725,0.088253,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.4598,-0.1175,-0.091949,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.26847,-0.11755,-0.088589,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.4598,-0.11767,-0.017726,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.016734,-0.11769,-0.095718,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.099158,-0.11841,-0.098604,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.37932,-0.11844,-0.059785,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.23589,-0.11869,-0.077383,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.046579,-0.11917,-0.25918,0,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.063042,-0.11952,-0.13967,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.02068,-0.11974,-0.16739,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.17099,-0.11979,-0.12675,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0695,-0.11999,-0.11079,0,0
1,GO EYE MORPHOGENESIS,0.11235,-0.1203,-0.069165,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.16828,-0.12085,-0.076462,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0069616,-0.12192,-0.10595,0,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.012508,-0.12195,-0.14666,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.28785,-0.12223,-0.13028,0,0
1,GO GERM CELL DEVELOPMENT,0.0060989,-0.12241,-0.10137,0,0
1,GO LONG TERM MEMORY,0.02268,-0.12257,-0.17346,0,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.014486,-0.12339,-0.1005,0,0
1,GO HEAT GENERATION,0.5726,-0.12366,-0.069929,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.045624,-0.12382,-0.098493,0,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.023741,-0.12387,-0.14252,0,0
1,GO BRAIN MORPHOGENESIS,0.011612,-0.12402,-0.15879,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.01282,-0.1244,-0.16602,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.025414,-0.12459,-0.096965,0,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.060602,-0.12493,-0.15141,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.24643,-0.12542,-0.11026,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.010245,-0.12551,-0.12898,0,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.049546,-0.12562,-0.057866,0,0
1,GO OXIDATIVE DEMETHYLATION,0.060602,-0.12586,-0.11046,0,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.050569,-0.12607,-0.26869,0,0
1,GO REGULATION OF EXCRETION,0.16559,-0.12608,-0.10361,0,0
1,GO KERATINIZATION,0.2839,-0.12627,-0.097901,0,0
1,GO REGULATION OF NEURON MIGRATION,0.02268,-0.12629,-0.19148,0,0
1,GO TRANSPORT ALONG MICROTUBULE,0.011904,-0.12679,-0.12635,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.088862,-0.1269,-0.13366,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.12259,-0.12693,-0.13469,0,0
1,GO INCLUSION BODY ASSEMBLY,0.33812,-0.12715,-0.12268,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.11636,-0.12731,-0.089397,0,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.00074557,-0.12854,-0.13551,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.0079323,-0.12863,-0.17616,0,0
1,GO MATING,0.00026903,-0.12905,-0.17737,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.1313,-0.12915,-0.20927,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.00036427,-0.13036,-0.15599,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.060602,-0.13037,-0.20164,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.69707,-0.13048,-0.015446,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.36991,-0.1306,-0.044495,0,0
1,GO ANIMAL ORGAN MATURATION,0.29184,-0.13068,-0.065994,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.044685,-0.13106,-0.1085,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.045624,-0.13115,-0.1235,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0087944,-0.13127,-0.153,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.063042,-0.13151,-0.23478,0,0
1,GO DIVALENT METAL ION EXPORT,0.44924,-0.1319,-0.072462,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.092194,-0.13201,-0.20914,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.072231,-0.13224,-0.11594,0,0
1,GO CHROMATIN SILENCING,0.16828,-0.13225,-0.044309,0,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.0023671,-0.1323,-0.11252,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.053746,-0.13232,-0.10167,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.25729,-0.13273,-0.079772,0,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,7.547e-05,-0.13295,-0.15878,0,0
1,GO EATING BEHAVIOR,0.013139,-0.13308,-0.12919,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.001191,-0.13336,-0.12241,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036164,-0.13336,-0.12925,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.043763,-0.13402,-0.1326,0,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.00087311,-0.13412,-0.13762,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.25363,-0.13414,-0.049302,0,0
1,GO REGULATION OF OOGENESIS,0.05161,-0.13416,-0.077192,0,0
1,GO G0 TO G1 TRANSITION,0.015953,-0.13427,-0.11407,0,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0064317,-0.13428,-0.16005,0,0
1,GO POLYOL TRANSPORT,0.085627,-0.13454,-0.13087,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.35607,-0.13512,0.010925,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.15015,-0.13526,-0.15635,0,0
1,GO RESPONSE TO PAIN,0.12689,-0.13543,-0.12148,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00031859,-0.13606,-0.16592,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.26847,-0.13606,-0.10933,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0062634,-0.1361,-0.14543,0,0
1,GO CGMP MEDIATED SIGNALING,0.079444,-0.13657,-0.13415,0,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0023671,-0.13657,-0.13988,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.027803,-0.13688,-0.14946,0,0
1,GO THYMUS DEVELOPMENT,0.28785,-0.13733,-0.079588,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.060602,-0.1375,-0.17286,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.013798,-0.13758,-0.12705,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.17099,-0.13761,-0.064407,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.066855,-0.13771,-0.13305,0,0
1,GO REGULATION OF GLIOGENESIS,0.02268,-0.13792,-0.10823,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.10845,-0.13813,-0.12724,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.073629,-0.13824,-0.13477,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.0053338,-0.13825,-0.11504,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.042857,-0.13832,-0.12283,0,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.0034322,-0.13847,-0.14081,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.19393,-0.13852,-0.13776,0,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,9.7346e-05,-0.13865,-0.18831,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.13814,-0.13869,-0.084521,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0097392,-0.13873,-0.1646,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.082489,-0.13887,-0.12208,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.14048,-0.13954,-0.07024,0,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.097379,-0.13963,-0.14708,0,0
1,GO REGULATION OF APPETITE,0.015953,-0.13994,-0.12777,0,0
1,GO V D J RECOMBINATION,0.19393,-0.14019,-0.11282,0,0
1,GO PROTEIN NITROSYLATION,0.088862,-0.14086,-0.1521,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.065563,-0.14091,-0.1135,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.48131,-0.1414,-0.04404,0,0
1,GO REGULATION OF BEHAVIOR,0.0073363,-0.14161,-0.14998,0,0
1,GO HINDBRAIN MORPHOGENESIS,0.0015189,-0.14161,-0.18311,0,0
1,GO SOMITOGENESIS,0.0075304,-0.14167,-0.1299,0,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.12908,-0.14187,-0.088172,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00019079,-0.14227,-0.19773,0,0
1,GO PARTURITION,0.12689,-0.14227,-0.14247,0,0
1,GO NOTCH SIGNALING PATHWAY,0.049546,-0.14254,-0.094557,0,0
1,GO CELL JUNCTION ORGANIZATION,0.00081984,-0.14258,-0.14104,0,0
1,GO BRONCHUS DEVELOPMENT,0.78962,-0.14265,-0.015754,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.59059,-0.1427,-0.035979,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.17099,-0.1429,-0.15453,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.055956,-0.14294,-0.14895,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.12473,-0.14303,-0.10924,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00027832,-0.14303,-0.11614,0,0
1,GO CELLULAR ANION HOMEOSTASIS,0.080955,-0.14331,-0.12186,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.61497,-0.14338,-0.033221,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.088862,-0.14365,-0.10627,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.057089,-0.1438,-0.12856,0,0
1,GO SPERMATID DIFFERENTIATION,0.011612,-0.14388,-0.10638,0,0
1,GO CELL CELL SIGNALING,9.7801e-06,-0.14429,-0.15931,0,0
1,GO SENSORY PERCEPTION OF TASTE,0.059411,-0.14452,-0.024763,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.017969,-0.1454,-0.12982,0,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0024367,-0.14553,-0.12638,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.0030654,-0.14571,-0.18036,0,0
1,GO CELL PROJECTION ORGANIZATION,0.00012074,-0.14658,-0.14754,0,0
1,GO VASCULAR WOUND HEALING,0.19095,-0.14662,-0.16755,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.019283,-0.14699,-0.10166,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.16828,-0.14752,-0.10976,0,0
1,GO MEMBRANE REPOLARIZATION,0.010245,-0.1479,-0.1769,0,0
1,GO MITOTIC DNA REPLICATION,0.064293,-0.14795,-0.13455,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.49227,-0.14804,-0.051171,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.28785,-0.14831,-0.050514,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.22235,-0.14835,-0.10427,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.053746,-0.14852,-0.15062,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.068167,-0.14871,-0.13586,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0032441,-0.14911,-0.14479,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.19095,-0.14924,-0.15671,0,0
1,GO INNER EAR MORPHOGENESIS,0.0094949,-0.14937,-0.17516,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.053746,-0.15004,-0.20471,0,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.0036303,-0.15062,-0.13519,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.0056288,-0.1519,-0.13875,0,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.024288,-0.1522,-0.17425,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.20309,-0.15235,-0.10674,0,0
1,GO CARDIAC CHAMBER FORMATION,0.31232,-0.15239,-0.18106,0,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0067808,-0.15248,-0.12758,0,0
1,GO POSITIVE REGULATION OF RNA SPLICING,4.3218e-05,-0.15301,-0.17642,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.0094949,-0.15308,-0.21714,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.02166,-0.1534,-0.13732,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.072231,-0.15359,-0.14647,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0024367,-0.15366,-0.18575,0,0
1,GO DETECTION OF LIGHT STIMULUS,0.00016595,-0.15377,-0.1766,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.073629,-0.15378,-0.15053,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.016339,-0.15448,-0.10625,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.019283,-0.15511,-0.17541,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.12049,-0.15531,-0.073594,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.084046,-0.15547,-0.084097,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.023205,-0.15575,-0.12873,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.12473,-0.15595,-0.083701,0,0
1,GO REGIONALIZATION,0.018398,-0.15678,-0.1364,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.088862,-0.15705,-0.12281,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.03245,-0.15737,-0.17145,0,0
1,GO RESPONSE TO VITAMIN D,0.21256,-0.15744,-0.13279,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0042883,-0.15747,-0.1445,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.001228,-0.15766,-0.14624,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.0695,-0.15787,-0.10942,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.14769,-0.1579,-0.15197,0,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.31653,-0.15797,-0.11578,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0022992,-0.15808,-0.1403,0,0
1,GO RENAL WATER HOMEOSTASIS,0.00092958,-0.15812,-0.16355,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.14048,-0.15816,-0.1426,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.17374,-0.15821,-0.083264,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.7495,-0.15821,-0.01349,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.070855,-0.1585,-0.15597,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.064293,-0.15868,-0.12441,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.18508,-0.15872,-0.076664,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.21256,-0.15991,-0.06379,0,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.090515,-0.1602,-0.13669,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.001228,-0.16026,-0.15082,0,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.00084609,-0.16073,-0.15527,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.69061,-0.16095,0.002064,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.041093,-0.1622,-0.10507,0,0
1,GO SLEEP,0.00079435,-0.16301,-0.17842,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.03939,-0.16342,-0.12599,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.17374,-0.16397,-0.10432,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.16294,-0.16413,-0.072235,0,0
1,GO DETECTION OF VISIBLE LIGHT,9.0551e-05,-0.1643,-0.18495,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.17374,-0.16473,-0.053382,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.024846,-0.16526,-0.13249,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.061812,-0.16554,-0.15444,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.14048,-0.16573,-0.11873,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.48131,-0.16601,-0.068232,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.17374,-0.16628,-0.022342,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.31653,-0.16639,-0.075503,0,0
1,GO MICROTUBULE POLYMERIZATION,0.00042998,-0.1665,-0.21382,0,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.022165,-0.16653,-0.23895,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0038387,-0.16679,-0.20902,0,0
1,GO REGULATION OF RESPIRATORY BURST,0.022165,-0.16716,-0.22261,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.23589,-0.16766,-0.056096,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.32506,-0.16776,-0.091656,0,0
1,GO INTESTINAL ABSORPTION,0.092194,-0.16847,-0.13607,0,0
1,GO RESPONSE TO MUSCLE STRETCH,0.54321,-0.16927,-0.013784,0,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,4.1617e-05,-0.16992,-0.17669,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.019739,-0.17156,-0.26471,0,0
1,GO AXO DENDRITIC TRANSPORT,0.0079323,-0.17176,-0.18289,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.099158,-0.17219,-0.14625,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.11039,-0.17361,-0.12506,0,0
1,GO RENAL SODIUM EXCRETION,0.22235,-0.17398,-0.073767,0,0
1,GO REGULATION OF SYSTEM PROCESS,1.2454e-05,-0.17437,-0.17781,0,0
1,GO RESPONSE TO FOOD,0.00026003,-0.175,-0.17717,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.001872,-0.17568,-0.16684,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,4.0073e-05,-0.17715,-0.18589,0,0
1,GO AXIS SPECIFICATION,0.0054795,-0.17785,-0.17516,0,0
1,GO COLLATERAL SPROUTING,0.016734,-0.17792,-0.19703,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.16294,-0.1783,-0.071136,0,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.013139,-0.17842,-0.16282,0,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.00052342,-0.17955,-0.2402,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.02068,-0.17956,-0.25178,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.015953,-0.17983,-0.20833,0,0
1,GO DEVELOPMENTAL CELL GROWTH,9.0551e-05,-0.17999,-0.20105,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.085627,-0.18024,-0.15584,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00010092,-0.18057,-0.18296,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0021689,-0.18086,-0.15313,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.007729,-0.18104,-0.18395,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.60272,-0.1811,-0.024027,0,0
1,GO MATING BEHAVIOR,0.015203,-0.18112,-0.16543,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.026586,-0.18123,-0.15776,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.059411,-0.18186,-0.12533,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.10845,-0.18286,-0.071892,0,0
1,GO SODIUM ION TRANSPORT,1.2454e-05,-0.18378,-0.20429,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.025414,-0.18382,-0.23558,0,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,1.1964e-05,-0.18523,-0.19743,0,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.0027346,-0.18591,-0.24841,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.12689,-0.18601,-0.14141,0,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,5.6174e-05,-0.1864,-0.16448,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0031536,-0.18642,-0.19424,0,0
1,GO CARTILAGE MORPHOGENESIS,0.26098,-0.18667,-0.13822,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.0090226,-0.18673,-0.16394,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.075049,-0.18784,-0.097969,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0023671,-0.18788,-0.2006,0,0
1,GO HEAD DEVELOPMENT,2.4346e-05,-0.18893,-0.19928,0,0
1,GO REGULATION OF CIRCADIAN RHYTHM,2.8077e-06,-0.18897,-0.20005,0,0
1,GO MULTICELLULAR ORGANISM AGING,0.00026003,-0.18915,-0.21968,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.16032,-0.18929,-0.15988,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00054072,-0.18972,-0.22761,0,0
1,GO IMPORT INTO CELL,0.00038934,-0.19063,-0.1711,0,0
1,GO NEUROGENESIS,1.1964e-05,-0.19118,-0.20504,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.017549,-0.19149,-0.13446,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.0017123,-0.19184,-0.21423,0,0
1,GO REGULATION OF ION TRANSPORT,5.2837e-06,-0.19236,-0.19317,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.066855,-0.1926,-0.17495,0,0
1,GO SECRETORY GRANULE ORGANIZATION,0.0029794,-0.1931,-0.18761,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0067808,-0.19415,-0.21392,0,0
1,GO RESPONSE TO AMINE,0.0022332,-0.19427,-0.19987,0,0
1,GO EAR DEVELOPMENT,0.00047456,-0.19449,-0.21125,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.054842,-0.1967,-0.22061,0,0
1,GO SPERM AXONEME ASSEMBLY,0.029719,-0.19728,-0.19788,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.009256,-0.19798,-0.22284,0,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,4.8379e-05,-0.19829,-0.26009,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0022992,-0.19872,-0.29892,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.25363,-0.19939,-0.14555,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0073363,-0.19941,-0.24553,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.13583,-0.20005,-0.1625,0,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0021689,-0.20007,-0.17549,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.0013457,-0.20189,-0.19219,0,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0012662,-0.20245,-0.18972,0,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00012964,-0.20271,-0.22956,0,0
1,GO REGULATION OF BLOOD CIRCULATION,2.7343e-05,-0.20307,-0.20274,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0028141,-0.20348,-0.21159,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.011047,-0.20364,-0.28531,0,0
1,GO NEUROBLAST PROLIFERATION,0.0071468,-0.2037,-0.21289,0,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00019079,-0.20379,-0.20042,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0040578,-0.20479,-0.19429,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.036948,-0.20518,-0.13796,0,0
1,GO REGULATION OF NEURON DIFFERENTIATION,1.0604e-05,-0.20545,-0.25356,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.041967,-0.20565,-0.16118,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.085627,-0.20578,-0.15016,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.44402,-0.20603,-0.083051,0,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,4.1617e-05,-0.20626,-0.22002,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.11235,-0.20649,-0.1788,0,0
1,GO NEURON PROJECTION ORGANIZATION,0.00041602,-0.20731,-0.22499,0,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,4.1617e-05,-0.20875,-0.20972,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00012512,-0.20876,-0.20117,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.00092958,-0.20912,-0.17042,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.16032,-0.21025,-0.19556,0,0
1,GO NEURON REMODELING,0.13355,-0.21029,-0.13361,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.0017123,-0.21088,-0.16534,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.070855,-0.2122,-0.1836,0,0
1,GO TELENCEPHALON DEVELOPMENT,1.0184e-05,-0.21229,-0.22956,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0025083,-0.21321,-0.24034,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.34702,-0.21325,-0.12097,0,0
1,GO NEUROMUSCULAR PROCESS,3.7145e-05,-0.21328,-0.25068,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0024367,-0.21337,-0.33511,0,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0011549,-0.21346,-0.2274,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,1.1964e-05,-0.21356,-0.23543,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00021167,-0.21394,-0.22809,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.059411,-0.21487,-0.13117,0,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0011199,-0.21519,-0.25279,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.015203,-0.21521,-0.18232,0,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,7.2754e-05,-0.21531,-0.21775,0,0
1,GO LIPOXYGENASE PATHWAY,0.084046,-0.21576,-0.22416,0,0
1,GO COPULATION,0.0046564,-0.21581,-0.19895,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.070855,-0.21629,-0.12004,0,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.045624,-0.21712,-0.21045,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.0013457,-0.21746,-0.22295,0,0
1,GO MEMBRANE FISSION,0.0013872,-0.21785,-0.24984,0,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,7.9801e-06,-0.21794,-0.24942,0,0
1,GO REGULATION OF AXONOGENESIS,3.8583e-05,-0.21854,-0.25752,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.057089,-0.21857,-0.1654,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.11235,-0.21941,-0.13104,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.25363,-0.21958,-0.23926,0,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0042883,-0.22011,-0.25667,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.188,-0.22067,-0.091384,0,0
1,GO NEURON PROJECTION EXTENSION,0.00019079,-0.22084,-0.22955,0,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,2.7343e-05,-0.22097,-0.19724,0,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,4.0073e-05,-0.22101,-0.22057,0,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0029794,-0.22106,-0.26931,0,0
1,GO AXONAL TRANSPORT,0.0026572,-0.22117,-0.22666,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00041602,-0.22227,-0.30364,0,0
1,GO NEURON PROJECTION GUIDANCE,0.00037661,-0.22262,-0.23261,0,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,2.0033e-05,-0.22426,-0.19281,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00047456,-0.22484,-0.24215,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.0013457,-0.22543,-0.26593,0,0
1,GO GENETIC IMPRINTING,0.017137,-0.22579,-0.14199,0,0
1,GO VESICLE DOCKING,0.0001165,-0.22581,-0.23207,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0028141,-0.22632,-0.16728,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.0054795,-0.22637,-0.17819,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.001872,-0.22656,-0.16094,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00081984,-0.22733,-0.21093,0,0
1,GO POSTSYNAPSE ORGANIZATION,2.2524e-05,-0.22796,-0.27423,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.036164,-0.22807,-0.21347,0,0
1,GO NEURON DIFFERENTIATION,1.6015e-06,-0.22853,-0.25069,0,0
1,GO HEART PROCESS,1.5816e-05,-0.22855,-0.21199,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.8583e-05,-0.22886,-0.35731,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.12259,-0.22901,-0.17378,0,0
1,GO STRIATED MUSCLE CONTRACTION,9.389e-05,-0.22935,-0.19458,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0021689,-0.2298,-0.17113,0,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,6.7596e-05,-0.23014,-0.23185,0,0
1,GO RESPONSE TO CAFFEINE,0.02268,-0.23032,-0.17593,0,0
1,GO REGULATION OF MICROTUBULE BINDING,8.7323e-05,-0.2308,-0.29105,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.32506,-0.23129,-0.13051,0,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00017186,-0.23162,-0.24531,0,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.017137,-0.23203,-0.20573,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0028957,-0.23206,-0.14937,0,0
1,GO AXON DEVELOPMENT,2.5308e-05,-0.23245,-0.25821,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.084046,-0.23329,-0.23949,0,0
1,GO MEMORY,1.1776e-06,-0.23374,-0.27435,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.36064,-0.23486,-0.031117,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.085627,-0.23486,-0.22123,0,0
1,GO FILOPODIUM ASSEMBLY,0.00098941,-0.23507,-0.22917,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.097379,-0.2356,-0.22917,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00055855,-0.23665,-0.27244,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.040234,-0.23684,-0.18735,0,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.0007696,-0.23711,-0.1985,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0042883,-0.23763,-0.19385,0,0
1,GO REGULATION OF HEAT GENERATION,0.15773,-0.23767,-0.2396,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,5.4121e-05,-0.23775,-0.27262,0,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00011241,-0.23822,-0.22562,0,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.033166,-0.23838,-0.21119,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.00041602,-0.23878,-0.25422,0,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,2.5308e-05,-0.24039,-0.24728,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.13814,-0.24043,-0.17546,0,0
1,GO RESPONSE TO HYDROXYUREA,0.001872,-0.2407,-0.24343,0,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.016734,-0.2407,-0.34182,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.061812,-0.24073,-0.18557,0,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.15264,-0.24203,-0.12391,0,0
1,GO NERVOUS SYSTEM PROCESS,2.3975e-07,-0.2424,-0.22439,0,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00016595,-0.24266,-0.23701,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00055855,-0.24298,-0.30305,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,5.2837e-06,-0.24351,-0.27361,0,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,1.0604e-05,-0.24448,-0.32908,0,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,2.6307e-05,-0.24472,-0.21739,0,0
1,GO RESPONSE TO AMPHETAMINE,0.00021167,-0.24536,-0.28459,0,0
1,GO REGULATION OF ACROSOME REACTION,0.0097392,-0.2458,-0.2776,0,0
1,GO ADULT HEART DEVELOPMENT,0.11039,-0.24613,-0.15025,0,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,3.1904e-06,-0.24618,-0.24538,0,0
1,GO PROTEIN DEPOLYMERIZATION,1.0604e-05,-0.24704,-0.24723,0,0
1,GO CELL JUNCTION MAINTENANCE,0.0029794,-0.24769,-0.24262,0,0
1,GO HIPPOCAMPUS DEVELOPMENT,3.8583e-05,-0.24818,-0.29076,0,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0017123,-0.24863,-0.29341,0,0
1,GO CRANIAL NERVE DEVELOPMENT,1.6455e-05,-0.24872,-0.30916,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.02268,-0.24881,-0.22494,0,0
1,GO HEART FORMATION,0.029719,-0.24922,-0.19109,0,0
1,GO PALLIUM DEVELOPMENT,1.0604e-05,-0.24965,-0.25162,0,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,9.7801e-06,-0.24972,-0.22108,0,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,4.4712e-06,-0.2498,-0.27416,0,0
1,GO DEVELOPMENTAL MATURATION,1.5331e-06,-0.25003,-0.2488,0,0
1,GO CELL AGGREGATION,0.02843,-0.25135,-0.17534,0,0
1,GO SECONDARY PALATE DEVELOPMENT,0.00044439,-0.25179,-0.28146,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.0056288,-0.25263,-0.16162,0,0
1,GO NEURON DEVELOPMENT,1.4044e-06,-0.25282,-0.25744,0,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00020448,-0.25321,-0.20202,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.00067758,-0.25376,-0.28111,0,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.00027832,-0.25383,-0.21257,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0013054,-0.25393,-0.2115,0,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,2.6307e-05,-0.25459,-0.25353,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00030804,-0.25523,-0.28755,0,0
1,GO COGNITION,3.0264e-07,-0.25542,-0.27667,0,0
1,GO LIMBIC SYSTEM DEVELOPMENT,5.9841e-06,-0.25564,-0.28819,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0085714,-0.2557,-0.45168,0,0
1,GO FOREBRAIN DEVELOPMENT,7.3528e-06,-0.25594,-0.24125,0,0
1,GO CELL PART MORPHOGENESIS,4.8612e-06,-0.25606,-0.26142,0,0
1,GO SEX DETERMINATION,0.0021689,-0.2562,-0.24517,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00022676,-0.25649,-0.2725,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.033894,-0.25777,-0.17579,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,2.2524e-05,-0.258,-0.25129,0,0
1,GO BEHAVIOR,1.2971e-07,-0.25855,-0.26819,0,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,3.3202e-07,-0.25879,-0.24211,0,0
1,GO CELL FATE DETERMINATION,0.0025083,-0.25946,-0.25865,0,0
1,GO MICROTUBULE BUNDLE FORMATION,0.0018173,-0.25973,-0.21463,0,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0056288,-0.26,-0.19722,0,0
1,GO LONG TERM SYNAPTIC POTENTIATION,3.3132e-05,-0.2605,-0.27469,0,0
1,GO REGULATION OF ACTION POTENTIAL,0.00084609,-0.26057,-0.22845,0,0
1,GO RESPONSE TO CATECHOLAMINE,2.5774e-06,-0.26063,-0.28371,0,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,5.7413e-06,-0.26132,-0.31074,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00028792,-0.26136,-0.27222,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00013433,-0.26156,-0.29469,0,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,2.8418e-05,-0.26318,-0.29242,0,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,3.0576e-06,-0.26427,-0.28185,0,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.6729e-06,-0.26438,-0.26227,0,0
1,GO VISUAL BEHAVIOR,1.104e-05,-0.2644,-0.25248,0,0
1,GO PANCREAS DEVELOPMENT,0.00020448,-0.26483,-0.24651,0,0
1,GO ACROSOME REACTION,0.00087311,-0.26611,-0.22994,0,0
1,GO MICROTUBULE SEVERING,0.024846,-0.26628,-0.16081,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0040578,-0.26747,-0.28663,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.015203,-0.26791,-0.3156,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.016339,-0.26828,-0.19882,0,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,6.2367e-06,-0.26894,-0.32621,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00055855,-0.26938,-0.3282,0,0
1,GO HEART FIELD SPECIFICATION,0.075049,-0.27131,-0.24212,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.30815,-0.27195,-0.12872,0,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.21905,-0.27286,-0.15595,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.2,-0.27321,-0.11795,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.030383,-0.27452,-0.20124,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0019282,-0.27454,-0.2545,0,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,9.0551e-05,-0.27549,-0.37225,0,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,1.1964e-05,-0.27653,-0.27822,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.14048,-0.27689,-0.23542,0,0
1,GO COCHLEA DEVELOPMENT,0.00021909,-0.27702,-0.29926,0,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,8.3127e-06,-0.28011,-0.30318,0,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,1.0184e-05,-0.28062,-0.23779,0,0
1,GO CHROMATIN SILENCING AT TELOMERE,4.8379e-05,-0.2811,-0.24707,0,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,5.6174e-05,-0.28188,-0.32297,0,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00030804,-0.28406,-0.30349,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00013917,-0.2844,-0.3129,0,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.00017796,-0.28518,-0.31337,0,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,2.4346e-05,-0.28531,-0.28358,0,0
1,GO DETECTION OF ABIOTIC STIMULUS,1.1237e-07,-0.28797,-0.29386,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.037747,-0.2881,-0.20228,0,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0010206,-0.28842,-0.23976,0,0
1,GO RESPONSE TO MAGNESIUM ION,0.042857,-0.29008,-0.2046,0,0
1,GO INTRACILIARY TRANSPORT,0.010773,-0.2918,-0.2021,0,0
1,GO WALKING BEHAVIOR,5.8301e-05,-0.29327,-0.33619,0,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00022676,-0.29527,-0.35267,0,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,1.4044e-06,-0.29607,-0.31787,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.001662,-0.29634,-0.25237,0,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00038934,-0.29721,-0.35803,0,0
1,GO SIGNAL RELEASE,2.5778e-08,-0.29747,-0.30869,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00050664,-0.29797,-0.28372,0,0
1,GO FOREBRAIN CELL MIGRATION,0.00019753,-0.29808,-0.27235,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.13814,-0.29851,-0.14464,0,0
1,GO RESPONSE TO FORSKOLIN,0.0045306,-0.29964,-0.32467,0,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0031536,-0.29966,-0.22354,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.15015,-0.30034,-0.13297,0,0
1,GO RESPONSE TO POTASSIUM ION,0.0032441,-0.30039,-0.32235,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00031859,-0.30057,-0.28046,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.030383,-0.30082,-0.21623,0,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00065623,-0.30115,-0.31571,0,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00019753,-0.30117,-0.27562,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0045306,-0.30125,-0.20563,0,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,5.8301e-05,-0.30144,-0.30694,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.059411,-0.3025,-0.19017,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.00072223,-0.30337,-0.27934,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,7.013e-05,-0.3034,-0.30003,0,0
1,GO PROTEIN PALMITOYLATION,2.5774e-06,-0.30349,-0.30565,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.17653,-0.30515,-0.14702,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0014738,-0.30636,-0.27036,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.16294,-0.30643,-0.25218,0,0
1,GO CARDIAC VENTRICLE FORMATION,0.033166,-0.30817,-0.39104,0,0
1,GO SENSORY PERCEPTION OF PAIN,2.3654e-06,-0.31048,-0.27185,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.0085714,-0.31145,-0.39768,0,0
1,GO PRESYNAPSE ORGANIZATION,0.0006154,-0.31259,-0.30087,0,0
1,GO RESPONSE TO LIGHT INTENSITY,0.00025131,-0.31611,-0.32479,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,9.389e-05,-0.31635,-0.28033,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0006154,-0.31648,-0.39496,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,4.2876e-06,-0.31839,-0.35879,0,0
1,GO ACROSOME ASSEMBLY,4.4878e-05,-0.31894,-0.30575,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.023205,-0.3202,-0.21681,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.25363,-0.32028,-0.13725,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0014738,-0.32094,-0.3244,0,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,4.1802e-07,-0.32133,-0.32786,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,4.6623e-06,-0.32183,-0.35258,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.26098,-0.32239,-0.20987,0,0
1,GO RESPONSE TO DOPAMINE,2.1831e-07,-0.32306,-0.31278,0,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.054842,-0.32339,-0.20609,0,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,1.9263e-05,-0.3239,-0.30899,0,0
1,GO LONG TERM SYNAPTIC DEPRESSION,1.5201e-05,-0.32484,-0.36601,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,1.349e-05,-0.32607,-0.2921,0,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,2.0784e-06,-0.32619,-0.32459,0,0
1,GO HINDBRAIN DEVELOPMENT,1.2366e-07,-0.32637,-0.35272,0,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,1.1493e-05,-0.32676,-0.29441,0,0
1,GO UTERUS DEVELOPMENT,0.0013872,-0.32805,-0.302,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0030654,-0.32864,-0.22884,0,0
1,GO CARDIAC CONDUCTION,3.3287e-06,-0.32988,-0.30818,0,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,2.6307e-05,-0.33061,-0.27202,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00079435,-0.33067,-0.29932,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.0026572,-0.33085,-0.35812,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00013917,-0.33085,-0.30851,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.001872,-0.33169,-0.31174,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.050569,-0.33292,-0.36112,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.0099891,-0.33295,-0.27419,0,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00018427,-0.333,-0.38746,0,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00029782,-0.33436,-0.31107,0,0
1,GO ASSOCIATIVE LEARNING,8.2505e-07,-0.33469,-0.32234,0,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,2.7343e-05,-0.33559,-0.33869,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,1.8958e-07,-0.33569,-0.3163,0,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,9.7801e-06,-0.33602,-0.34718,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,4.3218e-05,-0.33607,-0.30915,0,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0006154,-0.33628,-0.33883,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,6.5149e-05,-0.33682,-0.30552,0,0
1,GO ACIDIC AMINO ACID TRANSPORT,1.2971e-07,-0.33703,-0.38479,0,0
1,GO OTIC VESICLE MORPHOGENESIS,0.047551,-0.33821,-0.33865,0,0
1,GO LIPID DROPLET FORMATION,0.11636,-0.33885,-0.20433,0,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00024286,-0.3403,-0.30331,0,0
1,GO STRIATUM DEVELOPMENT,0.00012074,-0.34039,-0.34665,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.00010845,-0.3405,-0.33269,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0020453,-0.34134,-0.24321,0,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00040247,-0.34192,-0.36094,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.001986,-0.34206,-0.30388,0,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0021689,-0.34283,-0.25048,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.047551,-0.34412,-0.20817,0,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00038934,-0.34458,-0.30461,0,0
1,GO ADRENAL GLAND DEVELOPMENT,5.2139e-05,-0.34487,-0.39807,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.024288,-0.34527,-0.26435,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,2.2524e-05,-0.34533,-0.32406,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0087944,-0.34629,-0.27991,0,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0012662,-0.34658,-0.39012,0,0
1,GO AXONEME ASSEMBLY,0.0079323,-0.34954,-0.23453,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,9.0551e-05,-0.34964,-0.30473,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.0083534,-0.35023,-0.28149,0,0
1,GO MITOCHONDRION LOCALIZATION,0.00050664,-0.35054,-0.26902,0,0
1,GO LEARNING,3.17e-07,-0.35113,-0.36197,0,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0007696,-0.35196,-0.33348,0,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00030804,-0.35206,-0.31531,0,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.00035231,-0.35241,-0.31128,0,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0041716,-0.35343,-0.30408,0,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00010462,-0.3536,-0.38796,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,5.0683e-06,-0.35601,-0.35618,0,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,7.8282e-05,-0.35711,-0.37168,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.068167,-0.35727,-0.18565,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0054795,-0.35817,-0.29065,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.3605e-07,-0.35897,-0.39397,0,0
1,GO DENDRITE DEVELOPMENT,2.6322e-07,-0.35968,-0.33859,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.03939,-0.36028,-0.43702,0,0
1,GO REGULATION OF MEMBRANE POTENTIAL,2.2167e-08,-0.36042,-0.38693,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,4.4712e-06,-0.36162,-0.412,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.00052342,-0.36418,-0.37241,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0046564,-0.3648,-0.42676,0,0
1,GO DENDRITE MORPHOGENESIS,7.5427e-07,-0.36532,-0.35848,0,0
1,GO SYNAPSE ORGANIZATION,6.8936e-07,-0.36645,-0.33696,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,4.6623e-06,-0.36717,-0.41055,0,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,3.5759e-05,-0.36773,-0.38175,0,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.5331e-06,-0.36788,-0.36295,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00035231,-0.36902,-0.32872,0,0
1,GO ACTIN CROSSLINK FORMATION,0.0075304,-0.37041,-0.2825,0,0
1,GO NERVE DEVELOPMENT,2.1831e-07,-0.37098,-0.39275,0,0
1,GO ACTION POTENTIAL,2.3975e-07,-0.37252,-0.37733,0,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,6.7728e-06,-0.37261,-0.36174,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.012203,-0.37288,-0.30848,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,6.2367e-06,-0.37338,-0.3915,0,0
1,GO CELL MIGRATION IN HINDBRAIN,1.7118e-05,-0.37382,-0.45865,0,0
1,GO DETECTION OF MECHANICAL STIMULUS,3.4728e-06,-0.37388,-0.33629,0,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,1.4039e-05,-0.37511,-0.33784,0,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00018427,-0.37601,-0.42003,0,0
1,GO SYNAPTIC SIGNALING,2.9957e-08,-0.37842,-0.38855,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00055855,-0.37947,-0.39042,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,2.5308e-05,-0.38031,-0.3614,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0066042,-0.38062,-0.34075,0,0
1,GO NEUROTRANSMITTER REUPTAKE,7.3528e-06,-0.38205,-0.39299,0,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,3.6414e-07,-0.38388,-0.43414,0,0
1,GO POTASSIUM ION TRANSPORT,5.986e-08,-0.38401,-0.36725,0,0
1,GO REGULATION OF EXOCYTOSIS,1.905e-08,-0.38437,-0.39473,0,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,4.7955e-07,-0.38543,-0.4256,0,0
1,GO GROOMING BEHAVIOR,1.2962e-05,-0.38644,-0.41842,0,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,3.17e-07,-0.38663,-0.37457,0,0
1,GO PROTEIN POLYGLUTAMYLATION,2.7343e-05,-0.38754,-0.36152,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.0016129,-0.38821,-0.318,0,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,9.0551e-05,-0.38838,-0.37634,0,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,1.4268e-07,-0.38843,-0.3808,0,0
1,GO MEMBRANE DEPOLARIZATION,6.5896e-07,-0.38898,-0.38565,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,2.3418e-05,-0.39084,-0.42532,0,0
1,GO PARENTAL BEHAVIOR,0.00017186,-0.39326,-0.391,0,0
1,GO NEURON CELLULAR HOMEOSTASIS,7.0571e-06,-0.39335,-0.45564,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.4978,-0.39397,-0.10216,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.0604e-05,-0.39408,-0.40592,0,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,8.628e-07,-0.39629,-0.37026,0,0
1,GO SKELETAL MUSCLE ADAPTATION,0.00017796,-0.40052,-0.30645,0,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,4.6597e-05,-0.40257,-0.3788,0,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,5.6999e-08,-0.4046,-0.43652,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,8.628e-07,-0.40674,-0.40808,0,0
1,GO SEGMENT SPECIFICATION,6.7728e-06,-0.40714,-0.53012,0,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,7.3528e-06,-0.4079,-0.40478,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.2962e-05,-0.40791,-0.46876,0,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00054072,-0.40859,-0.35883,0,0
1,GO LOCOMOTORY BEHAVIOR,3.8423e-08,-0.40932,-0.43533,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.00059588,-0.40983,-0.34881,0,0
1,GO NEURON MIGRATION,1.0779e-06,-0.41124,-0.42583,0,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0010859,-0.4132,-0.43007,0,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,3.9926e-07,-0.41369,-0.39993,0,0
1,GO MICROTUBULE DEPOLYMERIZATION,7.889e-07,-0.41398,-0.43588,0,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00014935,-0.41413,-0.36962,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,3.8131e-07,-0.4153,-0.4698,0,0
1,GO METENCEPHALON DEVELOPMENT,6.6003e-08,-0.41531,-0.43045,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.11039,-0.42015,-0.21303,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0020453,-0.42088,-0.43444,0,0
1,GO RESPONSE TO NICOTINE,0.00017186,-0.4214,-0.29261,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.10465,-0.42276,-0.23201,0,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,1.7474e-06,-0.42341,-0.45251,0,0
1,GO TUBULIN DEACETYLATION,0.00045924,-0.42373,-0.3607,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,6.5149e-05,-0.42705,-0.38996,0,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,4.6623e-06,-0.42778,-0.42115,0,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,9.8628e-07,-0.42896,-0.52492,0,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,3.6563e-08,-0.42934,-0.42538,0,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,2.6307e-05,-0.43017,-0.35988,0,0
1,GO DENTATE GYRUS DEVELOPMENT,0.0083534,-0.43236,-0.44679,0,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,3.8131e-07,-0.43391,-0.43426,0,0
1,GO SEROTONIN TRANSPORT,1.2971e-07,-0.43436,-0.59364,0,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,5.2139e-05,-0.43467,-0.39207,0,0
1,GO RESPONSE TO COCAINE,7.2756e-08,-0.43526,-0.46879,0,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.00059588,-0.43618,-0.43032,0,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,9.0221e-07,-0.43826,-0.48175,0,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.00084609,-0.43835,-0.344,0,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.8301e-05,-0.44068,-0.53241,0,0
1,GO SECRETORY GRANULE LOCALIZATION,6.5149e-05,-0.4407,-0.65852,0,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,9.3916e-06,-0.44173,-0.44844,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,9.7801e-06,-0.44446,-0.46743,0,0
1,GO DENDRITIC TRANSPORT,0.00055855,-0.44673,-0.35362,0,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.00054072,-0.44886,-0.4091,0,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,8.2505e-07,-0.45052,-0.44763,0,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00067758,-0.45276,-0.41297,0,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.00069957,-0.45414,-0.54971,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,6.0504e-05,-0.4568,-0.53982,0,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,2.2658e-06,-0.45703,-0.45928,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,4.8379e-05,-0.45788,-0.4629,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.6322e-07,-0.45826,-0.44471,0,0
1,GO SYNAPSE ASSEMBLY,3.17e-07,-0.45912,-0.46144,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0013872,-0.4606,-0.37067,0,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,3.7791e-06,-0.46221,-0.46902,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,8.6584e-06,-0.46237,-0.4577,0,0
1,GO ADULT BEHAVIOR,2.0038e-08,-0.46329,-0.53298,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.011326,-0.46375,-0.45678,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,2.7343e-05,-0.46491,-0.47879,0,0
1,GO RESPONSE TO ACETYLCHOLINE,1.2862e-06,-0.46538,-0.47567,0,0
1,GO EPITHELIAL CELL MATURATION,5.508e-06,-0.46661,-0.50437,0,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,2.5308e-05,-0.46724,-0.50364,0,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,2.9301e-06,-0.47445,-0.53389,0,0
1,GO NEUROTRANSMITTER UPTAKE,7.5427e-07,-0.47568,-0.41731,0,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00014935,-0.47914,-0.51289,0,0
1,GO SYNAPTIC VESICLE RECYCLING,3.9926e-07,-0.48091,-0.4339,0,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,4.0073e-05,-0.48238,-0.5766,0,0
1,GO ADULT LOCOMOTORY BEHAVIOR,2.7104e-08,-0.48264,-0.49262,0,0
1,GO SYNAPTIC VESICLE LOCALIZATION,6.8936e-07,-0.48738,-0.55443,0,0
1,GO ENDOCARDIUM DEVELOPMENT,0.001228,-0.4889,-0.33643,0,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0021062,-0.48922,-0.44879,0,0
1,GO MAST CELL MIGRATION,0.00036427,-0.48999,-0.47898,0,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.7104e-08,-0.49095,-0.50746,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.00041602,-0.49469,-0.41215,0,0
1,GO NEURAL RETINA DEVELOPMENT,2.8891e-07,-0.49953,-0.48965,0,0
1,GO NEURON MATURATION,1.4963e-07,-0.50011,-0.49909,0,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,2.6902e-06,-0.50031,-0.46906,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.046579,-0.50173,-0.30522,0,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,2.3313e-08,-0.50754,-0.49818,0,0
1,GO NEURON RECOGNITION,7.5427e-07,-0.51074,-0.51993,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,2.0833e-05,-0.51129,-0.57654,0,0
1,GO TRANSMISSION OF NERVE IMPULSE,4.0375e-08,-0.51541,-0.54434,0,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,5.4121e-05,-0.51804,-0.43174,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,2.9532e-05,-0.51815,-0.47559,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,8.8325e-08,-0.51919,-0.5119,0,0
1,GO REGULATION OF VESICLE FUSION,1.5331e-06,-0.51986,-0.54422,0,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,7.6379e-08,-0.52106,-0.53572,0,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,7.0571e-06,-0.52635,-0.62283,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,3.9418e-06,-0.52883,-0.46979,0,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.00010462,-0.5332,-0.55387,0,0
1,GO PRESYNAPTIC ENDOCYTOSIS,2.7578e-07,-0.53877,-0.47639,0,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,5.986e-08,-0.54163,-0.54542,0,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,2.6322e-07,-0.54213,-0.55235,0,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,1.104e-05,-0.55192,-0.46122,0,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,7.0571e-06,-0.55208,-0.50296,0,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.6999e-08,-0.55377,-0.5265,0,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,1.8084e-07,-0.55674,-0.56141,0,0
1,GO RESPONSE TO LEUCINE,0.00012512,-0.56035,-0.49153,0,0
1,GO AXONAL FASCICULATION,0.00011241,-0.56264,-0.53131,0,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,7.5427e-07,-0.5635,-0.5163,0,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,1.5691e-07,-0.56657,-0.54129,0,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.3441e-06,-0.56795,-0.60994,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,5.2837e-06,-0.56847,-0.58088,0,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,2.9301e-06,-0.57113,-0.5006,0,0
1,GO SUBPALLIUM DEVELOPMENT,1.0604e-05,-0.57178,-0.51649,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,6.0198e-07,-0.57457,-0.58481,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,3.8423e-08,-0.57628,-0.56849,0,0
1,GO DETECTION OF CALCIUM ION,3.0689e-05,-0.57858,-0.50628,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.5816e-05,-0.57968,-0.49958,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,1.1964e-05,-0.58472,-0.58033,0,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,4.4712e-06,-0.58525,-0.65005,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,6.4994e-06,-0.58637,-0.5992,0,0
1,GO CEREBELLAR CORTEX FORMATION,4.7955e-07,-0.58696,-0.53356,0,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,3.9418e-06,-0.5901,-0.64308,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,2.6322e-07,-0.59386,-0.62781,0,0
1,GO CGMP METABOLIC PROCESS,1.5691e-07,-0.59435,-0.60451,0,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00032948,-0.59538,-0.62992,0,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,2.2167e-08,-0.59829,-0.59541,0,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,3.0264e-07,-0.60261,-0.6032,0,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.6015e-06,-0.60295,-0.61542,0,0
1,GO NEURAL NUCLEUS DEVELOPMENT,2.0829e-07,-0.60658,-0.53898,0,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,8.4205e-05,-0.60674,-0.63822,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,2.1831e-07,-0.60951,-0.55934,0,0
1,GO GLUTAMATE SECRETION,3.1491e-08,-0.61074,-0.60372,0,0
1,GO GROWTH HORMONE SECRETION,3.17e-07,-0.61447,-0.59858,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,2.0033e-05,-0.61519,-0.49421,0,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,2.0038e-08,-0.61931,-0.63963,0,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00017186,-0.62807,-0.53558,0,0
1,GO LUNG CELL DIFFERENTIATION,0.00095906,-0.63486,-0.47867,0,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.00032948,-0.64208,-0.51672,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,5.6999e-08,-0.64582,-0.6869,0,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,2.0038e-08,-0.6502,-0.67682,0,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,2.1077e-08,-0.65364,-0.66004,0,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,4.2424e-08,-0.65769,-0.6803,0,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,1.1267e-06,-0.65848,-0.59211,0,0
1,GO NEUROTRANSMITTER TRANSPORT,2.4515e-08,-0.65886,-0.64694,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.11636,-0.66317,-0.35513,0,0
1,GO STARTLE RESPONSE,4.7955e-07,-0.66452,-0.60677,0,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,2.3975e-07,-0.66659,-0.60259,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,8.628e-07,-0.66928,-0.62251,0,0
1,GO REGULATION OF SYNAPSE MATURATION,8.628e-07,-0.67521,-0.72142,0,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,2.1663e-05,-0.67638,-0.64653,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,3.6563e-08,-0.67851,-0.68592,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,1.5816e-05,-0.67927,-0.67763,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,1.8958e-07,-0.69797,-0.67956,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00014418,-0.70648,-0.57911,0,0
1,GO NEURONAL ACTION POTENTIAL,6.93e-08,-0.7157,-0.72133,0,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.9418e-06,-0.71737,-0.71247,0,0
1,GO NEUROTRANSMITTER SECRETION,2.5778e-08,-0.71782,-0.71379,0,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,2.6322e-07,-0.72341,-0.69566,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,5.986e-08,-0.72657,-0.72212,0,0
1,GO GLIAL CELL FATE COMMITMENT,8.4205e-05,-0.73483,-0.64465,0,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,8.6584e-06,-0.73726,-0.72046,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0025083,-0.74243,-0.5913,0,0
1,GO NEURON CELL CELL ADHESION,4.3763e-07,-0.74952,-0.98339,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,1.7474e-06,-0.7584,-0.78011,0,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.9957e-08,-0.75955,-0.70668,0,0
1,GO DENSE CORE GRANULE TRANSPORT,1.4044e-06,-0.76421,-1.0208,0,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,2.2167e-08,-0.76832,-0.76834,0,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,2.3975e-07,-0.77322,-0.70383,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,3.8423e-08,-0.7815,-0.71939,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.0024367,-0.78517,-0.54045,0,0
1,GO SEROTONIN SECRETION,6.2859e-08,-0.79114,-0.7281,0,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,1.5331e-06,-0.79997,-0.67886,0,0
1,GO RESPONSE TO AUDITORY STIMULUS,2.8496e-08,-0.81447,-0.81115,0,0
1,GO SYNAPTIC VESICLE DOCKING,7.6379e-08,-0.81637,-0.90957,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,8.2505e-07,-0.81725,-0.91177,0,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,2.4515e-08,-0.82188,-0.76708,0,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.2167e-08,-0.82572,-0.84053,0,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.0023671,-0.8366,-0.61552,0,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,4.6826e-08,-0.8381,-0.84475,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,4.0375e-08,-0.84036,-0.87449,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,3.31e-08,-0.84729,-0.85077,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,2.0833e-05,-0.87786,-0.75572,0,0
1,GO SEROTONIN METABOLIC PROCESS,1.8084e-07,-0.88537,-0.76657,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,3.1491e-08,-0.88622,-0.87188,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.1237e-07,-0.88779,-0.86942,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,9.7275e-08,-0.89905,-0.84597,0,0
1,GO DENDRITE EXTENSION,4.2424e-08,-0.9014,-0.83324,0,0
1,GO VOCALIZATION BEHAVIOR,4.7955e-07,-0.91556,-0.89884,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,3.6563e-08,-0.92226,-0.89838,0,0
1,GO RETINA LAYER FORMATION,3.4772e-07,-0.92323,-0.80029,0,0
1,GO PREPULSE INHIBITION,9.7275e-08,-0.92547,-0.87443,0,0
1,GO NEURONAL ION CHANNEL CLUSTERING,1.9904e-06,-0.94545,-0.85656,0,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,9.0221e-07,-0.94969,-0.83979,0,0
1,GO REGULATION OF DENDRITE EXTENSION,4.2424e-08,-0.97479,-0.94151,0,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.5331e-06,-0.98828,-0.94512,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,3.31e-08,-1.0127,-1.0999,0,0
1,GO NOSE DEVELOPMENT,3.0576e-06,-1.0142,-0.88053,0,0
1,GO PROTEIN LOCALIZATION TO AXON,6.2859e-08,-1.0508,-1.1289,0,0
1,GO SYNAPTIC VESICLE CLUSTERING,1.8084e-07,-1.0593,-1.0534,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,7.2756e-08,-1.0728,-0.9436,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,8.628e-07,-1.1324,-1.0092,0,0
1,GO MECHANOSENSORY BEHAVIOR,3.8423e-08,-1.1358,-1.1807,0,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,2.8496e-08,-1.1644,-1.1704,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,5.4272e-08,-1.175,-1.1927,0,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,3.31e-08,-1.4851,-1.4276,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,2.2879e-07,-1.5634,-1.4837,0,0
2,GO OXYGEN TRANSPORT,7.547e-05,0.81539,0.747,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.1888e-05,0.78882,0.71035,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.5816e-05,0.72334,0.66453,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.1964e-05,0.71028,0.61784,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0001547,0.67822,0.72094,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,5.2139e-05,0.64875,0.55119,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,3.3287e-06,0.63001,0.61814,1,1
2,GO RESPONSE TO HISTAMINE,2.0833e-05,0.61441,0.63341,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,9.7801e-06,0.60828,0.57979,1,1
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,2.9532e-05,0.59411,0.58126,1,1
2,GO SYNAPSE MATURATION,0.00042998,0.58389,0.55191,1,1
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,5.2139e-05,0.58202,0.58056,1,1
2,GO GAS TRANSPORT,0.00018427,0.57434,0.54092,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.2139e-05,0.56973,0.46119,1,1
2,GO RESPONSE TO L GLUTAMATE,1.7118e-05,0.5632,0.54731,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00079435,0.55166,0.45742,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00045924,0.54979,0.4128,1,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,3.3287e-06,0.53768,0.54006,1,1
2,GO GLYCINE TRANSPORT,0.0013054,0.53755,0.45246,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,6.7728e-06,0.52581,0.51835,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,5.8301e-05,0.52235,0.52449,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,2.9532e-05,0.52075,0.4714,1,1
2,GO RIBOSOME ASSEMBLY,1.2454e-05,0.51965,0.52271,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.00057693,0.51373,0.47329,1,1
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00063551,0.51371,0.55799,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,5.0226e-05,0.51244,0.43381,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,5.2139e-05,0.50845,0.43768,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1.5201e-05,0.50695,0.52578,1,1
2,GO UV PROTECTION,9.4334e-07,0.50261,0.49723,1,1
2,GO CYTOPLASMIC TRANSLATION,3.0689e-05,0.50222,0.49325,1,1
2,GO MATURATION OF LSU RRNA,4.1112e-06,0.502,0.52582,1,1
2,GO IMP METABOLIC PROCESS,6.7728e-06,0.49745,0.52991,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,7.6603e-06,0.49722,0.46517,1,1
2,GO SYNAPTIC VESICLE MATURATION,0.00032948,0.49002,0.46862,1,1
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,4.8612e-06,0.48957,0.52222,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,2.1663e-05,0.48707,0.4741,1,1
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0016129,0.48064,0.3453,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00023468,0.4804,0.55075,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,4.3218e-05,0.47808,0.45036,1,1
2,GO PLASMA MEMBRANE REPAIR,1.7118e-05,0.47515,0.43057,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00022676,0.47195,0.35921,1,1
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,9.7801e-06,0.46923,0.41322,1,1
2,GO AROMATIC AMINO ACID TRANSPORT,0.00055855,0.46866,0.47831,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,1.7474e-06,0.46223,0.46803,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,5.9841e-06,0.4566,0.47396,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0010206,0.45403,0.33701,1,1
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,4.6623e-06,0.45177,0.42629,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00090094,0.44779,0.4969,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00090094,0.44589,0.36452,1,1
2,GO POSTSYNAPSE ASSEMBLY,0.00081984,0.4442,0.43576,1,1
2,GO MYOBLAST PROLIFERATION,2.2658e-06,0.44337,0.42829,1,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,2.8077e-06,0.4422,0.38801,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0028141,0.43581,0.3201,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.0040578,0.43436,0.25227,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,3.7145e-05,0.43423,0.42594,1,1
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,2.8418e-05,0.43092,0.46841,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,7.9801e-06,0.4301,0.48694,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00010092,0.42967,0.42685,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.3132e-05,0.42733,0.37696,1,1
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.030383,0.42493,0.19913,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.00026003,0.42415,0.32079,1,1
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00055855,0.42385,0.41074,1,1
2,GO TRANSLATIONAL INITIATION,7.547e-05,0.41916,0.42211,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,3.1888e-05,0.41789,0.46439,1,1
2,GO SUCKLING BEHAVIOR,0.00026903,0.4172,0.33519,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00035231,0.41604,0.49831,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,5.0683e-06,0.41334,0.38134,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,0.025414,0.4128,0.3198,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.9263e-05,0.40305,0.42321,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,2.5308e-05,0.40108,0.41323,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.010506,0.40104,0.28928,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00012074,0.39933,0.39412,1,1
2,GO MATURATION OF SSU RRNA,6.2367e-06,0.39869,0.44019,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00042998,0.3971,0.41154,1,1
2,GO VIRAL TRANSLATION,7.2754e-05,0.3964,0.39111,1,1
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0001547,0.39577,0.46904,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,2.7343e-05,0.39541,0.37787,1,1
2,GO SNORNA METABOLIC PROCESS,0.00029782,0.39513,0.40738,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.00092958,0.39423,0.35709,1,1
2,GO TELOMERASE RNA LOCALIZATION,4.8612e-06,0.39353,0.45365,1,1
2,GO CRISTAE FORMATION,0.00054072,0.39055,0.29118,1,1
2,GO ADULT HEART DEVELOPMENT,0.00037661,0.38782,0.35746,1,1
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0027346,0.38363,0.34733,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,4.3218e-05,0.38243,0.41963,1,1
2,GO SNORNA 3 END PROCESSING,5.2139e-05,0.38121,0.44397,1,1
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.00050664,0.37775,0.38325,1,1
2,GO SHORT TERM MEMORY,0.00095906,0.37704,0.40963,1,1
2,GO L GLUTAMATE IMPORT,0.00029782,0.37583,0.3149,1,1
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00098941,0.37401,0.34407,1,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.00012964,0.3711,0.36059,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00050664,0.37102,0.42067,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00037661,0.36981,0.37519,1,1
2,GO MATURATION OF 5 8S RRNA,3.8583e-05,0.36945,0.37424,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00019753,0.36444,0.35376,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00054072,0.36443,0.38469,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,1.5201e-05,0.36311,0.41577,1,1
2,GO ARGININE METABOLIC PROCESS,0.0046564,0.36281,0.30972,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,4.6597e-05,0.36187,0.34182,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00012964,0.36154,0.30061,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.00035231,0.36102,0.32193,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00010462,0.3597,0.34641,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.046579,0.35692,0.20046,1,1
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.0010859,0.35691,0.32071,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0073363,0.3503,0.30711,1,1
2,GO INNERVATION,0.0039469,0.35026,0.33228,1,1
2,GO NEUROBLAST DIVISION,0.011612,0.34975,0.28156,1,1
2,GO PEPTIDYL ARGININE N METHYLATION,3.6228e-06,0.34889,0.39181,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00042998,0.34806,0.28949,1,1
2,GO PENTOSE METABOLIC PROCESS,0.00014935,0.34481,0.31658,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0069616,0.34396,0.22937,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00013433,0.34111,0.34542,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00037661,0.34094,0.27564,1,1
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0007696,0.3396,0.27294,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,3.7145e-05,0.33157,0.30388,1,1
2,GO MITOCHONDRIAL RNA PROCESSING,0.0015653,0.33131,0.30878,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0026572,0.32997,0.31892,1,1
2,GO MITOCHONDRIAL TRNA PROCESSING,0.013465,0.32818,0.24099,1,1
2,GO REGULATION OF MRNA BINDING,1.8521e-05,0.32602,0.39788,1,1
2,GO NUCLEOTIDE SALVAGE,0.009256,0.3254,0.29083,1,1
2,GO VIRAL GENE EXPRESSION,0.00084609,0.324,0.33686,1,1
2,GO TRNA MODIFICATION,1.7474e-06,0.32353,0.31884,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.014138,0.32351,0.28252,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,9.0551e-05,0.3233,0.37047,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,8.3127e-06,0.32282,0.32446,1,1
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0079323,0.32231,0.33252,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00059588,0.31962,0.31253,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00034072,0.31902,0.31313,1,1
2,GO PROTEIN TARGETING TO MEMBRANE,0.00038934,0.31485,0.30664,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00026003,0.31477,0.24803,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.017969,0.31376,0.23899,1,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,9.389e-05,0.31309,0.25901,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011326,0.31244,0.21095,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00050664,0.31142,0.28401,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00087311,0.30888,0.36835,1,1
2,GO ADAPTATION OF SIGNALING PATHWAY,0.0020453,0.30837,0.2676,1,1
2,GO RIBOSOME BIOGENESIS,1.5201e-05,0.30689,0.38255,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,3.0689e-05,0.30657,0.24294,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,7.2754e-05,0.30498,0.28153,1,1
2,GO RRNA MODIFICATION,0.00019079,0.3047,0.35171,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,3.1888e-05,0.30322,0.37676,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.010506,0.30297,0.20661,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.0020453,0.30247,0.24302,1,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.21763,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.018398,0.30166,0.21952,1,1
2,GO PEPTIDYL HISTIDINE MODIFICATION,9.7346e-05,0.30067,0.26078,1,1
2,GO SIALYLATION,0.014138,0.30053,0.27725,1,1
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00079435,0.30007,0.18658,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,6.7596e-05,0.29759,0.34957,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.010506,0.29461,0.26407,1,1
2,GO DIVALENT METAL ION EXPORT,0.0022332,0.2928,0.36634,1,1
2,GO MRNA MODIFICATION,4.8379e-05,0.29207,0.30818,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.015574,0.29146,0.20846,1,1
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00052342,0.29102,0.28985,1,1
2,GO TRNA PROCESSING,1.2962e-05,0.29098,0.2654,1,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,8.7323e-05,0.29082,0.30253,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.6584e-06,0.2905,0.29277,1,1
2,GO NAD METABOLIC PROCESS,0.0023671,0.28961,0.22695,1,1
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.014138,0.28954,0.28542,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,6.5149e-05,0.28915,0.28619,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00028792,0.28897,0.30145,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,9.0179e-06,0.28815,0.27527,1,1
2,GO TRANSLATIONAL ELONGATION,1.1964e-05,0.28733,0.32113,1,1
2,GO SYNAPTIC VESICLE PRIMING,0.0028957,0.2873,0.30296,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.029719,0.28363,0.18988,1,1
2,GO RRNA METABOLIC PROCESS,2.3418e-05,0.28323,0.34974,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,9.3916e-06,0.27902,0.3275,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00090094,0.27851,0.25073,1,1
2,GO RRNA METHYLATION,0.00026903,0.27841,0.29014,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00030804,0.27816,0.28971,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0016129,0.27614,0.26508,1,1
2,GO REGULATION OF RNA BINDING,1.1964e-05,0.27574,0.32944,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.00074557,0.27567,0.30316,1,1
2,GO MITOCHONDRIAL TRANSLATION,9.7346e-05,0.27364,0.32059,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,7.013e-05,0.27345,0.32831,1,1
2,GO TRNA METHYLATION,3.5759e-05,0.27313,0.26945,1,1
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00030804,0.27291,0.23048,1,1
2,GO ALANINE TRANSPORT,0.0087944,0.27138,0.26509,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.001662,0.27016,0.21343,1,1
2,GO AMINO ACID IMPORT,0.0012662,0.2701,0.22735,1,1
2,GO AORTA DEVELOPMENT,0.0085714,0.26865,0.15313,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0015189,0.26804,0.21471,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.017137,0.26785,0.23298,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.0001165,0.26645,0.3032,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0040578,0.26605,0.17922,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,7.2754e-05,0.26601,0.31884,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0085714,0.26571,0.18409,1,1
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.031748,0.26536,0.17453,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00072223,0.26487,0.30639,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.0023671,0.26395,0.24744,1,1
2,GO RNA SURVEILLANCE,0.00047456,0.26387,0.23038,1,1
2,GO HISTONE ARGININE METHYLATION,0.00026003,0.26385,0.24286,1,1
2,GO TRNA METABOLIC PROCESS,7.547e-05,0.2631,0.22931,1,1
2,GO RRNA TRANSCRIPTION,2.1663e-05,0.26243,0.2901,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00026903,0.25989,0.18357,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0011199,0.2595,0.25663,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.00029782,0.25896,0.22688,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.041093,0.25782,0.22084,1,1
2,GO BONE GROWTH,0.018398,0.25539,0.2292,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,8.4205e-05,0.25489,0.25305,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.00067758,0.25404,0.22668,1,1
2,GO HEME METABOLIC PROCESS,0.0087944,0.25225,0.22885,1,1
2,GO PEPTIDYL ARGININE METHYLATION,2.9532e-05,0.25169,0.27082,1,1
2,GO GLUCOSE CATABOLIC PROCESS,0.009256,0.25137,0.19355,1,1
2,GO RNA 5 END PROCESSING,0.0012662,0.25107,0.26658,1,1
2,GO AMINO ACID ACTIVATION,0.0038387,0.25083,0.24203,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.0041716,0.25013,0.19736,1,1
2,GO NCRNA PROCESSING,2.4346e-05,0.25012,0.28976,1,1
2,GO REGULATION OF LYASE ACTIVITY,0.00012512,0.25006,0.21597,1,1
2,GO MRNA METHYLATION,0.00047456,0.24908,0.26081,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,5.2139e-05,0.24816,0.30018,1,1
2,GO TRANSLATIONAL TERMINATION,9.389e-05,0.24753,0.30948,1,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0001165,0.24642,0.25393,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.001986,0.24464,0.23949,1,1
2,GO REPRODUCTIVE BEHAVIOR,0.013139,0.24426,0.19899,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.026586,0.24392,0.20827,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,2.0033e-05,0.24352,0.25784,1,1
2,GO L SERINE METABOLIC PROCESS,0.029068,0.2424,0.26917,1,1
2,GO RELAXATION OF MUSCLE,0.024846,0.24158,0.16698,1,1
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.027188,0.24155,0.2339,1,1
2,GO AEROBIC RESPIRATION,0.00022676,0.24054,0.21892,1,1
2,GO STRESS GRANULE ASSEMBLY,8.7323e-05,0.24006,0.20617,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.0029794,0.23994,0.18481,1,1
2,GO BASIC AMINO ACID TRANSPORT,0.014841,0.23992,0.23958,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0013054,0.23922,0.18418,1,1
2,GO NEURON REMODELING,0.0028957,0.23903,0.2714,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0057817,0.23891,0.21851,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00026003,0.23721,0.21392,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0030654,0.23662,0.19149,1,1
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.0066042,0.23485,0.36675,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0094949,0.23455,0.2142,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0024367,0.23401,0.19118,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0087944,0.23216,0.185,1,1
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,2.0833e-05,0.23187,0.24768,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.00047456,0.23181,0.26376,1,1
2,GO CELLULAR RESPONSE TO PH,5.4121e-05,0.23124,0.2288,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0033369,0.2308,0.20321,1,1
2,GO NCRNA METABOLIC PROCESS,6.0504e-05,0.23025,0.2474,1,1
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00042998,0.22875,0.20767,1,1
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.045624,0.22828,0.27378,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.011326,0.22693,0.18548,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,1.7806e-05,0.22669,0.26374,1,1
2,GO AMP METABOLIC PROCESS,0.029719,0.2251,0.16922,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.00084609,0.2226,0.17045,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040247,0.22204,0.26714,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.001986,0.22115,0.21126,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0018173,0.22081,0.17842,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.00012512,0.22077,0.19732,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00084609,0.21987,0.18513,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.001986,0.21957,0.161,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.020205,0.21892,0.15312,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.00025131,0.21733,0.17642,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.019283,0.21696,0.14742,1,1
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0031536,0.21505,0.20453,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.00042998,0.21449,0.21563,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.042857,0.21383,0.28053,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.030383,0.21117,0.15313,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.00012512,0.21083,0.22161,1,1
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,2.7343e-05,0.21048,0.31127,1,1
2,GO POSITIVE REGULATION OF MRNA PROCESSING,2.7343e-05,0.20975,0.1878,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0014738,0.20959,0.21568,1,1
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0021689,0.20851,0.35715,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.027188,0.20638,0.16504,1,1
2,GO RNA METHYLATION,9.7346e-05,0.20608,0.21429,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.013798,0.20505,0.17235,1,1
2,GO CELLULAR RESPIRATION,0.00055855,0.20466,0.20082,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0054795,0.2013,0.16895,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00084609,0.20001,0.17039,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,0.011612,0.19883,0.16015,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0079323,0.19813,0.17612,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0085714,0.19781,0.1853,1,1
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.042857,0.19738,0.2132,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.047551,0.19694,0.1282,1,1
2,GO TRNA TRANSPORT,0.00074557,0.19685,0.19311,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.0014299,0.1967,0.19765,1,1
2,GO RNA POLYADENYLATION,8.7323e-05,0.19661,0.16335,1,1
2,GO RNA MODIFICATION,9.0551e-05,0.19588,0.20752,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00055855,0.19512,0.18251,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00034072,0.19488,0.16853,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00063551,0.1948,0.18255,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.045624,0.19459,0.10704,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.00079435,0.19226,0.19157,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,7.013e-05,0.191,0.17125,1,1
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00050664,0.19092,0.22242,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.029719,0.1902,0.10359,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00024286,0.18877,0.24166,1,1
2,GO PROTEIN NITROSYLATION,0.034637,0.18795,0.16837,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.00098941,0.18773,0.21328,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.030383,0.18771,0.16601,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.025414,0.18693,0.14308,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00013917,0.18592,0.21921,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.00023468,0.18574,0.14786,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00016023,0.18542,0.16356,1,1
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0037331,0.18531,0.30413,1,1
2,GO ALDITOL METABOLIC PROCESS,0.0029794,0.18512,0.20195,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0013872,0.1845,0.18435,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,0.001986,0.18321,0.18447,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.001191,0.18259,0.16225,1,1
2,GO L AMINO ACID TRANSPORT,6.7596e-05,0.18257,0.25269,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,8.1192e-05,0.18232,0.1896,1,1
2,GO NUCLEAR PORE ORGANIZATION,0.0034322,0.18041,0.18694,1,1
2,GO DNA REPLICATION INITIATION,0.00044439,0.1803,0.17175,1,1
2,GO NCRNA 3 END PROCESSING,0.0015653,0.1799,0.16386,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,9.7346e-05,0.17928,0.14631,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.0028141,0.17695,0.12956,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.016734,0.17618,0.12509,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00067758,0.17613,0.17633,1,1
2,GO FEAR RESPONSE,0.040234,0.17401,0.14304,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.0020453,0.17382,0.15312,1,1
2,GO RNA CATABOLIC PROCESS,0.0010528,0.17373,0.18606,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.021165,0.17307,0.15703,1,1
2,GO PROTEIN TARGETING,0.0014299,0.17188,0.15307,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0050528,0.1712,0.15105,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0066042,0.17104,0.11742,1,1
2,GO RRNA 3 END PROCESSING,0.034637,0.17099,0.16181,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00055855,0.16987,0.16561,1,1
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.031748,0.16932,0.12568,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.03939,0.16857,0.12819,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.009256,0.16719,0.14266,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00010845,0.16676,0.16848,1,1
2,GO HISTONE H3 K9 DEMETHYLATION,0.02068,0.16455,0.17417,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.017137,0.16453,0.16453,1,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.041093,0.16446,0.12343,1,1
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0027346,0.16445,0.13019,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0056288,0.16343,0.16223,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0011199,0.16322,0.15465,1,1
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.033166,0.16174,0.13603,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.036948,0.16164,0.054186,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0027346,0.15925,0.1797,1,1
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0015189,0.15639,0.18525,1,1
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0087944,0.15523,0.11227,1,1
2,GO BASE EXCISION REPAIR,0.0025083,0.15485,0.1283,1,1
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0059384,0.15353,0.16122,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0049174,0.15252,0.19714,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.0029794,0.15153,0.13355,1,1
2,GO PROTEIN DENEDDYLATION,0.033166,0.1458,0.13333,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0015653,0.14574,0.12856,1,1
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.0057817,0.14571,0.22388,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0066042,0.1451,0.16892,1,1
2,GO BICARBONATE TRANSPORT,0.036948,0.14235,0.095248,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.011047,0.14122,0.12256,1,1
2,GO CARBOHYDRATE PHOSPHORYLATION,0.03939,0.14046,0.11655,1,1
2,GO REGULATION OF CELL CYCLE ARREST,0.0069616,0.14045,0.09516,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00092958,0.14039,0.15646,1,1
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0050528,0.13944,0.15305,1,1
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.027188,0.1394,0.10495,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0062634,0.13934,0.14105,1,1
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.036164,0.13919,0.14094,1,1
2,GO ATP METABOLIC PROCESS,0.00036427,0.13891,0.13733,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0015653,0.13878,0.12525,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.0032441,0.13858,0.15865,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013139,0.13854,0.13794,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0039469,0.1377,0.15345,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.0017123,0.13645,0.12495,1,1
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00021167,0.13509,0.13119,1,1
2,GO MRNA METABOLIC PROCESS,0.00010845,0.13445,0.15089,1,1
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.024846,0.13404,0.14161,1,1
2,GO TRNA 5 END PROCESSING,0.0067808,0.13388,0.21578,1,1
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.02268,0.13344,0.14731,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.031059,0.13289,0.11038,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0054795,0.13233,0.10657,1,1
2,GO AMINO ACID TRANSPORT,0.00044439,0.13035,0.15736,1,1
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0075304,0.12987,0.12196,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0040578,0.12982,0.098093,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.007729,0.12946,0.097881,1,1
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.02166,0.12856,0.14164,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0073363,0.12815,0.10145,1,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.029068,0.12728,0.13142,1,1
2,GO RNA 3 END PROCESSING,0.00044439,0.1272,0.12357,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.041093,0.12698,0.1597,1,1
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0050528,0.12566,0.083652,1,1
2,GO REGULATION OF MRNA PROCESSING,0.0032441,0.12523,0.093725,1,1
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0023671,0.12477,0.14432,1,1
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0056288,0.1247,0.13827,1,1
2,GO MRNA 3 END PROCESSING,0.0015189,0.12438,0.10174,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.11945,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.015574,0.12358,0.11078,1,1
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.011612,0.12247,0.2099,1,1
2,GO RNA CAPPING,0.0051916,0.12224,0.11244,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0067808,0.12224,0.10223,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00023468,0.12069,0.12789,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.0059384,0.12048,0.1204,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0046564,0.11946,0.12898,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.010245,0.11848,0.15949,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.014841,0.11796,0.095721,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0037331,0.11663,0.14972,1,1
2,GO APOPTOTIC DNA FRAGMENTATION,0.047551,0.11629,0.068816,1,1
2,GO RESPONSE TO HEAT,0.0071468,0.11603,0.094228,1,1
2,GO NCRNA TRANSCRIPTION,0.00021909,0.11512,0.1263,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.02068,0.1146,0.10974,1,1
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.027188,0.11392,0.13377,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.010245,0.11382,0.1319,1,1
2,GO PROTEIN TETRAMERIZATION,0.0011199,0.11376,0.12733,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0034322,0.11335,0.11355,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.011904,0.11264,0.084577,1,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.042857,0.11171,0.088376,1,1
2,GO RNA PROCESSING,1.8521e-05,0.11065,0.16722,1,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.014138,0.11022,0.11503,1,1
2,GO TELOMERE ORGANIZATION,0.00032948,0.1101,0.13039,1,1
2,GO PROTEIN HETEROTETRAMERIZATION,0.00353,0.10828,0.13485,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,0.03939,0.10794,0.11053,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0010206,0.10638,0.11963,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.011326,0.10624,0.099335,1,1
2,GO RNA LOCALIZATION,0.00055855,0.1058,0.14285,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.023205,0.10424,0.082899,1,1
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.046579,0.10341,0.079547,1,1
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.019283,0.10313,0.10302,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0094949,0.1026,0.079982,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.013139,0.10156,0.097536,1,1
2,GO PROTEIN NEDDYLATION,0.02166,0.10136,0.1262,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0075304,0.10107,0.10394,1,1
2,GO NUCLEAR EXPORT,0.0014299,0.099419,0.10354,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.011612,0.098656,0.094442,1,1
2,GO SNRNA PROCESSING,0.016734,0.098457,0.049846,1,1
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.017969,0.098273,0.16477,1,1
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0059384,0.097434,0.10635,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001191,0.095508,0.096131,1,1
2,GO METHYLATION,0.0019282,0.094303,0.087309,1,1
2,GO NUCLEOTIDE EXCISION REPAIR,0.013139,0.094189,0.076672,1,1
2,GO NUCLEAR TRANSPORT,0.0056288,0.093246,0.073385,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.009256,0.091452,0.093086,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.013139,0.090542,0.091484,1,1
2,GO CELLULAR RESPONSE TO UV,0.023741,0.089531,0.083355,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00079435,0.08906,0.11576,1,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.014486,0.088299,0.062428,1,1
2,GO MRNA PROCESSING,0.00054072,0.084613,0.10714,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0081404,0.084093,0.10753,1,1
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.017549,0.083357,0.069036,1,1
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0042883,0.081822,0.091204,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.022165,0.079204,0.08034,1,1
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.02268,0.077697,0.075358,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.004408,0.07556,0.082134,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.026586,0.075138,0.04598,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.043763,0.07361,0.049126,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0087944,0.073428,0.10102,1,1
2,GO RNA SPLICING,0.001986,0.072933,0.09655,1,1
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.010773,0.066106,0.069703,1,1
2,GO SNRNA METABOLIC PROCESS,0.027188,0.063685,0.057015,1,1
2,GO INTERSTRAND CROSS LINK REPAIR,0.0090226,0.063217,0.080227,1,1
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.013465,0.06315,0.08346,1,1
2,GO MRNA TRANSPORT,0.011326,0.05716,0.096608,1,1
2,GO MITOCHONDRION ORGANIZATION,0.046579,0.049212,0.052838,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.036948,0.043057,0.0782,1,1
2,GO BONE TRABECULA FORMATION,0.0064317,0.32979,0.37042,1,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.0073363,0.32156,0.31803,1,0
2,GO LEUKOCYTE AGGREGATION,0.044685,0.28668,0.15977,1,0
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.02166,0.28604,0.24007,1,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.045624,0.24726,0.14968,1,0
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0064317,0.24522,0.26465,1,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.041967,0.23278,0.14914,1,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0046564,0.21539,0.16425,1,0
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.029719,0.21174,0.15658,1,0
2,GO NOREPINEPHRINE TRANSPORT,0.011047,0.20419,0.17,1,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0079323,0.20104,0.20086,1,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.01282,0.19605,0.1674,1,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.036948,0.19486,0.15052,1,0
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.010506,0.19367,0.18348,1,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.035393,0.19288,0.1578,1,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.01282,0.18631,0.14046,1,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0064317,0.18258,0.16641,1,0
2,GO COPPER ION TRANSPORT,0.017137,0.17485,0.15388,1,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.027188,0.17296,0.17076,1,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0034322,0.17193,0.17248,1,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0087944,0.17001,0.19472,1,0
2,GO PIGMENT METABOLIC PROCESS,0.0049174,0.15784,0.18293,1,0
2,GO COPPER ION HOMEOSTASIS,0.019739,0.15663,0.14714,1,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.019283,0.15054,0.12565,1,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.02843,0.14525,0.14159,1,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.041093,0.14298,0.13307,1,0
2,GO LIVER REGENERATION,0.026586,0.13541,0.1025,1,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.035393,0.13526,0.091965,1,0
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.020205,0.13464,0.18444,1,0
2,GO IRON ION HOMEOSTASIS,0.020205,0.13287,0.10625,1,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.01282,0.13252,0.1515,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.018836,0.13008,0.20406,1,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.019283,0.1298,0.14549,1,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.035393,0.12512,0.10574,1,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0021062,0.12231,0.14635,1,0
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.027803,0.11878,0.18356,1,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.029719,0.11796,0.070651,1,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.0024367,0.11376,0.13229,1,0
2,GO REPLICATION FORK PROCESSING,0.013798,0.11194,0.11154,1,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.015574,0.11121,0.12535,1,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0016129,0.11108,0.11605,1,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.013465,0.10653,0.091337,1,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0064317,0.098564,0.11973,1,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.025414,0.098278,0.1227,1,0
2,GO EXCRETION,0.041093,0.096981,0.093838,1,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0025817,0.09519,0.1562,1,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.045624,0.092219,0.10937,1,0
2,GO PROTEASOME ASSEMBLY,0.031059,0.08244,0.15606,1,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0081404,0.081878,0.12484,1,0
2,GO MRNA CLEAVAGE,0.029719,0.077722,0.083571,1,0
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.031748,0.072663,0.080695,1,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.03245,0.072155,0.078427,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.034637,0.07083,0.071438,1,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.03245,0.060989,0.076835,1,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.026586,0.060199,0.10239,1,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0059384,0.055239,0.086292,1,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.033894,0.052704,0.046358,1,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.043763,0.051406,0.065806,1,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.046579,-0.032396,-0.182,1,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.041093,-0.034683,-0.064853,1,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.042857,-0.040677,-0.079576,1,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.031748,-0.041207,-0.068413,1,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.022165,-0.041648,-0.062282,1,0
2,GO CELL CYCLE,0.044685,-0.045233,-0.037469,1,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.029719,-0.045409,-0.06543,1,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.015953,-0.045526,-0.15863,1,0
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.010245,-0.049521,-0.090886,1,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.010773,-0.051587,-0.053613,1,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.016734,-0.05181,-0.071412,1,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.02166,-0.052689,-0.070334,1,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.043763,-0.052748,-0.096331,1,0
2,GO SINGLE FERTILIZATION,0.037747,-0.052812,-0.064119,1,0
2,GO REGULATION OF PHOSPHORYLATION,0.041967,-0.052881,-0.06667,1,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.038561,-0.053837,-0.070133,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.042857,-0.055128,-0.11814,1,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.02843,-0.055308,-0.065047,1,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.019739,-0.056054,-0.077075,1,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.046579,-0.056274,-0.047511,1,0
2,GO CELL CYCLE CHECKPOINT,0.033166,-0.057581,-0.059175,1,0
2,GO APOPTOTIC PROCESS,0.043763,-0.057694,-0.064353,1,0
2,GO REGULATION OF CELL DEATH,0.026586,-0.057967,-0.071216,1,0
2,GO MACROAUTOPHAGY,0.0034322,-0.060409,-0.083526,1,0
2,GO HUMORAL IMMUNE RESPONSE,0.0037331,-0.060529,-0.12668,1,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.036948,-0.060569,-0.056096,1,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.019739,-0.061727,-0.096454,1,0
2,GO GLYCOSYLATION,0.033894,-0.062103,-0.099527,1,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0030654,-0.062239,-0.077328,1,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.036164,-0.062598,-0.088158,1,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.019739,-0.063653,-0.06654,1,0
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.018836,-0.064111,-0.074825,1,0
2,GO VESICLE LOCALIZATION,0.034637,-0.064322,-0.075288,1,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.025994,-0.064691,-0.074248,1,0
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.043763,-0.065493,-0.075967,1,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.029719,-0.065646,-0.12487,1,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.015574,-0.065819,-0.083854,1,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.033166,-0.065947,-0.082162,1,0
2,GO HISTONE UBIQUITINATION,0.022165,-0.066014,-0.078085,1,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.047551,-0.066742,-0.091726,1,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0042883,-0.066799,-0.1011,1,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0032441,-0.067027,-0.11417,1,0
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.046579,-0.06812,-0.11564,1,0
2,GO LEUKOCYTE DIFFERENTIATION,0.0097392,-0.068341,-0.10918,1,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.02843,-0.068424,-0.065714,1,0
2,GO ERAD PATHWAY,0.03245,-0.068427,-0.09817,1,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0022992,-0.068543,-0.089772,1,0
2,GO VACUOLE ORGANIZATION,0.029719,-0.068789,-0.087836,1,0
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.027803,-0.068826,-0.094533,1,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.01282,-0.06915,-0.081101,1,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.027188,-0.069297,-0.081506,1,0
2,GO GLYCEROLIPID METABOLIC PROCESS,0.012203,-0.069809,-0.080974,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.025994,-0.070229,-0.15907,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.00098941,-0.07038,-0.087241,1,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.015203,-0.070479,-0.071089,1,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.029068,-0.070481,-0.17479,1,0
2,GO LIPID BIOSYNTHETIC PROCESS,0.02068,-0.070531,-0.080347,1,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.019283,-0.070877,-0.085042,1,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.047551,-0.070899,-0.1135,1,0
2,GO HISTONE H3 ACETYLATION,0.036164,-0.071031,-0.060251,1,0
2,GO METAPHASE PLATE CONGRESSION,0.0057817,-0.071151,-0.1242,1,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0069616,-0.071461,-0.084761,1,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0045306,-0.071646,-0.1055,1,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.036948,-0.073316,-0.0567,1,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.03245,-0.073759,-0.10594,1,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.001872,-0.074901,-0.096977,1,0
2,GO SECRETION,0.00090094,-0.075098,-0.10526,1,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.047551,-0.075238,-0.098128,1,0
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.014841,-0.075299,-0.14347,1,0
2,GO BIOLOGICAL ADHESION,0.013465,-0.075302,-0.10996,1,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.044685,-0.075663,-0.07275,1,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.03939,-0.075791,-0.054132,1,0
2,GO CELL MOTILITY,0.0025083,-0.075895,-0.11303,1,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.022165,-0.076208,-0.12031,1,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.036164,-0.076403,-0.079509,1,0
2,GO REGULATION OF RESPONSE TO STRESS,0.0047853,-0.07655,-0.094917,1,0
2,GO SENSORY PERCEPTION,0.043763,-0.077147,-0.057397,1,0
2,GO REGULATION OF SECRETION,0.0049174,-0.077627,-0.093904,1,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.030383,-0.07769,-0.13851,1,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0064317,-0.077733,-0.10364,1,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.025994,-0.077936,-0.05637,1,0
2,GO NATURAL KILLER CELL ACTIVATION,0.017969,-0.078464,-0.14171,1,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.001228,-0.078868,-0.11117,1,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.025414,-0.079132,-0.063193,1,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.043763,-0.079405,-0.087827,1,0
2,GO POSITIVE REGULATION OF SIGNALING,0.0021689,-0.079504,-0.088865,1,0
2,GO GOLGI VESICLE TRANSPORT,0.02268,-0.080398,-0.078751,1,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.0053338,-0.08042,-0.077277,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.014486,-0.080942,-0.12717,1,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0079323,-0.081379,-0.093064,1,0
2,GO REGULATION OF VASOCONSTRICTION,0.033894,-0.081741,-0.12261,1,0
2,GO REGULATION OF PROTEOLYSIS,0.011047,-0.081894,-0.10418,1,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.025414,-0.081906,-0.078005,1,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.010506,-0.081941,-0.082958,1,0
2,GO RENAL SYSTEM PROCESS,0.0081404,-0.082015,-0.1365,1,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.018398,-0.082158,-0.11135,1,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.02268,-0.082266,-0.12892,1,0
2,GO CELLULAR LIPID METABOLIC PROCESS,0.041093,-0.082295,-0.074639,1,0
2,GO REGULATION OF LIPID STORAGE,0.044685,-0.082949,-0.11337,1,0
2,GO REGULATION OF IMMUNE RESPONSE,0.0079323,-0.082975,-0.11408,1,0
2,GO PROTEOLYSIS,0.00090094,-0.083141,-0.10017,1,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.017969,-0.083422,-0.07602,1,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.017969,-0.08356,-0.15742,1,0
2,GO MACROPHAGE DIFFERENTIATION,0.041967,-0.084098,-0.13399,1,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0022332,-0.084106,-0.07251,1,0
2,GO NEUTROPHIL CHEMOTAXIS,0.0073363,-0.084681,-0.11307,1,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.017549,-0.084889,-0.097481,1,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.044685,-0.085697,-0.12252,1,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0073363,-0.085783,-0.093785,1,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.029719,-0.085865,-0.18157,1,0
2,GO VIRAL RNA GENOME REPLICATION,0.023741,-0.086106,-0.14202,1,0
2,GO PROTEIN MONOUBIQUITINATION,0.00069957,-0.086207,-0.097028,1,0
2,GO ORGANELLE DISASSEMBLY,0.017137,-0.086248,-0.085021,1,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0094949,-0.086325,-0.095408,1,0
2,GO MUSCLE ADAPTATION,0.014486,-0.086399,-0.11137,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.027188,-0.086674,-0.12629,1,0
2,GO REGULATION OF HEMOPOIESIS,0.010773,-0.086715,-0.10715,1,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.02068,-0.086788,-0.12532,1,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.01282,-0.086839,-0.12441,1,0
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.013139,-0.08715,-0.09978,1,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.01282,-0.087158,-0.12453,1,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00095906,-0.087194,-0.12317,1,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0071468,-0.087272,-0.13007,1,0
2,GO CENTRIOLE ASSEMBLY,0.031748,-0.087391,-0.10183,1,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.0066042,-0.088036,-0.11068,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0037331,-0.08809,-0.099837,1,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.040234,-0.088374,-0.13161,1,0
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028957,-0.088835,-0.094187,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0056288,-0.089289,-0.15354,1,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0067808,-0.089494,-0.087541,1,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.019739,-0.089649,-0.1693,1,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.022165,-0.089857,-0.075525,1,0
2,GO LYMPHOCYTE ACTIVATION,0.0049174,-0.090234,-0.11481,1,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.035393,-0.090727,-0.13499,1,0
2,GO NEGATIVE REGULATION OF SECRETION,0.031059,-0.090997,-0.074382,1,0
2,GO CELLULAR PIGMENTATION,0.0032441,-0.091369,-0.13615,1,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00040247,-0.091432,-0.11385,1,0
2,GO REGULATION OF PH,0.0026572,-0.091444,-0.10459,1,0
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.024288,-0.091662,-0.14891,1,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.010506,-0.092083,-0.083169,1,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0011549,-0.092301,-0.14096,1,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.02166,-0.092742,-0.13747,1,0
2,GO NEUTROPHIL MIGRATION,0.022165,-0.092829,-0.11915,1,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0049174,-0.092847,-0.11737,1,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.043763,-0.093058,-0.12778,1,0
2,GO EXOCYTOSIS,0.0019282,-0.093408,-0.12009,1,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0021062,-0.093551,-0.12399,1,0
2,GO REGULATION OF BODY FLUID LEVELS,0.00055855,-0.093563,-0.15115,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.014841,-0.093579,-0.18858,1,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0051916,-0.0936,-0.13708,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.013465,-0.093643,-0.11262,1,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.027188,-0.093862,-0.11528,1,0
2,GO REGULATION OF CELLULAR PH,0.001872,-0.093869,-0.1088,1,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.0013872,-0.094343,-0.12248,1,0
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0041716,-0.094344,-0.11336,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013465,-0.094359,-0.11686,1,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.027803,-0.094394,-0.083161,1,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.011047,-0.094624,-0.11566,1,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.014486,-0.09467,-0.09185,1,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.02268,-0.094853,-0.12145,1,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.041093,-0.094857,-0.13368,1,0
2,GO VESICLE TARGETING,0.0020453,-0.094945,-0.15101,1,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0073363,-0.094963,-0.090468,1,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0079323,-0.095186,-0.10866,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.031748,-0.095246,-0.16132,1,0
2,GO DETECTION OF STIMULUS,0.00087311,-0.095561,-0.09654,1,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.021165,-0.095633,-0.10852,1,0
2,GO REGULATION OF HORMONE SECRETION,0.0033369,-0.095647,-0.12274,1,0
2,GO TUBE MORPHOGENESIS,0.0081404,-0.095813,-0.12217,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.033894,-0.095997,-0.12914,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.025414,-0.096058,-0.12707,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.030383,-0.096326,-0.16532,1,0
2,GO GOLGI VESICLE BUDDING,0.015953,-0.09639,-0.10843,1,0
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0075304,-0.096782,-0.11778,1,0
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.02068,-0.096907,-0.17894,1,0
2,GO COPII COATED VESICLE BUDDING,0.0094949,-0.097142,-0.10779,1,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.047551,-0.097503,-0.095248,1,0
2,GO POSTREPLICATION REPAIR,0.016734,-0.097532,-0.085486,1,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00012964,-0.09769,-0.11114,1,0
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.044685,-0.097731,-0.10014,1,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0032441,-0.097931,-0.12872,1,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0047853,-0.098168,-0.1034,1,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00074557,-0.098255,-0.14094,1,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0017123,-0.09827,-0.12257,1,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0051916,-0.098468,-0.11435,1,0
2,GO RESPONSE TO ALCOHOL,0.0071468,-0.098516,-0.10258,1,0
2,GO CELL MATURATION,0.0047853,-0.09882,-0.10492,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.038561,-0.098867,-0.15723,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.045624,-0.099827,-0.1037,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0029794,-0.099889,-0.14195,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.035393,-0.099988,-0.14257,1,0
2,GO PROTEIN POLYUBIQUITINATION,0.00019753,-0.10004,-0.11932,1,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.046579,-0.10049,-0.084108,1,0
2,GO MYOBLAST DIFFERENTIATION,0.015953,-0.10055,-0.16242,1,0
2,GO MULTI ORGANISM PROCESS,0.00016023,-0.10055,-0.095058,1,0
2,GO ENDOSOMAL TRANSPORT,1.5816e-05,-0.10079,-0.12898,1,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.0014738,-0.10118,-0.11805,1,0
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.031059,-0.10137,-0.15048,1,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.034637,-0.1014,-0.092643,1,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.02843,-0.10164,-0.093213,1,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0025817,-0.10165,-0.10002,1,0
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.02843,-0.10181,-0.19452,1,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.010245,-0.10184,-0.24022,1,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0069616,-0.10192,-0.095238,1,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.011326,-0.10194,-0.17888,1,0
2,GO ECTODERM DEVELOPMENT,0.015203,-0.10208,-0.10824,1,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0056288,-0.1022,-0.14484,1,0
2,GO TEMPERATURE HOMEOSTASIS,0.016339,-0.10222,-0.089812,1,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0060989,-0.10222,-0.10382,1,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0079323,-0.10232,-0.11995,1,0
2,GO TUBE FORMATION,0.0053338,-0.10232,-0.11294,1,0
2,GO PROTEIN MATURATION,0.019283,-0.10233,-0.098846,1,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.0016129,-0.10236,-0.12975,1,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.036948,-0.10246,-0.082976,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0051916,-0.10248,-0.14193,1,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.01282,-0.10249,-0.10025,1,0
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0032441,-0.10265,-0.10455,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.047551,-0.10342,-0.087202,1,0
2,GO PROTEIN AUTOUBIQUITINATION,0.0018173,-0.10347,-0.097761,1,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.029068,-0.10387,-0.093135,1,0
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.026586,-0.10408,-0.19481,1,0
2,GO CELL ACTIVATION,0.0018173,-0.10428,-0.1409,1,0
2,GO PH REDUCTION,0.0015189,-0.10437,-0.15083,1,0
2,GO CHROMOSOME LOCALIZATION,0.0007696,-0.10445,-0.14285,1,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.011612,-0.10464,-0.11779,1,0
2,GO GOLGI ORGANIZATION,0.0014738,-0.10471,-0.12541,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.0079323,-0.10502,-0.16957,1,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.0034322,-0.10564,-0.13389,1,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.1192e-05,-0.10575,-0.14345,1,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.025994,-0.10592,-0.18998,1,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00090094,-0.10597,-0.14108,1,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.035393,-0.10611,-0.089584,1,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.010245,-0.10616,-0.12643,1,0
2,GO INNATE IMMUNE RESPONSE,0.001872,-0.10665,-0.16272,1,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.036948,-0.10678,-0.10607,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.00025131,-0.10679,-0.13298,1,0
2,GO REGULATION OF HORMONE LEVELS,0.0049174,-0.1071,-0.11379,1,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,7.2754e-05,-0.10718,-0.15212,1,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.031059,-0.10718,-0.089537,1,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0099891,-0.10724,-0.15904,1,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.011612,-0.1073,-0.1572,1,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0034322,-0.10754,-0.15457,1,0
2,GO PEPTIDE HORMONE SECRETION,0.033166,-0.10775,-0.09058,1,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.00026903,-0.10788,-0.10535,1,0
2,GO T CELL DIFFERENTIATION,0.0027346,-0.10858,-0.13202,1,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.024846,-0.10874,-0.095725,1,0
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00052342,-0.10924,-0.11581,1,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.001228,-0.10943,-0.10161,1,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.03939,-0.10963,-0.08978,1,0
2,GO REGULATION OF CELL MATURATION,0.007729,-0.10966,-0.11939,1,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0040578,-0.11063,-0.18061,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.0041716,-0.11074,-0.11128,1,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0083534,-0.11103,-0.13223,1,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.010506,-0.11115,-0.21788,1,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.035393,-0.11126,-0.093231,1,0
2,GO RESPONSE TO OSMOTIC STRESS,0.014138,-0.11133,-0.12568,1,0
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0022332,-0.11141,-0.11953,1,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00045924,-0.11158,-0.15372,1,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.038561,-0.1116,-0.12939,1,0
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0020453,-0.112,-0.11627,1,0
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0029794,-0.11222,-0.17521,1,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.0087944,-0.11257,-0.1013,1,0
2,GO RESPONSE TO BACTERIUM,0.013139,-0.11265,-0.12656,1,0
2,GO HORMONE TRANSPORT,0.0057817,-0.11267,-0.117,1,0
2,GO MITOTIC CYTOKINESIS,0.0021689,-0.11286,-0.14786,1,0
2,GO CARBOHYDRATE TRANSPORT,0.00353,-0.11335,-0.11185,1,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0021689,-0.11339,-0.11311,1,0
2,GO CYTOKINE SECRETION,0.0038387,-0.1136,-0.14055,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0013054,-0.11364,-0.14419,1,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.015203,-0.11384,-0.10581,1,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.045624,-0.11388,-0.14633,1,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00095906,-0.11407,-0.16242,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.021165,-0.11467,-0.17207,1,0
2,GO PLATELET MORPHOGENESIS,0.016734,-0.11472,-0.19134,1,0
2,GO VIRAL LATENCY,0.035393,-0.11506,-0.11359,1,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.001872,-0.11545,-0.15281,1,0
2,GO REGULATION OF CELL ACTIVATION,0.00092958,-0.11572,-0.1396,1,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.0012662,-0.11585,-0.16494,1,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0075304,-0.11648,-0.098854,1,0
2,GO TISSUE HOMEOSTASIS,2.3418e-05,-0.11649,-0.1758,1,0
2,GO FEMALE GAMETE GENERATION,0.004408,-0.11713,-0.098935,1,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.011326,-0.11733,-0.14367,1,0
2,GO PEPTIDE SECRETION,0.0013054,-0.1174,-0.11689,1,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.019283,-0.11741,-0.22768,1,0
2,GO VIRAL LIFE CYCLE,0.0053338,-0.11756,-0.16283,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.040234,-0.11771,-0.10305,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.013139,-0.11772,-0.12534,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0075304,-0.1178,-0.1057,1,0
2,GO REGULATION OF CELL ADHESION,0.00024286,-0.11787,-0.18036,1,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.013798,-0.11792,-0.10876,1,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.018836,-0.11798,-0.11435,1,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.020205,-0.11812,-0.15413,1,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.013798,-0.11824,-0.21648,1,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.01282,-0.11829,-0.1642,1,0
2,GO CELL CELL ADHESION,0.00019079,-0.11839,-0.15699,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0094949,-0.11862,-0.099291,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.010506,-0.11862,-0.12633,1,0
2,GO INTERLEUKIN 4 PRODUCTION,0.0050528,-0.11883,-0.18191,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0017123,-0.11887,-0.14557,1,0
2,GO REGULATION OF NUCLEAR DIVISION,0.0010859,-0.11895,-0.10036,1,0
2,GO RESPONSE TO INTERLEUKIN 15,0.036164,-0.11896,-0.15847,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00021909,-0.11925,-0.15725,1,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0083534,-0.1193,-0.12502,1,0
2,GO REGULATION OF PINOCYTOSIS,0.023205,-0.11957,-0.18237,1,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.034637,-0.11977,-0.1291,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010462,-0.11981,-0.1651,1,0
2,GO MYELOID CELL DIFFERENTIATION,0.00052342,-0.11983,-0.1339,1,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,2.7343e-05,-0.11986,-0.15455,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0017641,-0.11991,-0.1279,1,0
2,GO HEMOGLOBIN METABOLIC PROCESS,0.0054795,-0.11997,-0.17851,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.001662,-0.12008,-0.14253,1,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.015203,-0.12025,-0.14678,1,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.046579,-0.12026,-0.10495,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.0007696,-0.12086,-0.14923,1,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0038387,-0.12158,-0.155,1,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.012508,-0.12181,-0.14934,1,0
2,GO STEM CELL PROLIFERATION,0.0046564,-0.12184,-0.13878,1,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0007696,-0.12187,-0.13489,1,0
2,GO T CELL ACTIVATION,0.00047456,-0.12195,-0.15996,1,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0071468,-0.12206,-0.15388,1,0
2,GO REGULATION OF DEFENSE RESPONSE,0.00054072,-0.12208,-0.14666,1,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0042883,-0.12225,-0.18457,1,0
2,GO REGULATION OF T CELL ACTIVATION,0.00037661,-0.12243,-0.15611,1,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.012203,-0.12256,-0.17197,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.013798,-0.1233,-0.16293,1,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.00026903,-0.12341,-0.15728,1,0
2,GO DIGESTIVE SYSTEM PROCESS,0.013139,-0.12359,-0.13826,1,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.0057817,-0.12391,-0.19975,1,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.014138,-0.12405,-0.14335,1,0
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,7.013e-05,-0.12431,-0.13159,1,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0034322,-0.12443,-0.1786,1,0
2,GO PROTEIN DESTABILIZATION,0.0047853,-0.1245,-0.11798,1,0
2,GO REGULATION OF PEPTIDE SECRETION,0.00036427,-0.1246,-0.13004,1,0
2,GO POSITIVE CHEMOTAXIS,0.016339,-0.12486,-0.17802,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.031059,-0.12505,-0.16069,1,0
2,GO REGULATION OF B CELL ACTIVATION,0.0013872,-0.12526,-0.15571,1,0
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.041967,-0.1254,-0.13186,1,0
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0015189,-0.12582,-0.17967,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.046579,-0.12589,-0.10159,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.00031859,-0.12604,-0.14939,1,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0069616,-0.12604,-0.12417,1,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.03939,-0.12609,-0.18606,1,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.013798,-0.12609,-0.13432,1,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.00057693,-0.12635,-0.14434,1,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.012508,-0.12649,-0.15344,1,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.013798,-0.12669,-0.18439,1,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.001191,-0.12675,-0.14319,1,0
2,GO DEFENSE RESPONSE,0.00065623,-0.12697,-0.15075,1,0
2,GO LIPID LOCALIZATION,0.0030654,-0.12701,-0.13003,1,0
2,GO ERBB SIGNALING PATHWAY,0.011612,-0.12708,-0.12368,1,0
2,GO LEUKOCYTE PROLIFERATION,0.00020448,-0.12732,-0.1701,1,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.03245,-0.12742,-0.1834,1,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011904,-0.12749,-0.13521,1,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.03245,-0.1277,-0.139,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.035393,-0.1278,-0.15284,1,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.022165,-0.12804,-0.23898,1,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.014138,-0.12832,-0.15406,1,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.031059,-0.12833,-0.18594,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0014299,-0.12846,-0.17411,1,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.00044439,-0.12849,-0.1833,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.007729,-0.1286,-0.19003,1,0
2,GO DIENCEPHALON DEVELOPMENT,0.0081404,-0.12864,-0.17658,1,0
2,GO LYMPHOCYTE COSTIMULATION,0.0090226,-0.1287,-0.13035,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0013457,-0.1291,-0.16697,1,0
2,GO NEURAL TUBE DEVELOPMENT,0.00037661,-0.12933,-0.15216,1,0
2,GO RESPONSE TO COLD,0.022165,-0.12939,-0.18753,1,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0032441,-0.1294,-0.19542,1,0
2,GO INSULIN SECRETION,0.022165,-0.12951,-0.10085,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.013798,-0.12954,-0.19744,1,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.013798,-0.12974,-0.16339,1,0
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0050528,-0.1298,-0.17042,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.033166,-0.12985,-0.14,1,0
2,GO EPITHELIUM DEVELOPMENT,9.7801e-06,-0.12997,-0.17622,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.012508,-0.13016,-0.12247,1,0
2,GO ADAPTIVE THERMOGENESIS,0.0054795,-0.13017,-0.11052,1,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0060989,-0.13058,-0.15416,1,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0028957,-0.13079,-0.13731,1,0
2,GO RESPONSE TO CYTOKINE,0.0024367,-0.1309,-0.14724,1,0
2,GO COAGULATION,0.0020453,-0.13091,-0.1596,1,0
2,GO CYTOKINE PRODUCTION,0.00041602,-0.13156,-0.1686,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00092958,-0.13165,-0.16713,1,0
2,GO TISSUE MIGRATION,0.038561,-0.13168,-0.11595,1,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.13189,-0.17344,1,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.13192,-0.17204,1,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00019753,-0.13205,-0.20088,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00063551,-0.13205,-0.11843,1,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.022165,-0.13213,-0.14083,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0020453,-0.13214,-0.17416,1,0
2,GO DENDRITIC CELL MIGRATION,0.041093,-0.13265,-0.17049,1,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00057693,-0.13269,-0.16647,1,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00067758,-0.13281,-0.1783,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00050664,-0.13288,-0.1625,1,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.001228,-0.13324,-0.15078,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0059384,-0.13326,-0.16621,1,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.011612,-0.13357,-0.13446,1,0
2,GO RESPONSE TO WOUNDING,0.0030654,-0.13374,-0.15742,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.027188,-0.1338,-0.17838,1,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.011047,-0.13387,-0.2028,1,0
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.015574,-0.13402,-0.1989,1,0
2,GO LIPOPROTEIN LOCALIZATION,0.011612,-0.13434,-0.15444,1,0
2,GO ENDOCYTIC RECYCLING,4.6597e-05,-0.13455,-0.18029,1,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.0019282,-0.1346,-0.14841,1,0
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028957,-0.13468,-0.11781,1,0
2,GO RESPONSE TO DSRNA,0.047551,-0.13481,-0.11362,1,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.015203,-0.13486,-0.12712,1,0
2,GO CELL KILLING,0.0045306,-0.13513,-0.15828,1,0
2,GO BLOOD VESSEL REMODELING,0.017969,-0.13523,-0.19849,1,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,4.4878e-05,-0.1353,-0.1802,1,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0014738,-0.13533,-0.11041,1,0
2,GO ENTRY INTO HOST,0.0025817,-0.1358,-0.23649,1,0
2,GO DNA DEALKYLATION,0.017969,-0.13593,-0.13876,1,0
2,GO TRANSLESION SYNTHESIS,0.0087944,-0.13611,-0.10936,1,0
2,GO RESPONSE TO ESTRADIOL,0.014486,-0.13638,-0.11169,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0041716,-0.13651,-0.15592,1,0
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0034322,-0.13696,-0.1562,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0016129,-0.1371,-0.18961,1,0
2,GO WOUND HEALING,0.0022992,-0.1373,-0.1744,1,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0010859,-0.13742,-0.16011,1,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00084609,-0.13789,-0.15997,1,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00021167,-0.1379,-0.15162,1,0
2,GO APPENDAGE MORPHOGENESIS,0.040234,-0.13826,-0.1358,1,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00065623,-0.13867,-0.12699,1,0
2,GO B CELL ACTIVATION,5.6174e-05,-0.13878,-0.15951,1,0
2,GO OOCYTE DIFFERENTIATION,0.035393,-0.13927,-0.12582,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0066042,-0.13929,-0.18719,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00037661,-0.13965,-0.1913,1,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.02068,-0.1397,-0.098384,1,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00045924,-0.1397,-0.16936,1,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,7.8282e-05,-0.13992,-0.15189,1,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.0010859,-0.14002,-0.15772,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00063551,-0.14012,-0.18399,1,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00067758,-0.14205,-0.16759,1,0
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00041602,-0.14214,-0.22836,1,0
2,GO INTERACTION WITH HOST,0.001228,-0.14223,-0.18837,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0025083,-0.14224,-0.15303,1,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.03939,-0.14227,-0.35219,1,0
2,GO PROTEIN KINASE B SIGNALING,0.00065623,-0.14248,-0.16057,1,0
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00019079,-0.14266,-0.16749,1,0
2,GO RESPONSE TO CADMIUM ION,0.031748,-0.14295,-0.17718,1,0
2,GO INFLAMMATORY RESPONSE,0.00069957,-0.14296,-0.15213,1,0
2,GO V D J RECOMBINATION,0.0099891,-0.14309,-0.19923,1,0
2,GO SPINDLE LOCALIZATION,0.00030804,-0.14322,-0.16657,1,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.001662,-0.14322,-0.1271,1,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,7.013e-05,-0.14338,-0.21169,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0017641,-0.14373,-0.15211,1,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.001986,-0.144,-0.16389,1,0
2,GO RESPONSE TO ETHER,0.0053338,-0.14445,-0.13482,1,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.03245,-0.14456,-0.16562,1,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00029782,-0.14493,-0.18444,1,0
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0094949,-0.14505,-0.21996,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.019283,-0.14512,-0.22085,1,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0054795,-0.1452,-0.19984,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0012662,-0.14559,-0.18855,1,0
2,GO SECONDARY METABOLIC PROCESS,0.011904,-0.14566,-0.19,1,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00042998,-0.14566,-0.15322,1,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.017549,-0.14571,-0.14396,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00069957,-0.14573,-0.20554,1,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0060989,-0.14618,-0.15409,1,0
2,GO CELLULAR RESPONSE TO IRON ION,0.015953,-0.14692,-0.27402,1,0
2,GO SECRETION BY TISSUE,0.02166,-0.14693,-0.15417,1,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0099891,-0.14703,-0.18024,1,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0050528,-0.14743,-0.12426,1,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0090226,-0.14746,-0.13084,1,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0047853,-0.14794,-0.13657,1,0
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.013465,-0.14815,-0.18178,1,0
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00021167,-0.1482,-0.20055,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00027832,-0.14837,-0.17643,1,0
2,GO HISTONE MONOUBIQUITINATION,3.7145e-05,-0.14881,-0.16284,1,0
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,9.8628e-07,-0.14883,-0.18047,1,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0049174,-0.14899,-0.17322,1,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0071468,-0.14901,-0.19004,1,0
2,GO IMMUNE EFFECTOR PROCESS,0.00037661,-0.14917,-0.18236,1,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.017549,-0.14954,-0.26092,1,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.029719,-0.14977,-0.15496,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0097392,-0.14989,-0.22412,1,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0075304,-0.15016,-0.19006,1,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.021165,-0.15017,-0.12832,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0011199,-0.15026,-0.18673,1,0
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.001662,-0.15048,-0.26235,1,0
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0010206,-0.15078,-0.16317,1,0
2,GO GRANULOCYTE MIGRATION,0.00067758,-0.15079,-0.17211,1,0
2,GO FIBROBLAST MIGRATION,0.0034322,-0.15081,-0.1968,1,0
2,GO FOAM CELL DIFFERENTIATION,0.027188,-0.15103,-0.16387,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.007729,-0.15109,-0.18177,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.004408,-0.15109,-0.19016,1,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0071468,-0.15125,-0.1859,1,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.0039469,-0.15136,-0.14344,1,0
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.02166,-0.15173,-0.16829,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0027346,-0.15197,-0.16061,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0066042,-0.15227,-0.19074,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,3.4421e-05,-0.15257,-0.19344,1,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0032441,-0.15274,-0.16436,1,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00049035,-0.15281,-0.20009,1,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.001662,-0.15284,-0.19331,1,0
2,GO CELLULAR RESPONSE TO ALCOHOL,0.00036427,-0.15329,-0.15351,1,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00029782,-0.1536,-0.16887,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00084609,-0.15363,-0.17367,1,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0013054,-0.15369,-0.16206,1,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0045306,-0.15376,-0.16515,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00074557,-0.15386,-0.1957,1,0
2,GO ACTIN NUCLEATION,1.2962e-05,-0.15393,-0.1686,1,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0057817,-0.15394,-0.2178,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0007696,-0.15396,-0.16421,1,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00023468,-0.15411,-0.19422,1,0
2,GO B CELL APOPTOTIC PROCESS,0.011904,-0.15433,-0.19159,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.009256,-0.15442,-0.20318,1,0
2,GO DEFENSE RESPONSE TO BACTERIUM,3.5759e-05,-0.15451,-0.19397,1,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0010206,-0.15522,-0.17103,1,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.02166,-0.15539,-0.16244,1,0
2,GO LEUKOCYTE MIGRATION,0.00011241,-0.15541,-0.18764,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.027188,-0.15548,-0.16268,1,0
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0071468,-0.15595,-0.2045,1,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0049174,-0.15606,-0.13229,1,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.0047853,-0.15651,-0.16465,1,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00055855,-0.15662,-0.19096,1,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00014418,-0.15674,-0.18136,1,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.011047,-0.15688,-0.15735,1,0
2,GO RIG I SIGNALING PATHWAY,0.0087944,-0.15801,-0.1629,1,0
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.011047,-0.15826,-0.26814,1,0
2,GO ENDOTHELIAL CELL MIGRATION,0.013139,-0.15873,-0.14658,1,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00081984,-0.15877,-0.21103,1,0
2,GO RESPONSE TO VIRUS,0.00016595,-0.159,-0.20655,1,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.012508,-0.15911,-0.14871,1,0
2,GO PROTEIN DEMANNOSYLATION,0.041967,-0.15935,-0.1625,1,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0051916,-0.15951,-0.18234,1,0
2,GO LIPID DIGESTION,0.010245,-0.15971,-0.27841,1,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0011199,-0.15995,-0.17216,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.02068,-0.16092,-0.23241,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0006154,-0.16127,-0.19795,1,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00065623,-0.16127,-0.2399,1,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.00041602,-0.16147,-0.19522,1,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.1493e-05,-0.16156,-0.1721,1,0
2,GO RESPONSE TO INTERFERON BETA,0.025994,-0.16245,-0.38112,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.036164,-0.16263,-0.1418,1,0
2,GO CELLULAR RESPONSE TO VIRUS,0.00032948,-0.16279,-0.19792,1,0
2,GO PHAGOSOME ACIDIFICATION,0.0017641,-0.16286,-0.20229,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001191,-0.16295,-0.17348,1,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.009256,-0.16314,-0.17045,1,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00026903,-0.16323,-0.17013,1,0
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.010506,-0.16326,-0.1727,1,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00084609,-0.16348,-0.17906,1,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.029719,-0.16354,-0.18503,1,0
2,GO OLIGOPEPTIDE TRANSPORT,0.019283,-0.16385,-0.29524,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.041093,-0.16405,-0.11349,1,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.001191,-0.16411,-0.13304,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.036948,-0.16414,-0.16221,1,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.016339,-0.16431,-0.16759,1,0
2,GO MOVEMENT IN HOST ENVIRONMENT,0.00030804,-0.16441,-0.23835,1,0
2,GO CYTOLYSIS,0.009256,-0.165,-0.21787,1,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.025994,-0.16571,-0.19775,1,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.011326,-0.16573,-0.17743,1,0
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0018173,-0.16601,-0.21587,1,0
2,GO RESPONSE TO ISCHEMIA,0.0062634,-0.16624,-0.1478,1,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.016339,-0.16625,-0.21142,1,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.010245,-0.16653,-0.22173,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.03245,-0.16662,-0.213,1,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.0085714,-0.16677,-0.2186,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.00052342,-0.1668,-0.18735,1,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00012964,-0.16695,-0.16002,1,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0017123,-0.16701,-0.20683,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.024288,-0.16705,-0.16302,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.014841,-0.16755,-0.19586,1,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00090094,-0.16774,-0.2548,1,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00095906,-0.16806,-0.20819,1,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.011326,-0.16825,-0.16152,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00040247,-0.16897,-0.22176,1,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.043763,-0.16914,-0.13671,1,0
2,GO CELLULAR RESPONSE TO DSRNA,0.02068,-0.16917,-0.1803,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.02268,-0.16923,-0.32375,1,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.03245,-0.16928,-0.18367,1,0
2,GO PIGMENT GRANULE LOCALIZATION,0.004408,-0.16931,-0.18212,1,0
2,GO RETINOL METABOLIC PROCESS,0.040234,-0.16944,-0.183,1,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.016339,-0.16997,-0.16166,1,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.02068,-0.16999,-0.15733,1,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.547e-05,-0.17,-0.20865,1,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.0010206,-0.17012,-0.22263,1,0
2,GO RETINA HOMEOSTASIS,0.0056288,-0.17096,-0.076124,1,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.030383,-0.1717,-0.1684,1,0
2,GO IMMUNOGLOBULIN SECRETION,0.0017641,-0.17173,-0.28009,1,0
2,GO DIGESTION,0.00069957,-0.17194,-0.18199,1,0
2,GO DIOL METABOLIC PROCESS,0.023741,-0.17195,-0.15986,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00063551,-0.17214,-0.17725,1,0
2,GO ACUTE PHASE RESPONSE,0.0010206,-0.17217,-0.21569,1,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0037331,-0.17218,-0.18808,1,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0045306,-0.17218,-0.20026,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0073363,-0.17253,-0.2266,1,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00019079,-0.17267,-0.19742,1,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.6584e-06,-0.17277,-0.25385,1,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.036948,-0.17301,-0.19567,1,0
2,GO PHOSPHOLIPID TRANSPORT,0.00026903,-0.17331,-0.17209,1,0
2,GO PROTEIN PROCESSING,0.00035231,-0.1735,-0.17704,1,0
2,GO REGULATION OF RUFFLE ASSEMBLY,0.00098941,-0.17406,-0.18987,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0045306,-0.17442,-0.3037,1,0
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0025083,-0.17476,-0.17016,1,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.010773,-0.17477,-0.1784,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00041602,-0.17479,-0.19113,1,0
2,GO REGULATION OF CELL CELL ADHESION,2.7343e-05,-0.17479,-0.20571,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.018398,-0.17497,-0.18862,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0045306,-0.17511,-0.2066,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00084609,-0.17514,-0.23068,1,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00038934,-0.17532,-0.20336,1,0
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,7.547e-05,-0.17544,-0.20919,1,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,1.8521e-05,-0.17559,-0.20004,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.010506,-0.17565,-0.15519,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.001662,-0.17588,-0.2011,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.009256,-0.176,-0.19015,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0049174,-0.17603,-0.20618,1,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0014299,-0.17648,-0.2406,1,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.011904,-0.17713,-0.19481,1,0
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0013054,-0.17729,-0.19351,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0018173,-0.17754,-0.23576,1,0
2,GO REGULATION OF MAST CELL ACTIVATION,0.0075304,-0.17786,-0.1893,1,0
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.007729,-0.17792,-0.20272,1,0
2,GO SENSORY PERCEPTION OF TASTE,5.0226e-05,-0.17801,-0.21687,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.017969,-0.17802,-0.22052,1,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0029794,-0.17814,-0.21348,1,0
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00016595,-0.17818,-0.22027,1,0
2,GO B CELL DIFFERENTIATION,5.0683e-06,-0.17886,-0.20775,1,0
2,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0087944,-0.17934,-0.27848,1,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.025994,-0.1794,-0.17445,1,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00017796,-0.1794,-0.17246,1,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.021165,-0.17942,-0.24678,1,0
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00059588,-0.17945,-0.24184,1,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.014486,-0.17954,-0.15859,1,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0010206,-0.17959,-0.18112,1,0
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0069616,-0.18011,-0.21973,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,0.00019753,-0.18028,-0.21932,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00020448,-0.18029,-0.24031,1,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.031748,-0.18036,-0.22801,1,0
2,GO INTESTINAL LIPID ABSORPTION,0.0067808,-0.18058,-0.28825,1,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0075304,-0.1806,-0.16909,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00067758,-0.18083,-0.28436,1,0
2,GO HISTAMINE TRANSPORT,0.014841,-0.18089,-0.24686,1,0
2,GO CHEMOKINE PRODUCTION,0.00016023,-0.18113,-0.22972,1,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00087311,-0.18124,-0.28685,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,-0.18138,-0.22226,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0083534,-0.18149,-0.25475,1,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00067758,-0.1816,-0.20892,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.004408,-0.18197,-0.16559,1,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0040578,-0.18208,-0.19688,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.010773,-0.18257,-0.17993,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00037661,-0.18271,-0.20361,1,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0022332,-0.18297,-0.20308,1,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0020453,-0.183,-0.17933,1,0
2,GO MATURE B CELL DIFFERENTIATION,0.011612,-0.18363,-0.23318,1,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.6584e-06,-0.18368,-0.26101,1,0
2,GO T CELL CYTOKINE PRODUCTION,0.0027346,-0.18394,-0.19475,1,0
2,GO RESPONSE TO PROGESTERONE,0.00072223,-0.18408,-0.26844,1,0
2,GO MYELOID CELL HOMEOSTASIS,4.0073e-05,-0.18416,-0.19809,1,0
2,GO VIRAL GENOME REPLICATION,0.00040247,-0.18488,-0.23984,1,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0026572,-0.18595,-0.2616,1,0
2,GO RESPONSE TO INTERFERON GAMMA,0.0046564,-0.18616,-0.23618,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00095906,-0.18621,-0.19103,1,0
2,GO REGULATION OF SYMBIOTIC PROCESS,0.00019079,-0.18714,-0.21312,1,0
2,GO AMYLOID BETA CLEARANCE,0.0079323,-0.18738,-0.19228,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00019753,-0.18815,-0.20879,1,0
2,GO ENDOCRINE HORMONE SECRETION,0.00038934,-0.18852,-0.19053,1,0
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.02068,-0.18855,-0.27659,1,0
2,GO RESPONSE TO OXYGEN RADICAL,0.001662,-0.18911,-0.17616,1,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0056288,-0.18952,-0.23287,1,0
2,GO MYELOID CELL APOPTOTIC PROCESS,0.0079323,-0.18981,-0.20475,1,0
2,GO TYPE I INTERFERON PRODUCTION,0.00067758,-0.19007,-0.19751,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.025414,-0.19032,-0.27129,1,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00055855,-0.19054,-0.17654,1,0
2,GO MYELOID LEUKOCYTE MIGRATION,8.1192e-05,-0.19108,-0.19761,1,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0047853,-0.19122,-0.19504,1,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.4039e-05,-0.19246,-0.26092,1,0
2,GO KERATINOCYTE PROLIFERATION,0.0079323,-0.19259,-0.22235,1,0
2,GO RESPONSE TO INTERLEUKIN 6,0.00012964,-0.19283,-0.25339,1,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00016023,-0.19337,-0.17412,1,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7806e-05,-0.1935,-0.2,1,0
2,GO ENDOSOME ORGANIZATION,9.8628e-07,-0.19357,-0.20514,1,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0021689,-0.19373,-0.18013,1,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.015574,-0.19428,-0.24205,1,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0036303,-0.19447,-0.18983,1,0
2,GO REGULATION OF TISSUE REMODELING,0.00063551,-0.19459,-0.22502,1,0
2,GO RESPONSE TO INTERLEUKIN 2,0.0017123,-0.19464,-0.21941,1,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.2454e-05,-0.19526,-0.23285,1,0
2,GO B CELL MEDIATED IMMUNITY,0.00014935,-0.19528,-0.23777,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0064317,-0.19572,-0.21684,1,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0013457,-0.19584,-0.20568,1,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00059588,-0.19612,-0.19508,1,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,1.0604e-05,-0.19616,-0.20687,1,0
2,GO PLATELET ACTIVATION,8.3127e-06,-0.19632,-0.24082,1,0
2,GO EPITHELIAL CELL DEVELOPMENT,7.9801e-06,-0.19666,-0.25107,1,0
2,GO LIPID EXPORT FROM CELL,0.019283,-0.19725,-0.14265,1,0
2,GO ALPHA BETA T CELL ACTIVATION,1.1493e-05,-0.19733,-0.23471,1,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0047853,-0.1974,-0.19987,1,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00054072,-0.19751,-0.19225,1,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0030654,-0.19774,-0.20959,1,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.042857,-0.19785,-0.19265,1,0
2,GO POSITIVE REGULATION OF CELL KILLING,0.0018173,-0.19809,-0.21233,1,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0018173,-0.19838,-0.23213,1,0
2,GO ERYTHROCYTE HOMEOSTASIS,4.6597e-05,-0.19903,-0.19283,1,0
2,GO CYTOPLASM ORGANIZATION,0.037747,-0.19904,-0.15245,1,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,1.4044e-06,-0.19906,-0.20344,1,0
2,GO FORELIMB MORPHOGENESIS,0.0087944,-0.19925,-0.20257,1,0
2,GO ZYMOGEN ACTIVATION,0.010506,-0.19935,-0.25501,1,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,4.4712e-06,-0.19945,-0.25253,1,0
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.001986,-0.19959,-0.20691,1,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0033369,-0.20002,-0.15607,1,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.00012512,-0.20068,-0.23869,1,0
2,GO ERYTHROCYTE DEVELOPMENT,0.00035231,-0.201,-0.17775,1,0
2,GO CENTROSOME DUPLICATION,1.0184e-05,-0.20131,-0.22617,1,0
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,-0.20145,-0.25117,1,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.00090094,-0.20178,-0.18811,1,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00095906,-0.20202,-0.21834,1,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.011047,-0.20232,-0.20594,1,0
2,GO LIPID DROPLET ORGANIZATION,0.00013433,-0.20239,-0.25451,1,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00054072,-0.20256,-0.26312,1,0
2,GO MONOCYTE CHEMOTAXIS,0.00079435,-0.20291,-0.25447,1,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00023468,-0.20305,-0.23725,1,0
2,GO MACROPHAGE MIGRATION,0.0023671,-0.20323,-0.19232,1,0
2,GO REGULATION OF CELL KILLING,0.00032948,-0.20353,-0.2271,1,0
2,GO NEURAL TUBE FORMATION,8.6584e-06,-0.20371,-0.21032,1,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.015953,-0.20396,-0.20463,1,0
2,GO AUTOPHAGOSOME MATURATION,6.5149e-05,-0.20443,-0.22304,1,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.017137,-0.20448,-0.24266,1,0
2,GO T CELL MEDIATED IMMUNITY,0.0021689,-0.20466,-0.23984,1,0
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00087311,-0.2047,-0.21446,1,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0034322,-0.2048,-0.17526,1,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0054795,-0.20549,-0.22734,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00092958,-0.20549,-0.21748,1,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.02843,-0.20604,-0.15621,1,0
2,GO MONONUCLEAR CELL MIGRATION,0.00049035,-0.20635,-0.21886,1,0
2,GO CYTOKINETIC PROCESS,2.8418e-05,-0.20698,-0.24729,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,6.7728e-06,-0.20744,-0.21127,1,0
2,GO LIPID STORAGE,0.0007696,-0.20795,-0.20156,1,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,6.0504e-05,-0.2084,-0.24097,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0039469,-0.21012,-0.19107,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.8379e-05,-0.21014,-0.21227,1,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00087311,-0.21018,-0.32228,1,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.042857,-0.21035,-0.18089,1,0
2,GO RESPONSE TO ANGIOTENSIN,0.0014738,-0.21049,-0.23147,1,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00016595,-0.21064,-0.20396,1,0
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00021167,-0.21076,-0.24402,1,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.036164,-0.21078,-0.16761,1,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,9.389e-05,-0.21082,-0.26993,1,0
2,GO PEPTIDYL THREONINE MODIFICATION,1.5201e-05,-0.21091,-0.17533,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.8077e-06,-0.21106,-0.2419,1,0
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00087311,-0.21109,-0.19185,1,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,9.3916e-06,-0.2111,-0.28417,1,0
2,GO REGULATION OF GASTRULATION,0.001191,-0.21117,-0.20849,1,0
2,GO DEFENSE RESPONSE TO VIRUS,1.8521e-05,-0.21172,-0.27648,1,0
2,GO BONE RESORPTION,0.00055855,-0.21182,-0.2302,1,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00031859,-0.21214,-0.1961,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00025131,-0.21218,-0.23847,1,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0036303,-0.21283,-0.22582,1,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.0032441,-0.21293,-0.23387,1,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.038561,-0.21342,-0.14778,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,3.9418e-06,-0.21458,-0.23302,1,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,9.389e-05,-0.21469,-0.27946,1,0
2,GO CELL FATE SPECIFICATION,0.00023468,-0.21516,-0.24125,1,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0010859,-0.21558,-0.26293,1,0
2,GO ETHANOL METABOLIC PROCESS,0.010245,-0.2156,-0.23614,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.010245,-0.2159,-0.26236,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,1.349e-05,-0.21658,-0.23097,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00026003,-0.21678,-0.25223,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,4.6623e-06,-0.21722,-0.23079,1,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00036427,-0.21752,-0.25538,1,0
2,GO ACTIN CYTOSKELETON REORGANIZATION,3.0264e-07,-0.21779,-0.23031,1,0
2,GO MACROPHAGE CHEMOTAXIS,0.0020453,-0.21865,-0.20442,1,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0060989,-0.21908,-0.22912,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00031859,-0.22033,-0.22566,1,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00016023,-0.2204,-0.22611,1,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0030654,-0.22054,-0.17452,1,0
2,GO VIRION ASSEMBLY,7.3528e-06,-0.22068,-0.21016,1,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.00041602,-0.22078,-0.20392,1,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0025083,-0.22129,-0.16697,1,0
2,GO PARTURITION,0.0071468,-0.22169,-0.23068,1,0
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,8.4205e-05,-0.22181,-0.30704,1,0
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00020448,-0.22266,-0.27385,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00010462,-0.22284,-0.27109,1,0
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00026903,-0.22284,-0.26395,1,0
2,GO ENDODERMAL CELL FATE COMMITMENT,0.00079435,-0.22377,-0.22575,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00049035,-0.22428,-0.27696,1,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.00042998,-0.22436,-0.18971,1,0
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00035231,-0.22442,-0.35451,1,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.4205e-05,-0.22518,-0.26122,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00095906,-0.22539,-0.21258,1,0
2,GO INTERFERON BETA PRODUCTION,0.00029782,-0.22547,-0.21631,1,0
2,GO REGULATION OF CENTROSOME DUPLICATION,3.7791e-06,-0.22561,-0.24038,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0064317,-0.22562,-0.23673,1,0
2,GO PIGMENT ACCUMULATION,0.0066042,-0.22624,-0.19904,1,0
2,GO VIRAL RELEASE FROM HOST CELL,6.7728e-06,-0.22666,-0.24765,1,0
2,GO ICOSANOID METABOLIC PROCESS,5.2837e-06,-0.22668,-0.29333,1,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.001191,-0.22732,-0.21878,1,0
2,GO INTERLEUKIN 8 PRODUCTION,0.00014935,-0.22744,-0.24563,1,0
2,GO POSITIVE T CELL SELECTION,0.00010092,-0.22775,-0.22145,1,0
2,GO ER OVERLOAD RESPONSE,0.03939,-0.22781,-0.19044,1,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0049174,-0.22796,-0.26295,1,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0059384,-0.22843,-0.33284,1,0
2,GO BONE REMODELING,0.0014738,-0.22909,-0.21743,1,0
2,GO POSITIVE REGULATION OF CELL SIZE,0.00079435,-0.22939,-0.29463,1,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0056288,-0.22988,-0.26626,1,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00021909,-0.22999,-0.26012,1,0
2,GO CELLULAR DEFENSE RESPONSE,1.3441e-06,-0.23038,-0.30179,1,0
2,GO REGULATION OF CENTROSOME CYCLE,2.1702e-06,-0.23056,-0.22776,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.6623e-06,-0.23059,-0.27267,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.4421e-05,-0.23098,-0.24859,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.2524e-05,-0.23112,-0.24668,1,0
2,GO RUFFLE ASSEMBLY,6.2367e-06,-0.2315,-0.22726,1,0
2,GO CELL CHEMOTAXIS,1.7118e-05,-0.23169,-0.22361,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0013054,-0.23215,-0.30545,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0025817,-0.2323,-0.23819,1,0
2,GO MICROVILLUS ORGANIZATION,0.00084609,-0.23239,-0.29665,1,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0006154,-0.23253,-0.24592,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.0604e-05,-0.23314,-0.25455,1,0
2,GO TISSUE REMODELING,0.00021909,-0.23431,-0.23409,1,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.015574,-0.23449,-0.23391,1,0
2,GO ZYMOGEN INHIBITION,0.0033369,-0.2349,-0.33862,1,0
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0067808,-0.23506,-0.31829,1,0
2,GO REGULATION OF ACTIN NUCLEATION,4.0073e-05,-0.23542,-0.25847,1,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0090226,-0.23612,-0.18619,1,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.029068,-0.23633,-0.17743,1,0
2,GO LIVER MORPHOGENESIS,0.001228,-0.2369,-0.30395,1,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0012662,-0.23692,-0.31167,1,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.011047,-0.23693,-0.28264,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,4.4878e-05,-0.23722,-0.29182,1,0
2,GO BILE ACID METABOLIC PROCESS,0.00013917,-0.23739,-0.26,1,0
2,GO MULTIVESICULAR BODY ORGANIZATION,7.5427e-07,-0.23775,-0.24943,1,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.00020448,-0.23777,-0.29201,1,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0014738,-0.23778,-0.2126,1,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.019739,-0.23779,-0.2056,1,0
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.1493e-05,-0.23804,-0.24148,1,0
2,GO RUFFLE ORGANIZATION,3.7791e-06,-0.23837,-0.2376,1,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00025131,-0.2386,-0.23183,1,0
2,GO REGULATION OF B CELL DIFFERENTIATION,0.0013054,-0.23864,-0.22357,1,0
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.1493e-05,-0.23954,-0.26766,1,0
2,GO RESPONSE TO REDOX STATE,0.0013054,-0.23959,-0.23698,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.012203,-0.2398,-0.34938,1,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0012662,-0.24015,-0.29799,1,0
2,GO REGULATION OF ICOSANOID SECRETION,0.0094949,-0.24019,-0.18147,1,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0056288,-0.24052,-0.23058,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,2.0033e-05,-0.24073,-0.29548,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.015574,-0.24132,-0.19733,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00095906,-0.24132,-0.23594,1,0
2,GO APICAL PROTEIN LOCALIZATION,0.00069957,-0.24235,-0.20808,1,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00026003,-0.24255,-0.19671,1,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00095906,-0.24298,-0.22192,1,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00025131,-0.24388,-0.24645,1,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0057817,-0.24475,-0.27579,1,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.0022992,-0.24505,-0.2461,1,0
2,GO MALE SEX DETERMINATION,0.00044439,-0.24548,-0.31738,1,0
2,GO SPERM CAPACITATION,6.5149e-05,-0.24579,-0.2285,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.7343e-05,-0.24678,-0.25379,1,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00074557,-0.24811,-0.28743,1,0
2,GO ETHER METABOLIC PROCESS,0.0046564,-0.24862,-0.26408,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.0226e-05,-0.24879,-0.2547,1,0
2,GO ENDOCRINE PROCESS,0.00055855,-0.24889,-0.21744,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,8.6584e-06,-0.24894,-0.23333,1,0
2,GO SMOOTH MUSCLE CELL MIGRATION,4.1617e-05,-0.249,-0.32768,1,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0034322,-0.24907,-0.22582,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.753e-07,-0.24941,-0.30364,1,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.00037661,-0.24959,-0.22364,1,0
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0021689,-0.24975,-0.24919,1,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0025817,-0.24992,-0.2916,1,0
2,GO SKIN DEVELOPMENT,1.7806e-05,-0.25008,-0.25936,1,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00010462,-0.25195,-0.22452,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,8.4205e-05,-0.25228,-0.24272,1,0
2,GO PROGRAMMED NECROTIC CELL DEATH,0.0040578,-0.25258,-0.22948,1,0
2,GO RENAL ABSORPTION,0.021165,-0.25258,-0.28345,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00026003,-0.25312,-0.30329,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,3.3287e-06,-0.25363,-0.31411,1,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.001662,-0.25408,-0.25085,1,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.013e-05,-0.25418,-0.26495,1,0
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,5.6174e-05,-0.25474,-0.2393,1,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.0021062,-0.25553,-0.28148,1,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0010206,-0.25555,-0.26462,1,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00042998,-0.25643,-0.26198,1,0
2,GO TRANSCYTOSIS,0.0001547,-0.25655,-0.22486,1,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00037661,-0.25738,-0.3068,1,0
2,GO INTERLEUKIN 5 PRODUCTION,0.034637,-0.25795,-0.18066,1,0
2,GO BROWN FAT CELL DIFFERENTIATION,7.6603e-06,-0.25842,-0.33674,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00074557,-0.25856,-0.29804,1,0
2,GO ERBB2 SIGNALING PATHWAY,1.9263e-05,-0.25862,-0.27334,1,0
2,GO REGULATION OF RESPONSE TO WOUNDING,1.0184e-05,-0.25881,-0.28862,1,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00038934,-0.25885,-0.23302,1,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0011199,-0.25935,-0.27495,1,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.0090226,-0.25943,-0.22538,1,0
2,GO NECROTIC CELL DEATH,0.0034322,-0.26094,-0.21521,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.014138,-0.26244,-0.20034,1,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,7.013e-05,-0.26396,-0.28133,1,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.012203,-0.26472,-0.26045,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00026903,-0.26529,-0.24404,1,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.014138,-0.26657,-0.34046,1,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0031536,-0.26741,-0.32595,1,0
2,GO VASCULAR WOUND HEALING,0.0036303,-0.26848,-0.27024,1,0
2,GO REGULATION OF BONE REMODELING,0.00050664,-0.26877,-0.25577,1,0
2,GO INTERLEUKIN 6 PRODUCTION,1.0779e-06,-0.26931,-0.26279,1,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.0001547,-0.26931,-0.25314,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00012074,-0.26984,-0.24857,1,0
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.6584e-06,-0.27,-0.27426,1,0
2,GO T CELL SELECTION,0.00017186,-0.27061,-0.2088,1,0
2,GO CARDIOBLAST DIFFERENTIATION,0.007729,-0.27079,-0.24529,1,0
2,GO CENTROSOME SEPARATION,0.00052342,-0.27154,-0.262,1,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,5.9841e-06,-0.27192,-0.28685,1,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00012964,-0.2721,-0.28043,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.013798,-0.27229,-0.28854,1,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.009256,-0.2729,-0.26896,1,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,2.2524e-05,-0.27307,-0.27164,1,0
2,GO INTESTINAL ABSORPTION,0.00035231,-0.27352,-0.29987,1,0
2,GO FRUCTOSE METABOLIC PROCESS,0.033166,-0.27427,-0.28687,1,0
2,GO SIGNAL PEPTIDE PROCESSING,0.00014935,-0.27455,-0.33645,1,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0015653,-0.2748,-0.33305,1,0
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00047456,-0.27486,-0.33135,1,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,2.5308e-05,-0.27491,-0.30028,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,2.6307e-05,-0.27497,-0.27345,1,0
2,GO DENDRITIC CELL DIFFERENTIATION,5.8301e-05,-0.27599,-0.33815,1,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.001191,-0.27645,-0.28803,1,0
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.010245,-0.27779,-0.34294,1,0
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.0311e-06,-0.27789,-0.31892,1,0
2,GO MYOBLAST MIGRATION,0.033166,-0.27815,-0.25342,1,0
2,GO INTERLEUKIN 1 PRODUCTION,1.5816e-05,-0.27874,-0.32131,1,0
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0060989,-0.2792,-0.26169,1,0
2,GO MAGNESIUM ION TRANSPORT,1.906e-06,-0.27978,-0.32078,1,0
2,GO EPIDERMIS DEVELOPMENT,7.3528e-06,-0.28059,-0.26428,1,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.2505e-07,-0.28071,-0.30962,1,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.041093,-0.28084,-0.20928,1,0
2,GO MEMBRANE RAFT ORGANIZATION,0.007729,-0.28126,-0.32844,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0014738,-0.28173,-0.29782,1,0
2,GO TOLERANCE INDUCTION,0.0075304,-0.28373,-0.36324,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0018173,-0.28377,-0.31236,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00353,-0.28519,-0.29456,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00021909,-0.28526,-0.32909,1,0
2,GO REGULATION OF WOUND HEALING,1.0184e-05,-0.2856,-0.32068,1,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.045624,-0.28581,-0.21081,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,7.013e-05,-0.28586,-0.33146,1,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0060989,-0.28602,-0.33941,1,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.004408,-0.28606,-0.30433,1,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.020205,-0.28626,-0.2434,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00010462,-0.28655,-0.2974,1,0
2,GO CELLULAR RESPONSE TO ALKALOID,1.4609e-05,-0.28743,-0.28582,1,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.0041716,-0.28786,-0.25205,1,0
2,GO NATURAL KILLER CELL PROLIFERATION,0.0018173,-0.28911,-0.29853,1,0
2,GO PLATELET AGGREGATION,1.1493e-05,-0.28918,-0.30348,1,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.0094949,-0.28972,-0.28694,1,0
2,GO MUSCLE CELL MIGRATION,3.3132e-05,-0.29007,-0.31531,1,0
2,GO REGULATION OF EXOSOMAL SECRETION,1.2862e-06,-0.29027,-0.32679,1,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0028957,-0.2904,-0.35372,1,0
2,GO WATER HOMEOSTASIS,0.00065623,-0.29157,-0.26119,1,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0022992,-0.29307,-0.29346,1,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.0060989,-0.29324,-0.22321,1,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.011047,-0.2934,-0.28214,1,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.6414e-07,-0.29383,-0.3348,1,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.007729,-0.29395,-0.25665,1,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.026586,-0.29467,-0.25638,1,0
2,GO ANOIKIS,4.4878e-05,-0.29516,-0.31439,1,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0001547,-0.29604,-0.27673,1,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,1.1964e-05,-0.29628,-0.28953,1,0
2,GO OUTER DYNEIN ARM ASSEMBLY,3.4421e-05,-0.29668,-0.36244,1,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.03245,-0.29721,-0.21933,1,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00038934,-0.2983,-0.33785,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.2524e-05,-0.29932,-0.29405,1,0
2,GO SPLEEN DEVELOPMENT,4.5813e-07,-0.29966,-0.30501,1,0
2,GO GLOMERULUS DEVELOPMENT,0.00057693,-0.30136,-0.27543,1,0
2,GO ACTIN FILAMENT SEVERING,0.0013054,-0.30141,-0.39952,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,5.2139e-05,-0.30154,-0.33792,1,0
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0022992,-0.30182,-0.38399,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0049174,-0.30202,-0.36008,1,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,2.4692e-06,-0.30264,-0.30569,1,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.019283,-0.30267,-0.27804,1,0
2,GO REGULATION OF PLATELET ACTIVATION,6.2367e-06,-0.30324,-0.40132,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.018836,-0.30334,-0.31591,1,0
2,GO ALPHA BETA T CELL PROLIFERATION,2.0033e-05,-0.30343,-0.33706,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,9.7801e-06,-0.30351,-0.3767,1,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.00054072,-0.30382,-0.27702,1,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.5774e-06,-0.30535,-0.28761,1,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.027803,-0.30713,-0.28669,1,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.037747,-0.30852,-0.39807,1,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,6.7728e-06,-0.30895,-0.315,1,0
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0054795,-0.3093,-0.32295,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.01282,-0.31062,-0.26154,1,0
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.012508,-0.31249,-0.39312,1,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00044439,-0.31311,-0.37968,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00031859,-0.31341,-0.41209,1,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0056288,-0.31342,-0.26275,1,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00012964,-0.31398,-0.37241,1,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.628e-07,-0.31415,-0.30886,1,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,2.5308e-05,-0.31444,-0.29226,1,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00057693,-0.3147,-0.26648,1,0
2,GO REGULATION OF INTEGRIN ACTIVATION,5.0226e-05,-0.315,-0.33613,1,0
2,GO CELL CELL JUNCTION ORGANIZATION,4.7955e-07,-0.31541,-0.30645,1,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0022992,-0.31648,-0.31314,1,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00012512,-0.31665,-0.33851,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00010845,-0.31726,-0.40632,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.9301e-06,-0.31744,-0.3606,1,0
2,GO REGULATION OF NECROTIC CELL DEATH,0.00052342,-0.31763,-0.30615,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,2.3654e-06,-0.31765,-0.33963,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00016595,-0.31786,-0.34246,1,0
2,GO OSTEOBLAST PROLIFERATION,7.547e-05,-0.31976,-0.33165,1,0
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00079435,-0.32042,-0.3548,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.0023671,-0.32232,-0.45431,1,0
2,GO CELL CELL JUNCTION ASSEMBLY,3.4772e-07,-0.32295,-0.31894,1,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,1.0311e-06,-0.32332,-0.32007,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,1.3441e-06,-0.32366,-0.30789,1,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.033166,-0.32377,-0.30437,1,0
2,GO DNA DEAMINATION,0.010773,-0.32461,-0.30145,1,0
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0028957,-0.32505,-0.31941,1,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.00014935,-0.32512,-0.29447,1,0
2,GO T HELPER CELL LINEAGE COMMITMENT,1.0311e-06,-0.32599,-0.32887,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.2139e-05,-0.32673,-0.35194,1,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.010506,-0.32802,-0.40073,1,0
2,GO HAIR CELL DIFFERENTIATION,0.00021909,-0.32804,-0.33599,1,0
2,GO DETECTION OF OTHER ORGANISM,0.00049035,-0.32871,-0.34603,1,0
2,GO ESTROUS CYCLE,0.00022676,-0.32975,-0.32994,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0037331,-0.3298,-0.23854,1,0
2,GO SUPEROXIDE ANION GENERATION,0.00019753,-0.33044,-0.32869,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00012964,-0.33353,-0.34913,1,0
2,GO POSITIVE REGULATION OF COAGULATION,2.2658e-06,-0.3338,-0.36697,1,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.00036427,-0.33683,-0.39522,1,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.011326,-0.33707,-0.22085,1,0
2,GO PROSTANOID METABOLIC PROCESS,2.7343e-05,-0.33753,-0.42849,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00026903,-0.3402,-0.40128,1,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00019079,-0.34044,-0.35971,1,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00098941,-0.34256,-0.34758,1,0
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00063551,-0.34337,-0.39749,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.1964e-05,-0.34525,-0.38635,1,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0028141,-0.34544,-0.29998,1,0
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0046564,-0.34558,-0.27772,1,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0087944,-0.34698,-0.2929,1,0
2,GO INTERFERON ALPHA PRODUCTION,3.0576e-06,-0.34926,-0.35519,1,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.4039e-05,-0.34926,-0.33463,1,0
2,GO REGULATION OF ANOIKIS,0.00019753,-0.34973,-0.377,1,0
2,GO SPINAL CORD PATTERNING,0.0013054,-0.34994,-0.32001,1,0
2,GO HISTAMINE SECRETION,0.0028141,-0.35224,-0.35679,1,0
2,GO BARBED END ACTIN FILAMENT CAPPING,3.0689e-05,-0.35289,-0.44771,1,0
2,GO LIPID TRANSLOCATION,6.8936e-07,-0.35609,-0.33753,1,0
2,GO DECIDUALIZATION,0.00090094,-0.35635,-0.33185,1,0
2,GO T CELL LINEAGE COMMITMENT,5.0683e-06,-0.357,-0.32209,1,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,6.2786e-05,-0.35854,-0.4021,1,0
2,GO PROTEIN ADP RIBOSYLATION,3.0576e-06,-0.35936,-0.32976,1,0
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,2.4346e-05,-0.3597,-0.44339,1,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00019753,-0.35997,-0.38306,1,0
2,GO VIRAL BUDDING,2.7578e-07,-0.36018,-0.31951,1,0
2,GO PROGESTERONE METABOLIC PROCESS,0.00025131,-0.36121,-0.51242,1,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00029782,-0.36182,-0.28024,1,0
2,GO RESPONSE TO LEPTIN,0.0045306,-0.36305,-0.25145,1,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,3.4421e-05,-0.36547,-0.42209,1,0
2,GO PITUITARY GLAND DEVELOPMENT,0.00017186,-0.36669,-0.33981,1,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,9.0221e-07,-0.36691,-0.36478,1,0
2,GO KERATINOCYTE DIFFERENTIATION,6.7728e-06,-0.36752,-0.35407,1,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.010245,-0.36836,-0.41054,1,0
2,GO MITOTIC CYTOKINETIC PROCESS,4.0375e-08,-0.36848,-0.38634,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.3218e-05,-0.36938,-0.34745,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00024286,-0.3702,-0.35804,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.00095906,-0.37062,-0.30665,1,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0030654,-0.37116,-0.28291,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00032948,-0.37359,-0.45952,1,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0034322,-0.37386,-0.32627,1,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0028141,-0.37409,-0.31493,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,5.0683e-06,-0.37415,-0.34559,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0010206,-0.37546,-0.32863,1,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0010206,-0.37642,-0.34714,1,0
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0020453,-0.37969,-0.40054,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,3.0689e-05,-0.38047,-0.34918,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,2.8418e-05,-0.3813,-0.36154,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00025131,-0.38141,-0.44084,1,0
2,GO VASCULAR TRANSPORT,0.0022992,-0.382,-0.38376,1,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.0017641,-0.38309,-0.30894,1,0
2,GO RESPONSE TO TYPE I INTERFERON,0.00016595,-0.38612,-0.46326,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00045924,-0.38685,-0.35775,1,0
2,GO REFLEX,0.00034072,-0.38699,-0.40692,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,4.0073e-05,-0.38739,-0.44042,1,0
2,GO GAP JUNCTION ASSEMBLY,2.6307e-05,-0.38808,-0.48419,1,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.071e-07,-0.38885,-0.40931,1,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.01282,-0.39258,-0.41599,1,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0071468,-0.3963,-0.31373,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.8521e-05,-0.3966,-0.39583,1,0
2,GO GANGLION DEVELOPMENT,0.021165,-0.39697,-0.28143,1,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.725e-07,-0.39783,-0.47481,1,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0083534,-0.39797,-0.36067,1,0
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.4674e-06,-0.39968,-0.40163,1,0
2,GO REGULATION OF TOLERANCE INDUCTION,3.3132e-05,-0.39997,-0.46109,1,0
2,GO REGULATION OF TRANSPOSITION,1.5816e-05,-0.40073,-0.46673,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0099891,-0.40278,-0.37582,1,0
2,GO TOXIN METABOLIC PROCESS,0.00057693,-0.40603,-0.36559,1,0
2,GO POSITIVE REGULATION OF CELL MATURATION,2.3418e-05,-0.41063,-0.44936,1,0
2,GO HEPATOCYTE DIFFERENTIATION,0.00036427,-0.4138,-0.40771,1,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4039e-05,-0.4171,-0.37596,1,0
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,9.4334e-07,-0.41803,-0.50144,1,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.0025817,-0.42002,-0.34013,1,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.7806e-05,-0.42133,-0.44326,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,8.1192e-05,-0.42159,-0.48488,1,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0025817,-0.42889,-0.38599,1,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.4268e-07,-0.42915,-0.50799,1,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,1.2454e-05,-0.43047,-0.44669,1,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.5759e-05,-0.43125,-0.44395,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4692e-06,-0.43326,-0.4649,1,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00050664,-0.43513,-0.57634,1,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00059588,-0.44239,-0.40888,1,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.8521e-05,-0.44419,-0.43224,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00040247,-0.44435,-0.36483,1,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,2.7343e-05,-0.44496,-0.49912,1,0
2,GO LEYDIG CELL DIFFERENTIATION,0.0021689,-0.44632,-0.40799,1,0
2,GO RESPONSE TO INTERLEUKIN 18,0.00018427,-0.44644,-0.50559,1,0
2,GO RESPONSE TO LITHIUM ION,9.0551e-05,-0.44912,-0.43617,1,0
2,GO KERATINIZATION,1.1964e-05,-0.4492,-0.39241,1,0
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0006154,-0.45043,-0.55951,1,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.2454e-05,-0.45066,-0.41465,1,0
2,GO REGULATION OF CELL FATE SPECIFICATION,9.0551e-05,-0.45104,-0.40733,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.1237e-07,-0.45935,-0.48094,1,0
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,2.2524e-05,-0.45948,-0.43579,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,2.5122e-07,-0.45982,-0.47032,1,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0001547,-0.46555,-0.43733,1,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00081984,-0.46571,-0.41489,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9301e-06,-0.47305,-0.51574,1,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.9263e-05,-0.47602,-0.45052,1,0
2,GO POSITIVE REGULATION OF WOUND HEALING,2.5122e-07,-0.48106,-0.49064,1,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00040247,-0.48751,-0.3629,1,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,3.5759e-05,-0.48977,-0.43053,1,0
2,GO CORNIFICATION,1.7806e-05,-0.49011,-0.44254,1,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.4728e-06,-0.49691,-0.5218,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.349e-05,-0.50143,-0.55439,1,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,2.1831e-07,-0.50316,-0.45438,1,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,3.8583e-05,-0.50386,-0.42865,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00025131,-0.50602,-0.4146,1,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0056288,-0.50639,-0.34596,1,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,6.2786e-05,-0.50766,-0.44061,1,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,3.17e-07,-0.50816,-0.47471,1,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.7474e-06,-0.51331,-0.42925,1,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0015653,-0.51475,-0.45624,1,0
2,GO RESPONSE TO WATER,1.7118e-05,-0.52097,-0.47175,1,0
2,GO MIDBODY ABSCISSION,1.0207e-07,-0.52521,-0.49576,1,0
2,GO CARDIOBLAST PROLIFERATION,0.014486,-0.53014,-0.3812,1,0
2,GO MUCUS SECRETION,0.0030654,-0.54433,-0.48076,1,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,4.1617e-05,-0.54534,-0.50744,1,0
2,GO APICAL JUNCTION ASSEMBLY,4.6826e-08,-0.54725,-0.527,1,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.4674e-06,-0.54782,-0.60649,1,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,7.9801e-06,-0.55036,-0.52945,1,0
2,GO CYTIDINE TO URIDINE EDITING,0.0013457,-0.55542,-0.55396,1,0
2,GO NEURON FATE SPECIFICATION,0.00047456,-0.55851,-0.45962,1,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.00027832,-0.57307,-0.48694,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,2.4346e-05,-0.58141,-0.50358,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,2.0784e-06,-0.60457,-0.60175,1,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.7578e-07,-0.60625,-0.63166,1,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.5816e-05,-0.61639,-0.66557,1,0
2,GO PSEUDOPODIUM ORGANIZATION,3.0689e-05,-0.62889,-0.51229,1,0
2,GO GAMMA DELTA T CELL ACTIVATION,5.7413e-06,-0.64565,-0.56313,1,0
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.7801e-06,-0.66139,-0.59687,1,0
2,GO LIPID DROPLET FORMATION,3.0576e-06,-0.66758,-0.69903,1,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0001547,-0.67047,-0.67819,1,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00010845,-0.67913,-0.73843,1,0
2,GO CARDIAC CELL FATE COMMITMENT,5.2837e-06,-0.72322,-0.65418,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00081984,-0.74631,-0.75141,1,0
2,GO EPITHELIAL CELL CELL ADHESION,3.479e-08,-0.7504,-0.83357,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,2.8418e-05,-0.76712,-0.63291,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0010859,-0.90011,-0.91252,1,0
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,2.2879e-07,-1.2144,-1.1,1,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.19095,0.31034,0.14973,0,1
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.057089,0.30952,0.22906,0,1
2,GO CARDIAC VENTRICLE FORMATION,0.072231,0.29066,0.24654,0,1
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.10096,0.28377,0.17628,0,1
2,GO CARDIAC CHAMBER FORMATION,0.053746,0.27961,0.25441,0,1
2,GO TELENCEPHALON REGIONALIZATION,0.077957,0.25621,0.23496,0,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.1313,0.24322,0.096103,0,1
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.11636,0.2415,0.10275,0,1
2,GO RESPONSE TO PARATHYROID HORMONE,0.0695,0.23045,0.19538,0,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.063042,0.22817,0.2407,0,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.092194,0.22616,0.15761,0,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.088862,0.22333,0.15974,0,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.049546,0.2217,0.12492,0,1
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.055956,0.21101,0.12529,0,1
2,GO MESODERMAL CELL FATE SPECIFICATION,0.20309,0.20986,0.11736,0,1
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.12908,0.2089,0.13581,0,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.082489,0.20406,0.11046,0,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.085627,0.19294,0.18555,0,1
2,GO BONE TRABECULA MORPHOGENESIS,0.053746,0.19291,0.18045,0,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.049546,0.18836,0.19111,0,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.25363,0.186,0.10083,0,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.15015,0.18249,0.072211,0,1
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.050569,0.18238,0.20825,0,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.088862,0.1804,0.15001,0,1
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.15517,0.17456,0.097567,0,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.060602,0.17345,0.14804,0,1
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.25363,0.17195,0.073515,0,1
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.22235,0.16527,0.097275,0,1
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.14526,0.16521,0.13342,0,1
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.077957,0.16283,0.16226,0,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.088862,0.16153,0.13288,0,1
2,GO REGULATION OF DNA METHYLATION,0.082489,0.15952,0.10355,0,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.092194,0.15838,0.14638,0,1
2,GO PULMONARY VALVE MORPHOGENESIS,0.20621,0.15688,0.081098,0,1
2,GO CHYLOMICRON ASSEMBLY,0.21579,0.1558,0.057557,0,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.16032,0.15444,0.075341,0,1
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.30815,0.15403,0.069504,0,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.10654,0.15027,0.073831,0,1
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.32506,0.1491,0.080587,0,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.20309,0.14528,0.072542,0,1
2,GO BONE MORPHOGENESIS,0.27999,0.14458,0.047665,0,1
2,GO CELLULAR ANION HOMEOSTASIS,0.087232,0.14255,0.12873,0,1
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.068167,0.14146,0.12308,0,1
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.17374,0.13697,0.090013,0,1
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.087232,0.13664,0.093949,0,1
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.055956,0.13337,0.12663,0,1
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.068167,0.13125,0.11331,0,1
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.38888,0.13064,0.053212,0,1
2,GO AORTIC VALVE DEVELOPMENT,0.17934,0.12903,0.089401,0,1
2,GO MULTI ORGANISM LOCALIZATION,0.059411,0.12597,0.061581,0,1
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.35607,0.12549,0.061764,0,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.084046,0.12448,0.074074,0,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.11636,0.12317,0.19673,0,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.088862,0.12233,0.12343,0,1
2,GO RESPONSE TO VITAMIN A,0.32506,0.12124,0.075908,0,1
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.049546,0.11861,0.087356,0,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.084046,0.11765,0.087643,0,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0695,0.1128,0.066787,0,1
2,GO INTERACTION WITH SYMBIONT,0.082489,0.10304,0.053206,0,1
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.22235,0.10279,0.054223,0,1
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.14526,0.10112,0.065739,0,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.13583,0.098657,0.071962,0,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.4978,0.098467,0.028479,0,1
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.11636,0.096998,0.11805,0,1
2,GO PROTEIN DEMETHYLATION,0.092194,0.094641,0.088082,0,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092194,0.094406,0.086592,0,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.082489,0.094223,0.081947,0,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.080955,0.093843,0.087863,0,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.055956,0.093631,0.093391,0,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.090515,0.092987,0.080894,0,1
2,GO PRENYLATION,0.11434,0.09269,0.1325,0,1
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.050569,0.092058,0.13486,0,1
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.052669,0.08999,0.1324,0,1
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.18508,0.088075,0.055615,0,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.15264,0.087074,0.080426,0,1
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.4978,0.086638,0.047485,0,1
2,GO POSITIVE REGULATION OF RNA SPLICING,0.087232,0.085521,0.052467,0,1
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.99651,0.084925,-0.01442,0,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.31232,0.084131,0.055431,0,1
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.079444,0.083657,0.065693,0,1
2,GO PROTEIN HOMOTETRAMERIZATION,0.11636,0.08348,0.060179,0,1
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.15264,0.082719,0.074747,0,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.42347,0.082227,0.026832,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.073629,0.081249,0.061775,0,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.17934,0.080802,0.049863,0,1
2,GO BLASTOCYST GROWTH,0.17374,0.07605,0.051061,0,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.065563,0.075199,0.088538,0,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.16294,0.075074,0.068963,0,1
2,GO RECOMBINATIONAL REPAIR,0.10465,0.073986,0.046047,0,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.43367,0.071882,0.015966,0,1
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.35153,0.065583,0.039499,0,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.27227,0.062729,0.039784,0,1
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.099158,0.062645,0.056768,0,1
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.48131,0.061427,0.017464,0,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.19095,0.053419,0.077466,0,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.057089,0.051638,0.065322,0,1
2,GO SNRNA TRANSCRIPTION,0.10465,0.042408,0.047574,0,1
2,GO RESPONSE TO UV,0.097379,0.039549,0.045907,0,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.38408,0.030636,0.013652,0,1
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,5.0683e-06,0.9205,0.91235,0,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,4.1617e-05,0.61038,0.54245,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0067808,0.4664,0.44545,0,0
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0034322,0.46605,0.40317,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,2.8077e-06,0.46541,0.47652,0,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00016023,0.45571,0.56461,0,0
2,GO SECRETORY GRANULE LOCALIZATION,0.0025817,0.45138,0.4067,0,0
2,GO REGULATION OF SYNAPSE MATURATION,0.0034322,0.45113,0.40967,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.00026903,0.39258,0.45651,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.011326,0.38101,0.26645,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0081404,0.37973,0.38323,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,6.5149e-05,0.37968,0.31929,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.097379,0.36435,0.22988,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0017123,0.35626,0.39178,0,0
2,GO ELASTIC FIBER ASSEMBLY,0.0024367,0.35596,0.41574,0,0
2,GO PROTEIN TRIMERIZATION,0.00041602,0.35306,0.33001,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0021062,0.34723,0.33736,0,0
2,GO FACIAL NERVE MORPHOGENESIS,0.1313,0.34332,0.20569,0,0
2,GO DENSE CORE GRANULE TRANSPORT,0.024846,0.34184,0.33166,0,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.19095,0.33644,0.2567,0,0
2,GO NEGATIVE CHEMOTAXIS,0.00059588,0.33031,0.2949,0,0
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.004408,0.32824,0.28235,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.036164,0.32691,0.21922,0,0
2,GO PYRAMIDAL NEURON DIFFERENTIATION,0.0045306,0.32272,0.43871,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.045624,0.32228,0.27197,0,0
2,GO REGULATION OF VESICLE FUSION,0.0022992,0.32162,0.31981,0,0
2,GO GTP METABOLIC PROCESS,0.00067758,0.31441,0.28031,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00021167,0.30824,0.31654,0,0
2,GO REGULATION OF HIPPO SIGNALING,0.13583,0.30357,0.14721,0,0
2,GO PHAGOCYTOSIS RECOGNITION,0.016734,0.30286,0.22475,0,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.11235,0.30126,0.136,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.012508,0.30005,0.25019,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.00011241,0.29877,0.32346,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.0833e-05,0.29263,0.33567,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00025131,0.2877,0.32833,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.00072223,0.28453,0.43099,0,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.0022992,0.28452,0.2835,0,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0024367,0.28419,0.25027,0,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.011047,0.28022,0.27242,0,0
2,GO HEART VALVE FORMATION,0.0046564,0.27408,0.30475,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.093897,0.27345,0.17045,0,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.00353,0.27232,0.28126,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0062634,0.27115,0.23012,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.001191,0.27093,0.26433,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.016339,0.2705,0.29899,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.3746,0.269,0.078263,0,0
2,GO ADULT FEEDING BEHAVIOR,0.02068,0.26172,0.12264,0,0
2,GO GLUTAMATE SECRETION,0.0051916,0.26161,0.24051,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0067808,0.26079,0.18637,0,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.024846,0.25878,0.18147,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00092958,0.25825,0.34529,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.04854,0.2569,0.15756,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.11434,0.25612,0.19477,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.014841,0.25444,0.26426,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0695,0.25422,0.16884,0,0
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0040578,0.2496,0.26919,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0071468,0.24865,0.23727,0,0
2,GO PREPULSE INHIBITION,0.13583,0.24516,0.19399,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.060602,0.24473,0.1688,0,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.068167,0.24238,0.16395,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.16032,0.24222,0.1925,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0056288,0.24129,0.26117,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00079435,0.23986,0.22,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.13814,0.23912,0.10162,0,0
2,GO RESPONSE TO HYPEROXIA,0.31232,0.23675,0.084246,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0010206,0.23285,0.27033,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0695,0.23229,0.13285,0,0
2,GO COLLAGEN METABOLIC PROCESS,0.065563,0.2303,0.11424,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.044685,0.22964,0.15744,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0075304,0.22768,0.19368,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.00074557,0.22727,0.21785,0,0
2,GO NADH METABOLIC PROCESS,0.0007696,0.22498,0.22987,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.001986,0.22472,0.21687,0,0
2,GO REGULATION OF NEURON MIGRATION,0.017137,0.22398,0.19341,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0050528,0.22167,0.22295,0,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0090226,0.22067,0.23243,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.012203,0.22039,0.16538,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.013139,0.21845,0.23131,0,0
2,GO PROTEIN LOCALIZATION TO AXON,0.066855,0.21807,0.31057,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0056288,0.21762,0.20945,0,0
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.25729,0.21575,0.029571,0,0
2,GO FATTY ACID HOMEOSTASIS,0.030383,0.21499,0.22494,0,0
2,GO RESPONSE TO AMINE,0.0039469,0.21489,0.19535,0,0
2,GO PARENTAL BEHAVIOR,0.11636,0.21458,0.13339,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.017137,0.21422,0.18197,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.23937,0.21359,0.07005,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.19095,0.21028,0.12095,0,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.014841,0.20906,0.2444,0,0
2,GO MATING BEHAVIOR,0.1028,0.20895,0.13499,0,0
2,GO ENAMEL MINERALIZATION,0.46512,0.2084,0.058723,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.076492,0.20738,0.15981,0,0
2,GO LONG TERM MEMORY,0.0031536,0.20666,0.20571,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.044685,0.2061,0.16618,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.076492,0.20474,0.11575,0,0
2,GO CGMP METABOLIC PROCESS,0.012508,0.20313,0.23463,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.3746,0.20211,0.10426,0,0
2,GO POLYOL TRANSPORT,0.018836,0.20181,0.16247,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.015953,0.20135,0.28305,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.01282,0.20044,0.18865,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.14769,0.20012,0.12549,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.004408,0.19988,0.17253,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.0071468,0.19848,0.20601,0,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.017137,0.19747,0.21302,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.36064,0.19631,0.053091,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.013798,0.19484,0.18448,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.0040578,0.19445,0.20916,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.02068,0.19368,0.19109,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0079323,0.1929,0.15211,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.017137,0.19244,0.17848,0,0
2,GO SYNAPTIC VESICLE DOCKING,0.12473,0.18957,0.19528,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.0006154,0.18953,0.18551,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.097379,0.18856,0.1628,0,0
2,GO LEARNING,0.0069616,0.18828,0.16978,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.040234,0.18785,0.12711,0,0
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.059411,0.18674,0.088108,0,0
2,GO AXONAL FASCICULATION,0.15264,0.1867,0.1669,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0081404,0.1864,0.24206,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.080955,0.18553,0.25368,0,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0041716,0.18517,0.16423,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.013798,0.18486,0.19397,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.027803,0.18383,0.16377,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.15015,0.18339,0.13284,0,0
2,GO MEMBRANE DISASSEMBLY,0.065563,0.18323,0.088868,0,0
2,GO RESPONSE TO CAFFEINE,0.027188,0.18275,0.17407,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.14285,0.18197,0.097332,0,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.055956,0.18141,0.18713,0,0
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.059411,0.18052,0.10417,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.28785,0.17986,0.076709,0,0
2,GO SYNAPSE ORGANIZATION,0.011047,0.1797,0.14312,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.05161,0.17898,0.16018,0,0
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.077957,0.17887,0.14599,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.12049,0.17778,0.13047,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0028957,0.17765,0.15905,0,0
2,GO TOOTH MINERALIZATION,0.43883,0.17727,0.052733,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.17099,0.17721,0.14101,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.14769,0.17674,0.16338,0,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0071468,0.17642,0.10987,0,0
2,GO CAMP METABOLIC PROCESS,0.10654,0.17499,0.095835,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.05161,0.17495,0.13642,0,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.087232,0.17493,0.13264,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.019739,0.17482,0.15559,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.43883,0.17441,0.072465,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0034322,0.17417,0.18174,0,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.097379,0.17331,0.12035,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.029068,0.17307,0.13903,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.2839,0.17145,0.12858,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.11434,0.17097,0.1472,0,0
2,GO POSTSYNAPSE ORGANIZATION,0.0064317,0.17082,0.16044,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.30402,0.17061,0.084633,0,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.30402,0.17047,0.1036,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.19095,0.16959,0.10458,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.32077,0.169,0.02665,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.066855,0.1685,0.13596,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0049174,0.16787,0.18131,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.43883,0.16786,0.033859,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.009256,0.16517,0.19815,0,0
2,GO VITAMIN CATABOLIC PROCESS,0.11434,0.16512,0.21201,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.053746,0.16469,0.10407,0,0
2,GO RESPONSE TO LIGHT INTENSITY,0.072231,0.16397,0.18903,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.42855,0.16362,0.0595,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.018836,0.16346,0.14409,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.033894,0.16336,0.13585,0,0
2,GO ASSOCIATIVE LEARNING,0.0040578,0.16306,0.16534,0,0
2,GO LIPID IMPORT INTO CELL,0.27227,0.16238,0.051652,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0081404,0.16185,0.11942,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.51459,0.16108,0.055696,0,0
2,GO CGMP MEDIATED SIGNALING,0.076492,0.16063,0.102,0,0
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.004408,0.1605,0.1309,0,0
2,GO RESPONSE TO PROTOZOAN,0.72313,0.15989,0.0090345,0,0
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.1028,0.15925,0.1367,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.21905,0.15887,0.09842,0,0
2,GO HEPARIN METABOLIC PROCESS,0.050569,0.15858,0.22671,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.20937,0.15848,0.1326,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.16559,0.15835,0.069868,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0042883,0.15712,0.21215,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0085714,0.15651,0.13749,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.15264,0.15632,0.14022,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.012203,0.15608,0.1901,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.013139,0.1558,0.11652,0,0
2,GO ONE CARBON COMPOUND TRANSPORT,0.042857,0.15577,0.11004,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.013798,0.15504,0.17427,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.030383,0.15394,0.13708,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.019739,0.15387,0.11646,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.22235,0.15332,0.069031,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.049546,0.15298,0.12988,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.019283,0.15293,0.13831,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.049546,0.15168,0.10325,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.55487,0.15101,0.097265,0,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0695,0.14997,0.18598,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.29586,0.14956,0.032744,0,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.27227,0.14882,0.091175,0,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0060989,0.14836,0.20435,0,0
2,GO CELLULAR RESPONSE TO ETHANOL,0.063042,0.14788,0.14578,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.26098,0.14773,0.066702,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.16294,0.14772,0.1197,0,0
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.67776,0.14765,-0.012528,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.03939,0.1475,0.13272,0,0
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.11434,0.14694,0.14246,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.19095,0.14634,0.11353,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.082489,0.14607,0.10808,0,0
2,GO COLLATERAL SPROUTING,0.036164,0.14592,0.14537,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.3746,0.14582,0.05916,0,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.14048,0.14573,0.094029,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.13814,0.14568,0.12667,0,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.093897,0.14519,0.15664,0,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.17653,0.14481,0.084633,0,0
2,GO RESPONSE TO MANGANESE ION,0.22905,0.14426,0.07976,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.068167,0.14352,0.098187,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.090515,0.14293,0.12847,0,0
2,GO FOREBRAIN CELL MIGRATION,0.041093,0.14275,0.13448,0,0
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.045624,0.14267,0.092204,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.14526,0.14237,0.13758,0,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.10845,0.14222,0.071577,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.068167,0.14212,0.092423,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.025414,0.14158,0.1525,0,0
2,GO XENOBIOTIC TRANSPORT,0.43883,0.14139,0.012707,0,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0013872,0.14106,0.1409,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.31232,0.14089,0.051021,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.22235,0.14048,0.07954,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.064293,0.14016,0.12175,0,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.013798,0.14015,0.12367,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.052669,0.13973,0.1169,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.018398,0.13937,0.12625,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,0.0059384,0.13895,0.15741,0,0
2,GO RESPONSE TO UV B,0.69061,0.13872,-0.079753,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.007729,0.13843,0.12591,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.05161,0.13833,0.15556,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.10654,0.13833,0.11949,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.085627,0.13831,0.11713,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.17934,0.13797,0.071228,0,0
2,GO MITOCHONDRION LOCALIZATION,0.0039469,0.13788,0.15366,0,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.74288,0.13705,0.025909,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.14769,0.13599,0.14128,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.15015,0.13599,0.16894,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.30402,0.13562,0.11625,0,0
2,GO VOCALIZATION BEHAVIOR,0.47588,0.13544,0.1168,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.188,0.13485,0.10361,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.24288,0.13444,0.075406,0,0
2,GO CELL AGGREGATION,0.18219,0.13444,0.08419,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.090515,0.13411,0.17985,0,0
2,GO IMPORT INTO CELL,0.0023671,0.1341,0.1388,0,0
2,GO NEURON PROJECTION EXTENSION,0.037747,0.13322,0.10066,0,0
2,GO LIMB BUD FORMATION,0.15517,0.13315,0.23847,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.084046,0.13227,0.089646,0,0
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.034637,0.13143,0.20291,0,0
2,GO WALKING BEHAVIOR,0.004408,0.13133,0.19622,0,0
2,GO PROTEIN OXIDATION,0.11235,0.13088,0.080542,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.50337,0.12972,0.033652,0,0
2,GO EXPLORATION BEHAVIOR,0.034637,0.12965,0.21732,0,0
2,GO COCHLEA MORPHOGENESIS,0.14526,0.1296,0.097496,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.23245,0.12951,0.061162,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.018836,0.12866,0.11834,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.080955,0.12829,0.1066,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.080955,0.12815,0.12364,0,0
2,GO RNA STABILIZATION,0.061812,0.12799,0.090294,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.05824,0.12776,0.091806,0,0
2,GO TOXIN TRANSPORT,0.011326,0.12756,0.10998,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.12259,0.12701,0.081328,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.0695,0.12696,0.13367,0,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.019739,0.12678,0.15271,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.20621,0.12673,0.12583,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.17099,0.12658,0.050241,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.037747,0.126,0.15547,0,0
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.20937,0.12576,0.058962,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.47049,0.1252,0.072522,0,0
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.14526,0.12509,0.14873,0,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.082489,0.12495,0.15722,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.35153,0.12488,0.06732,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.017137,0.1248,0.14552,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.060602,0.12471,0.094129,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.077957,0.12469,0.096129,0,0
2,GO MEMBRANE REPOLARIZATION,0.042857,0.12457,0.10648,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.40349,0.12445,0.046151,0,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.031748,0.12374,0.091153,0,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.20309,0.12342,0.080321,0,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.018836,0.12279,0.10552,0,0
2,GO TETRAPYRROLE METABOLIC PROCESS,0.12259,0.12231,0.076083,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.23589,0.12222,0.054083,0,0
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.050569,0.12215,0.088028,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.018398,0.12196,0.14031,0,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.21579,0.12177,0.059596,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.59059,0.12169,0.032359,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.24643,0.12134,0.062544,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.11235,0.1204,0.063789,0,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.041093,0.12031,0.16321,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.19095,0.12007,0.10429,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.15517,0.11937,0.085766,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.27611,0.11908,0.079164,0,0
2,GO LYMPHANGIOGENESIS,0.22905,0.11819,0.071714,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.049546,0.11807,0.23578,0,0
2,GO NEURON RECOGNITION,0.16559,0.11777,0.11537,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.02268,0.1172,0.15048,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.29992,0.11711,0.055216,0,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.14048,0.11693,0.070023,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.019739,0.11665,0.10302,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.05161,0.11664,0.058763,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.10654,0.11627,0.14979,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.075049,0.11625,0.12621,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.016339,0.11607,0.12433,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.20937,0.11581,0.072476,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.052669,0.11571,0.095428,0,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00010462,0.11569,0.17534,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.14769,0.1156,0.055692,0,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.053746,0.11541,0.086327,0,0
2,GO DEVELOPMENTAL CELL GROWTH,0.031059,0.11541,0.080884,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.32506,0.11532,0.040718,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.077957,0.1153,0.097395,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.023205,0.11436,0.1835,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.011904,0.11417,0.18134,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.2839,0.11409,0.047716,0,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.020205,0.1138,0.16582,0,0
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.73628,0.11379,-0.01629,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.29992,0.11314,0.076811,0,0
2,GO DENDRITIC TRANSPORT,0.099158,0.11295,0.17168,0,0
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0094949,0.11277,0.15922,0,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.075049,0.11246,0.092922,0,0
2,GO BLASTOCYST FORMATION,0.047551,0.11239,0.08888,0,0
2,GO THYROID GLAND DEVELOPMENT,0.59664,0.11214,0.00054879,0,0
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.082489,0.11202,0.16327,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.023741,0.11196,0.090796,0,0
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.37932,0.11173,0.018891,0,0
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.31653,0.11127,0.028716,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.21579,0.1112,0.071744,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.063042,0.11064,0.092832,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.2,0.11043,0.046865,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.046579,0.11007,0.072861,0,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.2839,0.10977,0.07557,0,0
2,GO SEQUESTERING OF METAL ION,0.40843,0.10969,0.02378,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.51459,0.10937,0.048321,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.63978,0.10912,0.016152,0,0
2,GO FIBRINOLYSIS,0.39371,0.1091,-0.032119,0,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.085627,0.10877,0.095568,0,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.19695,0.10872,0.059129,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.33812,0.10818,0.053595,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.01282,0.10817,0.13567,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.52025,0.10807,-0.00091439,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.4545,0.10801,0.0010731,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.05161,0.10788,0.14311,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.066855,0.10773,0.10141,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.076492,0.10761,0.14464,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.19393,0.10748,0.038215,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.1313,0.10747,0.04758,0,0
2,GO ANION HOMEOSTASIS,0.188,0.10723,0.06613,0,0
2,GO PLASMINOGEN ACTIVATION,0.31653,0.10714,-0.0098727,0,0
2,GO DNA REPLICATION CHECKPOINT,0.027803,0.10672,0.1064,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.86455,0.10668,-0.016079,0,0
2,GO COCHLEA DEVELOPMENT,0.031059,0.10644,0.10417,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.16294,0.10632,0.062211,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.52594,0.10619,0.12075,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.17934,0.10596,0.088282,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.04854,0.10545,0.08285,0,0
2,GO PROTEIN FOLDING,0.04854,0.10506,0.071475,0,0
2,GO RESPONSE TO AMPHETAMINE,0.093897,0.10436,0.106,0,0
2,GO ENDODERM DEVELOPMENT,0.30402,0.10422,0.031694,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.092194,0.10401,0.078183,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.34702,0.10388,0.038078,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.14769,0.10386,0.043506,0,0
2,GO SYNAPTIC SIGNALING,0.12049,0.10342,0.079031,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.1313,0.10301,0.084176,0,0
2,GO NUCLEUS LOCALIZATION,0.14769,0.1027,0.08124,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.24643,0.1025,0.082335,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.061812,0.10241,0.15582,0,0
2,GO AXON EXTENSION,0.073629,0.10202,0.087028,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.077957,0.10151,0.092805,0,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.67776,0.10136,-0.011073,0,0
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.22235,0.10126,0.080949,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.22235,0.10117,0.060037,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.15773,0.10086,0.26238,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.42347,0.10069,0.059364,0,0
2,GO DRUG CATABOLIC PROCESS,0.10845,0.10059,0.08512,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.092194,0.10048,0.11907,0,0
2,GO DENDRITE DEVELOPMENT,0.055956,0.10037,0.099755,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.99651,0.10026,0.0040398,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.30815,0.09988,0.064178,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.29184,0.099778,0.06338,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.59664,0.099585,0.044991,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.02166,0.099319,0.083646,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.080955,0.099118,0.086423,0,0
2,GO CELL PART MORPHOGENESIS,0.13355,0.098553,0.070974,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.16032,0.09845,0.1543,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.4978,0.098054,0.026652,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.15517,0.098044,0.14909,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.26847,0.097986,0.071693,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.56075,0.097973,0.031506,0,0
2,GO SEROTONIN TRANSPORT,0.53167,0.097963,0.05305,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.15773,0.097797,0.069859,0,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.11434,0.0976,0.081688,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.72313,0.097442,0.0034879,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.26471,0.097188,0.11648,0,0
2,GO RESPONSE TO INTERLEUKIN 12,0.19695,0.097107,0.062915,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.28785,0.09703,0.071566,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.05161,0.097005,0.073418,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.0097392,0.096912,0.10888,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.0090226,0.096816,0.12352,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.32077,0.096687,0.036298,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.055956,0.096577,0.072692,0,0
2,GO NEUROTRANSMITTER SECRETION,0.095625,0.096572,0.13582,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.15264,0.096499,0.097708,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.11039,0.096406,0.096929,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.61497,0.096301,0.0014899,0,0
2,GO NADPH REGENERATION,0.34256,0.095991,0.069792,0,0
2,GO MECHANOSENSORY BEHAVIOR,0.54903,0.095948,0.12864,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.14048,0.09588,0.14063,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.99651,0.095811,-0.011277,0,0
2,GO PROSTATE GLAND GROWTH,0.4598,0.095745,0.0073899,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.18219,0.095479,0.080572,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.22568,0.095157,0.097298,0,0
2,GO RNA EXPORT FROM NUCLEUS,0.0030654,0.095103,0.13263,0,0
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.18508,0.095044,0.055907,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.05161,0.094784,0.089898,0,0
2,GO DENDRITE MORPHOGENESIS,0.10845,0.094021,0.0845,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.74288,0.093815,-0.023357,0,0
2,GO REGULATION OF DOPAMINE SECRETION,0.46512,0.093777,0.12908,0,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.66501,0.093714,0.055442,0,0
2,GO STRIATUM DEVELOPMENT,0.15015,0.093587,0.10795,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.36064,0.093579,0.034636,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.097379,0.093475,0.26418,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.19695,0.093215,0.066815,0,0
2,GO ARTERY DEVELOPMENT,0.15264,0.093115,0.033298,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.057089,0.09309,0.10753,0,0
2,GO MRNA SPLICE SITE SELECTION,0.4598,0.093081,0.043412,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.35153,0.092981,0.040938,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.85768,0.092798,-0.055454,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.22905,0.092693,0.067967,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.46512,0.09254,0.087937,0,0
2,GO LAMELLIPODIUM MORPHOGENESIS,0.98953,0.09237,-0.036545,0,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.10096,0.091974,0.10846,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.38888,0.091777,0.055422,0,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0695,0.091507,0.097623,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.23245,0.091206,0.048869,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.21905,0.091025,0.065,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.063042,0.090901,0.093147,0,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.25363,0.090771,0.061256,0,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.23589,0.09066,0.050148,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.69707,0.090614,0.010966,0,0
2,GO RESPONSE TO SALT,0.36991,0.090608,0.040233,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.11434,0.090602,0.094843,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.94073,0.090507,-0.040552,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.29184,0.090475,0.025129,0,0
2,GO ODONTOGENESIS,0.52025,0.08998,0.016904,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.15773,0.089817,0.096498,0,0
2,GO NOREPINEPHRINE SECRETION,0.29586,0.089701,0.062268,0,0
2,GO GLIAL CELL MIGRATION,0.084046,0.089393,0.12232,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.11039,0.089094,0.13447,0,0
2,GO NEUROMUSCULAR PROCESS,0.073629,0.089066,0.099478,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.12049,0.088633,0.1304,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.087232,0.088449,0.088138,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.16828,0.088351,0.065751,0,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.86455,0.088241,0.0011628,0,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.36064,0.088148,0.061831,0,0
2,GO GROOMING BEHAVIOR,0.31232,0.088031,0.082043,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.33812,0.087918,0.061206,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.62113,0.087791,0.033367,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.15773,0.087682,0.067905,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.59664,0.087667,-0.013965,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.2,0.087421,0.097797,0,0
2,GO RESPONSE TO AMYLOID BETA,0.029719,0.087272,0.10585,0,0
2,GO REGULATION OF AXON GUIDANCE,0.38888,0.087091,0.037917,0,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.12259,0.087011,0.095042,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.14526,0.086793,0.078283,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.055956,0.086737,0.064002,0,0
2,GO THIOESTER METABOLIC PROCESS,0.12049,0.086727,0.069068,0,0
2,GO NERVE DEVELOPMENT,0.47588,0.086516,0.038488,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.48131,0.086259,0.04187,0,0
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.4545,0.085799,0.042413,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.52594,0.08509,0.032059,0,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.39858,0.084712,0.053191,0,0
2,GO HISTONE H3 K36 METHYLATION,0.43883,0.084625,0.038995,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.097379,0.084583,0.06531,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.23245,0.084391,0.059413,0,0
2,GO VITAMIN TRANSPORT,0.16032,0.084336,0.10655,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.11841,0.084324,0.052132,0,0
2,GO RESPONSE TO ACIDIC PH,0.32938,0.083931,0.042928,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.71006,0.083643,0.0077632,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.42347,0.083425,0.048464,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.16559,0.083387,0.071155,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.33373,0.08331,0.042359,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.32077,0.083196,0.071397,0,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.092194,0.08316,0.064267,0,0
2,GO PHOSPHATE ION TRANSPORT,0.027803,0.08289,0.088009,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.72313,0.08277,-0.0022853,0,0
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.4978,0.082659,0.042054,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.16559,0.082368,0.098367,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.60883,0.082158,0.014452,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.87833,0.082149,-0.08118,0,0
2,GO NUCLEOSIDE SALVAGE,0.070855,0.0814,0.083625,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.18219,0.081316,0.067266,0,0
2,GO LACTATION,0.057089,0.081178,0.118,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.072231,0.081174,0.14192,0,0
2,GO METENCEPHALON DEVELOPMENT,0.16032,0.080965,0.082103,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.05824,0.080665,0.075728,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.69061,0.080616,0.038374,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0057817,0.080156,0.095867,0,0
2,GO DENDRITE SELF AVOIDANCE,0.68418,0.079969,0.021757,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.23937,0.079852,0.073452,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.040234,0.079823,0.052653,0,0
2,GO PIGMENT GRANULE MATURATION,0.41842,0.079675,0.012841,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.36991,0.079666,0.16523,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.099158,0.079538,0.081877,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.24288,0.079471,0.060483,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.20309,0.07942,0.11763,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.17374,0.079309,0.058289,0,0
2,GO SYNCYTIUM FORMATION,0.94769,0.079052,-0.008242,0,0
2,GO STARTLE RESPONSE,0.65866,0.078272,0.051064,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.059411,0.078189,0.097893,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.15773,0.078058,0.046049,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.14048,0.07805,0.075981,0,0
2,GO PRESYNAPSE ORGANIZATION,0.12259,0.07784,0.1304,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.22568,0.0778,0.052027,0,0
2,GO ENDODERM FORMATION,0.23245,0.077599,0.045717,0,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.25001,0.077403,0.041516,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.59059,0.077338,-0.035884,0,0
2,GO AXON DEVELOPMENT,0.17374,0.077112,0.075409,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.35607,0.076896,0.044506,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.27999,0.07687,0.057982,0,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.33373,0.0768,0.058719,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.18508,0.076709,0.05182,0,0
2,GO SYNAPSE ASSEMBLY,0.19695,0.076673,0.089211,0,0
2,GO NEURAL CREST FORMATION,0.39371,0.076568,0.071006,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.15517,0.076529,0.096888,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.19695,0.076369,0.1255,0,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.075049,0.076111,0.066236,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.81668,0.076004,-0.032636,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.22568,0.075929,0.097483,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.62113,0.075897,0.0013476,0,0
2,GO PORE COMPLEX ASSEMBLY,0.34256,0.07578,0.0085206,0,0
2,GO TRNA 5 LEADER REMOVAL,0.084046,0.07577,0.15022,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.59664,0.075603,0.013714,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.65234,0.075567,0.023663,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.16294,0.07521,0.044295,0,0
2,GO HISTONE DEUBIQUITINATION,0.073629,0.075153,0.073265,0,0
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.26471,0.074999,0.10415,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.04854,0.074749,0.075303,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.48678,0.074641,0.021074,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.46512,0.074631,0.051033,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.34702,0.074464,0.044892,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.3746,0.074348,0.042074,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.94769,0.074271,-0.023354,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.89907,0.073448,0.018344,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.40349,0.073263,0.049686,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.10096,0.073209,0.04609,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.94073,0.072925,-0.01309,0,0
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.29992,0.072915,0.075386,0,0
2,GO RHYTHMIC BEHAVIOR,0.29992,0.072645,0.054643,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.30402,0.072552,0.057875,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.29586,0.072441,0.056058,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.40349,0.072126,0.039982,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.7495,0.071828,0.033529,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.18508,0.071803,0.078762,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.44402,0.071656,0.05549,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.95466,0.0715,-0.0031225,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.57857,0.071367,0.070847,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.15773,0.071253,0.080002,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.13583,0.070946,0.060371,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.13355,0.070835,0.056989,0,0
2,GO REGULATION OF EXCRETION,0.16294,0.070778,0.091762,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.32077,0.070769,0.064092,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.56075,0.070748,-0.010541,0,0
2,GO PROSTATIC BUD FORMATION,0.84397,0.070535,-0.053246,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.16559,0.070368,0.095496,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.13355,0.070001,0.11479,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.32077,0.069564,0.023769,0,0
2,GO CELL RECOGNITION,0.093897,0.069529,0.060574,0,0
2,GO CONVERGENT EXTENSION,0.22568,0.069473,0.087078,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.050569,0.069442,0.084844,0,0
2,GO CELLULAR OXIDANT DETOXIFICATION,0.60883,0.069339,0.027863,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.32506,0.069006,0.038429,0,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.31653,0.068786,0.1074,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.34702,0.068671,0.025215,0,0
2,GO CERAMIDE TRANSPORT,0.052669,0.068442,0.070996,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.11636,0.068341,0.069082,0,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.060602,0.068316,0.12803,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.53167,0.068115,0.052675,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.34702,0.06808,0.041968,0,0
2,GO SYNAPTIC VESICLE RECYCLING,0.41341,0.06801,0.054923,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.4598,0.067988,0.025815,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.91293,0.067964,-0.063463,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.44402,0.067907,0.035124,0,0
2,GO CELL CYCLE DNA REPLICATION,0.10096,0.067864,0.075561,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.033894,0.067726,0.13192,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.11841,0.067439,0.06872,0,0
2,GO TRABECULA FORMATION,0.19695,0.067389,0.089833,0,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.4545,0.067341,-0.0064355,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.74288,0.067285,-0.0045993,0,0
2,GO TELENCEPHALON DEVELOPMENT,0.10096,0.067265,0.065375,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.70355,0.067151,-0.014778,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.12473,0.067116,0.072375,0,0
2,GO CATECHOLAMINE UPTAKE,0.63354,0.067065,0.040436,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.16828,0.066987,0.051514,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.22905,0.066971,0.098623,0,0
2,GO MITOCHONDRIAL FISSION,0.25363,0.066962,0.052019,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.56666,0.066952,0.030064,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.015574,0.066896,0.0807,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.29184,0.066693,0.13801,0,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.16032,0.066608,0.052802,0,0
2,GO HEXOSE CATABOLIC PROCESS,0.50337,0.066554,0.020451,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.54903,0.066329,0.040659,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.47588,0.06629,0.0063202,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.67137,0.066188,0.031406,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.52025,0.066147,0.011429,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.95466,0.065844,-0.051774,0,0
2,GO CARDIAC CONDUCTION,0.1313,0.065475,0.093044,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.57857,0.065444,0.03223,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.32938,0.065308,0.073977,0,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.30815,0.064722,0.054001,0,0
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.22568,0.064689,0.068893,0,0
2,GO COENZYME A METABOLIC PROCESS,0.55487,0.064626,0.017659,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.12259,0.064443,0.068319,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.35607,0.064419,0.091987,0,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.47049,0.064416,0.064104,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.090515,0.064412,0.063097,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.12049,0.064203,0.080028,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.29586,0.06413,0.06809,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.057089,0.064081,0.065968,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.33812,0.063997,0.052847,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.52025,0.063665,0.03832,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.15517,0.063624,0.10096,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.38408,0.063594,0.022996,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.79636,0.063367,0.0079558,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.32938,0.063282,0.071844,0,0
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.59059,0.063136,0.017971,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.84397,0.063118,0.049202,0,0
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.27611,0.063027,0.088378,0,0
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.95466,0.063018,-0.029422,0,0
2,GO DNA GEOMETRIC CHANGE,0.046579,0.062978,0.061629,0,0
2,GO CHOLESTEROL EFFLUX,0.57857,0.062895,0.0072254,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.89215,0.062822,-0.026983,0,0
2,GO NEURON PROJECTION GUIDANCE,0.21905,0.062799,0.070639,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.61497,0.062764,0.024554,0,0
2,GO MEMORY,0.088862,0.062756,0.087837,0,0
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.20937,0.062723,0.054297,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.63978,0.062687,0.0085889,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.13583,0.062556,0.069922,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.26098,0.062522,0.038157,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.54903,0.062207,0.068049,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.60272,0.0622,0.067214,0,0
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.32938,0.062074,0.031581,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.65234,0.062015,0.0040729,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.18508,0.061668,0.05576,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.98255,0.061656,-0.0036776,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.36526,0.061587,0.068694,0,0
2,GO REGULATION OF AXONOGENESIS,0.20621,0.061521,0.070157,0,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.3746,0.061509,0.038682,0,0
2,GO NAD BIOSYNTHETIC PROCESS,0.91293,0.061303,-0.016784,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.69061,0.061271,0.012707,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.27999,0.061175,0.073177,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.49227,0.061165,0.0077329,0,0
2,GO CYCLOOXYGENASE PATHWAY,0.5726,0.061087,0.039498,0,0
2,GO HYPOTONIC RESPONSE,0.20937,0.060873,0.078223,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.14526,0.060548,0.11017,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.70355,0.060531,-0.069945,0,0
2,GO REGULATION OF GENE SILENCING,0.16828,0.060435,0.047147,0,0
2,GO TUBULIN DEACETYLATION,0.25363,0.060383,0.097862,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.80312,0.060279,-0.051433,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.36991,0.060128,0.027202,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.25001,0.059879,0.054023,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.91293,0.059789,-0.041529,0,0
2,GO PROSTAGLANDIN SECRETION,0.4598,0.059545,0.044781,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.44402,0.05953,0.057459,0,0
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.40843,0.059469,0.038384,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.63354,0.059426,0.0029244,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.60272,0.059211,0.059267,0,0
2,GO PROTEIN HYDROXYLATION,0.65866,0.059074,0.039153,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.34702,0.05882,0.058338,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.26471,0.058732,0.092396,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.11636,0.058595,0.080541,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.11434,0.058519,0.13347,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.30402,0.058508,0.049542,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.2,0.058487,0.053573,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.35607,0.058445,0.028625,0,0
2,GO MATING,0.27999,0.058367,0.049701,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.2,0.058104,0.041441,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.12473,0.058008,0.056918,0,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.38408,0.057919,0.032613,0,0
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.2,0.057859,0.0693,0,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.50896,0.05759,0.017391,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41341,0.057564,0.031179,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.085627,0.05756,0.097878,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.072231,0.057513,0.10861,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.64605,0.057347,-0.024619,0,0
2,GO REGULATION OF HISTONE UBIQUITINATION,0.32077,0.05719,0.038572,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.54903,0.057012,0.041474,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.84397,0.056855,-0.0071487,0,0
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.52594,0.056844,0.018709,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.19695,0.056823,0.066719,0,0
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.76948,0.056775,0.0019162,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.76281,0.056664,0.012984,0,0
2,GO NEURAL CREST CELL MIGRATION,0.35607,0.056286,0.052701,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.58456,0.056176,0.054833,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.27611,0.05609,0.064462,0,0
2,GO CHROMOSOME CONDENSATION,0.12908,0.056019,0.058893,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.31653,0.055942,0.061977,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.36526,0.055756,0.042121,0,0
2,GO NADP METABOLIC PROCESS,0.26847,0.055751,0.029937,0,0
2,GO REGULATION OF CELL SIZE,0.26098,0.055687,0.03429,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.24288,0.055557,0.041003,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.62732,0.055398,0.032633,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.17099,0.055362,0.097151,0,0
2,GO FOREBRAIN REGIONALIZATION,0.43883,0.055347,0.090658,0,0
2,GO PALLIUM DEVELOPMENT,0.32077,0.05503,0.051232,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.80312,0.054812,0.0048177,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.077957,0.054783,0.068158,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.91987,0.054772,-0.020843,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.30402,0.054714,0.05772,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.60272,0.054627,0.00011078,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.097379,0.054263,0.051187,0,0
2,GO VASCULOGENESIS,0.60883,0.054249,0.0046344,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.59059,0.054221,-0.024825,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.7495,0.054206,0.00048659,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.48678,0.054106,0.011747,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.4545,0.053982,0.037377,0,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.39858,0.05394,0.032654,0,0
2,GO PROTEIN STABILIZATION,0.21579,0.053869,0.037921,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.99651,0.053807,-0.039613,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.16294,0.053776,0.046344,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.23589,0.05371,0.079671,0,0
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.56666,0.053703,0.055375,0,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.68418,0.053501,0.013985,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.21579,0.053381,0.070752,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.80312,0.053046,-0.017481,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.12908,0.052929,0.066832,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.39371,0.052867,0.068415,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.22235,0.052634,0.064371,0,0
2,GO RESPONSE TO CALCIUM ION,0.26098,0.052607,0.054234,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.12049,0.052365,0.10055,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.79636,0.05231,-0.027232,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.073629,0.052277,0.11976,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.22568,0.052199,0.10264,0,0
2,GO NUCLEOSOME ORGANIZATION,0.26847,0.052174,0.043323,0,0
2,GO RENAL SODIUM EXCRETION,0.19095,0.052167,0.05913,0,0
2,GO RNA INTERFERENCE,0.20937,0.052037,0.067167,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.8303,0.051913,-0.036679,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.95466,0.051599,-0.04667,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.53167,0.051515,0.13069,0,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.077957,0.051372,0.1305,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.87833,0.051146,-0.01793,0,0
2,GO MYOBLAST FUSION,0.75615,0.05105,-0.035335,0,0
2,GO REGULATION OF HEART RATE,0.31232,0.051025,0.057126,0,0
2,GO GRANULOCYTE DIFFERENTIATION,0.85768,0.050771,-0.041013,0,0
2,GO PROTEIN IMPORT,0.27227,0.050675,0.030545,0,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.54321,0.050528,0.031159,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.25363,0.050524,0.075995,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.51459,0.050237,0.031634,0,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.31653,0.04991,0.01929,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.12908,0.049905,0.058743,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.94073,0.049895,-0.023426,0,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.63978,0.049532,0.007549,0,0
2,GO BEHAVIOR,0.32938,0.049419,0.045134,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.41842,0.049364,0.033079,0,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.54903,0.049327,0.017995,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.17653,0.049301,0.077012,0,0
2,GO ANIMAL ORGAN REGENERATION,0.60883,0.049277,0.0036675,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.22568,0.049242,0.058136,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.40843,0.049215,0.024378,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.93377,0.048968,-0.0028933,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.48678,0.048913,0.052922,0,0
2,GO VESICLE CARGO LOADING,0.59059,0.04887,-0.0095624,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.10654,0.048806,0.13453,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.81668,0.04877,0.016703,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.12689,0.048685,0.076828,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.068167,0.048654,0.10533,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.35153,0.048612,0.043394,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.27999,0.048554,0.062978,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.1313,0.048522,0.06857,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.8303,0.048495,-0.0073822,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.65866,0.04843,0.00022936,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.62732,0.048407,0.030145,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.47049,0.048107,0.049886,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.30815,0.047971,0.033938,0,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.78289,0.047819,-0.092437,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.91293,0.047806,-0.0060566,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.43883,0.047698,0.01365,0,0
2,GO COGNITION,0.11235,0.04755,0.084171,0,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.32077,0.04754,0.040261,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.19095,0.047491,0.046053,0,0
2,GO T CELL HOMEOSTASIS,0.92682,0.047435,-0.0044166,0,0
2,GO SODIUM ION TRANSPORT,0.39371,0.047341,0.027893,0,0
2,GO GROWTH HORMONE SECRETION,0.63978,0.047294,0.039705,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.80989,0.047197,-0.0058946,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.59059,0.046846,0.0083562,0,0
2,GO NEURON DEVELOPMENT,0.36526,0.046792,0.036874,0,0
2,GO RESPONSE TO LEAD ION,0.54321,0.046779,0.030356,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.26471,0.046672,0.030317,0,0
2,GO NEURON PROJECTION ARBORIZATION,1,0.046481,0.017364,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.47588,0.046451,0.041914,0,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.63354,0.046339,0.05532,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.11636,0.046313,0.075296,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.15517,0.046174,0.060387,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.46512,0.046106,0.056425,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.76948,0.046074,0.018414,0,0
2,GO REGULATION OF CELL AGING,0.97557,0.046047,-0.024844,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.20621,0.04602,0.078893,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.4545,0.04595,0.037995,0,0
2,GO MIRNA METABOLIC PROCESS,0.51459,0.045931,0.031144,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.63354,0.04592,0.024683,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.38888,0.045489,0.061204,0,0
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.24643,0.045469,0.041274,0,0
2,GO PROTEIN KINASE A SIGNALING,0.69707,0.045452,0.013731,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.54903,0.045331,0.010674,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.61497,0.045174,0.0020427,0,0
2,GO MUSCLE CELL FATE COMMITMENT,0.43883,0.045156,0.029573,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.43883,0.044986,0.037419,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.40349,0.044919,0.048793,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.87833,0.044749,0.028381,0,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.64605,0.044613,-0.057547,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.17374,0.044505,0.048619,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.64605,0.044431,0.030338,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.65234,0.044184,0.028123,0,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.44402,0.04414,0.029821,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.03245,0.043942,0.07731,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.188,0.043851,0.065318,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.38408,0.043833,0.099113,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.35607,0.043818,0.032959,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.36526,0.043794,0.039256,0,0
2,GO IMMATURE T CELL PROLIFERATION,0.69707,0.04375,-0.016381,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.24643,0.04373,0.057075,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.19095,0.043713,0.040525,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.76281,0.043604,-0.02257,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.75615,0.043547,0.017203,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.23937,0.043486,0.041946,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.11434,0.043476,0.031351,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.56666,0.043451,-0.033323,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.61497,0.043091,0.06159,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.15773,0.043048,0.053935,0,0
2,GO DRUG METABOLIC PROCESS,0.33373,0.042753,0.025015,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.8303,0.042623,-0.018627,0,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.15264,0.042566,0.061547,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.36991,0.042486,0.029874,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.58456,0.042241,0.073235,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.2,0.042199,0.086413,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.092194,0.042024,0.088716,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.99651,0.041962,-0.035782,0,0
2,GO POLYOL METABOLIC PROCESS,0.22235,0.041906,0.036785,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.80312,0.041721,0.018267,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.60883,0.041597,-0.0084243,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.50896,0.041544,0.0055364,0,0
2,GO EPIBOLY,0.80989,0.041503,-0.071522,0,0
2,GO HYPEROSMOTIC RESPONSE,0.72313,0.041338,0.013402,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.36526,0.041311,0.021209,0,0
2,GO DNA CONFORMATION CHANGE,0.11636,0.041122,0.04401,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.95466,0.040761,-0.0090058,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.54903,0.040725,0.028677,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.75615,0.040696,-0.071384,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.44402,0.040674,0.056266,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.25001,0.040627,0.082925,0,0
2,GO BONE DEVELOPMENT,0.65866,0.040599,0.0017683,0,0
2,GO ORGANIC CATION TRANSPORT,0.23589,0.040472,0.061168,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.63354,0.040459,0.015066,0,0
2,GO METAL ION TRANSPORT,0.29992,0.040395,0.030374,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.71006,0.040319,0.017854,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.50337,0.040308,0.03509,0,0
2,GO CAMP BIOSYNTHETIC PROCESS,0.88523,0.040248,-0.024108,0,0
2,GO RECEPTOR INTERNALIZATION,0.30815,0.040068,0.039294,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.24643,0.04004,0.090826,0,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.37932,0.039993,0.092903,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.38408,0.03982,0.058863,0,0
2,GO L PHENYLALANINE METABOLIC PROCESS,0.52594,0.039494,-0.14045,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.91293,0.039332,-0.02527,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.41842,0.039256,0.040367,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.76281,0.039221,0.08787,0,0
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.50896,0.039127,0.017755,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.18219,0.038768,0.036946,0,0
2,GO PHOSPHOLIPID EFFLUX,0.87144,0.038735,0.019209,0,0
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.21579,0.038422,0.070608,0,0
2,GO PENILE ERECTION,0.48131,0.038204,0.036943,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.55487,0.03817,-0.0042794,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.44402,0.038066,0.041048,0,0
2,GO DORSAL AORTA DEVELOPMENT,0.60883,0.037939,0.036337,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.48678,0.037931,0.032615,0,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.65234,0.037892,0.026167,0,0
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.40349,0.037864,0.080963,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.12908,0.03782,0.10965,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.76948,0.037789,0.0080335,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.63978,0.037642,0.00083558,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.42855,0.037477,0.075228,0,0
2,GO ACETYL COA METABOLIC PROCESS,0.60883,0.037359,0.018824,0,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.30402,0.037326,0.047527,0,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.39371,0.037223,0.038079,0,0
2,GO NUCLEAR MIGRATION,0.30815,0.037209,0.061271,0,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.35153,0.036885,0.039156,0,0
2,GO CHROMATIN SILENCING,0.61497,0.036686,0.022562,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.64605,0.036493,0.030414,0,0
2,GO RECEPTOR CLUSTERING,0.60272,0.036482,0.025722,0,0
2,GO RESPONSE TO RETINOIC ACID,0.87833,0.036452,-0.019901,0,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.35153,0.03641,0.025479,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.41842,0.0364,0.018005,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.20621,0.036389,0.06787,0,0
2,GO MISMATCH REPAIR,0.36991,0.036133,0.032975,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.69707,0.035989,-0.032879,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.62732,0.035935,0.016937,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.69707,0.035896,0.011259,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.4545,0.035816,0.036691,0,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.54321,0.035797,0.032538,0,0
2,GO REGULATION OF ION TRANSPORT,0.7495,0.035697,0.013311,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.43883,0.035438,0.030966,0,0
2,GO RRNA CATABOLIC PROCESS,0.67137,0.035427,0.046648,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.76281,0.035425,0.0056431,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.47588,0.03537,0.0041544,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.17934,0.035289,0.068456,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.60272,0.03516,0.01245,0,0
2,GO DNA REPAIR,0.077957,0.035033,0.036105,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,1,0.034937,0.0029449,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.33812,0.03491,0.026854,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.61497,0.034779,-0.010475,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.76281,0.034774,0.050069,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.48131,0.034755,0.029145,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.21905,0.03474,0.044983,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.89215,0.034666,-0.075341,0,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.50896,0.034637,0.015918,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.20621,0.034507,0.031985,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.14285,0.034342,0.051481,0,0
2,GO OXIDATION REDUCTION PROCESS,0.35607,0.034337,0.030534,0,0
2,GO NCRNA CATABOLIC PROCESS,0.36991,0.034235,0.05382,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.79636,0.034189,0.0054242,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.4978,0.034151,0.021057,0,0
2,GO HEART VALVE DEVELOPMENT,0.49227,0.034098,0.048784,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.66501,0.034072,0.022379,0,0
2,GO LIPID PHOSPHORYLATION,0.51459,0.033942,0.0095146,0,0
2,GO REGULATION OF FERTILIZATION,0.48131,0.033886,0.026939,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.32077,0.033839,0.074249,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.54903,0.033812,0.021047,0,0
2,GO MIDDLE EAR MORPHOGENESIS,0.79636,0.03368,-0.0015757,0,0
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.53167,0.03368,0.048965,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.2,0.033679,0.021998,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.21579,0.033596,0.063521,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.20937,0.03341,0.054265,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.36064,0.03335,0.052068,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.69061,0.033241,0.038114,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.26847,0.033143,0.064467,0,0
2,GO HISTONE METHYLATION,0.18219,0.03308,0.040619,0,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.77618,0.03304,-0.0582,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.53167,0.032961,0.074641,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.94769,0.03294,-0.0090511,0,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.59664,0.032793,0.072766,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.087232,0.032489,0.060161,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.76948,0.032437,0.033595,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.32938,0.032403,0.036732,0,0
2,GO CATECHOLAMINE SECRETION,0.62113,0.032322,0.10213,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.42855,0.032237,0.024513,0,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.88523,0.032095,-0.002892,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.79636,0.031964,-0.0064984,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.54903,0.031901,-0.0053086,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.23589,0.03158,0.12895,0,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.29184,0.03155,0.033042,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.27611,0.031474,0.030773,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.52025,0.031384,0.0047172,0,0
2,GO TRANSITION METAL ION HOMEOSTASIS,0.48678,0.031333,0.02587,0,0
2,GO PROTEIN POLYGLUTAMYLATION,0.89215,0.031092,-0.032217,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.91293,0.03087,-0.029863,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.33812,0.030732,0.024437,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.38888,0.030687,0.03172,0,0
2,GO RESPONSE TO IONIZING RADIATION,0.88523,0.030677,-0.026178,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.96163,0.030632,0.0050266,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.30402,0.030525,0.015821,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.61497,0.030457,0.00019562,0,0
2,GO RESPONSE TO X RAY,0.86455,0.03039,-0.045833,0,0
2,GO COPII COATED VESICLE CARGO LOADING,0.88523,0.030032,-0.010829,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.9686,0.030016,-0.015321,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.4978,0.029952,0.039516,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.25729,0.029934,0.098383,0,0
2,GO G0 TO G1 TRANSITION,0.65234,0.029927,-0.020929,0,0
2,GO DNA PACKAGING,0.27999,0.029913,0.030213,0,0
2,GO QUINONE METABOLIC PROCESS,0.53167,0.029856,-0.13316,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.65234,0.029594,0.049879,0,0
2,GO TONGUE MORPHOGENESIS,0.98255,0.029586,0.044781,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.85768,0.029503,0.0085634,0,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.75615,0.029417,-0.033336,0,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.84397,0.029392,-0.03502,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.51459,0.029337,0.0054251,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.78962,0.029258,0.0071593,0,0
2,GO RESPONSE TO GONADOTROPIN,0.84397,0.029167,-0.040883,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.60272,0.029127,0.045646,0,0
2,GO PROTEIN SUMOYLATION,0.48131,0.029106,0.018182,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.73628,0.029071,-0.016728,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.47049,0.029057,0.012538,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.38888,0.028975,0.034065,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.27999,0.028501,0.053776,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.49227,0.028409,0.049331,0,0
2,GO TORC1 SIGNALING,0.12049,0.028336,0.073934,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.80989,0.028077,-0.003331,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.4978,0.027955,0.021365,0,0
2,GO REGULATION OF ACROSOME REACTION,0.54903,0.027939,0.047477,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.063042,0.027868,0.087762,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.46512,0.027821,0.028863,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.36991,0.027717,0.057797,0,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.33812,0.027681,0.036559,0,0
2,GO CELL CYCLE ARREST,0.27227,0.027653,0.034319,0,0
2,GO CELL GROWTH,0.3746,0.027333,0.019636,0,0
2,GO MICROTUBULE POLYMERIZATION,0.40843,0.027317,0.039006,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.69061,0.027175,0.012489,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.28785,0.027142,0.030651,0,0
2,GO ADULT BEHAVIOR,0.85082,0.026971,0.040552,0,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.62113,0.026963,0.031843,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.55487,0.026948,0.024027,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.85768,0.026772,0.0084521,0,0
2,GO MYELIN MAINTENANCE,0.98953,0.026715,-0.0032009,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.92682,0.02668,0.0015846,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.50896,0.026586,0.039486,0,0
2,GO HISTONE EXCHANGE,0.3746,0.026465,0.03506,0,0
2,GO DNA REPLICATION,0.28785,0.026462,0.028983,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.4598,0.026407,0.043065,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.78962,0.026357,-0.022547,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.28785,0.026089,0.062741,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.73628,0.02599,-0.026778,0,0
2,GO RESPONSE TO PH,0.65866,0.025889,0.015487,0,0
2,GO SLEEP,0.67776,0.025875,0.028231,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.88523,0.025837,-0.012495,0,0
2,GO POTASSIUM ION TRANSPORT,0.33812,0.025805,0.062224,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.62732,0.02577,0.067826,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.19695,0.025723,0.03808,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.51459,0.02561,0.025859,0,0
2,GO SEGMENTATION,0.7495,0.025492,0.0025867,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.68418,0.025486,0.019446,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.85082,0.025311,0.0039837,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.98953,0.025299,-0.030076,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.36064,0.025262,0.013214,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.71006,0.0252,0.015693,0,0
2,GO MIDBRAIN DEVELOPMENT,0.48678,0.025187,-0.050898,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.83713,0.025146,-0.014073,0,0
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.50337,0.024687,0.022901,0,0
2,GO HIPPO SIGNALING,0.65234,0.024658,-0.019354,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.51459,0.024557,0.03107,0,0
2,GO DNA RECOMBINATION,0.60883,0.024551,0.010179,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.41341,0.024545,0.029546,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.76948,0.024522,-0.012866,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.93377,0.024522,-0.023996,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.90599,0.024393,-0.021215,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.62113,0.024347,0.016249,0,0
2,GO REGULATION OF DNA BINDING,0.89907,0.024312,0.0054037,0,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.73628,0.024305,0.064593,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.83713,0.02426,-0.023391,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.60272,0.024101,-0.084205,0,0
2,GO CHROMOSOME SEPARATION,0.4598,0.024024,0.021754,0,0
2,GO METHIONINE METABOLIC PROCESS,0.73628,0.023918,-0.010175,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.36991,0.023848,0.072186,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.79636,0.023797,0.00084742,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.62732,0.023789,0.011728,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.72969,0.023757,0.0095575,0,0
2,GO LOCOMOTORY BEHAVIOR,0.57857,0.023743,0.051304,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.94073,0.023665,-0.016625,0,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.29992,0.023635,0.032052,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.98953,0.023618,0.0023302,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.49227,0.023542,0.027873,0,0
2,GO DNA METHYLATION,0.78289,0.023535,0.010426,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.94769,0.023328,0.0078824,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.96163,0.023325,-0.0030844,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.72313,0.02307,0.00068536,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.53167,0.022556,0.088618,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.94073,0.022401,-0.013438,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.71006,0.022338,0.010647,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.52025,0.022317,0.028919,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.89907,0.022217,-0.015316,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.34702,0.022122,0.032997,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.56075,0.022082,0.023841,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.55487,0.02182,0.029509,0,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.91293,0.021783,-0.0106,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.31232,0.021543,0.057307,0,0
2,GO CHROMATIN DISASSEMBLY,0.41842,0.021536,0.092908,0,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.40349,0.021458,0.04039,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.72313,0.02139,-0.033795,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.8303,0.021378,0.011747,0,0
2,GO TRACHEA DEVELOPMENT,0.82348,0.021152,0.020717,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.85768,0.021113,-0.034524,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.97557,0.021103,0.0034875,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.69707,0.021065,0.0086098,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.87833,0.021029,0.0083922,0,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.61497,0.020947,-0.0025913,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.8303,0.020862,0.018202,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.4598,0.020853,0.028536,0,0
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.89215,0.020786,-0.029363,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.60883,0.020747,-0.043255,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.86455,0.02027,0.0016064,0,0
2,GO FOREGUT MORPHOGENESIS,0.98953,0.02027,-0.032546,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.63978,0.020259,-0.03435,0,0
2,GO REGULATION OF RNA SPLICING,0.34702,0.020254,0.022772,0,0
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.5726,0.020182,0.0073005,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.90599,0.020113,-0.027536,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.88523,0.020112,-0.020668,0,0
2,GO CHROMATIN REMODELING,0.21579,0.020082,0.03908,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.26098,0.020003,-0.072128,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.44924,0.019912,0.039754,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.85082,0.019871,0.003969,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.76281,0.019698,-0.024493,0,0
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.48131,0.019683,0.049025,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.87144,0.019617,-0.0014587,0,0
2,GO TRABECULA MORPHOGENESIS,0.80989,0.019545,0.00070848,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.51459,0.01932,-0.087211,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.88523,0.01919,-0.0058154,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.32506,0.01916,0.033914,0,0
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.5726,0.019033,0.0040963,0,0
2,GO DNA MODIFICATION,0.8303,0.018973,-0.019389,0,0
2,GO IRON ION TRANSPORT,0.89215,0.018931,-0.023157,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.53742,0.018856,0.033341,0,0
2,GO DNA METABOLIC PROCESS,0.25363,0.018838,0.022475,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.88523,0.018803,-0.032402,0,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.91293,0.0187,-0.012034,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.96163,0.018663,-0.0087297,0,0
2,GO FEEDING BEHAVIOR,0.63978,0.018591,0.019777,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.44924,0.018591,0.028219,0,0
2,GO NEURON DIFFERENTIATION,0.56666,0.0182,0.024862,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.34256,0.018105,0.054424,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.80312,0.018072,-0.026003,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.72313,0.018001,0.068539,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.69707,0.017959,0.012655,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.25001,0.017792,0.042172,0,0
2,GO CATION TRANSPORT,0.44402,0.017726,0.023126,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.76948,0.017507,-0.033145,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.31232,0.017469,-0.089667,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.43883,0.017288,0.057686,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.56075,0.017216,0.025659,0,0
2,GO HAIR FOLLICLE MATURATION,0.4545,0.017204,-0.070184,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.72313,0.01717,0.010612,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.41341,0.017149,0.077076,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.89907,0.017129,-0.017776,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.89215,0.017069,-0.012464,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.62113,0.016949,0.052903,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.84397,0.016916,-0.011414,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.53742,0.016798,0.018682,0,0
2,GO REGULATION OF OOGENESIS,0.37932,0.01662,-0.065966,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72313,0.016593,0.020667,0,0
2,GO TERPENOID METABOLIC PROCESS,0.52025,0.01656,-0.051562,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.52025,0.016455,-0.068027,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,1,0.016445,-0.016702,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.99651,0.016438,0.015797,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.55487,0.016183,0.021279,0,0
2,GO MITOTIC RECOMBINATION,0.25001,0.016148,0.06036,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.57857,0.016116,0.022603,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.25729,0.015983,0.024026,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.71658,0.0159,0.12477,0,0
2,GO HEART PROCESS,0.40349,0.01581,0.03665,0,0
2,GO GLIAL CELL ACTIVATION,0.85082,0.015692,-0.021073,0,0
2,GO PROTEIN REFOLDING,0.75615,0.015667,-0.0036166,0,0
2,GO NODAL SIGNALING PATHWAY,0.69707,0.015654,-0.044847,0,0
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.54903,0.0155,-0.02951,0,0
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.82348,0.015492,-0.0039779,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.62113,0.015423,0.015762,0,0
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.60883,0.015396,-0.19237,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.46512,0.015387,0.02272,0,0
2,GO MICROTUBULE NUCLEATION,0.79636,0.015373,-0.015139,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.73628,0.015359,0.020463,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.88523,0.015242,-0.021361,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.2839,0.015223,0.029047,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,0.72969,0.015138,-0.06517,0,0
2,GO PROTEIN METHYLATION,0.52594,0.015123,0.022369,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.26098,0.015072,0.066575,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.85768,0.014846,-0.0019504,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.93377,0.014691,-7.3125e-06,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.72969,0.014671,0.011829,0,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.98953,0.014647,-0.016821,0,0
2,GO RESPONSE TO ESTROGEN,0.63978,0.014535,0.0034202,0,0
2,GO NUCLEOSOME ASSEMBLY,0.67137,0.014344,0.017304,0,0
2,GO CELL REDOX HOMEOSTASIS,0.69061,0.014237,0.0067433,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.90599,0.014217,0.00062267,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.8303,0.014016,-0.0059792,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.27999,0.014008,0.032141,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.69707,0.014002,0.024872,0,0
2,GO DOPAMINE TRANSPORT,0.63978,0.013941,0.0081436,0,0
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.96163,0.013916,-0.0027562,0,0
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.50896,0.013743,-0.078707,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.91293,0.013729,0.016368,0,0
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.17374,0.013563,0.10865,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.78962,0.013462,-0.010087,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.78962,0.01329,0.0065545,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.50337,0.013279,0.047375,0,0
2,GO ASYMMETRIC CELL DIVISION,0.89215,0.01313,0.018242,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.85768,0.013113,-0.012716,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.82348,0.01311,-0.0019827,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.4545,0.013091,0.028869,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.54903,0.013075,-0.06024,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.92682,0.013012,-0.0021,0,0
2,GO THALAMUS DEVELOPMENT,0.95466,0.012996,0.018345,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.78962,0.012948,-0.040671,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.78962,0.012924,-0.0094753,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.82348,0.012757,0.010167,0,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.79636,0.012529,-0.014215,0,0
2,GO DEVELOPMENTAL GROWTH,0.65866,0.012239,0.009896,0,0
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.36064,0.01215,0.037324,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.98953,0.012018,0.0028355,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.40349,0.012015,-0.082889,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.78962,0.011997,0.00062865,0,0
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.59059,0.01196,0.030528,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.82348,0.011832,-0.0020648,0,0
2,GO VASODILATION,0.50337,0.011816,0.027227,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.78289,0.011645,0.0093569,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.71006,0.011466,0.010936,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.65234,0.011304,0.016485,0,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.34702,0.011263,-0.059432,0,0
2,GO RESPONSE TO ATP,0.87144,0.011184,-0.0058987,0,0
2,GO ISOPRENOID METABOLIC PROCESS,0.40843,0.010938,-0.05225,0,0
2,GO CHLORIDE TRANSPORT,0.84397,0.010921,0.006621,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.86455,0.010641,0.0031363,0,0
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.55487,0.010495,0.019685,0,0
2,GO AXO DENDRITIC TRANSPORT,0.52594,0.01039,0.039747,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.94073,0.010296,-0.11377,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.79636,0.010126,-0.061248,0,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.88523,0.010095,-0.026856,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.48678,0.01004,-0.021597,0,0
2,GO ION TRANSPORT,0.78962,0.010002,0.006067,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.5726,0.0097964,0.025657,0,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.86455,0.0097503,-0.01235,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.92682,0.0096897,-0.03498,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.62732,0.0096661,0.036619,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.40843,0.0095956,0.016675,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.75615,0.009539,0.023193,0,0
2,GO VAGINA DEVELOPMENT,0.99651,0.0095358,-0.027999,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.94769,0.0094821,-0.0094635,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.72313,0.0094599,-0.059727,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.93377,0.009458,-0.0098098,0,0
2,GO REGULATION OF ORGAN GROWTH,0.42347,0.0094019,0.035632,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.49227,0.0093866,0.083523,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.66501,0.0093786,0.016685,0,0
2,GO NEURON MIGRATION,0.62732,0.0093618,0.041358,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.52025,0.0093476,0.025773,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.67776,0.009331,0.041884,0,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.4978,0.0093146,-0.043656,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.53167,0.0091812,0.011205,0,0
2,GO HISTONE DEACETYLATION,0.71006,0.0091255,-0.014648,0,0
2,GO URETER DEVELOPMENT,0.65234,0.0091179,-0.069572,0,0
2,GO HEAD MORPHOGENESIS,0.56075,0.0090675,-0.067869,0,0
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.85768,0.0090481,0.01119,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.76948,0.0090431,-0.0177,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.63978,0.0089488,0.050667,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.71658,0.0088391,0.00644,0,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.32506,0.0088074,0.027689,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.90599,0.0087486,-0.063608,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.56075,0.0087226,0.034606,0,0
2,GO RESPONSE TO STEROL DEPLETION,0.65866,0.0087161,-0.05881,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.25001,0.0087116,0.044155,0,0
2,GO DE NOVO PROTEIN FOLDING,0.98255,0.0086814,0.0081141,0,0
2,GO SKIN MORPHOGENESIS,0.54321,0.0086685,-0.12337,0,0
2,GO REGULATION OF DNA REPLICATION,1,0.008577,-0.0023858,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.25363,0.0084888,0.13628,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.9686,0.0084362,-0.015116,0,0
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.73628,0.0084304,-0.029921,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.39858,0.0084052,0.040374,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.54321,0.0083696,-0.089803,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.85768,0.0083657,-0.018395,0,0
2,GO CELL CELL SIGNALING,0.94073,0.0083447,-0.0075046,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.52025,0.0081692,0.067313,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.78962,0.0081344,-0.020532,0,0
2,GO FIBROBLAST ACTIVATION,0.92682,0.0081279,-0.033773,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.78962,0.0077524,0.027086,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.77618,0.0075588,0.0023202,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.54903,0.0074425,-0.065798,0,0
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.67137,0.007441,-0.033721,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.71658,0.00741,0.025162,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.89907,0.0073703,-0.0013593,0,0
2,GO MUSCLE SYSTEM PROCESS,0.50337,0.0072565,0.018812,0,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.43367,0.0072445,0.030145,0,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.78289,0.0072213,-0.0060799,0,0
2,GO OVULATION CYCLE PROCESS,0.99651,0.0071886,-0.009714,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.87144,0.0070766,0.016744,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.66501,0.0069479,0.046245,0,0
2,GO NERVOUS SYSTEM PROCESS,0.85082,0.0068036,0.001643,0,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.73628,0.0067746,0.019458,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.68418,0.0067294,0.0016549,0,0
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.52025,0.0064415,-0.032759,0,0
2,GO CELLULAR HOMEOSTASIS,0.60883,0.0064282,0.01402,0,0
2,GO REGULATION OF EXOCYTOSIS,0.87144,0.0064274,-0.0015096,0,0
2,GO MUSCLE ATROPHY,0.84397,0.0063985,-0.067493,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.49227,0.0063876,0.025251,0,0
2,GO MUSCLE CONTRACTION,0.35607,0.0062875,0.030956,0,0
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.34256,0.0061696,0.148,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.96163,0.0061449,0.0034374,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.92682,0.0061248,-0.0005327,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.8303,0.0060765,-0.055849,0,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.80312,0.0060164,-0.025969,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.80989,0.0059511,-0.028688,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.80989,0.0059008,-0.012625,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.67776,0.0058761,0.029919,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.91293,0.0058114,0.0070859,0,0
2,GO NEUROBLAST PROLIFERATION,0.7495,0.0057582,0.02441,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.27227,0.0056825,-0.034736,0,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.65866,0.0056245,0.01767,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.86455,0.0055788,0.0082836,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.42855,0.0055685,-0.066139,0,0
2,GO STEROL TRANSPORT,0.72313,0.0055668,-0.032079,0,0
2,GO GROWTH,0.8303,0.0054979,-0.010889,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.61497,0.0054051,-0.035887,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.89907,0.0053581,-0.0098558,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.8303,0.0053579,-0.017075,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.4545,0.0052244,-0.04705,0,0
2,GO MIDGUT DEVELOPMENT,0.92682,0.0051445,-0.026747,0,0
2,GO CHONDROCYTE PROLIFERATION,0.9686,0.0051153,0.011029,0,0
2,GO CELLULAR RESPONSE TO ATP,0.54321,0.0050817,0.021362,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.24643,0.0050261,0.046692,0,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.94769,0.0049136,-0.034977,0,0
2,GO VITAMIN METABOLIC PROCESS,0.56075,0.0047384,0.023287,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.66501,0.0046862,-0.066217,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.56075,0.0046429,0.08052,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.71658,0.0044672,0.067106,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.65234,0.0043662,-0.010346,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.38408,0.0043337,-0.065101,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.53742,0.0041339,-0.026516,0,0
2,GO INORGANIC ANION TRANSPORT,0.61497,0.00411,0.0087962,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.9686,0.0041064,-0.0077657,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.47588,0.0039977,-0.063468,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.80312,0.0038876,-0.012936,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.53742,0.0038835,0.015973,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.59664,0.0038315,0.028845,0,0
2,GO ACTIN FILAMENT BASED MOVEMENT,0.70355,0.0037939,-0.017072,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.93377,0.003226,-0.0030475,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1,0.0031747,-0.0052759,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.99651,0.003172,-0.0010033,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.88523,0.0030698,-0.010122,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.9686,0.002901,0.0011308,0,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.96163,0.0028891,-0.0065969,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.84397,0.0028497,-0.022511,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.5726,0.0027846,0.0328,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.79636,0.0027822,-0.010546,0,0
2,GO REGULATION OF CELL DEVELOPMENT,0.9686,0.0027228,0.0035403,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.91293,0.0026831,-0.00025874,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.65234,0.0025736,-0.025734,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.8303,0.00256,0.001977,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.95466,0.0025581,-0.014493,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.188,0.0024897,0.090534,0,0
2,GO PROTEIN PALMITOYLATION,0.82348,0.002359,-0.0024836,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.70355,0.0020387,-0.022696,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.82348,0.0019705,0.0040525,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.82348,0.0018575,-0.058235,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.48131,0.0017483,-0.019832,0,0
2,GO NEUROGENESIS,0.81668,0.0015997,0.011781,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.80312,0.0015985,-0.022976,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.98953,0.0015939,-0.014932,0,0
2,GO MITOPHAGY,0.60272,0.0015386,-0.048309,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.19095,0.0014556,0.10511,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.72313,0.0014074,-0.04195,0,0
2,GO CELL CELL SIGNALING BY WNT,0.83713,0.0013252,-0.014714,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.35153,0.0012478,0.059052,0,0
2,GO REGULATION OF DNA REPAIR,0.94073,0.001238,0.00012882,0,0
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.94769,0.0012121,-0.0081496,0,0
2,GO METAL ION HOMEOSTASIS,0.65234,0.0011846,-0.015686,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.81668,0.0010392,-0.014179,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.89907,0.00091341,0.024427,0,0
2,GO ACROSOME REACTION,0.98953,0.00085977,-0.014995,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.40843,0.00084009,0.015677,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.63978,0.00082385,-0.05123,0,0
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.95466,0.0008002,-0.010519,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.4978,0.00070797,-0.075628,0,0
2,GO ENERGY HOMEOSTASIS,0.91987,0.00056725,-0.030165,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.57857,0.00049936,-0.062279,0,0
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.95466,0.00029149,-0.023806,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.95466,0.00018089,-0.035136,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.87144,0.00013264,-0.0077626,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.59664,0.00011039,0.027602,0,0
2,GO INTRACELLULAR TRANSPORT,0.9686,6.1787e-05,-0.00088566,0,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.68418,-4.8057e-05,-0.013414,0,0
2,GO MAINTENANCE OF LOCATION,0.96163,-6.148e-05,-0.0029357,0,0
2,GO REGULATION OF GROWTH,0.54321,-0.00011209,-0.02352,0,0
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.17934,-0.00015641,-0.11614,0,0
2,GO PROTEIN AUTOPROCESSING,0.98255,-0.00016379,-0.026687,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.74288,-0.00024798,-0.12216,0,0
2,GO ORGAN GROWTH,0.84397,-0.00033556,-0.014221,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.72969,-0.00036335,0.009503,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.76948,-0.00041911,-0.044409,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.82348,-0.00042039,-0.027014,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.93377,-0.00048452,-0.00098598,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.90599,-0.00051995,0.0031147,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.52594,-0.00055466,-0.040137,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.99651,-0.00069125,-0.043001,0,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.94073,-0.0007256,0.032787,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.91987,-0.00079317,-0.0043769,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.81668,-0.00086836,0.0056712,0,0
2,GO SELECTIVE AUTOPHAGY,0.8303,-0.0011154,-0.024351,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.58456,-0.0012086,-0.041752,0,0
2,GO MACROMOLECULE DEACYLATION,0.95466,-0.0013367,0.0044703,0,0
2,GO ION HOMEOSTASIS,0.98255,-0.001394,-7.1603e-05,0,0
2,GO BODY FLUID SECRETION,0.73628,-0.0014761,0.006648,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.65866,-0.0016885,0.0085588,0,0
2,GO HINDBRAIN DEVELOPMENT,0.5726,-0.0016954,-0.013696,0,0
2,GO MYELIN ASSEMBLY,0.91987,-0.0017178,-0.018606,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.98255,-0.0017264,-0.016728,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.82348,-0.0019049,-0.031035,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.5726,-0.0019744,-0.052833,0,0
2,GO LYMPH NODE DEVELOPMENT,0.44402,-0.0020119,-0.067006,0,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.70355,-0.0020953,-0.098388,0,0
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.5726,-0.0021447,0.015259,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.67137,-0.0022028,0.029028,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.98953,-0.0023323,-0.010961,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.94769,-0.0023419,-0.0066323,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.69061,-0.0023444,-0.011346,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.89907,-0.0026231,-0.016383,0,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.76281,-0.0026711,-0.039345,0,0
2,GO OTIC VESICLE MORPHOGENESIS,0.91987,-0.0028899,0.056691,0,0
2,GO REGULATION OF LIPASE ACTIVITY,0.96163,-0.0030686,-0.018943,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.7495,-0.0030703,-0.11066,0,0
2,GO CHROMOSOME ORGANIZATION,0.79636,-0.0030851,-0.0016489,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.20937,-0.0031091,-0.16413,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.49227,-0.0032129,-0.034651,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.90599,-0.0032702,0.0019008,0,0
2,GO CHROMATIN ORGANIZATION,0.49227,-0.0033144,-0.013141,0,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.7495,-0.0033782,-0.013571,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.81668,-0.003475,0.027432,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.60272,-0.0035346,-0.013534,0,0
2,GO FOREBRAIN MORPHOGENESIS,0.94073,-0.0035371,0.014534,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.72969,-0.0036787,-0.024135,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.62113,-0.0037699,0.032486,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.86455,-0.0038334,-0.014578,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.9686,-0.0038826,0.0066162,0,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.89215,-0.0039421,-0.0035969,0,0
2,GO CHEMICAL HOMEOSTASIS,0.57857,-0.003967,-0.022768,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.98953,-0.0039912,-0.0040776,0,0
2,GO ORGANIC ACID TRANSPORT,0.68418,-0.0042215,0.011331,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.84397,-0.004325,-0.00026285,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.59664,-0.0043483,0.013767,0,0
2,GO AMELOGENESIS,0.65866,-0.0046126,-0.04294,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.64605,-0.0046491,-0.017626,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.65866,-0.0046824,-0.030989,0,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.98255,-0.0046847,-0.013614,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.44402,-0.0047296,-0.0278,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.41842,-0.0047526,-0.03567,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.72969,-0.0047639,-0.020234,0,0
2,GO RESPONSE TO SALT STRESS,0.53167,-0.004773,-0.0552,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.87833,-0.0048312,0.0029023,0,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.85082,-0.0048833,0.039438,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.98953,-0.0049002,0.001949,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.38888,-0.004938,-0.067462,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.98953,-0.0050262,0.0026497,0,0
2,GO REGULATION OF HEART GROWTH,0.55487,-0.0050349,0.033871,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.50896,-0.0050782,-0.072423,0,0
2,GO GENE SILENCING,0.61497,-0.0053529,-0.01459,0,0
2,GO HEART TRABECULA FORMATION,0.65866,-0.0056493,-0.040569,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.96163,-0.0056677,-0.052002,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.82348,-0.0056781,-0.057876,0,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.98953,-0.0057365,-0.012845,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.12473,-0.0057439,-0.068631,0,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.72313,-0.0057545,0.0069834,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.78962,-0.0057762,-0.02125,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.27999,-0.0058258,-0.072027,0,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.88523,-0.0059802,0.011274,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.44402,-0.0061909,-0.080853,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.58456,-0.0062059,-0.014933,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.48678,-0.006228,-0.037974,0,0
2,GO LIPID CATABOLIC PROCESS,0.51459,-0.0062484,-0.035188,0,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.83713,-0.0062948,-0.014332,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.34702,-0.0063962,-0.048257,0,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.51459,-0.0065651,-0.046456,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.80989,-0.0065955,0.029559,0,0
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.90599,-0.0066102,-0.040392,0,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.95466,-0.0066964,-0.028981,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.60272,-0.0067367,-0.021494,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.97557,-0.0068298,-0.0053473,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.62113,-0.0068908,-0.027022,0,0
2,GO BLASTODERM SEGMENTATION,0.44924,-0.0069007,0.11252,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.91293,-0.0069369,-0.012599,0,0
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.54903,-0.0071089,-0.071704,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.93377,-0.0071364,0.0082632,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.97557,-0.0071651,0.0031054,0,0
2,GO DNA STRAND ELONGATION,0.69061,-0.0072286,0.048575,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.66501,-0.0073873,-0.052326,0,0
2,GO MANNOSYLATION,0.62732,-0.0073983,-0.046152,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.76281,-0.0074564,-0.021703,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.8303,-0.0075437,-0.011513,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.56666,-0.0075787,-0.054973,0,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.47588,-0.0075877,0.035435,0,0
2,GO DEVELOPMENTAL MATURATION,0.80989,-0.0076031,0.00015207,0,0
2,GO CELL JUNCTION ORGANIZATION,0.93377,-0.0077046,-0.0096263,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.62732,-0.00779,-0.056412,0,0
2,GO ANION TRANSPORT,0.80989,-0.0078293,-0.0098897,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.66501,-0.0079039,0.040903,0,0
2,GO CELL CYCLE PROCESS,0.48131,-0.0079646,-0.015976,0,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.78289,-0.008001,-0.02364,0,0
2,GO SERTOLI CELL DEVELOPMENT,0.65866,-0.0080773,-0.037037,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.89907,-0.0081249,-0.016215,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.71006,-0.0081273,-0.022435,0,0
2,GO PROTEIN KINASE C SIGNALING,0.50896,-0.0081374,-0.05345,0,0
2,GO RESPONSE TO FATTY ACID,0.95466,-0.0081579,-0.024235,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.5726,-0.0081736,-0.052361,0,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.97557,-0.0082378,-0.016891,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.9686,-0.008254,-0.0064585,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.98255,-0.0083745,-0.0081423,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.62732,-0.0084986,-0.016232,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.56075,-0.0085146,-0.017871,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.5726,-0.0085272,-0.020547,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.24288,-0.0085516,-0.042615,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.76948,-0.0085715,-0.017124,0,0
2,GO COMPLEMENT ACTIVATION,0.72969,-0.0085819,-0.062362,0,0
2,GO REGULATION OF BINDING,0.32506,-0.0086176,-0.032591,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.26471,-0.0086256,-0.053964,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.39371,-0.0086369,-0.064321,0,0
2,GO GASTRULATION,0.79636,-0.0087489,-0.035426,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.34702,-0.0088168,-0.086386,0,0
2,GO CD40 SIGNALING PATHWAY,0.7495,-0.0088224,-0.037485,0,0
2,GO HISTONE H3 K4 METHYLATION,0.52025,-0.0088323,-0.016933,0,0
2,GO APOPTOTIC CELL CLEARANCE,0.79636,-0.0088617,-0.083523,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.52594,-0.008925,0.026741,0,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.49227,-0.0089429,0.12701,0,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.86455,-0.0090008,0.011689,0,0
2,GO ACTION POTENTIAL,0.92682,-0.0090027,0.0034161,0,0
2,GO DRINKING BEHAVIOR,0.89907,-0.0093318,-0.018493,0,0
2,GO HEART GROWTH,0.9686,-0.0094319,-0.001944,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15517,-0.0095126,-0.16056,0,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.34256,-0.0096237,-0.10403,0,0
2,GO REGULATION OF URINE VOLUME,0.92682,-0.0096354,-0.0060355,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.5726,-0.0097109,-0.032749,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.85768,-0.0097248,-0.044066,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.66501,-0.0098974,-0.048021,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.30402,-0.010054,-0.099511,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.3746,-0.010058,-0.013492,0,0
2,GO FOREBRAIN DEVELOPMENT,0.89907,-0.010115,-0.00046857,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.34256,-0.010146,-0.063363,0,0
2,GO PROSTATE GLAND DEVELOPMENT,0.92682,-0.010221,-0.051639,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.95466,-0.010257,-0.0080077,0,0
2,GO RESPONSE TO DRUG,0.72969,-0.010265,0.014816,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.72313,-0.010278,0.017348,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.88523,-0.010279,-0.0087314,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.54903,-0.010283,-0.079075,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.53167,-0.010351,-0.035353,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.61497,-0.010416,-0.040566,0,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.41341,-0.010519,-0.019388,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.98953,-0.010542,-0.0071721,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.63354,-0.010648,0.044099,0,0
2,GO CARTILAGE DEVELOPMENT,0.85768,-0.010679,-0.025141,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.85768,-0.010684,0.010589,0,0
2,GO ZINC ION TRANSPORT,0.98953,-0.010695,-0.0069211,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.47588,-0.0107,0.048582,0,0
2,GO HINDLIMB MORPHOGENESIS,0.47049,-0.010736,-0.076603,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.38408,-0.010749,-0.07337,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.83713,-0.010795,-0.0099395,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.65234,-0.010848,0.03164,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.3746,-0.010882,-0.040744,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.76948,-0.010928,-0.0019027,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.61497,-0.011032,-0.043179,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.87833,-0.011083,0.0029256,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.62732,-0.011117,-0.012908,0,0
2,GO RESPONSE TO DEXAMETHASONE,0.94073,-0.011136,-0.012647,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.75615,-0.011149,-0.010389,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.66501,-0.011172,-0.020159,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.59059,-0.011192,0.024034,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.57857,-0.011435,-0.017905,0,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.95466,-0.01147,-0.0098085,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.84397,-0.011613,-0.015076,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.53167,-0.011704,-0.023956,0,0
2,GO RESPONSE TO AXON INJURY,0.80989,-0.011778,-0.025051,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.77618,-0.01182,-0.029725,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.48678,-0.012007,-0.025243,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.27227,-0.012087,-0.028963,0,0
2,GO DOSAGE COMPENSATION,0.56075,-0.012247,-0.030506,0,0
2,GO SOMITOGENESIS,0.54321,-0.012258,-0.027113,0,0
2,GO PROTEIN ACYLATION,0.97557,-0.0123,0.0038658,0,0
2,GO HISTONE H2A ACETYLATION,0.4545,-0.012413,-0.03872,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.97557,-0.012423,0.032022,0,0
2,GO MEMBRANE DEPOLARIZATION,0.98255,-0.01243,0.0091559,0,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.16559,-0.012499,-0.053006,0,0
2,GO I KAPPAB PHOSPHORYLATION,0.44924,-0.012837,-0.075719,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.42347,-0.012938,-0.040017,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.5726,-0.013012,-0.059886,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.63978,-0.013174,-0.03689,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.72313,-0.013207,-0.014088,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.43367,-0.013268,-0.064135,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.96163,-0.013277,-0.019998,0,0
2,GO STEM CELL DIFFERENTIATION,0.29992,-0.013323,-0.040141,0,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.53167,-0.013401,-0.046856,0,0
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.50337,-0.013427,-0.069423,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.89907,-0.01344,0.0042484,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.26471,-0.013641,-0.05889,0,0
2,GO PHOTOPERIODISM,0.89215,-0.013648,0.0065279,0,0
2,GO PROTEIN ACETYLATION,0.87144,-0.013668,0.00079514,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.94073,-0.013694,-0.024806,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,1,-0.01374,0.0037877,0,0
2,GO RESPONSE TO CAMP,0.52025,-0.013777,0.023376,0,0
2,GO SERTOLI CELL DIFFERENTIATION,0.79636,-0.013871,-0.029909,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.51459,-0.01388,-0.037434,0,0
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.85082,-0.013899,-0.028294,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.86455,-0.013971,-0.033127,0,0
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.73628,-0.014084,-0.063765,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.76281,-0.014107,-0.04343,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.32938,-0.01413,-0.084645,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.47588,-0.014158,-0.050084,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.72313,-0.014279,-0.023583,0,0
2,GO POSITIVE REGULATION OF BINDING,0.87144,-0.014376,-0.0058185,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.68418,-0.014377,-0.02321,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.84397,-0.014378,0.007651,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.34702,-0.014577,-0.062028,0,0
2,GO VESICLE DOCKING,0.54321,-0.01464,-0.038461,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.79636,-0.014704,0.0075998,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.52594,-0.014717,-0.045035,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.52025,-0.014764,-0.073884,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.63354,-0.014843,0.066964,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.79636,-0.01516,-0.024127,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.35153,-0.015162,-0.05905,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.73628,-0.015176,-0.10097,0,0
2,GO NEURON DEATH,0.24288,-0.015344,-0.043511,0,0
2,GO CARTILAGE MORPHOGENESIS,0.81668,-0.015541,0.039297,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.67137,-0.015547,-0.030673,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.39371,-0.015562,-0.040103,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.33812,-0.01557,-0.044927,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.90599,-0.015593,-0.0098546,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.42855,-0.015836,-0.11232,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.40349,-0.015933,-0.014181,0,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.95466,-0.015957,0.00096462,0,0
2,GO HEART MORPHOGENESIS,0.42855,-0.01599,-0.048024,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.98953,-0.015996,0.0080932,0,0
2,GO CELL CELL RECOGNITION,0.57857,-0.016113,-0.034156,0,0
2,GO SPINDLE ORGANIZATION,0.17934,-0.016137,-0.049248,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.36991,-0.016172,-0.068516,0,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.85768,-0.016205,0.021122,0,0
2,GO AXONAL TRANSPORT,0.71658,-0.0163,0.027905,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.67776,-0.016464,-0.035757,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.94073,-0.016578,0.0071474,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.24288,-0.016644,-0.084611,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.35607,-0.016728,-0.048925,0,0
2,GO ENSHEATHMENT OF NEURONS,0.54903,-0.016785,-0.026586,0,0
2,GO DENDRITE EXTENSION,0.93377,-0.016884,0.036903,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.26098,-0.016887,-0.14225,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.63354,-0.016939,-0.016331,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.21256,-0.016957,-0.052298,0,0
2,GO NEURON MATURATION,0.73628,-0.017017,0.069857,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.70355,-0.017037,0.0077113,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.80989,-0.017164,0.02887,0,0
2,GO RESPONSE TO GLUCAGON,0.92682,-0.017234,-0.015062,0,0
2,GO LOCOMOTOR RHYTHM,0.99651,-0.017274,-0.003731,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.61497,-0.017283,-0.026969,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.44402,-0.017502,-0.031552,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.14526,-0.017578,-0.030918,0,0
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.26471,-0.017581,-0.1367,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.23589,-0.017602,-0.047117,0,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.73628,-0.017635,-0.1012,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.33812,-0.01778,-0.034634,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.97557,-0.017809,0.00084395,0,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.5726,-0.017821,-0.063207,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.36991,-0.017831,-0.076728,0,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.84397,-0.01788,-0.028645,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.33812,-0.017974,-0.064064,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.087232,-0.018008,-0.039079,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.98255,-0.018184,0.0016751,0,0
2,GO CELL MORPHOGENESIS,0.94073,-0.018186,-0.0011297,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.81668,-0.018208,-0.0053286,0,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.3746,-0.01823,-0.096729,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.98953,-0.0183,0.0075626,0,0
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.46512,-0.018404,-0.051377,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.51459,-0.018726,-0.059434,0,0
2,GO FIBROBLAST PROLIFERATION,0.46512,-0.01873,0.046519,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.39858,-0.018763,0.11197,0,0
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.81668,-0.018783,0.0058164,0,0
2,GO EXOCYTIC PROCESS,0.43883,-0.018789,-0.020622,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.16294,-0.018833,-0.032442,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.71006,-0.018987,-0.023838,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.94769,-0.019045,-0.02421,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.78962,-0.019216,-0.051655,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.67776,-0.019219,-0.033512,0,0
2,GO LAMELLIPODIUM ORGANIZATION,0.24643,-0.019267,-0.06403,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.50337,-0.019319,-0.042099,0,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.58456,-0.01951,-0.032156,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.50896,-0.019518,-0.022122,0,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.27227,-0.019559,-0.12909,0,0
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.41842,-0.019603,-0.057795,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.81668,-0.019705,0.11476,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.62113,-0.019797,-0.051516,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.20309,-0.019873,-0.11949,0,0
2,GO FATTY ACID BETA OXIDATION,0.94769,-0.019883,-0.015101,0,0
2,GO OXIDATIVE DEMETHYLATION,0.64605,-0.019906,0.031194,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26471,-0.019909,-0.028882,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.57857,-0.019914,-0.017538,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.72313,-0.01993,-0.066221,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.19695,-0.019984,-0.045597,0,0
2,GO KERATINOCYTE MIGRATION,0.98255,-0.01999,-0.010623,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.38408,-0.020471,-0.030784,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.25001,-0.020514,-0.02032,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.12908,-0.020664,-0.032859,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.67776,-0.020808,0.023687,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.84397,-0.020811,0.052348,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.36526,-0.020931,-0.11115,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.52025,-0.020985,-0.048475,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.84397,-0.021097,-0.0075382,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.59664,-0.021099,-0.035909,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.46512,-0.021117,-0.041799,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.35607,-0.021174,-0.031898,0,0
2,GO SISTER CHROMATID COHESION,0.69061,-0.0212,-0.011708,0,0
2,GO PIRNA METABOLIC PROCESS,0.20621,-0.02128,-0.13897,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.60883,-0.021369,-0.034647,0,0
2,GO ORGANIC ANION TRANSPORT,0.61497,-0.021437,-0.020446,0,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.35607,-0.021448,-0.047657,0,0
2,GO MUSCLE FILAMENT SLIDING,0.86455,-0.021468,0.019914,0,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.41842,-0.021583,-0.022336,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.3746,-0.021645,-0.062482,0,0
2,GO IMPORT INTO NUCLEUS,0.87833,-0.021777,0.0035539,0,0
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.67776,-0.022015,-0.019384,0,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.38888,-0.022046,-0.084483,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.54903,-0.022332,-0.088314,0,0
2,GO RESPONSE TO MUSCLE STRETCH,0.85082,-0.022374,-0.037333,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.23245,-0.022433,-0.053939,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.91293,-0.022502,0.0090184,0,0
2,GO MEMBRANE BIOGENESIS,0.26098,-0.02252,-0.10101,0,0
2,GO BIOMINERALIZATION,0.5726,-0.022669,-0.046066,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.36526,-0.022701,-0.059103,0,0
2,GO OVULATION CYCLE,0.76281,-0.022758,-0.023137,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.69061,-0.022768,0.026451,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.18508,-0.022817,-0.050058,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.55487,-0.022831,0.045491,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.65234,-0.022899,-0.017331,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.39858,-0.022926,-0.059234,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.5726,-0.023078,-0.061545,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.38408,-0.023137,-0.051524,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.7495,-0.023149,0.0067949,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.40843,-0.023164,-0.036065,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.87833,-0.023186,-0.04591,0,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.71006,-0.023226,-0.054929,0,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.72969,-0.02328,-0.11843,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.17374,-0.023425,-0.093614,0,0
2,GO PEROXISOMAL TRANSPORT,0.82348,-0.023545,-0.0098166,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.39371,-0.023612,-0.065497,0,0
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.98255,-0.023621,-0.0051095,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.33373,-0.023813,-0.033691,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15773,-0.024099,-0.049078,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.27611,-0.024186,-0.1074,0,0
2,GO ENDOCYTOSIS,0.82348,-0.02419,-0.013832,0,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.91987,-0.024193,-0.02623,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.40349,-0.024268,-0.036539,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.81668,-0.024286,-0.0075644,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.47588,-0.024303,-0.10116,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.50896,-0.024315,-0.032417,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.36991,-0.024366,-0.094681,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.94073,-0.024372,-0.0035945,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.94769,-0.0244,0.0054902,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.20937,-0.024416,-0.067879,0,0
2,GO WATER TRANSPORT,0.67137,-0.02449,-0.027703,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.33373,-0.024511,-0.048179,0,0
2,GO REGULATION OF MYELINATION,0.79636,-0.024565,0.032511,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.23245,-0.024792,-0.054834,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.49227,-0.024799,-0.030472,0,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.86455,-0.024906,0.004121,0,0
2,GO NIK NF KAPPAB SIGNALING,0.44402,-0.02493,-0.064904,0,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.39371,-0.024937,-0.098317,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.33373,-0.024951,-0.029538,0,0
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.71006,-0.02503,0.028838,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.85768,-0.025123,0.053565,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.44924,-0.025158,-0.056021,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.34256,-0.025198,-0.060049,0,0
2,GO BLEB ASSEMBLY,0.54903,-0.025225,-0.18642,0,0
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.41341,-0.025437,-0.12396,0,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.84397,-0.025496,0.023726,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.86455,-0.025523,-0.008417,0,0
2,GO MEMBRANE INVAGINATION,0.26471,-0.025558,-0.069864,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.188,-0.025559,-0.063846,0,0
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.62732,-0.025639,-0.11756,0,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.44402,-0.02593,-0.055819,0,0
2,GO BLASTOCYST DEVELOPMENT,0.37932,-0.02599,-0.026524,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.34702,-0.02613,-0.093526,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.76281,-0.026156,-0.019476,0,0
2,GO RESPONSE TO RADIATION,0.63978,-0.02629,0.00094669,0,0
2,GO AGING,0.13583,-0.026317,-0.067224,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.14048,-0.026516,-0.068028,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.46512,-0.026536,-0.029421,0,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.30402,-0.026602,-0.12989,0,0
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.57857,-0.026697,-0.093093,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11636,-0.026729,-0.12204,0,0
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.48678,-0.026793,-0.053459,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.41341,-0.026839,-0.043268,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.42855,-0.026861,-0.039921,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.79636,-0.026947,-0.023173,0,0
2,GO T CELL MIGRATION,0.50896,-0.02695,-0.06035,0,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.67137,-0.026957,-0.053332,0,0
2,GO AXIS SPECIFICATION,0.64605,-0.027023,-0.0042137,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.33812,-0.027051,-0.056853,0,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.84397,-0.027106,-0.00607,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.7495,-0.02729,-0.044215,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.98953,-0.02741,0.012985,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.60883,-0.027553,-0.029932,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.24288,-0.027556,-0.02892,0,0
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.4545,-0.027617,-0.072215,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.80989,-0.027686,-0.03712,0,0
2,GO PEROXISOME ORGANIZATION,0.70355,-0.027716,-0.013043,0,0
2,GO PRE MIRNA PROCESSING,0.89907,-0.027795,-0.0026399,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.17934,-0.027852,-0.051713,0,0
2,GO GLIAL CELL PROLIFERATION,0.21256,-0.027852,-0.10434,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.62732,-0.027862,0.083106,0,0
2,GO ORGANELLE FUSION,0.62732,-0.02792,-0.029113,0,0
2,GO MITOTIC CELL CYCLE,0.30815,-0.028051,-0.027433,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.16828,-0.028062,-0.092044,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.21256,-0.028103,-0.11231,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.4978,-0.028413,-0.048367,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1,-0.028467,0.046562,0,0
2,GO CELL PROJECTION ORGANIZATION,0.22568,-0.028482,-0.036686,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.46512,-0.028483,-0.040672,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.78289,-0.028582,0.00054349,0,0
2,GO RHYTHMIC PROCESS,0.36064,-0.028612,-0.024784,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.68418,-0.028654,-0.01835,0,0
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.76948,-0.028764,-0.020582,0,0
2,GO SISTER CHROMATID SEGREGATION,0.39371,-0.02877,-0.029771,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.188,-0.028815,-0.053354,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.94769,-0.028846,-0.014004,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.52594,-0.029016,-0.03682,0,0
2,GO AMINE METABOLIC PROCESS,0.24643,-0.029063,-0.0662,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.47049,-0.029082,-0.074006,0,0
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.11434,-0.029098,-0.071854,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.83713,-0.029106,-0.0071441,0,0
2,GO HOMEOSTATIC PROCESS,0.16032,-0.029135,-0.037144,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.54903,-0.029194,-0.079968,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.070855,-0.029237,-0.047532,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.81668,-0.02927,-0.054692,0,0
2,GO RESPONSE TO CHEMOKINE,0.71006,-0.029408,-0.036359,0,0
2,GO ALCOHOL CATABOLIC PROCESS,0.47588,-0.029463,-0.067054,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.27999,-0.029479,-0.035877,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.19393,-0.029527,-0.029762,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.91987,-0.030004,0.01188,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.75615,-0.030062,0.022301,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.46512,-0.030152,-0.066167,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.38888,-0.030155,-0.039205,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.86455,-0.030173,0.010198,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.31653,-0.03025,-0.077487,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.2,-0.03029,-0.067251,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.11039,-0.03056,-0.096492,0,0
2,GO GMP METABOLIC PROCESS,0.95466,-0.030648,0.014685,0,0
2,GO GLUTATHIONE METABOLIC PROCESS,0.9686,-0.030648,-0.0092514,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.47588,-0.030721,-0.10073,0,0
2,GO STEM CELL DIVISION,0.92682,-0.030731,0.0046617,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.47588,-0.030807,-0.057795,0,0
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.19095,-0.030931,-0.20232,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.65866,-0.030998,-0.047412,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.92682,-0.031042,0.0082032,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.60883,-0.031173,-0.04011,0,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.4598,-0.031382,-0.050868,0,0
2,GO NEPHRON TUBULE FORMATION,0.42855,-0.031387,-0.08693,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.44402,-0.031437,-0.030609,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.9686,-0.031444,0.00096786,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.53742,-0.031522,-0.049367,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.32506,-0.031553,-0.061697,0,0
2,GO LIPID MODIFICATION,0.093897,-0.031555,-0.070816,0,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.26847,-0.031622,-0.12248,0,0
2,GO MITOTIC DNA REPLICATION,0.65234,-0.031672,-0.03032,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.89215,-0.031684,-0.017589,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.54321,-0.031764,-0.054718,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.57857,-0.031849,-0.026391,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.30402,-0.031898,-0.057754,0,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.22905,-0.031966,-0.064716,0,0
2,GO SOMITE DEVELOPMENT,0.84397,-0.031997,-0.012614,0,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.87833,-0.032022,0.017418,0,0
2,GO RESPONSE TO GAMMA RADIATION,0.32506,-0.032333,-0.049645,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.26847,-0.032341,-0.068536,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.26471,-0.03243,-0.03882,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.27999,-0.032529,-0.067154,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.56075,-0.032553,-0.046736,0,0
2,GO FEVER GENERATION,0.91987,-0.032576,-0.0069729,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.4978,-0.032754,-0.025883,0,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.35153,-0.032951,-0.034018,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.20621,-0.032959,-0.065869,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.36991,-0.032966,-0.046627,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.52594,-0.032969,-0.047886,0,0
2,GO FERTILIZATION,0.15015,-0.033035,-0.037722,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.04854,-0.033048,-0.053847,0,0
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.61497,-0.033101,-0.037486,0,0
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.41842,-0.033134,-0.037008,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.89215,-0.033535,-0.006314,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.78962,-0.03357,-0.018766,0,0
2,GO DNA LIGATION,0.48678,-0.03366,-0.046821,0,0
2,GO REGULATION OF AUTOPHAGY,0.36991,-0.0337,-0.034544,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.59664,-0.033767,-0.035888,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.85768,-0.033809,-0.0021785,0,0
2,GO LIPID HOMEOSTASIS,0.30815,-0.033866,-0.060614,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.67137,-0.033926,-0.026821,0,0
2,GO ALCOHOL METABOLIC PROCESS,0.52594,-0.033941,-0.03645,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.24643,-0.033994,-0.07,0,0
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.093897,-0.034014,-0.077295,0,0
2,GO FATTY ACID CATABOLIC PROCESS,0.31653,-0.034062,-0.063187,0,0
2,GO PROTEIN CATABOLIC PROCESS,0.11235,-0.034215,-0.050256,0,0
2,GO REGULATION OF GLIOGENESIS,0.40349,-0.034228,-0.046305,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.48131,-0.034258,-0.056484,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.3746,-0.034357,-0.062707,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.63354,-0.034394,-0.075102,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.63354,-0.034462,0.024197,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.60272,-0.034574,-0.13755,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.24643,-0.034579,-0.042669,0,0
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.58456,-0.034617,-0.090478,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.48678,-0.034645,-0.030691,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.43883,-0.034665,-0.068664,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.36526,-0.034719,-0.0534,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.56666,-0.034743,-0.045952,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.3746,-0.034804,-0.027706,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.22905,-0.034986,-0.035883,0,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.5726,-0.034993,-0.037353,0,0
2,GO FATTY ACID TRANSPORT,0.48678,-0.035113,-0.040554,0,0
2,GO NON RECOMBINATIONAL REPAIR,0.22905,-0.035115,-0.04093,0,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.58456,-0.035182,-0.068592,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.40349,-0.035215,-0.049638,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.54903,-0.035303,-0.043711,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.43883,-0.035455,-0.068054,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.78289,-0.035532,0.0025769,0,0
2,GO TOR SIGNALING,0.27227,-0.035613,-0.02999,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.22568,-0.035614,-0.037523,0,0
2,GO SYMBIOTIC PROCESS,0.40349,-0.035697,-0.042426,0,0
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.4978,-0.035733,-0.056237,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.188,-0.035782,-0.060344,0,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.59664,-0.035852,-0.11574,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.057089,-0.035916,-0.038824,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.30402,-0.036011,-0.059999,0,0
2,GO CELL DIVISION,0.15517,-0.036138,-0.040357,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.78289,-0.036344,0.034919,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.29992,-0.036366,-0.078546,0,0
2,GO RESPONSE TO HYDROPEROXIDE,0.94073,-0.03645,0.0035729,0,0
2,GO RESPONSE TO THYROID HORMONE,0.7495,-0.036511,-0.042405,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.072231,-0.036519,-0.042633,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.75615,-0.03652,0.02848,0,0
2,GO REGULATION OF CELL CYCLE,0.084046,-0.036546,-0.031547,0,0
2,GO AMINE CATABOLIC PROCESS,0.44402,-0.036591,-0.091412,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.10845,-0.036648,-0.039142,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.83713,-0.036686,0.016813,0,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.29992,-0.036878,-0.13291,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.11636,-0.036968,-0.052007,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.74288,-0.036999,0.062547,0,0
2,GO LEUKOCYTE HOMEOSTASIS,0.15015,-0.037089,-0.088229,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.60883,-0.03717,-0.022477,0,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.54321,-0.037178,-0.032426,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.73628,-0.037201,0.040864,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.40349,-0.037225,-0.079752,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.76281,-0.037328,0.011244,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.27611,-0.037404,-0.02464,0,0
2,GO CELL AGING,0.43367,-0.037486,-0.040076,0,0
2,GO GLAND MORPHOGENESIS,0.17934,-0.037501,-0.13739,0,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.49227,-0.037615,-0.052011,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.02843,-0.03767,-0.065732,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.36064,-0.037676,-0.089183,0,0
2,GO HEAD DEVELOPMENT,0.47049,-0.037735,-0.020868,0,0
2,GO REGULATION OF T CELL MIGRATION,0.26471,-0.037818,-0.06513,0,0
2,GO RESPONSE TO ETHANOL,0.34256,-0.037836,-0.038939,0,0
2,GO RESPONSE TO CATECHOLAMINE,0.51459,-0.038011,-0.028639,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.34702,-0.038061,-0.071979,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.65234,-0.038201,-0.041235,0,0
2,GO OSSIFICATION,0.23589,-0.038407,-0.065649,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.17653,-0.038424,-0.052394,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.35153,-0.038467,-0.11874,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.088862,-0.038479,-0.063256,0,0
2,GO MESENCHYME DEVELOPMENT,0.39858,-0.038687,-0.050435,0,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.16294,-0.038831,-0.035058,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.3746,-0.038884,-0.073504,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.63978,-0.038893,-0.072679,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.33812,-0.038902,-0.081704,0,0
2,GO DIET INDUCED THERMOGENESIS,0.89907,-0.038937,-0.001434,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.25363,-0.038955,-0.059144,0,0
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.32938,-0.038962,-0.063027,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.090515,-0.039026,-0.086355,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.36526,-0.039076,-0.077276,0,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.85768,-0.039266,-0.015094,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.15264,-0.039321,-0.075653,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.30815,-0.039355,-0.044383,0,0
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.2839,-0.039374,-0.063616,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.76281,-0.039465,-0.037122,0,0
2,GO CALCIUM ION IMPORT,0.72969,-0.039576,-0.01284,0,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.98953,-0.039674,-0.0079965,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.31653,-0.039724,-0.093865,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.53167,-0.039815,-0.08422,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.095625,-0.039912,-0.066992,0,0
2,GO FLUID TRANSPORT,0.19393,-0.039947,-0.079175,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.88523,-0.039995,0.03141,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.5726,-0.040085,-0.059015,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.49227,-0.040147,-0.023876,0,0
2,GO LIPID OXIDATION,0.55487,-0.040258,-0.039677,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.39858,-0.040292,-0.03813,0,0
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.68418,-0.04031,-0.023482,0,0
2,GO LYSINE METABOLIC PROCESS,0.35153,-0.040549,-0.11279,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.87144,-0.040713,0.011125,0,0
2,GO REGULATION OF ODONTOGENESIS,0.67137,-0.040784,-0.057664,0,0
2,GO MOLTING CYCLE,0.29992,-0.040822,-0.077114,0,0
2,GO CHROMOSOME SEGREGATION,0.24643,-0.040884,-0.040777,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.80989,-0.040917,-0.0086481,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.67776,-0.040924,-0.013887,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.35153,-0.040975,-0.04702,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.26847,-0.040978,-0.067581,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.02268,-0.040981,-0.045749,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.76948,-0.04118,-0.022886,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.69061,-0.041295,-0.023351,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.34702,-0.041323,-0.045009,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.12689,-0.041396,-0.080716,0,0
2,GO MESODERM DEVELOPMENT,0.21905,-0.041464,-0.065698,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.62113,-0.041506,-0.07144,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.63978,-0.04151,-0.012513,0,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.49227,-0.041511,-0.05678,0,0
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.070855,-0.041536,-0.12112,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.69707,-0.041616,0.0042145,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.21256,-0.041616,-0.052012,0,0
2,GO CHOLESTEROL STORAGE,0.60883,-0.041642,-0.033408,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.22905,-0.041729,-0.05148,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.26847,-0.041744,-0.044162,0,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.080955,-0.041775,-0.092175,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.56666,-0.041792,-0.029111,0,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.39371,-0.041792,-0.049755,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11434,-0.041855,-0.045323,0,0
2,GO HEART DEVELOPMENT,0.15264,-0.041944,-0.06181,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.31232,-0.04199,-0.059456,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.60883,-0.04201,-0.052154,0,0
2,GO SPINDLE ASSEMBLY,0.076492,-0.042033,-0.060418,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.29184,-0.042078,-0.060694,0,0
2,GO AXIS ELONGATION,0.36064,-0.042082,-0.10353,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.11235,-0.042238,-0.091562,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.48131,-0.042368,-0.03911,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.48678,-0.042438,0.088799,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.15517,-0.04248,-0.044718,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.097379,-0.04255,-0.058675,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14526,-0.042576,-0.07894,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.98255,-0.042617,-0.0062961,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.40349,-0.042641,-0.026417,0,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.98255,-0.042662,-0.0058146,0,0
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.17374,-0.042679,-0.081484,0,0
2,GO STEROID ESTERIFICATION,0.63354,-0.042738,-0.083026,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.13583,-0.042748,-0.053686,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.23589,-0.042886,-0.10911,0,0
2,GO REGULATION OF BONE DEVELOPMENT,0.43883,-0.042906,-0.054382,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.17099,-0.042932,-0.076899,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.3746,-0.04295,-0.028209,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.084046,-0.042964,-0.073557,0,0
2,GO INTERLEUKIN 2 PRODUCTION,0.62732,-0.043012,-0.054977,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.033894,-0.043272,-0.056447,0,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.11636,-0.043505,-0.039491,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.67776,-0.043584,-0.013278,0,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.62113,-0.043596,-0.027811,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.093897,-0.043651,-0.085467,0,0
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.2839,-0.043805,-0.072877,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.32077,-0.04386,-0.034043,0,0
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.11235,-0.043934,-0.074635,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.41842,-0.043953,-0.06231,0,0
2,GO REGULATION OF MITOPHAGY,0.31653,-0.044058,-0.064312,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.25729,-0.044097,-0.086956,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.17653,-0.044108,-0.065873,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.17653,-0.044179,-0.094791,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.43883,-0.044233,-0.059793,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.16032,-0.044272,-0.040215,0,0
2,GO MACROPHAGE ACTIVATION,0.53742,-0.044395,-0.040427,0,0
2,GO PROTEIN AUTOPHOSPHORYLATION,0.16032,-0.044427,-0.050621,0,0
2,GO MAINTENANCE OF CELL NUMBER,0.076492,-0.044606,-0.078417,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.24643,-0.044662,-0.070866,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.44402,-0.044806,-0.064898,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.23245,-0.044884,-0.072974,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.32938,-0.044959,-0.065413,0,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.3746,-0.04497,-0.078786,0,0
2,GO CELL SUBSTRATE ADHESION,0.23245,-0.045022,-0.082612,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.32506,-0.045041,-0.037712,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.89215,-0.045191,-0.036489,0,0
2,GO FILOPODIUM ASSEMBLY,0.65866,-0.045235,-0.030373,0,0
2,GO PINOCYTOSIS,0.20937,-0.045298,-0.11567,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.073629,-0.045378,-0.079582,0,0
2,GO GLIOGENESIS,0.20309,-0.045407,-0.060505,0,0
2,GO ORGANELLE INHERITANCE,0.075049,-0.04542,-0.081011,0,0
2,GO VISUAL BEHAVIOR,0.63978,-0.045429,-0.025973,0,0
2,GO RECEPTOR CATABOLIC PROCESS,0.3746,-0.045482,-0.061906,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.67776,-0.045571,0.04929,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.29992,-0.045597,-0.035524,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.04854,-0.045668,-0.052658,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.070855,-0.045685,-0.063654,0,0
2,GO RECEPTOR RECYCLING,0.18508,-0.045795,-0.061201,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.15517,-0.045849,-0.072928,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.27611,-0.045903,-0.048596,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.11235,-0.045953,-0.07412,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.080955,-0.045975,-0.06306,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.96163,-0.045991,0.0057428,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.41842,-0.046056,-0.075258,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.088862,-0.046065,-0.078566,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.38408,-0.046175,-0.10924,0,0
2,GO REGULATION OF GASTRIC ACID SECRETION,0.27611,-0.04623,-0.11301,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.71006,-0.046243,-0.011201,0,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.066855,-0.046246,-0.051243,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.99651,-0.046382,0.01931,0,0
2,GO MUSCLE CELL PROLIFERATION,0.47049,-0.046403,-0.051427,0,0
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.44924,-0.046495,-0.027635,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.068167,-0.046565,-0.13006,0,0
2,GO DETOXIFICATION,0.60883,-0.046569,-0.033772,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.2,-0.046716,-0.13511,0,0
2,GO RESPONSE TO NUTRIENT,0.22568,-0.046753,-0.072972,0,0
2,GO ACTIVATION OF JNKK ACTIVITY,0.4545,-0.046845,-0.08167,0,0
2,GO MONOAMINE TRANSPORT,0.44402,-0.047135,0.0008588,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.81668,-0.047142,-0.0068613,0,0
2,GO RESPONSE TO FUNGUS,0.34702,-0.047162,-0.041554,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.060602,-0.047176,-0.05597,0,0
2,GO NOTOCHORD DEVELOPMENT,0.91293,-0.047265,-0.056994,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.42855,-0.0473,-0.11566,0,0
2,GO CELLULAR SENESCENCE,0.19393,-0.04733,-0.064177,0,0
2,GO ASTROCYTE DEVELOPMENT,0.21905,-0.047371,-0.10643,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.34702,-0.047449,-0.063988,0,0
2,GO RESPONSE TO PEPTIDE,0.085627,-0.047494,-0.052594,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.36991,-0.04752,-0.054313,0,0
2,GO MICROTUBULE BASED PROCESS,0.015953,-0.047563,-0.061614,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.22568,-0.047567,-0.071692,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.96163,-0.047713,-0.0023948,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.74288,-0.047945,0.074614,0,0
2,GO RESPONSE TO INSULIN,0.10654,-0.0481,-0.051335,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.20937,-0.048159,-0.063045,0,0
2,GO REGULATION OF PROTEIN BINDING,0.16828,-0.048185,-0.054485,0,0
2,GO CIRCADIAN RHYTHM,0.031059,-0.048237,-0.054546,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.53167,-0.048239,-0.027764,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.046579,-0.048313,-0.063978,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.55487,-0.048619,-0.025415,0,0
2,GO VACUOLAR ACIDIFICATION,0.42855,-0.048637,-0.070704,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.52594,-0.048742,-0.035142,0,0
2,GO POLYOL CATABOLIC PROCESS,0.16559,-0.048766,-0.085078,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.73628,-0.048799,-0.036857,0,0
2,GO MANGANESE ION TRANSPORT,0.7495,-0.048862,-0.016189,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.71658,-0.048873,-0.040804,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.036164,-0.048977,-0.044093,0,0
2,GO RESPONSE TO TUMOR CELL,0.57857,-0.049036,-0.03105,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.55487,-0.049193,-0.073074,0,0
2,GO REGULATION OF BEHAVIOR,0.76948,-0.049283,-0.017503,0,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.47049,-0.049297,-0.053482,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.24643,-0.049386,-0.062292,0,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.2,-0.049522,-0.058376,0,0
2,GO MUSCLE HYPERTROPHY,0.30815,-0.049561,-0.060898,0,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.12049,-0.049577,-0.14349,0,0
2,GO INTEGRIN ACTIVATION,0.23589,-0.049632,-0.09538,0,0
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.35607,-0.049646,-0.099283,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.71658,-0.049736,-0.027795,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.15264,-0.049837,-0.056709,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.097379,-0.049882,-0.067081,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.045624,-0.04992,-0.086551,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.64605,-0.049935,0.069685,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.41842,-0.049986,-0.058208,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.63978,-0.050077,-0.060554,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.27999,-0.050234,-0.047955,0,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.052669,-0.05025,-0.071365,0,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.097379,-0.050313,-0.067736,0,0
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.097379,-0.050324,-0.090782,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.095625,-0.050338,-0.058063,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.014841,-0.050429,-0.075563,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.21256,-0.050456,-0.11768,0,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.22235,-0.050572,-0.10084,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.17653,-0.050598,-0.089757,0,0
2,GO KINETOCHORE ORGANIZATION,0.23937,-0.050601,-0.094197,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.24643,-0.050639,-0.042706,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.79636,-0.050754,-0.013704,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.93377,-0.050779,0.00073953,0,0
2,GO REGULATION OF PHAGOCYTOSIS,0.11841,-0.050804,-0.10677,0,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.34702,-0.050847,-0.050739,0,0
2,GO SODIUM ION HOMEOSTASIS,0.16294,-0.050849,-0.057355,0,0
2,GO HISTONE PHOSPHORYLATION,0.32938,-0.050957,-0.052821,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.80989,-0.051057,0.081868,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.26847,-0.051105,-0.061433,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.15517,-0.051137,-0.068786,0,0
2,GO REGULATION OF TOR SIGNALING,0.32938,-0.0512,-0.039213,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.19695,-0.051313,-0.10876,0,0
2,GO HISTONE H3 K27 METHYLATION,0.89907,-0.051385,4.8425e-05,0,0
2,GO RESPONSE TO HORMONE,0.15517,-0.051493,-0.050102,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.10654,-0.05156,-0.052926,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.037747,-0.051605,-0.060858,0,0
2,GO ATP TRANSPORT,0.7495,-0.051613,0.032104,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.21256,-0.051719,-0.065019,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.084046,-0.05181,-0.09201,0,0
2,GO ERK1 AND ERK2 CASCADE,0.25363,-0.051832,-0.069428,0,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.18219,-0.052106,-0.04448,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.12689,-0.052275,-0.095738,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.22905,-0.052287,-0.15009,0,0
2,GO MEMBRANE ORGANIZATION,0.11235,-0.052761,-0.048579,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.42347,-0.052912,-0.057517,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.1028,-0.052972,-0.055722,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.41341,-0.052989,-0.07429,0,0
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.44402,-0.053085,-0.066708,0,0
2,GO REGULATION OF TRANSPORT,0.061812,-0.053259,-0.05031,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.066855,-0.053438,-0.054731,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.39371,-0.053468,-0.054175,0,0
2,GO PHAGOCYTOSIS,0.21905,-0.053521,-0.074103,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.20937,-0.053522,-0.037842,0,0
2,GO PROTEIN POLYMERIZATION,0.059411,-0.053603,-0.061225,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.17099,-0.053653,-0.060509,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.62113,-0.05369,-0.060718,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.26471,-0.053698,-0.10607,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.029068,-0.0537,-0.11358,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.015574,-0.053701,-0.066891,0,0
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.67776,-0.053944,-0.048307,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.02843,-0.053954,-0.074541,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.17934,-0.05401,-0.076676,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.15264,-0.054016,-0.099988,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0031536,-0.054019,-0.070285,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.24643,-0.054029,-0.076098,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.188,-0.054061,-0.17142,0,0
2,GO CYTOSOLIC TRANSPORT,0.054842,-0.054282,-0.05966,0,0
2,GO SULFATE TRANSPORT,0.04854,-0.054302,-0.070459,0,0
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.24288,-0.054326,-0.080185,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.093897,-0.054337,-0.070632,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.71658,-0.054364,-0.016571,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.41842,-0.054375,-0.03948,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.78289,-0.05447,0.042681,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.26471,-0.054584,-0.045012,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.55487,-0.054649,-0.030764,0,0
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.25729,-0.054699,-0.077667,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.041967,-0.054746,-0.052603,0,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.39858,-0.054815,-0.059298,0,0
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.27611,-0.05483,-0.090246,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.084046,-0.054868,-0.14983,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.29586,-0.054875,-0.061539,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.068167,-0.054914,-0.074397,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.56075,-0.054954,-0.031768,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.064293,-0.055053,-0.072127,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.053746,-0.055058,-0.10323,0,0
2,GO RESPONSE TO DOPAMINE,0.41341,-0.055282,-0.033488,0,0
2,GO CYTOKINESIS,0.010245,-0.055317,-0.095031,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.090515,-0.055447,-0.077601,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.87144,-0.055476,-0.030581,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.76948,-0.055477,-0.030709,0,0
2,GO REGULATION OF CYTOKINESIS,0.063042,-0.055525,-0.069542,0,0
2,GO FACE DEVELOPMENT,0.095625,-0.055662,-0.11633,0,0
2,GO JNK CASCADE,0.070855,-0.055697,-0.060503,0,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.18508,-0.055725,-0.0553,0,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.097379,-0.055854,-0.07248,0,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.26098,-0.055975,-0.10712,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.50896,-0.056018,-0.048874,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.35153,-0.056021,-0.056578,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.17374,-0.05608,-0.068911,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.23245,-0.05609,-0.03737,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.17934,-0.056268,-0.1333,0,0
2,GO NUCLEUS ORGANIZATION,0.045624,-0.056319,-0.053083,0,0
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.4598,-0.056348,-0.068815,0,0
2,GO BODY MORPHOGENESIS,0.19095,-0.056392,-0.096971,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0041716,-0.056423,-0.1041,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.15517,-0.056516,-0.089149,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.024288,-0.056616,-0.10256,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.15773,-0.056629,-0.11057,0,0
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.10654,-0.056685,-0.12085,0,0
2,GO INTERFERON GAMMA PRODUCTION,0.14526,-0.056857,-0.074325,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.073629,-0.056904,-0.098516,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.25729,-0.057168,-0.052367,0,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.0090226,-0.057277,-0.054285,0,0
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.19695,-0.057368,-0.096823,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.040234,-0.057426,-0.056369,0,0
2,GO HISTONE H3 K9 METHYLATION,0.21579,-0.05747,-0.049916,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.56666,-0.05749,-0.026942,0,0
2,GO PROTEIN MANNOSYLATION,0.3746,-0.057564,-0.049612,0,0
2,GO NEURON APOPTOTIC PROCESS,0.10845,-0.057601,-0.051861,0,0
2,GO T CELL CHEMOTAXIS,0.25001,-0.057641,-0.059279,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.023205,-0.057713,-0.10289,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0041716,-0.057719,-0.075917,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.12259,-0.057725,-0.055904,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.44402,-0.057819,-0.08193,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.059411,-0.05796,-0.088711,0,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.082489,-0.058127,-0.08307,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.17653,-0.05821,-0.077314,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.044685,-0.058247,-0.11395,0,0
2,GO TISSUE MORPHOGENESIS,0.0090226,-0.058374,-0.10346,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.061812,-0.058387,-0.054513,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.082489,-0.058403,-0.048418,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.86455,-0.058464,0.011388,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00353,-0.058474,-0.059746,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.32077,-0.058537,-0.071256,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.15517,-0.058829,-0.10346,0,0
2,GO RNA DESTABILIZATION,0.21256,-0.058831,-0.062354,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.35607,-0.058863,-0.07544,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.72313,-0.058891,-0.024969,0,0
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.077957,-0.058894,-0.090988,0,0
2,GO FATTY ACID METABOLIC PROCESS,0.050569,-0.05901,-0.09476,0,0
2,GO AMYLOID BETA FORMATION,0.66501,-0.059059,-0.029476,0,0
2,GO REGULATION OF DENDRITE EXTENSION,0.63354,-0.059078,-0.0006393,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.24643,-0.059096,-0.066814,0,0
2,GO REGENERATION,0.25001,-0.059097,-0.064219,0,0
2,GO INSEMINATION,0.53167,-0.059099,-0.071229,0,0
2,GO MYOTUBE DIFFERENTIATION,0.1028,-0.059202,-0.096107,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.52594,-0.059205,-0.044627,0,0
2,GO TONGUE DEVELOPMENT,0.15015,-0.059263,-0.16964,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.22235,-0.05931,-0.048459,0,0
2,GO RESPONSE TO INTERLEUKIN 1,0.097379,-0.059349,-0.094111,0,0
2,GO PIGMENTATION,0.076492,-0.059355,-0.076815,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.15264,-0.059504,-0.10324,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.090515,-0.059505,-0.066178,0,0
2,GO DNA CATABOLIC PROCESS,0.082489,-0.059539,-0.075325,0,0
2,GO PROTEIN DEGLYCOSYLATION,0.36526,-0.059617,-0.097804,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.17374,-0.059704,-0.10968,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.25363,-0.059774,-0.055793,0,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.4978,-0.059801,-0.092366,0,0
2,GO METANEPHROS DEVELOPMENT,0.097379,-0.059819,-0.10709,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.082489,-0.059831,-0.064951,0,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.31232,-0.059832,-0.1451,0,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.060602,-0.059905,-0.071601,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.093897,-0.059945,-0.096261,0,0
2,GO RESPONSE TO STARVATION,0.36526,-0.05998,-0.044047,0,0
2,GO STRESS FIBER ASSEMBLY,0.28785,-0.06015,-0.060972,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.045624,-0.060418,-0.066516,0,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.19095,-0.060454,-0.052906,0,0
2,GO VASCULATURE DEVELOPMENT,0.10654,-0.060488,-0.084804,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.12049,-0.060573,-0.12257,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.064293,-0.060598,-0.11053,0,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.2839,-0.060603,-0.074002,0,0
2,GO ORGANELLE LOCALIZATION,0.0013457,-0.060632,-0.078652,0,0
2,GO T CELL APOPTOTIC PROCESS,0.22235,-0.061098,-0.090661,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.14048,-0.061125,-0.05906,0,0
2,GO HEAT GENERATION,0.33812,-0.061151,-0.092862,0,0
2,GO OXALATE TRANSPORT,0.34702,-0.0613,-0.054455,0,0
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.22235,-0.061396,-0.062503,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.068167,-0.061518,-0.078479,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.51459,-0.061542,-0.077373,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.54903,-0.061588,-0.036208,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.065563,-0.061611,-0.052762,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.27611,-0.061612,-0.13214,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.3746,-0.061676,-0.042545,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.26098,-0.061759,-0.098831,0,0
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.090515,-0.062,-0.084036,0,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.52594,-0.062005,-0.032321,0,0
2,GO LYSOSOME LOCALIZATION,0.082489,-0.062045,-0.09981,0,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.25729,-0.062086,-0.11208,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.77618,-0.062102,-0.0026104,0,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.040234,-0.0624,-0.14155,0,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.055956,-0.062711,-0.11316,0,0
2,GO NEURAL TUBE PATTERNING,0.34702,-0.06273,-0.061416,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.15773,-0.062742,-0.082798,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.088862,-0.062807,-0.065386,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.19695,-0.062871,-0.041944,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.36064,-0.063109,-0.079876,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.027803,-0.063161,-0.10052,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.25001,-0.063233,-0.064027,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.16294,-0.063235,-0.079423,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.073629,-0.063268,-0.055925,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.12049,-0.06328,-0.072397,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.076492,-0.063371,-0.057849,0,0
2,GO P BODY ASSEMBLY,0.05161,-0.063545,-0.06778,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.17653,-0.063803,-0.1079,0,0
2,GO ORGANELLE FISSION,0.001872,-0.063817,-0.078898,0,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.20309,-0.063832,-0.10996,0,0
2,GO HISTONE H4 ACETYLATION,0.066855,-0.063837,-0.051884,0,0
2,GO RESPONSE TO COCAINE,0.63354,-0.063852,-0.013833,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.065563,-0.063977,-0.17111,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.49227,-0.06399,-0.067242,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.073629,-0.06414,-0.056858,0,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.21579,-0.064153,-0.075007,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.62113,-0.064202,-0.017238,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.11039,-0.06423,-0.072372,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.36526,-0.064486,-0.046196,0,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.32077,-0.064496,-0.091825,0,0
2,GO CELL FATE COMMITMENT,0.082489,-0.064547,-0.083285,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.2,-0.064578,-0.042436,0,0
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.20937,-0.064636,-0.076969,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.061812,-0.064737,-0.0654,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.077957,-0.064843,-0.080415,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.10465,-0.064846,-0.053925,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.71006,-0.064849,-0.034616,0,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.087232,-0.064912,-0.092745,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.27227,-0.065027,-0.08055,0,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.39371,-0.065128,-0.036197,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.034637,-0.065186,-0.10153,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.38888,-0.065203,-0.078894,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.15517,-0.065207,-0.10701,0,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.059411,-0.065349,-0.1085,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.42855,-0.065459,-0.032397,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.087232,-0.065473,-0.070882,0,0
2,GO PRIMARY MIRNA PROCESSING,0.66501,-0.065474,-0.027828,0,0
2,GO RESPONSE TO ACTIVITY,0.12473,-0.065507,-0.084063,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.099158,-0.06561,-0.16705,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.65234,-0.065615,-0.039421,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.85082,-0.065715,0.018127,0,0
2,GO GLIAL CELL DEVELOPMENT,0.095625,-0.065787,-0.089819,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.4978,-0.066048,-0.10505,0,0
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.77618,-0.066107,-0.0046425,0,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.088862,-0.066134,-0.31085,0,0
2,GO RESPONSE TO OXIDATIVE STRESS,0.11039,-0.066179,-0.06782,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.02843,-0.066524,-0.072165,0,0
2,GO REGULATION OF ANION TRANSPORT,0.05161,-0.066647,-0.094323,0,0
2,GO TAXIS,0.082489,-0.066771,-0.067506,0,0
2,GO ACROSOME ASSEMBLY,0.95466,-0.066773,0.042083,0,0
2,GO AUTOPHAGIC CELL DEATH,0.23937,-0.066855,-0.093267,0,0
2,GO REGULATION OF GTP BINDING,0.60272,-0.06694,-0.046248,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.43367,-0.066944,-0.081758,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.39858,-0.066951,-0.081626,0,0
2,GO RESPONSE TO LEUCINE,0.82348,-0.066961,0.039203,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.26471,-0.066961,-0.10851,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.053746,-0.067023,-0.087946,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.97557,-0.067074,0.0041699,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72969,-0.067076,-0.041855,0,0
2,GO PERICARDIUM DEVELOPMENT,0.21256,-0.067084,-0.10089,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.82348,-0.067147,0.039352,0,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.78289,-0.067173,-0.02288,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.11235,-0.067227,-0.080312,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.99651,-0.067271,-0.016423,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.25729,-0.067337,-0.056865,0,0
2,GO RESPONSE TO KETONE,0.087232,-0.067422,-0.084469,0,0
2,GO RESPONSE TO VITAMIN,0.20937,-0.06754,-0.090526,0,0
2,GO SPINAL CORD DEVELOPMENT,0.3746,-0.067596,-0.041247,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.072231,-0.067711,-0.050793,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.13583,-0.067847,-0.08824,0,0
2,GO MICROTUBULE ANCHORING,0.10096,-0.067977,-0.089345,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.15264,-0.068033,-0.1369,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.0081404,-0.068283,-0.082948,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.012203,-0.068322,-0.086597,0,0
2,GO REGULATION OF PROTEIN IMPORT,0.19393,-0.068329,-0.097615,0,0
2,GO OOCYTE MATURATION,0.23245,-0.068437,-0.060261,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.13355,-0.068515,-0.069911,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.25001,-0.068617,-0.059653,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.41341,-0.068763,-0.12973,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.13355,-0.068766,-0.12527,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.12473,-0.06906,-0.075196,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.51459,-0.069196,-0.077608,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.49227,-0.069307,-0.047559,0,0
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.10096,-0.069397,-0.08354,0,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0695,-0.069583,-0.083452,0,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.087232,-0.069586,-0.10243,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.61497,-0.069665,-0.033965,0,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.15773,-0.069718,-0.054633,0,0
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.17374,-0.069859,-0.065786,0,0
2,GO OOGENESIS,0.029068,-0.069865,-0.10662,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.12259,-0.07001,-0.058333,0,0
2,GO SIGNAL RELEASE,0.049546,-0.070023,-0.061967,0,0
2,GO RESPONSE TO EPINEPHRINE,0.61497,-0.070059,-0.058421,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.15015,-0.070077,-0.073359,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.05824,-0.07011,-0.11331,0,0
2,GO LYSOSOMAL TRANSPORT,0.066855,-0.07017,-0.084047,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.20621,-0.070281,-0.088629,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.40349,-0.070396,-0.10426,0,0
2,GO RESPONSE TO PAIN,0.23589,-0.070426,-0.12425,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.12049,-0.070492,-0.086208,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.084046,-0.070659,-0.088597,0,0
2,GO EMBRYO DEVELOPMENT,0.0049174,-0.070686,-0.084697,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.014841,-0.070785,-0.0927,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0046564,-0.070796,-0.077851,0,0
2,GO SPERM EGG RECOGNITION,0.4598,-0.070868,-0.024968,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.1313,-0.070931,-0.07796,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.068167,-0.071106,-0.070659,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.02268,-0.071201,-0.089913,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.51459,-0.071361,-0.031288,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.23245,-0.07139,-0.073338,0,0
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.14769,-0.071459,-0.07648,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.27999,-0.07151,-0.073135,0,0
2,GO REGULATION OF RESPONSE TO FOOD,0.16294,-0.071569,-0.096806,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.14048,-0.071608,-0.071661,0,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.097379,-0.071726,-0.24597,0,0
2,GO REGULATION OF APPETITE,0.057089,-0.071764,-0.10312,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.91987,-0.071896,-5.4763e-05,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.37932,-0.071948,-0.056765,0,0
2,GO BONE MINERALIZATION,0.39371,-0.072045,-0.046616,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.91987,-0.072046,0.037037,0,0
2,GO MESENCHYME MORPHOGENESIS,0.16828,-0.072191,-0.10966,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.093897,-0.072246,-0.13602,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.32938,-0.072254,-0.083643,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.018398,-0.072362,-0.063139,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.049546,-0.072652,-0.11029,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.30815,-0.072675,-0.080519,0,0
2,GO THYMIC T CELL SELECTION,0.079444,-0.072736,-0.082315,0,0
2,GO AORTA MORPHOGENESIS,0.21256,-0.072779,-0.10783,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.0695,-0.072838,-0.107,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.13583,-0.072968,-0.046813,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.15517,-0.072973,-0.11039,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.1028,-0.073032,-0.10003,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.023205,-0.07325,-0.12538,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.16828,-0.073457,-0.085625,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.26098,-0.073574,-0.12451,0,0
2,GO LYMPHOCYTE MIGRATION,0.16032,-0.073594,-0.088625,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.001986,-0.073643,-0.096646,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.58456,-0.073657,-0.010461,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.060602,-0.073672,-0.076111,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.30402,-0.073724,-0.10915,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.98953,-0.073843,0.047009,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.22235,-0.074115,-0.092782,0,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.20309,-0.074133,-0.052459,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.064293,-0.074143,-0.06674,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.11039,-0.074236,-0.09204,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.14048,-0.074241,-0.094763,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.47588,-0.074303,-0.054088,0,0
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.30815,-0.074412,-0.14554,0,0
2,GO BRAIN MORPHOGENESIS,0.85768,-0.074434,0.01554,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.21579,-0.07468,-0.038843,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.33373,-0.074747,-0.089291,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.62113,-0.074804,-0.0055691,0,0
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.087232,-0.074807,-0.11852,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.13583,-0.074819,-0.10049,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.25363,-0.074983,-0.14828,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.26847,-0.075231,-0.124,0,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.088862,-0.075306,-0.13213,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.014486,-0.075331,-0.079797,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.11434,-0.075348,-0.097783,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.019739,-0.075627,-0.10064,0,0
2,GO GLUCOSE METABOLIC PROCESS,0.05824,-0.075647,-0.065325,0,0
2,GO CYTOSKELETON ORGANIZATION,0.0010206,-0.075676,-0.094463,0,0
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.29586,-0.075736,-0.13918,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.035393,-0.075951,-0.065167,0,0
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.34702,-0.076096,-0.053005,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.0695,-0.076169,-0.098888,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.05161,-0.076253,-0.076124,0,0
2,GO RNA DECAPPING,0.23245,-0.076507,-0.059446,0,0
2,GO STEROL METABOLIC PROCESS,0.30402,-0.076559,-0.059001,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.59664,-0.07666,-0.031419,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.054842,-0.07668,-0.058898,0,0
2,GO DENDRITIC CELL CHEMOTAXIS,0.10654,-0.076713,-0.13363,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.024846,-0.076728,-0.11089,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.30815,-0.076791,-0.051452,0,0
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.19695,-0.076902,-0.080214,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.17099,-0.077036,-0.055192,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.02166,-0.077095,-0.07873,0,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.13355,-0.077327,-0.043003,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.034637,-0.077357,-0.086557,0,0
2,GO ACID SECRETION,0.11636,-0.077407,-0.075516,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.061812,-0.077452,-0.082246,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.05161,-0.077503,-0.071756,0,0
2,GO STEROL HOMEOSTASIS,0.34702,-0.077527,-0.077842,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.050569,-0.077556,-0.12926,0,0
2,GO REGULATION OF TUBE SIZE,0.068167,-0.077634,-0.093076,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.50337,-0.077704,0.0039192,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.62732,-0.077814,-0.076809,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.16294,-0.078241,-0.096357,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.029719,-0.078264,-0.089062,0,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.060602,-0.078309,-0.10508,0,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.087232,-0.07853,-0.11667,0,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.15015,-0.078621,-0.062698,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.64605,-0.078727,-0.069228,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.037747,-0.078749,-0.082999,0,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.19393,-0.078803,-0.075781,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.030383,-0.078836,-0.12384,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.41842,-0.07887,-0.039316,0,0
2,GO NEPHRON MORPHOGENESIS,0.025414,-0.078905,-0.13492,0,0
2,GO SEX DIFFERENTIATION,0.011047,-0.079119,-0.080037,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.49227,-0.079125,-0.11642,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.068167,-0.079335,-0.15847,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.085627,-0.07943,-0.098366,0,0
2,GO HISTONE H2B UBIQUITINATION,0.080955,-0.079461,-0.091907,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.11841,-0.079549,-0.083392,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.33812,-0.079661,-0.068327,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.011904,-0.079693,-0.08748,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.009256,-0.079736,-0.12037,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.53742,-0.079801,-0.052546,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.188,-0.079906,-0.079522,0,0
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.11841,-0.079932,-0.13652,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.95466,-0.080056,-0.011602,0,0
2,GO REGULATION OF ERAD PATHWAY,0.063042,-0.080101,-0.062021,0,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.53167,-0.080185,-0.039844,0,0
2,GO GOLGI RIBBON FORMATION,0.080955,-0.080192,-0.13419,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.16559,-0.080256,-0.10911,0,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.015203,-0.080377,-0.071168,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.053746,-0.080427,-0.067508,0,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.70355,-0.080457,-0.050176,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.17374,-0.080484,-0.087852,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0028141,-0.080671,-0.1002,0,0
2,GO RESPONSE TO NICOTINE,0.18508,-0.080679,-0.10242,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.021165,-0.080948,-0.075353,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.070855,-0.08095,-0.10771,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.4978,-0.080976,-0.068134,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.0021062,-0.081003,-0.12564,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.15264,-0.081055,-0.10756,0,0
2,GO DEMETHYLATION,0.037747,-0.081129,-0.064341,0,0
2,GO LIPID METABOLIC PROCESS,0.05824,-0.081135,-0.067387,0,0
2,GO RESPONSE TO STEROID HORMONE,0.075049,-0.081174,-0.087825,0,0
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.22905,-0.081216,-0.069857,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.03245,-0.081424,-0.11095,0,0
2,GO B CELL HOMEOSTASIS,0.24643,-0.081433,-0.081096,0,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.10096,-0.081472,-0.1229,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.27611,-0.081499,-0.10315,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.15517,-0.08151,-0.095332,0,0
2,GO PODOSOME ASSEMBLY,0.26098,-0.081526,-0.1146,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.030383,-0.081575,-0.078199,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.099158,-0.081665,-0.1036,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.44924,-0.081752,-0.024951,0,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0083534,-0.081892,-0.12579,0,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.98953,-0.08209,-0.072906,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.188,-0.082365,-0.099116,0,0
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.13814,-0.082412,-0.12028,0,0
2,GO GERMINAL CENTER FORMATION,0.11039,-0.082418,-0.21271,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.44924,-0.082527,-0.042343,0,0
2,GO VESICLE ORGANIZATION,0.0071468,-0.0827,-0.095652,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.027188,-0.082792,-0.085107,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.29992,-0.082916,-0.076586,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.16294,-0.082949,-0.065038,0,0
2,GO ANIMAL ORGAN FORMATION,0.061812,-0.08319,-0.12136,0,0
2,GO RESPONSE TO POTASSIUM ION,0.48131,-0.083199,-0.059134,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.20309,-0.083661,-0.050408,0,0
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.11039,-0.083758,-0.076323,0,0
2,GO CARNITINE SHUTTLE,0.98953,-0.084,0.031336,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.23937,-0.084056,-0.10497,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.25001,-0.084056,-0.081484,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.77618,-0.084097,-0.0043927,0,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.65234,-0.084164,-0.02348,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.036948,-0.084176,-0.061185,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.027803,-0.084293,-0.09182,0,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.85768,-0.084431,-0.024869,0,0
2,GO RESPONSE TO ALKALOID,0.063042,-0.084735,-0.083524,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.26471,-0.084735,-0.069893,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.32506,-0.084743,-0.078062,0,0
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.045624,-0.084971,-0.15573,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.18219,-0.085001,-0.11008,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.063042,-0.085074,-0.11086,0,0
2,GO NEURON PROJECTION REGENERATION,0.23937,-0.085397,-0.06964,0,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.17653,-0.085406,-0.096762,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.090515,-0.08545,-0.08693,0,0
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.18508,-0.085496,-0.070095,0,0
2,GO RESPONSE TO ANTIBIOTIC,0.070855,-0.085625,-0.095728,0,0
2,GO RESPONSE TO METAL ION,0.05161,-0.08582,-0.078152,0,0
2,GO THYMUS DEVELOPMENT,0.21579,-0.085855,-0.065936,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.093897,-0.085944,-0.079866,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.0060989,-0.086007,-0.1077,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.11039,-0.086164,-0.069397,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.11039,-0.086166,-0.13256,0,0
2,GO INTERLEUKIN 17 PRODUCTION,0.26471,-0.086188,-0.086141,0,0
2,GO TUBE DEVELOPMENT,0.0059384,-0.086193,-0.11859,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.15773,-0.086341,-0.094935,0,0
2,GO REGULATION OF CELL DIVISION,0.021165,-0.086384,-0.071939,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.017969,-0.086416,-0.098262,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.30815,-0.086562,-0.080141,0,0
2,GO TISSUE REGENERATION,0.12049,-0.08681,-0.10762,0,0
2,GO INOSITOL METABOLIC PROCESS,0.068167,-0.086994,-0.1042,0,0
2,GO RESPONSE TO LIPID,0.068167,-0.087034,-0.076981,0,0
2,GO MEMBRANE DOCKING,0.0073363,-0.087122,-0.087706,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.11235,-0.087247,-0.083196,0,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.04854,-0.087316,-0.090433,0,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.064293,-0.087477,-0.15411,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.10465,-0.087507,-0.14978,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.70355,-0.087581,-0.01482,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.21256,-0.08764,-0.097039,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.32938,-0.087814,-0.13053,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.2,-0.087926,-0.059513,0,0
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010773,-0.087982,-0.13079,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.19695,-0.088184,-0.05926,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.034637,-0.088237,-0.15137,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.14285,-0.088246,-0.1753,0,0
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.21905,-0.088588,-0.086455,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.16294,-0.088655,-0.096837,0,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.30402,-0.088678,-0.056621,0,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.043763,-0.088875,-0.10538,0,0
2,GO TRANSFERRIN TRANSPORT,0.064293,-0.088908,-0.1027,0,0
2,GO ORGANELLE ASSEMBLY,0.00081984,-0.088985,-0.072738,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.066855,-0.089014,-0.10395,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.097379,-0.089107,-0.18054,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.014138,-0.089169,-0.083915,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.13355,-0.089212,-0.069993,0,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.81668,-0.08953,-0.020955,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.055956,-0.089568,-0.14038,0,0
2,GO CELL JUNCTION ASSEMBLY,0.033894,-0.089719,-0.10079,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.22905,-0.089725,-0.076947,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.007729,-0.090052,-0.10345,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.44924,-0.090061,-0.049554,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.46512,-0.090256,-0.088024,0,0
2,GO ASTROCYTE ACTIVATION,0.059411,-0.090505,-0.15987,0,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.22235,-0.09056,-0.09773,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0094949,-0.090688,-0.12733,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.0062634,-0.090699,-0.084632,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.2,-0.090781,-0.069704,0,0
2,GO GOLGI LOCALIZATION,0.29184,-0.091096,-0.056653,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.38408,-0.091182,-0.11137,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.072231,-0.091195,-0.11632,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.090515,-0.091218,-0.12321,0,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0695,-0.091296,-0.11363,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.007729,-0.091433,-0.088435,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.00054072,-0.091464,-0.10275,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.025414,-0.091499,-0.080451,0,0
2,GO CELLULAR RESPONSE TO LIPID,0.099158,-0.091532,-0.077984,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.016734,-0.091532,-0.11105,0,0
2,GO REGULATION OF MAPK CASCADE,0.05161,-0.091538,-0.08029,0,0
2,GO GLUCOSE IMPORT,0.090515,-0.091548,-0.066186,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.28785,-0.0916,-0.087379,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.27999,-0.091885,-0.084062,0,0
2,GO MACROPHAGE PROLIFERATION,0.33812,-0.091977,-0.13397,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0011199,-0.092034,-0.12303,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.29586,-0.092187,-0.14926,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.13814,-0.092249,-0.13968,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.47049,-0.092274,-0.050985,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.073629,-0.092371,-0.067996,0,0
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.066855,-0.092557,-0.18622,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.44402,-0.092615,-0.048731,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.12689,-0.092627,-0.12035,0,0
2,GO ORGAN INDUCTION,0.090515,-0.092809,-0.1289,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.010773,-0.092821,-0.089748,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.035393,-0.092847,-0.075345,0,0
2,GO MITOCHONDRIAL FUSION,0.24288,-0.093065,-0.053896,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.25729,-0.093303,-0.062569,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.057089,-0.093336,-0.083795,0,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.12473,-0.093605,-0.085646,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.25001,-0.09375,-0.070137,0,0
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.4598,-0.093886,-0.072624,0,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.054842,-0.093985,-0.12474,0,0
2,GO TRACHEA MORPHOGENESIS,0.31653,-0.094076,-0.092515,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.040234,-0.094137,-0.07028,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0031536,-0.094306,-0.11137,0,0
2,GO CEREBELLAR CORTEX FORMATION,0.39858,-0.094338,-0.065511,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.4598,-0.094421,-0.034925,0,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.16294,-0.094489,-0.17814,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.22235,-0.094497,-0.065125,0,0
2,GO RESPONSE TO INACTIVITY,0.057089,-0.094531,-0.13226,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.10654,-0.094556,-0.061817,0,0
2,GO T CELL EXTRAVASATION,0.16032,-0.094581,-0.23119,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.25729,-0.094584,-0.062044,0,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.44924,-0.09462,-0.077814,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.29586,-0.094676,-0.07968,0,0
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.066855,-0.094678,-0.11499,0,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.20937,-0.094736,-0.14855,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.20309,-0.095,-0.14973,0,0
2,GO DEPHOSPHORYLATION,0.00037661,-0.095031,-0.093313,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.54903,-0.095058,-0.079478,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.38408,-0.095141,-0.095504,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.16032,-0.095184,-0.10131,0,0
2,GO STEROID METABOLIC PROCESS,0.049546,-0.095191,-0.09795,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.065563,-0.095266,-0.15783,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.030383,-0.095316,-0.081791,0,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.17099,-0.095526,-0.079421,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.017549,-0.095573,-0.10912,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0056288,-0.095618,-0.10223,0,0
2,GO HISTONE H4 DEACETYLATION,0.12259,-0.095672,-0.11659,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.12473,-0.095869,-0.098665,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.049546,-0.095925,-0.1924,0,0
2,GO AMINE TRANSPORT,0.23245,-0.096044,-0.034777,0,0
2,GO GENITALIA DEVELOPMENT,0.057089,-0.096223,-0.11216,0,0
2,GO CELLULAR EXTRAVASATION,0.10096,-0.09631,-0.079556,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.1313,-0.096392,-0.080015,0,0
2,GO PHAGOSOME MATURATION,0.068167,-0.096487,-0.10316,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.1028,-0.096559,-0.11828,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.099158,-0.096666,-0.16105,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.092194,-0.096694,-0.13743,0,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.50337,-0.09674,-0.087203,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.34702,-0.096773,-0.077536,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00016023,-0.096773,-0.10163,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.084046,-0.096798,-0.10293,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0037331,-0.096875,-0.088977,0,0
2,GO MEMBRANE FUSION,0.059411,-0.096959,-0.080456,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.080955,-0.097,-0.10486,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0039469,-0.097004,-0.10676,0,0
2,GO FAT CELL DIFFERENTIATION,0.00081984,-0.09705,-0.15547,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.016734,-0.097052,-0.14361,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.52594,-0.097561,-0.048056,0,0
2,GO RENAL WATER HOMEOSTASIS,0.088862,-0.097948,-0.099947,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.30815,-0.097988,-0.055967,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.16294,-0.09801,-0.10505,0,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.16294,-0.09806,-0.074078,0,0
2,GO HISTONE H3 DEACETYLATION,0.18219,-0.098169,-0.059008,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.061812,-0.098186,-0.10697,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.061812,-0.098392,-0.14317,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.1028,-0.09864,-0.12055,0,0
2,GO MESODERM MORPHOGENESIS,0.1028,-0.098651,-0.11189,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.24288,-0.098717,-0.13181,0,0
2,GO NEUTROPHIL HOMEOSTASIS,0.32077,-0.098881,-0.16471,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.10096,-0.099038,-0.10868,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.11841,-0.099492,-0.092838,0,0
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.031059,-0.09984,-0.10317,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.0054795,-0.099861,-0.09765,0,0
2,GO RESPONSE TO TESTOSTERONE,0.3746,-0.099893,-0.063626,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.033166,-0.099999,-0.11013,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.46512,-0.10023,-0.061229,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.060602,-0.10041,-0.11929,0,0
2,GO ACTIN FILAMENT ORGANIZATION,0.00090094,-0.10047,-0.1292,0,0
2,GO ARTERY MORPHOGENESIS,0.011904,-0.10049,-0.14214,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.070855,-0.10051,-0.091751,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.29184,-0.10053,-0.038156,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.30815,-0.10054,-0.038067,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.099158,-0.10065,-0.092796,0,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0017123,-0.10067,-0.13917,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.0021062,-0.10083,-0.14676,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.17374,-0.10086,-0.13222,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.060602,-0.10097,-0.10408,0,0
2,GO LEUKOTRIENE METABOLIC PROCESS,0.14285,-0.10128,-0.10904,0,0
2,GO LUNG MORPHOGENESIS,0.025994,-0.10152,-0.17475,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.16828,-0.10155,0.024053,0,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0071468,-0.1016,-0.1294,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.014138,-0.10173,-0.1058,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.017969,-0.10175,-0.099588,0,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.05824,-0.10237,-0.1338,0,0
2,GO MRNA TRANSCRIPTION,0.2,-0.10239,-0.082827,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.077957,-0.1024,-0.16175,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.17653,-0.1026,-0.087116,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.079444,-0.10272,-0.13581,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.12689,-0.10282,-0.13848,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.11039,-0.10298,-0.11997,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.54321,-0.10302,-0.050802,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.12259,-0.10315,-0.071554,0,0
2,GO RESPONSE TO STEROL,0.25001,-0.10319,-0.06284,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,3.3132e-05,-0.10334,-0.13251,0,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.12908,-0.10337,-0.096618,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.036948,-0.10338,-0.12137,0,0
2,GO ANDROGEN METABOLIC PROCESS,0.22235,-0.10338,-0.083534,0,0
2,GO APPENDAGE DEVELOPMENT,0.029068,-0.10352,-0.12221,0,0
2,GO REGULATION OF INSULIN SECRETION,0.11434,-0.10358,-0.064219,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.16032,-0.1037,-0.070162,0,0
2,GO MAST CELL MIGRATION,0.11841,-0.1038,-0.22667,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.001872,-0.10382,-0.13853,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.075049,-0.10387,-0.12986,0,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.43367,-0.10394,-0.089635,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.13355,-0.10399,-0.11072,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.03939,-0.10422,-0.16834,0,0
2,GO MALE SEX DIFFERENTIATION,0.0013872,-0.10436,-0.13802,0,0
2,GO COPULATION,0.099158,-0.10451,-0.10592,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.053746,-0.10453,-0.097235,0,0
2,GO VACUOLAR TRANSPORT,0.00065623,-0.10465,-0.12832,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.27999,-0.10469,-0.11171,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.10096,-0.10473,-0.21687,0,0
2,GO OVULATION,0.072231,-0.10476,-0.14744,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.21905,-0.105,-0.08679,0,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0695,-0.10502,-0.087609,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0011199,-0.10502,-0.1169,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.087232,-0.10505,-0.14323,0,0
2,GO KINETOCHORE ASSEMBLY,0.32506,-0.10537,-0.08621,0,0
2,GO B CELL PROLIFERATION,0.025414,-0.10547,-0.11874,0,0
2,GO P38MAPK CASCADE,0.095625,-0.10568,-0.11032,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.12259,-0.10591,-0.13173,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.14769,-0.10605,-0.11177,0,0
2,GO GLAND DEVELOPMENT,0.0025083,-0.10616,-0.12945,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.11841,-0.1063,-0.10681,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.027188,-0.10634,-0.096793,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.26098,-0.10637,-0.068419,0,0
2,GO SPROUTING ANGIOGENESIS,0.04854,-0.10648,-0.11492,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.42347,-0.10672,-0.062838,0,0
2,GO REGIONALIZATION,0.033894,-0.10673,-0.085016,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.69061,-0.10673,-0.032999,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.20309,-0.10711,-0.19065,0,0
2,GO INCLUSION BODY ASSEMBLY,0.49227,-0.10722,-0.036569,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.31232,-0.10758,-0.10708,0,0
2,GO EAR DEVELOPMENT,0.0031536,-0.1077,-0.13942,0,0
2,GO ACTIN FILAMENT BASED PROCESS,0.0020453,-0.1077,-0.10611,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.059411,-0.10782,-0.12112,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.022165,-0.10799,-0.17006,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.30815,-0.10817,-0.15756,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.076492,-0.10817,-0.073999,0,0
2,GO NEGATIVE REGULATION OF CELL SIZE,0.26847,-0.10821,-0.056631,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.0047853,-0.10839,-0.13442,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.092194,-0.10846,-0.10012,0,0
2,GO NEGATIVE T CELL SELECTION,0.00054072,-0.10853,-0.17331,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.05161,-0.10857,-0.10003,0,0
2,GO SPERM MOTILITY,0.0010859,-0.10861,-0.1242,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.038561,-0.10863,-0.10341,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.022165,-0.10865,-0.16812,0,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0030654,-0.10871,-0.17731,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.065563,-0.10876,-0.15407,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.19095,-0.10892,-0.098432,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.188,-0.10894,-0.089171,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.00044439,-0.10896,-0.13812,0,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.049546,-0.10898,-0.15995,0,0
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.076492,-0.10915,-0.10817,0,0
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.065563,-0.10916,-0.13009,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.029719,-0.10954,-0.08334,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.34702,-0.10975,-0.083105,0,0
2,GO RESPONSE TO ZINC ION,0.15773,-0.10996,-0.13339,0,0
2,GO SEXUAL REPRODUCTION,2.5308e-05,-0.10996,-0.10176,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.26471,-0.11013,-0.055491,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.30815,-0.1103,-0.10569,0,0
2,GO RESPONSE TO CORTICOSTEROID,0.12473,-0.11086,-0.089485,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.18508,-0.11104,-0.10672,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.072231,-0.11109,-0.14573,0,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.066855,-0.11157,-0.09592,0,0
2,GO REPLACEMENT OSSIFICATION,0.054842,-0.11165,-0.14868,0,0
2,GO BONE MATURATION,0.10465,-0.11189,-0.11515,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.092194,-0.1125,-0.071696,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.099158,-0.11254,-0.12817,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.0040578,-0.11259,-0.16405,0,0
2,GO FUCOSYLATION,0.17374,-0.113,-0.098459,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.057089,-0.11307,-0.12814,0,0
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.14048,-0.11327,-0.072863,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.02166,-0.11331,-0.11484,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.049546,-0.11337,-0.11143,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.19695,-0.11359,-0.1535,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.13355,-0.1136,-0.2992,0,0
2,GO NEURON CELL CELL ADHESION,0.30815,-0.11361,-0.14487,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.22905,-0.11366,-0.089347,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.27999,-0.11388,-0.13842,0,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.29586,-0.11395,-0.14621,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.50896,-0.11419,-0.03391,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.064293,-0.11421,-0.092059,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00069957,-0.11424,-0.1806,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.81668,-0.1144,0.010012,0,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.023205,-0.11448,-0.097759,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.11039,-0.11465,-0.099755,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0014299,-0.1148,-0.13539,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.011904,-0.11494,-0.12624,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.02068,-0.11517,-0.20571,0,0
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.064293,-0.11533,-0.083904,0,0
2,GO NUCLEOTIDE TRANSPORT,0.1313,-0.11536,-0.06816,0,0
2,GO MEIOTIC CELL CYCLE,1.1493e-05,-0.11536,-0.13571,0,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.17099,-0.11559,-0.14714,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0032441,-0.11566,-0.13405,0,0
2,GO RESPONSE TO VITAMIN D,0.27611,-0.11602,-0.058823,0,0
2,GO REPRODUCTION,1.349e-05,-0.11605,-0.11923,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.2839,-0.11622,-0.12501,0,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.077957,-0.11629,-0.1213,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.26471,-0.11631,-0.075292,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.068167,-0.11642,-0.08511,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.097379,-0.11665,-0.14668,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.001662,-0.11672,-0.16687,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.13583,-0.11697,-0.28446,0,0
2,GO KETONE CATABOLIC PROCESS,0.019739,-0.117,-0.22735,0,0
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.14769,-0.11725,-0.12034,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.95466,-0.11734,0.017295,0,0
2,GO GERM CELL DEVELOPMENT,0.00019753,-0.11758,-0.12079,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.23589,-0.1177,-0.11718,0,0
2,GO RESPONSE TO FOOD,0.010506,-0.11776,-0.13294,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.48678,-0.11788,-0.10558,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.077957,-0.11832,-0.17505,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.007729,-0.11842,-0.12635,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.14769,-0.11851,-0.15191,0,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.21905,-0.11851,-0.12884,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.050569,-0.11853,-0.17286,0,0
2,GO RESPONSE TO BMP,0.0090226,-0.11856,-0.1468,0,0
2,GO REGULATION OF SPINDLE ORGANIZATION,0.00095906,-0.11866,-0.14228,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.0064317,-0.11886,-0.14231,0,0
2,GO EMBRYO IMPLANTATION,0.19095,-0.11894,-0.11369,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.19695,-0.11897,-0.069075,0,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.060602,-0.11902,-0.14856,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.014841,-0.1191,-0.12599,0,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.033166,-0.11933,-0.17538,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.085627,-0.11935,-0.09228,0,0
2,GO STEROL IMPORT,0.30402,-0.11938,-0.058586,0,0
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0094949,-0.11946,-0.14451,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.0049174,-0.11946,-0.14468,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0079323,-0.11962,-0.14434,0,0
2,GO ERYTHROCYTE MATURATION,0.05824,-0.11964,-0.11855,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.02068,-0.11975,-0.11686,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.041093,-0.12004,-0.099859,0,0
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.33373,-0.12007,-0.055147,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.28785,-0.12028,-0.16274,0,0
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.38408,-0.12034,-0.091617,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.04854,-0.12082,-0.16233,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.14769,-0.12131,-0.19851,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.097379,-0.12177,-0.085118,0,0
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.38888,-0.12183,-0.12359,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.049546,-0.12184,-0.11873,0,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.188,-0.1222,-0.12997,0,0
2,GO PEPTIDE CROSS LINKING,0.065563,-0.12231,-0.18088,0,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.012508,-0.12235,-0.098879,0,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.39858,-0.12237,-0.083199,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.2,-0.12249,-0.16106,0,0
2,GO POLYAMINE METABOLIC PROCESS,0.04854,-0.12251,-0.11762,0,0
2,GO LACTATE METABOLIC PROCESS,0.14285,-0.12257,-0.10014,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.12259,-0.12265,-0.093254,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0024367,-0.1232,-0.11174,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.1028,-0.12321,-0.12123,0,0
2,GO CELL MATRIX ADHESION,0.014486,-0.12365,-0.14924,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.079444,-0.12408,-0.12834,0,0
2,GO KIDNEY MORPHOGENESIS,0.0045306,-0.12427,-0.15462,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.053746,-0.12463,-0.17173,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.053746,-0.12499,-0.11435,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.78962,-0.12506,-0.028338,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.42347,-0.12522,-0.032614,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.02166,-0.1253,-0.12307,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.11841,-0.126,-0.13108,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.13814,-0.12602,-0.16372,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.050569,-0.12603,-0.1935,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.026586,-0.12605,-0.13645,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,5.8301e-05,-0.12616,-0.10302,0,0
2,GO ACTIN CROSSLINK FORMATION,0.4598,-0.12617,-0.0095117,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.068167,-0.12632,-0.13451,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.068167,-0.12636,-0.14695,0,0
2,GO PANCREATIC JUICE SECRETION,0.12473,-0.12641,-0.087599,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.04854,-0.12678,-0.15384,0,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.38888,-0.12688,-0.042439,0,0
2,GO REGULATION OF OSSIFICATION,0.05161,-0.1269,-0.11507,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.0090226,-0.12698,-0.11245,0,0
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.099158,-0.12713,-0.11111,0,0
2,GO T HELPER 2 CELL DIFFERENTIATION,0.26847,-0.12718,-0.20713,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.02068,-0.12737,-0.2265,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.015574,-0.12743,-0.11816,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00019753,-0.12748,-0.15541,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.035393,-0.12764,-0.18513,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.053746,-0.12771,-0.13755,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.084046,-0.12818,-0.10113,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,1.349e-05,-0.12874,-0.12438,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.36064,-0.12881,-0.091609,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.060602,-0.1291,-0.12526,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.046579,-0.12913,-0.22886,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.25001,-0.12913,-0.13492,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.046579,-0.1294,-0.096962,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.084046,-0.12952,-0.10184,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.082489,-0.1301,-0.1467,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.11636,-0.13018,-0.083576,0,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.1028,-0.13055,-0.14676,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.14526,-0.13075,-0.17861,0,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.19095,-0.1312,-0.11175,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00014418,-0.13135,-0.13943,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.042857,-0.13159,-0.089382,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.030383,-0.13162,-0.17976,0,0
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.057089,-0.13174,-0.17963,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.27999,-0.13175,-0.079716,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.19393,-0.13217,-0.16476,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.24288,-0.13226,-0.12687,0,0
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.00026003,-0.13237,-0.19009,0,0
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.052669,-0.13279,-0.10835,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.18508,-0.13283,-0.071515,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.018398,-0.1329,-0.12033,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.087232,-0.13297,-0.26141,0,0
2,GO N GLYCAN PROCESSING,0.063042,-0.13327,-0.20635,0,0
2,GO GASTRIC ACID SECRETION,0.21256,-0.13338,-0.091894,0,0
2,GO RESPONSE TO UV C,0.023741,-0.13366,-0.14422,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.34702,-0.13368,-0.098197,0,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.11841,-0.13368,-0.1184,0,0
2,GO ARACHIDONIC ACID SECRETION,0.097379,-0.13378,-0.10887,0,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0024367,-0.13379,-0.17586,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.20621,-0.13401,-0.065992,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.025994,-0.13403,-0.13305,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.11235,-0.13404,-0.089061,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.3746,-0.13427,-0.064095,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.088862,-0.13517,-0.12794,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.59059,-0.13543,-0.068249,0,0
2,GO CILIUM MOVEMENT,0.00011241,-0.13545,-0.15453,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.23589,-0.13598,-0.095176,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.042857,-0.13599,-0.14101,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.009256,-0.13601,-0.11739,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.60883,-0.13612,-0.036371,0,0
2,GO EAR MORPHOGENESIS,0.00059588,-0.13652,-0.1629,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.34256,-0.1366,-0.057806,0,0
2,GO RESPONSE TO INSECTICIDE,0.52025,-0.13684,-0.045413,0,0
2,GO PLASMA MEMBRANE FUSION,0.16828,-0.13697,-0.12144,0,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.15773,-0.13703,-0.19801,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.18508,-0.13707,-0.10473,0,0
2,GO REGULATION OF T CELL CHEMOTAXIS,0.03939,-0.13717,-0.12099,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.17374,-0.13717,-0.1586,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.020205,-0.13723,-0.13316,0,0
2,GO T CELL PROLIFERATION,0.0010528,-0.13742,-0.16569,0,0
2,GO DEVELOPMENTAL INDUCTION,0.027188,-0.13771,-0.15254,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.98953,-0.13772,0.042634,0,0
2,GO NEURONAL ACTION POTENTIAL,0.036948,-0.13786,-0.20975,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.35607,-0.13834,-0.09294,0,0
2,GO RESPONSE TO HYDROXYUREA,0.047551,-0.13871,-0.14492,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.19695,-0.13938,-0.14743,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.018836,-0.13939,-0.16393,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.043763,-0.13943,-0.091912,0,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.34256,-0.13957,-0.062895,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,2.5308e-05,-0.1398,-0.16499,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.061812,-0.14006,-0.13596,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,1.0184e-05,-0.14014,-0.18263,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.077957,-0.14046,-0.20052,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.16294,-0.14048,-0.077058,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,2.9532e-05,-0.14055,-0.16047,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.077957,-0.14078,-0.11753,0,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.087232,-0.14087,-0.099143,0,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.099158,-0.14101,-0.15112,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.079444,-0.14102,-0.12027,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.092194,-0.14118,-0.12312,0,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.093897,-0.14148,-0.14801,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00092958,-0.14174,-0.12992,0,0
2,GO T HELPER 1 CELL DIFFERENTIATION,0.11039,-0.14184,-0.25406,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.22235,-0.14184,-0.10196,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.23245,-0.1419,-0.14294,0,0
2,GO GAMETE GENERATION,7.6603e-06,-0.14201,-0.12081,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0049174,-0.14203,-0.15638,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0099891,-0.14206,-0.15961,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.025414,-0.14252,-0.14783,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.12473,-0.14262,-0.034957,0,0
2,GO STEROID CATABOLIC PROCESS,0.25363,-0.14269,-0.093116,0,0
2,GO INNER EAR MORPHOGENESIS,0.0016129,-0.14314,-0.16408,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.012508,-0.14322,-0.16322,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.12259,-0.1433,-0.080648,0,0
2,GO MAST CELL MEDIATED IMMUNITY,0.007729,-0.14332,-0.22238,0,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.088862,-0.14355,-0.15244,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.076492,-0.14432,-0.16824,0,0
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.040234,-0.14517,-0.17913,0,0
2,GO RENAL FILTRATION,0.12259,-0.14524,-0.16163,0,0
2,GO FAT CELL PROLIFERATION,0.099158,-0.14535,-0.13517,0,0
2,GO NOTCH SIGNALING PATHWAY,0.00040247,-0.14566,-0.16607,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.001872,-0.14576,-0.18327,0,0
2,GO CARNITINE METABOLIC PROCESS,0.31232,-0.14588,-0.076261,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.033894,-0.14607,-0.1366,0,0
2,GO REGULATION OF HAIR CYCLE,0.023205,-0.14609,-0.16988,0,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.14285,-0.14614,-0.1366,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.29184,-0.14619,-0.099609,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.055956,-0.14652,-0.18561,0,0
2,GO REGULATION OF B CELL PROLIFERATION,0.0060989,-0.14658,-0.165,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.87144,-0.14725,0.0012881,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.060602,-0.14749,-0.16961,0,0
2,GO EATING BEHAVIOR,0.015203,-0.1475,-0.13187,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.066855,-0.14849,-0.22385,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.068167,-0.14855,-0.14665,0,0
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.060602,-0.14863,-0.09799,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.10845,-0.14863,-0.13022,0,0
2,GO LINOLEIC ACID METABOLIC PROCESS,0.073629,-0.14891,-0.17717,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.026586,-0.14949,-0.14702,0,0
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.063042,-0.15011,-0.19456,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.1028,-0.15083,-0.12579,0,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.02268,-0.15088,-0.15799,0,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.055956,-0.15103,-0.16964,0,0
2,GO EPITHELIAL TUBE FORMATION,2.2524e-05,-0.15111,-0.17864,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.055956,-0.15147,-0.199,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,2.1702e-06,-0.15163,-0.14766,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.0085714,-0.15167,-0.1809,0,0
2,GO HORMONE METABOLIC PROCESS,0.057089,-0.15199,-0.11621,0,0
2,GO MALE GAMETE GENERATION,6.2786e-05,-0.15206,-0.11871,0,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.0695,-0.15236,-0.16296,0,0
2,GO SPERMATID DIFFERENTIATION,0.00038934,-0.15284,-0.14413,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.12259,-0.1529,-0.1255,0,0
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.21905,-0.15303,-0.14766,0,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.05824,-0.15348,-0.12845,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.47049,-0.15397,-0.067465,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.02843,-0.1542,-0.13458,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.18219,-0.15469,-0.14201,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.1028,-0.15473,-0.21282,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,9.7346e-05,-0.15501,-0.15735,0,0
2,GO AMYLOID FIBRIL FORMATION,0.21579,-0.15512,-0.1366,0,0
2,GO MEMBRANE RAFT ASSEMBLY,0.33812,-0.15612,-0.23734,0,0
2,GO TELOMERE CAPPING,0.0022332,-0.15682,-0.12925,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.00081984,-0.15691,-0.15467,0,0
2,GO RESPONSE TO IRON ION,0.00087311,-0.15741,-0.23484,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.001191,-0.15743,-0.16186,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.2839,-0.15763,-0.10098,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.023741,-0.15793,-0.3831,0,0
2,GO SEX DETERMINATION,0.00353,-0.15844,-0.20516,0,0
2,GO REGULATION OF CHEMOTAXIS,8.4205e-05,-0.15891,-0.1702,0,0
2,GO REGULATION OF CELL SHAPE,0.0013872,-0.15903,-0.15343,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.00010845,-0.15924,-0.18482,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,7.9801e-06,-0.15944,-0.21772,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00081984,-0.15945,-0.17483,0,0
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.2839,-0.15953,-0.12587,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.11841,-0.15953,-0.17202,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.027188,-0.15983,-0.13748,0,0
2,GO GRANULOCYTE CHEMOTAXIS,0.00029782,-0.1605,-0.17355,0,0
2,GO BONE CELL DEVELOPMENT,0.0023671,-0.16065,-0.17857,0,0
2,GO RESPIRATORY BURST,0.0039469,-0.16153,-0.23564,0,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.46512,-0.16165,-0.067966,0,0
2,GO ZINC ION HOMEOSTASIS,0.10465,-0.16229,-0.18049,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.029719,-0.16247,-0.13272,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.0027346,-0.16262,-0.15415,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.16559,-0.16268,-0.1024,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.038561,-0.1629,-0.15008,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.026586,-0.16311,-0.14762,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.03939,-0.1634,-0.15398,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.27611,-0.16381,-0.11286,0,0
2,GO REGULATION OF CILIUM MOVEMENT,0.0064317,-0.16395,-0.16107,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.29586,-0.16436,-0.1133,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.040234,-0.16443,-0.13034,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.0094949,-0.16449,-0.13875,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.001191,-0.16466,-0.13372,0,0
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.10465,-0.16491,-0.15258,0,0
2,GO HISTONE H2A UBIQUITINATION,0.00072223,-0.1651,-0.14361,0,0
2,GO GENETIC IMPRINTING,0.0011199,-0.16511,-0.2005,0,0
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.25001,-0.16514,-0.10907,0,0
2,GO EYE MORPHOGENESIS,7.013e-05,-0.16569,-0.17496,0,0
2,GO EXIT FROM MITOSIS,0.0090226,-0.16575,-0.1236,0,0
2,GO CELL PROJECTION ASSEMBLY,1.2862e-06,-0.16653,-0.16284,0,0
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.14769,-0.16653,-0.12855,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.012203,-0.16663,-0.16986,0,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.19695,-0.16711,-0.11362,0,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0031536,-0.16761,-0.15245,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.15264,-0.16786,-0.13977,0,0
2,GO REGULATION OF HEAT GENERATION,0.20621,-0.16787,-0.13194,0,0
2,GO PLATELET DEGRANULATION,0.080955,-0.1682,-0.13985,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.099158,-0.16878,-0.17013,0,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0038387,-0.16891,-0.156,0,0
2,GO MEMBRANE FISSION,0.004408,-0.1691,-0.18504,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.036164,-0.16934,-0.17693,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.001228,-0.16935,-0.20702,0,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.10654,-0.16943,-0.16766,0,0
2,GO DOPAMINE METABOLIC PROCESS,0.33812,-0.16994,-0.062507,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.00019753,-0.16996,-0.15634,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.14285,-0.1703,-0.229,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11039,-0.17106,-0.1093,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.00030804,-0.17166,-0.16536,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.011904,-0.17268,-0.18817,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.26471,-0.17274,-0.095693,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,9.7801e-06,-0.17277,-0.18053,0,0
2,GO TRNA CATABOLIC PROCESS,0.17934,-0.17279,-0.1565,0,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,9.0551e-05,-0.17292,-0.15553,0,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0034322,-0.17298,-0.15539,0,0
2,GO SPECIFICATION OF SYMMETRY,0.00016023,-0.17306,-0.13723,0,0
2,GO HEART FORMATION,0.011904,-0.17336,-0.1964,0,0
2,GO TYPE 2 IMMUNE RESPONSE,0.065563,-0.17398,-0.19538,0,0
2,GO MYELOID CELL DEVELOPMENT,7.2754e-05,-0.17412,-0.18177,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.10654,-0.1742,-0.2261,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.053746,-0.17485,-0.12009,0,0
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.43367,-0.17523,-0.18516,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.019739,-0.1753,-0.14461,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011326,-0.17552,-0.15768,0,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0046564,-0.17556,-0.15513,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.079444,-0.17573,-0.13814,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.055956,-0.1758,-0.20707,0,0
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.017137,-0.17593,-0.22984,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.026586,-0.1761,-0.16918,0,0
2,GO DNA DEMETHYLATION,0.00041602,-0.17626,-0.19873,0,0
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0083534,-0.1763,-0.15215,0,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.041093,-0.1763,-0.24631,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.26098,-0.17636,-0.11512,0,0
2,GO RESPONSE TO DIETARY EXCESS,0.18508,-0.17643,-0.13628,0,0
2,GO EPOXYGENASE P450 PATHWAY,0.088862,-0.17744,-0.15891,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0016129,-0.17752,-0.14455,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.061812,-0.17753,-0.18963,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00045924,-0.17761,-0.21407,0,0
2,GO MAST CELL ACTIVATION,0.0030654,-0.1784,-0.214,0,0
2,GO ENDOTHELIUM DEVELOPMENT,8.1192e-05,-0.17872,-0.21786,0,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.035393,-0.17883,-0.23258,0,0
2,GO SPERM AXONEME ASSEMBLY,0.0083534,-0.17897,-0.1885,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,6.7728e-06,-0.17948,-0.16726,0,0
2,GO MESONEPHROS DEVELOPMENT,0.00057693,-0.17993,-0.20408,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.001191,-0.18009,-0.1982,0,0
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0064317,-0.18031,-0.23746,0,0
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00040247,-0.18063,-0.22508,0,0
2,GO T CELL MEDIATED CYTOTOXICITY,0.14769,-0.18194,-0.22307,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,5.4121e-05,-0.18257,-0.18266,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.00034072,-0.18266,-0.2037,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.057089,-0.1827,-0.20406,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.15773,-0.18272,-0.1608,0,0
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.24643,-0.18338,-0.2362,0,0
2,GO GENITALIA MORPHOGENESIS,0.15517,-0.18359,-0.14887,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.16032,-0.18476,-0.054028,0,0
2,GO FUCOSE METABOLIC PROCESS,0.14769,-0.18492,-0.12716,0,0
2,GO NEURON FATE COMMITMENT,0.04854,-0.18495,-0.19235,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.088862,-0.18518,-0.15627,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.0025817,-0.18534,-0.15251,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0019282,-0.18568,-0.15161,0,0
2,GO PHOTOTRANSDUCTION,0.0067808,-0.18616,-0.054528,0,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.18508,-0.18625,-0.13324,0,0
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0016129,-0.18693,-0.23813,0,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.001986,-0.18764,-0.1923,0,0
2,GO NEPHRON DEVELOPMENT,7.547e-05,-0.18798,-0.21986,0,0
2,GO BIOLOGICAL PHASE,0.12689,-0.18805,-0.26158,0,0
2,GO UTERUS DEVELOPMENT,0.084046,-0.1882,-0.1383,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,1.8521e-05,-0.18843,-0.23633,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.03939,-0.18888,-0.1468,0,0
2,GO REGULATION OF NEURON MATURATION,0.10654,-0.18944,-0.12183,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.0015189,-0.18946,-0.21302,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.093897,-0.1896,-0.17212,0,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00067758,-0.18982,-0.23308,0,0
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.001872,-0.19011,-0.21782,0,0
2,GO REGULATION OF VASCULOGENESIS,0.05824,-0.19122,-0.1669,0,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,5.6174e-05,-0.19163,-0.20347,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0018173,-0.19176,-0.21821,0,0
2,GO HEART INDUCTION,0.20937,-0.19214,-0.11296,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0010859,-0.19228,-0.18192,0,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.061812,-0.19235,-0.18598,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,2.4346e-05,-0.1929,-0.19186,0,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.05824,-0.19305,-0.17514,0,0
2,GO REPLICATIVE SENESCENCE,0.079444,-0.19326,-0.16119,0,0
2,GO MICROTUBULE SEVERING,0.009256,-0.19376,-0.17703,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00018427,-0.19378,-0.17459,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.059411,-0.19424,-0.21057,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.0090226,-0.19429,-0.18804,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.10465,-0.19472,-0.29266,0,0
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.012508,-0.1948,-0.15333,0,0
2,GO METANEPHROS MORPHOGENESIS,0.041093,-0.195,-0.14215,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.12049,-0.19535,-0.22533,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00038934,-0.19631,-0.18162,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0067808,-0.19645,-0.16941,0,0
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0695,-0.19732,-0.2046,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.66501,-0.19732,-0.042896,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.019739,-0.19764,-0.19564,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.066855,-0.19826,-0.18614,0,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.1964e-05,-0.19877,-0.20501,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.066855,-0.19891,-0.24449,0,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.19695,-0.19901,-0.08678,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.05824,-0.19946,-0.17278,0,0
2,GO EPITHELIAL CELL MATURATION,0.031059,-0.20011,-0.17049,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0013054,-0.20035,-0.26166,0,0
2,GO STEROID HORMONE SECRETION,0.12049,-0.20078,-0.12935,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00014935,-0.20109,-0.21327,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0042883,-0.20122,-0.23754,0,0
2,GO OTIC VESICLE DEVELOPMENT,0.11039,-0.20156,-0.16677,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0015189,-0.20228,-0.19653,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0028957,-0.20236,-0.16818,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.001986,-0.20239,-0.25784,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.070855,-0.20262,-0.13809,0,0
2,GO MICROTUBULE BUNDLE FORMATION,7.547e-05,-0.20279,-0.21222,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0059384,-0.20283,-0.27833,0,0
2,GO CELL FATE DETERMINATION,0.0017123,-0.20344,-0.24805,0,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.12049,-0.2045,-0.17564,0,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,7.2754e-05,-0.20457,-0.21012,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.28785,-0.20519,-0.11838,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00021909,-0.20544,-0.17126,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0013054,-0.20564,-0.19676,0,0
2,GO MALE MEIOSIS I,0.015953,-0.20576,-0.24224,0,0
2,GO CILIUM ORGANIZATION,2.0833e-05,-0.20674,-0.1752,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0094949,-0.20694,-0.17838,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.0064317,-0.20696,-0.23164,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.030383,-0.20747,-0.19476,0,0
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.04854,-0.20753,-0.24805,0,0
2,GO ETHANOL OXIDATION,0.061812,-0.20771,-0.2852,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.030383,-0.20787,-0.12367,0,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,0.0021689,-0.20794,-0.22138,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.2839,-0.20853,-0.029546,0,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.099158,-0.20855,-0.23413,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.0073363,-0.20866,-0.1602,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.090515,-0.20868,-0.25098,0,0
2,GO MALE GENITALIA DEVELOPMENT,0.013465,-0.20916,-0.18964,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.15015,-0.20926,-0.11171,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0028957,-0.20965,-0.17608,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.013798,-0.21084,-0.22068,0,0
2,GO O GLYCAN PROCESSING,0.00069957,-0.21272,-0.27482,0,0
2,GO SEROTONIN SECRETION,0.043763,-0.21289,-0.15027,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.00021167,-0.21379,-0.21506,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00040247,-0.21395,-0.19076,0,0
2,GO LEUKOCYTE CHEMOTAXIS,1.2962e-05,-0.21436,-0.21294,0,0
2,GO INTERLEUKIN 13 PRODUCTION,0.050569,-0.21516,-0.19624,0,0
2,GO ACTIVATED T CELL PROLIFERATION,0.00030804,-0.21613,-0.21341,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0025083,-0.21672,-0.20054,0,0
2,GO AMMONIUM TRANSPORT,0.019283,-0.21704,-0.24995,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,1.5201e-05,-0.21713,-0.21551,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.00052342,-0.21769,-0.25544,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00030804,-0.21843,-0.25758,0,0
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0010206,-0.21855,-0.20592,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.090515,-0.21866,-0.12544,0,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.00012074,-0.21958,-0.22391,0,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0030654,-0.21972,-0.21361,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.0087944,-0.2205,-0.16156,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.21905,-0.22055,-0.07101,0,0
2,GO BRONCHUS DEVELOPMENT,0.053746,-0.22059,-0.26161,0,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.011047,-0.22145,-0.20058,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,1.6455e-05,-0.22152,-0.23283,0,0
2,GO INTERLEUKIN 12 PRODUCTION,1.3441e-06,-0.22211,-0.30684,0,0
2,GO MICROVILLUS ASSEMBLY,0.007729,-0.22221,-0.26929,0,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,6.4994e-06,-0.22232,-0.23399,0,0
2,GO SULFATION,0.13355,-0.22253,-0.13816,0,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.066855,-0.22319,-0.19358,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.00021909,-0.22372,-0.19856,0,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.10654,-0.2257,-0.28662,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.015203,-0.22808,-0.22882,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,2.6307e-05,-0.22827,-0.23195,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0010859,-0.229,-0.18549,0,0
2,GO SUBPALLIUM DEVELOPMENT,0.030383,-0.2297,-0.17393,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.043763,-0.22994,-0.21823,0,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0025817,-0.23007,-0.22045,0,0
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,1.1964e-05,-0.23007,-0.26603,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0087944,-0.23096,-0.24323,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00065623,-0.23144,-0.18519,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,1.4039e-05,-0.23193,-0.25709,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00047456,-0.23243,-0.25882,0,0
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.013798,-0.23357,-0.25284,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.16559,-0.23403,-0.11337,0,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.0014738,-0.23404,-0.26869,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,3.3287e-06,-0.23442,-0.24629,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,3.5759e-05,-0.23472,-0.25905,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.0057817,-0.23492,-0.1788,0,0
2,GO SOMATIC STEM CELL DIVISION,0.23245,-0.23531,-0.1394,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.055956,-0.23556,-0.19538,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.00090094,-0.23631,-0.27061,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.070855,-0.23652,-0.12128,0,0
2,GO HORMONE CATABOLIC PROCESS,0.0011199,-0.23689,-0.30106,0,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.049546,-0.23784,-0.15027,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00054072,-0.23866,-0.26904,0,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.05161,-0.23907,-0.25798,0,0
2,GO ANIMAL ORGAN MATURATION,0.013798,-0.23958,-0.16851,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.14769,-0.24069,-0.26831,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,3.4421e-05,-0.24113,-0.24241,0,0
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00011241,-0.24162,-0.32128,0,0
2,GO SEGMENT SPECIFICATION,0.0021689,-0.24187,-0.29924,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.013e-05,-0.24199,-0.24975,0,0
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00014418,-0.24255,-0.23907,0,0
2,GO PLACENTA DEVELOPMENT,1.0311e-06,-0.24266,-0.27121,0,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.050569,-0.24299,-0.22469,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0015653,-0.24326,-0.21592,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0028141,-0.24439,-0.26948,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0075304,-0.24473,-0.21428,0,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.095625,-0.24545,-0.35379,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.057089,-0.24592,-0.27799,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,1.7118e-05,-0.24598,-0.24192,0,0
2,GO RESPONSE TO MUSCLE INACTIVITY,0.00013433,-0.24689,-0.32974,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.015203,-0.24716,-0.18099,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.099158,-0.24835,-0.27367,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,9.8628e-07,-0.24848,-0.26405,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0041716,-0.24887,-0.26335,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,7.8282e-05,-0.25096,-0.23025,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.013798,-0.25174,-0.26194,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,9.7801e-06,-0.25223,-0.23955,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.053746,-0.25322,-0.33231,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.00074557,-0.25379,-0.24486,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0050528,-0.25422,-0.22724,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.0057817,-0.25471,-0.2422,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00022676,-0.25485,-0.26336,0,0
2,GO RETINAL METABOLIC PROCESS,0.04854,-0.25519,-0.24132,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00010845,-0.25706,-0.27938,0,0
2,GO PANCREAS DEVELOPMENT,6.2786e-05,-0.25757,-0.27149,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.004408,-0.25827,-0.21216,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.0049174,-0.25844,-0.3645,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,1.1964e-05,-0.25987,-0.26892,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.12689,-0.26031,-0.16797,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.060602,-0.26063,-0.21762,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0014299,-0.26184,-0.2448,0,0
2,GO REGULATION OF COAGULATION,0.0001547,-0.26241,-0.30084,0,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.026586,-0.26333,-0.20368,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.010773,-0.26549,-0.16122,0,0
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.022165,-0.26611,-0.28973,0,0
2,GO MYOFIBRIL ASSEMBLY,0.00024286,-0.26621,-0.20109,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.013798,-0.26634,-0.24562,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.013139,-0.26737,-0.23631,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.021165,-0.26845,-0.23547,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00017796,-0.26886,-0.20927,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,1.8521e-05,-0.26993,-0.2581,0,0
2,GO CELL JUNCTION MAINTENANCE,0.0014738,-0.27055,-0.23655,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.00012964,-0.27075,-0.25705,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.011047,-0.27163,-0.31058,0,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00098941,-0.27177,-0.27496,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00024286,-0.27266,-0.255,0,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.04854,-0.27492,-0.20311,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0026572,-0.2771,-0.30802,0,0
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00074557,-0.27772,-0.34096,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.010506,-0.28258,-0.27334,0,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.0013054,-0.28302,-0.23091,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0028141,-0.28382,-0.20832,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00044439,-0.28391,-0.27431,0,0
2,GO INTRACILIARY TRANSPORT,0.00034072,-0.28456,-0.25001,0,0
2,GO PRO B CELL DIFFERENTIATION,0.0040578,-0.28668,-0.232,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0023671,-0.28708,-0.22674,0,0
2,GO EMBRYONIC HEMOPOIESIS,4.3218e-05,-0.28764,-0.3095,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,2.0033e-05,-0.28875,-0.30811,0,0
2,GO EOSINOPHIL MIGRATION,0.00092958,-0.29151,-0.37225,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00012512,-0.29245,-0.30239,0,0
2,GO HOMOTYPIC CELL CELL ADHESION,3.4421e-05,-0.29375,-0.32081,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.00010092,-0.29485,-0.31295,0,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.0081404,-0.2974,-0.30018,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.055956,-0.29961,-0.50009,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,3.0689e-05,-0.29966,-0.24362,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.010506,-0.2998,-0.29677,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.10465,-0.30212,-0.19418,0,0
2,GO LIPOXYGENASE PATHWAY,0.0031536,-0.30244,-0.3332,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00017186,-0.30279,-0.29762,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0015189,-0.30288,-0.29344,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,4.0073e-05,-0.30305,-0.29299,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.02166,-0.30349,-0.23258,0,0
2,GO RESPONSE TO COPPER ION,0.0025817,-0.30394,-0.32135,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0021689,-0.3061,-0.27008,0,0
2,GO INTERLEUKIN 10 PRODUCTION,9.0179e-06,-0.30613,-0.29452,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0075304,-0.30756,-0.2403,0,0
2,GO SARCOMERE ORGANIZATION,0.00059588,-0.30791,-0.23518,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.024846,-0.30805,-0.19676,0,0
2,GO DETECTION OF CALCIUM ION,0.011612,-0.30822,-0.2739,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.060602,-0.30914,-0.34625,0,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.011904,-0.3097,-0.2234,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.00017796,-0.31247,-0.29432,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.00013917,-0.3131,-0.26044,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0090226,-0.314,-0.32337,0,0
2,GO HETEROTYPIC CELL CELL ADHESION,2.0829e-07,-0.3189,-0.39039,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.00084609,-0.32116,-0.33522,0,0
2,GO EXTRACELLULAR TRANSPORT,1.6015e-06,-0.32295,-0.40046,0,0
2,GO LEFT RIGHT PATTERN FORMATION,0.00035231,-0.32382,-0.28757,0,0
2,GO HEART FIELD SPECIFICATION,0.0083534,-0.32516,-0.26176,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,6.2985e-07,-0.32744,-0.35471,0,0
2,GO BILE ACID AND BILE SALT TRANSPORT,3.8583e-05,-0.33076,-0.36255,0,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.02068,-0.33507,-0.22733,0,0
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,2.6307e-05,-0.33662,-0.29348,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,3.1888e-05,-0.33766,-0.30821,0,0
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0001165,-0.33769,-0.31733,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00027832,-0.3383,-0.34173,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00037661,-0.33863,-0.30236,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.0028957,-0.34171,-0.27243,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00013433,-0.34307,-0.27113,0,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,5.6174e-05,-0.34512,-0.36251,0,0
2,GO AXONEME ASSEMBLY,8.3127e-06,-0.34641,-0.34911,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.021165,-0.35147,-0.34631,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,7.5427e-07,-0.35314,-0.33908,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.0014738,-0.35326,-0.4539,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00021167,-0.35422,-0.32364,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.00084609,-0.35464,-0.35318,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00013917,-0.35511,-0.29926,0,0
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00023468,-0.35581,-0.43654,0,0
2,GO GDP METABOLIC PROCESS,0.00029782,-0.35975,-0.3357,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0040578,-0.35979,-0.30887,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.082489,-0.36194,-0.28507,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0026572,-0.36436,-0.37807,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.023205,-0.36573,-0.38621,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,1.0779e-06,-0.36655,-0.37397,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00026903,-0.36735,-0.34919,0,0
2,GO TRANSPOSITION,5.508e-06,-0.36827,-0.44093,0,0
2,GO IMMATURE B CELL DIFFERENTIATION,0.00095906,-0.37406,-0.26521,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.001986,-0.37447,-0.39186,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.0069616,-0.37542,-0.36861,0,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,1.5691e-07,-0.38261,-0.41346,0,0
2,GO GONADOTROPIN SECRETION,1.2962e-05,-0.38427,-0.43075,0,0
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.00092958,-0.38926,-0.32237,0,0
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.13355,-0.39392,-0.25513,0,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.0025083,-0.39796,-0.29924,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.0060989,-0.40518,-0.31789,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.00035231,-0.40606,-0.3283,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,1.725e-07,-0.41826,-0.38511,0,0
2,GO ADRENAL GLAND DEVELOPMENT,9.7346e-05,-0.42035,-0.36018,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0015653,-0.42326,-0.51624,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,9.4334e-07,-0.42384,-0.45862,0,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.00017186,-0.4258,-0.34175,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,5.6174e-05,-0.4273,-0.34413,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00098941,-0.42833,-0.3871,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,2.4346e-05,-0.4291,-0.46121,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.0026572,-0.43095,-0.46036,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,4.4878e-05,-0.43486,-0.44343,0,0
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,1.906e-06,-0.44912,-0.4746,0,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00027832,-0.44913,-0.39132,0,0
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00014418,-0.46546,-0.40918,0,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00024286,-0.48435,-0.44772,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,5.8301e-05,-0.48513,-0.48688,0,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00011241,-0.49218,-0.42004,0,0
2,GO RETINA LAYER FORMATION,0.00025131,-0.49361,-0.42195,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,1.906e-06,-0.49482,-0.48421,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00013917,-0.49931,-0.49525,0,0
2,GO RESPONSE TO FORSKOLIN,7.0571e-06,-0.50997,-0.45477,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,3.8583e-05,-0.52149,-0.45274,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.6584e-06,-0.52175,-0.57593,0,0
2,GO NOTCH RECEPTOR PROCESSING,5.7413e-06,-0.52724,-0.50548,0,0
2,GO SEROTONIN METABOLIC PROCESS,0.0014299,-0.53266,-0.39886,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,3.8583e-05,-0.53775,-0.5303,0,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.0062634,-0.54036,-0.3912,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,9.0179e-06,-0.54769,-0.56097,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,2.6307e-05,-0.55074,-0.46011,0,0
2,GO REGULATION OF PLATELET AGGREGATION,1.9904e-06,-0.55585,-0.57999,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,5.4121e-05,-0.5698,-0.56086,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,1.0779e-06,-0.57102,-0.64526,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,1.7118e-05,-0.57186,-0.52272,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,1.1776e-06,-0.57676,-0.59968,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,9.7801e-06,-0.57759,-0.5744,0,0
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,3.9926e-07,-0.58616,-0.54046,0,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.8077e-06,-0.58792,-0.6371,0,0
2,GO GLIAL CELL FATE COMMITMENT,0.00087311,-0.58808,-0.45619,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,4.8612e-06,-0.58825,-0.52577,0,0
2,GO ENTRY OF BACTERIUM INTO HOST CELL,4.6623e-06,-0.60767,-0.63767,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.0051916,-0.62237,-0.44343,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,7.3528e-06,-0.62299,-0.50544,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,6.7596e-05,-0.63709,-0.54699,0,0
2,GO LUNG CELL DIFFERENTIATION,2.7343e-05,-0.67843,-0.57055,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,2.2524e-05,-0.73332,-0.59099,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,2.9301e-06,-0.74682,-0.62777,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,2.0033e-05,-0.79675,-0.6512,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,7.9801e-06,-0.83124,-0.69472,0,0
2,GO NOSE DEVELOPMENT,0.00010462,-0.93158,-0.68796,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,5.986e-08,-0.95111,-0.89408,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,2.2879e-07,-1.0038,-0.8649,0,0
2,GO LABYRINTHINE LAYER MORPHOGENESIS,7.6379e-08,-1.0438,-0.95519,0,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,1.0207e-07,-1.0909,-1.1088,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00087311,1.8242,1.1555,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00095906,1.3792,0.92946,1,1
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,2.7343e-05,1.0841,0.78743,1,1
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.5427e-07,1.0704,1.1359,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00081984,1.0456,0.71919,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0099891,0.99549,0.71391,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,3.0576e-06,0.94768,0.69847,1,1
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,4.2876e-06,0.9265,0.75883,1,1
3,GO CYTIDINE TO URIDINE EDITING,1.7118e-05,0.89188,0.77183,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0034322,0.88417,0.6226,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,4.1617e-05,0.84644,0.74388,1,1
3,GO TOLERANCE INDUCTION,0.0013457,0.84255,0.61578,1,1
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00012512,0.82105,0.5537,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,7.9801e-06,0.81941,0.72158,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0014738,0.80247,0.50703,1,1
3,GO GERMINAL CENTER FORMATION,1.3441e-06,0.78625,0.71375,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,2.0829e-07,0.77592,0.75988,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,2.3418e-05,0.76384,0.63678,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00010092,0.76011,0.71256,1,1
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,2.0033e-05,0.75826,0.5872,1,1
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,1.1776e-06,0.74473,0.65077,1,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,6.7728e-06,0.73465,0.6467,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,3.9418e-06,0.72966,0.72603,1,1
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,5.2837e-06,0.71752,0.68755,1,1
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.2862e-06,0.71602,0.73453,1,1
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,3.4421e-05,0.71418,0.54968,1,1
3,GO RESPONSE TO TYPE I INTERFERON,1.2962e-05,0.71352,0.63289,1,1
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.001662,0.71231,0.47172,1,1
3,GO HISTAMINE SECRETION,2.6322e-07,0.70834,0.7571,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.011326,0.7015,0.48487,1,1
3,GO RENAL ABSORPTION,4.6623e-06,0.70055,0.70954,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0015189,0.69676,0.45614,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00050664,0.69215,0.55451,1,1
3,GO RESPONSE TO INTERFERON BETA,0.00028792,0.6851,0.54941,1,1
3,GO DOPAMINE BIOSYNTHETIC PROCESS,7.0571e-06,0.6838,0.72351,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.001228,0.68132,0.53278,1,1
3,GO MUCUS SECRETION,0.00034072,0.67366,0.60425,1,1
3,GO HISTAMINE TRANSPORT,2.5122e-07,0.6715,0.72999,1,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,2.6307e-05,0.65948,0.65417,1,1
3,GO PROGESTERONE METABOLIC PROCESS,0.00022676,0.65717,0.89245,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0006154,0.65565,0.53928,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,0.00090094,0.65239,0.44326,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00038934,0.64938,0.46583,1,1
3,GO GLYCOSIDE METABOLIC PROCESS,0.0024367,0.64589,0.78999,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.4334e-07,0.64432,0.62932,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.104e-05,0.64102,0.53357,1,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.029719,0.6404,0.28271,1,1
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,2.5122e-07,0.63542,0.66827,1,1
3,GO RETINAL METABOLIC PROCESS,0.00065623,0.6345,0.62113,1,1
3,GO MATURE B CELL DIFFERENTIATION,7.3528e-06,0.62553,0.49547,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00012512,0.62538,0.55124,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,1.7118e-05,0.62216,0.58585,1,1
3,GO NEGATIVE REGULATION OF CELL KILLING,0.015953,0.62207,0.41406,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,8.3127e-06,0.61966,0.55454,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,1.5201e-05,0.61732,0.49039,1,1
3,GO LIPID DROPLET FORMATION,4.8612e-06,0.61646,0.65665,1,1
3,GO NEGATIVE REGULATION OF BONE REMODELING,2.2658e-06,0.6122,0.59343,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,7.0571e-06,0.60589,0.56953,1,1
3,GO T CELL EXTRAVASATION,0.00037661,0.60292,0.56325,1,1
3,GO GALACTOSE METABOLIC PROCESS,3.0264e-07,0.60248,0.69498,1,1
3,GO RESPONSE TO INTERFERON ALPHA,0.001228,0.60158,0.41097,1,1
3,GO ACTIN FILAMENT SEVERING,0.00012964,0.60069,0.49517,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0037331,0.60055,0.68532,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,7.2754e-05,0.5878,0.44027,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,0.0028141,0.58699,0.40239,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00013433,0.58091,0.54721,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,9.7801e-06,0.57548,0.51994,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.5774e-06,0.57367,0.55037,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.8251e-06,0.56988,0.55852,1,1
3,GO PLASMINOGEN ACTIVATION,0.00017186,0.56797,0.5171,1,1
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,8.4205e-05,0.56478,0.43864,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,7.013e-05,0.56344,0.50881,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00013917,0.56147,0.47959,1,1
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.001228,0.55987,0.45508,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.7806e-05,0.55723,0.5795,1,1
3,GO CELLULAR DEFENSE RESPONSE,4.1802e-07,0.55685,0.48696,1,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,2.4346e-05,0.55608,0.45391,1,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,9.0179e-06,0.55399,0.49176,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00014935,0.55354,0.47227,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,0.0081404,0.55184,0.46337,1,1
3,GO CYCLOOXYGENASE PATHWAY,0.0012662,0.55032,0.51917,1,1
3,GO TOXIN METABOLIC PROCESS,4.5813e-07,0.55021,0.56649,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00020448,0.54979,0.41384,1,1
3,GO INTESTINAL LIPID ABSORPTION,9.7801e-06,0.54423,0.66274,1,1
3,GO REGULATION OF FIBRINOLYSIS,3.8583e-05,0.54275,0.5135,1,1
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00020448,0.54146,0.46447,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00069957,0.54132,0.50737,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00032948,0.54111,0.4283,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00013917,0.5404,0.48665,1,1
3,GO RESPONSE TO PAIN,1.4674e-06,0.5398,0.50108,1,1
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,2.8418e-05,0.53864,0.55316,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,1.5331e-06,0.53709,0.50733,1,1
3,GO RESPONSE TO NITROSATIVE STRESS,7.8282e-05,0.53558,0.4892,1,1
3,GO SUPEROXIDE ANION GENERATION,3.6228e-06,0.53536,0.53683,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00013433,0.53496,0.49447,1,1
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00081984,0.53454,0.3863,1,1
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00021167,0.53292,0.42288,1,1
3,GO FRUCTOSE METABOLIC PROCESS,0.0012662,0.52941,0.51924,1,1
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0060989,0.52871,0.36959,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00017186,0.52819,0.48907,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.547e-05,0.52612,0.4334,1,1
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,9.0179e-06,0.52562,0.51773,1,1
3,GO ADHESION OF SYMBIONT TO HOST,0.0030654,0.52551,0.38945,1,1
3,GO GLYCOLIPID CATABOLIC PROCESS,4.0073e-05,0.52462,0.50761,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00092958,0.52434,0.41597,1,1
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00059588,0.5235,0.38943,1,1
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,6.5149e-05,0.5233,0.49496,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.4205e-05,0.52109,0.39283,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.7955e-07,0.51996,0.51096,1,1
3,GO RESPONSE TO COLD,9.7275e-08,0.51916,0.49583,1,1
3,GO CYSTEINE METABOLIC PROCESS,0.0071468,0.5188,0.44344,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,9.3916e-06,0.51856,0.47634,1,1
3,GO INTESTINAL ABSORPTION,5.9841e-06,0.51834,0.60024,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,7.6603e-06,0.51774,0.45603,1,1
3,GO STEROID ESTERIFICATION,1.7474e-06,0.51766,0.70381,1,1
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.0184e-05,0.51709,0.65755,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,3.1888e-05,0.51562,0.50466,1,1
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00021909,0.51381,0.48535,1,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,3.8583e-05,0.51304,0.473,1,1
3,GO DETECTION OF OTHER ORGANISM,0.00028792,0.51251,0.47083,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.389e-05,0.51213,0.46548,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.9263e-05,0.5114,0.47359,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.7474e-06,0.51081,0.52572,1,1
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00052342,0.50934,0.42042,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00010092,0.50824,0.58956,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.0045306,0.50607,0.43155,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,4.1617e-05,0.50529,0.54607,1,1
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,3.4728e-06,0.50333,0.75173,1,1
3,GO RESPONSE TO DIETARY EXCESS,5.2837e-06,0.50082,0.50146,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0032441,0.49731,0.40298,1,1
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0059384,0.49719,0.30776,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,4.1617e-05,0.49709,0.49809,1,1
3,GO REFLEX,4.8379e-05,0.49432,0.52749,1,1
3,GO RESPONSE TO EPINEPHRINE,0.0023671,0.49377,0.35631,1,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,3.3287e-06,0.49246,0.61406,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0029794,0.49196,0.48289,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0036303,0.49,0.34371,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,8.7323e-05,0.48752,0.42948,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00044439,0.48537,0.35918,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,7.2111e-07,0.48535,0.50632,1,1
3,GO NEGATIVE REGULATION OF COAGULATION,0.00045924,0.48464,0.39258,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.2786e-05,0.48427,0.41426,1,1
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0037331,0.48415,0.32989,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,3.4772e-07,0.48196,0.53652,1,1
3,GO REGULATION OF ANOIKIS,3.1888e-05,0.47817,0.46637,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,8.1192e-05,0.47648,0.41833,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.0017123,0.47485,0.39222,1,1
3,GO REGULATION OF MYOBLAST FUSION,2.3418e-05,0.47453,0.4118,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00013433,0.47384,0.4517,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.7791e-06,0.47377,0.38034,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.8628e-07,0.4733,0.45979,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4609e-05,0.47307,0.40837,1,1
3,GO CORTICOSTEROID HORMONE SECRETION,0.00014935,0.47233,0.43843,1,1
3,GO REGULATION OF NEURON MATURATION,1.5816e-05,0.47152,0.41185,1,1
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0023671,0.46924,0.36373,1,1
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.035393,0.46886,0.21163,1,1
3,GO VASODILATION,1.1493e-05,0.4682,0.59235,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,2.2524e-05,0.46805,0.45767,1,1
3,GO REGULATION OF BONE REMODELING,6.0198e-07,0.46771,0.48223,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.1617e-05,0.46732,0.41959,1,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,5.9841e-06,0.46365,0.40481,1,1
3,GO ZYMOGEN ACTIVATION,4.0073e-05,0.46214,0.47229,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00098941,0.46193,0.4952,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,8.6584e-06,0.4586,0.45777,1,1
3,GO SIGNAL PEPTIDE PROCESSING,4.4712e-06,0.45727,0.46685,1,1
3,GO NADP METABOLIC PROCESS,0.00024286,0.45707,0.34617,1,1
3,GO BONE RESORPTION,3.9926e-07,0.45599,0.46505,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00028792,0.45595,0.49282,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00016023,0.45445,0.38401,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,1.1964e-05,0.45399,0.39267,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,1.4039e-05,0.45388,0.49322,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00063551,0.45386,0.36097,1,1
3,GO PROSTANOID METABOLIC PROCESS,0.00040247,0.4532,0.42374,1,1
3,GO RESPONSE TO ACIDIC PH,8.7323e-05,0.45304,0.3927,1,1
3,GO FOAM CELL DIFFERENTIATION,2.2524e-05,0.45253,0.37941,1,1
3,GO OPTIC NERVE DEVELOPMENT,8.1192e-05,0.4525,0.50253,1,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.001191,0.45056,0.49943,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00035231,0.45025,0.45298,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,2.2524e-05,0.44692,0.39466,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,3.8131e-07,0.44622,0.44184,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0056288,0.44609,0.2693,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1702e-06,0.44507,0.4761,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00012964,0.44365,0.43077,1,1
3,GO REGULATION OF WATER LOSS VIA SKIN,0.0017641,0.44306,0.37469,1,1
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0013054,0.44209,0.37111,1,1
3,GO QUINONE METABOLIC PROCESS,0.00012074,0.44202,0.61914,1,1
3,GO PROTEIN DEGLYCOSYLATION,1.5816e-05,0.44129,0.41173,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,1.8521e-05,0.43968,0.45916,1,1
3,GO LEYDIG CELL DIFFERENTIATION,0.00044439,0.43907,0.48778,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00036427,0.43859,0.47729,1,1
3,GO SMOOTH MUSCLE CELL MIGRATION,7.547e-05,0.4382,0.36273,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00029782,0.43715,0.35705,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,2.0833e-05,0.43678,0.4784,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0033369,0.43535,0.30863,1,1
3,GO NUCLEOTIDE SALVAGE,0.00037661,0.4353,0.36443,1,1
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00038934,0.43423,0.33808,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,7.0571e-06,0.4331,0.39447,1,1
3,GO SECONDARY METABOLIC PROCESS,0.00022676,0.43301,0.4134,1,1
3,GO GAP JUNCTION ASSEMBLY,0.0045306,0.43228,0.31773,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00017186,0.4312,0.42831,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00021909,0.43107,0.36161,1,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.037747,0.4306,0.2276,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.8301e-05,0.42986,0.37981,1,1
3,GO MICROVILLUS ORGANIZATION,0.00063551,0.42906,0.36705,1,1
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00063551,0.42905,0.40454,1,1
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.00012964,0.42905,0.44899,1,1
3,GO LIVER MORPHOGENESIS,7.547e-05,0.42898,0.4051,1,1
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00031859,0.42732,0.44656,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.3132e-05,0.42701,0.35298,1,1
3,GO RESPONSE TO THYROID HORMONE,0.00029782,0.42573,0.34413,1,1
3,GO ENDOTHELIAL CELL CHEMOTAXIS,5.8301e-05,0.4256,0.38527,1,1
3,GO LIPID DIGESTION,8.1192e-05,0.42387,0.56933,1,1
3,GO REGULATION OF TISSUE REMODELING,7.5427e-07,0.42377,0.4264,1,1
3,GO L PHENYLALANINE METABOLIC PROCESS,0.00012964,0.42376,0.60681,1,1
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.010506,0.4232,0.34905,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.001872,0.42291,0.41707,1,1
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00010462,0.42166,0.34212,1,1
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,3.5759e-05,0.4207,0.36506,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00037661,0.42061,0.36126,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0011199,0.4205,0.35637,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,3.3202e-07,0.41907,0.50359,1,1
3,GO B CELL APOPTOTIC PROCESS,2.5774e-06,0.41876,0.46111,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,2.2879e-07,0.41833,0.43985,1,1
3,GO KETONE BIOSYNTHETIC PROCESS,1.7806e-05,0.41796,0.38507,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0026572,0.41788,0.39184,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0042883,0.41739,0.27,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.41626,0.25814,1,1
3,GO REGULATION OF PLATELET ACTIVATION,0.00030804,0.41524,0.35254,1,1
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.001662,0.41521,0.36311,1,1
3,GO MITOCHONDRIAL DEPOLARIZATION,2.0033e-05,0.41459,0.37611,1,1
3,GO BASIC AMINO ACID TRANSPORT,0.00079435,0.41453,0.44437,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,3.0689e-05,0.41312,0.42655,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.011047,0.4131,0.2709,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0097392,0.41293,0.2747,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,1.104e-05,0.41266,0.45935,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,3.0689e-05,0.41216,0.39353,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.014486,0.41046,0.26413,1,1
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00047456,0.40992,0.35755,1,1
3,GO NADPH REGENERATION,0.0081404,0.40961,0.25019,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.7118e-05,0.40542,0.46099,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0036303,0.40492,0.30521,1,1
3,GO CERAMIDE CATABOLIC PROCESS,0.00063551,0.40406,0.38691,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.0184e-05,0.40394,0.3793,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,3.3287e-06,0.40337,0.34588,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00017186,0.40318,0.38001,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.104e-05,0.40303,0.32825,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,3.3132e-05,0.40243,0.3339,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,4.8379e-05,0.40199,0.37853,1,1
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0015653,0.40172,0.44725,1,1
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00024286,0.40136,0.38173,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,9.0551e-05,0.40128,0.31159,1,1
3,GO IMMUNOGLOBULIN SECRETION,0.00026903,0.40067,0.33905,1,1
3,GO LIPID DROPLET ORGANIZATION,5.7413e-06,0.40002,0.36225,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,6.0504e-05,0.39978,0.43612,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,5.8301e-05,0.3995,0.39399,1,1
3,GO REGULATION OF CELL PROJECTION SIZE,0.0015653,0.39826,0.32351,1,1
3,GO INTEGRIN ACTIVATION,2.5774e-06,0.39662,0.39659,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,1.5201e-05,0.39639,0.37044,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,3.1888e-05,0.39626,0.34794,1,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0028957,0.39519,0.35509,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00069957,0.39495,0.29671,1,1
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0066042,0.3947,0.32608,1,1
3,GO BONE REMODELING,2.8077e-06,0.39431,0.38378,1,1
3,GO PHAGOSOME ACIDIFICATION,8.628e-07,0.39428,0.39598,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0006154,0.3942,0.43096,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,4.1617e-05,0.39391,0.34574,1,1
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,8.1192e-05,0.39246,0.41325,1,1
3,GO PROTEIN DEMANNOSYLATION,2.1663e-05,0.3922,0.40434,1,1
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.001228,0.39162,0.33174,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0006154,0.39153,0.30852,1,1
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,2.8418e-05,0.39031,0.33645,1,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.00010092,0.39018,0.40741,1,1
3,GO STEROID HORMONE SECRETION,5.8301e-05,0.38984,0.39378,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00012512,0.38936,0.37998,1,1
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.016734,0.38885,0.3296,1,1
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.041093,0.38868,0.31389,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0021689,0.38843,0.37676,1,1
3,GO BLOOD VESSEL REMODELING,4.0073e-05,0.38839,0.34919,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.8418e-05,0.38766,0.30628,1,1
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0030654,0.38758,0.35578,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,2.4346e-05,0.38678,0.37067,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00044439,0.38479,0.3724,1,1
3,GO ACUTE PHASE RESPONSE,8.4205e-05,0.38449,0.34219,1,1
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00026003,0.3843,0.2757,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00036427,0.38385,0.3035,1,1
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.02166,0.38317,0.26856,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.0689e-05,0.3829,0.38071,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.014486,0.3812,0.22941,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,5.0226e-05,0.38111,0.36694,1,1
3,GO N GLYCAN PROCESSING,0.00081984,0.38045,0.32066,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,3.3132e-05,0.38008,0.31873,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.00029782,0.38006,0.33492,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0014738,0.3799,0.31653,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00019079,0.37901,0.36114,1,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00016023,0.37899,0.3416,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,5.8301e-05,0.37898,0.31918,1,1
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0015189,0.37791,0.25045,1,1
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00041602,0.37767,0.28263,1,1
3,GO DEFENSE RESPONSE TO VIRUS,0.00016595,0.37746,0.26991,1,1
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0024367,0.37711,0.37021,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,5.4121e-05,0.37669,0.33384,1,1
3,GO PHOSPHOLIPID EFFLUX,0.00011241,0.37666,0.4075,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00025131,0.37511,0.37166,1,1
3,GO RESPONSE TO INTERLEUKIN 2,0.00032948,0.3739,0.27494,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00011241,0.37352,0.31988,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.00063551,0.37222,0.27198,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00012964,0.37179,0.31586,1,1
3,GO THYMOCYTE APOPTOTIC PROCESS,0.001662,0.37179,0.28314,1,1
3,GO REGULATION OF ENDOCRINE PROCESS,1.7806e-05,0.37138,0.30379,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.3218e-05,0.37138,0.33764,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00017796,0.37118,0.34984,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,5.8301e-05,0.37101,0.33657,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,9.7346e-05,0.37064,0.35829,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00052342,0.37059,0.27448,1,1
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0050528,0.37011,0.3893,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00026003,0.36985,0.32964,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00079435,0.36955,0.38994,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,2.6307e-05,0.36925,0.38103,1,1
3,GO TISSUE REMODELING,6.4994e-06,0.36879,0.33439,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033166,0.36842,0.30694,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.5774e-06,0.36775,0.3193,1,1
3,GO RESPONSE TO REDOX STATE,0.0085714,0.36757,0.25442,1,1
3,GO OSTEOBLAST PROLIFERATION,0.00010462,0.36707,0.34573,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0007696,0.367,0.3944,1,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.0311e-06,0.36681,0.36737,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,7.547e-05,0.36656,0.38521,1,1
3,GO RESPONSE TO MUSCLE ACTIVITY,0.0025817,0.36634,0.26605,1,1
3,GO ENTRY INTO HOST,0.00072223,0.36551,0.25157,1,1
3,GO ICOSANOID METABOLIC PROCESS,5.0683e-06,0.36543,0.37255,1,1
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0015189,0.36493,0.34785,1,1
3,GO SNARE COMPLEX ASSEMBLY,0.00059588,0.36458,0.27379,1,1
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0011549,0.36413,0.35195,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00023468,0.3639,0.31707,1,1
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00034072,0.36383,0.33357,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00044439,0.36356,0.37907,1,1
3,GO PROTEIN AUTOPROCESSING,1.8521e-05,0.36317,0.40054,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.6597e-05,0.36275,0.28576,1,1
3,GO DIGESTION,4.4878e-05,0.36271,0.31021,1,1
3,GO MYOBLAST FUSION,0.00035231,0.36151,0.27797,1,1
3,GO RESPONSE TO DEXAMETHASONE,9.389e-05,0.3613,0.3146,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0045306,0.36125,0.28959,1,1
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0021062,0.36097,0.35153,1,1
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00020448,0.3606,0.36869,1,1
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,3.7145e-05,0.35991,0.41458,1,1
3,GO PROTEIN HYDROXYLATION,0.0016129,0.35935,0.28703,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.0001165,0.35792,0.30124,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00044439,0.35791,0.38814,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0050528,0.35783,0.25518,1,1
3,GO VASCULAR TRANSPORT,0.0030654,0.3572,0.3419,1,1
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.015574,0.35588,0.17796,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,9.0551e-05,0.35587,0.28545,1,1
3,GO RESPONSE TO STEROL DEPLETION,6.5149e-05,0.35572,0.44277,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,2.3418e-05,0.3553,0.37956,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,7.8282e-05,0.3551,0.2874,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,0.00042998,0.35504,0.29792,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.00016595,0.35501,0.2955,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,2.3418e-05,0.35421,0.38863,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00021909,0.35419,0.33016,1,1
3,GO METHIONINE METABOLIC PROCESS,5.0226e-05,0.35395,0.32618,1,1
3,GO RESPONSE TO MINERALOCORTICOID,0.0001547,0.35291,0.29154,1,1
3,GO B CELL MEDIATED IMMUNITY,6.7596e-05,0.35235,0.29828,1,1
3,GO T CELL MEDIATED IMMUNITY,0.0022332,0.35209,0.26736,1,1
3,GO ANOIKIS,1.5201e-05,0.35201,0.33558,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0012662,0.35183,0.22997,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.4994e-06,0.35161,0.31709,1,1
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.00021167,0.35124,0.32421,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00074557,0.35106,0.23646,1,1
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.00027832,0.35074,0.33735,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,0.00026903,0.35066,0.3321,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00047456,0.35064,0.24863,1,1
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.010773,0.35003,0.2531,1,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00013917,0.34965,0.24458,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00014935,0.34885,0.29062,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00012074,0.34885,0.37263,1,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00016023,0.34883,0.29371,1,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,1.2454e-05,0.34848,0.33901,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00047456,0.34837,0.28323,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.036948,0.34818,0.18286,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.2454e-05,0.3477,0.31348,1,1
3,GO RESPONSE TO INTERFERON GAMMA,0.00021167,0.34732,0.33088,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,6.0504e-05,0.34678,0.27649,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00042998,0.34613,0.39094,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.6455e-05,0.34559,0.34956,1,1
3,GO REGULATION OF LIGASE ACTIVITY,0.0022332,0.34525,0.23354,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00047456,0.34446,0.25608,1,1
3,GO RESPONSE TO LITHIUM ION,3.5759e-05,0.34401,0.42948,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00019753,0.34348,0.2891,1,1
3,GO STEROL METABOLIC PROCESS,3.7145e-05,0.34335,0.27412,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00057693,0.34278,0.31263,1,1
3,GO PLATELET DEGRANULATION,0.00023468,0.34277,0.28547,1,1
3,GO DETECTION OF BIOTIC STIMULUS,0.00025131,0.34239,0.35261,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00010462,0.34188,0.29631,1,1
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0029794,0.34181,0.29307,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,1.3441e-06,0.34169,0.38343,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0011199,0.34141,0.22493,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00040247,0.34129,0.238,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.0013872,0.34081,0.36832,1,1
3,GO REGULATION OF WOUND HEALING,4.8379e-05,0.34067,0.31079,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.4121e-05,0.34063,0.32972,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00010092,0.34043,0.30388,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,4.8612e-06,0.33964,0.29786,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0022332,0.33938,0.29751,1,1
3,GO FATTY ACID CATABOLIC PROCESS,2.2658e-06,0.33907,0.32114,1,1
3,GO RESPONSE TO PROTOZOAN,5.0226e-05,0.33897,0.28254,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00011241,0.33825,0.28476,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0011199,0.33817,0.32213,1,1
3,GO PROTEIN N LINKED GLYCOSYLATION,1.7118e-05,0.33767,0.28581,1,1
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0036303,0.33748,0.36276,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.0071468,0.33694,0.32583,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.007729,0.3369,0.25427,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,3.8583e-05,0.33641,0.32876,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00017186,0.33575,0.32219,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0021062,0.33562,0.30247,1,1
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.00049035,0.33561,0.3277,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.0576e-06,0.33557,0.25654,1,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,4.6597e-05,0.3352,0.38231,1,1
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00074557,0.33493,0.22242,1,1
3,GO STEROID METABOLIC PROCESS,1.7474e-06,0.33486,0.32335,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00069957,0.33458,0.28898,1,1
3,GO FUCOSE METABOLIC PROCESS,0.0064317,0.33445,0.31324,1,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00092958,0.33413,0.35514,1,1
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0060989,0.33377,0.28525,1,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00021909,0.33364,0.26074,1,1
3,GO VACUOLAR ACIDIFICATION,2.0784e-06,0.33349,0.3871,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.0051916,0.33335,0.23437,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.0031536,0.33322,0.2583,1,1
3,GO ETHER METABOLIC PROCESS,0.0041716,0.33312,0.23177,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,2.8077e-06,0.33282,0.27089,1,1
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00095906,0.33271,0.2543,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00013433,0.33249,0.32051,1,1
3,GO POSITIVE REGULATION OF BONE RESORPTION,7.547e-05,0.33197,0.40244,1,1
3,GO VIRAL GENOME REPLICATION,0.0010206,0.33156,0.21755,1,1
3,GO RESPONSE TO ISCHEMIA,9.0179e-06,0.33069,0.29155,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.00013433,0.33039,0.27657,1,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0017641,0.33037,0.19872,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.001228,0.33028,0.35846,1,1
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00013917,0.3297,0.33099,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,8.1192e-05,0.32923,0.30978,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00027832,0.32889,0.23306,1,1
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0021062,0.32869,0.25553,1,1
3,GO MACROPHAGE PROLIFERATION,0.014138,0.3286,0.27795,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,6.2985e-07,0.32832,0.34393,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.00044439,0.32826,0.47116,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.4039e-05,0.32825,0.29094,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.02068,0.32822,0.26483,1,1
3,GO FIBRINOLYSIS,0.034637,0.32814,0.29995,1,1
3,GO CARNITINE METABOLIC PROCESS,0.0013872,0.32807,0.27674,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,6.5149e-05,0.32753,0.39315,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00035231,0.32748,0.29222,1,1
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.010506,0.32695,0.2451,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.001986,0.32674,0.25527,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.104e-05,0.32646,0.35442,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00035231,0.32615,0.24179,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,6.7596e-05,0.32611,0.37245,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,6.5149e-05,0.32569,0.23939,1,1
3,GO UBIQUINONE METABOLIC PROCESS,4.1112e-06,0.32536,0.33811,1,1
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00020448,0.32525,0.29599,1,1
3,GO IMMUNE EFFECTOR PROCESS,3.3132e-05,0.32513,0.25006,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00057693,0.32503,0.24106,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.7118e-05,0.32489,0.30221,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0075304,0.32463,0.28742,1,1
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0059384,0.32461,0.24472,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00022676,0.32452,0.22071,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00035231,0.32418,0.24215,1,1
3,GO APICAL JUNCTION ASSEMBLY,9.389e-05,0.32402,0.33779,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.034637,0.32402,0.18215,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0007696,0.32396,0.2666,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00042998,0.32393,0.28761,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00020448,0.32393,0.28053,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.7118e-05,0.32365,0.26324,1,1
3,GO RETINOL METABOLIC PROCESS,0.00031859,0.32353,0.3996,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00030804,0.32292,0.32868,1,1
3,GO T HELPER 2 CELL DIFFERENTIATION,0.011904,0.32266,0.20148,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0064317,0.32236,0.19397,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00019079,0.3217,0.24755,1,1
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.018836,0.32158,0.32151,1,1
3,GO MUSCLE ATROPHY,0.031059,0.32131,0.21166,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.5774e-06,0.32106,0.36092,1,1
3,GO BILE ACID METABOLIC PROCESS,3.3132e-05,0.3209,0.35851,1,1
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0010528,0.32077,0.38776,1,1
3,GO EPITHELIAL CELL CELL ADHESION,0.0032441,0.32076,0.40207,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,9.0221e-07,0.32056,0.30214,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00034072,0.3198,0.33666,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00022676,0.31935,0.32059,1,1
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00010092,0.31933,0.28476,1,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0075304,0.31931,0.20645,1,1
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.00029782,0.31881,0.33311,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0033369,0.31828,0.22956,1,1
3,GO RESPONSE TO FATTY ACID,6.7596e-05,0.31799,0.26536,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0021689,0.31797,0.38584,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00069957,0.31762,0.26397,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.00038934,0.31613,0.28993,1,1
3,GO ALANINE TRANSPORT,0.00059588,0.31608,0.35297,1,1
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00052342,0.31573,0.29701,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.2524e-05,0.31526,0.27807,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,4.4712e-06,0.31519,0.2963,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0017123,0.31507,0.2547,1,1
3,GO LYTIC VACUOLE ORGANIZATION,2.3975e-07,0.31495,0.33823,1,1
3,GO CD40 SIGNALING PATHWAY,0.00095906,0.31478,0.22807,1,1
3,GO LIPID TRANSLOCATION,9.389e-05,0.31441,0.28184,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.0069616,0.3141,0.18177,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00098941,0.31392,0.21434,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,0.00074557,0.31384,0.22551,1,1
3,GO OUTER DYNEIN ARM ASSEMBLY,0.02843,0.31377,0.17546,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0011199,0.3136,0.28405,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00059588,0.31334,0.22412,1,1
3,GO INNATE IMMUNE RESPONSE,2.3418e-05,0.31309,0.24861,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.0184e-05,0.31301,0.28139,1,1
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00044439,0.31299,0.22582,1,1
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.0015189,0.31288,0.24967,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.6455e-05,0.31267,0.26525,1,1
3,GO ETHANOL METABOLIC PROCESS,0.0042883,0.31266,0.2615,1,1
3,GO STEROL TRANSPORT,2.7343e-05,0.31265,0.28893,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,2.1663e-05,0.31236,0.26813,1,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0021062,0.31213,0.26732,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,5.4121e-05,0.312,0.27775,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0024367,0.31141,0.28574,1,1
3,GO REGULATION OF B CELL ACTIVATION,5.9841e-06,0.31129,0.27219,1,1
3,GO RESPONSE TO CORTICOSTERONE,0.00059588,0.31126,0.3099,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,2.3418e-05,0.31126,0.33389,1,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,3.1888e-05,0.31125,0.33656,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0013054,0.31115,0.39369,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2962e-05,0.31107,0.28686,1,1
3,GO RESPONSE TO INTERLEUKIN 6,0.00010092,0.3106,0.32998,1,1
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0090226,0.31046,0.24347,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00028792,0.3103,0.22858,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00010462,0.31007,0.24602,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.024288,0.31003,0.21447,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.9263e-05,0.30999,0.28703,1,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0032441,0.30946,0.24214,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,7.9801e-06,0.30944,0.28634,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00012512,0.30927,0.29178,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,7.547e-05,0.3092,0.25753,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00026903,0.30907,0.29606,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.1663e-05,0.30869,0.24018,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,3.1904e-06,0.30838,0.3528,1,1
3,GO RESPONSE TO INSECTICIDE,0.00098941,0.30798,0.39513,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,3.4421e-05,0.30788,0.33327,1,1
3,GO ENDOCRINE PROCESS,7.8282e-05,0.30753,0.28018,1,1
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00059588,0.30689,0.29356,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00026903,0.3068,0.29917,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0039469,0.30673,0.28821,1,1
3,GO TYPE 2 IMMUNE RESPONSE,0.0013457,0.30662,0.27428,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.0033369,0.30651,0.28464,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00013433,0.30624,0.26539,1,1
3,GO INOSITOL METABOLIC PROCESS,5.9841e-06,0.30602,0.33601,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00067758,0.30588,0.25423,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.0045306,0.30576,0.23439,1,1
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00095906,0.30572,0.2501,1,1
3,GO TRANSCYTOSIS,1.2454e-05,0.30568,0.32445,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,4.0073e-05,0.30556,0.26839,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0011549,0.30552,0.20093,1,1
3,GO LIPID LOCALIZATION,7.5427e-07,0.30492,0.29651,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0028141,0.3049,0.28801,1,1
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00098941,0.30474,0.28694,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00023468,0.30445,0.29424,1,1
3,GO GLUTATHIONE METABOLIC PROCESS,0.0018173,0.30432,0.31967,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,2.0033e-05,0.30411,0.26306,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.00084609,0.30365,0.26476,1,1
3,GO REGULATION OF ICOSANOID SECRETION,0.00020448,0.30353,0.34044,1,1
3,GO RESPONSE TO VIRUS,0.00012074,0.30349,0.23248,1,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00072223,0.30332,0.24481,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00036427,0.30299,0.28097,1,1
3,GO INTERLEUKIN 5 PRODUCTION,0.010506,0.3027,0.23418,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00040247,0.30251,0.27491,1,1
3,GO MAGNESIUM ION TRANSPORT,0.00049035,0.30229,0.27291,1,1
3,GO B CELL HOMEOSTASIS,0.00021167,0.3019,0.26893,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0020453,0.30162,0.3157,1,1
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0047853,0.30161,0.21252,1,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.00021167,0.30158,0.2949,1,1
3,GO POSITIVE REGULATION OF CELL SIZE,2.8418e-05,0.30155,0.35367,1,1
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.007729,0.30142,0.27355,1,1
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.022165,0.30121,0.21818,1,1
3,GO LYMPHOCYTE MIGRATION,4.6597e-05,0.30101,0.2257,1,1
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.025994,0.30092,0.24272,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.6307e-05,0.30069,0.26409,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00050664,0.30045,0.35944,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0012662,0.30041,0.30683,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,1.104e-05,0.30039,0.27976,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00049035,0.30001,0.28576,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,6.5149e-05,0.29981,0.30567,1,1
3,GO SYNCYTIUM FORMATION,0.00044439,0.29948,0.21464,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,0.00038934,0.29919,0.25589,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0059384,0.29857,0.31647,1,1
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0020453,0.29855,0.32419,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,9.389e-05,0.29847,0.29432,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.0833e-05,0.29846,0.24787,1,1
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00028792,0.29835,0.34453,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.017137,0.2982,0.2499,1,1
3,GO RESPONSE TO WATER,0.03939,0.29818,0.23004,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,2.2524e-05,0.2979,0.25851,1,1
3,GO LOCOMOTOR RHYTHM,0.00021167,0.29788,0.29003,1,1
3,GO FUCOSYLATION,0.00095906,0.29784,0.3012,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,0.00030804,0.2977,0.23958,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.0042883,0.29748,0.26092,1,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.004408,0.29703,0.24325,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00072223,0.29701,0.24151,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0021062,0.297,0.22733,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.7343e-05,0.29683,0.24612,1,1
3,GO INTERLEUKIN 8 PRODUCTION,7.8282e-05,0.29592,0.27797,1,1
3,GO DIGESTIVE SYSTEM PROCESS,0.00016595,0.29564,0.26427,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0073363,0.29557,0.24509,1,1
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.017137,0.29511,0.23504,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0090226,0.29504,0.25484,1,1
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0041716,0.29493,0.28922,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.3418e-05,0.29489,0.25695,1,1
3,GO AMYLOID BETA CLEARANCE,0.001228,0.29481,0.21044,1,1
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0046564,0.29472,0.35267,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.8301e-05,0.29389,0.28822,1,1
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.547e-05,0.29358,0.23368,1,1
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0054795,0.2935,0.23841,1,1
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0034322,0.29313,0.27656,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00012074,0.29309,0.32061,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.9532e-05,0.293,0.27849,1,1
3,GO RESPONSE TO PH,0.00031859,0.29284,0.23498,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,8.1192e-05,0.29265,0.25498,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.00095906,0.29201,0.27275,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,9.389e-05,0.29136,0.2376,1,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00010092,0.29121,0.31269,1,1
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.014486,0.29116,0.20043,1,1
3,GO AMELOGENESIS,0.0017641,0.29099,0.26274,1,1
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.033166,0.29062,0.21518,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00025131,0.29032,0.26454,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00036427,0.2903,0.24988,1,1
3,GO T CELL CYTOKINE PRODUCTION,0.0081404,0.29029,0.21049,1,1
3,GO DEFENSE RESPONSE,1.104e-05,0.29016,0.23751,1,1
3,GO CYTOKINE METABOLIC PROCESS,8.1192e-05,0.29009,0.23936,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,7.8282e-05,0.29002,0.22739,1,1
3,GO REGULATION OF AMINO ACID TRANSPORT,0.0027346,0.28995,0.25265,1,1
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.0683e-06,0.28994,0.30535,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.00018427,0.28991,0.2582,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.00059588,0.28982,0.24107,1,1
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00049035,0.28963,0.24132,1,1
3,GO DOPAMINE METABOLIC PROCESS,0.00067758,0.28923,0.30545,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,2.6307e-05,0.28895,0.27477,1,1
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.0090226,0.28893,0.22034,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00079435,0.28885,0.22436,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00042998,0.2881,0.21087,1,1
3,GO MIDGUT DEVELOPMENT,0.020205,0.28808,0.25371,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.00092958,0.28806,0.23294,1,1
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0069616,0.28765,0.20346,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00029782,0.2876,0.23837,1,1
3,GO RESPONSE TO GONADOTROPIN,6.2786e-05,0.2876,0.29723,1,1
3,GO REGULATION OF EXOSOMAL SECRETION,0.0011549,0.28735,0.24342,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.0013457,0.28703,0.2766,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0010859,0.28657,0.31551,1,1
3,GO TETRAPYRROLE METABOLIC PROCESS,0.0007696,0.28647,0.27487,1,1
3,GO INTERLEUKIN 13 PRODUCTION,0.0057817,0.28639,0.23826,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.7145e-05,0.28616,0.29813,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0023671,0.28607,0.27562,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.00069957,0.28575,0.25013,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,7.2754e-05,0.28572,0.22988,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,7.3528e-06,0.2857,0.31063,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00016595,0.28535,0.29788,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,6.2786e-05,0.2853,0.26905,1,1
3,GO STEROL HOMEOSTASIS,6.2786e-05,0.28523,0.33113,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0017641,0.28508,0.23302,1,1
3,GO RESPONSE TO GROWTH HORMONE,1.1493e-05,0.28466,0.36344,1,1
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0033369,0.28462,0.28642,1,1
3,GO INSEMINATION,0.0062634,0.28433,0.25335,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.1493e-05,0.28426,0.31119,1,1
3,GO ANIMAL ORGAN REGENERATION,0.0007696,0.28415,0.20479,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.00012074,0.2841,0.23908,1,1
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0067808,0.28403,0.29269,1,1
3,GO XENOBIOTIC TRANSPORT,1.8521e-05,0.28392,0.37132,1,1
3,GO PURINE NUCLEOTIDE TRANSPORT,5.0226e-05,0.28357,0.24554,1,1
3,GO MUSCLE CELL MIGRATION,0.00072223,0.28357,0.24338,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00025131,0.28357,0.23776,1,1
3,GO OXALATE TRANSPORT,0.00029782,0.28329,0.2611,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,6.2367e-06,0.28309,0.24995,1,1
3,GO REGULATION OF CELL KILLING,0.00024286,0.28259,0.27304,1,1
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.001872,0.28249,0.20898,1,1
3,GO VASCULAR WOUND HEALING,0.001662,0.28243,0.37639,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0025083,0.28174,0.26203,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00044439,0.28171,0.31812,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00022676,0.28162,0.28644,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,4.0073e-05,0.28159,0.2708,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,3.1904e-06,0.28156,0.27281,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.00040247,0.28153,0.26137,1,1
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00029782,0.28148,0.24985,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,9.7346e-05,0.28113,0.27207,1,1
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0012662,0.28099,0.19956,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0045306,0.28049,0.24271,1,1
3,GO PH REDUCTION,1.2454e-05,0.28021,0.25705,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00013917,0.28009,0.23603,1,1
3,GO NAD BIOSYNTHETIC PROCESS,0.015574,0.27985,0.19797,1,1
3,GO RESPONSE TO CORTICOSTEROID,0.00013917,0.27977,0.23734,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0017641,0.27977,0.25437,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0099891,0.27973,0.21164,1,1
3,GO AEROBIC RESPIRATION,0.00081984,0.2788,0.24491,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00016595,0.27874,0.26428,1,1
3,GO ER NUCLEUS SIGNALING PATHWAY,0.00045924,0.27868,0.27695,1,1
3,GO CELL KILLING,2.4346e-05,0.27857,0.25496,1,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,4.8612e-06,0.27852,0.26215,1,1
3,GO CHEMOKINE PRODUCTION,0.00038934,0.27842,0.22728,1,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.010245,0.27817,0.23816,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0049174,0.27804,0.17704,1,1
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0059384,0.27785,0.29542,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.02166,0.27782,0.15857,1,1
3,GO POSITIVE REGULATION OF LIPID STORAGE,8.4205e-05,0.2774,0.28405,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00017796,0.27666,0.22718,1,1
3,GO PHOSPHOLIPID TRANSPORT,3.1904e-06,0.27628,0.25439,1,1
3,GO AMINE METABOLIC PROCESS,1.0311e-06,0.27622,0.29569,1,1
3,GO REGULATION OF CHLORIDE TRANSPORT,0.00098941,0.27578,0.36126,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00044439,0.27577,0.24562,1,1
3,GO RESPONSE TO ANGIOTENSIN,0.0038387,0.27571,0.24855,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00025131,0.27567,0.23313,1,1
3,GO REGULATION OF CELLULAR RESPIRATION,0.0023671,0.27538,0.26156,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.011904,0.27505,0.2963,1,1
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.017137,0.27495,0.18163,1,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,3.3132e-05,0.27488,0.28382,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,9.0551e-05,0.27473,0.26129,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,3.3132e-05,0.2746,0.22043,1,1
3,GO REGULATION OF ANION TRANSPORT,2.2524e-05,0.27455,0.27493,1,1
3,GO PHAGOSOME MATURATION,6.4994e-06,0.27445,0.31647,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00044439,0.27343,0.30101,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00069957,0.27341,0.20612,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.1964e-05,0.27301,0.30772,1,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0059384,0.27288,0.24242,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017549,0.2727,0.224,1,1
3,GO GLUCOSE METABOLIC PROCESS,6.5896e-07,0.27248,0.26996,1,1
3,GO HORMONE METABOLIC PROCESS,3.3132e-05,0.2723,0.30013,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0056288,0.27226,0.16924,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00014935,0.27226,0.21641,1,1
3,GO FLUID TRANSPORT,2.1663e-05,0.27208,0.25374,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,5.0683e-06,0.27174,0.24894,1,1
3,GO MACROMOLECULE DEPALMITOYLATION,8.4205e-05,0.27122,0.27948,1,1
3,GO RESPONSE TO FLUID SHEAR STRESS,0.0083534,0.27116,0.19396,1,1
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.016734,0.27114,0.19124,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,2.2524e-05,0.27087,0.25014,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,9.7801e-06,0.27087,0.24018,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.0006154,0.27083,0.27397,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.6902e-06,0.27077,0.32579,1,1
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.026586,0.27064,0.2349,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00074557,0.2706,0.24084,1,1
3,GO GLYCOSYLATION,9.3916e-06,0.27038,0.26887,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,2.8077e-06,0.27007,0.26485,1,1
3,GO SEQUESTERING OF TRIGLYCERIDE,0.0037331,0.27005,0.25933,1,1
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.010506,0.26999,0.20405,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.013139,0.26989,0.25395,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00019079,0.26988,0.22848,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.1267e-06,0.26973,0.2609,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,9.0551e-05,0.26963,0.26914,1,1
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0001165,0.26953,0.24319,1,1
3,GO SPERM CAPACITATION,0.00030804,0.26948,0.25223,1,1
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0046564,0.26942,0.24991,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0025817,0.26939,0.22308,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018173,0.26925,0.28039,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0050528,0.26903,0.23974,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0038387,0.26889,0.25111,1,1
3,GO CATECHOLAMINE UPTAKE,0.011904,0.26864,0.26325,1,1
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00074557,0.26858,0.20988,1,1
3,GO HEMOGLOBIN METABOLIC PROCESS,0.0083534,0.26843,0.22494,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00023468,0.26808,0.21917,1,1
3,GO HAIR CELL DIFFERENTIATION,0.0017641,0.26776,0.21154,1,1
3,GO DIOL METABOLIC PROCESS,0.0046564,0.26773,0.2671,1,1
3,GO CORNIFICATION,0.00057693,0.2676,0.26809,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0010859,0.26738,0.21405,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00057693,0.26698,0.25647,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.2669,0.21697,1,1
3,GO ALPHA BETA T CELL ACTIVATION,9.389e-05,0.26681,0.2372,1,1
3,GO DOPAMINE TRANSPORT,0.00072223,0.26673,0.35335,1,1
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014738,0.26654,0.2409,1,1
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.019283,0.26637,0.27822,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.9263e-05,0.26625,0.25599,1,1
3,GO AMYLOID FIBRIL FORMATION,0.013139,0.26625,0.21108,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,0.00021167,0.26601,0.32856,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00013433,0.26598,0.23267,1,1
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.0833e-05,0.26572,0.22512,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.00065623,0.26558,0.1913,1,1
3,GO ALCOHOL METABOLIC PROCESS,6.7728e-06,0.26523,0.26126,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.012203,0.26448,0.23345,1,1
3,GO FATTY ACID BETA OXIDATION,7.547e-05,0.26396,0.26773,1,1
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0050528,0.26355,0.20318,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0016129,0.26326,0.27397,1,1
3,GO GRANULOCYTE DIFFERENTIATION,0.036164,0.26308,0.17617,1,1
3,GO CHYLOMICRON ASSEMBLY,0.0042883,0.26283,0.30129,1,1
3,GO INFLAMMATORY RESPONSE,1.1964e-05,0.26276,0.23855,1,1
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00069957,0.26272,0.27801,1,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00045924,0.2627,0.30175,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.00084609,0.26248,0.28371,1,1
3,GO CELLULAR RESPONSE TO STARVATION,1.104e-05,0.26244,0.24352,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0012662,0.26238,0.1871,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0041716,0.26224,0.21568,1,1
3,GO RENAL SYSTEM PROCESS,5.4121e-05,0.26221,0.23005,1,1
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,1.7806e-05,0.26219,0.29701,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.0604e-05,0.26217,0.21835,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0006154,0.26215,0.2156,1,1
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.8583e-05,0.26213,0.23136,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,8.6584e-06,0.26213,0.28606,1,1
3,GO RESPONSE TO BACTERIUM,5.6174e-05,0.262,0.21522,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.00065623,0.26197,0.23083,1,1
3,GO PEROXISOMAL TRANSPORT,0.00013917,0.26186,0.24808,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,5.6174e-05,0.26168,0.22163,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.1776e-06,0.26155,0.25623,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,5.2139e-05,0.26152,0.20757,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0053338,0.26149,0.19267,1,1
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.013465,0.26113,0.17547,1,1
3,GO ARACHIDONIC ACID SECRETION,0.00026003,0.26088,0.25035,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.7806e-05,0.26079,0.22575,1,1
3,GO GRANULOCYTE MIGRATION,3.5759e-05,0.26065,0.22698,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0017123,0.26064,0.23707,1,1
3,GO LEUKOCYTE PROLIFERATION,0.0001547,0.26046,0.21123,1,1
3,GO NEUTRAL AMINO ACID TRANSPORT,0.0053338,0.26044,0.28232,1,1
3,GO LIPID OXIDATION,2.4346e-05,0.26008,0.25698,1,1
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0014738,0.25981,0.23375,1,1
3,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0012662,0.25962,0.20886,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,2.9301e-06,0.25951,0.27565,1,1
3,GO MACROPHAGE APOPTOTIC PROCESS,0.013798,0.25951,0.21287,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,1.7806e-05,0.25893,0.23325,1,1
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0037331,0.25892,0.22599,1,1
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0050528,0.25884,0.23888,1,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.00353,0.25878,0.21298,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00098941,0.25864,0.18858,1,1
3,GO FIBROBLAST PROLIFERATION,0.0024367,0.25863,0.19558,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00028792,0.25859,0.18847,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0081404,0.25852,0.16561,1,1
3,GO MYELIN MAINTENANCE,0.0073363,0.25807,0.28486,1,1
3,GO KERATINIZATION,0.00055855,0.25781,0.23244,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0030654,0.25764,0.19277,1,1
3,GO TRANSFERRIN TRANSPORT,2.4692e-06,0.25715,0.3362,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,3.1888e-05,0.25705,0.22655,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072223,0.25695,0.20674,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0031536,0.25661,0.22204,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00052342,0.25647,0.1822,1,1
3,GO RESPONSE TO INTERLEUKIN 4,0.00022676,0.25628,0.19619,1,1
3,GO WATER HOMEOSTASIS,0.00067758,0.25618,0.23171,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00017796,0.25587,0.1864,1,1
3,GO ELECTRON TRANSPORT CHAIN,0.00017796,0.2555,0.2517,1,1
3,GO LIPID STORAGE,0.00026003,0.25546,0.25219,1,1
3,GO REGULATION OF LIPID TRANSPORT,8.7323e-05,0.25542,0.24869,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.023741,0.25532,0.21041,1,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00079435,0.25501,0.24197,1,1
3,GO REGULATION OF LIPID STORAGE,0.00047456,0.255,0.21743,1,1
3,GO CELL REDOX HOMEOSTASIS,0.00028792,0.2549,0.28901,1,1
3,GO HUMORAL IMMUNE RESPONSE,1.1493e-05,0.25444,0.24782,1,1
3,GO REGULATION OF LIPID LOCALIZATION,6.2786e-05,0.25353,0.23767,1,1
3,GO RESPONSE TO CYTOKINE,4.6597e-05,0.25328,0.21155,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00035231,0.25311,0.19934,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.00010462,0.2529,0.24725,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00047456,0.25289,0.2321,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012964,0.25232,0.19423,1,1
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.0010528,0.2522,0.20383,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.4205e-05,0.25211,0.22389,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0022992,0.25191,0.26264,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,2.5774e-06,0.25174,0.22961,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0079323,0.25172,0.21154,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,6.0504e-05,0.2517,0.22208,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.25143,0.2641,1,1
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.0551e-05,0.25115,0.26571,1,1
3,GO MUSCLE HYPERTROPHY,8.7323e-05,0.25109,0.22613,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0015189,0.25092,0.19461,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.0013054,0.25062,0.19881,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0033369,0.25041,0.19721,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.2524e-05,0.25026,0.217,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.0017123,0.25023,0.18447,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00013433,0.24984,0.23251,1,1
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,1.9263e-05,0.24974,0.33765,1,1
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.001191,0.24938,0.19431,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0049174,0.24925,0.27626,1,1
3,GO EXOCYTOSIS,2.0833e-05,0.24921,0.21029,1,1
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0015653,0.2492,0.24739,1,1
3,GO RESPONSE TO PROGESTERONE,0.0006154,0.24905,0.2369,1,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,1.349e-05,0.24878,0.21784,1,1
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00092958,0.2486,0.19903,1,1
3,GO LEUKOCYTE MIGRATION,0.00010462,0.2485,0.21513,1,1
3,GO CYTOKINE PRODUCTION,5.6174e-05,0.24837,0.22037,1,1
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.047551,0.24837,0.22394,1,1
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.012203,0.24813,0.18599,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.0015189,0.24803,0.1959,1,1
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.044685,0.24802,0.17873,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00092958,0.2479,0.32137,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00013433,0.24755,0.24749,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00087311,0.24748,0.19721,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.00010462,0.24746,0.20097,1,1
3,GO ORGANELLE MEMBRANE FUSION,0.00018427,0.24735,0.21517,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,5.2139e-05,0.24734,0.25371,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00054072,0.24719,0.1916,1,1
3,GO COAGULATION,0.00041602,0.24713,0.18554,1,1
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.00081984,0.24707,0.26428,1,1
3,GO CERAMIDE TRANSPORT,0.017549,0.24689,0.31926,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.025414,0.24686,0.14706,1,1
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001662,0.24653,0.20666,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,0.00081984,0.24641,0.21514,1,1
3,GO PROSTAGLANDIN TRANSPORT,0.0032441,0.24628,0.30026,1,1
3,GO MACROPHAGE DIFFERENTIATION,0.0079323,0.24609,0.21074,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.00021167,0.24605,0.21435,1,1
3,GO P38MAPK CASCADE,0.00055855,0.24604,0.23543,1,1
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.030383,0.24586,0.21213,1,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.00028792,0.24565,0.23998,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0001165,0.2456,0.22889,1,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,5.8301e-05,0.24538,0.2187,1,1
3,GO LIPID EXPORT FROM CELL,0.00017186,0.24485,0.3204,1,1
3,GO AMINO ACID IMPORT,0.0090226,0.24465,0.20196,1,1
3,GO B CELL ACTIVATION,2.2524e-05,0.24464,0.21056,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,1.0604e-05,0.24457,0.22175,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.021165,0.24445,0.17972,1,1
3,GO NOREPINEPHRINE SECRETION,0.0034322,0.24411,0.25744,1,1
3,GO PROTEIN ACTIVATION CASCADE,0.015953,0.2439,0.27398,1,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.023205,0.24379,0.16922,1,1
3,GO REGULATION OF FATTY ACID TRANSPORT,0.00010845,0.24341,0.35488,1,1
3,GO RESPONSE TO NUTRIENT,0.00057693,0.243,0.18993,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,4.8379e-05,0.24299,0.20764,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00016023,0.24288,0.24386,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0053338,0.24276,0.23895,1,1
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.036164,0.24193,0.15183,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,4.0073e-05,0.24188,0.2573,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00059588,0.24156,0.22092,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.001228,0.24154,0.23724,1,1
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,1.6455e-05,0.24129,0.23915,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0013457,0.24087,0.24435,1,1
3,GO CAMP BIOSYNTHETIC PROCESS,0.027803,0.24061,0.2181,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,2.7343e-05,0.24042,0.22907,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00037661,0.24034,0.20973,1,1
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,8.1192e-05,0.24032,0.2232,1,1
3,GO LIPID IMPORT INTO CELL,0.0081404,0.24018,0.23324,1,1
3,GO CELL CHEMOTAXIS,4.1617e-05,0.23979,0.21882,1,1
3,GO ERK1 AND ERK2 CASCADE,0.00095906,0.23972,0.18284,1,1
3,GO SECRETION BY TISSUE,0.0038387,0.23962,0.20551,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,3.7145e-05,0.23949,0.22977,1,1
3,GO REGULATION OF BODY FLUID LEVELS,0.00027832,0.2394,0.17988,1,1
3,GO NUCLEOTIDE TRANSPORT,8.1192e-05,0.23923,0.23506,1,1
3,GO STEROL BIOSYNTHETIC PROCESS,0.00065623,0.23895,0.23693,1,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00019079,0.23879,0.22774,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.029719,0.23869,0.13003,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.013139,0.23861,0.23276,1,1
3,GO MUSCLE ADAPTATION,0.00044439,0.2386,0.18935,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0042883,0.23857,0.19559,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,2.6307e-05,0.23839,0.27999,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0013457,0.23809,0.26852,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,3.4421e-05,0.23788,0.19458,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0060989,0.23787,0.15355,1,1
3,GO RESPONSE TO ACTIVITY,0.00054072,0.23783,0.21741,1,1
3,GO HYALURONAN METABOLIC PROCESS,0.0012662,0.23783,0.16523,1,1
3,GO KERATINOCYTE DIFFERENTIATION,0.00074557,0.23737,0.21112,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.6597e-05,0.23722,0.18526,1,1
3,GO CAMP METABOLIC PROCESS,0.0039469,0.23715,0.22806,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.00026903,0.23714,0.28605,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00014935,0.23703,0.24694,1,1
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00050664,0.23682,0.22869,1,1
3,GO ANDROGEN METABOLIC PROCESS,5.2139e-05,0.23656,0.41627,1,1
3,GO REGULATION OF DOPAMINE SECRETION,0.02268,0.23638,0.31833,1,1
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.030383,0.23615,0.17471,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.043763,0.236,0.1758,1,1
3,GO CELLULAR RESPONSE TO DSRNA,0.0067808,0.23578,0.18102,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0010528,0.23572,0.23415,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.00087311,0.23568,0.19402,1,1
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.027188,0.23554,0.23031,1,1
3,GO ER OVERLOAD RESPONSE,0.0018173,0.23538,0.26943,1,1
3,GO CELL ACTIVATION,7.2754e-05,0.23495,0.19527,1,1
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0017641,0.2349,0.27255,1,1
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.010773,0.2347,0.24704,1,1
3,GO INTERACTION WITH HOST,0.0014299,0.2347,0.17271,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0049174,0.23437,0.27423,1,1
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0064317,0.23432,0.21253,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,9.7801e-06,0.23406,0.27381,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00079435,0.23404,0.22932,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00074557,0.23365,0.28179,1,1
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00055855,0.23319,0.17546,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,2.7343e-05,0.23298,0.20971,1,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.026586,0.23282,0.1661,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,6.2786e-05,0.23272,0.22702,1,1
3,GO RENAL SODIUM EXCRETION,0.00059588,0.23257,0.22487,1,1
3,GO PEROXISOME ORGANIZATION,0.00016023,0.23248,0.23128,1,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00054072,0.23238,0.20253,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.012508,0.2321,0.16159,1,1
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.00069957,0.23208,0.20153,1,1
3,GO PARTURITION,0.041093,0.23201,0.18349,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0010206,0.23199,0.294,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.00014418,0.23199,0.19612,1,1
3,GO REGULATION OF IMMUNE RESPONSE,0.00019753,0.23182,0.17801,1,1
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0099891,0.23178,0.205,1,1
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0028957,0.23145,0.25416,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.001872,0.23137,0.21144,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.001872,0.23116,0.19626,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,8.1192e-05,0.23114,0.25723,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015653,0.23113,0.21912,1,1
3,GO PEPTIDE SECRETION,6.2367e-06,0.23109,0.21112,1,1
3,GO SODIUM ION HOMEOSTASIS,0.0010528,0.23089,0.20073,1,1
3,GO REGULATION OF FERTILIZATION,0.001191,0.23082,0.29512,1,1
3,GO LIPID HOMEOSTASIS,7.547e-05,0.23082,0.24669,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0081404,0.23082,0.24671,1,1
3,GO B CELL DIFFERENTIATION,1.1964e-05,0.23078,0.22142,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,3.3132e-05,0.23047,0.21221,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00022676,0.23046,0.18257,1,1
3,GO MEMBRANE FUSION,5.2139e-05,0.23036,0.2074,1,1
3,GO NEUTROPHIL MIGRATION,1.349e-05,0.23035,0.21762,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,6.2786e-05,0.23029,0.23109,1,1
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.00090094,0.2302,0.21301,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,2.8418e-05,0.22999,0.23921,1,1
3,GO REGULATION OF PH,5.0683e-06,0.22996,0.22635,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00065623,0.22994,0.19836,1,1
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00024286,0.22987,0.22775,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00028792,0.22977,0.20773,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0023671,0.22947,0.27756,1,1
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.001872,0.22929,0.29044,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,8.1192e-05,0.22909,0.25112,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.001872,0.22878,0.19907,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.010773,0.22868,0.21724,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00026003,0.22861,0.19373,1,1
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00098941,0.22852,0.21964,1,1
3,GO REGULATION OF DEFENSE RESPONSE,4.0073e-05,0.22839,0.20411,1,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0010206,0.22835,0.22274,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.036164,0.22814,0.26731,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00026903,0.22786,0.18891,1,1
3,GO TISSUE HOMEOSTASIS,0.00026003,0.22779,0.19228,1,1
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0013457,0.2277,0.1854,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0062634,0.22742,0.16396,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0029794,0.2274,0.17904,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.0085714,0.22721,0.17873,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0014299,0.2272,0.17151,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.0226e-05,0.22705,0.22806,1,1
3,GO POSITIVE REGULATION OF MITOPHAGY,0.001662,0.22701,0.22023,1,1
3,GO STORE OPERATED CALCIUM ENTRY,0.012508,0.22683,0.20663,1,1
3,GO WOUND HEALING,0.0010528,0.22651,0.17422,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.0006154,0.2264,0.20953,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.014138,0.22635,0.19639,1,1
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.02843,0.22606,0.13728,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00019753,0.22601,0.24144,1,1
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00018427,0.22568,0.21659,1,1
3,GO COMPLEMENT ACTIVATION,0.00353,0.2255,0.22615,1,1
3,GO PLATELET MORPHOGENESIS,0.00074557,0.22533,0.24107,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.0057817,0.22523,0.22335,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00030804,0.22512,0.16835,1,1
3,GO POSITIVE CHEMOTAXIS,0.0039469,0.22497,0.1611,1,1
3,GO PIGMENTATION,0.00021909,0.22479,0.17586,1,1
3,GO SELECTIVE AUTOPHAGY,0.00011241,0.2246,0.22963,1,1
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00027832,0.22459,0.28581,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0014299,0.2243,0.22504,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0033369,0.22358,0.17401,1,1
3,GO CATECHOLAMINE METABOLIC PROCESS,0.0010528,0.22339,0.27564,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00052342,0.22307,0.18368,1,1
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00069957,0.22282,0.31039,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.5308e-05,0.2227,0.23526,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.00031859,0.22259,0.20834,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00021167,0.22232,0.28903,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0006154,0.22229,0.15877,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.001228,0.22227,0.15974,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00021909,0.22226,0.21982,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00090094,0.2222,0.20583,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00084609,0.22212,0.14701,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.00072223,0.22206,0.20156,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00042998,0.22198,0.18254,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.026586,0.22191,0.18073,1,1
3,GO PROTEIN PROCESSING,1.0184e-05,0.22164,0.26667,1,1
3,GO REGULATION OF PROTEOLYSIS,7.8282e-05,0.22162,0.18448,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.00074557,0.22152,0.19673,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.00019753,0.2214,0.18082,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.00014418,0.22129,0.23113,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00081984,0.22115,0.18788,1,1
3,GO REGULATION OF NUCLEASE ACTIVITY,0.0021689,0.22077,0.18488,1,1
3,GO REGULATION OF EXCRETION,0.0069616,0.22068,0.18352,1,1
3,GO REGULATION OF CELL ADHESION,0.00087311,0.2206,0.16737,1,1
3,GO ORGANELLE FUSION,0.00020448,0.22058,0.18899,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,5.4121e-05,0.22052,0.18367,1,1
3,GO SENSORY PERCEPTION OF SMELL,1.7806e-05,0.22047,0.20898,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00031859,0.22046,0.20752,1,1
3,GO INTERLEUKIN 6 PRODUCTION,0.00079435,0.22038,0.18782,1,1
3,GO PEPTIDYL PROLINE MODIFICATION,0.012508,0.21997,0.15562,1,1
3,GO REGULATION OF CELLULAR PH,5.2837e-06,0.21993,0.2244,1,1
3,GO REGULATION OF TUBE SIZE,8.4205e-05,0.2199,0.22924,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.0024367,0.21975,0.19781,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.3218e-05,0.2196,0.19543,1,1
3,GO PLATELET AGGREGATION,0.0054795,0.21954,0.17867,1,1
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0011549,0.21932,0.25383,1,1
3,GO T CELL MIGRATION,0.0016129,0.21892,0.19992,1,1
3,GO REGULATION OF CELL CELL ADHESION,0.00067758,0.21881,0.18472,1,1
3,GO RESPONSE TO STARVATION,2.5308e-05,0.21879,0.23202,1,1
3,GO VITAMIN TRANSPORT,0.0069616,0.21861,0.20984,1,1
3,GO ATP BIOSYNTHETIC PROCESS,0.0069616,0.21852,0.19697,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0079323,0.21841,0.30284,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0001165,0.21835,0.23634,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.6174e-05,0.21806,0.1969,1,1
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.036164,0.21795,0.13642,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.001191,0.21788,0.18142,1,1
3,GO PROTEIN KINASE B SIGNALING,0.00090094,0.21771,0.16122,1,1
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.011326,0.21759,0.17581,1,1
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.03939,0.21756,0.17994,1,1
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00018427,0.21722,0.21758,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0040578,0.21712,0.18364,1,1
3,GO REGULATION OF PROTON TRANSPORT,0.040234,0.21695,0.16697,1,1
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.0013054,0.21693,0.1757,1,1
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00014418,0.21676,0.2368,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.0028957,0.21673,0.20038,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0015653,0.21655,0.19123,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,2.8077e-06,0.21645,0.24743,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00013917,0.21644,0.23408,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00026903,0.2164,0.23119,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,9.0551e-05,0.21635,0.22342,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0015189,0.2163,0.2273,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.0057817,0.2163,0.19738,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.21627,0.19407,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0066042,0.21599,0.21346,1,1
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.0045306,0.21592,0.15029,1,1
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0033369,0.21587,0.28389,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.0013457,0.21576,0.2247,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,3.3132e-05,0.21557,0.19535,1,1
3,GO SKIN DEVELOPMENT,0.0036303,0.2152,0.15091,1,1
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0001547,0.21504,0.24416,1,1
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0039469,0.21477,0.27499,1,1
3,GO REGULATION OF CELL ACTIVATION,0.00042998,0.21471,0.16322,1,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0087944,0.21469,0.16922,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.00042998,0.21461,0.18611,1,1
3,GO SPLEEN DEVELOPMENT,0.0021062,0.21429,0.19538,1,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00035231,0.21412,0.2519,1,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00098941,0.21394,0.23564,1,1
3,GO RESPONSE TO CHEMOKINE,3.5759e-05,0.21361,0.21436,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0094949,0.21343,0.19417,1,1
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.014841,0.21307,0.25239,1,1
3,GO CARNITINE SHUTTLE,0.001191,0.21282,0.24811,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00084609,0.21258,0.18163,1,1
3,GO EPIDERMIS DEVELOPMENT,0.001986,0.2125,0.16364,1,1
3,GO CYTOPLASM ORGANIZATION,0.041093,0.21247,0.1833,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0031536,0.21239,0.19542,1,1
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0067808,0.21234,0.16838,1,1
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0033369,0.21211,0.16186,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0021062,0.21187,0.17307,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00095906,0.21183,0.16879,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00016023,0.2117,0.25001,1,1
3,GO FATTY ACID TRANSPORT,2.1663e-05,0.21164,0.23516,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.001986,0.21148,0.25703,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,1.9263e-05,0.21148,0.19116,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.001191,0.21138,0.17147,1,1
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0049174,0.21135,0.20389,1,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.014138,0.21131,0.17071,1,1
3,GO ANION HOMEOSTASIS,0.0073363,0.21126,0.18307,1,1
3,GO LYMPHOCYTE ACTIVATION,0.00031859,0.21124,0.15536,1,1
3,GO SULFUR COMPOUND TRANSPORT,0.00012512,0.21092,0.21492,1,1
3,GO GOLGI VESICLE BUDDING,7.8282e-05,0.21087,0.22641,1,1
3,GO HORMONE BIOSYNTHETIC PROCESS,0.0016129,0.21069,0.23697,1,1
3,GO ENERGY HOMEOSTASIS,0.0050528,0.21066,0.20392,1,1
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00090094,0.21049,0.19741,1,1
3,GO REGULATION OF HORMONE SECRETION,6.5149e-05,0.21048,0.19425,1,1
3,GO VIRION ASSEMBLY,0.00065623,0.21033,0.16037,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00012074,0.21027,0.20271,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00032948,0.21027,0.16762,1,1
3,GO RESPONSE TO INSULIN,5.2139e-05,0.21012,0.17832,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.104e-05,0.21008,0.20134,1,1
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.031059,0.21004,0.13245,1,1
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00034072,0.20991,0.20465,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00072223,0.20976,0.17649,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.7323e-05,0.20973,0.17092,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.0028957,0.20964,0.18951,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00087311,0.20959,0.24289,1,1
3,GO KERATINOCYTE MIGRATION,0.0025083,0.2094,0.18324,1,1
3,GO DEVELOPMENTAL PIGMENTATION,0.0015189,0.20926,0.16169,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.547e-05,0.20893,0.17919,1,1
3,GO GLIAL CELL PROLIFERATION,0.02068,0.20877,0.17284,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0010859,0.20852,0.25597,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0010206,0.2085,0.13726,1,1
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00035231,0.20848,0.20244,1,1
3,GO NECROTIC CELL DEATH,0.00074557,0.2083,0.23749,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,1.0184e-05,0.20817,0.2166,1,1
3,GO REGULATION OF PEPTIDE SECRETION,1.0604e-05,0.20813,0.20381,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.0064317,0.20808,0.22395,1,1
3,GO T CELL ACTIVATION,0.00047456,0.20803,0.17587,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0006154,0.20784,0.17817,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0060989,0.20783,0.16539,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,2.2524e-05,0.20766,0.19313,1,1
3,GO T CELL DIFFERENTIATION,0.00016023,0.20746,0.16276,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,5.0683e-06,0.20669,0.21809,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00092958,0.20666,0.15021,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.015203,0.20644,0.1577,1,1
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.0081404,0.2064,0.16009,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00037661,0.20638,0.19282,1,1
3,GO VIRAL LIFE CYCLE,0.00065623,0.20636,0.16854,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.00074557,0.20608,0.17041,1,1
3,GO CELLULAR RESPIRATION,0.0021689,0.20602,0.19789,1,1
3,GO RESPONSE TO TESTOSTERONE,0.0085714,0.206,0.16192,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0018173,0.20599,0.15983,1,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0013457,0.20584,0.19724,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.0026572,0.20557,0.16281,1,1
3,GO DRINKING BEHAVIOR,0.0031536,0.20523,0.29001,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.0001547,0.20514,0.20411,1,1
3,GO IRON ION TRANSPORT,6.5149e-05,0.20503,0.23605,1,1
3,GO ENDOCYTIC RECYCLING,0.0010206,0.20491,0.15905,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,4.4712e-06,0.20469,0.23605,1,1
3,GO CELL CELL ADHESION,0.0031536,0.20465,0.13379,1,1
3,GO RESPONSE TO KETONE,0.00037661,0.20446,0.18457,1,1
3,GO OXIDATION REDUCTION PROCESS,1.2962e-05,0.20394,0.22776,1,1
3,GO MITOPHAGY,0.0049174,0.20385,0.17614,1,1
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.026586,0.20362,0.14337,1,1
3,GO FATTY ACID METABOLIC PROCESS,2.0833e-05,0.20344,0.25112,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00024286,0.20342,0.20655,1,1
3,GO REGULATION OF CARDIAC CONDUCTION,0.0006154,0.20341,0.19324,1,1
3,GO NATURAL KILLER CELL ACTIVATION,0.00041602,0.20326,0.18728,1,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.012203,0.20324,0.16813,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00041602,0.20321,0.19497,1,1
3,GO PSEUDOPODIUM ORGANIZATION,0.045624,0.2023,0.22066,1,1
3,GO CYTOKINE SECRETION,0.00072223,0.20228,0.19295,1,1
3,GO CARBOHYDRATE TRANSPORT,2.5308e-05,0.20216,0.23935,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00023468,0.20205,0.23365,1,1
3,GO RESPONSE TO INTERLEUKIN 1,0.00028792,0.20183,0.17347,1,1
3,GO DENDRITIC CELL MIGRATION,0.014486,0.20167,0.14167,1,1
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00055855,0.20149,0.23563,1,1
3,GO SECRETION,2.0833e-05,0.20146,0.18295,1,1
3,GO POSITIVE REGULATION OF HEART RATE,0.019739,0.20133,0.22608,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.016734,0.20125,0.13452,1,1
3,GO PLASMA MEMBRANE ORGANIZATION,0.00095906,0.20122,0.18062,1,1
3,GO RESPONSE TO STEROL,0.0023671,0.20111,0.22289,1,1
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.041967,0.20103,0.18745,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.03939,0.20099,0.16644,1,1
3,GO INSULIN SECRETION,0.00023468,0.2009,0.19018,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0042883,0.20083,0.16705,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0021062,0.20073,0.14635,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00074557,0.2007,0.16735,1,1
3,GO REGULATION OF VASCULAR PERMEABILITY,0.00031859,0.20068,0.24986,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00010092,0.20062,0.19515,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,3.4421e-05,0.20053,0.20288,1,1
3,GO PLATELET ACTIVATION,0.0020453,0.2003,0.1695,1,1
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0027346,0.2001,0.2025,1,1
3,GO GPI ANCHOR METABOLIC PROCESS,0.0032441,0.20009,0.19232,1,1
3,GO REGULATION OF GLUCONEOGENESIS,7.013e-05,0.19986,0.2518,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00035231,0.19979,0.17193,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0032441,0.19948,0.27745,1,1
3,GO BICARBONATE TRANSPORT,0.0039469,0.19943,0.20859,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00018427,0.19911,0.22792,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0032441,0.19894,0.13905,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.019739,0.19877,0.15021,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00026003,0.19859,0.15963,1,1
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0083534,0.19849,0.15253,1,1
3,GO ACETYL COA METABOLIC PROCESS,0.0027346,0.19848,0.19181,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0040578,0.19835,0.17839,1,1
3,GO ORGANIC ANION TRANSPORT,4.2876e-06,0.1982,0.22242,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00054072,0.19805,0.21669,1,1
3,GO RESPONSE TO WOUNDING,0.0021062,0.19804,0.15279,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00027832,0.19782,0.17415,1,1
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.00353,0.19778,0.14943,1,1
3,GO POSITIVE REGULATION OF SECRETION,2.1663e-05,0.19774,0.19591,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.0017641,0.19768,0.13484,1,1
3,GO LYMPHOCYTE CHEMOTAXIS,0.019739,0.19763,0.1152,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.001986,0.19761,0.15018,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,0.00010462,0.1973,0.21664,1,1
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.00021167,0.19724,0.1779,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.104e-05,0.19715,0.21018,1,1
3,GO PROTEIN MATURATION,2.5308e-05,0.19708,0.21717,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.8521e-05,0.197,0.18767,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00018427,0.19687,0.19344,1,1
3,GO GLUTAMATE METABOLIC PROCESS,0.0011199,0.19685,0.19087,1,1
3,GO RESPONSE TO ALCOHOL,0.00026003,0.19679,0.1568,1,1
3,GO CELLULAR RESPONSE TO VIRUS,0.00069957,0.19652,0.18947,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.00026903,0.19645,0.15508,1,1
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.012203,0.19627,0.1881,1,1
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0083534,0.19618,0.17028,1,1
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.010245,0.19612,0.27948,1,1
3,GO HORMONE TRANSPORT,5.4121e-05,0.196,0.20402,1,1
3,GO LIPID METABOLIC PROCESS,2.5308e-05,0.196,0.20219,1,1
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0039469,0.19559,0.23419,1,1
3,GO REGULATION OF T CELL MIGRATION,0.01282,0.19553,0.16089,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00030804,0.19549,0.20911,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0028141,0.19541,0.18788,1,1
3,GO TERPENOID METABOLIC PROCESS,0.0059384,0.19523,0.18144,1,1
3,GO REGULATION OF HEART RATE,0.001662,0.19512,0.20099,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.017137,0.19506,0.13391,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,2.1663e-05,0.19491,0.22908,1,1
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0027346,0.1949,0.20026,1,1
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.9263e-05,0.19444,0.2469,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.036948,0.19438,0.15583,1,1
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.020205,0.19403,0.12878,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,1.4609e-05,0.19385,0.24609,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.0027346,0.19385,0.20412,1,1
3,GO RESPONSE TO STEROID HORMONE,0.00017186,0.19384,0.1822,1,1
3,GO REGULATION OF BLOOD PRESSURE,3.7145e-05,0.19356,0.20509,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00081984,0.19343,0.14877,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.010245,0.19332,0.12877,1,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00019079,0.19327,0.19847,1,1
3,GO BROWN FAT CELL DIFFERENTIATION,0.0040578,0.19325,0.19215,1,1
3,GO CYTOLYSIS,0.03245,0.19314,0.17764,1,1
3,GO COPII COATED VESICLE BUDDING,0.00026003,0.19304,0.20842,1,1
3,GO POLYAMINE METABOLIC PROCESS,0.001986,0.19295,0.20825,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0056288,0.19275,0.1781,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.00023468,0.19269,0.14274,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00034072,0.19256,0.18527,1,1
3,GO REGULATION OF MITOPHAGY,0.004408,0.19251,0.17472,1,1
3,GO TISSUE MIGRATION,0.001986,0.19242,0.16475,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0067808,0.19231,0.16246,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,4.8379e-05,0.1922,0.18249,1,1
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.0022332,0.19201,0.19773,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0010859,0.19188,0.18886,1,1
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.038561,0.19179,0.21598,1,1
3,GO INORGANIC ANION TRANSPORT,2.5308e-05,0.19169,0.17581,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00031859,0.19148,0.18188,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00024286,0.19138,0.15638,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00072223,0.19123,0.19594,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.001872,0.19121,0.1463,1,1
3,GO AGING,2.8418e-05,0.19118,0.17088,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,1.1964e-05,0.19115,0.28098,1,1
3,GO INCLUSION BODY ASSEMBLY,0.019283,0.19105,0.24292,1,1
3,GO LYSOSOME LOCALIZATION,0.00026003,0.19079,0.18065,1,1
3,GO CHLORIDE TRANSPORT,8.4205e-05,0.19046,0.17045,1,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.013465,0.19046,0.23381,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00052342,0.19043,0.16734,1,1
3,GO REGULATION OF HORMONE LEVELS,4.8612e-06,0.19042,0.23667,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,8.1192e-05,0.19031,0.17646,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,2.9532e-05,0.19022,0.20467,1,1
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0021689,0.1902,0.18985,1,1
3,GO ADAPTIVE THERMOGENESIS,4.8379e-05,0.19012,0.19476,1,1
3,GO CELLULAR RESPONSE TO IRON ION,0.036948,0.1901,0.1789,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,5.8301e-05,0.18982,0.16723,1,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0014738,0.1898,0.17854,1,1
3,GO MONOAMINE TRANSPORT,0.0028141,0.18947,0.26263,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00014418,0.18946,0.16598,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.026586,0.18934,0.12298,1,1
3,GO REGULATION OF STEROL TRANSPORT,0.0051916,0.18847,0.16637,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.00049035,0.18831,0.16658,1,1
3,GO REGULATION OF VASOCONSTRICTION,0.00021909,0.18808,0.22375,1,1
3,GO STRIATED MUSCLE ADAPTATION,0.0030654,0.18795,0.20138,1,1
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0006154,0.18789,0.19423,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.0014738,0.18775,0.16196,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0010528,0.1877,0.1976,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.7346e-05,0.18757,0.18769,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0023671,0.18754,0.18554,1,1
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.029068,0.18728,0.11936,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.034637,0.18727,0.26122,1,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.035393,0.18709,0.14174,1,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0090226,0.18658,0.15679,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00063551,0.18653,0.14833,1,1
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0075304,0.18638,0.18556,1,1
3,GO VACUOLE ORGANIZATION,3.6228e-06,0.18629,0.23028,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.00021167,0.18625,0.22602,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.013798,0.18592,0.16833,1,1
3,GO RIG I SIGNALING PATHWAY,0.010245,0.18579,0.12877,1,1
3,GO NIK NF KAPPAB SIGNALING,0.00098941,0.18571,0.14995,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0062634,0.18541,0.15571,1,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.004408,0.18541,0.17281,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,6.7596e-05,0.18537,0.20458,1,1
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.031748,0.18514,0.18241,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.010245,0.1847,0.12854,1,1
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0053338,0.18464,0.27144,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,5.4121e-05,0.18452,0.16691,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00049035,0.18424,0.15174,1,1
3,GO GOLGI TO VACUOLE TRANSPORT,0.0081404,0.18415,0.1687,1,1
3,GO MANGANESE ION TRANSPORT,0.0046564,0.18384,0.18788,1,1
3,GO IMMUNOGLOBULIN PRODUCTION,0.00010092,0.18381,0.1715,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.0010528,0.1836,0.16152,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0029794,0.18355,0.11872,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0021062,0.18346,0.20292,1,1
3,GO CATECHOLAMINE SECRETION,0.0050528,0.18323,0.28412,1,1
3,GO RESPONSE TO MECHANICAL STIMULUS,6.5149e-05,0.18318,0.20258,1,1
3,GO NEUTROPHIL CHEMOTAXIS,0.0001547,0.18307,0.15142,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.019283,0.183,0.21896,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,8.7323e-05,0.18299,0.16183,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0090226,0.18269,0.19862,1,1
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.015953,0.18264,0.14452,1,1
3,GO PEPTIDE HORMONE SECRETION,0.00020448,0.1823,0.18285,1,1
3,GO ANION TRANSPORT,5.7413e-06,0.18226,0.20187,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0013872,0.18223,0.14185,1,1
3,GO REGULATION OF VACUOLE ORGANIZATION,0.0013872,0.18214,0.17827,1,1
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0081404,0.18201,0.18281,1,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0027346,0.18174,0.19449,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00010462,0.18139,0.22622,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0079323,0.18135,0.24014,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00022676,0.18135,0.18973,1,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0025817,0.18111,0.13471,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.0017641,0.18068,0.1411,1,1
3,GO CHEMICAL HOMEOSTASIS,3.5759e-05,0.18046,0.16747,1,1
3,GO RESPONSE TO LIPID,0.00045924,0.1803,0.15103,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.0016129,0.17997,0.13546,1,1
3,GO REGULATION OF HEMOPOIESIS,0.00059588,0.17996,0.13504,1,1
3,GO LIPID CATABOLIC PROCESS,9.0179e-06,0.17976,0.23783,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.5308e-05,0.17943,0.18265,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.011047,0.17941,0.15951,1,1
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0062634,0.17939,0.16954,1,1
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,7.8282e-05,0.17886,0.19589,1,1
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.013465,0.17876,0.19619,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00012074,0.17857,0.14709,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0046564,0.17825,0.15105,1,1
3,GO RESPONSE TO ETHER,0.0027346,0.17797,0.1838,1,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00031859,0.17786,0.23231,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.00014935,0.1776,0.1646,1,1
3,GO RESPONSE TO METAL ION,0.00011241,0.17748,0.18975,1,1
3,GO ENDOSOME ORGANIZATION,0.00065623,0.17737,0.16772,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,7.547e-05,0.17709,0.18452,1,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.036948,0.17704,0.20996,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00044439,0.17703,0.17477,1,1
3,GO T CELL APOPTOTIC PROCESS,0.0071468,0.17702,0.16675,1,1
3,GO CELLULAR PIGMENTATION,0.00055855,0.17671,0.18054,1,1
3,GO CHOLESTEROL STORAGE,0.009256,0.17658,0.2078,1,1
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.040234,0.17642,0.14319,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0099891,0.17621,0.10392,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.046579,0.17608,0.15531,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00069957,0.17595,0.16867,1,1
3,GO PHAGOCYTOSIS,0.0038387,0.17591,0.13848,1,1
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0020453,0.17546,0.17527,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.00079435,0.17517,0.13433,1,1
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.00072223,0.17483,0.18441,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00030804,0.17477,0.17594,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00042998,0.17456,0.13986,1,1
3,GO LYMPH NODE DEVELOPMENT,0.0057817,0.17442,0.21399,1,1
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.016734,0.17435,0.14526,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00031859,0.17433,0.17416,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.019739,0.17379,0.12966,1,1
3,GO MULTI ORGANISM CELLULAR PROCESS,0.02166,0.17377,0.13378,1,1
3,GO METAL ION HOMEOSTASIS,0.00025131,0.17373,0.13614,1,1
3,GO MACROPHAGE ACTIVATION,0.00038934,0.17371,0.18149,1,1
3,GO MULTIVESICULAR BODY ORGANIZATION,0.0041716,0.17288,0.13114,1,1
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0075304,0.17275,0.16699,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00036427,0.17247,0.13869,1,1
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0020453,0.17243,0.13763,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.00025131,0.17234,0.17754,1,1
3,GO INTERFERON GAMMA PRODUCTION,0.0050528,0.17226,0.134,1,1
3,GO RESPONSE TO DRUG,0.00035231,0.17205,0.16548,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0025083,0.17181,0.18559,1,1
3,GO RETINA HOMEOSTASIS,0.013465,0.17181,0.086948,1,1
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0022332,0.17171,0.13521,1,1
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.031748,0.1716,0.14079,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.00016023,0.17135,0.16795,1,1
3,GO AMINE TRANSPORT,0.0038387,0.17131,0.24096,1,1
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.030383,0.17114,0.11081,1,1
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0032441,0.17048,0.38798,1,1
3,GO EXCRETION,0.0001547,0.17046,0.20138,1,1
3,GO REGULATION OF INSULIN SECRETION,0.00074557,0.17038,0.16543,1,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00037661,0.17026,0.17157,1,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.027803,0.17025,0.14403,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,5.0226e-05,0.16996,0.16256,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0021062,0.16973,0.14715,1,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.03939,0.16973,0.099159,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00024286,0.16965,0.16252,1,1
3,GO ACID SECRETION,0.0014299,0.1694,0.17985,1,1
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0039469,0.16937,0.16421,1,1
3,GO ATP TRANSPORT,0.02843,0.16918,0.10754,1,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.0023671,0.16906,0.19515,1,1
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0071468,0.16887,0.18624,1,1
3,GO BIOLOGICAL ADHESION,0.0067808,0.16867,0.11451,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.00038934,0.16856,0.17117,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,9.7346e-05,0.16848,0.2025,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,8.1192e-05,0.16835,0.15789,1,1
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.015953,0.16794,0.12522,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00013433,0.16777,0.20626,1,1
3,GO LACTATE METABOLIC PROCESS,0.045624,0.16776,0.14454,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0015653,0.16772,0.16897,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,4.8612e-06,0.16763,0.18967,1,1
3,GO RESPONSE TO FUNGUS,0.0019282,0.16747,0.14832,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00095906,0.16743,0.24454,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00010462,0.16741,0.16772,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00090094,0.16738,0.13119,1,1
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.02068,0.16725,0.12611,1,1
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.038561,0.16715,0.22109,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.010773,0.16712,0.14394,1,1
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.010506,0.16696,0.10076,1,1
3,GO MAMMARY GLAND DEVELOPMENT,0.0090226,0.16661,0.12002,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.00010092,0.16649,0.16393,1,1
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.00050664,0.16648,0.18991,1,1
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0097392,0.16644,0.15332,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0059384,0.16644,0.15019,1,1
3,GO THIOESTER METABOLIC PROCESS,0.00063551,0.16634,0.19394,1,1
3,GO CHOLESTEROL EFFLUX,0.0028141,0.16632,0.19167,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.047551,0.16604,0.24816,1,1
3,GO EPITHELIUM DEVELOPMENT,0.0019282,0.16552,0.11828,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,1.1964e-05,0.16545,0.20319,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00016595,0.16536,0.1652,1,1
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.026586,0.16532,0.18374,1,1
3,GO STEROID CATABOLIC PROCESS,0.012508,0.16512,0.24981,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00029782,0.16495,0.19879,1,1
3,GO DEFENSE RESPONSE TO FUNGUS,0.0056288,0.16494,0.14202,1,1
3,GO REGULATION OF SECRETION,9.0551e-05,0.16459,0.1602,1,1
3,GO ORGANELLE DISASSEMBLY,0.00010462,0.16438,0.17945,1,1
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.015574,0.16417,0.17187,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.0026572,0.16413,0.15172,1,1
3,GO WATER TRANSPORT,0.013139,0.16407,0.11373,1,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0034322,0.16396,0.12592,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.011904,0.16394,0.1181,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0040578,0.16384,0.17014,1,1
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0045306,0.16375,0.14748,1,1
3,GO PROTEIN DESTABILIZATION,0.0011199,0.16367,0.16062,1,1
3,GO ION HOMEOSTASIS,0.00017796,0.16366,0.14559,1,1
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.019739,0.16357,0.14745,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0062634,0.16351,0.16176,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0046564,0.16348,0.13159,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0022332,0.16345,0.15361,1,1
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.035393,0.16279,0.1338,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,5.9841e-06,0.16247,0.2071,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0046564,0.16229,0.14184,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00072223,0.16209,0.15199,1,1
3,GO T CELL LINEAGE COMMITMENT,0.0010206,0.16204,0.17716,1,1
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0012662,0.16199,0.2271,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00025131,0.16187,0.15586,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0036303,0.16186,0.16002,1,1
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.042857,0.16183,0.14461,1,1
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011326,0.16142,0.12162,1,1
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0010206,0.16121,0.18426,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.00023468,0.16029,0.14325,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.8418e-05,0.16014,0.18809,1,1
3,GO CIRCULATORY SYSTEM PROCESS,0.00032948,0.16,0.14649,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.00013433,0.15993,0.19513,1,1
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0046564,0.15983,0.11873,1,1
3,GO RESPONSE TO CALCIUM ION,0.001662,0.15979,0.17514,1,1
3,GO REGULATION OF CELL MATURATION,0.0039469,0.15932,0.16825,1,1
3,GO TEMPERATURE HOMEOSTASIS,0.00026903,0.15927,0.1673,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0010528,0.15866,0.12412,1,1
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0067808,0.15851,0.12759,1,1
3,GO PROTEOLYSIS,5.4121e-05,0.1585,0.15015,1,1
3,GO GLIAL CELL ACTIVATION,0.011904,0.15848,0.14785,1,1
3,GO RUFFLE ORGANIZATION,0.0094949,0.15833,0.16379,1,1
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00067758,0.15832,0.17883,1,1
3,GO MACROPHAGE CHEMOTAXIS,0.016339,0.15804,0.12408,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0039469,0.15776,0.1863,1,1
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00353,0.15726,0.2007,1,1
3,GO DETECTION OF STIMULUS,3.5759e-05,0.15724,0.13761,1,1
3,GO ION TRANSPORT,0.00010845,0.1572,0.15668,1,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.017549,0.15718,0.10354,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00037661,0.15701,0.13644,1,1
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.025414,0.15668,0.18561,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0013457,0.15648,0.13052,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010245,0.15638,0.136,1,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.016734,0.15637,0.12804,1,1
3,GO RESPONSE TO CARBOHYDRATE,0.00035231,0.1563,0.15023,1,1
3,GO ENDOCRINE HORMONE SECRETION,0.0017123,0.15629,0.19133,1,1
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00020448,0.15615,0.21278,1,1
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.033166,0.15615,0.16422,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.00047456,0.15583,0.12991,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0099891,0.15484,0.10537,1,1
3,GO CARDIAC CELL DEVELOPMENT,0.0064317,0.15449,0.14368,1,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00044439,0.15447,0.13774,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.00041602,0.15443,0.16692,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0021062,0.15407,0.13864,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,8.7323e-05,0.15383,0.15992,1,1
3,GO RESPONSE TO HORMONE,9.389e-05,0.15364,0.16063,1,1
3,GO ENDOCYTOSIS,0.044685,0.15355,0.080213,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,1.9263e-05,0.15312,0.15816,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.00041602,0.153,0.13059,1,1
3,GO RESPONSE TO DSRNA,0.0028957,0.15297,0.14707,1,1
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0014738,0.15259,0.13363,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00021167,0.15259,0.17889,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.02268,0.15212,0.128,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00020448,0.15195,0.18083,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0034322,0.15193,0.17,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.00018427,0.15184,0.18742,1,1
3,GO VIRAL RNA GENOME REPLICATION,0.038561,0.15184,0.086875,1,1
3,GO VIRAL BUDDING,0.0017641,0.15177,0.1549,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0030654,0.15172,0.13034,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.00084609,0.15151,0.1157,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.019739,0.15149,0.15354,1,1
3,GO MITOCHONDRIAL FISSION,0.0033369,0.15141,0.19675,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00032948,0.15118,0.13761,1,1
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00098941,0.1511,0.14256,1,1
3,GO GOLGI ORGANIZATION,6.5149e-05,0.15093,0.17775,1,1
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0021689,0.15086,0.23729,1,1
3,GO ACTIN NUCLEATION,0.010506,0.15073,0.14425,1,1
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0010206,0.15064,0.23011,1,1
3,GO HOMEOSTATIC PROCESS,3.8583e-05,0.1506,0.13934,1,1
3,GO ALCOHOL CATABOLIC PROCESS,0.00040247,0.15052,0.19772,1,1
3,GO SYMBIOTIC PROCESS,0.0045306,0.15024,0.10482,1,1
3,GO PEPTIDE CATABOLIC PROCESS,0.0064317,0.14996,0.21672,1,1
3,GO DE NOVO PROTEIN FOLDING,0.0047853,0.14905,0.16517,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0014299,0.14868,0.14023,1,1
3,GO AUTOPHAGOSOME ORGANIZATION,0.00050664,0.14844,0.1846,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00029782,0.14837,0.1681,1,1
3,GO ORGANIC CATION TRANSPORT,0.009256,0.14803,0.19612,1,1
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0011549,0.14802,0.17537,1,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.026586,0.14777,0.10286,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.00055855,0.1475,0.1249,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00098941,0.14746,0.14874,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,9.0551e-05,0.1474,0.14773,1,1
3,GO RESPONSE TO MONOSACCHARIDE,0.00034072,0.14737,0.15381,1,1
3,GO ERBB SIGNALING PATHWAY,0.016734,0.14728,0.13408,1,1
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.015203,0.14676,0.13798,1,1
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.001228,0.14636,0.16868,1,1
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00027832,0.14632,0.15395,1,1
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.001872,0.146,0.13804,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00092958,0.14599,0.12506,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00037661,0.14582,0.12915,1,1
3,GO OOCYTE DIFFERENTIATION,0.0057817,0.14568,0.12435,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.03245,0.1455,0.077319,1,1
3,GO ENERGY RESERVE METABOLIC PROCESS,0.001662,0.14499,0.16726,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,8.1192e-05,0.14485,0.17572,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.015953,0.14447,0.13577,1,1
3,GO REGULATION OF MAPK CASCADE,0.00095906,0.14446,0.14403,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,4.4878e-05,0.14383,0.14316,1,1
3,GO CALCIUM ION IMPORT,0.027188,0.1436,0.08806,1,1
3,GO ORGANIC ACID TRANSPORT,1.7806e-05,0.14295,0.21754,1,1
3,GO METAL ION TRANSPORT,0.0032441,0.1428,0.11561,1,1
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.013139,0.14253,0.19265,1,1
3,GO MYELOID CELL HOMEOSTASIS,0.0041716,0.1424,0.12463,1,1
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00074557,0.14191,0.17351,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00037661,0.14174,0.16411,1,1
3,GO L AMINO ACID TRANSPORT,0.043763,0.14171,0.14766,1,1
3,GO CATION TRANSPORT,0.0010206,0.14165,0.13005,1,1
3,GO RESPONSE TO MISFOLDED PROTEIN,0.0073363,0.14161,0.17521,1,1
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.045624,0.14159,0.15794,1,1
3,GO CELL MATURATION,0.00031859,0.14156,0.13955,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00025131,0.14143,0.15004,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00013917,0.14126,0.19505,1,1
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.024846,0.1411,0.11177,1,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00050664,0.14093,0.14245,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.0050528,0.14087,0.23093,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.011326,0.14066,0.10093,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.015574,0.14061,0.10469,1,1
3,GO RESPONSE TO ETHANOL,0.004408,0.14034,0.12436,1,1
3,GO IRON ION HOMEOSTASIS,0.014841,0.14023,0.1502,1,1
3,GO PROTEIN FOLDING,0.010245,0.14015,0.12903,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00010845,0.14002,0.14011,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.00017796,0.13992,0.13991,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00095906,0.13972,0.13768,1,1
3,GO REGULATION OF PROTEIN BINDING,0.0015189,0.13966,0.13723,1,1
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.0079323,0.13966,0.14782,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,0.00045924,0.1396,0.13493,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.013139,0.13917,0.23001,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.025994,0.13913,0.10143,1,1
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.00031859,0.13911,0.144,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.015953,0.13906,0.14229,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.0069616,0.13905,0.15731,1,1
3,GO TRANSMEMBRANE TRANSPORT,9.7346e-05,0.13897,0.15161,1,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.012508,0.13896,0.083426,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0013872,0.13896,0.10778,1,1
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025083,0.13896,0.12599,1,1
3,GO VITAMIN METABOLIC PROCESS,0.016339,0.1389,0.17036,1,1
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.018398,0.13879,0.1523,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0083534,0.13866,0.15587,1,1
3,GO CELL MOTILITY,0.0067808,0.13849,0.10115,1,1
3,GO ESTROGEN METABOLIC PROCESS,0.024846,0.13839,0.15452,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.023741,0.13823,0.14518,1,1
3,GO PROSTAGLANDIN SECRETION,0.02068,0.13818,0.21051,1,1
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.00044439,0.138,0.15384,1,1
3,GO REGENERATION,0.042857,0.13796,0.079295,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.020205,0.13794,0.18651,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00021909,0.13776,0.13387,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0011549,0.13766,0.1485,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.025994,0.13742,0.11357,1,1
3,GO MAINTENANCE OF LOCATION,0.0017641,0.13737,0.12469,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.00030804,0.13736,0.11902,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00074557,0.13703,0.13405,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0033369,0.13679,0.10624,1,1
3,GO MEMBRANE ORGANIZATION,0.001986,0.13672,0.10831,1,1
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.045624,0.13671,0.12091,1,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.036948,0.13669,0.15346,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.014138,0.13669,0.10327,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.011612,0.1365,0.11114,1,1
3,GO REGULATION OF PROTEIN DEACETYLATION,0.0097392,0.13596,0.14432,1,1
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.0037331,0.13579,0.11032,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0030654,0.13574,0.11759,1,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0085714,0.13476,0.10531,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0013457,0.13475,0.14378,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0020453,0.13467,0.17488,1,1
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00045924,0.13464,0.13861,1,1
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.041093,0.13438,0.1456,1,1
3,GO RESPONSE TO ESTRADIOL,0.0094949,0.13419,0.1016,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.0025083,0.1336,0.10795,1,1
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00017186,0.13356,0.12058,1,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00026903,0.13347,0.16791,1,1
3,GO GOLGI RIBBON FORMATION,0.038561,0.13309,0.14623,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00067758,0.13307,0.13768,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0010528,0.13305,0.11564,1,1
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.035393,0.13279,0.13255,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0054795,0.13245,0.11892,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00087311,0.13243,0.14595,1,1
3,GO REGULATION OF GLUCOSE IMPORT,0.016734,0.13243,0.13399,1,1
3,GO T CELL SELECTION,0.0037331,0.13242,0.1237,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.046579,0.13241,0.14001,1,1
3,GO APOPTOTIC CELL CLEARANCE,0.036948,0.1323,0.096204,1,1
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.009256,0.13229,0.14325,1,1
3,GO REGULATION OF CELL DEATH,0.00081984,0.13223,0.11313,1,1
3,GO FEEDING BEHAVIOR,0.00353,0.13201,0.14579,1,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0011549,0.13191,0.14057,1,1
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.010245,0.13149,0.13396,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0054795,0.13144,0.24752,1,1
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0017123,0.13138,0.13585,1,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.013465,0.13097,0.17227,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.0014299,0.1309,0.13965,1,1
3,GO MITOCHONDRIAL TRANSPORT,0.0021689,0.13084,0.10266,1,1
3,GO MUSCLE CELL PROLIFERATION,0.014486,0.13072,0.099487,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.033166,0.13032,0.10693,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0022992,0.13026,0.11273,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.019739,0.1302,0.096602,1,1
3,GO REGULATION OF PROTEIN STABILITY,0.00022676,0.12998,0.13126,1,1
3,GO PROTEIN AUTOUBIQUITINATION,0.0013457,0.12989,0.11636,1,1
3,GO INTERMEMBRANE LIPID TRANSFER,0.010506,0.12943,0.14332,1,1
3,GO T CELL HOMEOSTASIS,0.033166,0.12911,0.12164,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0011549,0.12893,0.1398,1,1
3,GO TRANSITION METAL ION TRANSPORT,0.00016023,0.12873,0.20969,1,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0079323,0.12811,0.10664,1,1
3,GO APOPTOTIC PROCESS,0.00063551,0.12757,0.11538,1,1
3,GO PIGMENT METABOLIC PROCESS,0.015953,0.1275,0.16857,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.00079435,0.12745,0.10418,1,1
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.001191,0.1273,0.11837,1,1
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0041716,0.12726,0.11484,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.0031536,0.12704,0.11691,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.0045306,0.12691,0.10325,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00019753,0.12687,0.12616,1,1
3,GO GLUCOSE IMPORT,0.015574,0.12674,0.14241,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.015574,0.12661,0.091353,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0013054,0.12643,0.10869,1,1
3,GO POTASSIUM ION HOMEOSTASIS,0.031748,0.12598,0.13742,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0030654,0.1259,0.12764,1,1
3,GO REGULATION OF MACROPHAGE MIGRATION,0.015953,0.12552,0.13508,1,1
3,GO RESPONSE TO PEPTIDE,0.00049035,0.12547,0.12189,1,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0015653,0.12491,0.12205,1,1
3,GO RESPONSE TO ALKALOID,0.02268,0.12484,0.099488,1,1
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.014841,0.12481,0.17109,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0067808,0.12464,0.10278,1,1
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0030654,0.12443,0.13023,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.013465,0.12426,0.13163,1,1
3,GO CALCIUM MEDIATED SIGNALING,0.0007696,0.12426,0.10579,1,1
3,GO RESPONSE TO CAMP,0.0051916,0.12426,0.16414,1,1
3,GO MAINTENANCE OF LOCATION IN CELL,0.001662,0.12413,0.12323,1,1
3,GO CRISTAE FORMATION,0.037747,0.124,0.14198,1,1
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0054795,0.12358,0.11137,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0050528,0.12331,0.13914,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00050664,0.12297,0.11625,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.00034072,0.1229,0.11882,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.011904,0.1227,0.10255,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00026903,0.12221,0.12797,1,1
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00029782,0.12181,0.12784,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.041967,0.12179,0.12855,1,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0047853,0.12142,0.15432,1,1
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0037331,0.12071,0.14043,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0010206,0.12069,0.11079,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.035393,0.12013,0.10853,1,1
3,GO SINGLE FERTILIZATION,0.016734,0.12011,0.086543,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0066042,0.11954,0.12515,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.001872,0.11936,0.11171,1,1
3,GO ATP METABOLIC PROCESS,0.0010206,0.11909,0.14845,1,1
3,GO EXOCYTIC PROCESS,0.0049174,0.11885,0.18523,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0029794,0.11876,0.10602,1,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0039469,0.11847,0.12749,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.025994,0.11835,0.071045,1,1
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.013798,0.11764,0.09719,1,1
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.00067758,0.11755,0.1735,1,1
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.015574,0.11754,0.075905,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.0016129,0.11733,0.10911,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0018173,0.1171,0.11354,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0057817,0.11693,0.098962,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0018173,0.1169,0.10701,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0062634,0.11678,0.096386,1,1
3,GO CELLULAR HOMEOSTASIS,0.00044439,0.11641,0.12605,1,1
3,GO CELL CELL RECOGNITION,0.033894,0.11621,0.12261,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.00084609,0.1162,0.10632,1,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.031748,0.11598,0.076566,1,1
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.041967,0.11528,0.11281,1,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.023741,0.11503,0.093759,1,1
3,GO POLYOL METABOLIC PROCESS,0.0081404,0.11444,0.11935,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00012512,0.11425,0.15386,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.02268,0.11405,0.085538,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0049174,0.11389,0.11733,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0024367,0.11363,0.11439,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.026586,0.11357,0.1078,1,1
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.010773,0.1133,0.11074,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.013139,0.11286,0.093521,1,1
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0083534,0.11276,0.11401,1,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.022165,0.11249,0.10725,1,1
3,GO DNA CATABOLIC PROCESS,0.0011549,0.11206,0.11775,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.029719,0.11187,0.15578,1,1
3,GO REGULATION OF ENDOCYTOSIS,0.047551,0.11185,0.076576,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.012508,0.11155,0.11848,1,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.021165,0.1111,0.079663,1,1
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.036948,0.11047,0.095369,1,1
3,GO PROTEIN CATABOLIC PROCESS,0.00095906,0.11031,0.1017,1,1
3,GO SULFATE TRANSPORT,0.041967,0.10961,0.098514,1,1
3,GO CELLULAR EXTRAVASATION,0.035393,0.10945,0.095393,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.024288,0.10933,0.10348,1,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.013798,0.10877,0.097109,1,1
3,GO PROTEIN STABILIZATION,0.0042883,0.10866,0.10474,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.010245,0.10742,0.092244,1,1
3,GO FATTY ACYL COA METABOLIC PROCESS,0.038561,0.10735,0.16869,1,1
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.038561,0.10686,0.07668,1,1
3,GO MITOTIC CELL CYCLE ARREST,0.019283,0.10681,0.2095,1,1
3,GO ENDOSOMAL TRANSPORT,0.00063551,0.10628,0.10097,1,1
3,GO BODY FLUID SECRETION,0.033894,0.10578,0.088495,1,1
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0053338,0.10565,0.12128,1,1
3,GO REGULATION OF AUTOPHAGY,0.00063551,0.10482,0.12275,1,1
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0042883,0.10473,0.10603,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00092958,0.10374,0.12619,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.016339,0.10369,0.13457,1,1
3,GO TOR SIGNALING,0.0021689,0.10335,0.079563,1,1
3,GO MITOCHONDRION ORGANIZATION,0.0013054,0.10297,0.11795,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.012508,0.10295,0.079663,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0099891,0.10174,0.076872,1,1
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.047551,0.10167,0.085428,1,1
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.012203,0.10081,0.13462,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0073363,0.1008,0.10078,1,1
3,GO SPERM EGG RECOGNITION,0.017549,0.10027,0.11391,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.036948,0.099053,0.10912,1,1
3,GO POLYOL CATABOLIC PROCESS,0.025994,0.098919,0.12829,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0030654,0.098172,0.10898,1,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00019753,0.097897,0.13378,1,1
3,GO SENSORY PERCEPTION,0.0097392,0.097559,0.077317,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.010506,0.097559,0.083434,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.011326,0.097204,0.10387,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.001662,0.096503,0.1056,1,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0038387,0.096089,0.092123,1,1
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.023205,0.095849,0.068794,1,1
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.033894,0.0955,0.069219,1,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.02268,0.094033,0.11424,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0066042,0.093762,0.086178,1,1
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0064317,0.093305,0.10357,1,1
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.004408,0.09329,0.091001,1,1
3,GO CYTOSOLIC TRANSPORT,0.0022992,0.093116,0.1106,1,1
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.045624,0.092832,0.07248,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.02843,0.091519,0.12818,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0056288,0.091238,0.091747,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.042857,0.089532,0.066687,1,1
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00079435,0.088711,0.10063,1,1
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.041093,0.088208,0.086236,1,1
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.0075304,0.088158,0.10702,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.036164,0.087774,0.091734,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0049174,0.087366,0.087844,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.011904,0.086289,0.083812,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY,0.018398,0.08526,0.080843,1,1
3,GO MACROMOLECULE CATABOLIC PROCESS,0.014138,0.085064,0.066766,1,1
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.023741,0.084707,0.1072,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0060989,0.08436,0.1096,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.015953,0.081303,0.088573,1,1
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.041967,0.080741,0.079288,1,1
3,GO MULTI ORGANISM PROCESS,0.036948,0.080565,0.054671,1,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.031748,0.079115,0.096146,1,1
3,GO MACROMOLECULE DEACYLATION,0.042857,0.077897,0.055569,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0039469,0.077731,0.092103,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0030654,0.077458,0.089511,1,1
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.044685,0.077405,0.055436,1,1
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.017549,0.075011,0.08168,1,1
3,GO NEGATIVE REGULATION OF SIGNALING,0.035393,0.072754,0.069531,1,1
3,GO REGULATION OF CATABOLIC PROCESS,0.0071468,0.072058,0.078354,1,1
3,GO AMINO ACID TRANSPORT,0.025994,0.071734,0.14242,1,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.009256,0.071681,0.081989,1,1
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0073363,0.070556,0.086879,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0087944,0.069805,0.093798,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0081404,0.069789,0.090124,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.035393,0.069646,0.071608,1,1
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.034637,0.069564,0.050357,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.019283,0.068846,0.10657,1,1
3,GO VESICLE LOCALIZATION,0.019739,0.06884,0.095849,1,1
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.021165,0.056497,0.071559,1,1
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.022165,0.054812,0.054694,1,1
3,GO INTRACELLULAR TRANSPORT,0.0053338,0.054562,0.070655,1,1
3,GO MACROAUTOPHAGY,0.0020453,0.05403,0.11991,1,1
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.046579,0.053363,0.13732,1,1
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.010245,0.046732,0.068925,1,1
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.031059,0.046347,0.05028,1,1
3,GO REGULATION OF MACROAUTOPHAGY,0.026586,0.030058,0.091305,1,1
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.4121e-05,0.74598,0.78803,1,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00026003,0.38059,0.39983,1,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.024288,0.33649,0.38094,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.023741,0.33398,0.31563,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.045624,0.32184,0.24169,1,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.001872,0.32023,0.33379,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0049174,0.3188,0.30392,1,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0014738,0.31504,0.29521,1,0
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.017137,0.30908,0.31791,1,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.041967,0.30402,0.20476,1,0
3,GO ZYMOGEN INHIBITION,0.0029794,0.30065,0.21769,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,0.00057693,0.29868,0.25611,1,0
3,GO DNA DEAMINATION,0.0064317,0.29669,0.29868,1,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.011047,0.29334,0.25875,1,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00074557,0.29073,0.3396,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0017641,0.28592,0.2659,1,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.0029794,0.28507,0.24366,1,0
3,GO REGULATION OF TRANSPOSITION,0.037747,0.27527,0.21636,1,0
3,GO HYALURONAN CATABOLIC PROCESS,0.014138,0.27121,0.14896,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0036303,0.26389,0.21427,1,0
3,GO ENAMEL MINERALIZATION,0.016734,0.26067,0.22935,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.023205,0.26066,0.18277,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.013798,0.25304,0.19549,1,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.014841,0.24521,0.16947,1,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.03939,0.24191,0.15354,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.00059588,0.23844,0.24138,1,0
3,GO MONOCYTE CHEMOTAXIS,0.0033369,0.23629,0.18925,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.004408,0.23131,0.31203,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.03245,0.22618,0.20904,1,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0021062,0.22583,0.29101,1,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0023671,0.21986,0.24703,1,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0017641,0.21983,0.25205,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.0056288,0.21717,0.15134,1,0
3,GO INTERFERON ALPHA PRODUCTION,0.0014738,0.21708,0.21877,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.033166,0.21417,0.15332,1,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.038561,0.21269,0.20955,1,0
3,GO ARGININE METABOLIC PROCESS,0.011904,0.20794,0.34822,1,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.035393,0.20567,0.1971,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.011047,0.20554,0.22466,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.0071468,0.20427,0.20341,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0022992,0.20421,0.20071,1,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00055855,0.20327,0.28631,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0046564,0.20322,0.15173,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0022992,0.20301,0.17543,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0042883,0.20257,0.19681,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00353,0.20061,0.21328,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0025083,0.20039,0.1522,1,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0037331,0.20019,0.26489,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.02068,0.19643,0.31485,1,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.004408,0.19202,0.13354,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.047551,0.18624,0.14957,1,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0057817,0.18544,0.20527,1,0
3,GO POSITIVE REGULATION OF COAGULATION,0.0049174,0.18513,0.20088,1,0
3,GO VESICLE TARGETING,0.00098941,0.18386,0.2011,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,0.001228,0.18374,0.1776,1,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.014138,0.18321,0.1793,1,0
3,GO SPHINGOID METABOLIC PROCESS,0.026586,0.18185,0.21822,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.026586,0.18163,0.1716,1,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.040234,0.18088,0.10171,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0060989,0.18055,0.13888,1,0
3,GO AUTOPHAGOSOME MATURATION,0.0049174,0.17953,0.18713,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.020205,0.17439,0.15972,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.019283,0.1735,0.11732,1,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.001986,0.17115,0.31481,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.0059384,0.17078,0.14265,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.042857,0.16881,0.15236,1,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.041967,0.16862,0.095927,1,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.015574,0.167,0.198,1,0
3,GO HEPATOCYTE DIFFERENTIATION,0.03939,0.16589,0.18013,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.02166,0.16579,0.14168,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0050528,0.16408,0.16112,1,0
3,GO COPPER ION TRANSPORT,0.0064317,0.16378,0.22385,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.012203,0.16268,0.15259,1,0
3,GO INTERFERON BETA PRODUCTION,0.0069616,0.16124,0.1526,1,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.040234,0.16016,0.11211,1,0
3,GO ERAD PATHWAY,0.0083534,0.15852,0.13776,1,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.040234,0.15466,0.1205,1,0
3,GO PROTEIN TARGETING TO VACUOLE,0.0028141,0.15291,0.17036,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0022992,0.15033,0.15385,1,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.044685,0.1502,0.14265,1,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00029782,0.14864,0.19172,1,0
3,GO HEME METABOLIC PROCESS,0.010773,0.14639,0.27436,1,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00059588,0.14137,0.16923,1,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.018398,0.14094,0.13174,1,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0081404,0.14084,0.12227,1,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.034637,0.13858,0.16135,1,0
3,GO MIDBODY ABSCISSION,0.011612,0.13778,0.19455,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.014486,0.13763,0.13087,1,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.011612,0.13584,0.18113,1,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.019739,0.13469,0.14464,1,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0071468,0.13333,0.18507,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.023741,0.13291,0.11832,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.033894,0.13271,0.091414,1,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0032441,0.13116,0.1105,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.037747,0.12842,0.20625,1,0
3,GO CYTOKINETIC PROCESS,0.015574,0.12515,0.11369,1,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.036948,0.12388,0.13225,1,0
3,GO STEROL IMPORT,0.0087944,0.12368,0.24293,1,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0030654,0.12226,0.14451,1,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.02268,0.11832,0.15237,1,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.031748,0.11723,0.19144,1,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.023741,0.11622,0.13672,1,0
3,GO RESPONSE TO MANGANESE ION,0.044685,0.11531,0.15047,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.013465,0.11106,0.12526,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.017969,0.11065,0.11465,1,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.014138,0.10854,0.20828,1,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.0057817,0.10853,0.11158,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.01282,0.10084,0.072952,1,0
3,GO TRANSLESION SYNTHESIS,0.036164,0.0997,0.084012,1,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.035393,0.097491,0.15749,1,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0042883,0.097203,0.15295,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00353,0.091954,0.14119,1,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.031059,0.076876,0.11604,1,0
3,GO PROTEIN POLYUBIQUITINATION,0.0050528,0.076583,0.082068,1,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.047551,0.075101,0.081743,1,0
3,GO POSITIVE T CELL SELECTION,0.044685,0.065152,0.088958,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.015953,0.06491,0.089426,1,0
3,GO GOLGI VESICLE TRANSPORT,0.0073363,0.064625,0.10307,1,0
3,GO URONIC ACID METABOLIC PROCESS,0.035393,0.062904,0.12409,1,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.031059,0.059267,0.10638,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.045624,0.052125,0.1046,1,0
3,GO REGULATION OF BINDING,0.043763,0.050037,0.064201,1,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.013798,0.047617,0.068219,1,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.03245,0.045458,0.04757,1,0
3,GO COVALENT CHROMATIN MODIFICATION,0.0090226,-0.026192,-0.066098,1,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.0028141,-0.034511,-0.058266,1,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.03939,-0.044289,-0.064548,1,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.044685,-0.045272,-0.054828,1,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.031748,-0.048476,-0.044013,1,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.010506,-0.051297,-0.063565,1,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.0087944,-0.057225,-0.065627,1,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.031059,-0.061633,-0.080267,1,0
3,GO DOUBLE STRAND BREAK REPAIR,0.0047853,-0.061856,-0.086295,1,0
3,GO PROTEIN ACETYLATION,0.017549,-0.064197,-0.044281,1,0
3,GO PROTEIN METHYLATION,0.0047853,-0.064853,-0.070122,1,0
3,GO CHROMATIN ORGANIZATION,0.0029794,-0.066772,-0.069575,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.033166,-0.06755,-0.074195,1,0
3,GO HISTONE UBIQUITINATION,0.024846,-0.069,-0.078954,1,0
3,GO PROTEIN MONOUBIQUITINATION,0.010245,-0.069164,-0.07762,1,0
3,GO CHROMOSOME ORGANIZATION,0.0028957,-0.069227,-0.059033,1,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.040234,-0.069345,-0.17607,1,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.033894,-0.071651,-0.14536,1,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0025083,-0.074589,-0.093128,1,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.027803,-0.074913,-0.063391,1,0
3,GO REGULATION OF MRNA POLYADENYLATION,0.029719,-0.076993,-0.10839,1,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.0049174,-0.078582,-0.075025,1,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.029068,-0.078699,-0.084337,1,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.036948,-0.078954,-0.1033,1,0
3,GO RNA 3 END PROCESSING,0.025994,-0.082591,-0.091673,1,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.036948,-0.082766,-0.094779,1,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.015574,-0.083545,-0.079414,1,0
3,GO DNA RECOMBINATION,0.018836,-0.084564,-0.06036,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.025994,-0.085342,-0.078398,1,0
3,GO CELL CYCLE DNA REPLICATION,0.0023671,-0.088159,-0.13564,1,0
3,GO REGULATION OF HISTONE METHYLATION,0.02166,-0.088613,-0.095734,1,0
3,GO MRNA PROCESSING,0.00081984,-0.088841,-0.096945,1,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0094949,-0.090037,-0.15169,1,0
3,GO HISTONE MRNA METABOLIC PROCESS,0.014138,-0.090263,-0.11251,1,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.047551,-0.090537,-0.063701,1,0
3,GO HISTONE METHYLATION,0.00081984,-0.091494,-0.10708,1,0
3,GO CELLULAR RESPONSE TO X RAY,0.0075304,-0.09242,-0.21348,1,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0011549,-0.092977,-0.13871,1,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0040578,-0.093592,-0.15212,1,0
3,GO SISTER CHROMATID SEGREGATION,0.0066042,-0.093816,-0.083742,1,0
3,GO REGULATION OF RNA SPLICING,0.0038387,-0.093946,-0.08716,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.012203,-0.093972,-0.13463,1,0
3,GO RNA LOCALIZATION,0.020205,-0.094341,-0.097599,1,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.021165,-0.095469,-0.15435,1,0
3,GO MRNA 3 END PROCESSING,0.0038387,-0.096136,-0.10859,1,0
3,GO CELL DIVISION,0.0085714,-0.096207,-0.074393,1,0
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02166,-0.096266,-0.095883,1,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0020453,-0.096862,-0.094449,1,0
3,GO DNA CONFORMATION CHANGE,0.00047456,-0.096996,-0.10135,1,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.007729,-0.097441,-0.14916,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0042883,-0.09762,-0.10392,1,0
3,GO REGULATION OF LYASE ACTIVITY,0.042857,-0.097682,-0.12875,1,0
3,GO HISTONE H3 K9 MODIFICATION,0.0045306,-0.097754,-0.13516,1,0
3,GO HISTONE H3 K9 METHYLATION,0.0067808,-0.099772,-0.15095,1,0
3,GO CHROMOSOME SEGREGATION,0.0021062,-0.099929,-0.087817,1,0
3,GO PEPTIDYL LYSINE METHYLATION,0.0010528,-0.10038,-0.11076,1,0
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.02068,-0.10246,-0.094915,1,0
3,GO REGULATION OF ORGAN GROWTH,0.024846,-0.10479,-0.12789,1,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.00067758,-0.10504,-0.12642,1,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.00059588,-0.1063,-0.11168,1,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.0028141,-0.1071,-0.13102,1,0
3,GO CHROMATIN SILENCING,0.0010206,-0.10718,-0.16479,1,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.00035231,-0.10748,-0.13581,1,0
3,GO REPLICATION FORK PROCESSING,0.0049174,-0.10769,-0.17487,1,0
3,GO MRNA TRANSPORT,0.0064317,-0.10818,-0.10454,1,0
3,GO HISTONE H3 K4 METHYLATION,0.0060989,-0.10844,-0.11414,1,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.023741,-0.1088,-0.088595,1,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.017969,-0.10925,-0.14186,1,0
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00087311,-0.11137,-0.11629,1,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.017137,-0.1121,-0.10778,1,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.0030654,-0.11363,-0.18315,1,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.014486,-0.11428,-0.13911,1,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.00353,-0.11459,-0.13373,1,0
3,GO CENTROSOME DUPLICATION,0.033894,-0.11493,-0.083775,1,0
3,GO REGULATION OF MYELINATION,0.0049174,-0.11553,-0.13987,1,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0047853,-0.11625,-0.093347,1,0
3,GO RNA SPLICING,0.00010092,-0.11625,-0.11825,1,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0066042,-0.11644,-0.11807,1,0
3,GO SINGLE STRAND BREAK REPAIR,0.015203,-0.11646,-0.14662,1,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.046579,-0.11701,-0.10769,1,0
3,GO CELLULAR RESPONSE TO UV,0.025414,-0.11767,-0.091473,1,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0021689,-0.11796,-0.14728,1,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.036164,-0.11877,-0.16149,1,0
3,GO RECOMBINATIONAL REPAIR,0.00027832,-0.11914,-0.12827,1,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.012508,-0.11959,-0.11255,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.024288,-0.12074,-0.20282,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02268,-0.12129,-0.14447,1,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.010506,-0.12132,-0.082087,1,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.044685,-0.12314,-0.17886,1,0
3,GO REGULATION OF DNA RECOMBINATION,0.014486,-0.12323,-0.091408,1,0
3,GO STRESS GRANULE ASSEMBLY,0.01282,-0.12412,-0.138,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00098941,-0.12428,-0.12036,1,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.0046564,-0.12482,-0.19605,1,0
3,GO CHROMATIN REMODELING,0.00022676,-0.12494,-0.11181,1,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.014486,-0.1282,-0.093069,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.043763,-0.1289,-0.1691,1,0
3,GO MITOCHONDRION DISTRIBUTION,0.038561,-0.12911,-0.12044,1,0
3,GO HISTONE H4 DEACETYLATION,0.023741,-0.13009,-0.15136,1,0
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.013798,-0.13033,-0.17029,1,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.00081984,-0.13116,-0.14641,1,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.02068,-0.13252,-0.12417,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.018836,-0.13265,-0.11699,1,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0010528,-0.13293,-0.14792,1,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.029719,-0.13299,-0.13435,1,0
3,GO HISTONE H3 K9 DEMETHYLATION,0.014841,-0.13312,-0.17531,1,0
3,GO MITOTIC RECOMBINATION,0.016339,-0.13364,-0.1353,1,0
3,GO REGULATION OF DNA REPAIR,9.3916e-06,-0.13383,-0.14004,1,0
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.009256,-0.13422,-0.19125,1,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.01282,-0.13475,-0.13038,1,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.011904,-0.13527,-0.11299,1,0
3,GO RNA STABILIZATION,0.00353,-0.1363,-0.14472,1,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,3.0689e-05,-0.13751,-0.147,1,0
3,GO DNA REPLICATION INITIATION,6.0504e-05,-0.13755,-0.20526,1,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.001872,-0.13848,-0.13914,1,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.001872,-0.13855,-0.11596,1,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.037747,-0.13944,-0.15482,1,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.00035231,-0.14047,-0.13612,1,0
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,5.4121e-05,-0.14113,-0.14982,1,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.035393,-0.14117,-0.10963,1,0
3,GO DNA PACKAGING,5.8301e-05,-0.14421,-0.1228,1,0
3,GO REGULATION OF MRNA PROCESSING,9.0551e-05,-0.14652,-0.13325,1,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.011047,-0.14655,-0.15303,1,0
3,GO REGULATION OF HEART GROWTH,0.0023671,-0.14902,-0.17475,1,0
3,GO CENTRIOLE ASSEMBLY,0.001662,-0.14998,-0.12976,1,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0011199,-0.1501,-0.17145,1,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,1.2962e-05,-0.15016,-0.14382,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0081404,-0.15048,-0.12615,1,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.0020453,-0.15129,-0.17398,1,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.015203,-0.15141,-0.23638,1,0
3,GO CELL FATE SPECIFICATION,0.02268,-0.15357,-0.12108,1,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.00098941,-0.15373,-0.18156,1,0
3,GO REGULATION OF SENSORY PERCEPTION,0.0099891,-0.15533,-0.14959,1,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0041716,-0.15536,-0.11533,1,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0019282,-0.15587,-0.21648,1,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.02166,-0.15656,-0.16904,1,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00092958,-0.1567,-0.1265,1,0
3,GO HISTONE EXCHANGE,0.001872,-0.15711,-0.13985,1,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00065623,-0.15868,-0.17685,1,0
3,GO HISTONE H3 K27 METHYLATION,0.0013054,-0.16085,-0.19273,1,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.036948,-0.1618,-0.098503,1,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0071468,-0.16254,-0.1685,1,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0039469,-0.16374,-0.18996,1,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.023205,-0.16499,-0.12026,1,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0054795,-0.16522,-0.14008,1,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0015189,-0.16547,-0.17167,1,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.01282,-0.1659,-0.13287,1,0
3,GO HINDLIMB MORPHOGENESIS,0.037747,-0.16639,-0.16413,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0067808,-0.16646,-0.10054,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0094949,-0.16712,-0.16142,1,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,4.3218e-05,-0.16874,-0.16755,1,0
3,GO NUCLEOSOME ORGANIZATION,4.3218e-05,-0.16886,-0.1578,1,0
3,GO NEURAL TUBE PATTERNING,0.0042883,-0.17054,-0.18119,1,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.00037661,-0.17166,-0.23517,1,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.046579,-0.17237,-0.14506,1,0
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0024367,-0.17252,-0.22803,1,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.011047,-0.17381,-0.13538,1,0
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.009256,-0.17549,-0.26297,1,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.00014418,-0.17606,-0.171,1,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.0017123,-0.17662,-0.15336,1,0
3,GO KINETOCHORE ORGANIZATION,0.007729,-0.17705,-0.18853,1,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,2.9532e-05,-0.1777,-0.14977,1,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0020453,-0.17827,-0.16862,1,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.043763,-0.18342,-0.16182,1,0
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0013054,-0.18454,-0.22934,1,0
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00081984,-0.18545,-0.17503,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,3.0689e-05,-0.1875,-0.17378,1,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.012508,-0.1879,-0.14341,1,0
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00017796,-0.18999,-0.16723,1,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.010506,-0.19048,-0.1732,1,0
3,GO NUCLEOSOME ASSEMBLY,0.00022676,-0.19085,-0.17438,1,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.031748,-0.19268,-0.20341,1,0
3,GO LYMPHANGIOGENESIS,0.001662,-0.19449,-0.24212,1,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0064317,-0.19552,-0.17931,1,0
3,GO REPLACEMENT OSSIFICATION,0.0073363,-0.19688,-0.21599,1,0
3,GO APPENDAGE MORPHOGENESIS,0.0028141,-0.19721,-0.18138,1,0
3,GO BONE GROWTH,0.0094949,-0.19952,-0.24206,1,0
3,GO MUSCLE CELL FATE COMMITMENT,0.015953,-0.20041,-0.23055,1,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.004408,-0.20066,-0.16251,1,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0056288,-0.20093,-0.14972,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00081984,-0.20123,-0.19065,1,0
3,GO KINETOCHORE ASSEMBLY,0.014138,-0.20216,-0.18121,1,0
3,GO SPINAL CORD DEVELOPMENT,0.0006154,-0.20234,-0.19862,1,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0069616,-0.20315,-0.15701,1,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.013465,-0.20432,-0.23218,1,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0056288,-0.20565,-0.14898,1,0
3,GO HISTONE H4 K16 ACETYLATION,0.00045924,-0.20734,-0.21216,1,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0050528,-0.20755,-0.17645,1,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0037331,-0.20801,-0.22664,1,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00020448,-0.20898,-0.2585,1,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.03939,-0.21111,-0.1669,1,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.045624,-0.21151,-0.18441,1,0
3,GO NUCLEAR PORE ORGANIZATION,0.0049174,-0.21153,-0.18913,1,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00022676,-0.21171,-0.17769,1,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.016339,-0.21354,-0.20586,1,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.0011549,-0.21364,-0.20321,1,0
3,GO NEURON FATE COMMITMENT,0.017549,-0.21726,-0.19406,1,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.043763,-0.22101,-0.19814,1,0
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00065623,-0.22275,-0.23,1,0
3,GO FORELIMB MORPHOGENESIS,0.0090226,-0.22407,-0.2255,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,3.3132e-05,-0.22435,-0.20018,1,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.0057817,-0.22448,-0.24741,1,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00016023,-0.22514,-0.20208,1,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00038934,-0.22581,-0.24536,1,0
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.015953,-0.22834,-0.17261,1,0
3,GO MRNA SPLICE SITE SELECTION,0.00055855,-0.22875,-0.21514,1,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.042857,-0.23455,-0.20473,1,0
3,GO HIPPO SIGNALING,0.00081984,-0.2377,-0.30159,1,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.02268,-0.2394,-0.25035,1,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00024286,-0.24071,-0.22535,1,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0027346,-0.24102,-0.29455,1,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0014738,-0.24299,-0.30526,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0006154,-0.24412,-0.21522,1,0
3,GO NEPHRON TUBULE FORMATION,0.0099891,-0.24464,-0.29344,1,0
3,GO SNORNA 3 END PROCESSING,0.0017123,-0.24519,-0.26698,1,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0050528,-0.24529,-0.23414,1,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00040247,-0.2458,-0.27799,1,0
3,GO SNORNA METABOLIC PROCESS,0.0067808,-0.24632,-0.21866,1,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00010845,-0.24762,-0.45177,1,0
3,GO LEUKOCYTE AGGREGATION,0.0087944,-0.24861,-0.3458,1,0
3,GO NEURAL CREST FORMATION,0.013139,-0.25255,-0.23432,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.014486,-0.25328,-0.18296,1,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.00022676,-0.25678,-0.29998,1,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.00021909,-0.2573,-0.23995,1,0
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0017641,-0.25913,-0.18278,1,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,5.4121e-05,-0.26006,-0.27225,1,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.00018427,-0.26036,-0.23417,1,0
3,GO SOMATIC STEM CELL DIVISION,0.0067808,-0.26515,-0.43239,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0085714,-0.26772,-0.22602,1,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0011549,-0.26866,-0.3723,1,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.00087311,-0.2687,-0.40953,1,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00017186,-0.27401,-0.23397,1,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0027346,-0.27401,-0.2336,1,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.010506,-0.27442,-0.30309,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00042998,-0.27456,-0.21382,1,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00023468,-0.27714,-0.26709,1,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.00090094,-0.27808,-0.34967,1,0
3,GO BONE TRABECULA FORMATION,0.018398,-0.28124,-0.36365,1,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.004408,-0.28377,-0.28509,1,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,3.3287e-06,-0.28934,-0.3267,1,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.0064317,-0.29199,-0.28883,1,0
3,GO TONGUE DEVELOPMENT,0.014841,-0.29287,-0.25083,1,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00049035,-0.29485,-0.23268,1,0
3,GO EMBRYONIC BRAIN DEVELOPMENT,1.8521e-05,-0.29542,-0.31212,1,0
3,GO DENDRITE SELF AVOIDANCE,0.0075304,-0.29787,-0.26356,1,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0034322,-0.2994,-0.23257,1,0
3,GO RESPONSE TO L GLUTAMATE,0.0034322,-0.30437,-0.31768,1,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.0050528,-0.30532,-0.24417,1,0
3,GO LATERAL MESODERM DEVELOPMENT,0.00087311,-0.30812,-0.39236,1,0
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00090094,-0.31281,-0.33437,1,0
3,GO CARTILAGE MORPHOGENESIS,0.034637,-0.31473,-0.27669,1,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00010462,-0.32416,-0.3606,1,0
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00027832,-0.32431,-0.38533,1,0
3,GO FOREBRAIN REGIONALIZATION,0.0069616,-0.3282,-0.25375,1,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.00040247,-0.33148,-0.35732,1,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.001228,-0.33162,-0.31384,1,0
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00045924,-0.33562,-0.32474,1,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.02166,-0.33583,-0.28681,1,0
3,GO MYOBLAST MIGRATION,0.0081404,-0.35045,-0.35338,1,0
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.3132e-05,-0.3636,-0.49048,1,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,8.7323e-05,-0.36698,-0.33453,1,0
3,GO CORPUS CALLOSUM DEVELOPMENT,0.0049174,-0.37065,-0.28816,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00017796,-0.38018,-0.41448,1,0
3,GO CARDIOBLAST PROLIFERATION,0.0087944,-0.38797,-0.43718,1,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0028957,-0.39088,-0.34007,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00016595,-0.3992,-0.43646,1,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0017641,-0.40792,-0.31073,1,0
3,GO CARDIOBLAST DIFFERENTIATION,4.4878e-05,-0.41831,-0.40441,1,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.00084609,-0.43201,-0.44581,1,0
3,GO POSTSYNAPSE ASSEMBLY,0.001986,-0.45307,-0.4643,1,0
3,GO CARDIAC CELL FATE COMMITMENT,0.00090094,-0.46692,-0.42025,1,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.00010845,-0.47391,-0.48307,1,0
3,GO LIMB BUD FORMATION,0.0022332,-0.5182,-0.40327,1,0
3,GO TONGUE MORPHOGENESIS,0.0053338,-0.52272,-0.36615,1,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00014935,-0.53108,-0.45359,1,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,1.8521e-05,-0.54886,-0.52714,1,0
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00017796,-0.55324,-0.44789,1,0
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00087311,-0.576,-0.52378,1,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,1.4044e-06,-0.58536,-0.68717,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00059588,-0.62408,-0.65435,1,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,6.2985e-07,-0.63368,-0.65865,1,0
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.11434,0.56336,0.29352,0,1
3,GO LYSINE METABOLIC PROCESS,0.095625,0.38981,0.19425,0,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.092194,0.38407,0.20968,0,1
3,GO PARENTAL BEHAVIOR,0.099158,0.37749,0.17799,0,1
3,GO HEPARIN METABOLIC PROCESS,0.055956,0.32043,0.18535,0,1
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.090515,0.31371,0.22278,0,1
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.076492,0.30518,0.28528,0,1
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.11636,0.28877,0.16986,0,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.082489,0.28539,0.14726,0,1
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.060602,0.27867,0.24774,0,1
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.066855,0.27822,0.13638,0,1
3,GO PENTOSE METABOLIC PROCESS,0.14048,0.26727,0.14709,0,1
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.075049,0.26692,0.1576,0,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.072231,0.26678,0.18968,0,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.087232,0.26478,0.12825,0,1
3,GO FATTY ACID HOMEOSTASIS,0.05824,0.2598,0.19598,0,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.20937,0.24616,0.13396,0,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0695,0.24559,0.20944,0,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.10654,0.24076,0.13184,0,1
3,GO RESPONSE TO LEUCINE,0.087232,0.23926,0.17298,0,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.073629,0.23518,0.24735,0,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.066855,0.23317,0.13103,0,1
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.16032,0.22964,0.046552,0,1
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.12049,0.22566,0.088528,0,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.12908,0.22504,0.080485,0,1
3,GO MEMBRANE FISSION,0.072231,0.21921,0.14848,0,1
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.088862,0.21554,0.20772,0,1
3,GO REGULATION OF VESICLE FUSION,0.061812,0.21261,0.18849,0,1
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.17099,0.20818,0.13069,0,1
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.082489,0.20802,0.088742,0,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.054842,0.20749,0.096015,0,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.085627,0.20692,0.12213,0,1
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.085627,0.20659,0.11107,0,1
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.082489,0.2062,0.14048,0,1
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.088862,0.20236,0.14802,0,1
3,GO PLASMA MEMBRANE FUSION,0.060602,0.20173,0.15975,0,1
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.090515,0.20122,0.20887,0,1
3,GO NATURAL KILLER CELL PROLIFERATION,0.12689,0.20108,0.17124,0,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.065563,0.20004,0.13567,0,1
3,GO GLYCINE TRANSPORT,0.21256,0.19928,0.15418,0,1
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.055956,0.19788,0.21274,0,1
3,GO CELLULAR OXIDANT DETOXIFICATION,0.10096,0.1976,0.12187,0,1
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.14048,0.19737,0.20803,0,1
3,GO MITOCHONDRIAL TRNA PROCESSING,0.12473,0.19554,0.11682,0,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.068167,0.19192,0.10497,0,1
3,GO COLLAGEN CATABOLIC PROCESS,0.065563,0.19054,0.097442,0,1
3,GO REGULATION OF RUFFLE ASSEMBLY,0.061812,0.18626,0.14633,0,1
3,GO OSTEOBLAST DEVELOPMENT,0.0695,0.1858,0.070964,0,1
3,GO ENDODERM DEVELOPMENT,0.063042,0.18223,0.10479,0,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.15517,0.18189,0.16344,0,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.087232,0.18008,0.15146,0,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.087232,0.17968,0.18672,0,1
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.049546,0.17941,0.11239,0,1
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.1313,0.17679,0.2025,0,1
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.12259,0.1762,0.083327,0,1
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.17374,0.17516,0.067354,0,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.065563,0.17488,0.12442,0,1
3,GO RESPONSE TO PROSTAGLANDIN,0.063042,0.17172,0.17683,0,1
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.072231,0.17016,0.14242,0,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.19393,0.1693,0.075536,0,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.10845,0.16878,0.088574,0,1
3,GO RENAL WATER HOMEOSTASIS,0.070855,0.16866,0.085861,0,1
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.054842,0.16768,0.15079,0,1
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.15517,0.16763,0.12535,0,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.055956,0.16681,0.10577,0,1
3,GO PODOSOME ASSEMBLY,0.80989,0.16607,-0.013687,0,1
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.10465,0.16584,0.12589,0,1
3,GO CHRONIC INFLAMMATORY RESPONSE,0.075049,0.1655,0.10584,0,1
3,GO BONE CELL DEVELOPMENT,0.11434,0.1632,0.11646,0,1
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.060602,0.16267,0.20714,0,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.10845,0.1625,0.11331,0,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.42347,0.16249,0.046957,0,1
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.05824,0.16229,0.18283,0,1
3,GO IMMATURE T CELL PROLIFERATION,0.13814,0.1604,0.16075,0,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.89215,0.15866,-0.040583,0,1
3,GO CELLULAR ANION HOMEOSTASIS,0.099158,0.15771,0.10276,0,1
3,GO MACROPHAGE MIGRATION,0.082489,0.15551,0.092352,0,1
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.11636,0.15465,0.12442,0,1
3,GO TRNA 5 LEADER REMOVAL,0.13814,0.15379,0.10627,0,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.076492,0.15299,0.10738,0,1
3,GO SECRETORY GRANULE ORGANIZATION,0.085627,0.15242,0.1072,0,1
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.055956,0.15221,0.10105,0,1
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.18508,0.15181,0.16936,0,1
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.14285,0.15132,0.12476,0,1
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.052669,0.15071,0.1043,0,1
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.049546,0.1494,0.15692,0,1
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.13814,0.14928,0.14667,0,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.092194,0.14765,0.12603,0,1
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.12259,0.14614,0.076279,0,1
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.053746,0.14281,0.084997,0,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.057089,0.14125,0.15961,0,1
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.065563,0.14094,0.10101,0,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.065563,0.14064,0.12288,0,1
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.05161,0.13814,0.13457,0,1
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.27227,0.13803,0.10046,0,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.15015,0.1379,0.14058,0,1
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.21579,0.1367,0.07301,0,1
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.080955,0.13654,0.080159,0,1
3,GO RESPONSE TO ESTROGEN,0.085627,0.13653,0.088902,0,1
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.39371,0.13562,0.075381,0,1
3,GO RESPONSE TO GAMMA RADIATION,0.076492,0.13538,0.086929,0,1
3,GO LIVER REGENERATION,0.20937,0.13531,0.080115,0,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.05824,0.13528,0.19386,0,1
3,GO AMINO SUGAR METABOLIC PROCESS,0.093897,0.13449,0.10706,0,1
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.088862,0.13377,0.15082,0,1
3,GO PROTEIN REFOLDING,0.055956,0.13245,0.15716,0,1
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.099158,0.13232,0.06763,0,1
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.05824,0.13139,0.07651,0,1
3,GO FORMATION OF PRIMARY GERM LAYER,0.085627,0.13126,0.084783,0,1
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.068167,0.13098,0.088182,0,1
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.23245,0.13021,0.014418,0,1
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0695,0.13017,0.084819,0,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.11636,0.12939,0.081499,0,1
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.12908,0.12935,0.068158,0,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.20937,0.12932,0.052952,0,1
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.10654,0.12666,0.075792,0,1
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.17653,0.12416,0.046544,0,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.099158,0.1233,0.12926,0,1
3,GO PHOSPHATE ION TRANSPORT,0.077957,0.12169,0.088283,0,1
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.12908,0.12167,0.092834,0,1
3,GO ALDEHYDE CATABOLIC PROCESS,0.12473,0.12076,0.13691,0,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.12908,0.1207,0.068223,0,1
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.05824,0.11849,0.096419,0,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.088862,0.11762,0.11837,0,1
3,GO ACROSOME REACTION,0.12259,0.11722,0.13563,0,1
3,GO REGULATION OF PHAGOCYTOSIS,0.072231,0.11716,0.088296,0,1
3,GO RESPONSE TO RETINOIC ACID,0.1313,0.11617,0.067524,0,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.41842,0.11601,0.053655,0,1
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.077957,0.11491,0.058902,0,1
3,GO MITOCHONDRIAL FUSION,0.11235,0.11469,0.10585,0,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.050569,0.11415,0.09603,0,1
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.05161,0.11283,0.15623,0,1
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.27227,0.1114,0.074012,0,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.087232,0.11108,0.061713,0,1
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.11235,0.11058,0.07177,0,1
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.17099,0.11008,0.058655,0,1
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.27999,0.10986,0.048293,0,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.055956,0.10935,0.1555,0,1
3,GO OSTEOCLAST DIFFERENTIATION,0.2839,0.10921,0.038393,0,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.080955,0.10912,0.10647,0,1
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0695,0.10743,0.12619,0,1
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.12908,0.10686,0.049679,0,1
3,GO GASTRULATION,0.11841,0.10683,0.068642,0,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.13355,0.10541,0.088087,0,1
3,GO SPROUTING ANGIOGENESIS,0.15264,0.10431,0.055949,0,1
3,GO NEUROTRANSMITTER REUPTAKE,0.27999,0.10431,0.091978,0,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.065563,0.1039,0.13269,0,1
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.15773,0.1031,0.11429,0,1
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.063042,0.10299,0.062384,0,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.05161,0.10255,0.11212,0,1
3,GO POSTREPLICATION REPAIR,0.11636,0.10207,0.046605,0,1
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.25001,0.10142,0.049362,0,1
3,GO ADHERENS JUNCTION ORGANIZATION,0.16294,0.10127,0.076245,0,1
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.29992,0.10082,0.062681,0,1
3,GO CELL SUBSTRATE ADHESION,0.066855,0.098873,0.074699,0,1
3,GO RESPONSE TO GLUCAGON,0.065563,0.098468,0.11015,0,1
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.066855,0.097363,0.06685,0,1
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.34256,0.095269,0.036348,0,1
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.10845,0.094742,0.050088,0,1
3,GO CELLULAR IRON ION HOMEOSTASIS,0.092194,0.094101,0.11624,0,1
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.14285,0.092011,0.11164,0,1
3,GO TRNA METABOLIC PROCESS,0.69707,0.090882,0.014872,0,1
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.085627,0.090795,0.15375,0,1
3,GO NUCLEOSIDE METABOLIC PROCESS,0.079444,0.090473,0.056481,0,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.095625,0.090298,0.056432,0,1
3,GO MYOBLAST DIFFERENTIATION,0.60272,0.088498,0.013009,0,1
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.085627,0.088408,0.0508,0,1
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.093897,0.088011,0.076484,0,1
3,GO MELANOCYTE DIFFERENTIATION,0.04854,0.087842,0.12062,0,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.14285,0.087591,0.11285,0,1
3,GO ETHANOL CATABOLIC PROCESS,0.29586,0.087309,0.061914,0,1
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.11039,0.086855,0.059397,0,1
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.10465,0.086764,0.03965,0,1
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.093897,0.086642,0.0741,0,1
3,GO RNA MODIFICATION,0.5726,0.086544,0.026617,0,1
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.23245,0.084284,0.066751,0,1
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.17374,0.083801,0.057206,0,1
3,GO POSITIVE REGULATION OF BINDING,0.075049,0.08347,0.063104,0,1
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.47588,0.083093,0.022646,0,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.10654,0.083092,0.050254,0,1
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.33373,0.082741,0.046053,0,1
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.50896,0.082685,0.024833,0,1
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.21579,0.081854,0.096816,0,1
3,GO OOCYTE MATURATION,0.43367,0.081327,0.035739,0,1
3,GO COENZYME A METABOLIC PROCESS,0.21256,0.080535,0.093296,0,1
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.049546,0.080198,0.088193,0,1
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.068167,0.079369,0.061787,0,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.12689,0.07859,0.078492,0,1
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.15773,0.077964,0.049659,0,1
3,GO RESPONSE TO OXYGEN RADICAL,0.13355,0.077044,0.097045,0,1
3,GO FERTILIZATION,0.05161,0.077036,0.063139,0,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.25001,0.076647,0.068098,0,1
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.27611,0.075909,0.0417,0,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.12049,0.074526,0.066915,0,1
3,GO REGULATION OF EXOCYTOSIS,0.05824,0.07408,0.10248,0,1
3,GO RESPONSE TO GROWTH FACTOR,0.073629,0.07347,0.061471,0,1
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.32938,0.072086,0.047187,0,1
3,GO MESODERM MORPHOGENESIS,0.44924,0.071382,0.018405,0,1
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.1313,0.070852,0.078572,0,1
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.14769,0.069363,0.082574,0,1
3,GO PHOTOTRANSDUCTION,0.093897,0.06793,0.044153,0,1
3,GO REGULATION OF PODOSOME ASSEMBLY,0.96163,0.067686,-0.043453,0,1
3,GO CILIUM MOVEMENT,0.17099,0.065794,0.03973,0,1
3,GO CELLULAR RESPONSE TO CAMP,0.1313,0.064838,0.084159,0,1
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.20937,0.063426,0.031612,0,1
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.19393,0.062982,0.039631,0,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23937,0.062732,0.044733,0,1
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.1313,0.061781,0.031917,0,1
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.32077,0.06167,0.032522,0,1
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.12908,0.061469,0.055052,0,1
3,GO REGULATION OF PROTEIN SUMOYLATION,0.38888,0.061399,0.030732,0,1
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.16032,0.05972,0.046512,0,1
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.25001,0.057798,0.033515,0,1
3,GO REGULATION OF ERAD PATHWAY,0.48131,0.055932,0.030876,0,1
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.14285,0.055904,0.022762,0,1
3,GO PROTEIN TETRAMERIZATION,0.20309,0.0539,0.056554,0,1
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.50337,0.053866,0.0096714,0,1
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.076492,0.051293,0.044393,0,1
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.74288,0.050776,-0.035872,0,1
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.32506,0.050627,0.024455,0,1
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.055956,0.050544,0.052838,0,1
3,GO NCRNA CATABOLIC PROCESS,0.15773,0.049486,0.070813,0,1
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.20621,0.048425,0.035154,0,1
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.073629,0.043909,0.056453,0,1
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.14526,0.041553,0.034041,0,1
3,GO DEMETHYLATION,0.44402,0.039089,0.023384,0,1
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.26098,0.037995,0.019981,0,1
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.35607,0.037755,0.038916,0,1
3,GO REGULATION OF PROTEIN TARGETING,0.36526,0.037303,0.044639,0,1
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.080955,0.030787,0.043115,0,1
3,GO EOSINOPHIL MIGRATION,0.00038934,0.52013,0.41253,0,0
3,GO NEGATIVE REGULATION OF ANOIKIS,4.6597e-05,0.50146,0.53341,0,0
3,GO O GLYCAN PROCESSING,3.7145e-05,0.50004,0.43443,0,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.4346e-05,0.48847,0.47739,0,0
3,GO KETONE CATABOLIC PROCESS,0.0013457,0.45459,0.428,0,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.012508,0.44814,0.33923,0,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00020448,0.44028,0.45261,0,0
3,GO REGULATION OF PLATELET AGGREGATION,0.0026572,0.44001,0.33732,0,0
3,GO EOSINOPHIL CHEMOTAXIS,0.00065623,0.4231,0.39432,0,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0010206,0.41639,0.42813,0,0
3,GO SEROTONIN METABOLIC PROCESS,0.00016023,0.40678,0.46009,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0010859,0.40557,0.37374,0,0
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0045306,0.40521,0.47382,0,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0030654,0.40137,0.33736,0,0
3,GO LIPOXYGENASE PATHWAY,0.016339,0.39824,0.28446,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00041602,0.39822,0.32656,0,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.00017186,0.38828,0.36379,0,0
3,GO REGULATION OF COAGULATION,0.00013917,0.38207,0.33546,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,8.4205e-05,0.37679,0.29807,0,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.00018427,0.37664,0.35886,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.004408,0.36628,0.31136,0,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.023205,0.36386,0.28722,0,0
3,GO BILE ACID AND BILE SALT TRANSPORT,0.00026003,0.3612,0.58306,0,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00059588,0.35647,0.42462,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0046564,0.35562,0.39037,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0097392,0.35175,0.30249,0,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0010528,0.3483,0.33774,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.11841,0.34742,0.18811,0,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.0069616,0.34047,0.39799,0,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.017969,0.33975,0.3441,0,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010092,0.33752,0.24877,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.052669,0.33388,0.1814,0,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,7.6603e-06,0.33164,0.32033,0,0
3,GO VITAMIN D METABOLIC PROCESS,0.0029794,0.32795,0.27651,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.15517,0.32591,0.12321,0,0
3,GO PROTEIN O LINKED GLYCOSYLATION,2.8418e-05,0.32373,0.29499,0,0
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00010092,0.31624,0.36546,0,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.0022332,0.3151,0.36353,0,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.082489,0.31417,0.21565,0,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.012203,0.31327,0.26732,0,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.00027832,0.31165,0.31901,0,0
3,GO REGULATION OF B CELL PROLIFERATION,7.9801e-06,0.30997,0.31127,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.0019282,0.30661,0.29924,0,0
3,GO LUNG CELL DIFFERENTIATION,0.0041716,0.30659,0.37595,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.001191,0.30585,0.2168,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00014935,0.30433,0.29036,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.0014299,0.30153,0.34496,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,2.6307e-05,0.29813,0.31055,0,0
3,GO ETHANOL OXIDATION,0.0069616,0.29775,0.44563,0,0
3,GO MAST CELL ACTIVATION,1.2962e-05,0.29759,0.31069,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.030383,0.29688,0.2617,0,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,0.0026572,0.29513,0.27245,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.31232,0.29473,0.070716,0,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0001165,0.29067,0.34108,0,0
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0083534,0.28854,0.30781,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.013139,0.28838,0.23632,0,0
3,GO INTERLEUKIN 10 PRODUCTION,0.00010462,0.28714,0.23625,0,0
3,GO MAST CELL MEDIATED IMMUNITY,3.1888e-05,0.28247,0.30298,0,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.0057817,0.28193,0.25789,0,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00017796,0.2813,0.33724,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0071468,0.27776,0.26043,0,0
3,GO EPITHELIAL CELL MORPHOGENESIS,0.004408,0.27737,0.29885,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0006154,0.27588,0.24284,0,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.099158,0.27389,0.23432,0,0
3,GO RESPONSE TO HISTAMINE,0.055956,0.27209,0.20445,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.029068,0.27081,0.18223,0,0
3,GO RESPIRATORY BURST,0.0025083,0.26769,0.23522,0,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0021689,0.26654,0.23287,0,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.011326,0.26644,0.18973,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.0038387,0.26574,0.2882,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.010773,0.2646,0.21787,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00059588,0.26347,0.2981,0,0
3,GO B CELL PROLIFERATION,1.8521e-05,0.26342,0.24809,0,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00087311,0.26226,0.29055,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.072231,0.26178,0.15891,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.00084609,0.26129,0.23553,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.022165,0.2608,0.24171,0,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.13355,0.26055,0.12413,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00057693,0.26047,0.24451,0,0
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.11434,0.25857,0.17707,0,0
3,GO HOMOTYPIC CELL CELL ADHESION,0.00025131,0.25843,0.26876,0,0
3,GO REGULATION OF RESPIRATORY BURST,0.0010206,0.2544,0.28709,0,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,2.0033e-05,0.25358,0.32247,0,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.34256,0.25351,0.095668,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.037747,0.25258,0.23411,0,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.035393,0.25115,0.25586,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.011612,0.2501,0.29528,0,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0029794,0.24844,0.21968,0,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,5.2139e-05,0.24764,0.21634,0,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.17374,0.24722,0.0951,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0066042,0.24495,0.29428,0,0
3,GO TRANSPOSITION,0.019283,0.24411,0.21765,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.024846,0.24403,0.20982,0,0
3,GO RESPONSE TO COPPER ION,0.033166,0.24338,0.21651,0,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.10845,0.24247,0.20193,0,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.00090094,0.2414,0.21158,0,0
3,GO POLYOL TRANSPORT,0.0069616,0.24127,0.27817,0,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00022676,0.24006,0.27908,0,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.024846,0.23868,0.16644,0,0
3,GO REGULATION OF VASCULOGENESIS,0.034637,0.23854,0.21843,0,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.090515,0.23831,0.20952,0,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.0040578,0.23783,0.32502,0,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.27999,0.23653,0.05891,0,0
3,GO INTERLEUKIN 12 PRODUCTION,6.7596e-05,0.23558,0.24581,0,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0046564,0.23551,0.22021,0,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.059411,0.23377,0.11712,0,0
3,GO EPOXYGENASE P450 PATHWAY,0.05824,0.23366,0.19248,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.49227,0.23319,0.03752,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.41341,0.23125,0.14397,0,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.018836,0.23034,0.22912,0,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,2.0033e-05,0.22906,0.25772,0,0
3,GO MANNOSYLATION,4.8379e-05,0.22889,0.22651,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.026586,0.22872,0.24342,0,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.079444,0.22789,0.26388,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.12049,0.22784,0.1716,0,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0060989,0.2265,0.17357,0,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0059384,0.22649,0.20214,0,0
3,GO DETECTION OF CALCIUM ION,0.060602,0.22639,0.20905,0,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00036427,0.22634,0.26686,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.03245,0.22567,0.19801,0,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,1.2962e-05,0.22365,0.23696,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0017641,0.22346,0.24008,0,0
3,GO ADRENAL GLAND DEVELOPMENT,0.0033369,0.22027,0.29227,0,0
3,GO REGULATION OF ACROSOME REACTION,0.052669,0.21982,0.28075,0,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00019079,0.2182,0.21057,0,0
3,GO REGULATION OF RECEPTOR BINDING,0.017137,0.21795,0.21244,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.052669,0.21727,0.19824,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.079444,0.21711,0.15164,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.031059,0.21707,0.23231,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00023468,0.21701,0.20773,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0085714,0.21585,0.1692,0,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.016339,0.21529,0.3788,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00092958,0.21473,0.20373,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0085714,0.21471,0.29584,0,0
3,GO LEUKOCYTE CHEMOTAXIS,7.2754e-05,0.21448,0.20414,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.029719,0.21416,0.21511,0,0
3,GO MEMBRANE RAFT ORGANIZATION,0.099158,0.21384,0.13904,0,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.024846,0.21359,0.16,0,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.11434,0.21357,0.071521,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.060602,0.2131,0.18186,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.084046,0.21305,0.11636,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.001191,0.21161,0.23557,0,0
3,GO NEURONAL ACTION POTENTIAL,0.0033369,0.20964,0.31105,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.001986,0.20835,0.17253,0,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0057817,0.20789,0.15853,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.016339,0.20763,0.17776,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.082489,0.20757,0.18493,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.02166,0.20712,0.25271,0,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,6.5149e-05,0.20664,0.24038,0,0
3,GO CERAMIDE METABOLIC PROCESS,0.00021909,0.20504,0.21807,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.017549,0.20499,0.22553,0,0
3,GO GRANULOCYTE CHEMOTAXIS,0.00020448,0.20499,0.17502,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0051916,0.20479,0.1839,0,0
3,GO RESPONSE TO IRON ION,0.0015653,0.20458,0.2236,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.016734,0.20436,0.25545,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0033369,0.20362,0.2081,0,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.0047853,0.20307,0.28463,0,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.1028,0.20263,0.15535,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.0042883,0.20112,0.24298,0,0
3,GO HORMONE CATABOLIC PROCESS,0.019283,0.20023,0.31283,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.042857,0.20017,0.17004,0,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00014935,0.19996,0.18687,0,0
3,GO AMYLOID BETA FORMATION,0.0051916,0.19963,0.2107,0,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0022332,0.19855,0.19445,0,0
3,GO SPHINGOLIPID METABOLIC PROCESS,5.6174e-05,0.19839,0.23898,0,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.040234,0.19806,0.11442,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.12908,0.19765,0.17224,0,0
3,GO AMMONIUM TRANSPORT,0.0085714,0.19715,0.2064,0,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.0057817,0.19682,0.21298,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.059411,0.19669,0.1144,0,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.21256,0.19654,0.082165,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.019739,0.19634,0.1663,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0066042,0.19616,0.17977,0,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.12908,0.19605,0.089329,0,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00017796,0.1953,0.21011,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0042883,0.19441,0.21274,0,0
3,GO DRUG METABOLIC PROCESS,0.00072223,0.19428,0.27016,0,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.16828,0.19419,0.069314,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.099158,0.19377,0.15247,0,0
3,GO HETEROTYPIC CELL CELL ADHESION,0.044685,0.19341,0.14245,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.012203,0.19237,0.2033,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.0013054,0.19215,0.14535,0,0
3,GO DIET INDUCED THERMOGENESIS,0.080955,0.19206,0.13625,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0022332,0.19196,0.20762,0,0
3,GO MEMBRANE DEPOLARIZATION,0.01282,0.19169,0.16673,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0012662,0.19047,0.20503,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0040578,0.19046,0.21904,0,0
3,GO OXYGEN TRANSPORT,0.34256,0.18992,0.098237,0,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00052342,0.18944,0.21753,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.061812,0.18913,0.15593,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.24643,0.18903,0.039767,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.030383,0.18744,0.17202,0,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.085627,0.18712,0.17412,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.11434,0.18638,0.17645,0,0
3,GO KERATINOCYTE DEVELOPMENT,0.055956,0.18588,0.23524,0,0
3,GO PROTEIN OXIDATION,0.19695,0.18551,0.07893,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.047551,0.18532,0.20679,0,0
3,GO RESPONSE TO LIGHT INTENSITY,0.041967,0.18419,0.11888,0,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.072231,0.18419,0.094494,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.045624,0.18392,0.14405,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0022332,0.18324,0.29887,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.14526,0.18322,0.15225,0,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0033369,0.18318,0.19962,0,0
3,GO RESPONSE TO TUMOR CELL,0.045624,0.18306,0.22721,0,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.0094949,0.18281,0.2112,0,0
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.78962,0.18277,0.071138,0,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0039469,0.18238,0.18019,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.31653,0.18225,0.12378,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.14285,0.18218,0.20403,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.30402,0.18167,0.033885,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0083534,0.18053,0.20257,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.19695,0.18043,0.10594,0,0
3,GO RESPONSE TO CAFFEINE,0.025994,0.17829,0.17387,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0040578,0.17777,0.14703,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.092194,0.1765,0.20191,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.13814,0.17601,0.13461,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0059384,0.17598,0.18622,0,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.11235,0.17571,0.12302,0,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.16294,0.17564,0.034081,0,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0021689,0.17551,0.22049,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0094949,0.17457,0.26457,0,0
3,GO PROTEIN ADP RIBOSYLATION,0.072231,0.17396,0.12406,0,0
3,GO MYOTUBE DIFFERENTIATION,0.00020448,0.17394,0.18865,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.0050528,0.17393,0.19963,0,0
3,GO NOTCH SIGNALING PATHWAY,0.0022992,0.17383,0.15008,0,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.038561,0.17279,0.11046,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0066042,0.1726,0.13492,0,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0071468,0.17247,0.20386,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0024367,0.17178,0.16651,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION,0.0011199,0.17028,0.15967,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00067758,0.17008,0.16624,0,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.25001,0.17003,0.073209,0,0
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.21579,0.16966,0.067097,0,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.0081404,0.16957,0.13881,0,0
3,GO AMINE CATABOLIC PROCESS,0.0054795,0.16895,0.28646,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.088862,0.16841,0.077901,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.084046,0.16805,0.11389,0,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.027188,0.1675,0.17616,0,0
3,GO T CELL PROLIFERATION,0.0015189,0.16714,0.18072,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.0045306,0.16695,0.18801,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.33373,0.16604,0.028052,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.27611,0.16565,0.086497,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.077957,0.16536,0.14259,0,0
3,GO RESPONSE TO CADMIUM ION,0.10845,0.16505,0.11081,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.27227,0.16414,0.10595,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.14285,0.16311,0.076343,0,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.10845,0.16269,0.12609,0,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.082489,0.16268,0.082392,0,0
3,GO CHEMOSENSORY BEHAVIOR,0.13355,0.16249,0.10578,0,0
3,GO RESPONSE TO FORSKOLIN,0.16828,0.16213,0.15081,0,0
3,GO RESPONSE TO HYPEROXIA,0.093897,0.16203,0.085109,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.17653,0.16178,0.088265,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.079444,0.16135,0.16897,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.17374,0.16114,0.088171,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.1313,0.16054,0.10396,0,0
3,GO EATING BEHAVIOR,0.0056288,0.16025,0.15634,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.064293,0.15991,0.12153,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.041093,0.15964,0.14981,0,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.077957,0.1594,0.13851,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.036948,0.15938,0.20179,0,0
3,GO NEGATIVE T CELL SELECTION,0.015203,0.15892,0.11669,0,0
3,GO RESPONSE TO AMINE,0.25363,0.15883,0.069997,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.013465,0.15874,0.25202,0,0
3,GO REGULATION OF CHEMOTAXIS,0.0050528,0.15863,0.11245,0,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.00098941,0.15812,0.18632,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0021689,0.15806,0.16869,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.19393,0.15774,0.053804,0,0
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.3746,0.15772,0.1268,0,0
3,GO ENDODERM FORMATION,0.12473,0.15762,0.090069,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0045306,0.15715,0.17062,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.053746,0.15681,0.13365,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.088862,0.15678,0.21845,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.04854,0.15676,0.11712,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.12259,0.15656,0.29334,0,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.088862,0.15651,0.15866,0,0
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.05824,0.15646,0.16858,0,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.064293,0.15554,0.28856,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.0042883,0.15503,0.13798,0,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0081404,0.15496,0.14049,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.011612,0.15495,0.2055,0,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0013457,0.15465,0.1504,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.14769,0.15459,0.073619,0,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.011612,0.15434,0.12316,0,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.012203,0.15406,0.22718,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.24288,0.15365,0.10436,0,0
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.16032,0.15348,0.13882,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.014138,0.15269,0.1341,0,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.076492,0.15241,0.10578,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.02068,0.15221,0.20952,0,0
3,GO CELL MATRIX ADHESION,0.010773,0.15204,0.12549,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.03245,0.15189,0.14858,0,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.0019282,0.15177,0.1378,0,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.036948,0.15145,0.21432,0,0
3,GO RENAL TUBULE DEVELOPMENT,0.042857,0.15142,0.10289,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.079444,0.15139,0.11035,0,0
3,GO PROTEIN KINASE C SIGNALING,0.082489,0.15109,0.1596,0,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0051916,0.15079,0.13862,0,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.059411,0.15056,0.16279,0,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.19393,0.15055,0.052531,0,0
3,GO RESPONSE TO VITAMIN,0.10096,0.15013,0.078358,0,0
3,GO MALE MEIOSIS I,0.44924,0.14996,0.10665,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.018398,0.14954,0.16155,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0038387,0.14952,0.17314,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0097392,0.14931,0.23372,0,0
3,GO GLAND MORPHOGENESIS,0.059411,0.14914,0.10966,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.095625,0.14874,0.18535,0,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.11841,0.1485,0.10834,0,0
3,GO AMINO ACID ACTIVATION,0.10465,0.14846,0.13093,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.26098,0.14826,0.008745,0,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00353,0.14796,0.22727,0,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.099158,0.14653,0.16125,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.15517,0.14622,0.12028,0,0
3,GO REGULATION OF ION TRANSPORT,0.0069616,0.14615,0.11282,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0071468,0.14573,0.18164,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.073629,0.14554,0.13431,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.024288,0.14537,0.18412,0,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.061812,0.14514,0.1034,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0023671,0.14496,0.20896,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.11039,0.14476,0.12048,0,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.014138,0.14423,0.15746,0,0
3,GO REPLICATIVE SENESCENCE,0.012203,0.14421,0.19611,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.11841,0.14416,0.18342,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.013798,0.14408,0.1134,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.68418,0.14378,0.02774,0,0
3,GO DETOXIFICATION,0.19695,0.14375,0.12954,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0026572,0.14357,0.17393,0,0
3,GO ASTROCYTE ACTIVATION,0.11235,0.14355,0.099199,0,0
3,GO EPITHELIAL CELL PROLIFERATION,0.011326,0.14336,0.11262,0,0
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.061812,0.14285,0.11761,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.014486,0.14216,0.14395,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.015203,0.14206,0.13491,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.055956,0.14202,0.099786,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0073363,0.14202,0.13595,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.16828,0.1417,0.14972,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.027803,0.14102,0.12498,0,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.012203,0.14066,0.14783,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.064293,0.1404,0.12382,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.20937,0.14037,0.12208,0,0
3,GO PLACENTA DEVELOPMENT,0.1313,0.14036,0.0822,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.33812,0.14026,0.058168,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.2839,0.14022,0.045729,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0032441,0.14019,0.1603,0,0
3,GO NAD METABOLIC PROCESS,0.099158,0.14013,0.12572,0,0
3,GO ACTIVATED T CELL PROLIFERATION,0.012508,0.13999,0.14244,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.5726,0.13984,0.035254,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.047551,0.13984,0.1591,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0024367,0.13974,0.14521,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.01282,0.13913,0.15071,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.36526,0.13883,0.053642,0,0
3,GO EXECUTION PHASE OF APOPTOSIS,5.4121e-05,0.13881,0.17673,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.023741,0.13857,0.13136,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.02268,0.13846,0.13227,0,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.092194,0.13845,0.074357,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.26847,0.13783,0.087246,0,0
3,GO PIGMENT ACCUMULATION,0.093897,0.13768,0.10072,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.46512,0.13765,0.035878,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.015574,0.13733,0.15782,0,0
3,GO VESICLE ORGANIZATION,0.00020448,0.13699,0.16781,0,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.11841,0.13653,0.1076,0,0
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.33373,0.13646,0.065939,0,0
3,GO PROTEIN MANNOSYLATION,0.024846,0.13642,0.11664,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0017123,0.13625,0.16888,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.19695,0.13605,0.18437,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.021165,0.13599,0.13703,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.084046,0.1357,0.10976,0,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.075049,0.1355,0.080435,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.11434,0.13531,0.10741,0,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.016339,0.13518,0.11618,0,0
3,GO ESTROUS CYCLE,0.41842,0.13515,0.06969,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.090515,0.13504,0.12537,0,0
3,GO ENDOTHELIUM DEVELOPMENT,0.020205,0.13469,0.12446,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.12049,0.13466,0.1535,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.035393,0.13465,0.19421,0,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.011904,0.13451,0.17623,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.12908,0.13434,0.089497,0,0
3,GO LIPID MODIFICATION,6.5149e-05,0.13414,0.18435,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.34702,0.13359,0.1415,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.013798,0.13339,0.13741,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.066855,0.13324,0.10685,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26471,0.13318,0.09943,0,0
3,GO COPPER ION HOMEOSTASIS,0.049546,0.13313,0.1452,0,0
3,GO LUNG MORPHOGENESIS,0.10845,0.133,0.084301,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.32506,0.13295,0.024159,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.061812,0.13281,0.14027,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.50896,0.13263,0.049461,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0069616,0.13259,0.20037,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.080955,0.13254,0.090096,0,0
3,GO BIOMINERALIZATION,0.011612,0.13209,0.12363,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.017969,0.13192,0.12288,0,0
3,GO REGULATION OF APPETITE,0.05161,0.13186,0.096281,0,0
3,GO RESPONSE TO ANTIBIOTIC,0.010245,0.13175,0.1168,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0066042,0.1316,0.1916,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.15015,0.13147,0.072842,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00095906,0.13141,0.13338,0,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.25001,0.13123,0.071959,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0019282,0.13044,0.16425,0,0
3,GO RESPONSE TO UV C,0.05161,0.13043,0.11582,0,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.43367,0.13028,0.064223,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.19393,0.13007,0.063987,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0695,0.12926,0.095488,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.35153,0.12892,0.055397,0,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.17653,0.12891,0.054444,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.65234,0.12879,0.0029776,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.075049,0.12877,0.094091,0,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.58456,0.12839,0.032514,0,0
3,GO ALDITOL METABOLIC PROCESS,0.2839,0.12838,0.062918,0,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.014841,0.12826,0.14649,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.8303,0.12764,-0.035824,0,0
3,GO GLIAL CELL DEVELOPMENT,0.047551,0.12743,0.10809,0,0
3,GO DNA DEMETHYLATION,0.11235,0.12714,0.084362,0,0
3,GO DRUG CATABOLIC PROCESS,0.02843,0.127,0.17074,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.050569,0.12694,0.16396,0,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.48678,0.1269,0.058221,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.070855,0.12641,0.15776,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.036164,0.1261,0.10233,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.099158,0.12569,0.083102,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.10654,0.12505,0.089355,0,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.17653,0.12481,0.19726,0,0
3,GO PENILE ERECTION,0.59664,0.12476,0.038038,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.17934,0.12466,0.081753,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.019283,0.12448,0.13619,0,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.076492,0.12404,0.21533,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.047551,0.12399,0.12116,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.0064317,0.12382,0.16463,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.1313,0.12377,0.12102,0,0
3,GO CARDIAC CONDUCTION,0.072231,0.12345,0.10173,0,0
3,GO PROTEIN PALMITOYLATION,0.015574,0.12291,0.14983,0,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.22568,0.12275,0.093415,0,0
3,GO SODIUM ION TRANSPORT,0.009256,0.12274,0.13833,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.065563,0.12261,0.12051,0,0
3,GO GAMMA DELTA T CELL ACTIVATION,0.25363,0.12235,0.12671,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.12259,0.12189,0.14409,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,0.095625,0.12176,0.098338,0,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.1313,0.12166,0.068291,0,0
3,GO REGULATION OF DENDRITE EXTENSION,0.13355,0.12134,0.20123,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.19095,0.12051,0.12464,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.17653,0.12036,0.26558,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.15015,0.12025,0.052025,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0695,0.12015,0.10129,0,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.070855,0.12006,0.1101,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.034637,0.11986,0.14555,0,0
3,GO GLAND DEVELOPMENT,0.0066042,0.11975,0.10413,0,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.064293,0.11959,0.11547,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.024288,0.1194,0.089336,0,0
3,GO GLYCINE METABOLIC PROCESS,0.62113,0.11933,0.11241,0,0
3,GO ZINC ION TRANSPORT,0.068167,0.11915,0.13874,0,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.014138,0.11901,0.13242,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.0047853,0.11866,0.13951,0,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.10845,0.11838,0.11944,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.02268,0.11834,0.13093,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.51459,0.11829,0.092124,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.12473,0.11821,0.072034,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.76948,0.11805,-0.076839,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.16559,0.11796,0.092804,0,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.4545,0.1178,0.03446,0,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.7495,0.11769,-0.015331,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0022992,0.11759,0.13906,0,0
3,GO SKIN MORPHOGENESIS,0.73628,0.11759,-0.096456,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.11841,0.11751,0.09046,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.20621,0.1175,0.097928,0,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.052669,0.11732,0.10131,0,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.068167,0.11729,0.12131,0,0
3,GO FAT CELL DIFFERENTIATION,0.0062634,0.11682,0.13256,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.22905,0.11677,0.16875,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.11434,0.11615,0.1179,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.17374,0.11608,0.062092,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0069616,0.11596,0.09967,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.15773,0.11565,0.11283,0,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.13814,0.1156,0.059309,0,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0081404,0.11505,0.15435,0,0
3,GO GLOMERULUS DEVELOPMENT,0.082489,0.11491,0.10852,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.12689,0.1147,0.087468,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0038387,0.1145,0.12234,0,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.44924,0.11441,0.050816,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.1313,0.11423,0.11286,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.12689,0.11417,0.091759,0,0
3,GO EPIBOLY,0.50896,0.11407,0.0028409,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.024846,0.11405,0.14306,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0081404,0.11389,0.12463,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0066042,0.11386,0.14955,0,0
3,GO ANIMAL ORGAN MATURATION,0.080955,0.11377,0.11448,0,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.030383,0.11371,0.089667,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.060602,0.11365,0.093789,0,0
3,GO REGULATION OF TRANSPORT,0.001191,0.11346,0.10234,0,0
3,GO RESPONSE TO SALT,0.088862,0.11343,0.085993,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.21905,0.1134,0.055862,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.36991,0.11338,0.061369,0,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.092194,0.11318,0.094318,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.38408,0.11263,0.075285,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.047551,0.11111,0.11443,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.0075304,0.11096,0.10558,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0083534,0.11071,0.13083,0,0
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.1313,0.11067,0.20507,0,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.17374,0.11044,0.093933,0,0
3,GO VIRAL RELEASE FROM HOST CELL,0.05824,0.11013,0.11596,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.03939,0.11012,0.18091,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.095625,0.10962,0.094926,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.50896,0.10925,0.044527,0,0
3,GO SEX DETERMINATION,0.32506,0.10914,0.069526,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.13814,0.10914,0.084311,0,0
3,GO HEART PROCESS,0.035393,0.10908,0.097147,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.079444,0.10899,0.086631,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.007729,0.10896,0.16946,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.51459,0.10893,0.065745,0,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.11636,0.10889,0.12067,0,0
3,GO MICROVILLUS ASSEMBLY,0.27227,0.10881,0.097131,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.90599,0.10801,-0.0076391,0,0
3,GO STRESS FIBER ASSEMBLY,0.19695,0.10799,0.055545,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.029719,0.10796,0.11361,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.14285,0.10783,0.096634,0,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.14285,0.10757,0.052381,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.087232,0.10736,0.089704,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.015574,0.10735,0.11712,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.085627,0.10725,0.073425,0,0
3,GO PSEUDOURIDINE SYNTHESIS,0.9686,0.10698,0.0081196,0,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.29586,0.1068,0.10642,0,0
3,GO AXONEME ASSEMBLY,0.23937,0.10667,0.07637,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.47049,0.10662,0.040897,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.085627,0.10657,0.12467,0,0
3,GO NERVE DEVELOPMENT,0.25363,0.10617,0.083946,0,0
3,GO NEPHRON DEVELOPMENT,0.097379,0.10615,0.07163,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0042883,0.10598,0.11501,0,0
3,GO TOXIN TRANSPORT,0.0047853,0.10584,0.18658,0,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.05161,0.10563,0.13461,0,0
3,GO REGULATION OF SYNAPSE MATURATION,0.95466,0.10552,-0.062068,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.026586,0.10535,0.12071,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.22568,0.10516,0.072032,0,0
3,GO REGULATION OF HAIR CYCLE,0.093897,0.10471,0.11844,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.17099,0.10419,0.13229,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.092194,0.1039,0.064125,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.76281,0.10371,-0.0005976,0,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.16828,0.10369,0.11685,0,0
3,GO CIRCADIAN RHYTHM,0.0013457,0.10357,0.10318,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.01282,0.10356,0.11046,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.18508,0.10355,0.11278,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.075049,0.10324,0.069799,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.011047,0.10324,0.16211,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.16559,0.103,0.07186,0,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.49227,0.10281,0.033662,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.068167,0.10268,0.17721,0,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.94073,0.10267,-0.063939,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0015653,0.10258,0.099739,0,0
3,GO VESICLE DOCKING,0.063042,0.10231,0.12046,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.19095,0.10188,0.086374,0,0
3,GO SIGNAL RELEASE,0.0032441,0.10186,0.12396,0,0
3,GO PANCREATIC JUICE SECRETION,0.26847,0.10185,0.10371,0,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.3746,0.10179,0.092969,0,0
3,GO NEURON REMODELING,0.25729,0.10174,0.063225,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.17653,0.10173,0.01999,0,0
3,GO DECIDUALIZATION,0.41341,0.1015,0.074615,0,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.15264,0.1015,0.18048,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.30402,0.10139,0.089748,0,0
3,GO ACTION POTENTIAL,0.054842,0.10138,0.1148,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.13355,0.10124,0.099543,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.14526,0.10122,0.13733,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.24288,0.10121,0.055359,0,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.084046,0.10113,0.061073,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.087232,0.10105,0.14135,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.054842,0.1008,0.067758,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.40349,0.10034,0.07925,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.20309,0.10027,0.048657,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.85768,0.10008,-0.023379,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.090515,0.10006,0.080201,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.65234,0.099852,0.0016106,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.43883,0.099796,0.081331,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.53167,0.099499,0.020032,0,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.43883,0.099448,0.10562,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.040234,0.099279,0.088883,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.4545,0.099107,0.055139,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.052669,0.099012,0.11555,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.084046,0.098801,0.06363,0,0
3,GO HEAD MORPHOGENESIS,0.48678,0.098599,0.016861,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.00353,0.098579,0.11496,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.96163,0.09856,-0.030411,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.11434,0.098495,0.095307,0,0
3,GO TRNA 5 END PROCESSING,0.31232,0.09835,0.056842,0,0
3,GO VACUOLAR TRANSPORT,0.00052342,0.098245,0.1604,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.44402,0.098051,0.069949,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.15517,0.098023,0.088562,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.25363,0.097958,0.071338,0,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.19393,0.09765,0.098795,0,0
3,GO EMBRYO IMPLANTATION,0.22905,0.097638,0.085597,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.18219,0.097485,0.095953,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.14048,0.097411,0.14771,0,0
3,GO PEPTIDE METABOLIC PROCESS,0.17099,0.097239,0.061964,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.87833,0.097091,-0.00020536,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.13583,0.097073,0.095284,0,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.13814,0.097063,0.048596,0,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0083534,0.097043,0.12593,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.22905,0.097038,0.038296,0,0
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.011612,0.096729,0.14309,0,0
3,GO VASCULATURE DEVELOPMENT,0.12473,0.096725,0.050351,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.7495,0.096687,-0.048159,0,0
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.71006,0.096562,0.037541,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.49227,0.096521,0.042159,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.17374,0.096378,0.11762,0,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.0085714,0.096359,0.10599,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.41341,0.096226,0.0073393,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,0.50337,0.096201,0.039939,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.64605,0.096122,0.019108,0,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.0053338,0.096117,0.098032,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.095625,0.096116,0.075947,0,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.23937,0.096026,0.032355,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.56075,0.095662,0.068659,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.19695,0.095481,0.12221,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.48131,0.095445,0.096454,0,0
3,GO HEART INDUCTION,0.60272,0.095325,0.073389,0,0
3,GO ORGANELLE INHERITANCE,0.075049,0.09483,0.091263,0,0
3,GO TUBE MORPHOGENESIS,0.090515,0.094824,0.057548,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.052669,0.094747,0.13354,0,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.093897,0.094703,0.046647,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.55487,0.094448,0.06639,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.0046564,0.094436,0.12057,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.30815,0.094345,0.039941,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.17653,0.09419,0.0982,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.60272,0.094181,0.017189,0,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.068167,0.094129,0.050773,0,0
3,GO URETER DEVELOPMENT,0.29184,0.093933,0.040069,0,0
3,GO FOLIC ACID METABOLIC PROCESS,0.95466,0.093792,-0.045256,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.69061,0.093754,0.10214,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.15015,0.093685,0.082937,0,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.46512,0.0936,0.022853,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.26098,0.093521,0.058408,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.073629,0.093141,0.083371,0,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.088862,0.093081,0.15532,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.090515,0.093057,0.085405,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.21579,0.092971,0.041516,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.14769,0.092754,0.06639,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.16294,0.092283,0.070377,0,0
3,GO RESPONSE TO NICOTINE,0.24643,0.091793,0.070838,0,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.22568,0.091775,0.055269,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.070855,0.091734,0.070876,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.29992,0.091641,0.11037,0,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.010245,0.091445,0.17479,0,0
3,GO REGULATION OF RESPONSE TO FOOD,0.72969,0.091393,0.0213,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025817,0.091356,0.13534,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.070855,0.091305,0.098088,0,0
3,GO SEGMENT SPECIFICATION,0.76281,0.091188,-0.055226,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.10096,0.091064,0.12165,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.76281,0.09062,0.016026,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.077957,0.0906,0.10374,0,0
3,GO JNK CASCADE,0.0087944,0.090592,0.098099,0,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.84397,0.090466,-0.013044,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.12259,0.090355,0.10709,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.14048,0.09031,0.057854,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.48131,0.090281,0.0061564,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.065563,0.09021,0.089638,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.40843,0.089936,0.10918,0,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.16559,0.089814,0.040555,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.092194,0.089606,0.05679,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.72313,0.089452,0.0050116,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.11434,0.089362,0.080706,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.19393,0.089353,0.10076,0,0
3,GO MULTICELLULAR ORGANISM AGING,0.021165,0.089021,0.10965,0,0
3,GO ZINC ION HOMEOSTASIS,0.46512,0.088859,0.055074,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.26471,0.088323,0.039552,0,0
3,GO TISSUE MORPHOGENESIS,0.13355,0.088288,0.039475,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.087232,0.087768,0.13347,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.39858,0.087617,0.050105,0,0
3,GO NUCLEOSIDE SALVAGE,0.20309,0.087542,0.052165,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.16032,0.087323,0.09624,0,0
3,GO REPRODUCTION,0.031748,0.086817,0.057951,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.073629,0.086598,0.10145,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.029719,0.086449,0.093449,0,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.15517,0.086197,0.070133,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.009256,0.086182,0.088443,0,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.030383,0.086138,0.058422,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.097379,0.086138,0.13295,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.32077,0.086097,0.050243,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.15517,0.086012,0.10961,0,0
3,GO PIGMENT GRANULE MATURATION,0.19695,0.085968,0.058437,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.3746,0.085822,0.054101,0,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0079323,0.085515,0.11134,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.11434,0.085399,0.10665,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.041093,0.085231,0.089374,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.16828,0.085062,0.079274,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.018836,0.085034,0.10927,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.077957,0.084984,0.10057,0,0
3,GO PIRNA METABOLIC PROCESS,0.27999,0.084956,0.14721,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.18219,0.084915,0.059178,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.16032,0.084776,0.096201,0,0
3,GO THYMIC T CELL SELECTION,0.063042,0.084616,0.073485,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.65234,0.084455,0.050183,0,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.65866,0.084434,0.017828,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.16294,0.084222,0.03706,0,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.16032,0.08422,0.051148,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.27227,0.08389,0.036112,0,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.70355,0.083837,0.010577,0,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.30402,0.083687,0.060644,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.32938,0.08368,0.058866,0,0
3,GO MESONEPHROS DEVELOPMENT,0.087232,0.083485,0.094719,0,0
3,GO COPULATION,0.057089,0.083445,0.14459,0,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.19095,0.083392,0.10103,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.055956,0.083312,0.070252,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.60272,0.082935,0.030518,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.17934,0.08291,0.1567,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.36991,0.082821,0.034942,0,0
3,GO CELL JUNCTION ASSEMBLY,0.14048,0.082805,0.060535,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.65234,0.082773,-0.0057354,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.13355,0.082689,0.1721,0,0
3,GO MALE SEX DIFFERENTIATION,0.12259,0.082424,0.050007,0,0
3,GO KERATINOCYTE PROLIFERATION,0.17374,0.082419,0.066545,0,0
3,GO AMIDE BIOSYNTHETIC PROCESS,0.29184,0.082332,0.043741,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.017137,0.082209,0.080969,0,0
3,GO TUBE DEVELOPMENT,0.072231,0.082063,0.06246,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.62732,0.082054,0.020915,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.60883,0.081832,0.024665,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.60883,0.08182,0.020627,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.036164,0.081474,0.085288,0,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.027803,0.081358,0.097434,0,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.095625,0.081333,0.071103,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.26098,0.081205,0.048023,0,0
3,GO DNA DEALKYLATION,0.41341,0.081156,0.023673,0,0
3,GO BRONCHUS DEVELOPMENT,0.50896,0.081155,0.083698,0,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.17099,0.081147,0.062185,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.14285,0.080998,0.074624,0,0
3,GO CRANIAL NERVE DEVELOPMENT,0.31232,0.080918,0.072,0,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.17934,0.080891,0.088779,0,0
3,GO ASSOCIATIVE LEARNING,0.20309,0.080732,0.061872,0,0
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.04854,0.080474,0.26304,0,0
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.32077,0.080174,0.069681,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.049546,0.080143,0.086374,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.15773,0.079982,0.16776,0,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.090515,0.079571,0.1566,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.14769,0.079518,0.059471,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.29586,0.079499,0.045641,0,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.31653,0.079176,0.10827,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.52025,0.07903,0.058488,0,0
3,GO PRIMARY MIRNA PROCESSING,0.47049,0.07902,0.02503,0,0
3,GO FACE DEVELOPMENT,0.59664,0.078409,0.017498,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.033166,0.078386,0.0913,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.65866,0.078369,0.025768,0,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.11841,0.07804,0.085504,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.62732,0.078037,-0.0054373,0,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.53167,0.077766,0.017016,0,0
3,GO RESPONSE TO AMPHETAMINE,0.35607,0.077682,0.073616,0,0
3,GO MUSCLE SYSTEM PROCESS,0.009256,0.077568,0.10052,0,0
3,GO REGULATION OF TOR SIGNALING,0.010773,0.077455,0.081382,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.15517,0.07739,0.077548,0,0
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.22905,0.077148,0.16714,0,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.13583,0.076995,0.046569,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.16559,0.076831,0.083436,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.085627,0.076821,0.093468,0,0
3,GO LYSOSOMAL TRANSPORT,0.004408,0.076449,0.15223,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.4978,0.076379,0.058499,0,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.05824,0.07635,0.078904,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.24288,0.076118,0.034465,0,0
3,GO RELAXATION OF MUSCLE,0.27999,0.076014,0.06931,0,0
3,GO MEMBRANE REPOLARIZATION,0.087232,0.075916,0.10891,0,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.68418,0.0758,0.011664,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.71006,0.075734,0.0044952,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.14048,0.075666,0.070255,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.084046,0.075591,0.091348,0,0
3,GO RESPONSE TO INTERLEUKIN 7,0.13355,0.075447,0.07356,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.4978,0.075374,0.0092822,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17934,0.075092,0.060147,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.64605,0.075066,0.043341,0,0
3,GO PROTEIN TRIMERIZATION,0.34702,0.074937,0.053463,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.085627,0.074711,0.09693,0,0
3,GO PROTEIN TARGETING,0.21579,0.074616,0.052072,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.62732,0.074606,0.048958,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.30815,0.074573,0.037774,0,0
3,GO RIBOSOME ASSEMBLY,0.74288,0.074489,0.0089523,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10654,0.074386,0.13033,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.53167,0.074208,0.013205,0,0
3,GO PHOTOPERIODISM,0.13814,0.074148,0.10337,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.55487,0.074125,0.087585,0,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.16032,0.074121,0.089476,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.91987,0.074108,0.0020129,0,0
3,GO NADH METABOLIC PROCESS,0.20937,0.073985,0.11391,0,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.5726,0.073949,0.056637,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.011326,0.073864,0.1013,0,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.42855,0.073601,0.097276,0,0
3,GO L SERINE METABOLIC PROCESS,0.91987,0.073462,-0.018222,0,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.62113,0.073137,0.0087219,0,0
3,GO NUCLEUS LOCALIZATION,0.48678,0.073105,0.032151,0,0
3,GO PROTEASOME ASSEMBLY,0.097379,0.073101,0.11295,0,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.068167,0.073066,0.046251,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.59059,0.072956,-0.0062228,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.04854,0.072908,0.076262,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.34702,0.072647,0.097427,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.38888,0.072298,0.030554,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.053746,0.072268,0.10438,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.059411,0.072248,0.068721,0,0
3,GO OSSIFICATION,0.043763,0.072244,0.08327,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.057089,0.072207,0.1972,0,0
3,GO RESPONSE TO LEPTIN,0.14526,0.072176,0.12325,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.66501,0.071991,0.01187,0,0
3,GO TRNA MODIFICATION,0.90599,0.071986,-0.021368,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.26471,0.071874,0.095718,0,0
3,GO DEPHOSPHORYLATION,0.03245,0.071715,0.058712,0,0
3,GO SOMITOGENESIS,0.026586,0.071706,0.098518,0,0
3,GO REGULATION OF SYSTEM PROCESS,0.060602,0.071569,0.072816,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.17934,0.071369,0.04934,0,0
3,GO REGULATION OF OSSIFICATION,0.016734,0.071233,0.12011,0,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.60883,0.071146,0.020075,0,0
3,GO ERBB2 SIGNALING PATHWAY,0.93377,0.070978,0.019808,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.21579,0.07074,0.10361,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.05161,0.070556,0.081938,0,0
3,GO REGULATION OF MRNA BINDING,0.71658,0.070395,-0.0069662,0,0
3,GO NEURON MATURATION,0.099158,0.070386,0.13119,0,0
3,GO GOLGI LOCALIZATION,0.48131,0.070375,0.039243,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29992,0.070365,0.04695,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.25001,0.070358,0.053964,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.095625,0.070317,0.066786,0,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.4598,0.070284,0.022573,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.23589,0.06987,0.050751,0,0
3,GO SYNAPTIC VESICLE DOCKING,0.36991,0.069559,0.1383,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.52025,0.069436,0.033595,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.22905,0.069307,0.098458,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.26847,0.069259,0.044739,0,0
3,GO ASTROCYTE DEVELOPMENT,0.49227,0.0691,0.057229,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.076492,0.068962,0.098416,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.18508,0.068956,0.079965,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.12259,0.068893,0.055609,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.17934,0.068832,0.055595,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031748,0.068694,0.059217,0,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.31232,0.068395,0.022483,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.10845,0.068275,0.078455,0,0
3,GO REGULATION OF ODONTOGENESIS,0.36991,0.068154,0.035301,0,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.57857,0.068104,0.012766,0,0
3,GO FEAR RESPONSE,0.23245,0.068036,0.055192,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.035393,0.067979,0.075537,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.43883,0.067965,0.052736,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.22568,0.067932,0.063037,0,0
3,GO PROTEIN IMPORT,0.20621,0.067724,0.052065,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.30402,0.067635,0.044726,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.13583,0.067552,0.077167,0,0
3,GO REPRODUCTIVE BEHAVIOR,0.34256,0.06755,0.053584,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.02166,0.067491,0.059157,0,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.095625,0.067443,0.13803,0,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.44402,0.067372,0.048421,0,0
3,GO RESPONSE TO HEAT,0.082489,0.067362,0.08736,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.63978,0.067323,-0.0017572,0,0
3,GO TRNA PROCESSING,0.81668,0.066902,-0.019549,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.67776,0.066823,0.051243,0,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.72969,0.066753,0.059928,0,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.1028,0.066636,0.09179,0,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.055956,0.066458,0.062617,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.52025,0.066433,0.024182,0,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.89215,0.066235,-0.042207,0,0
3,GO OVULATION CYCLE,0.25363,0.066084,0.052791,0,0
3,GO RNA 5 END PROCESSING,0.47588,0.066031,0.048435,0,0
3,GO MALE GENITALIA DEVELOPMENT,0.56075,0.065946,0.036705,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.031059,0.065683,0.096096,0,0
3,GO AUTOPHAGIC CELL DEATH,0.0695,0.065604,0.12339,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.78962,0.065504,0.0071158,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.14769,0.06548,0.11756,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.39371,0.065235,0.044172,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.53167,0.065231,0.074352,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.20621,0.065199,0.065328,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.084046,0.065016,0.075327,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.62732,0.064934,-0.013036,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.17653,0.064903,0.064076,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.24643,0.064612,0.02844,0,0
3,GO CELL AGING,0.16294,0.064539,0.052395,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.69061,0.064509,0.025545,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.057089,0.064501,0.075474,0,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.046579,0.064387,0.093113,0,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.17653,0.064262,0.10284,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.78962,0.064205,-0.0027755,0,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.33812,0.064167,0.093469,0,0
3,GO TISSUE REGENERATION,0.13814,0.064119,0.082997,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.11039,0.064094,0.10388,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.42347,0.063995,0.058771,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.4545,0.063838,0.052194,0,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.34256,0.063696,0.028095,0,0
3,GO HISTONE DEACETYLATION,0.27611,0.063536,0.031749,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.27999,0.063369,0.06026,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.23589,0.063274,0.069623,0,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.11841,0.063104,0.067823,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.031748,0.063069,0.056784,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.49227,0.062603,0.060436,0,0
3,GO AMP METABOLIC PROCESS,0.21256,0.062494,0.12999,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.25001,0.06219,0.11264,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.82348,0.062107,-0.020279,0,0
3,GO MOLTING CYCLE,0.30402,0.062071,0.034658,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.42347,0.062054,0.069178,0,0
3,GO OOGENESIS,0.53742,0.061967,0.022306,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.59059,0.061951,0.056305,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.36991,0.061791,0.038509,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.075049,0.061735,0.07114,0,0
3,GO MEMBRANE INVAGINATION,0.13814,0.061727,0.070467,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.16294,0.061696,0.031747,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.22568,0.061639,0.064546,0,0
3,GO RUFFLE ASSEMBLY,0.33812,0.061595,0.067454,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.63978,0.061581,-0.10976,0,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.99651,0.061477,-0.076319,0,0
3,GO CGMP MEDIATED SIGNALING,0.76948,0.061401,0.023894,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.55487,0.061305,0.066129,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.22905,0.060997,0.044113,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.26847,0.06079,0.092034,0,0
3,GO GLIAL CELL MIGRATION,0.95466,0.060722,-0.010579,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.48131,0.060673,0.051247,0,0
3,GO DEVELOPMENTAL MATURATION,0.079444,0.060607,0.082362,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.57857,0.060437,0.13733,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.61497,0.060378,0.055987,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.24643,0.060347,0.034351,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.16559,0.060332,0.050114,0,0
3,GO INTERACTION WITH SYMBIONT,0.23589,0.060316,0.027222,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.26098,0.060117,0.19839,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.94073,0.060044,0.0010572,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.14285,0.059887,0.080558,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.72313,0.059733,0.016758,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12908,0.059656,0.061125,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.17934,0.05955,0.1506,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.052669,0.059492,0.14333,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.20309,0.059329,0.049324,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.17653,0.059107,0.034446,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.62113,0.059075,0.018647,0,0
3,GO MRNA MODIFICATION,0.94073,0.058905,-0.023427,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.37932,0.058858,0.051183,0,0
3,GO MYELOID CELL DEVELOPMENT,0.085627,0.058539,0.073682,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.61497,0.058341,0.013792,0,0
3,GO ACTIN FILAMENT ORGANIZATION,0.10465,0.058194,0.050543,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.51459,0.058165,0.054335,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.057089,0.058077,0.066351,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.079444,0.058073,0.069473,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.74288,0.057976,0.037095,0,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.019283,0.05781,0.07099,0,0
3,GO TAXIS,0.74288,0.057722,0.0066156,0,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.21256,0.057692,0.04931,0,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.26098,0.057474,0.036039,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.23245,0.05747,0.075984,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.61497,0.057249,-0.019912,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.43367,0.057196,0.023794,0,0
3,GO VESICLE CARGO LOADING,0.50896,0.057016,0.057938,0,0
3,GO MYOFIBRIL ASSEMBLY,0.03939,0.056969,0.092381,0,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.67776,0.056844,-0.013552,0,0
3,GO POTASSIUM ION TRANSPORT,0.23245,0.056528,0.071663,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.34256,0.056207,0.066457,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.14769,0.056115,0.098476,0,0
3,GO MYELIN ASSEMBLY,0.30402,0.056032,0.080738,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.19695,0.055953,0.046154,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.41842,0.055825,0.064279,0,0
3,GO INTERLEUKIN 17 PRODUCTION,0.20937,0.055718,0.075761,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.25729,0.05567,0.10499,0,0
3,GO NEURON DEATH,0.066855,0.055325,0.050823,0,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.98953,0.055321,0.1042,0,0
3,GO GDP METABOLIC PROCESS,0.78962,0.055312,0.010444,0,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.72969,0.055299,-0.0073101,0,0
3,GO RNA CATABOLIC PROCESS,0.99651,0.055297,-0.022136,0,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.34256,0.055265,0.066014,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.39858,0.055252,0.029937,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.11841,0.055181,0.041514,0,0
3,GO NCRNA METABOLIC PROCESS,0.87833,0.055141,-0.0041658,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.25001,0.055057,0.024592,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.77618,0.05499,-0.034488,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.26098,0.054841,0.043426,0,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.085627,0.054803,0.043197,0,0
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.60272,0.054779,0.064256,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.39858,0.054594,0.033361,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.087232,0.054493,0.084611,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.27611,0.054265,0.050982,0,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.23589,0.054263,0.094056,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.59664,0.054207,0.033387,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.090515,0.054016,0.063372,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.84397,0.053996,-0.099261,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.22905,0.05393,0.039523,0,0
3,GO IMPORT INTO CELL,0.041967,0.053907,0.10785,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.26847,0.053898,0.028485,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.057089,0.053739,0.094367,0,0
3,GO CELLULAR RESPONSE TO DRUG,0.65234,0.053683,0.022421,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.70355,0.053668,0.0095665,0,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.14048,0.053646,0.092965,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.73628,0.053597,0.025144,0,0
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.70355,0.053591,0.0086398,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.86455,0.053578,-0.030135,0,0
3,GO POSITIVE REGULATION OF TRANSLATION,1,0.05352,-0.025981,0,0
3,GO ACTIN FILAMENT BASED PROCESS,0.16828,0.053354,0.039081,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.18219,0.05331,0.039656,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.37932,0.053187,0.058958,0,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.53742,0.053153,0.050569,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.60272,0.053089,0.038014,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.30402,0.052984,0.060012,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.034637,0.052919,0.075782,0,0
3,GO RESPONSE TO UV B,0.85768,0.052904,-0.032924,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.22905,0.052902,0.090211,0,0
3,GO MITOCHONDRIAL TRANSLATION,0.29992,0.052854,0.084026,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.78962,0.052802,0.016064,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.96163,0.052537,-0.012331,0,0
3,GO PEPTIDE CROSS LINKING,0.20937,0.052413,0.060689,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.15015,0.052355,0.053987,0,0
3,GO TOOTH MINERALIZATION,0.38408,0.052348,0.061963,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.79636,0.052341,-0.051083,0,0
3,GO MUSCLE CONTRACTION,0.033166,0.052187,0.084162,0,0
3,GO EXTRACELLULAR TRANSPORT,0.31232,0.052048,0.066016,0,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.013798,0.051948,0.070027,0,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.1313,0.051608,0.11069,0,0
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.099158,0.051425,0.098206,0,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.32077,0.051403,0.096785,0,0
3,GO REGULATION OF CELL AGING,0.9686,0.051398,-0.0068361,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.11434,0.051385,0.1185,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.54903,0.051042,0.0017264,0,0
3,GO RHYTHMIC PROCESS,0.046579,0.051024,0.061623,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.14526,0.050882,0.078483,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.98953,0.050812,-0.021909,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.1313,0.050749,0.070679,0,0
3,GO GAS TRANSPORT,0.61497,0.050679,0.017691,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.5726,0.050675,0.0039095,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.54903,0.050639,0.040621,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.50896,0.050563,0.034898,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.47049,0.05046,0.023136,0,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.27227,0.05031,0.11376,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.64605,0.050303,0.008791,0,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.21579,0.050146,0.044954,0,0
3,GO RNA DECAPPING,0.74288,0.050027,0.028965,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.72313,0.050016,-0.052019,0,0
3,GO BLASTOCYST FORMATION,0.079444,0.049884,0.1126,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.035393,0.049726,0.10325,0,0
3,GO BONE MINERALIZATION,0.10845,0.049726,0.085152,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.044685,0.049724,0.073556,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.35607,0.049722,0.088909,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.40843,0.049483,0.075355,0,0
3,GO SEX DIFFERENTIATION,0.31653,0.049381,0.021553,0,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.62113,0.049179,-0.0036756,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.5726,0.04892,0.023461,0,0
3,GO RESPONSE TO ATP,0.43883,0.048789,0.056079,0,0
3,GO BLASTOCYST DEVELOPMENT,0.02166,0.048648,0.077277,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.40843,0.048576,0.098506,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.98255,0.048544,-0.045993,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.27227,0.048161,0.042315,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.070855,0.048041,0.063118,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.98255,0.047278,-0.018838,0,0
3,GO REGULATION OF GROWTH,0.21905,0.047085,0.034664,0,0
3,GO BLEB ASSEMBLY,0.72969,0.047026,-0.03054,0,0
3,GO CELLULAR SENESCENCE,0.22235,0.046912,0.04406,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.23937,0.04686,0.058487,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.38888,0.04683,0.026712,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.084046,0.046817,0.095986,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.79636,0.046671,-0.052755,0,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.38408,0.04666,0.030054,0,0
3,GO GERM CELL DEVELOPMENT,0.46512,0.046565,0.017116,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.34256,0.046548,0.058156,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.54321,0.046491,0.029039,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.86455,0.046491,0.020231,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.35153,0.046482,0.028916,0,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,1,0.046463,-0.015373,0,0
3,GO PINOCYTOSIS,0.44924,0.046373,0.020001,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.25363,0.046364,0.055173,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.084046,0.046363,0.067713,0,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.27611,0.046299,0.065607,0,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.075049,0.046265,0.053184,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.67776,0.046264,-0.061667,0,0
3,GO SULFATION,0.43883,0.046264,0.04394,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.21905,0.046192,0.024981,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.69061,0.046164,-0.026056,0,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.55487,0.046117,0.033973,0,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.15264,0.046009,0.052549,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.61497,0.045999,-0.038235,0,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.1313,0.045757,0.045219,0,0
3,GO NOTOCHORD DEVELOPMENT,0.62113,0.045664,-0.12708,0,0
3,GO RESPONSE TO POTASSIUM ION,0.5726,0.045347,0.063202,0,0
3,GO PRO B CELL DIFFERENTIATION,0.19393,0.045148,0.10734,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.53742,0.04514,0.12177,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.082489,0.044917,0.074132,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.42855,0.044639,0.085675,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.61497,0.044205,0.01186,0,0
3,GO ARTERY MORPHOGENESIS,0.4545,0.044162,0.0062255,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.029068,0.044159,0.14935,0,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.36064,0.044117,0.025986,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.87833,0.044111,0.016399,0,0
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.26471,0.044035,0.085855,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.16294,0.044007,0.058492,0,0
3,GO IMP METABOLIC PROCESS,0.90599,0.043939,0.013089,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.55487,0.043882,0.06787,0,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.066855,0.043644,0.090986,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.27611,0.043613,0.033137,0,0
3,GO REGULATION OF GASTRULATION,0.99651,0.043568,-0.022867,0,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.47588,0.043405,0.082464,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.22235,0.043384,0.10767,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.95466,0.043012,-0.025398,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.27227,0.042823,0.05931,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.22235,0.042761,0.058736,0,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.14526,0.042752,0.086459,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.2,0.042702,0.095139,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.62732,0.04268,0.047273,0,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.96163,0.042648,-0.010788,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.44924,0.042406,0.038308,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.60883,0.04236,-0.020162,0,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.36991,0.042326,0.026887,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.32506,0.042156,0.049641,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.59664,0.042045,0.021377,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.23937,0.041968,0.056561,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.56666,0.041918,0.0077225,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.67776,0.041754,-0.03916,0,0
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.86455,0.041732,-0.006339,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.35153,0.041637,0.025609,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.15015,0.04147,0.028687,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.37932,0.041373,0.036734,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.12049,0.041216,0.084432,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.19095,0.041124,0.091491,0,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.91293,0.041121,0.0099053,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.077957,0.040551,0.048002,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.1313,0.040549,0.053578,0,0
3,GO CELL GROWTH,0.49227,0.040454,0.027256,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.50896,0.040395,0.054236,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.34256,0.040384,0.053552,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.62113,0.040361,0.010571,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.63354,0.040236,0.012123,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.13583,0.039913,0.15046,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.95466,0.039802,-0.0077192,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.76281,0.039524,0.019946,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.65866,0.039389,0.015287,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.13814,0.03926,0.048971,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.76281,0.039224,0.013312,0,0
3,GO GLIOGENESIS,0.58456,0.039028,0.028036,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.65866,0.038922,0.032619,0,0
3,GO ACTIN CROSSLINK FORMATION,0.71006,0.038906,-0.044027,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.16559,0.038904,0.055512,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.42347,0.038733,0.040535,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.67137,0.038686,0.058823,0,0
3,GO RESPONSE TO FOOD,0.50896,0.038661,0.028945,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.65866,0.038589,0.035079,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.76948,0.038476,-0.0049122,0,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.36526,0.037991,0.040447,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.057089,0.037813,0.080791,0,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.60272,0.037737,0.029535,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.37932,0.03766,0.041686,0,0
3,GO REGULATION OF URINE VOLUME,0.83713,0.037594,0.0053652,0,0
3,GO SEXUAL REPRODUCTION,0.19393,0.037486,0.026463,0,0
3,GO LEUKOCYTE TETHERING OR ROLLING,0.13814,0.037479,0.05356,0,0
3,GO PANCREAS DEVELOPMENT,0.2,0.037319,0.085619,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.29992,0.037311,0.048916,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.46512,0.037303,0.00709,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.40349,0.037232,0.047976,0,0
3,GO CELL CYCLE ARREST,0.25729,0.037153,0.031846,0,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.21256,0.037076,0.022265,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.23245,0.036924,0.056878,0,0
3,GO MALE GAMETE GENERATION,0.40843,0.036755,0.014105,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.24643,0.036731,0.16264,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.91987,0.036548,1.2831e-05,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.066855,0.036335,0.08016,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.65234,0.03633,0.0094584,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.42347,0.036295,0.072622,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.26098,0.036146,0.024598,0,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.39371,0.036133,0.0068909,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.44402,0.03609,0.0033005,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.60883,0.036074,0.029776,0,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.89907,0.035803,-0.0042025,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.63354,0.035641,0.023463,0,0
3,GO METANEPHROS DEVELOPMENT,0.62113,0.035544,0.019454,0,0
3,GO GROWTH,0.77618,0.035521,0.0017893,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.63354,0.035488,0.016833,0,0
3,GO HYPEROSMOTIC RESPONSE,0.71658,0.035385,0.036757,0,0
3,GO SPERM MOTILITY,0.49227,0.035378,0.018488,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.65234,0.035309,0.013817,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.11841,0.035304,0.052918,0,0
3,GO REGULATION OF CELL SHAPE,0.19095,0.034786,0.037825,0,0
3,GO STARTLE RESPONSE,0.94073,0.034676,0.0016421,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.19393,0.034579,0.17607,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.52594,0.034494,0.021694,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17934,0.034394,0.040431,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.57857,0.034295,0.019367,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.40349,0.034257,0.027144,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.1028,0.034141,0.088988,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.84397,0.034094,-0.011256,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.23589,0.034086,0.088481,0,0
3,GO PEPTIDYL SERINE MODIFICATION,0.079444,0.034071,0.051408,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.50337,0.033996,0.018322,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.36064,0.033922,0.071419,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.83713,0.033818,-0.041141,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.69061,0.033783,0.013934,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.50896,0.033721,0.010794,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.26847,0.033549,0.04079,0,0
3,GO RESPONSE TO INACTIVITY,0.44402,0.033491,0.067711,0,0
3,GO NCRNA PROCESSING,0.80312,0.033378,-0.026862,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.39858,0.033362,0.031032,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.24643,0.033291,0.019692,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.96163,0.033243,-0.0019179,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.53742,0.033146,0.065494,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.25001,0.032776,0.032745,0,0
3,GO GAMETE GENERATION,0.38888,0.032728,0.014216,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.084046,0.032504,0.037566,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.32938,0.032479,0.026726,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.42347,0.032257,0.045098,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.87144,0.032236,0.0033577,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.71006,0.032058,0.0018191,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.53742,0.031991,0.017571,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.30402,0.03195,0.036104,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.48678,0.03191,0.047856,0,0
3,GO LACTATION,0.4978,0.031722,0.047084,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.075049,0.031575,0.088727,0,0
3,GO RESPONSE TO RADIATION,0.41341,0.031515,0.01651,0,0
3,GO CHONDROCYTE PROLIFERATION,0.47588,0.031372,-0.1026,0,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.71658,0.031333,0.0039048,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.89215,0.031278,-0.042514,0,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.59059,0.031201,0.049891,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.92682,0.031175,-0.0079446,0,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.26847,0.030943,0.018334,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.46512,0.030871,0.030265,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.70355,0.030858,0.0020184,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.25363,0.030678,0.085866,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.18219,0.030363,0.028258,0,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.82348,0.030251,-0.011919,0,0
3,GO MEIOTIC CELL CYCLE,0.15264,0.030082,0.029106,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.91293,0.03007,0.014767,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.19095,0.03007,0.064519,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.98255,0.030063,-0.019086,0,0
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.36991,0.029911,0.071477,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.21905,0.029836,0.049098,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.26847,0.029664,0.04145,0,0
3,GO LOCOMOTORY BEHAVIOR,0.51459,0.029616,0.058867,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.56666,0.029401,0.03863,0,0
3,GO ORGAN INDUCTION,0.63354,0.029367,0.0087646,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.24288,0.029341,0.070643,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.36991,0.029265,0.089421,0,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.18508,0.029238,0.035588,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.2,0.029075,0.038811,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.64605,0.029,0.00806,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.30402,0.028843,0.034811,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.78962,0.028734,0.0057629,0,0
3,GO MATURATION OF 5 8S RRNA,0.80312,0.028711,-0.025019,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.84397,0.028595,0.0030743,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.42347,0.028458,0.050108,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.49227,0.028458,0.016644,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.093897,0.02841,0.092292,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.87833,0.028339,-0.044663,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.95466,0.028311,-0.0048621,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.72313,0.028257,-0.049203,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.43883,0.028213,0.070746,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.53167,0.028133,-0.006012,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.2839,0.027698,0.054438,0,0
3,GO RESPONSE TO SALT STRESS,0.73628,0.027623,-0.01556,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.67776,0.027616,0.058192,0,0
3,GO EMBRYO DEVELOPMENT,0.98953,0.027484,-0.0098342,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.52594,0.027295,0.019632,0,0
3,GO BODY MORPHOGENESIS,0.71006,0.027249,0.014828,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.72969,0.027092,0.032219,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.89907,0.027068,-0.016085,0,0
3,GO RESPONSE TO HYDROXYUREA,0.53742,0.027019,0.036539,0,0
3,GO SEQUESTERING OF METAL ION,0.75615,0.027018,-0.0070473,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.88523,0.026999,-0.008199,0,0
3,GO SARCOMERE ORGANIZATION,0.14526,0.026711,0.092277,0,0
3,GO SNRNA PROCESSING,0.47049,0.026652,-0.0020249,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.18508,0.026403,0.072966,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.14285,0.026201,0.057659,0,0
3,GO VISUAL BEHAVIOR,0.42855,0.025936,0.058292,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.57857,0.025854,0.049231,0,0
3,GO RECEPTOR RECYCLING,0.4598,0.025806,0.047749,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.82348,0.025705,0.00047888,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.37932,0.0256,0.082843,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.72969,0.025505,0.014459,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.87144,0.025361,-0.020112,0,0
3,GO CELLULAR RESPONSE TO ATP,0.36064,0.025225,0.065645,0,0
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.65234,0.025184,-0.040222,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.12473,0.025105,0.044203,0,0
3,GO GLIAL CELL FATE COMMITMENT,0.59059,0.024863,0.10561,0,0
3,GO DIVALENT METAL ION EXPORT,0.67137,0.024821,-0.086368,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.71658,0.024752,0.012954,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.188,0.024691,0.054352,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.33812,0.02464,0.026718,0,0
3,GO RHYTHMIC BEHAVIOR,0.36991,0.024627,0.05112,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.79636,0.024623,-0.019498,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.95466,0.024562,-0.023792,0,0
3,GO ORGANELLE LOCALIZATION,0.27611,0.024548,0.022775,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.53167,0.024231,0.027773,0,0
3,GO SOMITE DEVELOPMENT,0.29992,0.024165,0.043799,0,0
3,GO ENSHEATHMENT OF NEURONS,0.53742,0.024136,0.029237,0,0
3,GO HISTONE H2B UBIQUITINATION,0.61497,0.024133,0.01405,0,0
3,GO ERYTHROCYTE DEVELOPMENT,0.62113,0.0239,0.018101,0,0
3,GO GONADOTROPIN SECRETION,0.42347,0.023791,0.073597,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.83713,0.023764,-0.0029252,0,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.76281,0.023286,-0.0638,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.31653,0.023273,0.057235,0,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.13814,0.023214,0.14403,0,0
3,GO NOSE DEVELOPMENT,0.92682,0.023162,0.11668,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.77618,0.023112,0.023769,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.56075,0.023064,0.017286,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.72969,0.023005,0.0047919,0,0
3,GO MATING,0.25729,0.022884,0.057405,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.19393,0.02287,0.038375,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.59664,0.022826,0.013546,0,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.85768,0.022751,-0.058849,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.34702,0.022613,0.028863,0,0
3,GO MISMATCH REPAIR,0.91293,0.022541,-0.0092223,0,0
3,GO EAR DEVELOPMENT,0.91987,0.022477,-0.0064771,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.40349,0.022272,0.012817,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.52594,0.022262,0.038855,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.79636,0.022223,0.011775,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.37932,0.022186,0.033498,0,0
3,GO AROMATIC AMINO ACID TRANSPORT,0.53167,0.022059,0.070915,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.11636,0.021935,0.091893,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.50337,0.021927,0.016903,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.94073,0.0218,-0.024063,0,0
3,GO TORC1 SIGNALING,0.52594,0.021628,0.015328,0,0
3,GO TRANSLATIONAL INITIATION,0.74288,0.021599,-0.064666,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.85768,0.021467,0.0088346,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.78289,0.021391,-0.0063261,0,0
3,GO EPITHELIAL TUBE FORMATION,0.52594,0.021359,-0.057345,0,0
3,GO CYTOPLASMIC TRANSLATION,0.66501,0.021135,-0.081019,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.65866,0.021121,0.011831,0,0
3,GO MESENCHYME DEVELOPMENT,0.98953,0.021069,-0.025657,0,0
3,GO GENITALIA DEVELOPMENT,0.95466,0.021066,-0.010791,0,0
3,GO IMPORT INTO NUCLEUS,0.59664,0.020955,0.022019,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.90599,0.020693,-0.0073856,0,0
3,GO OVULATION,0.59664,0.020487,0.056026,0,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.83713,0.020453,-0.011006,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.26098,0.020433,0.07714,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.95466,0.019961,0.034109,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.99651,0.019933,-0.030345,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.34256,0.019586,0.040918,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.26847,0.019542,0.041868,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.52594,0.019471,0.031049,0,0
3,GO MITOTIC DNA REPLICATION,0.94769,0.019361,-0.0076132,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.83713,0.019204,0.01344,0,0
3,GO GROOMING BEHAVIOR,0.46512,0.019189,0.062089,0,0
3,GO SNRNA METABOLIC PROCESS,0.59664,0.018928,0.0040601,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.62732,0.018849,0.026119,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.54903,0.018708,0.04524,0,0
3,GO TRANSLATIONAL TERMINATION,0.50337,0.018398,0.054785,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.46512,0.018226,0.026353,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.78962,0.018212,-0.020984,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.51459,0.01819,0.017985,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.34702,0.018078,0.025585,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.2839,0.018026,0.041803,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.24643,0.017985,0.03408,0,0
3,GO DEVELOPMENTAL INDUCTION,0.35607,0.017966,0.054929,0,0
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.98953,0.017954,-0.031025,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.075049,0.017927,0.04549,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.44402,0.017907,0.032579,0,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.43883,0.017878,0.026919,0,0
3,GO FEVER GENERATION,0.41842,0.017636,-0.083072,0,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.41842,0.017513,0.078291,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.82348,0.017435,-0.020694,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.48678,0.017417,0.055264,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.33373,0.017341,0.024374,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.89907,0.017174,0.084964,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.68418,0.016952,0.0014019,0,0
3,GO TRNA CATABOLIC PROCESS,0.62113,0.016934,0.068005,0,0
3,GO RESPONSE TO BMP,0.56666,0.016908,0.0070658,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.59664,0.016886,0.046353,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.56666,0.016737,0.0059467,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.33812,0.016627,0.020359,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.188,0.016483,0.20543,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.84397,0.016441,-0.0065113,0,0
3,GO T CELL CHEMOTAXIS,0.51459,0.016433,0.028893,0,0
3,GO ODONTOGENESIS,0.98255,0.016367,-0.021444,0,0
3,GO REGULATION OF GTP BINDING,0.67137,0.016185,0.022483,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.7495,0.01609,0.026403,0,0
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.74288,0.015886,-0.03265,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.76948,0.015868,-0.021242,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.23589,0.015731,0.09929,0,0
3,GO BONE DEVELOPMENT,0.39858,0.01553,-0.058742,0,0
3,GO MEMBRANE RAFT ASSEMBLY,0.47588,0.015503,0.067723,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.95466,0.015247,-0.0038295,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.85768,0.015208,0.014989,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.78289,0.015161,0.042822,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.76281,0.014916,-0.093264,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.48678,0.01479,0.024524,0,0
3,GO KIDNEY MORPHOGENESIS,0.71658,0.014709,0.015111,0,0
3,GO RESPONSE TO MUSCLE INACTIVITY,0.51459,0.014676,0.072542,0,0
3,GO REGULATION OF NUCLEAR DIVISION,0.65234,0.014662,0.013567,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.54903,0.014497,0.060309,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.93377,0.014412,0.011445,0,0
3,GO ERYTHROCYTE MATURATION,0.87144,0.014238,-0.041168,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.38408,0.014218,0.054132,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.43367,0.014061,0.12517,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.50337,0.013914,0.037903,0,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.70355,0.013821,0.021221,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.85768,0.013813,-0.016701,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.79636,0.013783,-0.017198,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.24288,0.013475,0.10111,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.94073,0.01343,-0.044412,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.85768,0.013355,0.012653,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.4978,0.013244,0.052243,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.62113,0.01323,0.033717,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.96163,0.013059,-0.0202,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.61497,0.01297,0.034203,0,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.30402,0.012904,0.059574,0,0
3,GO HISTONE ARGININE METHYLATION,0.70355,0.012871,0.016295,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.66501,0.012857,0.085927,0,0
3,GO REGULATION OF GONAD DEVELOPMENT,0.88523,0.012774,-0.014539,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.96163,0.012708,0.0034917,0,0
3,GO OVULATION CYCLE PROCESS,0.42347,0.01248,0.047461,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.48678,0.012479,-0.057533,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.72969,0.012405,-0.016881,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.93377,0.012239,-0.017169,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.3746,0.012166,0.13001,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.44402,0.012009,0.0037803,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.80312,0.011755,-0.0010375,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.86455,0.011649,-0.0032972,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.85768,0.011368,0.0074337,0,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.63354,0.011366,0.068196,0,0
3,GO CARTILAGE DEVELOPMENT,0.89215,0.011355,-0.025783,0,0
3,GO REGULATION OF CELL CYCLE ARREST,0.98953,0.011017,-0.00072228,0,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.13814,0.011005,0.055568,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.89215,0.010941,-0.012912,0,0
3,GO EMBRYONIC MORPHOGENESIS,0.97557,0.010621,-0.0095839,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.60883,0.010607,-0.00039787,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.92682,0.010015,0.011175,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.87144,0.010004,0.030272,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,1,0.0099989,-0.0058532,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.97557,0.0099717,-0.043094,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.62732,0.0099244,-0.031163,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.54903,0.0098453,0.011767,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.72313,0.0097919,-0.031755,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.39858,0.009492,0.10323,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.25363,0.009481,0.098303,0,0
3,GO CYTOSKELETON ORGANIZATION,0.98255,0.0093802,-0.0082344,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.64605,0.0092685,0.075005,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.59059,0.0092664,0.045178,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.40843,0.0092231,-0.17578,0,0
3,GO SYNAPSE MATURATION,0.7495,0.0090734,-0.048712,0,0
3,GO INNERVATION,0.7495,0.0089203,0.077735,0,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.57857,0.0088613,0.060877,0,0
3,GO RRNA CATABOLIC PROCESS,0.77618,0.0087623,0.01489,0,0
3,GO EPITHELIAL CELL MATURATION,0.52594,0.0086645,0.090038,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.67776,0.0085937,0.014408,0,0
3,GO NERVOUS SYSTEM PROCESS,0.35607,0.0084899,0.033756,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.72313,0.0084857,-0.068141,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.94769,0.008424,0.012725,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.98255,0.0081764,-0.0072724,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.89907,0.008081,-0.0064555,0,0
3,GO NEPHRON MORPHOGENESIS,0.48678,0.007717,0.038678,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.87144,0.0077049,-0.015407,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.87833,0.0075902,0.002996,0,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.65234,0.0075736,-0.040167,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.61497,0.0074925,0.010675,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.97557,0.0073948,-0.0015519,0,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.89907,0.0073555,0.027745,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.8303,0.0073286,-0.014093,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.69707,0.00727,0.0042699,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.71006,0.007102,0.0036389,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.73628,0.0069705,-0.040542,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.84397,0.0069291,-0.02496,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.25001,0.006797,0.046556,0,0
3,GO SPERMATID DIFFERENTIATION,0.94769,0.0067397,-0.0026065,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.42855,0.0067367,0.028232,0,0
3,GO VIRAL GENE EXPRESSION,0.7495,0.0067181,-0.059735,0,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.70355,0.0065511,-0.016885,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.69061,0.0065482,0.0070504,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.48678,0.006543,-0.082838,0,0
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1,0.0065422,-0.022058,0,0
3,GO RNA DESTABILIZATION,0.73628,0.0065352,-0.038204,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.80312,0.0063608,-0.012539,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.39371,0.0062454,-0.043247,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.87144,0.006228,-0.0028315,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.5726,0.0061817,-0.024642,0,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.41842,0.006102,-0.044995,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.69707,0.0060488,-0.021321,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.81668,0.0060122,0.049556,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.50896,0.0057576,0.041641,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.42855,0.0055894,-0.040656,0,0
3,GO MESODERM DEVELOPMENT,0.38888,0.0055821,-0.056969,0,0
3,GO PROTEIN LOCALIZATION TO AXON,0.66501,0.0055142,-0.045427,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.94769,0.0054552,-0.021042,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.72313,0.0053814,-0.040413,0,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.56666,0.0053635,-0.026375,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.66501,0.0053035,-0.0086621,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.58456,0.0052693,0.041908,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.48131,0.005224,-0.042799,0,0
3,GO HEART DEVELOPMENT,0.7495,0.0051669,-0.023856,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.94073,0.0051004,0.003841,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.80312,0.005084,0.018246,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.71658,0.0049843,-0.1251,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.62732,0.0049682,0.0092751,0,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.42347,0.0049476,0.04164,0,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.89907,0.0047511,0.014035,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.55487,0.0047304,0.03059,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.94769,0.0046825,-0.010022,0,0
3,GO MATING BEHAVIOR,0.63978,0.0046599,0.016046,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.33812,0.0044082,0.025936,0,0
3,GO TRANSLATIONAL ELONGATION,0.70355,0.0043073,0.019127,0,0
3,GO NEURAL TUBE FORMATION,0.33373,0.0043032,-0.069178,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.42855,0.0042591,-0.058659,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.85082,0.0041394,-0.025108,0,0
3,GO GASTRIC ACID SECRETION,0.39858,0.0040789,0.057764,0,0
3,GO RIBOSOME BIOGENESIS,0.80989,0.0040756,-0.028732,0,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.87833,0.00397,-0.013335,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.67137,0.0039272,-0.065179,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.80989,0.0039123,0.0084271,0,0
3,GO TRABECULA MORPHOGENESIS,0.56666,0.0038282,-0.051702,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.78962,0.0037871,0.0092978,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.76948,0.0036844,-0.05574,0,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.93377,0.0033489,-0.020164,0,0
3,GO CELL CELL SIGNALING BY WNT,0.59664,0.0033031,-0.025771,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.34256,0.003258,-0.068392,0,0
3,GO ORGANELLE FISSION,0.77618,0.0032523,-0.0068622,0,0
3,GO AXIS SPECIFICATION,0.80989,0.0032499,-0.025556,0,0
3,GO MICROTUBULE BUNDLE FORMATION,0.53742,0.0031868,0.03143,0,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.39858,0.0030704,-0.10827,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.53167,0.0029673,-0.072722,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.59664,0.0029572,0.02223,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.93377,0.0028856,-0.013816,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.53742,0.0028742,0.021729,0,0
3,GO REGULATION OF DNA METHYLATION,0.5726,0.002863,-0.039825,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.50337,0.0026287,-0.045568,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.82348,0.0025241,-0.0035998,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.85082,0.0024426,-0.013833,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.90599,0.0023919,0.0024073,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1,0.0022424,-0.0070815,0,0
3,GO FEMALE GAMETE GENERATION,0.76281,0.0021383,0.012111,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.3746,0.0020693,-0.057193,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.70355,0.0020603,0.02903,0,0
3,GO RESPONSE TO VITAMIN A,0.66501,0.001889,-0.046191,0,0
3,GO DNA MODIFICATION,0.52594,0.0017153,0.019763,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.88523,0.0016742,0.00034993,0,0
3,GO SLEEP,0.78289,0.0014995,0.019258,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.43367,0.0013783,0.076437,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.36991,0.0013082,-0.054587,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.32077,0.0013011,-0.087278,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.8303,0.0012063,0.010377,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.96163,0.0011253,0.052719,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.36064,0.0010561,-0.078475,0,0
3,GO PROTEIN NITROSYLATION,0.38888,0.00099404,-0.12629,0,0
3,GO GLUTAMINE METABOLIC PROCESS,0.47588,0.00085107,-0.064268,0,0
3,GO PRENYLATION,0.9686,0.0006528,-0.013095,0,0
3,GO FAT CELL PROLIFERATION,0.9686,0.0005883,0.017931,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.91293,0.00056326,-0.0073599,0,0
3,GO DOSAGE COMPENSATION,0.60883,0.00053274,-0.034647,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.31232,0.00052792,0.091846,0,0
3,GO RESPONSE TO COCAINE,0.59664,0.00046705,-0.035725,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.98255,0.00034271,0.0023762,0,0
3,GO HEART TRABECULA FORMATION,0.5726,0.0003164,0.10524,0,0
3,GO CELL CELL SIGNALING,0.54321,0.00020379,0.021856,0,0
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.80989,-5.2752e-05,0.10097,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.22568,-0.00014456,0.10091,0,0
3,GO BEHAVIOR,0.78962,-0.00014539,0.016976,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.63354,-0.00023073,0.048227,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.98255,-0.00023917,0.010539,0,0
3,GO RESPONSE TO ZINC ION,0.91987,-0.00033747,-0.010266,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.49227,-0.00036495,-0.094565,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.59059,-0.00054554,0.018784,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.97557,-0.00059937,-0.0037497,0,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.94073,-0.00081348,0.025744,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.94073,-0.00095972,-0.0036988,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.65234,-0.0010097,0.033836,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.91987,-0.0010203,-0.0049487,0,0
3,GO PORE COMPLEX ASSEMBLY,0.73628,-0.0010576,-0.0090795,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.29992,-0.0012019,0.031812,0,0
3,GO RRNA METABOLIC PROCESS,0.78962,-0.0012055,-0.029572,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.91293,-0.0013098,0.0079131,0,0
3,GO NON RECOMBINATIONAL REPAIR,0.94073,-0.0013225,-0.0043381,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.78289,-0.0013502,0.038214,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.38408,-0.0013635,0.086546,0,0
3,GO HYPOTONIC RESPONSE,0.52025,-0.0013745,-0.086704,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.63978,-0.0014355,-0.0035519,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.42855,-0.0014466,-0.0489,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.56666,-0.0015384,0.014544,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.73628,-0.0016108,-0.017067,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.3746,-0.0016565,0.10626,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.92682,-0.0017073,0.0080974,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.14526,-0.0017096,0.094338,0,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.91293,-0.0019052,-0.014159,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.87144,-0.0021312,-0.0069555,0,0
3,GO RECEPTOR INTERNALIZATION,0.65234,-0.0022673,-0.036323,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.85768,-0.0023768,-0.011272,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.78962,-0.0023913,-0.048516,0,0
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.96163,-0.0030053,0.0054719,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.87144,-0.0030153,-0.014905,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.38888,-0.0031276,-0.028488,0,0
3,GO MITOTIC CYTOKINESIS,0.39858,-0.0032258,-0.03921,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.78962,-0.003302,0.02149,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.7495,-0.0033314,-0.043709,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.84397,-0.0033557,0.0052355,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.85082,-0.0033842,0.0018978,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.94073,-0.0034089,-0.022837,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.89907,-0.0034189,0.00015253,0,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.95466,-0.0034763,-0.015455,0,0
3,GO HISTONE H3 ACETYLATION,0.49227,-0.0035999,-0.021411,0,0
3,GO STEM CELL DIFFERENTIATION,0.41842,-0.0037467,-0.036136,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.91987,-0.0037767,-0.0099969,0,0
3,GO NEURON APOPTOTIC PROCESS,0.98255,-0.0037829,0.0014137,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.78289,-0.0040207,-0.0035237,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.83713,-0.0040748,-0.0047341,0,0
3,GO CELLULAR RESPONSE TO HEAT,0.92682,-0.0040801,-0.0034207,0,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.65234,-0.0043654,0.015726,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.81668,-0.0045845,-0.022035,0,0
3,GO REGULATION OF GLIOGENESIS,0.97557,-0.0047407,0.014864,0,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.92682,-0.0047557,0.0079271,0,0
3,GO METANEPHROS MORPHOGENESIS,0.87833,-0.0047559,0.012454,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.96163,-0.0048029,-0.042978,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.98953,-0.0048807,-0.01172,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.26098,-0.0050866,-0.067292,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.59664,-0.0051443,0.02656,0,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.85082,-0.00527,0.00077124,0,0
3,GO PROTEIN KINASE A SIGNALING,0.54903,-0.0053306,-0.047025,0,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.94073,-0.005348,0.02942,0,0
3,GO FACIAL NERVE MORPHOGENESIS,0.56075,-0.0055107,-0.11375,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.87833,-0.0055898,0.01068,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.55487,-0.0056448,0.025954,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.94073,-0.0058936,0.029252,0,0
3,GO NEURAL TUBE DEVELOPMENT,0.27227,-0.0059364,-0.06695,0,0
3,GO MYOBLAST PROLIFERATION,0.8303,-0.0059937,-0.03212,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.85082,-0.0060127,0.016765,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.40843,-0.0062157,-0.037255,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.81668,-0.0062786,0.020413,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.61497,-0.0063821,0.095235,0,0
3,GO CELL JUNCTION ORGANIZATION,0.58456,-0.0064762,0.020347,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.77618,-0.006579,-0.019397,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.32506,-0.0068274,-0.05004,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.80989,-0.0069089,0.017469,0,0
3,GO ORGANELLE ASSEMBLY,0.67137,-0.006988,-0.010987,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.77618,-0.0071949,-0.042686,0,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.67776,-0.0074537,0.035782,0,0
3,GO EXIT FROM MITOSIS,0.75615,-0.0074765,0.016368,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.5726,-0.0075573,0.041639,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.59059,-0.0076628,0.015851,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.76948,-0.0077049,-0.025562,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.76948,-0.0077511,0.016012,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.4978,-0.0078163,-0.024033,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.68418,-0.0079675,-0.06152,0,0
3,GO PERICARDIUM DEVELOPMENT,0.99651,-0.0080048,-0.033001,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.85768,-0.0081162,-0.01235,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.66501,-0.0086672,0.18091,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.53167,-0.0087319,-0.10992,0,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.78289,-0.0087704,-0.026033,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.72969,-0.0087789,0.029715,0,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.63978,-0.0088126,-0.042477,0,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.78289,-0.0089284,-0.035907,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.94073,-0.0089867,0.10381,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.93377,-0.0089942,-0.02837,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.93377,-0.0090427,-0.012389,0,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.63354,-0.009062,-0.041186,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.13355,-0.0093427,-0.070831,0,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.53167,-0.0093749,-0.01591,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.69061,-0.0095346,0.039555,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.15773,-0.0096037,-0.077006,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.91987,-0.0097287,-0.022285,0,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.60272,-0.009744,-0.051604,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.93377,-0.0098988,0.015152,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.47049,-0.010229,0.074937,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.47049,-0.010274,-0.12523,0,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.40843,-0.010649,0.10825,0,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.83713,-0.010736,0.050736,0,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.33373,-0.010744,-0.054457,0,0
3,GO NUCLEUS ORGANIZATION,0.89907,-0.01086,0.0074495,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.80312,-0.010886,-0.006062,0,0
3,GO TUBE FORMATION,0.41341,-0.010895,-0.064296,0,0
3,GO SEGMENTATION,0.87833,-0.01093,0.013894,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.76281,-0.010969,-0.00058023,0,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.62113,-0.011463,0.031825,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.81668,-0.011466,-0.0078314,0,0
3,GO NOTCH RECEPTOR PROCESSING,0.65866,-0.01169,0.054618,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.80312,-0.011972,-0.011927,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.93377,-0.012101,0.011444,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.8303,-0.012191,-0.030761,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.46512,-0.012267,-0.095967,0,0
3,GO AORTA MORPHOGENESIS,0.98255,-0.012351,-0.0043949,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.79636,-0.012355,0.0061621,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.4978,-0.012413,-0.036192,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.40843,-0.012612,-0.058892,0,0
3,GO METAPHASE PLATE CONGRESSION,0.51459,-0.012878,-0.023409,0,0
3,GO RNA METHYLATION,0.52025,-0.012907,-0.033152,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.83713,-0.012949,0.02039,0,0
3,GO ENDOCARDIUM DEVELOPMENT,0.63978,-0.013032,0.054795,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.73628,-0.013185,-0.053185,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.40843,-0.013205,-0.077614,0,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.53742,-0.01331,-0.028605,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.80989,-0.01337,0.059831,0,0
3,GO PROTEIN ACYLATION,0.39858,-0.013425,-0.012927,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.86455,-0.013486,-0.013021,0,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.9686,-0.01354,-0.0047717,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.97557,-0.01358,-0.041203,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.87833,-0.013692,-0.012773,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.70355,-0.013829,0.010477,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.65234,-0.013874,-0.034147,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.39858,-0.013922,-0.090326,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.69707,-0.014215,-0.023022,0,0
3,GO LEFT RIGHT PATTERN FORMATION,0.92682,-0.014225,-0.014652,0,0
3,GO P BODY ASSEMBLY,0.87833,-0.014225,-0.011128,0,0
3,GO CYTOKINESIS,0.25729,-0.014461,-0.041503,0,0
3,GO TRNA METHYLATION,0.94769,-0.014481,-0.0076629,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.27999,-0.014862,-0.028389,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.72313,-0.014948,0.0088324,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.42855,-0.015067,-0.043693,0,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.76948,-0.015158,-0.022946,0,0
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.84397,-0.015185,0.047647,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.63354,-0.015203,-0.040203,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.51459,-0.015257,-0.10816,0,0
3,GO CELLULAR RESPONSE TO PH,0.65234,-0.015291,-0.036091,0,0
3,GO GROWTH HORMONE SECRETION,0.91293,-0.015544,0.044315,0,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.64605,-0.015669,-0.082841,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.63354,-0.015683,0.016926,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.92682,-0.015821,-0.00088912,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.96163,-0.015969,0.023934,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.98953,-0.016074,-0.011909,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.73628,-0.016172,-0.020424,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.51459,-0.016393,0.037848,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.91987,-0.016396,-0.062873,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.3746,-0.016451,-0.031407,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.41842,-0.01658,-0.027746,0,0
3,GO TRNA WOBBLE BASE MODIFICATION,0.47049,-0.016742,-0.043709,0,0
3,GO EYE MORPHOGENESIS,0.3746,-0.016833,-0.052046,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.50896,-0.016849,-0.040543,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.52025,-0.016855,-0.022194,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.94769,-0.016889,0.0032437,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.65234,-0.016966,-0.039323,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.85082,-0.017013,-0.042073,0,0
3,GO EAR MORPHOGENESIS,0.55487,-0.017199,-0.040559,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.69061,-0.017294,-0.015571,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.20309,-0.017329,-0.050388,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.54321,-0.017385,0.033558,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.36064,-0.017421,-0.043177,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.33373,-0.01782,-0.072208,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.96163,-0.017937,-0.002081,0,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.15517,-0.017943,-0.10644,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.34256,-0.017988,-0.067621,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.92682,-0.018023,-0.0025144,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.62732,-0.018169,-0.047585,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.52025,-0.018181,-0.043947,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.75615,-0.018361,0.030578,0,0
3,GO RESPONSE TO AXON INJURY,0.67776,-0.01837,-0.010779,0,0
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.91293,-0.018418,-0.01828,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.60883,-0.018457,-0.029215,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.77618,-0.018546,0.012832,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.84397,-0.018635,0.023741,0,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.8303,-0.018658,-0.040862,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.55487,-0.018725,-0.014942,0,0
3,GO DEVELOPMENTAL GROWTH,0.34256,-0.01876,-0.044531,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.33373,-0.018785,-0.023531,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.87833,-0.018888,-0.0010553,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.44402,-0.018983,-0.050613,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.66501,-0.019009,-0.032964,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.49227,-0.019243,0.054049,0,0
3,GO PREPULSE INHIBITION,0.80312,-0.019467,-0.039648,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.19695,-0.019587,-0.11194,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.64605,-0.019617,-0.025213,0,0
3,GO REGULATION OF PINOCYTOSIS,0.65866,-0.019699,-0.072666,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.16559,-0.019711,-0.039495,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.73628,-0.019768,-0.055238,0,0
3,GO MESENCHYME MORPHOGENESIS,0.40843,-0.019782,-0.091508,0,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.85082,-0.019929,0.041784,0,0
3,GO CELL PROJECTION ASSEMBLY,0.31653,-0.020157,-0.031926,0,0
3,GO CHROMOSOME LOCALIZATION,0.21905,-0.020239,-0.049506,0,0
3,GO CELL FATE COMMITMENT,0.34702,-0.020415,-0.033425,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.94073,-0.020421,-0.010762,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.72969,-0.020543,-0.035548,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.48678,-0.020547,-0.025212,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.63354,-0.020568,-0.019326,0,0
3,GO VASCULOGENESIS,0.60272,-0.020612,-0.076226,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.37932,-0.020631,-0.043511,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.95466,-0.020641,-0.02376,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.64605,-0.020659,-0.015064,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.40349,-0.02082,-0.10144,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.23937,-0.020828,-0.040216,0,0
3,GO METHYLATION,0.48678,-0.020985,-0.02771,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.94073,-0.021002,-0.0058821,0,0
3,GO NUCLEAR TRANSPORT,0.63354,-0.021268,-0.01917,0,0
3,GO MALE SEX DETERMINATION,0.2839,-0.021371,0.10978,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.66501,-0.021377,-0.068962,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.71006,-0.021473,-0.026201,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.44402,-0.021499,-0.053369,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.78962,-0.021707,-0.0175,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.94073,-0.02175,-0.00060728,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.48131,-0.021802,-0.03055,0,0
3,GO FIBROBLAST MIGRATION,0.94073,-0.021855,-0.011658,0,0
3,GO REGULATION OF CELL CYCLE,0.96163,-0.021961,-0.0015865,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.38888,-0.022025,-0.02757,0,0
3,GO MRNA TRANSCRIPTION,0.84397,-0.02204,-0.020596,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.72313,-0.022055,-0.057707,0,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.69707,-0.022294,0.032264,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.7495,-0.022338,0.027613,0,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.77618,-0.022428,0.028979,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.78289,-0.022461,0.037242,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.84397,-0.022469,-0.033151,0,0
3,GO LIPID PHOSPHORYLATION,0.80312,-0.022485,0.034364,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.29992,-0.022717,-0.11023,0,0
3,GO TELOMERE ORGANIZATION,0.36064,-0.022863,-0.041824,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.71006,-0.023326,-0.029957,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.80989,-0.023423,0.027528,0,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.68418,-0.023552,-0.093333,0,0
3,GO PROTEIN POLYMERIZATION,0.87144,-0.023568,0.00012125,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.54321,-0.023609,-0.025654,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.48131,-0.023737,-0.057104,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.50337,-0.023778,-0.021238,0,0
3,GO MIDBRAIN DEVELOPMENT,0.50337,-0.02386,-0.028135,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.73628,-0.023875,-0.013296,0,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.20937,-0.023936,-0.054492,0,0
3,GO PROTEIN DENEDDYLATION,0.7495,-0.023985,-0.013928,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.84397,-0.02412,-0.030305,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.49227,-0.024296,-0.043541,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.79636,-0.024549,-0.010912,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.43367,-0.024578,-0.040986,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.5726,-0.024684,-0.077055,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.91987,-0.024796,0.027645,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.44402,-0.024861,-0.018971,0,0
3,GO HEART VALVE DEVELOPMENT,0.60272,-0.025108,-0.048639,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.24288,-0.025213,-0.10723,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.093897,-0.025319,-0.042018,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.92682,-0.025411,-0.013885,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.4545,-0.025711,-0.074455,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.33812,-0.025747,-0.10602,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.46512,-0.025918,-0.024998,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.68418,-0.026001,-0.023254,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.99651,-0.026392,-0.0065701,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.63354,-0.02652,-0.0073456,0,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.34702,-0.026569,-0.055413,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.66501,-0.026933,-0.0062676,0,0
3,GO REGULATION OF CELL SIZE,0.25729,-0.027114,-0.058698,0,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.73628,-0.027155,-0.028433,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.055956,-0.027264,-0.099538,0,0
3,GO PROTEIN NEDDYLATION,0.48678,-0.027339,-0.033582,0,0
3,GO RNA PROCESSING,0.18508,-0.027346,-0.059021,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.63354,-0.027391,-0.0058119,0,0
3,GO INNER EAR MORPHOGENESIS,0.47049,-0.027921,-0.039424,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.67137,-0.028237,-0.044943,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.29586,-0.028439,-0.091957,0,0
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.50337,-0.028502,-0.059593,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.44402,-0.028568,-0.041655,0,0
3,GO PROTEIN SUMOYLATION,0.2,-0.028584,-0.03905,0,0
3,GO GANGLION DEVELOPMENT,0.97557,-0.028822,0.073819,0,0
3,GO REGULATION OF CELL DIVISION,0.56075,-0.028839,-0.020044,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.91987,-0.028841,-0.029201,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.98255,-0.029085,-0.0050523,0,0
3,GO SPERM AXONEME ASSEMBLY,0.49227,-0.029306,-0.024384,0,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.24643,-0.029307,-0.078409,0,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.52025,-0.029323,-0.066534,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.71006,-0.029641,0.0034976,0,0
3,GO NCRNA TRANSCRIPTION,0.33373,-0.029674,-0.047665,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.85768,-0.029851,0.0042233,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.69061,-0.030079,-0.032729,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.71658,-0.030357,-0.056686,0,0
3,GO SNRNA TRANSCRIPTION,0.12259,-0.030362,-0.052257,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.74288,-0.030382,-0.0099105,0,0
3,GO MEMORY,0.90599,-0.030635,0.00015183,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.29184,-0.030706,-0.026749,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.65866,-0.03086,-0.028677,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.20309,-0.030917,-0.04147,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.068167,-0.031041,-0.09345,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.62113,-0.031199,-0.013857,0,0
3,GO ADULT BEHAVIOR,0.55487,-0.031205,0.0040122,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.72969,-0.031207,-0.048613,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.81668,-0.031283,0.027982,0,0
3,GO DNA METABOLIC PROCESS,0.13583,-0.031367,-0.032295,0,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.23589,-0.031428,-0.05933,0,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.16294,-0.03143,-0.047032,0,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.25729,-0.031553,-0.049044,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.47049,-0.031709,0.04292,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.72969,-0.032024,-0.052535,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.19095,-0.032252,-0.03615,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.54321,-0.032356,-0.025724,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.48678,-0.032623,-0.023369,0,0
3,GO CELL FATE DETERMINATION,0.89215,-0.032641,-0.0062757,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.8303,-0.032742,-0.014578,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.59059,-0.032744,-0.029533,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.99651,-0.033013,0.0076311,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.78962,-0.033399,0.0098496,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.78289,-0.033609,0.0082103,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.56666,-0.033693,-0.071879,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.48678,-0.033728,0.040122,0,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.36064,-0.033781,-0.085791,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.15773,-0.034008,-0.031081,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.80312,-0.034094,-0.055827,0,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.71658,-0.034327,0.075538,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.56075,-0.034803,0.071473,0,0
3,GO REGULATION OF RNA BINDING,0.27999,-0.034835,-0.085021,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.87144,-0.034901,0.00088194,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.35153,-0.035011,-0.075154,0,0
3,GO CELL CYCLE,0.59664,-0.035029,-0.012971,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.51459,-0.035061,-0.01565,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.61497,-0.035225,-0.020155,0,0
3,GO HISTONE H4 ACETYLATION,0.23245,-0.03528,-0.041047,0,0
3,GO RNA POLYADENYLATION,0.12908,-0.035341,-0.06865,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.27999,-0.035397,-0.10409,0,0
3,GO NUCLEAR MIGRATION,0.81668,-0.035397,-0.03152,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.8303,-0.035632,0.060313,0,0
3,GO FOREGUT MORPHOGENESIS,0.24288,-0.036021,-0.11357,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.52025,-0.036173,-0.01196,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.13355,-0.03633,-0.11308,0,0
3,GO VIRAL TRANSLATION,0.16032,-0.036513,-0.14042,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.32077,-0.036718,-0.041838,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.21256,-0.036725,-0.079328,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.32506,-0.036887,-0.098296,0,0
3,GO SUCKLING BEHAVIOR,0.50337,-0.036978,-0.073351,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.24288,-0.037018,-0.095205,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.74288,-0.037226,-0.040692,0,0
3,GO STRIATUM DEVELOPMENT,0.7495,-0.037281,0.047216,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.86455,-0.037544,-0.0074859,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.93377,-0.037985,0.0023406,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.98255,-0.038068,0.020144,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.43367,-0.038393,-0.051593,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.86455,-0.038408,0.013361,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.36064,-0.038491,-0.039829,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.76948,-0.038565,-0.034373,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.39371,-0.038713,-0.061774,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.72313,-0.038732,-0.034197,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.44402,-0.038838,-0.10999,0,0
3,GO REGULATION OF GENE SILENCING,0.36991,-0.038948,-0.046043,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.52025,-0.039172,-0.0010942,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.60272,-0.03924,-0.037747,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.21905,-0.039402,-0.039728,0,0
3,GO NUCLEAR EXPORT,0.27227,-0.039483,-0.052002,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.91293,-0.039536,-0.00083564,0,0
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.97557,-0.039679,0.0083249,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.49227,-0.039687,-0.077376,0,0
3,GO AXONAL FASCICULATION,0.10845,-0.039776,-0.18347,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.74288,-0.040107,-0.015787,0,0
3,GO ADULT HEART DEVELOPMENT,0.36991,-0.040128,-0.10856,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.087232,-0.040278,-0.053608,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.17374,-0.040415,-0.058993,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.40349,-0.040479,-0.045968,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.79636,-0.040595,-0.015824,0,0
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.4978,-0.040665,-0.10293,0,0
3,GO NEUROMUSCULAR PROCESS,0.67776,-0.040712,-0.020398,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.14285,-0.040761,-0.038248,0,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.84397,-0.041022,0.0052346,0,0
3,GO HISTONE MONOUBIQUITINATION,0.053746,-0.041095,-0.090897,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.54903,-0.041141,-0.094295,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.26098,-0.041224,-0.068679,0,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.67137,-0.041385,-0.036151,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.17099,-0.041746,-0.097995,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.52025,-0.041816,-0.057764,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.47588,-0.041856,-0.027702,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.25363,-0.042012,-0.05356,0,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0695,-0.042187,-0.087515,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.1313,-0.042198,-0.037248,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.62113,-0.042429,-0.020601,0,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.16559,-0.042642,-0.17281,0,0
3,GO SHORT TERM MEMORY,0.79636,-0.04285,-0.036737,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.26471,-0.043008,-0.035942,0,0
3,GO HISTONE PHOSPHORYLATION,0.47049,-0.043043,-0.025879,0,0
3,GO MEMBRANE DOCKING,0.2839,-0.043243,-0.03082,0,0
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.57857,-0.043354,-0.030378,0,0
3,GO RNA SURVEILLANCE,0.44924,-0.043468,-0.05418,0,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.097379,-0.04356,-0.083427,0,0
3,GO MRNA METABOLIC PROCESS,0.10654,-0.043565,-0.06688,0,0
3,GO ECTODERM DEVELOPMENT,0.35153,-0.044098,-0.075706,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.63354,-0.04419,-0.030926,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.69061,-0.044313,-0.036091,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.61497,-0.044538,-0.067491,0,0
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.53167,-0.044627,-0.083095,0,0
3,GO PRE MIRNA PROCESSING,0.35153,-0.044684,-0.074728,0,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.099158,-0.044776,-0.074704,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.22905,-0.045011,-0.070722,0,0
3,GO RNA INTERFERENCE,0.56666,-0.045072,-0.021213,0,0
3,GO ORGAN GROWTH,0.16294,-0.045302,-0.069189,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.61497,-0.045562,-0.010817,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.35153,-0.045651,-0.051463,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.59664,-0.045659,-0.026378,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.78962,-0.045903,0.035194,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.21579,-0.046026,-0.15143,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.31653,-0.046088,-0.10919,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.2839,-0.046318,-0.069557,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.3746,-0.046388,-0.10349,0,0
3,GO BLASTODERM SEGMENTATION,0.40349,-0.046489,-0.094277,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.32938,-0.046659,-0.014265,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.89215,-0.046827,-0.012333,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.51459,-0.04685,-0.060757,0,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.24643,-0.047335,-0.04605,0,0
3,GO RESPONSE TO PROSTAGLANDIN E,0.78289,-0.047509,0.023704,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.60883,-0.047572,-0.046641,0,0
3,GO MIRNA METABOLIC PROCESS,0.21256,-0.047598,-0.062621,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.7495,-0.0477,-0.0036021,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.83713,-0.047758,-0.021851,0,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.76948,-0.047852,-0.047164,0,0
3,GO GENE SILENCING,0.16559,-0.048068,-0.050343,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.29992,-0.048117,-0.040661,0,0
3,GO REGULATION OF OOGENESIS,0.98255,-0.048139,0.036604,0,0
3,GO CELL CYCLE CHECKPOINT,0.22905,-0.048364,-0.028718,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.74288,-0.048559,-0.025206,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.48678,-0.048796,-0.050897,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.33373,-0.048976,-0.074393,0,0
3,GO RESPONSE TO DOPAMINE,0.76281,-0.049003,-0.011608,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.38888,-0.049204,-0.049759,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.15264,-0.049207,-0.064826,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.30402,-0.049241,-0.077046,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.20309,-0.049264,-0.075931,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.22568,-0.049274,-0.062829,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.068167,-0.049801,-0.08094,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.28785,-0.049981,-0.049333,0,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.088862,-0.050093,-0.089231,0,0
3,GO CELL MORPHOGENESIS,0.088862,-0.0501,-0.077673,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.2839,-0.050108,-0.058374,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.94769,-0.050353,-0.021957,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.81668,-0.050389,-0.00087539,0,0
3,GO BASE EXCISION REPAIR,0.17374,-0.050564,-0.066585,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.66501,-0.05069,-0.041363,0,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,0.5726,-0.050713,-0.04321,0,0
3,GO NCRNA 3 END PROCESSING,0.7495,-0.050824,-0.045325,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.22235,-0.050936,-0.050725,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.22235,-0.050994,-0.087373,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.04854,-0.051084,-0.10087,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.17374,-0.051167,-0.049156,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.97557,-0.051285,0.023964,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.061812,-0.051414,-0.062143,0,0
3,GO DNA METHYLATION,0.24643,-0.051506,-0.05059,0,0
3,GO MAST CELL MIGRATION,0.99651,-0.051567,-0.015046,0,0
3,GO HISTONE H2A UBIQUITINATION,0.066855,-0.051605,-0.11141,0,0
3,GO CELL CYCLE PROCESS,0.077957,-0.051635,-0.03321,0,0
3,GO FIBROBLAST ACTIVATION,0.91987,-0.052331,-0.0022777,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.50896,-0.05242,-0.0409,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.11039,-0.052487,-0.069768,0,0
3,GO RESPONSE TO VITAMIN D,0.52025,-0.052868,-0.06896,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.055956,-0.052955,-0.094161,0,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.28785,-0.052992,-0.063065,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.32077,-0.053073,-0.029635,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.39371,-0.053251,-0.042109,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.27999,-0.05332,-0.077917,0,0
3,GO ASYMMETRIC CELL DIVISION,0.7495,-0.053326,-0.025982,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.23245,-0.053371,-0.041828,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.53742,-0.053752,-0.053657,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.15015,-0.053898,-0.10838,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.25363,-0.05403,-0.095631,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.4978,-0.054057,-0.031626,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.63354,-0.054184,-0.041427,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.92682,-0.05426,0.018306,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.23245,-0.054311,-0.085285,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.20937,-0.054434,-0.16339,0,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.76281,-0.054466,-0.022184,0,0
3,GO RESPONSE TO AMYLOID BETA,0.48131,-0.054479,-0.035188,0,0
3,GO VIRAL LATENCY,0.16559,-0.054541,-0.10308,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.31653,-0.054685,-0.06058,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.63978,-0.054764,-0.010266,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.46512,-0.054786,-0.02351,0,0
3,GO MITOTIC CELL CYCLE,0.18508,-0.054874,-0.028869,0,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.5726,-0.055051,-0.083412,0,0
3,GO PEPTIDYL ARGININE METHYLATION,0.44402,-0.055076,-0.03816,0,0
3,GO WALKING BEHAVIOR,0.27999,-0.055108,-0.075455,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.085627,-0.05518,-0.073106,0,0
3,GO LONG TERM MEMORY,0.47049,-0.055209,-0.065145,0,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.56666,-0.055534,0.010129,0,0
3,GO RESPONSE TO X RAY,0.19695,-0.055659,-0.11712,0,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.060602,-0.055736,-0.090828,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.59059,-0.055857,-0.047635,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.63354,-0.055892,-0.067497,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.85768,-0.055932,-0.028666,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.41842,-0.055991,-0.05411,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.3746,-0.056037,-0.089652,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.16032,-0.056465,-0.087122,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.16032,-0.056647,-0.066533,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.76281,-0.056968,-0.0011944,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.4598,-0.057294,-0.034465,0,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.18508,-0.057436,-0.091904,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.076492,-0.057799,-0.10414,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.082489,-0.057847,-0.050197,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.47588,-0.058194,-0.04278,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.27227,-0.058331,-0.08611,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.76948,-0.058546,0.0013366,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.090515,-0.05867,-0.059595,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.87144,-0.058724,-0.014887,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.072231,-0.058878,-0.084421,0,0
3,GO SPECIFICATION OF SYMMETRY,0.05824,-0.058894,-0.078617,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.4545,-0.059009,-0.045682,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.33812,-0.059192,-0.057902,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.5726,-0.059447,-0.069113,0,0
3,GO SPINDLE ASSEMBLY,0.017549,-0.059623,-0.0644,0,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.26847,-0.059643,-0.093683,0,0
3,GO MATURATION OF SSU RRNA,0.5726,-0.059903,-0.061706,0,0
3,GO GENITALIA MORPHOGENESIS,0.41842,-0.06005,-0.092317,0,0
3,GO RETINA LAYER FORMATION,0.65866,-0.060209,0.0022654,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.63354,-0.060359,-0.027317,0,0
3,GO HISTONE H3 DEACETYLATION,0.56075,-0.060534,-0.030093,0,0
3,GO VAGINA DEVELOPMENT,0.64605,-0.060756,-0.075675,0,0
3,GO REGULATION OF DNA BINDING,0.17099,-0.061013,-0.040049,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.22568,-0.061052,-0.060705,0,0
3,GO HEART GROWTH,0.25001,-0.061271,-0.054466,0,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.21256,-0.061464,-0.074507,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.66501,-0.061664,-0.020166,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.054842,-0.061823,-0.041179,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.55487,-0.062008,-0.017527,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.066855,-0.062591,-0.10605,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.66501,-0.062636,-0.017911,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.12259,-0.062683,-0.068884,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.16294,-0.062836,-0.0474,0,0
3,GO SPINDLE LOCALIZATION,0.0695,-0.062885,-0.075179,0,0
3,GO MRNA METHYLATION,0.088862,-0.063538,-0.11492,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.05161,-0.063594,-0.11092,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.19695,-0.063678,-0.054808,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.2839,-0.06395,-0.1094,0,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.78289,-0.064034,-0.039661,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.060602,-0.06431,-0.07488,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.62113,-0.064422,-0.15823,0,0
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.043763,-0.064564,-0.1055,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.15264,-0.064681,-0.064227,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.029068,-0.064819,-0.12258,0,0
3,GO CELL PROJECTION ORGANIZATION,0.079444,-0.065123,-0.062117,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.05824,-0.065196,-0.1339,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.066855,-0.06535,-0.11099,0,0
3,GO RRNA TRANSCRIPTION,0.38408,-0.06538,-0.057674,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.11235,-0.06546,-0.076824,0,0
3,GO DNA GEOMETRIC CHANGE,0.0094949,-0.066069,-0.099779,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.26098,-0.066225,-0.10548,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.39371,-0.066412,-0.09985,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.41842,-0.066718,-0.026602,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.4978,-0.066741,-0.068746,0,0
3,GO DEVELOPMENTAL CELL GROWTH,0.15015,-0.067142,-0.076612,0,0
3,GO DNA REPAIR,0.0049174,-0.067167,-0.062313,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.050569,-0.067175,-0.083426,0,0
3,GO OXIDATIVE DEMETHYLATION,0.188,-0.06724,-0.056093,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.43367,-0.067252,-0.068794,0,0
3,GO RESPONSE TO UV,0.12473,-0.067419,-0.050004,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.12473,-0.067591,-0.10615,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.52594,-0.067979,-0.05998,0,0
3,GO MICROTUBULE BASED PROCESS,0.0042883,-0.068173,-0.068325,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.037747,-0.068397,-0.11801,0,0
3,GO PEPTIDYL ARGININE N METHYLATION,0.39371,-0.068519,-0.065202,0,0
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.3746,-0.068623,-0.043671,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.036948,-0.068676,-0.10411,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.43883,-0.068802,-0.048139,0,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.22235,-0.068884,-0.075296,0,0
3,GO RNA CAPPING,0.054842,-0.068916,-0.075106,0,0
3,GO CENTROSOME SEPARATION,0.46512,-0.069028,-0.020501,0,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.26471,-0.06903,-0.092315,0,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.65866,-0.069085,0.077104,0,0
3,GO HEART MORPHOGENESIS,0.23937,-0.069146,-0.061758,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.22905,-0.069274,-0.049195,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.91293,-0.069422,-0.0074889,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.69061,-0.069531,-0.03571,0,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.021165,-0.070322,-0.13069,0,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.1313,-0.070527,-0.059477,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.188,-0.070636,-0.073509,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.0695,-0.070713,-0.08667,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.59664,-0.070728,-0.081076,0,0
3,GO ARTERY DEVELOPMENT,0.23245,-0.07073,-0.079969,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.15517,-0.070747,-0.053763,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.05824,-0.070807,-0.073935,0,0
3,GO MICROTUBULE ANCHORING,0.11841,-0.070942,-0.065113,0,0
3,GO CELL RECOGNITION,0.26847,-0.071583,-0.06838,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.27611,-0.071621,-0.071273,0,0
3,GO RRNA MODIFICATION,0.27999,-0.071797,-0.07957,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.26471,-0.071972,-0.065625,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.097379,-0.072011,-0.12758,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.10465,-0.072042,-0.068412,0,0
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.47049,-0.072204,-0.093984,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.25729,-0.072502,-0.063291,0,0
3,GO NEUROGENESIS,0.060602,-0.072518,-0.071702,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0028957,-0.072643,-0.073277,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.40349,-0.073092,-0.18945,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.67137,-0.073139,-0.022185,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.092194,-0.073366,-0.063913,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.62732,-0.073735,-0.026997,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.34256,-0.073997,-0.052495,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.097379,-0.074012,-0.16594,0,0
3,GO THYROID GLAND DEVELOPMENT,0.073629,-0.07436,-0.18015,0,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.15517,-0.074597,-0.19149,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.4545,-0.074635,-0.057814,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE,0.05161,-0.074703,-0.082784,0,0
3,GO THYMUS DEVELOPMENT,0.51459,-0.074757,-0.047123,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.0051916,-0.074883,-0.10885,0,0
3,GO MEMBRANE DISASSEMBLY,0.13583,-0.074955,-0.11077,0,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.20309,-0.074959,-0.090687,0,0
3,GO HINDBRAIN DEVELOPMENT,0.4598,-0.075077,-0.032663,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.066855,-0.075445,-0.081412,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.84397,-0.075528,-0.0037041,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.17653,-0.075789,-0.11232,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.22905,-0.075966,-0.14878,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.12908,-0.075986,-0.20496,0,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.69707,-0.076066,-0.039628,0,0
3,GO BONE MATURATION,0.25001,-0.076261,-0.083422,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.018836,-0.076713,-0.074424,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.188,-0.07687,-0.13808,0,0
3,GO HEAD DEVELOPMENT,0.0695,-0.076934,-0.062454,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.68418,-0.076943,-0.011306,0,0
3,GO ADULT FEEDING BEHAVIOR,0.24288,-0.077099,-0.10211,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.22568,-0.077115,-0.089493,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.049546,-0.077187,-0.059515,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.25363,-0.077513,-0.11428,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.63978,-0.077566,-0.038274,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.076492,-0.077786,-0.12802,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.29184,-0.077932,-0.11844,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.082489,-0.078186,-0.065828,0,0
3,GO COLLATERAL SPROUTING,0.39858,-0.078284,-0.072822,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.8303,-0.07832,0.013317,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.0011549,-0.078352,-0.090772,0,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.13814,-0.078434,-0.092477,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.69061,-0.078657,-0.014761,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.42855,-0.078693,-0.067488,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.2839,-0.078828,-0.053117,0,0
3,GO AORTA DEVELOPMENT,0.10845,-0.078851,-0.11969,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.092194,-0.07942,-0.075035,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.052669,-0.079457,-0.15161,0,0
3,GO SEROTONIN TRANSPORT,0.78289,-0.079484,-0.0016771,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.55487,-0.079617,-0.0438,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.11235,-0.079635,-0.060011,0,0
3,GO GTP METABOLIC PROCESS,0.16559,-0.079682,-0.11674,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.17653,-0.079948,-0.065134,0,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.050569,-0.080478,-0.13904,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.35153,-0.080493,-0.038828,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.30815,-0.080835,-0.067029,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.10654,-0.080859,-0.11429,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.30815,-0.081035,-0.050936,0,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.2839,-0.081191,-0.092276,0,0
3,GO COGNITION,0.20937,-0.081291,-0.057917,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.099158,-0.081334,-0.12729,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.10654,-0.081337,-0.12371,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.085627,-0.081387,-0.06281,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.83713,-0.081566,0.027475,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.29586,-0.081785,-0.062152,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.5726,-0.082083,-0.026745,0,0
3,GO MRNA CLEAVAGE,0.12908,-0.082401,-0.061221,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.024288,-0.082413,-0.10015,0,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.12689,-0.082563,-0.10478,0,0
3,GO REGULATION OF BEHAVIOR,0.11636,-0.082811,-0.088707,0,0
3,GO PROSTATE GLAND GROWTH,0.17099,-0.083206,-0.1488,0,0
3,GO CILIUM ORGANIZATION,0.072231,-0.083263,-0.067901,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.027188,-0.08335,-0.12062,0,0
3,GO CELL JUNCTION MAINTENANCE,0.59059,-0.083371,-0.016485,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.35153,-0.083466,-0.086088,0,0
3,GO NODAL SIGNALING PATHWAY,0.15517,-0.083677,-0.093854,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.38888,-0.084195,-0.084559,0,0
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.22235,-0.084632,-0.061933,0,0
3,GO REGULATION OF CYTOKINESIS,0.025414,-0.084692,-0.066383,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.15264,-0.084715,-0.12068,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.31232,-0.085011,-0.14874,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.18508,-0.085099,-0.10425,0,0
3,GO DENDRITE EXTENSION,0.54321,-0.085152,-0.012652,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.077957,-0.085313,-0.06806,0,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.59664,-0.085405,-0.036494,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.073629,-0.085407,-0.074726,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.13583,-0.085441,-0.055749,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.17934,-0.08557,-0.11107,0,0
3,GO DNA STRAND ELONGATION,0.031059,-0.085615,-0.11648,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.075049,-0.085659,-0.27733,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.05824,-0.085738,-0.15391,0,0
3,GO TRNA TRANSPORT,0.11039,-0.085742,-0.092388,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.33373,-0.085773,-0.084431,0,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.32938,-0.085847,-0.10386,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.036164,-0.086628,-0.14897,0,0
3,GO BONE MORPHOGENESIS,0.05161,-0.086677,-0.13531,0,0
3,GO MICROTUBULE NUCLEATION,0.065563,-0.086772,-0.0756,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.20309,-0.086934,-0.099259,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.20621,-0.086974,-0.068985,0,0
3,GO VITAMIN CATABOLIC PROCESS,0.53167,-0.087343,0.09663,0,0
3,GO MUSCLE FILAMENT SLIDING,0.04854,-0.087364,-0.17105,0,0
3,GO TUBULIN DEACETYLATION,0.53742,-0.087581,-0.022352,0,0
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.17653,-0.08761,-0.16321,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.0028141,-0.087916,-0.10335,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.087232,-0.088,-0.10481,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.23589,-0.088156,-0.12309,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.001662,-0.08825,-0.10542,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0695,-0.088415,-0.07983,0,0
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.47588,-0.088444,-0.069906,0,0
3,GO HISTONE H2A ACETYLATION,0.090515,-0.088538,-0.10238,0,0
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.50896,-0.088824,-0.065387,0,0
3,GO REGIONALIZATION,0.31653,-0.088851,-0.041013,0,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.2,-0.088945,-0.11882,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.40843,-0.08899,-0.030412,0,0
3,GO DNA REPLICATION,0.0021062,-0.08907,-0.094013,0,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.21579,-0.089359,-0.080434,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.11636,-0.089444,-0.13295,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.94769,-0.089577,0.020044,0,0
3,GO REGULATION OF DNA REPLICATION,0.14048,-0.0896,-0.054356,0,0
3,GO TRABECULA FORMATION,0.36991,-0.089651,-0.090826,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.12049,-0.089653,-0.092225,0,0
3,GO MITOCHONDRION LOCALIZATION,0.041967,-0.089796,-0.089591,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.15264,-0.090043,-0.069271,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.76281,-0.090059,0.028997,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.13355,-0.090139,-0.061192,0,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.7495,-0.090265,0.049927,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.12689,-0.090323,-0.1063,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.084046,-0.090535,-0.091267,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.4978,-0.09068,-0.029029,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.17934,-0.090789,-0.094506,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.21905,-0.09093,-0.11904,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.012508,-0.091049,-0.10143,0,0
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.88523,-0.091491,-0.036046,0,0
3,GO NEURON DEVELOPMENT,0.027803,-0.091667,-0.090779,0,0
3,GO HAIR FOLLICLE MATURATION,0.24643,-0.091971,-0.099458,0,0
3,GO RRNA METHYLATION,0.22568,-0.09209,-0.070992,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.15264,-0.092158,-0.074002,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.13814,-0.092542,-0.07001,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.40843,-0.092846,-0.057993,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.46512,-0.093003,-0.042879,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.00059588,-0.0936,-0.12307,0,0
3,GO EXPLORATION BEHAVIOR,0.14285,-0.093602,-0.16754,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.00041602,-0.094012,-0.10503,0,0
3,GO SPINDLE ORGANIZATION,0.0013457,-0.09461,-0.091987,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.91293,-0.095078,-0.04066,0,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.55487,-0.095356,-0.048308,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.3746,-0.095507,-0.05558,0,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.72313,-0.095823,-0.036378,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.037747,-0.096044,-0.087321,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.24643,-0.096071,-0.056836,0,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.16828,-0.096518,-0.12659,0,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.29184,-0.096582,-0.096845,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.064293,-0.097363,-0.079908,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.40349,-0.097431,-0.1023,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.7495,-0.098257,0.023337,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.16828,-0.098418,-0.1907,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.0085714,-0.098665,-0.12752,0,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.20621,-0.098802,-0.093043,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.30815,-0.098853,-0.075328,0,0
3,GO NEUROTRANSMITTER TRANSPORT,0.3746,-0.099004,-0.011538,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.12049,-0.099249,-0.07339,0,0
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.40349,-0.099288,-0.047745,0,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.15015,-0.099724,-0.024975,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.10465,-0.099873,-0.13015,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.10845,-0.10037,-0.13029,0,0
3,GO GLUTAMATE SECRETION,0.26847,-0.10072,-0.061989,0,0
3,GO SEROTONIN SECRETION,0.42855,-0.10081,-0.029826,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.33812,-0.10087,-0.11198,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.022165,-0.10127,-0.11858,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.11636,-0.10127,-0.1184,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.46512,-0.10163,-0.12476,0,0
3,GO PROSTATIC BUD FORMATION,0.023741,-0.10203,-0.31817,0,0
3,GO AXO DENDRITIC TRANSPORT,0.018836,-0.10225,-0.11339,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.014486,-0.10226,-0.1186,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.10465,-0.10236,-0.14381,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0090226,-0.10269,-0.13328,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.14285,-0.10283,-0.0827,0,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.05161,-0.10312,-0.092569,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.029068,-0.10359,-0.10088,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.27611,-0.10361,-0.068651,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.33373,-0.10374,-0.085808,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.88523,-0.10398,0.00012895,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.036948,-0.10398,-0.088255,0,0
3,GO RENAL FILTRATION,0.60272,-0.10442,-0.031843,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.16294,-0.1051,-0.10372,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.0090226,-0.10522,-0.12674,0,0
3,GO NEURON DIFFERENTIATION,0.025994,-0.1058,-0.093394,0,0
3,GO RNA EXPORT FROM NUCLEUS,0.0094949,-0.10588,-0.10621,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.033894,-0.10634,-0.13632,0,0
3,GO TELOMERIC LOOP DISASSEMBLY,0.14526,-0.10642,-0.081286,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.18508,-0.10706,-0.092439,0,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.082489,-0.10735,-0.10903,0,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.42855,-0.10757,-0.073693,0,0
3,GO AXIS ELONGATION,0.064293,-0.10784,-0.16607,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.23937,-0.10785,-0.096987,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.057089,-0.10831,-0.13233,0,0
3,GO LEARNING,0.12689,-0.10836,-0.092913,0,0
3,GO ANIMAL ORGAN FORMATION,0.023741,-0.1089,-0.13608,0,0
3,GO L GLUTAMATE IMPORT,0.072231,-0.10896,-0.1448,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.014841,-0.10899,-0.16763,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.188,-0.10923,-0.081802,0,0
3,GO SYNAPTIC VESICLE PRIMING,0.91293,-0.10977,0.07912,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.10465,-0.11018,-0.15418,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.16828,-0.11027,-0.08313,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.10845,-0.11076,-0.11115,0,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.16032,-0.11078,-0.042301,0,0
3,GO TELOMERE CAPPING,0.065563,-0.11097,-0.059618,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.14048,-0.11107,-0.096558,0,0
3,GO HEAT GENERATION,0.22905,-0.11111,-0.076957,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.16294,-0.11111,-0.088587,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.0026572,-0.1112,-0.11392,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.018836,-0.11133,-0.13791,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.23245,-0.11162,-0.042115,0,0
3,GO RRNA 3 END PROCESSING,0.57857,-0.11199,-0.023083,0,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.055956,-0.11254,-0.12857,0,0
3,GO CHROMOSOME SEPARATION,0.015953,-0.11266,-0.093582,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.052669,-0.11278,-0.094449,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.188,-0.11279,-0.15236,0,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.05161,-0.11298,-0.17944,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.085627,-0.1131,-0.11713,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.082489,-0.11359,-0.092268,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.075049,-0.1137,-0.075111,0,0
3,GO MICROTUBULE POLYMERIZATION,0.0037331,-0.11378,-0.1445,0,0
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.39858,-0.1143,-0.11721,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0075304,-0.1145,-0.14063,0,0
3,GO STEM CELL PROLIFERATION,0.14769,-0.11453,-0.076085,0,0
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.19695,-0.11494,-0.081778,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.0097392,-0.11494,-0.15326,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.072231,-0.11532,-0.19264,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.063042,-0.11538,-0.16376,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.093897,-0.11598,-0.048108,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.19695,-0.11612,-0.1133,0,0
3,GO STEM CELL DIVISION,0.13355,-0.11612,-0.11565,0,0
3,GO AXONAL TRANSPORT,0.017549,-0.11626,-0.12528,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.066855,-0.11656,-0.1142,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.10096,-0.11719,-0.11244,0,0
3,GO GMP METABOLIC PROCESS,0.32938,-0.11727,-0.068261,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.0083534,-0.1175,-0.12699,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.052669,-0.11752,-0.14092,0,0
3,GO THALAMUS DEVELOPMENT,0.11039,-0.1183,-0.13863,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.00059588,-0.1189,-0.10252,0,0
3,GO SYNAPTIC SIGNALING,0.23937,-0.11913,-0.058622,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.049546,-0.11926,-0.091686,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.17099,-0.1194,-0.10515,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.00087311,-0.11976,-0.20434,0,0
3,GO UV PROTECTION,0.36526,-0.11986,-0.10979,0,0
3,GO HISTONE DEUBIQUITINATION,0.03939,-0.11989,-0.079394,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.39371,-0.12017,-0.067982,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.00037661,-0.1204,-0.14043,0,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.17374,-0.12142,-0.089402,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.4545,-0.12146,-0.070907,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.14769,-0.12151,-0.10162,0,0
3,GO REGULATION OF CYCLASE ACTIVITY,0.0059384,-0.12181,-0.18909,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.093897,-0.12201,-0.14367,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.11434,-0.12207,-0.086081,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.32077,-0.12208,-0.09539,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.080955,-0.12232,-0.080612,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.13355,-0.12242,-0.088238,0,0
3,GO RESPONSE TO LEAD ION,0.034637,-0.12279,-0.10155,0,0
3,GO METENCEPHALON DEVELOPMENT,0.25363,-0.123,-0.038427,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.11841,-0.12311,-0.15376,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.049546,-0.12327,-0.081434,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.047551,-0.12374,-0.08532,0,0
3,GO NEURAL CREST CELL MIGRATION,0.024846,-0.12376,-0.18461,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,1.5816e-05,-0.12395,-0.13713,0,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.10096,-0.12409,-0.055231,0,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.20937,-0.12421,-0.056581,0,0
3,GO CHROMOSOME CONDENSATION,0.0036303,-0.12458,-0.12589,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.036948,-0.12461,-0.11923,0,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.13355,-0.12514,-0.20354,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.74288,-0.12547,-0.012855,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.087232,-0.12582,-0.074118,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0087944,-0.12629,-0.17636,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.44402,-0.12657,-0.11261,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.053746,-0.12678,-0.13137,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.25363,-0.12699,-0.076833,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.059411,-0.12705,-0.16398,0,0
3,GO CELL PART MORPHOGENESIS,0.0017641,-0.12717,-0.1558,0,0
3,GO MEMBRANE BIOGENESIS,0.15015,-0.12795,-0.11809,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.0069616,-0.12811,-0.10286,0,0
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.36526,-0.12824,-0.10716,0,0
3,GO BLASTOCYST GROWTH,0.23589,-0.12835,-0.04877,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.10845,-0.12871,-0.1515,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.065563,-0.12882,-0.11649,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.013139,-0.12909,-0.14884,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.15015,-0.12931,-0.1206,0,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.20937,-0.12934,-0.068045,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.25729,-0.12938,-0.064919,0,0
3,GO REGULATION OF AXON GUIDANCE,0.055956,-0.13009,-0.13634,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.092194,-0.13027,-0.10092,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.077957,-0.13035,-0.15229,0,0
3,GO G0 TO G1 TRANSITION,0.0006154,-0.13046,-0.16373,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.063042,-0.13056,-0.14154,0,0
3,GO FILOPODIUM ASSEMBLY,0.045624,-0.13072,-0.1281,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.32938,-0.13093,-0.095433,0,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.053746,-0.13094,-0.15963,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.17374,-0.13137,-0.088382,0,0
3,GO SYNAPSE ORGANIZATION,0.10465,-0.13154,-0.096105,0,0
3,GO NEUROBLAST DIVISION,0.27611,-0.13274,-0.10682,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.054842,-0.13287,-0.17382,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.049546,-0.13301,-0.10968,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.052669,-0.13324,-0.16381,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.36526,-0.13327,-0.04479,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.14526,-0.1335,-0.12122,0,0
3,GO TRACHEA DEVELOPMENT,0.2,-0.13362,-0.11393,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.35607,-0.13382,-0.081511,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.33812,-0.13395,-0.063448,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.20621,-0.13427,-0.08392,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.12049,-0.13448,-0.12288,0,0
3,GO NEUROTRANSMITTER SECRETION,0.10465,-0.13553,-0.051825,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.068167,-0.13627,-0.13004,0,0
3,GO NEURON PROJECTION EXTENSION,0.029068,-0.13679,-0.13944,0,0
3,GO PROTEIN DEMETHYLATION,0.024846,-0.13694,-0.13199,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.61497,-0.13695,-0.037482,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.029719,-0.13715,-0.11394,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.011047,-0.13744,-0.12742,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.26471,-0.13748,-0.011085,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.27227,-0.13766,-0.092556,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.075049,-0.1377,-0.10407,0,0
3,GO REGULATION OF HEAT GENERATION,0.21256,-0.1379,-0.10297,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.0031536,-0.13791,-0.19282,0,0
3,GO MECHANOSENSORY BEHAVIOR,0.80989,-0.13792,-0.023034,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.055956,-0.13792,-0.089707,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0019282,-0.13839,-0.12644,0,0
3,GO ACROSOME ASSEMBLY,0.054842,-0.13866,-0.13174,0,0
3,GO FOREBRAIN DEVELOPMENT,0.0031536,-0.13867,-0.12063,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.16294,-0.1387,-0.098075,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.17653,-0.13872,-0.13113,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.023205,-0.13918,-0.11796,0,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.188,-0.13933,-0.058054,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.024846,-0.13949,-0.14934,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.047551,-0.13989,-0.14063,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.03245,-0.14004,-0.13162,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.19393,-0.14022,-0.10653,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.0007696,-0.14055,-0.15839,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.16559,-0.14056,-0.07795,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.89215,-0.14074,0.0060516,0,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.077957,-0.1413,-0.13487,0,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.029719,-0.1416,-0.084476,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.51459,-0.14219,-0.08995,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.14285,-0.14225,-0.19865,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.24288,-0.14243,-0.083505,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0067808,-0.14285,-0.13788,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.033166,-0.14317,-0.16714,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.29992,-0.1433,-0.08725,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.072231,-0.14371,-0.089979,0,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.075049,-0.14397,-0.14314,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.15773,-0.14409,-0.21515,0,0
3,GO NEURON PROJECTION ORGANIZATION,0.017549,-0.14429,-0.15719,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.049546,-0.14433,-0.11553,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.084046,-0.14435,-0.12165,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.20309,-0.14521,-0.12066,0,0
3,GO SIALYLATION,0.91987,-0.14559,-0.021389,0,0
3,GO NEURON PROJECTION REGENERATION,0.097379,-0.14564,-0.10638,0,0
3,GO CELL AGGREGATION,0.12473,-0.14616,-0.13002,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.017969,-0.14624,-0.13674,0,0
3,GO SYNAPSE ASSEMBLY,0.23589,-0.14666,-0.072671,0,0
3,GO V D J RECOMBINATION,0.39371,-0.14669,-0.07614,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0028141,-0.1467,-0.13655,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.10845,-0.14701,-0.10712,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.25001,-0.14718,-0.10947,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.11434,-0.14726,-0.17681,0,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.12259,-0.14798,-0.084264,0,0
3,GO AXON DEVELOPMENT,0.0029794,-0.14808,-0.185,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.060602,-0.14815,-0.12214,0,0
3,GO NEURON CELL CELL ADHESION,0.39371,-0.14875,-0.076154,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.00032948,-0.14928,-0.12819,0,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.099158,-0.14994,-0.096796,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.60883,-0.15006,-0.037053,0,0
3,GO CGMP METABOLIC PROCESS,0.48131,-0.15031,-0.058146,0,0
3,GO DNA REPLICATION CHECKPOINT,0.0015189,-0.15092,-0.18352,0,0
3,GO APPENDAGE DEVELOPMENT,0.010506,-0.1515,-0.13817,0,0
3,GO TELOMERASE RNA LOCALIZATION,0.14769,-0.15151,-0.1254,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0012662,-0.15186,-0.17796,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.054842,-0.15285,-0.13297,0,0
3,GO MATURATION OF LSU RRNA,0.32938,-0.15286,-0.10354,0,0
3,GO REGULATION OF AXONOGENESIS,0.012203,-0.15343,-0.17647,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.0027346,-0.15368,-0.15438,0,0
3,GO NEURON PROJECTION GUIDANCE,0.00054072,-0.15423,-0.22022,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.40349,-0.15499,-0.069249,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.11434,-0.15513,-0.13519,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.02068,-0.15548,-0.29619,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.0053338,-0.15599,-0.11899,0,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.0071468,-0.15601,-0.18345,0,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.090515,-0.15726,-0.13247,0,0
3,GO RESPONSE TO ACETYLCHOLINE,0.057089,-0.15735,-0.20685,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.13355,-0.15745,-0.14315,0,0
3,GO SISTER CHROMATID COHESION,0.0028957,-0.15779,-0.12244,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.017969,-0.15792,-0.21203,0,0
3,GO NEURON CELLULAR HOMEOSTASIS,0.077957,-0.15905,-0.16897,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.13814,-0.1597,-0.10221,0,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.10465,-0.1598,-0.17234,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.04854,-0.16082,-0.16536,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.011904,-0.16121,-0.13174,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.0060989,-0.16129,-0.19176,0,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.40349,-0.16129,-0.068495,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.24643,-0.16136,-0.14843,0,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.2,-0.16223,-0.079614,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0059384,-0.16266,-0.16033,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0073363,-0.16344,-0.16638,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.073629,-0.16362,-0.14169,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.070855,-0.16411,-0.099841,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.049546,-0.16454,-0.13445,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.014486,-0.16475,-0.19564,0,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.063042,-0.16528,-0.10355,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.00074557,-0.16529,-0.1512,0,0
3,GO PALLIUM DEVELOPMENT,0.00021167,-0.16735,-0.15332,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.022165,-0.16741,-0.20781,0,0
3,GO BIOLOGICAL PHASE,0.61497,-0.16768,-0.032285,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.14285,-0.16786,-0.15416,0,0
3,GO TRACHEA MORPHOGENESIS,0.16828,-0.16865,-0.11015,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.26098,-0.16945,-0.088746,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.087232,-0.17035,-0.17627,0,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.0079323,-0.17101,-0.1347,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0050528,-0.17117,-0.1878,0,0
3,GO FOREBRAIN CELL MIGRATION,0.0020453,-0.17117,-0.19368,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.22905,-0.17142,-0.092774,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.0090226,-0.17223,-0.20175,0,0
3,GO OTIC VESICLE MORPHOGENESIS,0.076492,-0.17235,-0.21143,0,0
3,GO PRESYNAPSE ORGANIZATION,0.075049,-0.17328,-0.14623,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0073363,-0.1733,-0.23418,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.27999,-0.17333,-0.10239,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.031059,-0.17337,-0.19191,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.01282,-0.17366,-0.18732,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.027803,-0.17386,-0.20015,0,0
3,GO INTRACILIARY TRANSPORT,0.001872,-0.17453,-0.20394,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.02843,-0.17487,-0.17582,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.0042883,-0.17552,-0.16961,0,0
3,GO PLASMA MEMBRANE REPAIR,0.33812,-0.17607,-0.074743,0,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0001547,-0.17659,-0.15971,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.26471,-0.17674,-0.10182,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.090515,-0.17685,-0.18611,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.075049,-0.17713,-0.15381,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0023671,-0.17725,-0.14388,0,0
3,GO POSTSYNAPSE ORGANIZATION,0.013139,-0.17741,-0.16429,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.061812,-0.17769,-0.26695,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.082489,-0.17781,-0.15795,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.044685,-0.17829,-0.1184,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.031748,-0.17835,-0.19208,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.055956,-0.17876,-0.13261,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.036164,-0.17906,-0.20769,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00054072,-0.17916,-0.2885,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,3.5759e-05,-0.17971,-0.182,0,0
3,GO NEGATIVE CHEMOTAXIS,0.188,-0.17975,-0.14024,0,0
3,GO AXON EXTENSION,0.0040578,-0.17989,-0.19683,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.043763,-0.17992,-0.2734,0,0
3,GO SECRETORY GRANULE LOCALIZATION,0.53167,-0.17993,-0.049153,0,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.05161,-0.17993,-0.17265,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.14769,-0.18112,-0.078104,0,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00092958,-0.18277,-0.20617,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.89215,-0.18404,0.063923,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.031748,-0.18432,-0.099516,0,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0019282,-0.18479,-0.23946,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.14285,-0.18494,-0.099018,0,0
3,GO REGULATION OF HIPPO SIGNALING,0.064293,-0.18675,-0.17496,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0037331,-0.18682,-0.1827,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.010245,-0.18682,-0.13901,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.41842,-0.1872,-0.028502,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.073629,-0.18742,-0.16254,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.1493e-05,-0.18768,-0.17262,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0013872,-0.1884,-0.17773,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0050528,-0.1887,-0.15381,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.02166,-0.18973,-0.16427,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.084046,-0.18993,-0.2041,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.034637,-0.19,-0.18034,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.099158,-0.19049,-0.1295,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00035231,-0.1906,-0.26177,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.076492,-0.19099,-0.1648,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.11636,-0.19151,-0.12988,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0021062,-0.19206,-0.15263,0,0
3,GO DENDRITE DEVELOPMENT,0.00353,-0.19302,-0.14527,0,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.02166,-0.19365,-0.17519,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.17374,-0.19381,-0.088212,0,0
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.010506,-0.19438,-0.22608,0,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.026586,-0.19459,-0.14265,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.076492,-0.19667,-0.10458,0,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.26471,-0.19674,-0.10107,0,0
3,GO HEART FORMATION,0.02268,-0.19714,-0.1674,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.2839,-0.19726,-0.075413,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.011047,-0.1975,-0.18619,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.018398,-0.19813,-0.15671,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.090515,-0.19894,-0.15432,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.41341,-0.19933,-0.077562,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0025817,-0.19947,-0.20413,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.010245,-0.19967,-0.18972,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.04854,-0.19973,-0.13641,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.0033369,-0.19985,-0.18297,0,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.059411,-0.20004,-0.14552,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.015953,-0.20012,-0.1611,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.010773,-0.20113,-0.27113,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.0066042,-0.20147,-0.19794,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.03939,-0.20227,-0.17883,0,0
3,GO MICROTUBULE SEVERING,0.084046,-0.2026,-0.12864,0,0
3,GO HEART FIELD SPECIFICATION,0.19095,-0.20622,-0.13462,0,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.18219,-0.20688,-0.1321,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.00090094,-0.20721,-0.18798,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.00081984,-0.20758,-0.18331,0,0
3,GO HISTONE H3 K36 METHYLATION,0.015574,-0.20777,-0.14825,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.076492,-0.20834,-0.21121,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00087311,-0.20884,-0.19878,0,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.012508,-0.20964,-0.2176,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0045306,-0.20981,-0.19156,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00017186,-0.21034,-0.20942,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0032441,-0.21091,-0.20146,0,0
3,GO REGULATION OF NEURON MIGRATION,0.0010859,-0.21335,-0.25399,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.0083534,-0.21427,-0.20497,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.064293,-0.21522,-0.17499,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.034637,-0.21635,-0.29166,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0037331,-0.21719,-0.203,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.061812,-0.21763,-0.16295,0,0
3,GO HIPPOCAMPUS DEVELOPMENT,9.7346e-05,-0.21801,-0.22195,0,0
3,GO IRON COORDINATION ENTITY TRANSPORT,0.7495,-0.21974,0.019056,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.83713,-0.22002,0.075767,0,0
3,GO GENETIC IMPRINTING,0.0041716,-0.22087,-0.21104,0,0
3,GO COCHLEA MORPHOGENESIS,0.011612,-0.22142,-0.23316,0,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00026003,-0.22149,-0.21078,0,0
3,GO RECEPTOR CLUSTERING,0.0029794,-0.22172,-0.19675,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.011612,-0.22183,-0.30715,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.073629,-0.22194,-0.15675,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.011047,-0.222,-0.20432,0,0
3,GO NEURON MIGRATION,0.0015189,-0.22235,-0.21148,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0015189,-0.2224,-0.18825,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.077957,-0.22247,-0.13372,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.02166,-0.22578,-0.137,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.29586,-0.22595,-0.10225,0,0
3,GO UTERUS DEVELOPMENT,0.04854,-0.22727,-0.2014,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.11434,-0.22743,-0.14024,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.016734,-0.22909,-0.18332,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.010245,-0.22983,-0.3276,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00014418,-0.2301,-0.22673,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.041093,-0.23035,-0.27442,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.11235,-0.2305,-0.16176,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.20937,-0.23067,-0.12088,0,0
3,GO NEUROBLAST PROLIFERATION,0.0030654,-0.23088,-0.20692,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.084046,-0.23242,-0.13943,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.097379,-0.23264,-0.19431,0,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0015653,-0.23273,-0.28544,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.04854,-0.23593,-0.15861,0,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00072223,-0.23823,-0.19183,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.015574,-0.23863,-0.25642,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.15015,-0.23903,-0.19794,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00353,-0.24029,-0.2506,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.001191,-0.24125,-0.24225,0,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00098941,-0.24176,-0.26972,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0013872,-0.24189,-0.2349,0,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.17653,-0.24205,-0.21726,0,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.019739,-0.24323,-0.19075,0,0
3,GO SPINAL CORD PATTERNING,0.13583,-0.2438,-0.12796,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.36991,-0.24461,-0.049976,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.00054072,-0.24595,-0.24683,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.064293,-0.24648,-0.20658,0,0
3,GO BRAIN MORPHOGENESIS,0.0021689,-0.24916,-0.17309,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.066855,-0.25022,-0.28359,0,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.00023468,-0.25038,-0.26066,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.057089,-0.25068,-0.14064,0,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.00010092,-0.25151,-0.30148,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,0.0014299,-0.25291,-0.24068,0,0
3,GO ELASTIC FIBER ASSEMBLY,0.04854,-0.25485,-0.27111,0,0
3,GO DENDRITE MORPHOGENESIS,0.0013872,-0.25486,-0.18952,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.059411,-0.25497,-0.22726,0,0
3,GO SYNAPTIC VESICLE MATURATION,0.097379,-0.25833,-0.17194,0,0
3,GO COCHLEA DEVELOPMENT,0.012508,-0.25936,-0.17682,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.0031536,-0.25951,-0.26278,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.011047,-0.25971,-0.25894,0,0
3,GO DENTATE GYRUS DEVELOPMENT,0.042857,-0.26221,-0.19518,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.011904,-0.26733,-0.21021,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.0059384,-0.26748,-0.24388,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.013798,-0.26762,-0.2598,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.00084609,-0.26825,-0.20606,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.010245,-0.26968,-0.38451,0,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.41341,-0.27071,-0.096719,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.097379,-0.27091,-0.20479,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0087944,-0.27227,-0.22494,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.029068,-0.27255,-0.21034,0,0
3,GO DNA LIGATION,0.0028141,-0.27433,-0.21158,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0047853,-0.27525,-0.19207,0,0
3,GO NEURON RECOGNITION,0.009256,-0.27591,-0.24971,0,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0062634,-0.27599,-0.20859,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.025994,-0.27922,-0.27112,0,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.019283,-0.28094,-0.29282,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.037747,-0.28155,-0.29198,0,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0025817,-0.28256,-0.30863,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0064317,-0.28286,-0.22928,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.00030804,-0.28635,-0.26536,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.011047,-0.28744,-0.23877,0,0
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.068167,-0.29051,-0.24401,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.027188,-0.29216,-0.21492,0,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0064317,-0.29338,-0.28402,0,0
3,GO FOREBRAIN MORPHOGENESIS,0.0090226,-0.29512,-0.20245,0,0
3,GO CONVERGENT EXTENSION,0.02268,-0.29604,-0.19889,0,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,6.5149e-05,-0.29725,-0.34606,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.10654,-0.29753,-0.20319,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0010206,-0.29867,-0.26593,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0695,-0.2988,-0.16821,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.034637,-0.29959,-0.30207,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0083534,-0.30626,-0.21294,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0040578,-0.31411,-0.24241,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.0029794,-0.31507,-0.27764,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.024288,-0.31836,-0.20308,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00057693,-0.31888,-0.33036,0,0
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00353,-0.31937,-0.42142,0,0
3,GO CHROMATIN DISASSEMBLY,4.3218e-05,-0.32202,-0.29173,0,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.019283,-0.32587,-0.18718,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0011549,-0.32797,-0.29345,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0090226,-0.32919,-0.33633,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0067808,-0.33005,-0.24635,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0026572,-0.33054,-0.30829,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,1.349e-05,-0.33181,-0.35551,0,0
3,GO PHAGOCYTOSIS RECOGNITION,0.0029794,-0.33352,-0.30113,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.00019753,-0.33533,-0.30553,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.00063551,-0.33716,-0.32103,0,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.00059588,-0.33959,-0.36878,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,1.1964e-05,-0.34084,-0.31391,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.010773,-0.3457,-0.32004,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.013465,-0.34684,-0.20784,0,0
3,GO PYRAMIDAL NEURON DIFFERENTIATION,0.0079323,-0.34921,-0.29661,0,0
3,GO DENDRITIC TRANSPORT,8.1192e-05,-0.35104,-0.34914,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,1.0604e-05,-0.35715,-0.35028,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.025994,-0.35836,-0.22784,0,0
3,GO HEART VALVE FORMATION,0.046579,-0.36244,-0.258,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.041093,-0.36268,-0.19762,0,0
3,GO NEURON FATE SPECIFICATION,0.095625,-0.36549,-0.16089,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.00038934,-0.37865,-0.40738,0,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0013054,-0.38225,-0.42111,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0021689,-0.38773,-0.31292,0,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.0057817,-0.38797,-0.40228,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.012508,-0.3885,-0.32873,0,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.00035231,-0.40846,-0.31475,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00018427,-0.42737,-0.3896,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0013054,-0.43854,-0.48198,0,0
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,5.6174e-05,-0.44517,-0.47971,0,0
3,GO TELENCEPHALON REGIONALIZATION,0.0054795,-0.47015,-0.39113,0,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.00034072,-0.4747,-0.52025,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.072231,-0.49139,-0.26123,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.011612,-0.50106,-0.4832,0,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0014299,-0.50456,-0.4124,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00084609,-0.50777,-0.42829,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00026003,-0.51338,-0.41689,0,0
3,GO VOCALIZATION BEHAVIOR,0.0067808,-0.5236,-0.41993,0,0
3,GO CARDIAC CHAMBER FORMATION,0.00032948,-0.56311,-0.52265,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,8.4205e-05,-0.58148,-0.56809,0,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00012074,-0.58542,-0.56978,0,0
3,GO CARDIAC VENTRICLE FORMATION,0.00063551,-0.59463,-0.53917,0,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00042998,-0.60876,-0.67917,0,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.02068,-0.62756,-0.35715,0,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.00028792,-0.67828,-0.57677,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.389e-05,-0.68558,-0.53452,0,0
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.2876e-06,0.93086,0.8835,1,1
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.00010092,0.67655,0.86206,1,1
4,GO CARDIOBLAST PROLIFERATION,0.00013433,0.67562,0.69151,1,1
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.4039e-05,0.61808,0.63723,1,1
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00024286,0.60299,0.55258,1,1
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,4.3218e-05,0.58596,0.60783,1,1
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.00031859,0.56255,0.57167,1,1
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.00012074,0.55205,0.50705,1,1
4,GO CARDIAC CELL FATE COMMITMENT,0.00012964,0.53353,0.56691,1,1
4,GO SOMATIC STEM CELL DIVISION,0.0036303,0.51072,0.40392,1,1
4,GO NEURON FATE COMMITMENT,2.2658e-06,0.50808,0.52615,1,1
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,9.0551e-05,0.49839,0.43105,1,1
4,GO ECTODERMAL PLACODE DEVELOPMENT,4.6597e-05,0.49751,0.5871,1,1
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0042883,0.49113,0.45631,1,1
4,GO NEURON FATE SPECIFICATION,5.8301e-05,0.48688,0.56503,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,3.8583e-05,0.47708,0.43939,1,1
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.00020448,0.47526,0.38478,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.4878e-05,0.4627,0.47456,1,1
4,GO GANGLION DEVELOPMENT,0.00042998,0.44535,0.5137,1,1
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0007696,0.44523,0.44036,1,1
4,GO RETINAL ROD CELL DIFFERENTIATION,0.00054072,0.44056,0.39595,1,1
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00037661,0.43729,0.42475,1,1
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0033369,0.4281,0.40121,1,1
4,GO MYOBLAST MIGRATION,0.00021167,0.42339,0.47432,1,1
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,2.3418e-05,0.42322,0.50676,1,1
4,GO LATERAL MESODERM DEVELOPMENT,0.004408,0.41936,0.30387,1,1
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0090226,0.41606,0.40783,1,1
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.00087311,0.41326,0.42362,1,1
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,1.6455e-05,0.40686,0.37512,1,1
4,GO ATRIAL SEPTUM DEVELOPMENT,0.00353,0.38066,0.32462,1,1
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00031859,0.37921,0.40648,1,1
4,GO NEURAL CREST FORMATION,0.0033369,0.37264,0.28512,1,1
4,GO FORELIMB MORPHOGENESIS,0.00029782,0.37048,0.34467,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00084609,0.37003,0.47362,1,1
4,GO THALAMUS DEVELOPMENT,0.00022676,0.36958,0.36151,1,1
4,GO FAT CELL PROLIFERATION,0.0015189,0.36809,0.31388,1,1
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0038387,0.36552,0.31963,1,1
4,GO DENDRITE SELF AVOIDANCE,2.0033e-05,0.36494,0.35579,1,1
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0033369,0.36309,0.30385,1,1
4,GO CELL DIFFERENTIATION IN SPINAL CORD,1.5331e-06,0.36288,0.35041,1,1
4,GO CARDIOBLAST DIFFERENTIATION,0.00035231,0.36054,0.37474,1,1
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0011199,0.36032,0.43034,1,1
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,4.4878e-05,0.35976,0.39388,1,1
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,6.5149e-05,0.35604,0.36344,1,1
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,5.6174e-05,0.35264,0.40219,1,1
4,GO ESTROUS CYCLE,0.0019282,0.35244,0.26626,1,1
4,GO LEFT RIGHT AXIS SPECIFICATION,0.023205,0.3454,0.21169,1,1
4,GO MALE SEX DETERMINATION,0.0027346,0.34154,0.28373,1,1
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.01282,0.33772,0.23924,1,1
4,GO V D J RECOMBINATION,0.00095906,0.33616,0.27179,1,1
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.1493e-05,0.33048,0.30375,1,1
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0023671,0.32784,0.32581,1,1
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054795,0.32436,0.24608,1,1
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.045624,0.31796,0.23819,1,1
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.007729,0.31437,0.28216,1,1
4,GO POSITIVE REGULATION OF BEHAVIOR,0.001986,0.3132,0.30363,1,1
4,GO DECIDUALIZATION,0.01282,0.31062,0.20901,1,1
4,GO SPINAL CORD PATTERNING,0.00029782,0.30655,0.40139,1,1
4,GO HINDLIMB MORPHOGENESIS,0.020205,0.30184,0.22565,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0054795,0.2945,0.29943,1,1
4,GO TONGUE DEVELOPMENT,0.0025083,0.29444,0.29462,1,1
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00028792,0.28554,0.27171,1,1
4,GO PROSTATE GLAND MORPHOGENESIS,0.035393,0.28171,0.3457,1,1
4,GO CARTILAGE MORPHOGENESIS,0.009256,0.28121,0.37864,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00019079,0.27983,0.25416,1,1
4,GO CELL FATE SPECIFICATION,5.0226e-05,0.27723,0.31206,1,1
4,GO HISTONE H3 K9 METHYLATION,8.3127e-06,0.27692,0.24013,1,1
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.014841,0.27569,0.23487,1,1
4,GO TONGUE MORPHOGENESIS,0.0053338,0.27528,0.38094,1,1
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0011199,0.2705,0.28035,1,1
4,GO PITUITARY GLAND DEVELOPMENT,0.012203,0.26896,0.25074,1,1
4,GO POST ANAL TAIL MORPHOGENESIS,0.00047456,0.26859,0.22976,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0094949,0.26806,0.20152,1,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0057817,0.267,0.26827,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,2.6307e-05,0.26418,0.33212,1,1
4,GO SINGLE STRAND BREAK REPAIR,0.0017123,0.26162,0.1716,1,1
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0011199,0.25922,0.27752,1,1
4,GO APICAL PROTEIN LOCALIZATION,6.2786e-05,0.25853,0.31685,1,1
4,GO CELLULAR RESPONSE TO VITAMIN D,0.013139,0.25823,0.2819,1,1
4,GO CELLULAR RESPONSE TO X RAY,0.0024367,0.25811,0.18244,1,1
4,GO FOREBRAIN REGIONALIZATION,0.0026572,0.25369,0.24714,1,1
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.021165,0.25281,0.21951,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.025994,0.24932,0.24028,1,1
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.0029794,0.24885,0.23261,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0014299,0.24875,0.23027,1,1
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.001228,0.24734,0.29506,1,1
4,GO DIENCEPHALON DEVELOPMENT,0.012508,0.2464,0.20631,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.2962e-05,0.24304,0.28999,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.010245,0.2429,0.18964,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0014738,0.24226,0.22882,1,1
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.00021909,0.2415,0.25417,1,1
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.042857,0.23955,0.21306,1,1
4,GO HISTONE H3 K9 MODIFICATION,3.3132e-05,0.23942,0.20841,1,1
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0047853,0.23603,0.26519,1,1
4,GO TRACHEA DEVELOPMENT,0.033166,0.2347,0.21599,1,1
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.004408,0.23408,0.19835,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0017641,0.23294,0.25965,1,1
4,GO REGULATION OF SISTER CHROMATID COHESION,0.00012074,0.23154,0.22616,1,1
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.018398,0.23008,0.21036,1,1
4,GO REGULATION OF STEM CELL PROLIFERATION,0.00079435,0.22787,0.21304,1,1
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.0042883,0.22584,0.21313,1,1
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00019079,0.22556,0.19652,1,1
4,GO MATERNAL PLACENTA DEVELOPMENT,0.0032441,0.2245,0.22467,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00016595,0.22391,0.2019,1,1
4,GO CHONDROCYTE DEVELOPMENT,0.025414,0.22329,0.19859,1,1
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.03939,0.22285,0.18658,1,1
4,GO RESPONSE TO VITAMIN D,0.029068,0.22156,0.237,1,1
4,GO LIMB BUD FORMATION,0.013465,0.22058,0.37467,1,1
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.007729,0.21962,0.25567,1,1
4,GO AXIS ELONGATION,0.046579,0.21812,0.24709,1,1
4,GO NEURAL TUBE PATTERNING,0.0014738,0.21553,0.22945,1,1
4,GO PARTURITION,0.035393,0.21489,0.17559,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.004408,0.21443,0.20105,1,1
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.012203,0.21335,0.19955,1,1
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0066042,0.21177,0.23357,1,1
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0097392,0.21093,0.21905,1,1
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.0042883,0.21043,0.19571,1,1
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00052342,0.20876,0.20343,1,1
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.03245,0.20874,0.19575,1,1
4,GO GAMMA DELTA T CELL ACTIVATION,0.03939,0.20862,0.21212,1,1
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0010528,0.20848,0.19473,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0014299,0.20678,0.21793,1,1
4,GO HISTONE H3 K9 TRIMETHYLATION,0.00023468,0.20671,0.21365,1,1
4,GO KINETOCHORE ORGANIZATION,0.00087311,0.20638,0.22633,1,1
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.017549,0.20592,0.21653,1,1
4,GO REPLACEMENT OSSIFICATION,0.036164,0.20566,0.20219,1,1
4,GO VIRAL LATENCY,0.009256,0.20533,0.16637,1,1
4,GO DORSAL VENTRAL PATTERN FORMATION,0.00019753,0.20511,0.22383,1,1
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.014841,0.20437,0.16204,1,1
4,GO HISTONE H4 K5 ACETYLATION,5.0226e-05,0.20353,0.23906,1,1
4,GO ESCRT COMPLEX DISASSEMBLY,0.011612,0.20064,0.16271,1,1
4,GO HISTONE H4 K16 ACETYLATION,3.8583e-05,0.1995,0.22283,1,1
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.010506,0.19827,0.20179,1,1
4,GO MRNA SPLICE SITE SELECTION,0.0021689,0.19808,0.19724,1,1
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.0026572,0.19805,0.1815,1,1
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0017641,0.1977,0.18484,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.015574,0.19703,0.16133,1,1
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.026586,0.19578,0.21611,1,1
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.046579,0.19547,0.20421,1,1
4,GO MIDDLE EAR MORPHOGENESIS,0.012203,0.19524,0.27511,1,1
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,9.7346e-05,0.1952,0.18472,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.004408,0.19432,0.15947,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.0083534,0.19414,0.20655,1,1
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.036948,0.19402,0.20862,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING,0.0053338,0.19386,0.1579,1,1
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.025414,0.19354,0.21411,1,1
4,GO KINETOCHORE ASSEMBLY,0.0047853,0.19216,0.17593,1,1
4,GO SPINAL CORD DEVELOPMENT,0.0001165,0.19208,0.24725,1,1
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0060989,0.19198,0.15261,1,1
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.0085714,0.19133,0.21226,1,1
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.030383,0.19131,0.1544,1,1
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0025817,0.19058,0.21634,1,1
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.018836,0.18839,0.18102,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00081984,0.18524,0.21843,1,1
4,GO MITOTIC DNA REPLICATION,0.024288,0.18516,0.13541,1,1
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0024367,0.18393,0.16737,1,1
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0011549,0.18337,0.20355,1,1
4,GO MITOTIC SISTER CHROMATID COHESION,0.0013054,0.17986,0.19976,1,1
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0056288,0.17879,0.1646,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.010506,0.17734,0.23565,1,1
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.045624,0.17702,0.1162,1,1
4,GO CARDIAC ATRIUM DEVELOPMENT,0.02268,0.17479,0.18009,1,1
4,GO HISTONE H3 K27 METHYLATION,0.021165,0.17192,0.12949,1,1
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.015953,0.16941,0.11857,1,1
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.0059384,0.16913,0.20038,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0030654,0.16779,0.17737,1,1
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00038934,0.16766,0.16892,1,1
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.015203,0.16459,0.15113,1,1
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.011047,0.16395,0.15112,1,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0045306,0.16293,0.21063,1,1
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.034637,0.16108,0.11716,1,1
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0015189,0.16092,0.13622,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0047853,0.16048,0.16069,1,1
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.014841,0.16005,0.15245,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0020453,0.15926,0.17788,1,1
4,GO CELL CELL JUNCTION MAINTENANCE,0.041967,0.15884,0.21158,1,1
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0028141,0.15837,0.16366,1,1
4,GO APPENDAGE MORPHOGENESIS,0.0034322,0.15795,0.21193,1,1
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.041967,0.15733,0.1208,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.025414,0.15479,0.1803,1,1
4,GO CENTROSOME DUPLICATION,0.00026003,0.15447,0.15554,1,1
4,GO SULFATION,0.047551,0.15407,0.11531,1,1
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.018398,0.1532,0.23916,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.024846,0.15065,0.11967,1,1
4,GO REGULATION OF CENTRIOLE REPLICATION,0.013139,0.14985,0.11175,1,1
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.026586,0.14965,0.18065,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,6.0504e-05,0.14878,0.15086,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0022992,0.14773,0.17542,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0015653,0.14595,0.16459,1,1
4,GO REGULATION OF CELL FATE SPECIFICATION,0.019283,0.14514,0.30884,1,1
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0013872,0.14438,0.12402,1,1
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.035393,0.14309,0.14656,1,1
4,GO ROOF OF MOUTH DEVELOPMENT,0.0069616,0.14262,0.1626,1,1
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.021165,0.14219,0.12956,1,1
4,GO THYMUS DEVELOPMENT,0.037747,0.13923,0.11839,1,1
4,GO MAINTENANCE OF CELL NUMBER,0.036948,0.13819,0.12181,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.0081404,0.13743,0.12913,1,1
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00044439,0.13635,0.13496,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.00092958,0.13627,0.12227,1,1
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00035231,0.13522,0.15823,1,1
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0062634,0.13491,0.14165,1,1
4,GO MESENCHYMAL CELL PROLIFERATION,0.019739,0.13375,0.21325,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.00031859,0.13346,0.11801,1,1
4,GO REGULATION OF HELICASE ACTIVITY,0.041093,0.13343,0.14231,1,1
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.0015653,0.13298,0.15049,1,1
4,GO MITOTIC CHROMOSOME CONDENSATION,0.00092958,0.13284,0.16972,1,1
4,GO HISTONE H3 K4 TRIMETHYLATION,0.0042883,0.12959,0.12569,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.00063551,0.12935,0.15497,1,1
4,GO POST EMBRYONIC DEVELOPMENT,0.010773,0.12836,0.12687,1,1
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.019739,0.12682,0.17048,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.00057693,0.12664,0.11728,1,1
4,GO ECTODERM DEVELOPMENT,0.017137,0.12648,0.13209,1,1
4,GO STEM CELL PROLIFERATION,0.0023671,0.12568,0.16896,1,1
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.011612,0.12536,0.13448,1,1
4,GO CENTRIOLE ASSEMBLY,0.011612,0.12422,0.10311,1,1
4,GO CENTROMERE COMPLEX ASSEMBLY,0.00084609,0.12197,0.18325,1,1
4,GO REGULATION OF MYELINATION,0.034637,0.12184,0.11022,1,1
4,GO POSITIVE T CELL SELECTION,0.017137,0.12077,0.10177,1,1
4,GO REGULATION OF CENTROSOME DUPLICATION,0.0079323,0.11901,0.11226,1,1
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.00028792,0.11867,0.11445,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.034637,0.11762,0.082675,1,1
4,GO REGULATION OF HISTONE METHYLATION,0.00074557,0.11693,0.11785,1,1
4,GO CHROMOSOME LOCALIZATION,0.0039469,0.11532,0.10187,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.019739,0.11514,0.12903,1,1
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0025083,0.11362,0.11258,1,1
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.047551,0.11314,0.098042,1,1
4,GO HISTONE UBIQUITINATION,0.0062634,0.11293,0.084748,1,1
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0079323,0.11085,0.14038,1,1
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0051916,0.11067,0.1362,1,1
4,GO PEPTIDYL LYSINE METHYLATION,0.00026003,0.11058,0.10938,1,1
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.02166,0.11054,0.10452,1,1
4,GO REGULATION OF DNA REPAIR,0.001986,0.10976,0.096699,1,1
4,GO REGULATION OF CENTROSOME CYCLE,0.00098941,0.10899,0.12143,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.046579,0.1085,0.21906,1,1
4,GO HISTONE MONOUBIQUITINATION,0.0071468,0.10836,0.097072,1,1
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.029719,0.10706,0.10318,1,1
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.017137,0.10658,0.1016,1,1
4,GO NUCLEOSOME ORGANIZATION,0.00035231,0.10629,0.11424,1,1
4,GO ERYTHROCYTE DEVELOPMENT,0.0085714,0.10563,0.10299,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.027803,0.10474,0.098675,1,1
4,GO HISTONE H3 K4 METHYLATION,0.0013457,0.10317,0.13533,1,1
4,GO SOMITE DEVELOPMENT,0.0039469,0.10295,0.15161,1,1
4,GO CENTROSOME SEPARATION,0.030383,0.10267,0.13325,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.012508,0.10261,0.16571,1,1
4,GO NUCLEOSOME ASSEMBLY,0.0024367,0.10233,0.13221,1,1
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.02166,0.1014,0.095906,1,1
4,GO T CELL SELECTION,0.015203,0.099531,0.09478,1,1
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00023468,0.098024,0.11137,1,1
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.0028141,0.096341,0.12218,1,1
4,GO CELL FATE COMMITMENT,0.0041716,0.095836,0.14757,1,1
4,GO DNA INTEGRITY CHECKPOINT,0.0062634,0.095388,0.066991,1,1
4,GO HISTONE H4 ACETYLATION,0.0021062,0.095012,0.10052,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,8.7323e-05,0.094134,0.10888,1,1
4,GO CHROMATIN REMODELING,0.00024286,0.093236,0.11745,1,1
4,GO CHROMATIN REMODELING AT CENTROMERE,0.0085714,0.092893,0.16228,1,1
4,GO POSITIVE THYMIC T CELL SELECTION,0.027188,0.092651,0.12372,1,1
4,GO HISTONE H3 K9 DEMETHYLATION,0.025994,0.091848,0.16121,1,1
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.0075304,0.091545,0.15046,1,1
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.025994,0.09152,0.079043,1,1
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0014738,0.089212,0.119,1,1
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.0057817,0.088526,0.071584,1,1
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.031059,0.08763,0.1107,1,1
4,GO CELL CYCLE CHECKPOINT,0.0023671,0.087136,0.075364,1,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.0057817,0.08581,0.097999,1,1
4,GO CELL CYCLE DNA REPLICATION,0.03245,0.085602,0.076866,1,1
4,GO REGULATION OF DNA BINDING,0.014841,0.084919,0.097291,1,1
4,GO DNA PACKAGING,0.0011549,0.084302,0.095798,1,1
4,GO CHROMATIN ORGANIZATION,0.00027832,0.082632,0.079317,1,1
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.015953,0.08251,0.059072,1,1
4,GO RECOMBINATIONAL REPAIR,0.01282,0.081921,0.069341,1,1
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.026586,0.081684,0.10779,1,1
4,GO METAPHASE PLATE CONGRESSION,0.0079323,0.081581,0.09766,1,1
4,GO CHROMATIN SILENCING,0.027188,0.08146,0.082165,1,1
4,GO HISTONE METHYLATION,0.001986,0.079774,0.079316,1,1
4,GO SISTER CHROMATID SEGREGATION,0.0042883,0.07908,0.087216,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0099891,0.077811,0.081789,1,1
4,GO CHROMOSOME SEGREGATION,0.011612,0.076511,0.065156,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.024288,0.076418,0.081445,1,1
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.01282,0.076243,0.11627,1,1
4,GO DNA CONFORMATION CHANGE,0.0062634,0.076173,0.072796,1,1
4,GO REPLICATION FORK PROCESSING,0.038561,0.075776,0.081698,1,1
4,GO PEPTIDYL LYSINE MODIFICATION,0.0030654,0.075762,0.061023,1,1
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.015574,0.07508,0.083613,1,1
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0054795,0.071996,0.064286,1,1
4,GO HISTONE EXCHANGE,0.014486,0.071902,0.11151,1,1
4,GO PROTEIN ACETYLATION,0.0059384,0.07048,0.074004,1,1
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.017137,0.069767,0.068226,1,1
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.013465,0.065599,0.084132,1,1
4,GO PROTEIN METHYLATION,0.0060989,0.06345,0.064215,1,1
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0024367,0.06314,0.069257,1,1
4,GO HISTONE H3 ACETYLATION,0.047551,0.062328,0.063063,1,1
4,GO COVALENT CHROMATIN MODIFICATION,0.0030654,0.061231,0.067113,1,1
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.02166,0.059927,0.074199,1,1
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.014486,0.059197,0.087596,1,1
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.022165,0.058686,0.056323,1,1
4,GO CHROMOSOME ORGANIZATION,0.0064317,0.051776,0.049927,1,1
4,GO REGULATION OF RNA SPLICING,0.015203,0.049972,0.066448,1,1
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.038561,0.043834,0.075848,1,1
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.034637,0.039878,0.045885,1,1
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.02843,0.03155,0.069958,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.007729,0.31309,0.25485,1,0
4,GO TRACHEA MORPHOGENESIS,0.0023671,0.27079,0.28527,1,0
4,GO NEPHRON TUBULE FORMATION,0.017969,0.25361,0.27858,1,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.027188,0.23165,0.13623,1,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0051916,0.20791,0.22196,1,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.0064317,0.20714,0.20239,1,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.036164,0.19399,0.19809,1,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.024288,0.17833,0.10187,1,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.015953,0.1741,0.20719,1,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.02843,0.15219,0.11988,1,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.020205,0.14146,0.11192,1,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.013139,0.11997,0.10009,1,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.019739,0.11677,0.18028,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0054795,0.11093,0.093532,1,0
4,GO REGULATION OF MRNA PROCESSING,0.009256,0.099215,0.085202,1,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.034637,0.095912,0.1123,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.030383,0.090288,0.11555,1,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.026586,0.081136,0.070542,1,0
4,GO CELLULAR RESPONSE TO UV,0.047551,0.060043,0.069291,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.03245,0.052038,0.066184,1,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.042857,0.045671,0.063542,1,0
4,GO HUMORAL IMMUNE RESPONSE,0.03939,-0.031805,-0.11426,1,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.042857,-0.046788,-0.17194,1,0
4,GO ANTIMICROBIAL HUMORAL RESPONSE,0.035393,-0.050076,-0.12605,1,0
4,GO SECRETION,0.015953,-0.056414,-0.089946,1,0
4,GO DNA BIOSYNTHETIC PROCESS,0.034637,-0.058374,-0.057253,1,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.033166,-0.058691,-0.072942,1,0
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.046579,-0.060037,-0.080627,1,0
4,GO DETECTION OF STIMULUS,0.031059,-0.061012,-0.055114,1,0
4,GO NEGATIVE REGULATION OF TRANSPORT,0.03245,-0.061193,-0.064868,1,0
4,GO GLYCEROLIPID METABOLIC PROCESS,0.037747,-0.063914,-0.076587,1,0
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.044685,-0.064227,-0.086351,1,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.010245,-0.06484,-0.084659,1,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0014738,-0.065438,-0.06179,1,0
4,GO PROTEIN CATABOLIC PROCESS,0.043763,-0.065695,-0.051816,1,0
4,GO RESPONSE TO INTERLEUKIN 1,0.042857,-0.06635,-0.1118,1,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.041093,-0.066463,-0.062947,1,0
4,GO POSITIVE REGULATION OF TRANSPORT,0.036948,-0.06652,-0.063868,1,0
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.037747,-0.06918,-0.090932,1,0
4,GO ACUTE INFLAMMATORY RESPONSE,0.033166,-0.069345,-0.17932,1,0
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.023205,-0.069396,-0.1359,1,0
4,GO RESPONSE TO ABIOTIC STIMULUS,0.014841,-0.0714,-0.071781,1,0
4,GO PIGMENTATION,0.036948,-0.071672,-0.090158,1,0
4,GO EXOCYTOSIS,0.02068,-0.073283,-0.1097,1,0
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.016734,-0.074315,-0.09534,1,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0059384,-0.074904,-0.075382,1,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.042857,-0.075104,-0.081938,1,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.040234,-0.075587,-0.064349,1,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.040234,-0.075653,-0.089214,1,0
4,GO RNA MODIFICATION,0.0057817,-0.07566,-0.11819,1,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.029068,-0.076002,-0.14647,1,0
4,GO LIPID BIOSYNTHETIC PROCESS,0.014138,-0.076332,-0.098019,1,0
4,GO HOMEOSTATIC PROCESS,0.0060989,-0.076492,-0.070742,1,0
4,GO GPI ANCHOR METABOLIC PROCESS,0.012203,-0.076665,-0.12595,1,0
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.044685,-0.077482,-0.053272,1,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.047551,-0.079533,-0.1777,1,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.03245,-0.080451,-0.10864,1,0
4,GO RESPONSE TO HORMONE,0.034637,-0.08049,-0.074408,1,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0056288,-0.081194,-0.091982,1,0
4,GO HISTONE ARGININE METHYLATION,0.014841,-0.081815,-0.1229,1,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.034637,-0.082153,-0.13157,1,0
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.046579,-0.082229,-0.16047,1,0
4,GO REGULATION OF PROTEIN BINDING,0.033166,-0.082301,-0.094236,1,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0013872,-0.08258,-0.069329,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0087944,-0.083792,-0.10479,1,0
4,GO RESPONSE TO CARBOHYDRATE,0.013465,-0.084861,-0.075392,1,0
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.041093,-0.084889,-0.13531,1,0
4,GO INORGANIC ANION TRANSPORT,0.0081404,-0.085205,-0.086649,1,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.018398,-0.085759,-0.056215,1,0
4,GO COMPLEMENT ACTIVATION,0.02166,-0.086203,-0.16326,1,0
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.009256,-0.086405,-0.1426,1,0
4,GO MYELOID LEUKOCYTE MIGRATION,0.041967,-0.086691,-0.11297,1,0
4,GO RNA METHYLATION,0.016339,-0.086781,-0.11394,1,0
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.010773,-0.087193,-0.12987,1,0
4,GO LIPID METABOLIC PROCESS,0.010245,-0.087219,-0.10377,1,0
4,GO STEROID BIOSYNTHETIC PROCESS,0.0064317,-0.087225,-0.13676,1,0
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0067808,-0.087408,-0.082346,1,0
4,GO CYTOKINE METABOLIC PROCESS,0.033894,-0.087744,-0.14295,1,0
4,GO ORGANIC ACID TRANSPORT,0.024288,-0.087957,-0.082383,1,0
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.041093,-0.088493,-0.060268,1,0
4,GO MYELOID LEUKOCYTE ACTIVATION,0.017549,-0.08851,-0.14121,1,0
4,GO MEMBRANE FUSION,0.038561,-0.088554,-0.074518,1,0
4,GO LIPID LOCALIZATION,0.02843,-0.088866,-0.10449,1,0
4,GO RESPONSE TO STARVATION,0.033894,-0.08889,-0.097209,1,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.018398,-0.089147,-0.064248,1,0
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.021165,-0.090255,-0.075643,1,0
4,GO ACTIVATION OF IMMUNE RESPONSE,0.042857,-0.090282,-0.093785,1,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.0030654,-0.090391,-0.071788,1,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.036164,-0.090514,-0.10652,1,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017137,-0.090583,-0.087801,1,0
4,GO HORMONE METABOLIC PROCESS,0.033894,-0.091093,-0.11981,1,0
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.034637,-0.091227,-0.070045,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.042857,-0.091379,-0.079304,1,0
4,GO CELLULAR KETONE METABOLIC PROCESS,0.0053338,-0.092135,-0.14418,1,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.0083534,-0.092403,-0.076985,1,0
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.011047,-0.092581,-0.097181,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.036164,-0.093145,-0.078958,1,0
4,GO CELLULAR LIPID METABOLIC PROCESS,0.0060989,-0.093408,-0.11035,1,0
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.034637,-0.09362,-0.10646,1,0
4,GO COPII COATED VESICLE BUDDING,0.0075304,-0.093727,-0.12375,1,0
4,GO MUSCLE HYPERTROPHY,0.044685,-0.094009,-0.10917,1,0
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0030654,-0.094023,-0.11996,1,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.022165,-0.094106,-0.15011,1,0
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.001872,-0.094226,-0.11513,1,0
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.030383,-0.094241,-0.072634,1,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0060989,-0.094245,-0.084445,1,0
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.023205,-0.09426,-0.15427,1,0
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0042883,-0.095035,-0.17077,1,0
4,GO STEROID METABOLIC PROCESS,0.010506,-0.095573,-0.13623,1,0
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.02268,-0.096244,-0.10707,1,0
4,GO RESPONSE TO NITROGEN COMPOUND,0.018836,-0.096387,-0.068371,1,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.025994,-0.096639,-0.071075,1,0
4,GO RESPONSE TO INSULIN,0.0099891,-0.09677,-0.087343,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.03939,-0.096934,-0.12472,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.024846,-0.096981,-0.16773,1,0
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.010506,-0.097012,-0.10645,1,0
4,GO RESPONSE TO OXYGEN LEVELS,0.02166,-0.097182,-0.10411,1,0
4,GO REGULATION OF CATABOLIC PROCESS,0.01282,-0.097196,-0.075184,1,0
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.010773,-0.097279,-0.15916,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.012203,-0.097788,-0.10925,1,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.012508,-0.098143,-0.09324,1,0
4,GO ANION TRANSPORT,0.015574,-0.098619,-0.084714,1,0
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.020205,-0.098749,-0.16768,1,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0028957,-0.098924,-0.12783,1,0
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0097392,-0.09903,-0.15115,1,0
4,GO LIVER REGENERATION,0.020205,-0.099135,-0.16209,1,0
4,GO RESPONSE TO OXIDATIVE STRESS,0.019283,-0.099289,-0.099901,1,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.024288,-0.099434,-0.14356,1,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0045306,-0.099813,-0.10405,1,0
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.045624,-0.099891,-0.084804,1,0
4,GO CERAMIDE CATABOLIC PROCESS,0.036164,-0.10014,-0.23881,1,0
4,GO RNA CATABOLIC PROCESS,0.0075304,-0.10026,-0.12878,1,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.026586,-0.10043,-0.18786,1,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.013465,-0.1009,-0.11934,1,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.01282,-0.101,-0.10793,1,0
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.012203,-0.10102,-0.12961,1,0
4,GO STEROL TRANSPORT,0.043763,-0.10117,-0.11636,1,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0059384,-0.10146,-0.1151,1,0
4,GO GOLGI VESICLE BUDDING,0.0053338,-0.10157,-0.1269,1,0
4,GO ORGANIC ANION TRANSPORT,0.012203,-0.10181,-0.094382,1,0
4,GO SINGLE FERTILIZATION,0.017969,-0.10188,-0.082271,1,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0013054,-0.10193,-0.13849,1,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0021689,-0.102,-0.14308,1,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0021062,-0.10237,-0.1269,1,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0050528,-0.10239,-0.096713,1,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017549,-0.10242,-0.11395,1,0
4,GO RESPONSE TO CORTICOSTEROID,0.03939,-0.1028,-0.12801,1,0
4,GO INTRACELLULAR TRANSPORT,0.00353,-0.10326,-0.067731,1,0
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.026586,-0.10331,-0.09082,1,0
4,GO ORGANELLE DISASSEMBLY,0.011612,-0.10347,-0.096099,1,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0025083,-0.10359,-0.094882,1,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.027803,-0.10373,-0.12028,1,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.043763,-0.10382,-0.096232,1,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.02166,-0.10385,-0.12944,1,0
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0015653,-0.10389,-0.10072,1,0
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.026586,-0.10401,-0.11334,1,0
4,GO MEMBRANE ORGANIZATION,0.0085714,-0.1043,-0.081092,1,0
4,GO RESPONSE TO MONOSACCHARIDE,0.02068,-0.10433,-0.077492,1,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.029068,-0.10443,-0.065038,1,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.018836,-0.10451,-0.091728,1,0
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.017969,-0.10484,-0.099099,1,0
4,GO SULFUR COMPOUND TRANSPORT,0.024288,-0.10505,-0.11861,1,0
4,GO PROTEIN AUTOPROCESSING,0.036164,-0.10517,-0.14929,1,0
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.001662,-0.10523,-0.14711,1,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0025083,-0.10582,-0.095194,1,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0071468,-0.10615,-0.087858,1,0
4,GO AUTOPHAGY OF MITOCHONDRION,0.015203,-0.10617,-0.11146,1,0
4,GO ALCOHOL METABOLIC PROCESS,0.0017123,-0.10624,-0.13989,1,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.011326,-0.10665,-0.17803,1,0
4,GO REGULATION OF GLUCONEOGENESIS,0.019739,-0.1067,-0.10488,1,0
4,GO ORGANELLE MEMBRANE FUSION,0.040234,-0.10673,-0.097705,1,0
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.011326,-0.10704,-0.10938,1,0
4,GO AMINE METABOLIC PROCESS,0.0081404,-0.10732,-0.11506,1,0
4,GO ORGANELLE FUSION,0.033894,-0.1078,-0.083913,1,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.016339,-0.10835,-0.15812,1,0
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0011549,-0.10851,-0.11251,1,0
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.033894,-0.10875,-0.25173,1,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0037331,-0.10878,-0.19337,1,0
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.018398,-0.1089,-0.079737,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0038387,-0.10921,-0.1222,1,0
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.041093,-0.10931,-0.11699,1,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0059384,-0.1095,-0.12191,1,0
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.02843,-0.11024,-0.13517,1,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.046579,-0.11029,-0.15287,1,0
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.013798,-0.11035,-0.079215,1,0
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.014486,-0.11047,-0.12306,1,0
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.0062634,-0.11053,-0.12407,1,0
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0031536,-0.11061,-0.1521,1,0
4,GO TRNA METHYLATION,0.0047853,-0.11117,-0.15287,1,0
4,GO CALCIUM MEDIATED SIGNALING,0.031748,-0.11124,-0.06334,1,0
4,GO REGULATION OF MYOBLAST FUSION,0.043763,-0.11141,-0.20688,1,0
4,GO CIRCULATORY SYSTEM PROCESS,0.014841,-0.11281,-0.089709,1,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.036164,-0.11323,-0.11007,1,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.00019079,-0.11333,-0.1104,1,0
4,GO ENDOTHELIAL CELL MIGRATION,0.03939,-0.11412,-0.14703,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.027188,-0.11415,-0.11418,1,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.020205,-0.11424,-0.12263,1,0
4,GO CELLULAR RESPONSE TO HEAT,0.027803,-0.11426,-0.081179,1,0
4,GO ACYLGLYCEROL HOMEOSTASIS,0.030383,-0.11431,-0.12758,1,0
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.027803,-0.11483,-0.19495,1,0
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0047853,-0.115,-0.11104,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.047551,-0.11512,-0.11053,1,0
4,GO REGULATION OF MRNA BINDING,0.026586,-0.11589,-0.17602,1,0
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.046579,-0.11601,-0.10644,1,0
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0026572,-0.11607,-0.1084,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.00067758,-0.11617,-0.12359,1,0
4,GO PROTEIN DENEDDYLATION,0.012508,-0.11621,-0.13842,1,0
4,GO CHLORIDE TRANSPORT,0.042857,-0.11625,-0.069501,1,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0025083,-0.11652,-0.14456,1,0
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.021165,-0.11659,-0.090649,1,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.024846,-0.11665,-0.074525,1,0
4,GO CHEMICAL HOMEOSTASIS,0.0020453,-0.1167,-0.097623,1,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0087944,-0.11685,-0.17199,1,0
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.046579,-0.11697,-0.085558,1,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.0081404,-0.11703,-0.13313,1,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.015574,-0.11732,-0.14707,1,0
4,GO ANDROGEN METABOLIC PROCESS,0.034637,-0.11743,-0.15516,1,0
4,GO BILE ACID METABOLIC PROCESS,0.026586,-0.11747,-0.15305,1,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.036164,-0.11769,-0.13701,1,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0057817,-0.11773,-0.11002,1,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.014486,-0.11794,-0.085672,1,0
4,GO ESTROGEN METABOLIC PROCESS,0.033166,-0.11798,-0.1408,1,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.011047,-0.11822,-0.1167,1,0
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.019739,-0.11838,-0.096291,1,0
4,GO RNA 5 END PROCESSING,0.024846,-0.11853,-0.14719,1,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.00081984,-0.11878,-0.13174,1,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.009256,-0.11962,-0.20292,1,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.0047853,-0.11966,-0.18398,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0016129,-0.11966,-0.13304,1,0
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.017137,-0.1199,-0.11626,1,0
4,GO ICOSANOID METABOLIC PROCESS,0.011047,-0.11997,-0.15882,1,0
4,GO ION TRANSPORT,0.0056288,-0.12005,-0.098976,1,0
4,GO NCRNA PROCESSING,0.015574,-0.12011,-0.14325,1,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.0085714,-0.12013,-0.1239,1,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.016734,-0.1203,-0.16564,1,0
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.00049035,-0.12077,-0.14307,1,0
4,GO TEMPERATURE HOMEOSTASIS,0.015203,-0.12087,-0.094094,1,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0059384,-0.12115,-0.13913,1,0
4,GO ANION TRANSMEMBRANE TRANSPORT,0.016734,-0.12127,-0.08179,1,0
4,GO TRANSMEMBRANE TRANSPORT,0.0028957,-0.12128,-0.097223,1,0
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.031059,-0.12139,-0.11634,1,0
4,GO TRNA METABOLIC PROCESS,0.0040578,-0.12145,-0.13864,1,0
4,GO TRICARBOXYLIC ACID CYCLE,0.0049174,-0.12168,-0.15767,1,0
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.0067808,-0.12181,-0.08793,1,0
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.046579,-0.12198,-0.10233,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.031748,-0.12204,-0.12333,1,0
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0071468,-0.12224,-0.1274,1,0
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.011612,-0.12229,-0.15706,1,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.001986,-0.12231,-0.13885,1,0
4,GO PHAGOCYTOSIS,0.024846,-0.12234,-0.12659,1,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.014486,-0.12295,-0.1397,1,0
4,GO NCRNA METABOLIC PROCESS,0.0051916,-0.12297,-0.14427,1,0
4,GO INTERFERON GAMMA PRODUCTION,0.030383,-0.12304,-0.12269,1,0
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0050528,-0.12317,-0.1028,1,0
4,GO VACUOLAR ACIDIFICATION,0.0022992,-0.12327,-0.17093,1,0
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.018836,-0.12332,-0.13329,1,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0054795,-0.12353,-0.12103,1,0
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.00090094,-0.12424,-0.11159,1,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.036164,-0.12439,-0.14549,1,0
4,GO VESICLE TARGETING,0.0040578,-0.12487,-0.1383,1,0
4,GO CELL CELL RECOGNITION,0.0027346,-0.12516,-0.16163,1,0
4,GO TRNA PROCESSING,0.0071468,-0.12523,-0.13091,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.040234,-0.12543,-0.11223,1,0
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00026003,-0.12605,-0.15431,1,0
4,GO RESPONSE TO DRUG,0.0045306,-0.1263,-0.12419,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.029068,-0.12641,-0.11294,1,0
4,GO LIPID OXIDATION,0.023205,-0.12681,-0.12697,1,0
4,GO CATION TRANSPORT,0.0060989,-0.12691,-0.10002,1,0
4,GO METAL ION TRANSPORT,0.0062634,-0.12739,-0.093466,1,0
4,GO FATTY ACID BETA OXIDATION,0.037747,-0.12756,-0.12273,1,0
4,GO REGULATION OF NECROTIC CELL DEATH,0.017549,-0.1276,-0.21663,1,0
4,GO IRON ION HOMEOSTASIS,0.0021062,-0.12762,-0.1575,1,0
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.022165,-0.12762,-0.12528,1,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.004408,-0.12781,-0.1427,1,0
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0081404,-0.12824,-0.1113,1,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.019739,-0.12827,-0.13085,1,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0045306,-0.12842,-0.12038,1,0
4,GO ION TRANSMEMBRANE TRANSPORT,0.0067808,-0.12844,-0.09701,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.027803,-0.12913,-0.13279,1,0
4,GO MITOCHONDRION ORGANIZATION,1.2454e-05,-0.12942,-0.12407,1,0
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0010206,-0.12952,-0.14049,1,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.00012964,-0.12963,-0.14691,1,0
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.011904,-0.12978,-0.14404,1,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.047551,-0.1298,-0.098794,1,0
4,GO RESPONSE TO PH,0.036948,-0.13047,-0.1395,1,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.019739,-0.13065,-0.1003,1,0
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00036427,-0.13096,-0.13263,1,0
4,GO LACTATION,0.03245,-0.13139,-0.12519,1,0
4,GO THIOESTER METABOLIC PROCESS,0.014486,-0.13156,-0.12102,1,0
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.011326,-0.13157,-0.18446,1,0
4,GO MITOCHONDRIAL TRANSPORT,7.013e-05,-0.13157,-0.11929,1,0
4,GO GLYCOLIPID CATABOLIC PROCESS,0.024846,-0.13164,-0.2763,1,0
4,GO LYTIC VACUOLE ORGANIZATION,0.009256,-0.13192,-0.13358,1,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.031748,-0.13208,-0.15621,1,0
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.02166,-0.13252,-0.15792,1,0
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0053338,-0.1326,-0.1055,1,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00081984,-0.13266,-0.16928,1,0
4,GO LIPID CATABOLIC PROCESS,0.0032441,-0.13278,-0.13829,1,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.03245,-0.13289,-0.085572,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.043763,-0.13313,-0.14689,1,0
4,GO PEPTIDYL ARGININE METHYLATION,0.011612,-0.13313,-0.13676,1,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.011047,-0.13316,-0.14271,1,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.023741,-0.13321,-0.14539,1,0
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0012662,-0.13344,-0.13221,1,0
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0022992,-0.13345,-0.14905,1,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.011904,-0.1335,-0.15807,1,0
4,GO TRNA 5 END PROCESSING,0.041093,-0.13351,-0.13192,1,0
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.022165,-0.13387,-0.20793,1,0
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.017549,-0.13398,-0.11147,1,0
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.012508,-0.13414,-0.12743,1,0
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00034072,-0.13443,-0.15556,1,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.019739,-0.13448,-0.17485,1,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.0062634,-0.13455,-0.1507,1,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.00050664,-0.13486,-0.15158,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.036164,-0.13517,-0.22288,1,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.0081404,-0.13519,-0.23416,1,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0067808,-0.13534,-0.085959,1,0
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0028141,-0.13538,-0.15069,1,0
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.015203,-0.13549,-0.10998,1,0
4,GO IMMUNOGLOBULIN SECRETION,0.017969,-0.13565,-0.18627,1,0
4,GO AMINO SUGAR CATABOLIC PROCESS,0.0028957,-0.1358,-0.21005,1,0
4,GO RRNA MODIFICATION,0.0047853,-0.1362,-0.19275,1,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.011612,-0.13646,-0.096576,1,0
4,GO CELLULAR COMPONENT DISASSEMBLY,0.0015189,-0.13648,-0.10559,1,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0017641,-0.13667,-0.13112,1,0
4,GO RESPONSE TO COLD,0.047551,-0.13669,-0.15347,1,0
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.0011549,-0.13683,-0.13226,1,0
4,GO MACROMOLECULE DEPALMITOYLATION,0.0057817,-0.13688,-0.18721,1,0
4,GO VACUOLE ORGANIZATION,0.013465,-0.13707,-0.103,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0064317,-0.13708,-0.20523,1,0
4,GO REGULATION OF FERTILIZATION,0.0017123,-0.1371,-0.21255,1,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0073363,-0.13727,-0.15626,1,0
4,GO ORGANIC ACID METABOLIC PROCESS,0.00014935,-0.13737,-0.14782,1,0
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.004408,-0.13743,-0.10147,1,0
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0049174,-0.13759,-0.12469,1,0
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0066042,-0.13774,-0.1661,1,0
4,GO MAINTENANCE OF LOCATION,0.0018173,-0.13791,-0.1237,1,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.024846,-0.13802,-0.17102,1,0
4,GO METAL ION HOMEOSTASIS,0.00063551,-0.13803,-0.1171,1,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.0053338,-0.13807,-0.11391,1,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0085714,-0.13812,-0.12859,1,0
4,GO TRNA MODIFICATION,0.0042883,-0.13821,-0.1483,1,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.014486,-0.13823,-0.21039,1,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0053338,-0.13847,-0.10606,1,0
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.038561,-0.13879,-0.16286,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0013457,-0.13925,-0.17551,1,0
4,GO TRANSITION METAL ION TRANSPORT,0.0024367,-0.13944,-0.10455,1,0
4,GO ION HOMEOSTASIS,0.00067758,-0.13956,-0.11809,1,0
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00074557,-0.13974,-0.12023,1,0
4,GO TRANSFERRIN TRANSPORT,0.0028957,-0.1398,-0.16323,1,0
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.017969,-0.13985,-0.12682,1,0
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.017137,-0.14006,-0.11591,1,0
4,GO RESPONSE TO HEAT,0.009256,-0.14021,-0.10147,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.022165,-0.14035,-0.20316,1,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.02068,-0.14068,-0.19274,1,0
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0085714,-0.14083,-0.11753,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.019739,-0.14093,-0.10836,1,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.001986,-0.14122,-0.21265,1,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.009256,-0.14129,-0.081199,1,0
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.00013917,-0.14179,-0.1466,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.02843,-0.14179,-0.17856,1,0
4,GO RESPONSE TO CAMP,0.033894,-0.14242,-0.10877,1,0
4,GO REGULATION OF VASCULAR PERMEABILITY,0.037747,-0.14276,-0.11591,1,0
4,GO RRNA METABOLIC PROCESS,0.017137,-0.14282,-0.16063,1,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.011904,-0.1429,-0.16979,1,0
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00013433,-0.14304,-0.13196,1,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.02843,-0.14324,-0.14075,1,0
4,GO RESPONSE TO PROTOZOAN,0.018398,-0.1434,-0.16905,1,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.016339,-0.14362,-0.13166,1,0
4,GO TRNA 5 LEADER REMOVAL,0.046579,-0.14368,-0.13838,1,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.021165,-0.14377,-0.1414,1,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.03939,-0.144,-0.15472,1,0
4,GO CELLULAR ION HOMEOSTASIS,0.00055855,-0.14401,-0.11211,1,0
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.023741,-0.14415,-0.099582,1,0
4,GO REGULATION OF ENDOCYTOSIS,0.023205,-0.14428,-0.094875,1,0
4,GO CHOLESTEROL EFFLUX,0.017969,-0.14452,-0.13396,1,0
4,GO ADAPTIVE THERMOGENESIS,0.012203,-0.14462,-0.10314,1,0
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0014738,-0.14483,-0.12538,1,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.041967,-0.14513,-0.14452,1,0
4,GO NECROTIC CELL DEATH,0.02166,-0.14523,-0.19788,1,0
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.024846,-0.14533,-0.17714,1,0
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.025994,-0.14575,-0.13206,1,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0071468,-0.14579,-0.11123,1,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.042857,-0.14591,-0.098869,1,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0006154,-0.14655,-0.17882,1,0
4,GO RIBOSOME BIOGENESIS,0.012508,-0.14655,-0.17451,1,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.033894,-0.1468,-0.15081,1,0
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0028141,-0.14706,-0.19431,1,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.027188,-0.14739,-0.14771,1,0
4,GO REGULATION OF AUTOPHAGY,0.0019282,-0.14741,-0.11874,1,0
4,GO SENSORY PERCEPTION OF TASTE,0.043763,-0.14745,-0.097133,1,0
4,GO PLATELET MORPHOGENESIS,0.0069616,-0.14767,-0.15132,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.044685,-0.14768,-0.19293,1,0
4,GO PEPTIDYL ARGININE N METHYLATION,0.026586,-0.14775,-0.15465,1,0
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.041093,-0.14783,-0.17783,1,0
4,GO CARBOHYDRATE HOMEOSTASIS,0.0031536,-0.14795,-0.11295,1,0
4,GO CELLULAR RESPONSE TO ATP,0.042857,-0.14808,-0.11206,1,0
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.0090226,-0.14809,-0.16367,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.02166,-0.14846,-0.14395,1,0
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0015653,-0.14863,-0.14566,1,0
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.020205,-0.14914,-0.099312,1,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.033166,-0.14986,-0.17684,1,0
4,GO RESPONSE TO CORTICOSTERONE,0.015574,-0.14999,-0.22729,1,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.029719,-0.15053,-0.17816,1,0
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00021909,-0.1506,-0.147,1,0
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0054795,-0.15061,-0.12397,1,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.00034072,-0.15091,-0.16204,1,0
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0073363,-0.15107,-0.16571,1,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0013872,-0.15119,-0.20536,1,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00040247,-0.15125,-0.16189,1,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0099891,-0.15136,-0.14425,1,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00014935,-0.15143,-0.19508,1,0
4,GO ENERGY RESERVE METABOLIC PROCESS,0.016734,-0.1516,-0.10981,1,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0057817,-0.15162,-0.17297,1,0
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0039469,-0.15176,-0.15655,1,0
4,GO RRNA METHYLATION,0.0079323,-0.15198,-0.18428,1,0
4,GO RESPONSE TO MANGANESE ION,0.025414,-0.15204,-0.16168,1,0
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0041716,-0.15208,-0.18616,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00054072,-0.15212,-0.12323,1,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.019283,-0.15242,-0.16113,1,0
4,GO MACROPHAGE ACTIVATION,0.0028957,-0.15266,-0.16449,1,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0037331,-0.15269,-0.13189,1,0
4,GO IRON ION TRANSPORT,0.0015653,-0.15286,-0.13346,1,0
4,GO EXCRETION,0.0073363,-0.15288,-0.13406,1,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0018173,-0.15304,-0.15812,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.027803,-0.15339,-0.18924,1,0
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0031536,-0.15343,-0.16671,1,0
4,GO CARBOHYDRATE METABOLIC PROCESS,0.00024286,-0.15343,-0.14571,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0049174,-0.15381,-0.1677,1,0
4,GO ORGANIC ACID CATABOLIC PROCESS,0.001228,-0.15385,-0.15559,1,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.00095906,-0.15394,-0.22792,1,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.0087944,-0.15456,-0.18496,1,0
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.01282,-0.15462,-0.15387,1,0
4,GO PEPTIDE METABOLIC PROCESS,0.00022676,-0.15462,-0.16713,1,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.017137,-0.15465,-0.20695,1,0
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.017969,-0.15472,-0.10753,1,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00012964,-0.15483,-0.16356,1,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.00044439,-0.15497,-0.12974,1,0
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0024367,-0.15534,-0.21536,1,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.02166,-0.15549,-0.16921,1,0
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.010773,-0.15568,-0.17369,1,0
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0031536,-0.15579,-0.22289,1,0
4,GO PROGESTERONE METABOLIC PROCESS,0.027188,-0.15585,-0.35588,1,0
4,GO RESPONSE TO ATP,0.0087944,-0.15595,-0.12174,1,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.030383,-0.15617,-0.16645,1,0
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.013798,-0.15637,-0.15662,1,0
4,GO GLUCOSE METABOLIC PROCESS,0.00036427,-0.15678,-0.14185,1,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.00020448,-0.15697,-0.16838,1,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.013139,-0.15725,-0.13882,1,0
4,GO FLUID TRANSPORT,0.00040247,-0.15729,-0.19686,1,0
4,GO TRANSITION METAL ION HOMEOSTASIS,0.0025817,-0.15762,-0.14602,1,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.00035231,-0.15776,-0.16387,1,0
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0030654,-0.15787,-0.17193,1,0
4,GO PROTEIN TETRAMERIZATION,0.0010859,-0.15813,-0.12297,1,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.00074557,-0.15827,-0.20185,1,0
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.013139,-0.1583,-0.16401,1,0
4,GO PLASMA MEMBRANE ORGANIZATION,0.011326,-0.1585,-0.14274,1,0
4,GO REGULATION OF ATP METABOLIC PROCESS,0.00040247,-0.15856,-0.13896,1,0
4,GO RESPONSE TO MINERALOCORTICOID,0.017969,-0.15889,-0.17124,1,0
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00011241,-0.15895,-0.14057,1,0
4,GO SCHWANN CELL DEVELOPMENT,0.0083534,-0.159,-0.1358,1,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.00045924,-0.15948,-0.13327,1,0
4,GO TRANSLATIONAL TERMINATION,0.0014738,-0.1595,-0.19758,1,0
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.031748,-0.16027,-0.10905,1,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0056288,-0.16048,-0.23238,1,0
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00040247,-0.1605,-0.14329,1,0
4,GO INTERLEUKIN 17 PRODUCTION,0.0053338,-0.16064,-0.18697,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0013457,-0.16164,-0.20122,1,0
4,GO PROTEIN TARGETING,1.8521e-05,-0.16183,-0.18732,1,0
4,GO CELLULAR HOMEOSTASIS,0.0006154,-0.16214,-0.11356,1,0
4,GO RESPONSE TO INTERLEUKIN 12,0.031748,-0.16219,-0.14432,1,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.023205,-0.16239,-0.16423,1,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0006154,-0.16267,-0.15319,1,0
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.0073363,-0.16277,-0.15618,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0041716,-0.16287,-0.2023,1,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0028957,-0.16304,-0.14092,1,0
4,GO OXIDATION REDUCTION PROCESS,7.013e-05,-0.1631,-0.16569,1,0
4,GO VITAMIN METABOLIC PROCESS,0.0015189,-0.16322,-0.15843,1,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.024846,-0.16322,-0.1754,1,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.0007696,-0.16325,-0.15166,1,0
4,GO REPRODUCTIVE BEHAVIOR,0.0039469,-0.16342,-0.18277,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.031059,-0.16354,-0.20036,1,0
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00092958,-0.16371,-0.12148,1,0
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00021167,-0.16379,-0.1487,1,0
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.014486,-0.16384,-0.22985,1,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.034637,-0.16386,-0.21526,1,0
4,GO CD40 SIGNALING PATHWAY,0.0040578,-0.16439,-0.23565,1,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.011612,-0.16453,-0.13005,1,0
4,GO STORE OPERATED CALCIUM ENTRY,0.041093,-0.16493,-0.1574,1,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00090094,-0.16512,-0.21125,1,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.019739,-0.1652,-0.11424,1,0
4,GO PHOSPHOLIPID EFFLUX,0.024288,-0.16552,-0.19917,1,0
4,GO FATTY ACID CATABOLIC PROCESS,0.0057817,-0.16569,-0.15282,1,0
4,GO PROTEIN FOLDING,1.5201e-05,-0.16608,-0.17996,1,0
4,GO ENGULFMENT OF APOPTOTIC CELL,0.02166,-0.16648,-0.15167,1,0
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,8.3127e-06,-0.16656,-0.18597,1,0
4,GO FUCOSYLATION,0.047551,-0.16701,-0.14912,1,0
4,GO BODY FLUID SECRETION,0.016734,-0.16702,-0.12166,1,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.035393,-0.1673,-0.16577,1,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0010528,-0.16786,-0.21019,1,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0030654,-0.16799,-0.21751,1,0
4,GO REGULATION OF LIGASE ACTIVITY,0.03939,-0.16812,-0.14701,1,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.027188,-0.16812,-0.26436,1,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.00013917,-0.16835,-0.15367,1,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0033369,-0.16835,-0.174,1,0
4,GO COPPER ION TRANSPORT,0.013465,-0.16858,-0.18151,1,0
4,GO PROTEIN HYDROXYLATION,0.001662,-0.16912,-0.28449,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.015203,-0.16924,-0.20596,1,0
4,GO FATTY ACID METABOLIC PROCESS,0.00074557,-0.16968,-0.15929,1,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.017969,-0.16983,-0.1555,1,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00079435,-0.16983,-0.16504,1,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.025994,-0.16994,-0.15746,1,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.019283,-0.17012,-0.23543,1,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.00029782,-0.17022,-0.16752,1,0
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0071468,-0.17054,-0.14817,1,0
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.029068,-0.17062,-0.19111,1,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.012508,-0.17065,-0.16307,1,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00054072,-0.17075,-0.16941,1,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0067808,-0.17081,-0.19398,1,0
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.0017123,-0.17118,-0.15477,1,0
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0081404,-0.17131,-0.11457,1,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,5.0683e-06,-0.17198,-0.17928,1,0
4,GO ETHER METABOLIC PROCESS,0.0060989,-0.17224,-0.21457,1,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0029794,-0.17229,-0.18607,1,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0075304,-0.17234,-0.21202,1,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.011904,-0.17261,-0.21308,1,0
4,GO ORGANIC CATION TRANSPORT,0.017969,-0.1727,-0.14342,1,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0090226,-0.17273,-0.2161,1,0
4,GO PYRUVATE METABOLIC PROCESS,6.0504e-05,-0.17318,-0.17824,1,0
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0021062,-0.17362,-0.19548,1,0
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.029068,-0.1739,-0.19863,1,0
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00034072,-0.17423,-0.14527,1,0
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00016023,-0.17433,-0.14302,1,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040247,-0.17443,-0.22831,1,0
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.038561,-0.17511,-0.17905,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0073363,-0.17524,-0.17373,1,0
4,GO RESPONSE TO ACIDIC PH,0.017137,-0.17553,-0.17699,1,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0053338,-0.17557,-0.16677,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0057817,-0.1756,-0.13436,1,0
4,GO ELECTRON TRANSPORT CHAIN,1.7806e-05,-0.17581,-0.2129,1,0
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.019283,-0.17592,-0.16202,1,0
4,GO AUTOPHAGY OF NUCLEUS,0.02843,-0.17671,-0.14624,1,0
4,GO LIPID DIGESTION,0.023741,-0.1768,-0.20891,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.017137,-0.17695,-0.1522,1,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.03939,-0.17748,-0.14277,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00031859,-0.17781,-0.16451,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.02068,-0.17809,-0.19122,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0041716,-0.17824,-0.20835,1,0
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00023468,-0.17835,-0.14467,1,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.029068,-0.17841,-0.18787,1,0
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00079435,-0.17851,-0.13126,1,0
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,4.1112e-06,-0.17856,-0.1822,1,0
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.036164,-0.17864,-0.20097,1,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.02068,-0.17874,-0.14994,1,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.0010859,-0.17882,-0.15166,1,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.014486,-0.17889,-0.20381,1,0
4,GO REGULATION OF LYASE ACTIVITY,0.011326,-0.1789,-0.16215,1,0
4,GO RENAL SODIUM EXCRETION,0.00045924,-0.17897,-0.2031,1,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.011047,-0.17902,-0.20189,1,0
4,GO MONOSACCHARIDE METABOLIC PROCESS,4.1617e-05,-0.17908,-0.17939,1,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00067758,-0.17965,-0.17596,1,0
4,GO MATURATION OF LSU RRNA,0.040234,-0.17971,-0.20156,1,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.0066042,-0.17975,-0.28527,1,0
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,1.104e-05,-0.17992,-0.18069,1,0
4,GO RESPONSE TO CHEMOKINE,0.0079323,-0.18001,-0.10981,1,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0033369,-0.18039,-0.15198,1,0
4,GO RESPONSE TO CALCIUM ION,0.0030654,-0.18093,-0.17034,1,0
4,GO PSEUDOURIDINE SYNTHESIS,0.0090226,-0.18159,-0.2216,1,0
4,GO MATURATION OF 5 8S RRNA,0.019739,-0.18202,-0.17575,1,0
4,GO MUSCLE FILAMENT SLIDING,0.0053338,-0.18215,-0.20869,1,0
4,GO MAINTENANCE OF LOCATION IN CELL,0.00031859,-0.18215,-0.15282,1,0
4,GO SULFATE TRANSPORT,0.00052342,-0.18224,-0.18223,1,0
4,GO REGULATION OF URINE VOLUME,0.016339,-0.1829,-0.13155,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0036303,-0.18291,-0.17811,1,0
4,GO RESPONSE TO DEXAMETHASONE,0.026586,-0.18297,-0.15409,1,0
4,GO OVULATION,0.03939,-0.18341,-0.15666,1,0
4,GO SEQUESTERING OF METAL ION,0.025994,-0.18358,-0.14959,1,0
4,GO APOPTOTIC CELL CLEARANCE,0.024846,-0.18409,-0.17457,1,0
4,GO MATURATION OF SSU RRNA,0.026586,-0.1844,-0.19076,1,0
4,GO DRINKING BEHAVIOR,0.0085714,-0.18449,-0.23043,1,0
4,GO POSITIVE CHEMOTAXIS,0.017969,-0.18489,-0.12836,1,0
4,GO CARBOHYDRATE CATABOLIC PROCESS,5.6174e-05,-0.18508,-0.18141,1,0
4,GO RESPONSE TO STEROL DEPLETION,0.016734,-0.1852,-0.18804,1,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0010528,-0.18524,-0.1651,1,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0085714,-0.18541,-0.22341,1,0
4,GO PIGMENT METABOLIC PROCESS,0.00052342,-0.18572,-0.21139,1,0
4,GO SECONDARY METABOLIC PROCESS,0.0007696,-0.18592,-0.24273,1,0
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.015574,-0.18602,-0.16206,1,0
4,GO MITOCHONDRIAL TRANSLATION,0.00072223,-0.18626,-0.21345,1,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0017123,-0.1866,-0.17184,1,0
4,GO ATP METABOLIC PROCESS,1.906e-06,-0.18677,-0.19085,1,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.02166,-0.1869,-0.16191,1,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.00030804,-0.18702,-0.20774,1,0
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00019753,-0.18717,-0.22351,1,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0028957,-0.18738,-0.21084,1,0
4,GO RESPONSE TO METAL ION,0.0016129,-0.18749,-0.14338,1,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,8.1192e-05,-0.18769,-0.23382,1,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.019739,-0.18801,-0.14219,1,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.017549,-0.18819,-0.16305,1,0
4,GO QUINONE METABOLIC PROCESS,0.0028141,-0.18854,-0.26726,1,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0010206,-0.18879,-0.12479,1,0
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.029068,-0.18891,-0.10981,1,0
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0015189,-0.18892,-0.14467,1,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0097392,-0.18929,-0.18401,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.03245,-0.19024,-0.20894,1,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.021165,-0.19025,-0.19182,1,0
4,GO CELLULAR RESPONSE TO DRUG,0.0028141,-0.19042,-0.14182,1,0
4,GO TETRAPYRROLE METABOLIC PROCESS,0.0028957,-0.19126,-0.18074,1,0
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00098941,-0.19128,-0.14586,1,0
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0030654,-0.19155,-0.15867,1,0
4,GO CELLULAR RESPIRATION,2.7343e-05,-0.19263,-0.22238,1,0
4,GO FOLIC ACID METABOLIC PROCESS,0.0081404,-0.1928,-0.17704,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.010506,-0.19295,-0.15264,1,0
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0062634,-0.19342,-0.15755,1,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.00022676,-0.19366,-0.21613,1,0
4,GO BEHAVIORAL RESPONSE TO PAIN,0.019739,-0.1937,-0.26877,1,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00020448,-0.1941,-0.2336,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.012203,-0.19452,-0.14456,1,0
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00026903,-0.19482,-0.15176,1,0
4,GO POLYOL METABOLIC PROCESS,0.00020448,-0.1949,-0.16403,1,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0021062,-0.19505,-0.23395,1,0
4,GO AEROBIC RESPIRATION,3.3132e-05,-0.19588,-0.22374,1,0
4,GO CELLULAR RESPONSE TO PH,0.0015189,-0.1959,-0.17322,1,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.00010845,-0.1962,-0.21744,1,0
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.00079435,-0.19632,-0.14757,1,0
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00353,-0.19641,-0.18774,1,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00022676,-0.19659,-0.23977,1,0
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.013798,-0.19689,-0.20284,1,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,2.7343e-05,-0.19695,-0.19312,1,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0046564,-0.19697,-0.23331,1,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.001228,-0.19723,-0.19719,1,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0016129,-0.19741,-0.22566,1,0
4,GO SENSORY PERCEPTION OF SMELL,1.5816e-05,-0.19762,-0.18881,1,0
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0057817,-0.19793,-0.2013,1,0
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00017186,-0.19799,-0.1999,1,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.00072223,-0.19811,-0.22914,1,0
4,GO REGULATION OF FIBRINOLYSIS,0.0042883,-0.19856,-0.28281,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00087311,-0.19945,-0.19839,1,0
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.036164,-0.19982,-0.13445,1,0
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00027832,-0.19989,-0.2699,1,0
4,GO B CELL HOMEOSTASIS,0.014138,-0.20024,-0.15156,1,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.00059588,-0.20031,-0.21366,1,0
4,GO POLYOL BIOSYNTHETIC PROCESS,6.0504e-05,-0.20049,-0.19822,1,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.00028792,-0.20071,-0.213,1,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00067758,-0.20092,-0.17651,1,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00041602,-0.20109,-0.22515,1,0
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.033166,-0.20111,-0.13958,1,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0045306,-0.20111,-0.23951,1,0
4,GO SNARE COMPLEX ASSEMBLY,0.007729,-0.20112,-0.17657,1,0
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.001662,-0.2021,-0.21273,1,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.00032948,-0.20214,-0.23453,1,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.00055855,-0.20227,-0.22137,1,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.031059,-0.20232,-0.19536,1,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0012662,-0.20281,-0.17992,1,0
4,GO SPERM EGG RECOGNITION,0.00044439,-0.20299,-0.17545,1,0
4,GO RESPONSE TO LEPTIN,0.0010206,-0.20307,-0.20936,1,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.018836,-0.20369,-0.26415,1,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0032441,-0.20385,-0.19359,1,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.009256,-0.20454,-0.18044,1,0
4,GO NADPH REGENERATION,0.015203,-0.20542,-0.18944,1,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00047456,-0.20663,-0.22617,1,0
4,GO RESPONSE TO MISFOLDED PROTEIN,0.00353,-0.20676,-0.17744,1,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.0047853,-0.20694,-0.16377,1,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0042883,-0.20799,-0.20402,1,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.001872,-0.2081,-0.16031,1,0
4,GO DIOL METABOLIC PROCESS,0.0014299,-0.20848,-0.23779,1,0
4,GO NUCLEOTIDE PHOSPHORYLATION,1.0604e-05,-0.20852,-0.20709,1,0
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,5.508e-06,-0.20854,-0.2049,1,0
4,GO PEPTIDYL HISTIDINE MODIFICATION,0.001191,-0.20875,-0.20534,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.025414,-0.2088,-0.18768,1,0
4,GO VIRAL TRANSLATION,0.014138,-0.20898,-0.20726,1,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.025994,-0.20902,-0.15219,1,0
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.023205,-0.20908,-0.32194,1,0
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.010506,-0.20919,-0.1869,1,0
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.00050664,-0.20928,-0.16734,1,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0099891,-0.20953,-0.2213,1,0
4,GO PEROXISOME ORGANIZATION,1.5201e-05,-0.20981,-0.23139,1,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00057693,-0.21133,-0.26028,1,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.018398,-0.21213,-0.14908,1,0
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,9.389e-05,-0.21228,-0.19706,1,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0039469,-0.21319,-0.24684,1,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.017969,-0.21323,-0.20533,1,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00072223,-0.2137,-0.21604,1,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0007696,-0.21439,-0.19324,1,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001986,-0.21441,-0.2405,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.015953,-0.21446,-0.17054,1,0
4,GO POSITIVE REGULATION OF HEART RATE,0.0064317,-0.21446,-0.25321,1,0
4,GO PROSTAGLANDIN SECRETION,0.012203,-0.21448,-0.17908,1,0
4,GO MYELIN MAINTENANCE,0.034637,-0.21508,-0.19306,1,0
4,GO CORTICOSTEROID HORMONE SECRETION,0.046579,-0.2151,-0.16309,1,0
4,GO KETONE BIOSYNTHETIC PROCESS,0.0006154,-0.21516,-0.23784,1,0
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0019282,-0.2152,-0.28881,1,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0025817,-0.21526,-0.18702,1,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0079323,-0.21605,-0.2138,1,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.024288,-0.2169,-0.13988,1,0
4,GO ALDITOL METABOLIC PROCESS,0.00054072,-0.21701,-0.23637,1,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0073363,-0.21707,-0.17996,1,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.00026903,-0.21734,-0.21054,1,0
4,GO ANIMAL ORGAN REGENERATION,0.0060989,-0.21747,-0.18186,1,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00018427,-0.2175,-0.20542,1,0
4,GO ACID SECRETION,0.0021689,-0.21766,-0.16138,1,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,5.2139e-05,-0.21816,-0.21713,1,0
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.02843,-0.21889,-0.27728,1,0
4,GO VIRAL GENE EXPRESSION,0.0099891,-0.21938,-0.21227,1,0
4,GO SPHINGOID METABOLIC PROCESS,0.00087311,-0.22036,-0.24049,1,0
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.019739,-0.22049,-0.28851,1,0
4,GO TRANSLATIONAL ELONGATION,5.6174e-05,-0.2208,-0.23481,1,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0021689,-0.22101,-0.22712,1,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,9.389e-05,-0.22113,-0.2338,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00084609,-0.22124,-0.19641,1,0
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.01282,-0.22132,-0.19859,1,0
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.011326,-0.22249,-0.24844,1,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00014418,-0.22349,-0.22477,1,0
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011904,-0.2238,-0.16835,1,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0087944,-0.22381,-0.3131,1,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0042883,-0.22481,-0.2888,1,0
4,GO MITOCHONDRIAL DEPOLARIZATION,0.0014299,-0.22549,-0.24749,1,0
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0027346,-0.22623,-0.20325,1,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.00019079,-0.22653,-0.17937,1,0
4,GO HEME METABOLIC PROCESS,0.0025083,-0.22653,-0.2893,1,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0001547,-0.22668,-0.23853,1,0
4,GO RETINOL METABOLIC PROCESS,0.0012662,-0.22689,-0.26341,1,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.018836,-0.22719,-0.19394,1,0
4,GO CELL REDOX HOMEOSTASIS,0.00038934,-0.2274,-0.23471,1,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0026572,-0.22779,-0.23693,1,0
4,GO OXIDATIVE PHOSPHORYLATION,1.104e-05,-0.22836,-0.25689,1,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.0090226,-0.2286,-0.19552,1,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.020205,-0.2287,-0.22217,1,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.00026903,-0.22877,-0.25443,1,0
4,GO RESPONSE TO REDOX STATE,0.0025083,-0.22883,-0.23927,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.036948,-0.22911,-0.16631,1,0
4,GO REGULATION OF CARDIAC CONDUCTION,0.0053338,-0.22915,-0.1607,1,0
4,GO GLYCINE TRANSPORT,0.015574,-0.22919,-0.28839,1,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00079435,-0.22926,-0.21155,1,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.03939,-0.2296,-0.21569,1,0
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00026903,-0.22962,-0.31472,1,0
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0087944,-0.22977,-0.25811,1,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0041716,-0.22988,-0.22092,1,0
4,GO DE NOVO PROTEIN FOLDING,3.5759e-05,-0.2303,-0.2293,1,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.033894,-0.23051,-0.26471,1,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0010206,-0.23168,-0.39222,1,0
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.00353,-0.23191,-0.38614,1,0
4,GO OXALATE TRANSPORT,1.104e-05,-0.23237,-0.25789,1,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00026903,-0.23265,-0.228,1,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.0083534,-0.23285,-0.24406,1,0
4,GO HORMONE BIOSYNTHETIC PROCESS,0.00074557,-0.23315,-0.21945,1,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0039469,-0.23318,-0.2,1,0
4,GO TRANSLATIONAL INITIATION,0.0031536,-0.23391,-0.25792,1,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.001872,-0.23402,-0.23154,1,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0083534,-0.23412,-0.22253,1,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0034322,-0.23425,-0.2342,1,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.027188,-0.23447,-0.15616,1,0
4,GO RIBOSOME ASSEMBLY,0.0033369,-0.23493,-0.27427,1,0
4,GO PEROXISOMAL TRANSPORT,2.0033e-05,-0.23508,-0.24303,1,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00087311,-0.23707,-0.25286,1,0
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00069957,-0.23734,-0.2097,1,0
4,GO AMINO ACID ACTIVATION,0.00081984,-0.23839,-0.22635,1,0
4,GO XENOBIOTIC TRANSPORT,0.00020448,-0.23909,-0.24295,1,0
4,GO CRISTAE FORMATION,0.00072223,-0.23911,-0.25484,1,0
4,GO NADP METABOLIC PROCESS,0.00013433,-0.23984,-0.25994,1,0
4,GO BICARBONATE TRANSPORT,0.0010859,-0.23988,-0.18819,1,0
4,GO COPPER ION HOMEOSTASIS,0.013798,-0.23991,-0.18691,1,0
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0053338,-0.24047,-0.2284,1,0
4,GO CYTOPLASMIC TRANSLATION,0.0028141,-0.24157,-0.27885,1,0
4,GO REGULATION OF HEART RATE,0.00050664,-0.24194,-0.21914,1,0
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0034322,-0.24213,-0.20118,1,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.034637,-0.24313,-0.12262,1,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.0047853,-0.24352,-0.21446,1,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00017796,-0.24438,-0.23515,1,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0053338,-0.24515,-0.28085,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.02843,-0.24537,-0.21509,1,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0060989,-0.24579,-0.26172,1,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,5.0226e-05,-0.24597,-0.2515,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0081404,-0.24621,-0.29176,1,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.0010528,-0.25022,-0.24031,1,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0021689,-0.25047,-0.22915,1,0
4,GO RELAXATION OF MUSCLE,0.0050528,-0.25142,-0.20216,1,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00035231,-0.25252,-0.3118,1,0
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0099891,-0.25482,-0.27123,1,0
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.019739,-0.25512,-0.23101,1,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.040234,-0.25519,-0.17644,1,0
4,GO RETINAL METABOLIC PROCESS,0.023741,-0.25577,-0.2961,1,0
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.00019753,-0.25579,-0.26164,1,0
4,GO RESPONSE TO GROWTH HORMONE,0.012203,-0.25755,-0.1937,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.00017796,-0.25911,-0.25648,1,0
4,GO RESPONSE TO PAIN,0.00032948,-0.25934,-0.30275,1,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,8.7323e-05,-0.26069,-0.23712,1,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00027832,-0.26122,-0.2935,1,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.029068,-0.26139,-0.17818,1,0
4,GO SYNAPTIC VESICLE PRIMING,0.017137,-0.26163,-0.14972,1,0
4,GO SEQUESTERING OF CALCIUM ION,0.00026003,-0.26194,-0.19843,1,0
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.010245,-0.2625,-0.21188,1,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.037747,-0.26333,-0.24056,1,0
4,GO CERAMIDE TRANSPORT,0.00034072,-0.26338,-0.275,1,0
4,GO MONOSACCHARIDE CATABOLIC PROCESS,1.7806e-05,-0.26342,-0.25158,1,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.00020448,-0.26388,-0.26474,1,0
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0049174,-0.26401,-0.37329,1,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0026572,-0.2652,-0.22448,1,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,1.1964e-05,-0.267,-0.27131,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.004408,-0.26783,-0.22725,1,0
4,GO PENTOSE METABOLIC PROCESS,0.00016595,-0.26889,-0.31401,1,0
4,GO KERATAN SULFATE METABOLIC PROCESS,0.0001547,-0.27013,-0.27701,1,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.011612,-0.27061,-0.31006,1,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0097392,-0.27288,-0.29393,1,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0085714,-0.27467,-0.19074,1,0
4,GO AMINE TRANSPORT,0.014841,-0.27468,-0.14997,1,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.012203,-0.27481,-0.22217,1,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.00014935,-0.27487,-0.25177,1,0
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00081984,-0.2751,-0.27281,1,0
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00079435,-0.27516,-0.31252,1,0
4,GO GALACTOSE METABOLIC PROCESS,0.0032441,-0.27522,-0.29898,1,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.015203,-0.27526,-0.24354,1,0
4,GO IMP METABOLIC PROCESS,0.001662,-0.27583,-0.31882,1,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.045624,-0.27618,-0.21475,1,0
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,2.6307e-05,-0.27619,-0.26945,1,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.029068,-0.27641,-0.24726,1,0
4,GO MONOAMINE TRANSPORT,0.013798,-0.2768,-0.15531,1,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00072223,-0.27687,-0.33622,1,0
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.004408,-0.27764,-0.2146,1,0
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0041716,-0.28303,-0.32036,1,0
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00014418,-0.28312,-0.31017,1,0
4,GO HEXOSE CATABOLIC PROCESS,1.5201e-05,-0.28341,-0.27929,1,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0087944,-0.28353,-0.24419,1,0
4,GO STEROID ESTERIFICATION,0.0032441,-0.2849,-0.31549,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0027346,-0.28586,-0.28863,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0027346,-0.28597,-0.35594,1,0
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00010092,-0.28603,-0.27037,1,0
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00037661,-0.28736,-0.34321,1,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,1.349e-05,-0.28755,-0.26236,1,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.03939,-0.28852,-0.21929,1,0
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0047853,-0.28883,-0.2359,1,0
4,GO MATURE B CELL DIFFERENTIATION,0.00092958,-0.2889,-0.27224,1,0
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0097392,-0.28966,-0.24207,1,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.001228,-0.29137,-0.26999,1,0
4,GO SIGNAL PEPTIDE PROCESSING,0.00081984,-0.29349,-0.28083,1,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,7.013e-05,-0.29399,-0.26312,1,0
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.007729,-0.29417,-0.30444,1,0
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0014299,-0.29442,-0.30644,1,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,8.4205e-05,-0.29447,-0.31029,1,0
4,GO RESPONSE TO GONADOTROPIN,6.5149e-05,-0.2955,-0.29417,1,0
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0013872,-0.2958,-0.25598,1,0
4,GO VITAMIN TRANSPORT,6.0504e-05,-0.29606,-0.26543,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.012508,-0.29615,-0.2181,1,0
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.03245,-0.29755,-0.2411,1,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0011199,-0.29838,-0.24612,1,0
4,GO LIPID IMPORT INTO CELL,0.00047456,-0.30009,-0.2687,1,0
4,GO INCLUSION BODY ASSEMBLY,0.015203,-0.30127,-0.21491,1,0
4,GO POSITIVE REGULATION OF FERTILIZATION,0.0029794,-0.30209,-0.28186,1,0
4,GO STEROL IMPORT,0.0007696,-0.30273,-0.29571,1,0
4,GO GLUTATHIONE METABOLIC PROCESS,0.00013433,-0.30312,-0.32606,1,0
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0010528,-0.30329,-0.29994,1,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.02843,-0.30362,-0.27432,1,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0023671,-0.30556,-0.31345,1,0
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.013798,-0.30603,-0.25544,1,0
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.017137,-0.30631,-0.24085,1,0
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.047551,-0.3073,-0.27617,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.017549,-0.3087,-0.27797,1,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.025414,-0.30885,-0.25756,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00040247,-0.3091,-0.28906,1,0
4,GO NUCLEOTIDE SALVAGE,0.00028792,-0.30913,-0.37035,1,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.00047456,-0.30955,-0.28866,1,0
4,GO CATECHOLAMINE SECRETION,0.015574,-0.30977,-0.16857,1,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.018398,-0.3114,-0.25874,1,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.00017186,-0.31205,-0.33011,1,0
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.0090226,-0.31208,-0.33657,1,0
4,GO L SERINE METABOLIC PROCESS,0.031059,-0.3124,-0.21887,1,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,8.7323e-05,-0.31308,-0.33323,1,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00014418,-0.31332,-0.3666,1,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.0019282,-0.31389,-0.37517,1,0
4,GO VASODILATION,0.00059588,-0.31409,-0.30481,1,0
4,GO CYSTEINE METABOLIC PROCESS,0.0010859,-0.31475,-0.4005,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0021689,-0.31499,-0.26295,1,0
4,GO GLUCOSE CATABOLIC PROCESS,2.8418e-05,-0.31527,-0.32825,1,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0067808,-0.3153,-0.23644,1,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00044439,-0.3156,-0.32908,1,0
4,GO ESTROGEN BIOSYNTHETIC PROCESS,3.1888e-05,-0.31632,-0.34919,1,0
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,1.104e-05,-0.31633,-0.32923,1,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.014138,-0.31855,-0.34874,1,0
4,GO REGULATION OF CELLULAR RESPIRATION,5.6174e-05,-0.31878,-0.28511,1,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,7.013e-05,-0.32077,-0.29133,1,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0025817,-0.32174,-0.29855,1,0
4,GO NAD METABOLIC PROCESS,1.2454e-05,-0.32219,-0.33912,1,0
4,GO PLASMINOGEN ACTIVATION,0.0021689,-0.3224,-0.32349,1,0
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.001872,-0.32302,-0.30061,1,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0042883,-0.32367,-0.36923,1,0
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00032948,-0.32749,-0.39796,1,0
4,GO ARGININE METABOLIC PROCESS,0.024288,-0.32767,-0.24368,1,0
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00069957,-0.32801,-0.29282,1,0
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,7.8282e-05,-0.32816,-0.33409,1,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.00092958,-0.32852,-0.3905,1,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.00031859,-0.32943,-0.32925,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.019739,-0.33084,-0.29595,1,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0017123,-0.3317,-0.38037,1,0
4,GO L PHENYLALANINE METABOLIC PROCESS,7.013e-05,-0.33239,-0.41146,1,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,8.1192e-05,-0.33918,-0.35964,1,0
4,GO GAS TRANSPORT,0.0046564,-0.34142,-0.32056,1,0
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00040247,-0.34331,-0.3468,1,0
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0020453,-0.34984,-0.296,1,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,5.2139e-05,-0.35096,-0.36965,1,0
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00035231,-0.35127,-0.36465,1,0
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00055855,-0.35636,-0.38174,1,0
4,GO AMP METABOLIC PROCESS,3.4421e-05,-0.3574,-0.37659,1,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.0007696,-0.36499,-0.41486,1,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00059588,-0.3652,-0.3987,1,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.013798,-0.37138,-0.3251,1,0
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00032948,-0.37571,-0.32683,1,0
4,GO DOPAMINE TRANSPORT,0.0062634,-0.376,-0.27053,1,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,5.8301e-05,-0.37719,-0.37364,1,0
4,GO MITOCHONDRIAL TRANSCRIPTION,4.2876e-06,-0.37955,-0.39815,1,0
4,GO CATECHOLAMINE UPTAKE,0.00049035,-0.3842,-0.35261,1,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.011047,-0.3852,-0.34346,1,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.013465,-0.38585,-0.22952,1,0
4,GO REGULATION OF DOPAMINE SECRETION,0.014486,-0.38705,-0.2809,1,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0041716,-0.39817,-0.28019,1,0
4,GO FRUCTOSE METABOLIC PROCESS,0.00026003,-0.39836,-0.49841,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,1.7118e-05,-0.40135,-0.40287,1,0
4,GO ADHESION OF SYMBIONT TO HOST,0.00067758,-0.40454,-0.35705,1,0
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00098941,-0.4047,-0.48911,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00018427,-0.4062,-0.43999,1,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,1.1776e-06,-0.4074,-0.39484,1,0
4,GO RESPONSE TO EPINEPHRINE,0.01282,-0.40798,-0.31948,1,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,9.7346e-05,-0.41254,-0.34086,1,0
4,GO NEURON REMODELING,0.00065623,-0.41418,-0.39688,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00023468,-0.4219,-0.43688,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,2.7343e-05,-0.42268,-0.48383,1,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.00059588,-0.42544,-0.43668,1,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00020448,-0.42645,-0.4436,1,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00040247,-0.42982,-0.36415,1,0
4,GO OXYGEN TRANSPORT,0.0025083,-0.45491,-0.4535,1,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,4.6623e-06,-0.45699,-0.46508,1,0
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.015574,-0.46151,-0.35674,1,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,5.4121e-05,-0.47739,-0.39171,1,0
4,GO CYCLOOXYGENASE PATHWAY,1.9904e-06,-0.48337,-0.62872,1,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.00047456,-0.53306,-0.52995,1,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0014299,-0.54993,-0.51746,1,0
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00027832,-0.63295,-0.57097,1,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.16032,0.48533,0.18018,0,1
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.064293,0.35991,0.224,0,1
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.05824,0.33139,0.19798,0,1
4,GO RESPONSE TO MUSCLE INACTIVITY,0.10845,0.33098,0.14415,0,1
4,GO BRONCHUS DEVELOPMENT,0.080955,0.28816,0.17683,0,1
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.088862,0.26878,0.19188,0,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.05824,0.25736,0.20244,0,1
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.32077,0.25288,0.11051,0,1
4,GO PROSTATIC BUD FORMATION,0.17934,0.24818,0.25321,0,1
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.23937,0.2322,0.17742,0,1
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.12908,0.23213,0.16778,0,1
4,GO PROSTATE GLAND GROWTH,0.21905,0.22328,0.11096,0,1
4,GO KERATINOCYTE PROLIFERATION,0.099158,0.21869,0.15186,0,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.36991,0.21703,0.057369,0,1
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.30815,0.21684,0.068384,0,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.070855,0.2139,0.20566,0,1
4,GO EPIDERMIS MORPHOGENESIS,0.04854,0.21058,0.15489,0,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.19095,0.20621,0.093494,0,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.20621,0.20618,0.09964,0,1
4,GO HEART VALVE FORMATION,0.27227,0.20444,0.12389,0,1
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.17934,0.20338,0.16323,0,1
4,GO GONADOTROPIN SECRETION,0.21579,0.19876,0.15632,0,1
4,GO DORSAL AORTA DEVELOPMENT,0.05161,0.19826,0.18564,0,1
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.05161,0.19823,0.1478,0,1
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.26098,0.19431,0.11742,0,1
4,GO LEFT RIGHT PATTERN FORMATION,0.04854,0.19384,0.14642,0,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.065563,0.19295,0.2115,0,1
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.10096,0.18736,0.13086,0,1
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.14048,0.18155,0.14688,0,1
4,GO MESODERMAL CELL FATE SPECIFICATION,0.19695,0.18005,0.1162,0,1
4,GO MESODERMAL CELL FATE COMMITMENT,0.16559,0.17785,0.1262,0,1
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.12908,0.17694,0.1335,0,1
4,GO RENAL FILTRATION,0.17099,0.17624,0.163,0,1
4,GO PERICARDIUM DEVELOPMENT,0.20309,0.17235,0.16218,0,1
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.059411,0.16637,0.20208,0,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.059411,0.16577,0.145,0,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.19393,0.15732,0.11976,0,1
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.25001,0.15596,0.067021,0,1
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.095625,0.15147,0.14493,0,1
4,GO NEURAL TUBE DEVELOPMENT,0.070855,0.15012,0.1101,0,1
4,GO ADHERENS JUNCTION ASSEMBLY,0.188,0.14989,0.12552,0,1
4,GO ACTIVATION OF JNKK ACTIVITY,0.16294,0.14933,0.10734,0,1
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.27227,0.14719,0.13597,0,1
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.12259,0.14586,0.12842,0,1
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.36526,0.13997,0.06345,0,1
4,GO MITOTIC RECOMBINATION,0.12259,0.13929,0.082649,0,1
4,GO CONVERGENT EXTENSION,0.057089,0.1374,0.17506,0,1
4,GO ACTIVATION OF MAPKK ACTIVITY,0.050569,0.1373,0.099724,0,1
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.052669,0.13336,0.11767,0,1
4,GO SPLEEN DEVELOPMENT,0.070855,0.13125,0.10641,0,1
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.061812,0.13005,0.17601,0,1
4,GO REGULATION OF EXIT FROM MITOSIS,0.049546,0.12879,0.1256,0,1
4,GO RESPONSE TO VITAMIN,0.088862,0.12801,0.13626,0,1
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.11434,0.12517,0.090607,0,1
4,GO INTERLEUKIN 2 PRODUCTION,0.46512,0.11713,0.034875,0,1
4,GO REGULATION OF GLIOGENESIS,0.059411,0.11659,0.081739,0,1
4,GO TUMOR NECROSIS FACTOR SECRETION,0.1028,0.11519,0.072505,0,1
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.30402,0.11444,0.073991,0,1
4,GO NEUROBLAST PROLIFERATION,0.057089,0.11356,0.12073,0,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.066855,0.11332,0.10313,0,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.36991,0.11203,0.095164,0,1
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.087232,0.1101,0.12359,0,1
4,GO REGULATION OF HEART GROWTH,0.48131,0.10717,0.06125,0,1
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.085627,0.10607,0.094828,0,1
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0695,0.10604,0.072307,0,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.059411,0.10471,0.055061,0,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.29184,0.10304,0.052371,0,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.42347,0.10265,0.03339,0,1
4,GO PROSTATE GLAND DEVELOPMENT,0.16828,0.10099,0.188,0,1
4,GO COCHLEA DEVELOPMENT,0.15517,0.10098,0.11834,0,1
4,GO HISTONE H3 K9 ACETYLATION,0.073629,0.10051,0.1002,0,1
4,GO DNA STRAND ELONGATION,0.063042,0.099172,0.088061,0,1
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.10096,0.098786,0.059488,0,1
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.05161,0.098749,0.077153,0,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.15517,0.097322,0.064903,0,1
4,GO HISTONE H2A ACETYLATION,0.079444,0.096795,0.084767,0,1
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.05824,0.095776,0.11066,0,1
4,GO RESPONSE TO UV C,0.14048,0.094661,0.082501,0,1
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.05824,0.09446,0.086157,0,1
4,GO POSITIVE REGULATION OF DNA BINDING,0.049546,0.093619,0.1006,0,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.076492,0.093492,0.099618,0,1
4,GO TUBE FORMATION,0.14769,0.093106,0.085864,0,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.13355,0.087002,0.088335,0,1
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.11636,0.086903,0.099928,0,1
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.11434,0.086174,0.13073,0,1
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.080955,0.085851,0.088921,0,1
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.17099,0.085515,0.083584,0,1
4,GO APPENDAGE DEVELOPMENT,0.059411,0.085449,0.1288,0,1
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.097379,0.0835,0.055126,0,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.32938,0.080861,0.063192,0,1
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.076492,0.079977,0.094831,0,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.054842,0.078982,0.095751,0,1
4,GO SPECIFICATION OF SYMMETRY,0.064293,0.076622,0.079879,0,1
4,GO REGULATION OF PROTEIN ACETYLATION,0.066855,0.072935,0.064804,0,1
4,GO REGULATION OF ORGAN GROWTH,0.63978,0.071756,0.032277,0,1
4,GO DNA REPLICATION CHECKPOINT,0.39858,0.071161,0.0544,0,1
4,GO P BODY ASSEMBLY,0.079444,0.071022,0.062062,0,1
4,GO NEURON PROJECTION GUIDANCE,0.14769,0.069209,0.091461,0,1
4,GO ENDOCRINE HORMONE SECRETION,0.72313,0.067898,0.0038592,0,1
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.04854,0.065564,0.088313,0,1
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.21905,0.065489,0.048281,0,1
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.17099,0.064132,0.10393,0,1
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.053746,0.063885,0.062141,0,1
4,GO SPINDLE LOCALIZATION,0.20621,0.057949,0.060585,0,1
4,GO INTERSTRAND CROSS LINK REPAIR,0.11434,0.057215,0.056554,0,1
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.04854,0.055395,0.059092,0,1
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.060602,0.055345,0.043106,0,1
4,GO DOUBLE STRAND BREAK REPAIR,0.049546,0.053348,0.046627,0,1
4,GO REGULATION OF HISTONE MODIFICATION,0.065563,0.050881,0.059532,0,1
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.14769,0.044813,0.035557,0,1
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.27999,0.044062,0.04688,0,1
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.53742,0.042101,0.042257,0,1
4,GO CELL DIVISION,0.097379,0.041505,0.044858,0,1
4,GO MITOTIC NUCLEAR DIVISION,0.10096,0.040738,0.053734,0,1
4,GO SPINDLE ASSEMBLY,0.37932,0.039973,0.023655,0,1
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.11235,0.038817,0.053666,0,1
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.16828,0.035702,0.035308,0,1
4,GO DNA REPLICATION,0.11841,0.030547,0.044765,0,1
4,GO PROTEIN SUMOYLATION,0.63354,0.026822,0.012938,0,1
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.00012074,0.57871,0.59657,0,0
4,GO GLIAL CELL FATE COMMITMENT,0.026586,0.36075,0.31318,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.064293,0.34813,0.28464,0,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.085627,0.33983,0.23848,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.0050528,0.32523,0.32655,0,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.47588,0.31644,0.014546,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0028957,0.31484,0.39169,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.082489,0.30818,0.28459,0,0
4,GO FOREBRAIN MORPHOGENESIS,0.0064317,0.29587,0.23111,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.082489,0.2936,0.22694,0,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.017137,0.28332,0.29426,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0031536,0.27983,0.24582,0,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.02166,0.27848,0.31399,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.099158,0.27306,0.28291,0,0
4,GO LUNG CELL DIFFERENTIATION,0.037747,0.25663,0.28547,0,0
4,GO CELL FATE DETERMINATION,0.015953,0.25319,0.20549,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.085627,0.24756,0.17453,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.34256,0.24586,0.093786,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.016734,0.24556,0.42666,0,0
4,GO SEGMENT SPECIFICATION,0.085627,0.24515,0.18898,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.033894,0.24406,0.18508,0,0
4,GO CARDIAC CHAMBER FORMATION,0.013139,0.24301,0.3424,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.12049,0.24147,0.22788,0,0
4,GO LUNG MORPHOGENESIS,0.095625,0.23944,0.14773,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.031059,0.22851,0.2879,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.046579,0.22564,0.27265,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.027803,0.2254,0.27584,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.061812,0.22376,0.18771,0,0
4,GO CARDIAC VENTRICLE FORMATION,0.017549,0.22357,0.35177,0,0
4,GO REGULATORY T CELL DIFFERENTIATION,0.011904,0.22048,0.18532,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.36991,0.21839,0.13416,0,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.050569,0.21621,0.28753,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.10096,0.21532,0.16989,0,0
4,GO RESPONSE TO INTERFERON ALPHA,0.34702,0.21467,0.034446,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.26098,0.21417,0.12614,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.23937,0.21229,0.24935,0,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.0028141,0.21042,0.22465,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0695,0.20949,0.26589,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.12473,0.20521,0.22784,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.066855,0.20389,0.18467,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.013465,0.20371,0.2521,0,0
4,GO SEX DETERMINATION,0.030383,0.20354,0.1744,0,0
4,GO ADENOHYPOPHYSIS DEVELOPMENT,0.35153,0.2016,0.14764,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.007729,0.19875,0.14517,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.66501,0.19811,0.0020144,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.052669,0.1966,0.15039,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.042857,0.19599,0.23564,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.41341,0.1946,0.051399,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.23589,0.19366,0.34356,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.055956,0.19274,0.23031,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00095906,0.19033,0.35086,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.12049,0.18703,0.14286,0,0
4,GO THYROID GLAND DEVELOPMENT,0.12689,0.18623,0.14366,0,0
4,GO PRO B CELL DIFFERENTIATION,0.22905,0.18523,0.10818,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.04854,0.18481,0.11213,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.022165,0.18363,0.1647,0,0
4,GO REGULATION OF PLATELET AGGREGATION,0.38408,0.18176,0.10798,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.26847,0.18147,0.13935,0,0
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0023671,0.17955,0.34481,0,0
4,GO NOSE DEVELOPMENT,0.012203,0.17926,0.39067,0,0
4,GO EPITHELIAL CELL CELL ADHESION,0.24288,0.17904,0.13303,0,0
4,GO TRANSPOSITION,0.27227,0.17888,0.10193,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.099158,0.1763,0.13655,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.040234,0.17604,0.16268,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.19393,0.17433,0.16325,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.021165,0.17364,0.28798,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.021165,0.1727,0.21198,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.16559,0.17233,0.16771,0,0
4,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.22235,0.16985,0.082248,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.023741,0.16799,0.19442,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.095625,0.16771,0.086977,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.016734,0.16696,0.20251,0,0
4,GO SIALYLATION,0.1028,0.16682,0.15827,0,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.20621,0.16612,0.16063,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.16828,0.16499,0.1712,0,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.044685,0.16496,0.24243,0,0
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.066855,0.16455,0.12848,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.04854,0.16291,0.23498,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.092194,0.16199,0.079588,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.12259,0.16153,0.1664,0,0
4,GO MIDGUT DEVELOPMENT,0.17099,0.16141,0.13451,0,0
4,GO GROWTH HORMONE SECRETION,0.029068,0.16052,0.18938,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.15517,0.15984,0.14846,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.041967,0.15689,0.1873,0,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.0075304,0.15588,0.16207,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.36064,0.15564,0.17268,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.33373,0.15472,0.12126,0,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.088862,0.15412,0.17327,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.17934,0.15406,0.13386,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.35153,0.15342,0.062465,0,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.079444,0.15266,0.09142,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.0047853,0.1525,0.1825,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.15264,0.15121,0.12408,0,0
4,GO SKIN MORPHOGENESIS,0.11434,0.15119,0.2154,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.037747,0.15113,0.20656,0,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.20309,0.15031,0.10662,0,0
4,GO RESPONSE TO FOOD,0.0029794,0.15017,0.13215,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.30815,0.14929,0.054196,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.50337,0.14886,0.060528,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.090515,0.14848,0.32398,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.063042,0.14737,0.17661,0,0
4,GO MUSCLE CELL FATE COMMITMENT,0.31653,0.14703,0.12704,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.26847,0.14685,0.104,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.15773,0.14665,0.059543,0,0
4,GO HIPPO SIGNALING,0.14769,0.14655,0.11743,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.12049,0.1461,0.13781,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.10845,0.14569,0.13699,0,0
4,GO HEART FORMATION,0.15773,0.14522,0.14083,0,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.70355,0.14481,-0.0044152,0,0
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.1313,0.14445,0.13566,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.075049,0.14385,0.092905,0,0
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.068167,0.14359,0.071806,0,0
4,GO REGULATION OF B CELL DIFFERENTIATION,0.082489,0.14286,0.13858,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.14526,0.14229,0.070269,0,0
4,GO GDP METABOLIC PROCESS,0.24643,0.14192,0.093756,0,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.16294,0.14109,0.23414,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.16828,0.14102,0.10334,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.015574,0.14032,0.14206,0,0
4,GO REGULATION OF ODONTOGENESIS,0.04854,0.13864,0.14426,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.10096,0.13827,0.13874,0,0
4,GO REGULATION OF TRANSPOSITION,0.36526,0.13798,0.076646,0,0
4,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.097379,0.13735,0.22301,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1,0.13723,0.0022848,0,0
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.070855,0.13568,0.099575,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.18219,0.13565,0.086411,0,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.188,0.13541,0.081683,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.055956,0.13529,0.13675,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.11235,0.1352,0.2395,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.073629,0.13452,0.15589,0,0
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.64605,0.13344,0.022888,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.26471,0.13299,0.10241,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.10845,0.13258,0.1633,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.31232,0.13174,0.07363,0,0
4,GO HORMONE CATABOLIC PROCESS,0.56666,0.13157,0.042569,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.14285,0.13144,0.049784,0,0
4,GO RESPONSE TO INACTIVITY,0.76948,0.13107,-0.038776,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.043763,0.13029,0.091588,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.33373,0.13027,0.078912,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.13583,0.12973,0.13958,0,0
4,GO RESPONSE TO FORSKOLIN,0.50896,0.12906,0.084584,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.27999,0.12849,0.076555,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.14769,0.12785,0.085036,0,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.48678,0.12745,0.036799,0,0
4,GO G0 TO G1 TRANSITION,0.0024367,0.12635,0.13553,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.33812,0.12585,0.049141,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.10845,0.12573,0.18433,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.093897,0.1257,0.11538,0,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.013139,0.12543,0.15758,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.10654,0.12503,0.17445,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.027803,0.12502,0.30875,0,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.099158,0.12459,0.091472,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.26471,0.12382,0.21079,0,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.52025,0.12379,0.027041,0,0
4,GO GENETIC IMPRINTING,0.05824,0.12355,0.10694,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.4978,0.12324,0.10603,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.079444,0.1231,0.15572,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.26471,0.1224,0.077087,0,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.26098,0.12216,0.073307,0,0
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.16559,0.12208,0.13313,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.10096,0.12195,0.17303,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.011612,0.12189,0.21458,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.16828,0.12187,0.15163,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.44924,0.12163,0.051826,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.13355,0.12158,0.1161,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.046579,0.12146,0.1371,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.17653,0.12131,0.077963,0,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.13355,0.12099,0.14562,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.04854,0.12041,0.10081,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.98255,0.11931,-7.3593e-05,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.027188,0.11918,0.11004,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.188,0.11904,0.09507,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.52025,0.11861,0.034352,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.65866,0.11811,0.026142,0,0
4,GO PROTEIN DEMETHYLATION,0.027188,0.11787,0.1446,0,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0083534,0.11776,0.13413,0,0
4,GO PLACENTA DEVELOPMENT,0.20937,0.1175,0.067847,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.068167,0.11603,0.16578,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.082489,0.11551,0.15218,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.088862,0.11513,0.069855,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.46512,0.11495,0.056275,0,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.67137,0.11493,-0.033725,0,0
4,GO ERYTHROCYTE MATURATION,0.27227,0.11485,0.046964,0,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.23245,0.11447,0.11812,0,0
4,GO MEMBRANE FISSION,0.066855,0.11443,0.16858,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.080955,0.11413,0.14496,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.26098,0.11411,0.066729,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.02268,0.114,0.12911,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.50337,0.11394,0.013567,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.043763,0.11384,0.2926,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.51459,0.11254,0.068479,0,0
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.11841,0.11232,0.084217,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.14048,0.112,0.16592,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.097379,0.11145,0.10596,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.016339,0.11143,0.12187,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.064293,0.11134,0.12821,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.80989,0.11133,-0.037584,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0099891,0.1111,0.16527,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.83713,0.11069,0.064026,0,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.2839,0.11038,0.060819,0,0
4,GO COCHLEA MORPHOGENESIS,0.70355,0.11011,0.054254,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.023205,0.10964,0.17931,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.47049,0.10956,0.05447,0,0
4,GO NEURAL TUBE FORMATION,0.14526,0.10944,0.097382,0,0
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.10465,0.10919,0.074073,0,0
4,GO HISTONE H2A UBIQUITINATION,0.0066042,0.10909,0.11639,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.11841,0.10885,0.086851,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.20937,0.10853,0.12359,0,0
4,GO RETINA LAYER FORMATION,0.15264,0.10808,0.15283,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.022165,0.10776,0.13101,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.40349,0.10764,0.15487,0,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.029719,0.10758,0.16547,0,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.016734,0.10721,0.12341,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.080955,0.10659,0.25029,0,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.23589,0.10659,0.11576,0,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.2839,0.10659,0.05408,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.077957,0.10657,0.14263,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.2,0.10621,0.1296,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.090515,0.10608,0.14588,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.17374,0.10599,0.20715,0,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.60272,0.10574,0.027177,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.30402,0.10528,0.044593,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.36064,0.10526,0.17361,0,0
4,GO INSEMINATION,0.30402,0.10518,0.081087,0,0
4,GO INTRACILIARY TRANSPORT,0.076492,0.10474,0.12856,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.28785,0.10461,0.038467,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.04854,0.10459,0.15496,0,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.25729,0.10399,0.077416,0,0
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.73628,0.10347,0.0082278,0,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.04854,0.10329,0.094004,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.9686,0.10294,-0.037075,0,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.51459,0.10293,0.042436,0,0
4,GO ADULT HEART DEVELOPMENT,0.40349,0.10289,0.032652,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.070855,0.10284,0.19499,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.20621,0.10252,0.18821,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.40843,0.1025,0.10995,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.56075,0.10202,0.063881,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.13814,0.10191,0.18431,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.14285,0.10186,0.1258,0,0
4,GO DNA LIGATION,0.41842,0.10095,0.055084,0,0
4,GO KERATINIZATION,0.20937,0.10095,0.096277,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.12049,0.099849,0.059215,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.10845,0.099808,0.098046,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.082489,0.099691,0.1303,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.24643,0.09927,0.09073,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.12473,0.099152,0.10769,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.12689,0.099071,0.11537,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.038561,0.098557,0.074376,0,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.13355,0.098501,0.071984,0,0
4,GO RESPONSE TO NITROSATIVE STRESS,0.92682,0.09841,-0.055634,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.55487,0.098194,0.041597,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.79636,0.09783,0.054445,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.16032,0.09746,0.1487,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.093897,0.097135,0.10652,0,0
4,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.32506,0.097065,0.057794,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.20621,0.096755,0.082105,0,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.41341,0.096356,0.086809,0,0
4,GO RESPONSE TO ETHER,0.060602,0.096241,0.10974,0,0
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.15015,0.096112,0.084627,0,0
4,GO TELENCEPHALON REGIONALIZATION,0.48131,0.095681,0.087239,0,0
4,GO EPITHELIAL TUBE FORMATION,0.13355,0.095341,0.094123,0,0
4,GO SISTER CHROMATID COHESION,0.0024367,0.095162,0.13151,0,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.47049,0.094702,0.16991,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.065563,0.094422,0.1229,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.52025,0.094399,0.056955,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.47588,0.094374,0.061173,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.20621,0.094351,0.094392,0,0
4,GO INNER EAR MORPHOGENESIS,0.22235,0.094041,0.072241,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.052669,0.093346,0.14377,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.188,0.093019,0.088045,0,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.024846,0.092084,0.097987,0,0
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.98255,0.091988,-0.041788,0,0
4,GO MRNA METHYLATION,0.10845,0.091572,0.080417,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.15773,0.091225,0.11581,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.28785,0.091127,0.045227,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.063042,0.090942,0.19476,0,0
4,GO REGULATION OF GTP BINDING,0.48678,0.090477,0.062944,0,0
4,GO AORTA MORPHOGENESIS,0.19095,0.090331,0.13982,0,0
4,GO HISTONE H3 K36 METHYLATION,0.084046,0.089822,0.068306,0,0
4,GO CHROMATIN DISASSEMBLY,0.20937,0.089777,0.073728,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.71658,0.089762,-0.056556,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.30815,0.089761,0.10248,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.48678,0.08915,0.097289,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.30815,0.089138,0.1624,0,0
4,GO ASTROCYTE ACTIVATION,0.33812,0.089011,0.053928,0,0
4,GO RESPONSE TO UV B,0.46512,0.088687,0.06087,0,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.2839,0.08854,0.059476,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.33373,0.088136,0.086098,0,0
4,GO TRANSCYTOSIS,0.21579,0.088075,0.056255,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.15773,0.08786,0.084666,0,0
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.8303,0.087825,-0.059417,0,0
4,GO MRNA EXPORT FROM NUCLEUS,0.087232,0.087714,0.049571,0,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.36526,0.08769,0.17245,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.39371,0.087342,0.074072,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.3746,0.087227,0.096967,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.63978,0.086938,0.010479,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.71006,0.086867,0.0023714,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.20309,0.086414,0.060149,0,0
4,GO SEROTONIN SECRETION,0.32077,0.085979,0.094452,0,0
4,GO ER OVERLOAD RESPONSE,0.27227,0.085759,0.083226,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.31653,0.085646,0.02953,0,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.46512,0.085639,0.060096,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.30815,0.085589,0.0032455,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.49227,0.085428,0.057905,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.2,0.085135,0.073942,0,0
4,GO CELL CELL JUNCTION ORGANIZATION,0.50337,0.084995,0.042282,0,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.041967,0.084948,0.090589,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.50896,0.084662,0.10795,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.80312,0.084601,-0.044618,0,0
4,GO RESPONSE TO PROGESTERONE,0.5726,0.084591,0.025511,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.090515,0.084573,0.063981,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.063042,0.08441,0.11161,0,0
4,GO PROTEIN O LINKED MANNOSYLATION,0.35607,0.084285,0.052014,0,0
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.20621,0.084202,0.1128,0,0
4,GO UTERUS DEVELOPMENT,0.2839,0.08414,0.10046,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.64605,0.083787,0.04249,0,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.4978,0.083399,0.095814,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.52025,0.083289,0.085232,0,0
4,GO SKIN DEVELOPMENT,0.23245,0.083275,0.063673,0,0
4,GO HEPATOCYTE DIFFERENTIATION,0.88523,0.083203,-0.059088,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.21579,0.083145,0.098751,0,0
4,GO FOREGUT MORPHOGENESIS,0.25729,0.083004,0.10553,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.69061,0.082429,-0.0044259,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.36064,0.082096,0.034428,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.1313,0.081857,0.05479,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.14048,0.081689,0.097513,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.17374,0.08163,0.062567,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.27999,0.081399,0.073931,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.94073,0.081172,-0.041775,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.29992,0.081058,0.036229,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.090515,0.080985,0.10914,0,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.064293,0.080945,0.072278,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.13355,0.080921,0.072699,0,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.31232,0.080478,0.068175,0,0
4,GO OLIGODENDROCYTE DEVELOPMENT,0.13814,0.080471,0.084087,0,0
4,GO BRAIN MORPHOGENESIS,0.11235,0.080158,0.091573,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.15015,0.079987,0.062781,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.65866,0.079903,-0.05776,0,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.29586,0.079802,0.04096,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.30402,0.079102,0.070666,0,0
4,GO HISTONE H2B UBIQUITINATION,0.10654,0.079056,0.10162,0,0
4,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.20937,0.078653,0.10305,0,0
4,GO EAR DEVELOPMENT,0.29184,0.0786,0.077181,0,0
4,GO STEM CELL DIVISION,0.3746,0.078363,0.078626,0,0
4,GO PROTEIN MANNOSYLATION,0.23589,0.078265,0.07226,0,0
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.14526,0.077532,0.14212,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.19695,0.077165,0.091662,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.53742,0.077061,0.063402,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.40349,0.077044,0.094634,0,0
4,GO DNA DEMETHYLATION,0.14285,0.07699,0.084538,0,0
4,GO LEUKOCYTE AGGREGATION,0.36526,0.076693,0.0934,0,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.65234,0.076687,-0.0090724,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.17653,0.076676,0.16778,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.30402,0.076578,0.080279,0,0
4,GO MUSCLE CELL MIGRATION,0.097379,0.076557,0.13115,0,0
4,GO CELL PROLIFERATION IN FOREBRAIN,0.40843,0.076416,0.053731,0,0
4,GO BONE MATURATION,0.57857,0.076081,-0.039863,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.38408,0.07596,0.023385,0,0
4,GO IMMATURE B CELL DIFFERENTIATION,0.19095,0.075836,0.089443,0,0
4,GO MYOBLAST DIFFERENTIATION,0.25363,0.075756,0.088769,0,0
4,GO MESODERM MORPHOGENESIS,0.51459,0.075708,0.056189,0,0
4,GO DNA GEOMETRIC CHANGE,0.085627,0.075588,0.050905,0,0
4,GO FACE DEVELOPMENT,0.15015,0.075487,0.11409,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.20621,0.075432,0.068952,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.12908,0.0753,0.070605,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.047551,0.075165,0.062957,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.084046,0.075082,0.21065,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.52025,0.074809,0.025394,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.57857,0.0745,0.039116,0,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.20309,0.074494,0.21187,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.53167,0.074129,0.064461,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.27611,0.07379,0.10738,0,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.031748,0.073689,0.10565,0,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.32077,0.073116,0.039628,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.188,0.072862,0.083087,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.11039,0.072829,0.078962,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.12908,0.072644,0.11187,0,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.21256,0.072565,0.042888,0,0
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.67776,0.072399,0.01236,0,0
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.079444,0.072355,0.080772,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.084046,0.071998,0.097432,0,0
4,GO DNA REPLICATION INITIATION,0.084046,0.071969,0.073167,0,0
4,GO DNA DEAMINATION,0.48131,0.071935,0.049841,0,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.61497,0.071765,0.017717,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.29184,0.071091,0.020382,0,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.26847,0.07108,0.056674,0,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.64605,0.07098,0.02993,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.38888,0.070963,0.09831,0,0
4,GO LYMPH NODE DEVELOPMENT,0.49227,0.070948,0.030912,0,0
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.22568,0.070887,0.10851,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.22568,0.070613,0.076136,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.54321,0.070399,0.074583,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.2,0.070384,0.047717,0,0
4,GO OLIGOPEPTIDE TRANSPORT,0.68418,0.070198,0.025106,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.92682,0.070161,-0.035197,0,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.15517,0.070124,0.055576,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.52025,0.070005,0.017846,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.50896,0.069878,0.057797,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.95466,0.069238,-0.00040795,0,0
4,GO REGULATION OF HIPPO SIGNALING,0.84397,0.069185,-0.047357,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.89907,0.069152,-0.036699,0,0
4,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.31653,0.068578,0.083863,0,0
4,GO CENTRIOLE CENTRIOLE COHESION,0.11636,0.068477,0.11832,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.9686,0.068363,-0.0060626,0,0
4,GO CELL CELL JUNCTION ASSEMBLY,0.73628,0.068342,0.025509,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.35153,0.068332,0.02807,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.96163,0.068315,-0.050912,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.082489,0.068203,0.087229,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.17653,0.067728,0.05162,0,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.030383,0.067543,0.10877,0,0
4,GO GLIAL CELL APOPTOTIC PROCESS,0.32077,0.066993,0.12884,0,0
4,GO RNA DESTABILIZATION,0.2,0.066987,0.05971,0,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.065563,0.066968,0.15216,0,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.78962,0.066921,-0.059565,0,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.91987,0.066661,-0.032892,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.44402,0.066646,0.05713,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.05824,0.066463,0.043022,0,0
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.69061,0.066389,-0.0045456,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.52594,0.06592,0.020539,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.82348,0.065555,0.012118,0,0
4,GO NEURON PROJECTION REGENERATION,0.27227,0.065307,0.090926,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.53742,0.065305,0.013043,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.71006,0.065039,0.015405,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.40843,0.065022,0.10383,0,0
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.65234,0.064899,-0.063756,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.188,0.064798,0.02778,0,0
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.69061,0.064776,-0.0051184,0,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.25001,0.064655,0.055408,0,0
4,GO ARTERY MORPHOGENESIS,0.13814,0.064499,0.12134,0,0
4,GO REGULATION OF OOGENESIS,0.34256,0.064026,0.052056,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.073629,0.06395,0.062556,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.26847,0.063809,0.1057,0,0
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.87833,0.063748,-0.07097,0,0
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.85768,0.063699,-0.049674,0,0
4,GO RESPONSE TO LITHIUM ION,0.16828,0.063631,0.1764,0,0
4,GO MESODERM DEVELOPMENT,0.43367,0.06357,0.074248,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.2,0.063447,0.13515,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.21905,0.063446,0.042844,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.20621,0.063441,0.052151,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.16294,0.063426,0.084669,0,0
4,GO NATURAL KILLER CELL PROLIFERATION,0.48678,0.063307,0.083317,0,0
4,GO CHROMOSOME CONDENSATION,0.084046,0.062808,0.069161,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.73628,0.062704,0.040686,0,0
4,GO THYMIC T CELL SELECTION,0.22235,0.062466,0.054404,0,0
4,GO MITOTIC CYTOKINESIS,0.26098,0.062391,0.039636,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.48131,0.062167,0.049638,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.22905,0.062106,0.054746,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.080955,0.062052,0.085489,0,0
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.27227,0.062044,0.042087,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.20309,0.062032,0.075053,0,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.40349,0.061896,0.02831,0,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.024288,0.061754,0.096586,0,0
4,GO EPITHELIAL CELL FATE COMMITMENT,0.99651,0.061676,0.0021297,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.05824,0.061369,0.075966,0,0
4,GO DOSAGE COMPENSATION,0.05161,0.06128,0.077031,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.10465,0.060704,0.18307,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0050528,0.060547,0.10104,0,0
4,GO MALE SEX DIFFERENTIATION,0.27227,0.060496,0.054277,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.2839,0.060289,0.1735,0,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.66501,0.060248,0.057376,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.57857,0.060092,0.016333,0,0
4,GO RESPONSE TO ANTIBIOTIC,0.46512,0.059887,0.031761,0,0
4,GO HEAD MORPHOGENESIS,0.041967,0.059725,0.20246,0,0
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.48131,0.059695,0.046354,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.40349,0.059686,0.029977,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.25363,0.059684,0.034465,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.91293,0.059563,-0.02097,0,0
4,GO EPITHELIAL CELL MATURATION,0.25729,0.059458,0.1323,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.76948,0.059373,0.030241,0,0
4,GO FILOPODIUM ASSEMBLY,0.70355,0.059233,0.046339,0,0
4,GO DEMETHYLATION,0.016339,0.058928,0.088417,0,0
4,GO T CELL HOMEOSTASIS,0.65866,0.058906,0.041952,0,0
4,GO BODY MORPHOGENESIS,0.090515,0.058828,0.15123,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.16828,0.05864,0.10479,0,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.2839,0.058607,0.050425,0,0
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.35607,0.058583,0.042137,0,0
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.83713,0.058555,-0.064005,0,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.74288,0.058395,0.0081713,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.61497,0.058282,0.096864,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.10845,0.058173,0.069242,0,0
4,GO PANCREAS DEVELOPMENT,0.35153,0.058046,0.06519,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.30815,0.057875,0.035586,0,0
4,GO HISTONE H4 DEACETYLATION,0.2,0.057737,0.077478,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.1313,0.057527,0.10277,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.27611,0.057496,0.055382,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.23937,0.057371,0.07989,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.63354,0.057345,0.043015,0,0
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.62732,0.057293,-0.048341,0,0
4,GO RESPONSE TO LEUCINE,0.39858,0.057136,0.10173,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.60272,0.056479,0.03958,0,0
4,GO OOCYTE MATURATION,0.50896,0.056417,0.024842,0,0
4,GO REGULATION OF PINOCYTOSIS,0.27611,0.056254,0.050173,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION,0.50337,0.056234,0.03637,0,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.26847,0.056152,0.025052,0,0
4,GO EXIT FROM MITOSIS,0.16559,0.055986,0.067696,0,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.60272,0.055776,0.040871,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.87833,0.055761,0.0044008,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.32077,0.055667,0.09904,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.23589,0.055655,0.022622,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.41842,0.055461,0.06366,0,0
4,GO INTERLEUKIN 10 PRODUCTION,0.80312,0.055443,-0.0062141,0,0
4,GO PROTEIN MONOUBIQUITINATION,0.13814,0.055214,0.029088,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.097379,0.055174,0.092079,0,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.097379,0.055098,0.077008,0,0
4,GO EPITHELIUM DEVELOPMENT,0.65866,0.055045,0.023969,0,0
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.37932,0.054846,0.078203,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.22235,0.054844,0.040566,0,0
4,GO RNA SPLICING,0.060602,0.05478,0.051506,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.25729,0.054687,0.097184,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.34256,0.054478,0.048593,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.14526,0.054448,0.082306,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.21905,0.054342,0.084481,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.65234,0.054248,0.038294,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.85082,0.054236,-0.040496,0,0
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.52594,0.054206,0.024944,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.12259,0.054184,0.079088,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.75615,0.053995,0.011393,0,0
4,GO ENDOCARDIUM DEVELOPMENT,0.31232,0.053956,0.10572,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.80312,0.053953,0.0015288,0,0
4,GO REGULATION OF CIRCADIAN RHYTHM,0.059411,0.053589,0.05836,0,0
4,GO RNA DECAPPING,0.11636,0.05346,0.05333,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.24288,0.053309,0.089221,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.26098,0.053234,0.054935,0,0
4,GO RESPONSE TO HYDROXYUREA,0.080955,0.053183,0.12517,0,0
4,GO MICROTUBULE SEVERING,0.20621,0.053153,0.10943,0,0
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.80312,0.053083,0.028296,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.87144,0.052967,-0.019089,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.40349,0.052938,0.04456,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.80312,0.052793,0.0098094,0,0
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.8303,0.052774,-0.0155,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.52025,0.052629,0.041971,0,0
4,GO FOREBRAIN DEVELOPMENT,0.041093,0.052616,0.10554,0,0
4,GO EAR MORPHOGENESIS,0.32938,0.052591,0.068137,0,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.36064,0.05253,0.12797,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.50896,0.052252,0.029832,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.43883,0.052101,0.050205,0,0
4,GO EPIDERMIS DEVELOPMENT,0.26847,0.051784,0.055908,0,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.59664,0.051711,0.0089065,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.66501,0.051489,0.00040361,0,0
4,GO RESPONSE TO UV,0.093897,0.05145,0.048928,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.035393,0.051363,0.077763,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.63978,0.051248,0.051415,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.70355,0.051226,0.019604,0,0
4,GO REGULATION OF CHLORIDE TRANSPORT,0.8303,0.051203,0.026937,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.36064,0.051004,0.054267,0,0
4,GO REGULATION OF PROTEIN DEACETYLATION,0.35607,0.050995,0.047436,0,0
4,GO REGULATION OF APPETITE,0.27999,0.050989,0.057275,0,0
4,GO HISTONE H3 DEACETYLATION,0.48131,0.050832,0.031625,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.20937,0.050751,0.035667,0,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.188,0.050717,0.071973,0,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.068167,0.050468,0.055145,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.26471,0.050275,0.026856,0,0
4,GO MRNA 3 END PROCESSING,0.26471,0.050126,0.034056,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.2839,0.049879,0.040122,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.11636,0.049839,0.10165,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.075049,0.049807,0.081273,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.12473,0.049754,0.058226,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.87144,0.049731,0.0030945,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.62732,0.049696,0.076885,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.76948,0.049627,-0.058844,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.22568,0.049554,0.038299,0,0
4,GO NOREPINEPHRINE SECRETION,0.33812,0.049412,0.069219,0,0
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.12689,0.049109,0.050234,0,0
4,GO CORNIFICATION,0.38888,0.048876,0.070906,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.58456,0.048859,0.019287,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.62732,0.048682,0.064013,0,0
4,GO SMOOTH MUSCLE CELL MIGRATION,0.47588,0.048412,0.062511,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.87833,0.0484,0.013075,0,0
4,GO CELL JUNCTION MAINTENANCE,0.36064,0.048305,0.076384,0,0
4,GO MRNA CLEAVAGE,0.97557,0.048237,0.0040452,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.60883,0.048142,0.010431,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.44924,0.048102,0.036628,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.17374,0.047975,0.069636,0,0
4,GO CYTOKINE SECRETION,0.81668,0.047893,0.0010417,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.85768,0.04781,-0.025543,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.69707,0.047794,0.025739,0,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.29184,0.047719,0.07356,0,0
4,GO DISTAL TUBULE DEVELOPMENT,0.4545,0.047551,0.053,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.25001,0.047541,0.035528,0,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.60272,0.047355,0.016449,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.3746,0.047317,-0.20269,0,0
4,GO APICAL JUNCTION ASSEMBLY,0.62113,0.047251,0.04666,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.94073,0.047188,0.0065537,0,0
4,GO T CELL LINEAGE COMMITMENT,0.29992,0.047043,0.053778,0,0
4,GO T HELPER CELL LINEAGE COMMITMENT,0.92682,0.04699,-0.00020862,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.20621,0.046882,0.064464,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.60272,0.046877,0.075795,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.65234,0.046394,0.063288,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.37932,0.046384,0.02929,0,0
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.35607,0.046322,0.05498,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.80989,0.046302,0.014239,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.54321,0.045977,0.068,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.25729,0.045797,0.095181,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.31232,0.045665,0.040596,0,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.22905,0.045663,0.10266,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.78289,0.045653,0.033631,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.69707,0.04561,0.019154,0,0
4,GO REGULATION OF MAST CELL ACTIVATION,0.76281,0.045556,0.014616,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.24288,0.045511,0.068368,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.60883,0.045376,-0.045176,0,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.66501,0.045316,0.063549,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.83713,0.045201,-0.039805,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.54321,0.04517,0.088426,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.98255,0.045086,-0.0036869,0,0
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.72969,0.045015,0.015051,0,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.91987,0.044879,0.019282,0,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.10845,0.044734,0.04643,0,0
4,GO RESPONSE TO WATER,0.62732,0.044684,0.061393,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.11841,0.044673,0.045277,0,0
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.28785,0.04464,0.079493,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.39371,0.044622,0.047638,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.79636,0.044621,0.00023599,0,0
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.90599,0.044621,-0.011522,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.15773,0.044513,0.047449,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.99651,0.044443,-0.010367,0,0
4,GO VASCULAR TRANSPORT,0.76948,0.04432,0.019898,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.87833,0.044312,-0.00020177,0,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.47049,0.044132,0.024535,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.95466,0.043973,-0.032259,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.42347,0.043865,0.043283,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.188,0.043865,0.055306,0,0
4,GO REGULATION OF SYMBIOTIC PROCESS,0.71658,0.0438,-0.049842,0,0
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.85082,0.043746,0.021099,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.89907,0.043657,-0.00073873,0,0
4,GO PINOCYTOSIS,0.41842,0.043618,0.035173,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.97557,0.04358,-0.0060997,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.1028,0.043349,0.037534,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.62113,0.043082,0.035995,0,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.70355,0.043066,0.032214,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.81668,0.043045,0.009752,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.11235,0.042791,0.14809,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.12689,0.042615,0.054777,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.20309,0.042605,0.064029,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.17099,0.042515,0.040658,0,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.54903,0.042468,0.026545,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.85768,0.042402,-0.043187,0,0
4,GO REGULATION OF RECEPTOR BINDING,0.90599,0.042271,-0.012972,0,0
4,GO REGULATION OF HAIR CYCLE,0.43367,0.042225,0.060559,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.46512,0.04221,0.027352,0,0
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.40349,0.04215,0.041833,0,0
4,GO PROTEIN O LINKED GLYCOSYLATION,0.99651,0.04214,-0.047145,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.7495,0.04213,0.022877,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.77618,0.041896,0.0010175,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.26098,0.041772,0.040875,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.58456,0.041741,0.030062,0,0
4,GO DETECTION OF MECHANICAL STIMULUS,0.10654,0.041702,0.097194,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.49227,0.041484,0.019028,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.44402,0.041457,0.021272,0,0
4,GO MRNA PROCESSING,0.079444,0.04133,0.045653,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.12689,0.041051,0.067666,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.71006,0.040886,0.014494,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.90599,0.040876,-0.01033,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.61497,0.040828,0.0097638,0,0
4,GO MYELOID CELL DEVELOPMENT,0.24643,0.040812,0.045702,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.73628,0.040583,0.0071945,0,0
4,GO CILIUM ORGANIZATION,0.13355,0.040509,0.065784,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.5726,0.0405,-0.044134,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.084046,0.040321,0.12063,0,0
4,GO AXIS SPECIFICATION,0.8303,0.040299,0.021531,0,0
4,GO PROTEIN ADP RIBOSYLATION,0.71658,0.040245,0.037398,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.31232,0.040214,0.0288,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION,0.4978,0.040083,0.020617,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.084046,0.039928,0.10628,0,0
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.61497,0.039808,0.010387,0,0
4,GO MICROTUBULE ANCHORING,0.52594,0.039607,0.032418,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.20309,0.039579,0.031997,0,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.93377,0.039388,-0.0027587,0,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.24643,0.039356,0.096752,0,0
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.91293,0.039342,0.0049845,0,0
4,GO MRNA TRANSPORT,0.21579,0.03925,0.02718,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.053746,0.039141,0.04827,0,0
4,GO EMBRYO DEVELOPMENT,0.48678,0.039139,0.030456,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.4545,0.039107,0.095506,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.20309,0.039017,0.096339,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.16294,0.038986,0.055326,0,0
4,GO RESPONSE TO ACETYLCHOLINE,0.52594,0.038921,0.067603,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.95466,0.038909,-0.0276,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.5726,0.038868,0.028936,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.36064,0.038821,0.087035,0,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.16294,0.038681,0.075814,0,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.090515,0.038638,0.039523,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.27227,0.038112,0.03808,0,0
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.69061,0.038106,0.0075352,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.52594,0.038082,0.034316,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.72313,0.037822,0.016466,0,0
4,GO CELLULAR SENESCENCE,0.39858,0.03778,0.043848,0,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.38888,0.037344,0.045482,0,0
4,GO DNA RECOMBINATION,0.097379,0.037338,0.039323,0,0
4,GO RRNA CATABOLIC PROCESS,0.66501,0.037296,0.03163,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.37932,0.037284,0.047273,0,0
4,GO REGULATION OF VIRAL LIFE CYCLE,0.62113,0.037022,-0.075416,0,0
4,GO REGULATION OF ACTIN NUCLEATION,0.55487,0.036902,0.0071999,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.72969,0.03673,0.014047,0,0
4,GO BLASTOCYST GROWTH,0.33812,0.036717,0.029806,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.34702,0.036693,0.048221,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.86455,0.036563,-0.017516,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.51459,0.036561,0.1333,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.7495,0.036401,-0.0039142,0,0
4,GO HISTONE DEACETYLATION,0.56666,0.036368,0.017834,0,0
4,GO GENE SILENCING,0.42855,0.036214,0.018,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.14285,0.036146,0.13447,0,0
4,GO CHEMOKINE PRODUCTION,0.80312,0.036123,-0.023264,0,0
4,GO CYTOKINESIS,0.47049,0.036011,0.024234,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.64605,0.035959,0.17691,0,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.52594,0.035953,0.022827,0,0
4,GO CHROMOSOME SEPARATION,0.12049,0.035732,0.051761,0,0
4,GO TRNA TRANSPORT,0.81668,0.035473,0.0065424,0,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.76948,0.035401,0.020364,0,0
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.79636,0.035326,0.0026907,0,0
4,GO DNA DEALKYLATION,0.4978,0.035312,0.036677,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.44402,0.035243,0.093119,0,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.59664,0.035034,0.071884,0,0
4,GO PROTEIN ACYLATION,0.11039,0.034898,0.05482,0,0
4,GO REGULATION OF CELL DIVISION,0.19393,0.034839,0.047875,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.77618,0.034839,0.057579,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98255,0.034791,0.023802,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.57857,0.034601,0.050613,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.29992,0.03458,0.055917,0,0
4,GO HEAD DEVELOPMENT,0.24288,0.034548,0.064888,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.87833,0.034532,0.000228,0,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.14048,0.034523,0.12685,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.2,0.034453,0.038971,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.80312,0.034439,0.022855,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.9686,0.034359,-0.0045932,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.88523,0.034076,0.012915,0,0
4,GO ACROSOME ASSEMBLY,0.31232,0.034059,0.07545,0,0
4,GO WALKING BEHAVIOR,0.4545,0.033916,0.04907,0,0
4,GO ACTIVATION OF GTPASE ACTIVITY,0.81668,0.033845,0.0081562,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.90599,0.033743,-0.0376,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.98953,0.033728,0.0044943,0,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.36526,0.033539,0.037047,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.72969,0.033512,0.020954,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.48678,0.033497,0.047222,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.60883,0.033386,0.021765,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.48678,0.033381,0.054965,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.27227,0.033373,0.087691,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.7495,0.033334,0.021342,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.066855,0.03329,0.10637,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.98255,0.03325,0.0023666,0,0
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.36526,0.033206,0.10081,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.62732,0.033083,0.068004,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.38408,0.033079,0.08204,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.65866,0.033071,0.040082,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.40349,0.032507,0.061815,0,0
4,GO PENILE ERECTION,0.72969,0.03236,0.013834,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.95466,0.03191,-0.0055599,0,0
4,GO CHONDROCYTE PROLIFERATION,0.26098,0.03189,0.10795,0,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.20937,0.031827,0.09137,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.64605,0.031714,0.0090973,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.11636,0.031507,0.10483,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.32506,0.031297,0.025129,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.16828,0.031273,0.078439,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.69707,0.030992,-0.086503,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.31653,0.030895,0.082812,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.43367,0.030787,0.046754,0,0
4,GO ALPHA BETA T CELL ACTIVATION,0.98255,0.030675,-0.015847,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.46512,0.030505,0.031672,0,0
4,GO REGULATION OF CYTOKINESIS,0.4545,0.030504,0.022588,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.21256,0.030497,0.063393,0,0
4,GO MOLTING CYCLE,0.65866,0.030379,0.023552,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.94769,0.030333,-0.085142,0,0
4,GO EYE MORPHOGENESIS,0.10465,0.030323,0.10218,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.95466,0.030301,0.011857,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.3746,0.030253,0.027381,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.076492,0.030163,0.052715,0,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.94073,0.030142,-0.0025629,0,0
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.70355,0.0301,-0.035251,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.4598,0.030053,0.065111,0,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.99651,0.03003,-0.039755,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.53742,0.030004,0.043834,0,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.097379,0.029599,0.037853,0,0
4,GO HEART GROWTH,0.93377,0.029576,0.0093124,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.62732,0.029397,0.046779,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.81668,0.02901,-0.085278,0,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.85768,0.028951,-0.0050006,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.54903,0.028781,0.049375,0,0
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.3746,0.028768,0.057531,0,0
4,GO VIRAL GENOME REPLICATION,0.54903,0.028692,-0.069671,0,0
4,GO OOGENESIS,0.33373,0.028598,0.035754,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.15773,0.028434,0.089551,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.43367,0.028379,0.063046,0,0
4,GO RENAL WATER HOMEOSTASIS,0.8303,0.028279,0.0056185,0,0
4,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.88523,0.028226,-0.029912,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.11841,0.02819,0.061947,0,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.36991,0.028186,-0.067174,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.80989,0.028179,-0.006946,0,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.78289,0.027969,-0.098738,0,0
4,GO STEM CELL DIFFERENTIATION,0.16294,0.027899,0.073437,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.88523,0.027875,-0.02417,0,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.74288,0.027857,0.0021658,0,0
4,GO REGULATION OF DNA REPLICATION,0.17099,0.027811,0.045517,0,0
4,GO CYTOKINETIC PROCESS,0.40349,0.027738,0.035262,0,0
4,GO REGULATION OF BONE REMODELING,0.92682,0.027558,-0.033387,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.87833,0.02749,0.0087775,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.8303,0.027358,0.012807,0,0
4,GO REGIONALIZATION,0.49227,0.027312,0.04607,0,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.54903,0.027267,-0.026822,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.62732,0.027204,-0.067506,0,0
4,GO RNA CAPPING,0.58456,0.027125,0.0056144,0,0
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.55487,0.027108,0.045146,0,0
4,GO MRNA MODIFICATION,0.82348,0.026958,-0.0031164,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.74288,0.026856,-0.016322,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.49227,0.026767,0.04588,0,0
4,GO GLAND MORPHOGENESIS,0.66501,0.026744,0.045385,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.34256,0.026601,0.040999,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.91987,0.02637,-0.0011105,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.32938,0.026132,0.028937,0,0
4,GO N GLYCAN PROCESSING,0.75615,0.026,0.025888,0,0
4,GO HEART TRABECULA MORPHOGENESIS,0.99651,0.025779,0.022092,0,0
4,GO CYTOLYSIS,0.77618,0.025745,-0.048986,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.32506,0.025433,0.051309,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.63354,0.025409,0.0084506,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.22905,0.02507,0.023404,0,0
4,GO DNA METABOLIC PROCESS,0.57857,0.025069,0.0079679,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.62732,0.025055,-0.037265,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.7495,0.024951,0.01696,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.50337,0.024841,0.029622,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.68418,0.024784,0.043978,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.20937,0.024759,0.11854,0,0
4,GO RNA STABILIZATION,0.58456,0.024684,0.018153,0,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,1,0.02463,0.012319,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.75615,0.024589,0.020085,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.58456,0.024553,0.042628,0,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.85768,0.02453,-9.6009e-05,0,0
4,GO ATP TRANSPORT,0.97557,0.024529,-0.0045809,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.85082,0.024524,0.024318,0,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.24288,0.024494,0.042395,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.81668,0.024423,-0.012103,0,0
4,GO INTERFERON BETA PRODUCTION,0.80989,0.024342,-0.023709,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.26471,0.024224,0.084935,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.42347,0.024164,0.059093,0,0
4,GO REGULATION OF NEURON MIGRATION,0.34702,0.024141,0.079636,0,0
4,GO PHAGOLYSOSOME ASSEMBLY,1,0.024098,-0.0061096,0,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.88523,0.024009,0.0051358,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.9686,0.023858,-0.0024574,0,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.94769,0.023829,-0.0053768,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.56075,0.023765,0.035437,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.62732,0.023637,0.011566,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.30402,0.023546,0.044926,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.62732,0.023533,0.036967,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.15264,0.023496,0.080061,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.71658,0.023496,0.02815,0,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.77618,0.023449,0.0085881,0,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.22568,0.023351,0.066708,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.71658,0.023081,0.024519,0,0
4,GO RUFFLE ASSEMBLY,0.34702,0.022932,0.050362,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.97557,0.022915,-0.0051014,0,0
4,GO TISSUE MORPHOGENESIS,0.87833,0.022899,0.014321,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.67776,0.022876,0.016623,0,0
4,GO EPIDERMAL CELL DIFFERENTIATION,0.28785,0.022735,0.075458,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.38408,0.022735,0.024138,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.69061,0.022599,0.027445,0,0
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.91987,0.022552,-0.0033242,0,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.76948,0.022547,0.0059277,0,0
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.60272,0.022319,-0.022672,0,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.36064,0.022151,-0.070349,0,0
4,GO VIRAL RNA GENOME REPLICATION,0.96163,0.022034,-0.013872,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.75615,0.022025,-0.00017954,0,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.69707,0.021881,0.026274,0,0
4,GO RESPONSE TO X RAY,0.59664,0.021808,0.03095,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.28785,0.021674,0.070292,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.54321,0.021605,-0.070572,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.39858,0.021578,0.081896,0,0
4,GO NEURON MIGRATION,0.18508,0.021461,0.13034,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.38408,0.021392,0.085304,0,0
4,GO FIBROBLAST MIGRATION,0.4598,0.021391,0.034287,0,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.24288,0.021309,0.043574,0,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.89215,0.021039,0.020588,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.16828,0.020961,0.20134,0,0
4,GO REGULATION OF HEMOPOIESIS,0.63354,0.020934,-0.025775,0,0
4,GO HEART MORPHOGENESIS,0.85082,0.02088,0.03863,0,0
4,GO MITOCHONDRIAL FUSION,0.95466,0.02074,-0.014428,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.92682,0.020688,-0.0047828,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.89907,0.020645,-0.0073588,0,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.16828,0.020613,0.11822,0,0
4,GO REGULATION OF AXONOGENESIS,0.85082,0.020295,0.040362,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.93377,0.02015,-0.01557,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.53742,0.020122,0.071696,0,0
4,GO T CELL DIFFERENTIATION,0.58456,0.020117,0.014958,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.95466,0.020073,0.028396,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.50896,0.020033,0.039767,0,0
4,GO NOTCH SIGNALING PATHWAY,0.90599,0.02002,-0.0012986,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.43883,0.01995,0.059812,0,0
4,GO MITOTIC CELL CYCLE,0.31232,0.019908,0.017033,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.97557,0.019864,-0.0072976,0,0
4,GO MACROPHAGE DIFFERENTIATION,0.88523,0.019848,-0.034371,0,0
4,GO METENCEPHALON DEVELOPMENT,0.24288,0.019635,0.088273,0,0
4,GO BONE TRABECULA FORMATION,0.76281,0.019631,0.052895,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.7495,0.019588,0.03785,0,0
4,GO BONE MORPHOGENESIS,0.18219,0.01955,0.098526,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.40843,0.019546,0.011887,0,0
4,GO ONE CARBON COMPOUND TRANSPORT,0.8303,0.019519,-0.048383,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.31653,0.019465,0.039315,0,0
4,GO SNRNA TRANSCRIPTION,0.76281,0.019424,0.002822,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.38408,0.019415,0.042643,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.44402,0.019329,0.017411,0,0
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.31232,0.019274,0.075419,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.78289,0.019116,0.029165,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.36526,0.019054,0.050093,0,0
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.60272,0.019022,0.034623,0,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.98953,0.018995,0.045643,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.36991,0.018861,0.050963,0,0
4,GO NUCLEAR EXPORT,0.69707,0.018783,0.00056793,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.62113,0.018615,0.11263,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.62113,0.018529,0.04334,0,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.3746,0.018426,0.070275,0,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.47588,0.018412,0.047356,0,0
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.76948,0.018306,0.043887,0,0
4,GO REGULATION OF GLUCOSE IMPORT,0.46512,0.018292,0.037038,0,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.97557,0.01824,-0.010505,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.53742,0.018226,0.069216,0,0
4,GO RUFFLE ORGANIZATION,0.50896,0.018224,0.035479,0,0
4,GO COPULATION,0.56666,0.018176,0.041409,0,0
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.40843,0.018062,0.054066,0,0
4,GO CELL JUNCTION ASSEMBLY,0.97557,0.01803,0.010162,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.26098,0.017996,0.057612,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.16294,0.017822,0.02381,0,0
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.63978,0.017682,0.050423,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.64605,0.017485,0.019997,0,0
4,GO BARBED END ACTIN FILAMENT CAPPING,0.77618,0.017478,-0.058202,0,0
4,GO CELL CYCLE,0.38408,0.017477,0.014613,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.40349,0.017422,0.027018,0,0
4,GO AMMONIUM TRANSPORT,0.98255,0.01741,0.026661,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.7495,0.017318,-0.034242,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.97557,0.01728,-0.026922,0,0
4,GO POSITIVE REGULATION OF CELL GROWTH,0.95466,0.017207,0.024906,0,0
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.79636,0.017009,-0.017781,0,0
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.68418,0.016995,-0.019257,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.17934,0.016922,0.073021,0,0
4,GO NATURAL KILLER CELL ACTIVATION,0.25001,0.01689,0.048357,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.30402,0.016843,0.019874,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.39858,0.016809,0.03427,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.51459,0.016727,0.03788,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.37932,0.016661,-0.11807,0,0
4,GO HISTONE DEUBIQUITINATION,0.50337,0.016622,0.022333,0,0
4,GO LEYDIG CELL DIFFERENTIATION,0.71006,0.01656,0.082435,0,0
4,GO CELLULAR RESPONSE TO VIRUS,0.96163,0.016548,-0.017316,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.93377,0.016534,-0.0029122,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.2839,0.016534,-0.084077,0,0
4,GO KERATINOCYTE DIFFERENTIATION,0.37932,0.016533,0.063885,0,0
4,GO DETECTION OF ABIOTIC STIMULUS,0.71006,0.016529,0.025282,0,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.26471,0.016523,0.03567,0,0
4,GO IMPORT INTO NUCLEUS,0.36064,0.016487,0.035288,0,0
4,GO LIPID PHOSPHORYLATION,0.35153,0.016436,0.032791,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.42347,0.016434,0.093218,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.69707,0.016301,-0.037387,0,0
4,GO PHAGOSOME ACIDIFICATION,0.89907,0.016295,-0.012104,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.69707,0.016217,0.056827,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.95466,0.016171,-0.026533,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.38888,0.016116,0.054039,0,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.96163,0.015989,-0.0060589,0,0
4,GO CELL CYCLE PROCESS,0.55487,0.015978,0.0047582,0,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.85768,0.015848,0.076747,0,0
4,GO GAMETE GENERATION,0.60883,0.015844,0.013989,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.71658,0.015751,0.046588,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.98255,0.015691,0.015427,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.79636,0.015591,0.035436,0,0
4,GO REGULATION OF CELL CYCLE,0.4978,0.015571,0.013484,0,0
4,GO MAGNESIUM ION TRANSPORT,0.54321,0.0154,0.038558,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.9686,0.015342,0.026034,0,0
4,GO SNORNA 3 END PROCESSING,0.98255,0.01508,-0.0083195,0,0
4,GO GLIAL CELL PROLIFERATION,0.93377,0.014966,0.014076,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.59059,0.014739,0.036552,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.39371,0.014713,0.086705,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.80989,0.014627,-0.011424,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.83713,0.014615,-0.011243,0,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.58456,0.014534,0.031945,0,0
4,GO MIDBODY ABSCISSION,0.29586,0.014527,0.090517,0,0
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.62113,0.014483,0.014754,0,0
4,GO RESPIRATORY SYSTEM PROCESS,0.60883,0.014405,0.029231,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.8303,0.014393,-0.012899,0,0
4,GO ETHANOL METABOLIC PROCESS,0.49227,0.014385,-0.070355,0,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.2839,0.014383,-0.065729,0,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.80312,0.014359,-0.0037366,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.40843,0.014321,0.05787,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.23589,0.014219,0.14473,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.92682,0.014081,0.035898,0,0
4,GO ORGANELLE FISSION,0.41842,0.013974,0.020063,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.41341,0.013956,0.084526,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.32938,0.01392,0.10362,0,0
4,GO RESPONSE TO NUTRIENT,0.91293,0.013917,-0.0033586,0,0
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.87833,0.013866,0.0061421,0,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.93377,0.013853,-0.0084164,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.94073,0.013848,0.031193,0,0
4,GO RESPONSE TO BMP,0.44924,0.013844,0.068102,0,0
4,GO DNA REPAIR,0.27227,0.013793,0.020324,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.81668,0.013725,0.049164,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.91293,0.013721,-0.009403,0,0
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.66501,0.013707,-0.012495,0,0
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.91987,0.013706,0.028914,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.73628,0.013598,0.01742,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.47588,0.013579,0.011988,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.77618,0.013509,0.010102,0,0
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.32938,0.013483,-0.073987,0,0
4,GO HINDBRAIN DEVELOPMENT,0.29586,0.013468,0.078685,0,0
4,GO DENDRITIC TRANSPORT,0.94769,0.013095,0.024046,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.78962,0.012728,0.012431,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.53742,0.012705,0.024182,0,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.33373,0.012682,-0.16677,0,0
4,GO HISTAMINE SECRETION,0.42347,0.012611,-0.11715,0,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.59059,0.012562,-0.040247,0,0
4,GO CELLULAR RESPONSE TO ALCOHOL,0.8303,0.012367,-0.018062,0,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.43883,0.012348,0.025728,0,0
4,GO INTESTINAL ABSORPTION,0.89215,0.012237,-0.028751,0,0
4,GO MICROTUBULE BASED PROCESS,0.70355,0.012095,0.021198,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.20621,0.012074,0.1028,0,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.59059,0.011994,0.034589,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.74288,0.011966,0.017866,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.65866,0.011958,0.0062736,0,0
4,GO SPINDLE ORGANIZATION,0.4598,0.011879,0.024077,0,0
4,GO EPITHELIAL CELL PROLIFERATION,0.85082,0.011762,-0.0020673,0,0
4,GO STRESS GRANULE ASSEMBLY,0.50896,0.011722,-0.030469,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.3746,0.011646,0.09628,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.53167,0.011629,0.049966,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.64605,0.011615,-0.04195,0,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.68418,0.011567,0.044158,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.42347,0.011525,0.045364,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.53167,0.011394,-0.057666,0,0
4,GO INTERLEUKIN 12 PRODUCTION,0.83713,0.0113,-0.022474,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.9686,0.011298,0.01651,0,0
4,GO RNA LOCALIZATION,0.89907,0.011282,-0.020103,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.81668,0.011253,0.008077,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.84397,0.011189,-0.026605,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.7495,0.011183,0.0082775,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.42347,0.011115,0.047509,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.89215,0.011019,-0.0035585,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.96163,0.010954,-0.0060291,0,0
4,GO CELL PART MORPHOGENESIS,0.40843,0.010943,0.059302,0,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.91987,0.010917,-0.0036974,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.67137,0.010892,0.025551,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.47049,0.010851,-0.076904,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.53167,0.010846,0.014522,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.71658,0.010841,0.023449,0,0
4,GO DNA METHYLATION,0.85768,0.010747,0.0030849,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.80312,0.010609,-0.016104,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.4598,0.010605,-0.046154,0,0
4,GO MUSCLE ATROPHY,0.80312,0.010568,-0.03563,0,0
4,GO MIDBRAIN DEVELOPMENT,0.40349,0.010482,0.060787,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.47588,0.010477,0.062899,0,0
4,GO NUCLEAR TRANSPORT,0.59059,0.010453,0.0074312,0,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.50896,0.010437,0.047002,0,0
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.99651,0.010424,0.0080386,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.65866,0.010271,-0.050029,0,0
4,GO LYMPHANGIOGENESIS,0.91293,0.010077,-0.005936,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.94073,0.0099226,-0.02864,0,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.7495,0.009874,0.015606,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.54903,0.009831,0.061546,0,0
4,GO TORC1 SIGNALING,0.85768,0.0098126,-0.030021,0,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.88523,0.0097372,-0.048941,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.98953,0.0096111,0.023919,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.39858,0.0095737,0.027244,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.76948,0.0095169,-0.0024942,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.96163,0.0094568,-0.010477,0,0
4,GO MACROMOLECULE DEACYLATION,0.78962,0.0094371,-0.0088787,0,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.71658,0.0094053,0.044863,0,0
4,GO NCRNA TRANSCRIPTION,0.91987,0.0093924,-0.00033224,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.37932,0.0093865,0.089513,0,0
4,GO CELL PROJECTION ASSEMBLY,0.84397,0.0093701,0.01852,0,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.78962,0.0091415,0.0065267,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.85082,0.0087601,-0.035297,0,0
4,GO PALLIUM DEVELOPMENT,0.75615,0.0086136,0.03049,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.98953,0.0084941,-0.0038193,0,0
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.71006,0.0084303,-0.031077,0,0
4,GO OVULATION CYCLE,0.75615,0.0083522,-0.010598,0,0
4,GO INTERLEUKIN 6 PRODUCTION,0.83713,0.008339,-0.020902,0,0
4,GO ADULT FEEDING BEHAVIOR,0.72969,0.0083013,0.036916,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.18508,0.0082979,0.16458,0,0
4,GO REPRODUCTION,0.69707,0.0082765,-0.0093344,0,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.73628,0.0082598,0.004422,0,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.96163,0.0082497,-0.0019056,0,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.94073,0.0082115,0.016221,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.34256,0.0082079,0.01362,0,0
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.94769,0.0081733,-0.0039352,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.76948,0.0081227,0.0053968,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.78962,0.0080488,0.022742,0,0
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.27999,0.0079956,-0.072481,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.96163,0.0079939,-0.00011477,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.60272,0.0078519,-0.063203,0,0
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.72313,0.0075716,-0.031975,0,0
4,GO HAIR CELL DIFFERENTIATION,0.31232,0.007524,0.069756,0,0
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.38888,0.0074867,0.073159,0,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.65234,0.0073253,0.01954,0,0
4,GO EPITHELIAL CELL DEVELOPMENT,0.71006,0.0072871,0.024052,0,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.87144,0.0070377,0.018412,0,0
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.99651,0.0070185,-0.000995,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.74288,0.0069683,0.040772,0,0
4,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.78289,0.0068377,-0.040426,0,0
4,GO INTERLEUKIN 1 PRODUCTION,0.92682,0.006777,-0.027721,0,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.70355,0.0067533,0.042696,0,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.8303,0.0066888,-0.05641,0,0
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.46512,0.0066721,-0.057862,0,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.58456,0.0065837,0.032023,0,0
4,GO FAT CELL DIFFERENTIATION,0.44924,0.0065754,-0.044764,0,0
4,GO PROTEIN IMPORT,0.99651,0.0065732,-0.0020254,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.59664,0.0065676,0.01363,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.22905,0.0063248,-0.083646,0,0
4,GO FEMALE GAMETE GENERATION,0.91987,0.0062868,0.0090839,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.97557,0.0062683,0.017632,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.76281,0.0062249,0.02099,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.63354,0.0060734,-0.042639,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.66501,0.0059849,0.0019594,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.4545,0.0059364,-0.088536,0,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.79636,0.0058797,-0.0053731,0,0
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.47588,0.0057759,0.10121,0,0
4,GO BONE GROWTH,0.4978,0.0057634,-0.086209,0,0
4,GO TELENCEPHALON DEVELOPMENT,0.68418,0.0057542,0.036975,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.71006,0.0056476,0.048508,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.80312,0.0055834,0.0011894,0,0
4,GO REGULATION OF BEHAVIOR,0.78962,0.0055798,0.0097816,0,0
4,GO PYRAMIDAL NEURON DIFFERENTIATION,0.50896,0.0054579,0.082225,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.36991,0.0053955,-0.17592,0,0
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.36991,0.0053808,0.10527,0,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.63354,0.0053719,0.031316,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.60272,0.0051401,0.015469,0,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.80989,0.0050024,-0.027715,0,0
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.71006,0.0048081,-0.025954,0,0
4,GO POSITIVE REGULATION OF SECRETION,0.43883,0.0046833,-0.032552,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.91293,0.004643,-0.011536,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.74288,0.0046045,0.025398,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.70355,0.0044526,0.016165,0,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.62732,0.0044127,0.021598,0,0
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.27999,0.0043497,-0.07167,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.68418,0.0043247,0.049792,0,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.89907,0.0042776,0.0025346,0,0
4,GO O GLYCAN PROCESSING,0.64605,0.0042548,-0.07804,0,0
4,GO REGULATION OF CELL AGING,0.91293,0.0041393,0.0092557,0,0
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.78289,0.0041266,-0.0069136,0,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.78289,0.0040582,-0.0097464,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.61497,0.0039263,-0.041487,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.91293,0.003878,-0.0082102,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.97557,0.0038436,0.019284,0,0
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.89215,0.0038086,-0.024503,0,0
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.53742,0.0037386,-0.066421,0,0
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.76948,0.0036855,-0.021748,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.61497,0.0036014,-0.046303,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.51459,0.0035899,0.030748,0,0
4,GO INTRACELLULAR STEROL TRANSPORT,0.90599,0.0033854,0.0040568,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.62113,0.0033681,-0.013299,0,0
4,GO SPERM MOTILITY,0.84397,0.0032608,0.0067924,0,0
4,GO PARENTAL BEHAVIOR,0.86455,0.0032569,0.0033616,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.23937,0.003225,-0.12379,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.69061,0.0032245,-0.0086545,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.97557,0.0031457,-0.009611,0,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.88523,0.0031308,0.017841,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.61497,0.0028991,0.045777,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.83713,0.0028927,-0.01452,0,0
4,GO CELL MORPHOGENESIS,0.76948,0.0027797,0.036547,0,0
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.62732,0.0027491,-0.018422,0,0
4,GO ADRENAL GLAND DEVELOPMENT,0.85768,0.0027048,-0.0052158,0,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.63354,0.0026684,-0.038513,0,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.54903,0.0026047,-0.036005,0,0
4,GO NEURON APOPTOTIC PROCESS,0.33812,0.0025243,0.050007,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.63354,0.0023832,0.05222,0,0
4,GO REGULATION OF DNA METHYLATION,0.60883,0.002351,-0.046136,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.80312,0.0022904,-0.012322,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.81668,0.0022583,-0.048103,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.71658,0.0022382,0.0093726,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.8303,0.002238,-0.00043082,0,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.79636,0.0022158,0.014524,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.87144,0.0021534,0.021777,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.8303,0.0021335,0.024732,0,0
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.63354,0.0020818,0.059133,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.93377,0.0020304,-0.023401,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.57857,0.0019464,-0.027287,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.67776,0.001933,0.024352,0,0
4,GO REGULATION OF CELL SHAPE,0.78289,0.0018417,0.030179,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.7495,0.0017761,0.023642,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.53742,0.0013067,-0.03177,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.58456,0.0012004,0.049083,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.66501,0.0010902,-0.01849,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.7495,0.0010898,-0.081576,0,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.74288,0.0010254,0.031494,0,0
4,GO DEFENSE RESPONSE TO VIRUS,0.94073,0.0010197,-0.031306,0,0
4,GO PROTEIN POLYUBIQUITINATION,0.89907,0.0010003,-0.0078271,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.76281,0.00095124,-0.028172,0,0
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.71006,0.00092791,-0.015873,0,0
4,GO EMBRYONIC EYE MORPHOGENESIS,0.28785,0.00092535,0.11214,0,0
4,GO MAST CELL MEDIATED IMMUNITY,0.83713,0.00082465,0.017223,0,0
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.25001,0.0007687,0.10717,0,0
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.48131,0.00076806,0.054656,0,0
4,GO PRENYLATION,0.72969,0.00056839,0.012984,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.9686,0.00053387,0.034219,0,0
4,GO NEUROGENESIS,0.50337,0.00047096,0.050171,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.67137,0.00041535,0.06435,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.49227,0.00034507,-0.061565,0,0
4,GO ANIMAL ORGAN FORMATION,0.94073,0.00027891,0.043537,0,0
4,GO HEART FIELD SPECIFICATION,0.69707,0.00027684,0.050308,0,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.71658,2.9178e-05,-0.0055807,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.60883,1.3769e-05,0.10766,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.70355,5.8161e-06,-0.056485,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.85082,-3.6194e-06,0.036946,0,0
4,GO AXON DEVELOPMENT,0.47049,-7.2173e-06,0.062998,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.87144,-2.0781e-05,0.045367,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.65866,-9.2217e-05,-0.0618,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.92682,-9.4328e-05,-0.021112,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.67137,-0.00013739,-0.021079,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.24643,-0.00020263,0.087911,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.80312,-0.0002359,-0.03727,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.91987,-0.00023869,0.0098248,0,0
4,GO AUTOPHAGOSOME MATURATION,0.34702,-0.00031374,-0.059035,0,0
4,GO GLAND DEVELOPMENT,0.90599,-0.00040286,0.0093042,0,0
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.85082,-0.00044349,-0.026403,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.74288,-0.00046375,-0.020119,0,0
4,GO ASTROCYTE DEVELOPMENT,0.80312,-0.00047472,0.027262,0,0
4,GO MALE GAMETE GENERATION,0.94073,-0.00050404,0.00087944,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.85082,-0.00052648,0.010558,0,0
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.4978,-0.00060881,-0.047288,0,0
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.31653,-0.00063332,-0.075665,0,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.89907,-0.00070913,-3.5074e-05,0,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.36991,-0.00072923,-0.17474,0,0
4,GO NEURON DIFFERENTIATION,0.4978,-0.00084728,0.054696,0,0
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.69061,-0.001059,-0.032524,0,0
4,GO MEIOTIC CELL CYCLE,0.97557,-0.0012048,-0.004897,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.91987,-0.0013703,-0.0047222,0,0
4,GO DEVELOPMENTAL INDUCTION,0.71658,-0.0013844,0.077296,0,0
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.56666,-0.0014251,-0.10082,0,0
4,GO VITAMIN D METABOLIC PROCESS,0.54321,-0.0014586,-0.070408,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.84397,-0.0014693,-0.022165,0,0
4,GO ACTIN NUCLEATION,1,-0.0014715,-0.012261,0,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.67137,-0.0015212,-0.019384,0,0
4,GO MUSCLE CELL DIFFERENTIATION,0.56666,-0.0015533,-0.01467,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.44924,-0.0015646,-0.046705,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.73628,-0.0016215,-0.0026751,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.95466,-0.0016653,0.0023632,0,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.46512,-0.0017261,0.074826,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.36526,-0.0017269,-0.089326,0,0
4,GO MITOCHONDRIAL FISSION,0.5726,-0.0017458,-0.018547,0,0
4,GO EPIBOLY,0.62113,-0.0018199,-0.080158,0,0
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.88523,-0.001868,-0.048306,0,0
4,GO WOUND HEALING,0.33812,-0.0018881,-0.069228,0,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.90599,-0.0019018,0.0048939,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.97557,-0.0019724,-0.007949,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.99651,-0.0019898,0.0066626,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.69707,-0.0022729,-0.016207,0,0
4,GO MAMMARY GLAND DEVELOPMENT,0.99651,-0.0022833,0.012764,0,0
4,GO TISSUE HOMEOSTASIS,0.87144,-0.0023875,0.0050396,0,0
4,GO RESPONSE TO VIRUS,0.59664,-0.0024042,-0.050413,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.48131,-0.002456,-0.045153,0,0
4,GO REGULATION OF HEAT GENERATION,0.93377,-0.002482,0.044047,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.93377,-0.0025199,-0.025284,0,0
4,GO REGULATION OF ERAD PATHWAY,0.55487,-0.0025508,-0.032731,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.56075,-0.0025995,0.07168,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.83713,-0.0026149,-0.023726,0,0
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.91987,-0.0026596,-0.024842,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.60883,-0.0027337,0.0081933,0,0
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.91987,-0.0028205,0.0055627,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61497,-0.003027,-0.06075,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.76948,-0.0030549,0.017918,0,0
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.76281,-0.0032236,0.014687,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.81668,-0.0032354,0.0065007,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.99651,-0.0032503,0.017485,0,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.69061,-0.0033632,-0.04589,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.73628,-0.0033866,0.0015692,0,0
4,GO ENDOCRINE PROCESS,0.50896,-0.0034619,-0.041633,0,0
4,GO ARTERY DEVELOPMENT,0.80312,-0.0034734,0.045061,0,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.60272,-0.0035329,0.04973,0,0
4,GO IMMUNE SYSTEM DEVELOPMENT,0.71006,-0.0035689,-0.018075,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.71006,-0.0036161,-0.012128,0,0
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.25729,-0.0036455,-0.088502,0,0
4,GO REGULATION OF CELL DEVELOPMENT,0.74288,-0.0036968,0.03934,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.69707,-0.0037675,0.018355,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.93377,-0.0038862,0.00012976,0,0
4,GO ODONTOGENESIS,0.43883,-0.0039284,0.079737,0,0
4,GO TELOMERIC LOOP DISASSEMBLY,0.60883,-0.0039322,-0.044434,0,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.93377,-0.0039576,-0.023584,0,0
4,GO CIRCADIAN RHYTHM,0.76281,-0.0040486,-0.014262,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.92682,-0.0041391,-0.039934,0,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.59664,-0.0041564,0.051399,0,0
4,GO NEGATIVE T CELL SELECTION,0.85082,-0.0042264,-0.0065643,0,0
4,GO NUCLEUS ORGANIZATION,0.84397,-0.0042752,-0.0089085,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.91987,-0.0043874,-0.00088991,0,0
4,GO RESPONSE TO RETINOIC ACID,0.84397,-0.0043933,0.036583,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.98255,-0.0044244,-0.04139,0,0
4,GO SOMITOGENESIS,0.30402,-0.0044506,0.072546,0,0
4,GO CARTILAGE DEVELOPMENT,0.36064,-0.0045159,0.065589,0,0
4,GO NEURON DEATH,0.94073,-0.0045322,0.014553,0,0
4,GO NEURON RECOGNITION,0.54321,-0.0045346,0.065879,0,0
4,GO RNA PROCESSING,0.36991,-0.0045349,-0.036489,0,0
4,GO DENDRITE MORPHOGENESIS,0.48131,-0.0045389,0.057717,0,0
4,GO REGULATION OF GASTRULATION,0.90599,-0.0045524,0.058277,0,0
4,GO PROTEIN TARGETING TO LYSOSOME,0.52025,-0.0046389,-0.066952,0,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.66501,-0.0046633,0.047828,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.47588,-0.0046734,-0.027076,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.99651,-0.0046912,0.027959,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.98255,-0.0048081,0.027182,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.48678,-0.0048112,-0.082663,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.69707,-0.0049446,0.039554,0,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.95466,-0.0049491,-0.002995,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.87833,-0.0050754,-0.0089221,0,0
4,GO PHOTOTRANSDUCTION,0.98953,-0.0051651,-0.016628,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.60272,-0.0052434,-0.012412,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.52594,-0.0052607,-0.063497,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.91293,-0.0052735,0.011867,0,0
4,GO REGULATION OF GENE SILENCING,0.83713,-0.0053672,-0.016942,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.84397,-0.0054379,-0.01008,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.82348,-0.0054659,-0.012377,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.5726,-0.0055313,-0.05221,0,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.59059,-0.0056296,0.068396,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.9686,-0.0057189,-0.0046774,0,0
4,GO MITOCHONDRIAL TRNA PROCESSING,0.3746,-0.0057425,-0.063517,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.4545,-0.0058068,0.083863,0,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.61497,-0.0058436,0.047163,0,0
4,GO ORGAN GROWTH,0.76948,-0.0059687,0.034181,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.71006,-0.0060589,0.024141,0,0
4,GO MUSCLE CELL PROLIFERATION,0.97557,-0.0060761,0.0062654,0,0
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.96163,-0.0062235,0.0053674,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.93377,-0.006229,-0.00028971,0,0
4,GO VIRAL RELEASE FROM HOST CELL,0.78962,-0.0062322,-0.026854,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.96163,-0.0062595,-0.0086962,0,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.97557,-0.0063135,-0.0024632,0,0
4,GO TRNA CATABOLIC PROCESS,0.83713,-0.0063534,-0.024314,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.66501,-0.0063759,-0.038102,0,0
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.65866,-0.0064475,-0.012032,0,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.31232,-0.0065247,-0.061819,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.7495,-0.0065933,0.039206,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.80989,-0.006698,-0.026242,0,0
4,GO REGULATION OF CELL ACTIVATION,0.38408,-0.0067532,-0.044731,0,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.67137,-0.0067538,0.051621,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.93377,-0.0067549,-0.00053202,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.98953,-0.0068163,-0.024471,0,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.88523,-0.0068884,0.0094347,0,0
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.99651,-0.0069172,-0.0060275,0,0
4,GO HEART VALVE DEVELOPMENT,0.99651,-0.0069507,0.013186,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.96163,-0.006971,-0.0022897,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.54321,-0.0070951,-0.085861,0,0
4,GO HEART DEVELOPMENT,0.91987,-0.0071102,0.019439,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.85082,-0.0072057,0.0036434,0,0
4,GO REGULATION OF B CELL ACTIVATION,0.42347,-0.0073024,-0.049545,0,0
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.5726,-0.0073246,-0.03051,0,0
4,GO RNA SURVEILLANCE,0.94073,-0.0074058,0.0065498,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.87833,-0.0074072,0.010858,0,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.87144,-0.007412,-0.094587,0,0
4,GO ACTIVATED T CELL PROLIFERATION,0.67776,-0.0074415,-0.034826,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.42855,-0.0074717,-0.038526,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.65234,-0.0075007,-0.018353,0,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.97557,-0.0075307,0.042868,0,0
4,GO CELL CELL SIGNALING BY WNT,0.89215,-0.0075469,0.015009,0,0
4,GO ENTRY INTO HOST,0.2839,-0.0075526,-0.10399,0,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.59059,-0.0076898,-0.05133,0,0
4,GO CELL JUNCTION ORGANIZATION,0.59059,-0.0077591,-0.010817,0,0
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.62113,-0.0078993,-0.035554,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.41341,-0.0079599,0.060837,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.68418,-0.0080162,0.053548,0,0
4,GO RRNA 3 END PROCESSING,0.49227,-0.0080465,-0.053136,0,0
4,GO PORE COMPLEX ASSEMBLY,0.82348,-0.0080817,0.0042896,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.78962,-0.0080899,-0.0062236,0,0
4,GO MICROTUBULE BASED MOVEMENT,1,-0.0081086,0.0085195,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.8303,-0.0081455,-0.017212,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.67137,-0.0081715,-0.014853,0,0
4,GO ENDOCYTIC RECYCLING,0.5726,-0.0082658,-0.020715,0,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.39371,-0.0083425,-0.18106,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.41341,-0.0083513,-0.11549,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.96163,-0.008407,0.022121,0,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.7495,-0.0084623,-0.020841,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.73628,-0.0084688,0.014314,0,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.24643,-0.0086339,-0.070476,0,0
4,GO SEXUAL REPRODUCTION,0.72969,-0.0086679,-0.0085683,0,0
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.53742,-0.0086686,0.033702,0,0
4,GO NEUTRAL AMINO ACID TRANSPORT,0.36991,-0.0086927,-0.086104,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.92682,-0.0087079,0.0032764,0,0
4,GO PROTEIN DESTABILIZATION,0.69061,-0.0087379,-0.019293,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.56075,-0.0088675,-0.026917,0,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.75615,-0.0088829,-0.01201,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.90599,-0.0089813,0.00099851,0,0
4,GO NEURON DEVELOPMENT,0.72969,-0.0089887,0.04073,0,0
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.84397,-0.0090076,-0.011375,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.58456,-0.0090465,-0.059444,0,0
4,GO CELL KILLING,0.30402,-0.0093051,-0.065828,0,0
4,GO BONE CELL DEVELOPMENT,0.85082,-0.0093698,-0.021795,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.53167,-0.0093824,0.039633,0,0
4,GO MESENCHYME MORPHOGENESIS,0.7495,-0.0094319,0.090185,0,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.54903,-0.0095749,-0.058623,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.55487,-0.0095948,0.11624,0,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.33373,-0.0096542,-0.089617,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION,0.3746,-0.0096765,-0.021565,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.99651,-0.0097099,0.012415,0,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.43883,-0.0097141,0.051234,0,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.80312,-0.0098522,-0.024193,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.70355,-0.0099424,-0.035721,0,0
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.85768,-0.010015,-0.0020258,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.90599,-0.010033,-0.0071558,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.78962,-0.010076,-0.00031373,0,0
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.29184,-0.010084,-0.13524,0,0
4,GO POSITIVE REGULATION OF JNK CASCADE,0.27999,-0.010146,-0.050816,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.28785,-0.010235,-0.041126,0,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.21579,-0.010371,-0.15903,0,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.62113,-0.010451,-0.014323,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.77618,-0.010675,0.015739,0,0
4,GO CELL AGING,0.84397,-0.010735,0.011655,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.63978,-0.010754,-0.012348,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.75615,-0.010836,-0.024372,0,0
4,GO DEFENSE RESPONSE TO BACTERIUM,0.18219,-0.01097,-0.081723,0,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.60272,-0.011026,-0.027628,0,0
4,GO DEVELOPMENTAL GROWTH,0.94073,-0.011141,0.026888,0,0
4,GO VIRAL LIFE CYCLE,0.32077,-0.011202,-0.073361,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.76281,-0.011246,0.016717,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.73628,-0.011344,0.035243,0,0
4,GO VESICLE CARGO LOADING,0.73628,-0.011399,-0.034955,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.85768,-0.011525,0.01521,0,0
4,GO RESPONSE TO HYPEROXIA,0.86455,-0.011584,0.035123,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.89907,-0.011598,0.0066313,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.77618,-0.011625,0.023687,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.54321,-0.011626,-0.049848,0,0
4,GO DENDRITE DEVELOPMENT,0.68418,-0.011637,0.037786,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.62732,-0.011845,-0.0095665,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.67137,-0.011863,-0.032862,0,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.89215,-0.011966,-0.030175,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.67137,-0.012,-0.015789,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.42347,-0.012023,-0.089717,0,0
4,GO GOLGI LOCALIZATION,0.99651,-0.012026,0.00015303,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.49227,-0.012111,-0.086802,0,0
4,GO PROTEIN PROCESSING,0.29184,-0.012165,-0.064081,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.83713,-0.012168,0.02531,0,0
4,GO PRE MIRNA PROCESSING,0.95466,-0.01219,-0.020014,0,0
4,GO TOOTH MINERALIZATION,0.76281,-0.012396,0.051753,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.82348,-0.012422,0.0048557,0,0
4,GO CELL AGGREGATION,0.80989,-0.012422,0.025164,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.23245,-0.012426,0.18806,0,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.94073,-0.012509,0.030286,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.90599,-0.012515,0.010496,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.51459,-0.012541,-0.033872,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.67776,-0.012567,-0.045105,0,0
4,GO INTERACTION WITH SYMBIONT,0.29184,-0.012628,-0.063632,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.63978,-0.012638,0.019768,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.60272,-0.012852,-0.01563,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.80989,-0.012879,-0.013557,0,0
4,GO TELOMERE CAPPING,0.60272,-0.012936,-0.01298,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.72969,-0.012982,-0.037533,0,0
4,GO METHYLATION,0.43367,-0.012994,-0.016027,0,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.5726,-0.013064,-0.038719,0,0
4,GO SNORNA METABOLIC PROCESS,0.72969,-0.013077,-0.030501,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.87833,-0.013123,0.0076402,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.78289,-0.013176,-0.023702,0,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.76948,-0.013177,-0.016064,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.72313,-0.013237,-0.013205,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.27611,-0.013244,-0.076572,0,0
4,GO URETER DEVELOPMENT,0.62732,-0.013285,0.079732,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.69707,-0.01329,-0.025217,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.39371,-0.013306,-0.068613,0,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.91987,-0.013312,0.0099124,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.99651,-0.013483,-0.014694,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.67776,-0.013539,-0.020979,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.67137,-0.013587,0.036231,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.54903,-0.01363,-0.01541,0,0
4,GO GERM CELL DEVELOPMENT,0.64605,-0.013684,0.017835,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.94769,-0.013781,0.0034443,0,0
4,GO MAST CELL ACTIVATION,0.61497,-0.013878,-0.031909,0,0
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.89215,-0.013882,-0.032586,0,0
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.74288,-0.013899,-0.027595,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.93377,-0.013907,-0.037836,0,0
4,GO SLEEP,0.69061,-0.013981,-0.035438,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.78289,-0.014022,0.043047,0,0
4,GO CYTOSKELETON ORGANIZATION,0.65234,-0.014023,-0.0018406,0,0
4,GO INNATE IMMUNE RESPONSE,0.20937,-0.014123,-0.082543,0,0
4,GO SNRNA METABOLIC PROCESS,0.20937,-0.014173,-0.090599,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.82348,-0.014292,0.027368,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.52594,-0.014313,-0.061418,0,0
4,GO MYOTUBE DIFFERENTIATION,0.65866,-0.01442,-0.017719,0,0
4,GO COLLATERAL SPROUTING,0.95466,-0.014491,0.01665,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.99651,-0.014495,-0.0010983,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.68418,-0.014576,-0.0094049,0,0
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.20309,-0.014577,-0.097372,0,0
4,GO LIPID EXPORT FROM CELL,0.52025,-0.014591,-0.049183,0,0
4,GO REGULATION OF RESPONSE TO STRESS,0.32938,-0.014613,-0.036132,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.38888,-0.014699,0.13652,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.72313,-0.014729,0.038284,0,0
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.89215,-0.014764,-0.035157,0,0
4,GO OXIDATIVE DEMETHYLATION,0.66501,-0.014855,-0.01581,0,0
4,GO SECRETORY GRANULE ORGANIZATION,0.81668,-0.014863,-0.0033763,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.98953,-0.014888,0.00064225,0,0
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.41341,-0.015003,-0.047906,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.97557,-0.01506,0.0060465,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.2839,-0.015089,-0.09288,0,0
4,GO CYTOKINE PRODUCTION,0.24288,-0.015126,-0.071932,0,0
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.75615,-0.015141,-0.021195,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.30402,-0.015285,-0.075633,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.87833,-0.015296,0.0053105,0,0
4,GO LEUKOCYTE TETHERING OR ROLLING,0.8303,-0.015317,0.00084051,0,0
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.76948,-0.01535,0.033695,0,0
4,GO CELL CELL ADHESION,0.40843,-0.015363,-0.036394,0,0
4,GO CELL MATRIX ADHESION,0.52025,-0.015442,-0.048305,0,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.78962,-0.015448,-0.019687,0,0
4,GO GROWTH,0.71006,-0.015501,0.0079887,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.60272,-0.015645,0.045746,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.87144,-0.015697,0.0315,0,0
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.78289,-0.015785,0.028989,0,0
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.21579,-0.01587,-0.063572,0,0
4,GO POLYOL CATABOLIC PROCESS,0.71658,-0.015877,0.026783,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.39858,-0.015895,-0.047223,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.33373,-0.016017,-0.094771,0,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.35153,-0.016069,-0.022834,0,0
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.42347,-0.016139,-0.04505,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.9686,-0.016154,0.014396,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.91987,-0.016183,-0.0076785,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.58456,-0.016364,0.0020275,0,0
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.5726,-0.016386,-0.047804,0,0
4,GO REGULATION OF CELL ADHESION,0.28785,-0.016399,-0.059188,0,0
4,GO MOVEMENT IN HOST ENVIRONMENT,0.34702,-0.016431,-0.082342,0,0
4,GO MYELOID CELL DIFFERENTIATION,0.23245,-0.016451,-0.053614,0,0
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.91987,-0.01647,-0.00054992,0,0
4,GO SODIUM ION HOMEOSTASIS,0.56666,-0.016559,-0.02596,0,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.87833,-0.016605,-0.0045651,0,0
4,GO GLIOGENESIS,0.66501,-0.016636,0.03116,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.42855,-0.016669,-0.082436,0,0
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,1,-0.016684,-0.021621,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.62113,-0.016693,-0.0186,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.89907,-0.016753,0.00098247,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.71006,-0.01677,-0.02738,0,0
4,GO RESPONSE TO ESTRADIOL,0.68418,-0.017007,-0.00071152,0,0
4,GO CILIUM MOVEMENT,0.73628,-0.017008,-0.0086405,0,0
4,GO HEART TRABECULA FORMATION,0.42855,-0.017029,-0.087102,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.50896,-0.017034,0.084866,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.69061,-0.017394,-0.026811,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.92682,-0.017402,0.026664,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.13814,-0.017468,-0.053804,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.91293,-0.017533,0.022246,0,0
4,GO RECEPTOR CATABOLIC PROCESS,0.15264,-0.017556,-0.10384,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.87833,-0.017708,-0.0047789,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.55487,-0.017735,0.0588,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.59664,-0.017787,-0.017581,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.91987,-0.01788,0.013351,0,0
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.7495,-0.017917,-0.041127,0,0
4,GO RESPONSE TO BIOTIC STIMULUS,0.12908,-0.017924,-0.083378,0,0
4,GO SARCOMERE ORGANIZATION,0.92682,-0.017938,-0.0073294,0,0
4,GO NUCLEAR PORE ORGANIZATION,0.92682,-0.017948,-0.0097748,0,0
4,GO BONE DEVELOPMENT,0.79636,-0.018149,0.040174,0,0
4,GO CYTOPLASM ORGANIZATION,0.79636,-0.018234,0.0042836,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.93377,-0.018266,0.0033802,0,0
4,GO AXON EXTENSION,0.62732,-0.018324,0.021823,0,0
4,GO AXONAL FASCICULATION,0.92682,-0.018412,0.044918,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.26098,-0.018469,-0.14199,0,0
4,GO REGULATION OF T CELL ACTIVATION,0.32506,-0.018503,-0.055523,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.86455,-0.018527,-0.018502,0,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.24643,-0.018613,-0.058456,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.5726,-0.018631,-0.0055098,0,0
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.17099,-0.018638,-0.091501,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.59059,-0.018659,-0.036654,0,0
4,GO CELL MOTILITY,0.50337,-0.018768,-0.022733,0,0
4,GO REGULATION OF MITOPHAGY,0.32938,-0.018824,-0.075449,0,0
4,GO REGULATION OF VASOCONSTRICTION,0.91987,-0.018904,0.0011942,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.40349,-0.018964,-0.072337,0,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.96163,-0.018997,0.053516,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.70355,-0.019056,0.029406,0,0
4,GO MICROTUBULE NUCLEATION,0.60883,-0.019215,-0.010657,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.71006,-0.019275,0.02237,0,0
4,GO SEX DIFFERENTIATION,0.60883,-0.019304,0.0012389,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.43883,-0.019373,-0.04302,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.91987,-0.019375,-0.0020535,0,0
4,GO REGULATION OF ANION TRANSPORT,0.27999,-0.01938,-0.045622,0,0
4,GO DNA MODIFICATION,0.36526,-0.019483,-0.021092,0,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.72969,-0.019495,-0.00607,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.92682,-0.019579,-0.010328,0,0
4,GO REGULATION OF GROWTH,0.47588,-0.019603,-0.0061247,0,0
4,GO CELLULAR RESPONSE TO DSRNA,0.60272,-0.01975,-0.053867,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.82348,-0.019784,0.023293,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.89907,-0.019786,0.014251,0,0
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.5726,-0.019892,-0.036377,0,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.4598,-0.019942,-0.053004,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.16828,-0.019989,-0.10688,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.87144,-0.020018,-0.010511,0,0
4,GO ORGANELLE LOCALIZATION,0.70355,-0.020045,0.0073073,0,0
4,GO JNK CASCADE,0.54903,-0.020194,-0.019161,0,0
4,GO EMBRYO IMPLANTATION,0.77618,-0.020353,-0.0096561,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.94769,-0.020429,0.019108,0,0
4,GO PROTEIN AUTOUBIQUITINATION,0.97557,-0.020529,0.00098457,0,0
4,GO MANNOSYLATION,0.91293,-0.020548,-0.016557,0,0
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.63354,-0.020562,-0.072531,0,0
4,GO TRABECULA MORPHOGENESIS,0.66501,-0.020575,0.065306,0,0
4,GO LACTATE METABOLIC PROCESS,0.63978,-0.020671,-0.022787,0,0
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.41341,-0.02068,-0.034094,0,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.78289,-0.020822,0.034232,0,0
4,GO DENDRITIC CELL MIGRATION,0.60883,-0.020847,-0.0081556,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.43367,-0.020868,-0.10038,0,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.63978,-0.020918,-0.0060872,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.7495,-0.020971,-0.0046061,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.89215,-0.021021,0.020613,0,0
4,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.91293,-0.021075,-0.024338,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.60272,-0.021124,-0.041387,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.33373,-0.021183,0.113,0,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.53742,-0.021255,-0.034708,0,0
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.12473,-0.021324,-0.12777,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.65234,-0.021363,0.038294,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.76281,-0.021415,-0.0077559,0,0
4,GO TAXIS,0.58456,-0.021435,-0.0070503,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.38408,-0.021523,-0.016439,0,0
4,GO RESPONSE TO LIGHT STIMULUS,0.44402,-0.02163,-0.015295,0,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.97557,-0.021777,0.0070967,0,0
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.38408,-0.021791,-0.017667,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.62113,-0.021918,0.012232,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.8303,-0.021925,0.036671,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.52594,-0.021932,-0.0063188,0,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.51459,-0.021974,-0.019694,0,0
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.39858,-0.022072,-0.04648,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.35153,-0.022089,-0.036319,0,0
4,GO SNRNA PROCESSING,0.51459,-0.022101,-0.089889,0,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.39371,-0.022155,-0.026752,0,0
4,GO PROTEIN NITROSYLATION,0.79636,-0.022158,-0.023936,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.61497,-0.022164,-0.00022125,0,0
4,GO LYMPHOCYTE DIFFERENTIATION,0.94073,-0.022166,-0.0057434,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.32938,-0.022243,-0.080889,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.67776,-0.022281,-0.02656,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.63978,-0.02229,-0.0038008,0,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.79636,-0.022304,0.030911,0,0
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.14285,-0.022391,-0.087308,0,0
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.21256,-0.022457,-0.055726,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.81668,-0.022554,0.0083563,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.89215,-0.022713,0.027349,0,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.99651,-0.022801,0.0098419,0,0
4,GO T CELL CHEMOTAXIS,0.44924,-0.022872,-0.069534,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.54321,-0.022891,-0.011081,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.68418,-0.022897,-1.4394e-05,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.80989,-0.022937,0.002941,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.40843,-0.023008,-0.050589,0,0
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.38408,-0.023018,-0.05057,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.82348,-0.023145,0.0066349,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.8303,-0.02317,0.010076,0,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.29586,-0.023194,-0.15071,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.55487,-0.023209,-0.021732,0,0
4,GO GLIAL CELL DEVELOPMENT,0.92682,-0.023254,0.0022962,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.52594,-0.023299,-0.041567,0,0
4,GO MRNA METABOLIC PROCESS,0.31232,-0.023442,-0.036626,0,0
4,GO GRANULOCYTE MIGRATION,0.19393,-0.023453,-0.082034,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.65866,-0.023453,0.013767,0,0
4,GO REGULATION OF AXON GUIDANCE,0.76948,-0.023464,0.050719,0,0
4,GO MICROTUBULE POLYMERIZATION,0.39371,-0.023515,-0.029498,0,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.76281,-0.023579,0.014877,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.29992,-0.023621,-0.038301,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.57857,-0.023628,-0.0039019,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.19393,-0.02372,-0.088889,0,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.76281,-0.023763,-0.036605,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.54321,-0.023817,-0.11476,0,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.63978,-0.023974,-0.0011915,0,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.66501,-0.023996,-0.021456,0,0
4,GO INTERACTION WITH HOST,0.38888,-0.024002,-0.069039,0,0
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.73628,-0.024067,-0.014563,0,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.32077,-0.024108,-0.047034,0,0
4,GO INFLAMMATORY RESPONSE,0.16559,-0.024203,-0.08047,0,0
4,GO STEROL BIOSYNTHETIC PROCESS,0.40349,-0.024204,-0.058622,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.16032,-0.02422,-0.056445,0,0
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.070855,-0.024297,-0.13298,0,0
4,GO PROTEIN KINASE B SIGNALING,0.50896,-0.024371,-0.034207,0,0
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.65866,-0.024474,-0.022822,0,0
4,GO MACROPHAGE MIGRATION,0.54321,-0.024475,-0.039225,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.94073,-0.024602,0.0058572,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.74288,-0.024627,-0.024129,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.30402,-0.024635,-0.07798,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.69707,-0.024701,-0.014229,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.26847,-0.024829,-0.088006,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.35607,-0.024871,-0.024148,0,0
4,GO RESPONSE TO MECHANICAL STIMULUS,0.58456,-0.024933,-0.026527,0,0
4,GO DEFENSE RESPONSE,0.11841,-0.025068,-0.084423,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.72969,-0.025119,-0.034252,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.70355,-0.025137,0.053562,0,0
4,GO OSSIFICATION,0.71658,-0.025214,-0.0077388,0,0
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.31653,-0.02523,-0.079601,0,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.36064,-0.025382,-0.011917,0,0
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.21579,-0.025385,-0.057275,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.93377,-0.025453,0.018625,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.67776,-0.025604,-0.020023,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.37932,-0.025645,-0.035902,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.54903,-0.02567,-0.034719,0,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.54321,-0.025791,-0.074482,0,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.7495,-0.025818,0.0063263,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.44402,-0.02582,-0.054763,0,0
4,GO REGULATION OF ENDOCRINE PROCESS,0.34702,-0.025912,-0.059854,0,0
4,GO POSITIVE REGULATION OF SIGNALING,0.24288,-0.025954,-0.033926,0,0
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.15015,-0.026042,-0.060252,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.41341,-0.026071,-0.021124,0,0
4,GO MITOCHONDRION LOCALIZATION,0.95466,-0.026109,0.030625,0,0
4,GO LYSINE METABOLIC PROCESS,0.53167,-0.026113,-0.086168,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.36991,-0.0262,-0.051422,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.56075,-0.026206,-0.043458,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.80989,-0.02623,-0.034728,0,0
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.33373,-0.02625,-0.043041,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.86455,-0.026486,0.023359,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.67137,-0.026511,-0.014897,0,0
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.97557,-0.026518,-0.00059671,0,0
4,GO SENSORY PERCEPTION OF PAIN,0.90599,-0.02654,0.0030007,0,0
4,GO RESPONSE TO WOUNDING,0.31653,-0.026586,-0.060522,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.94073,-0.026626,0.017125,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.66501,-0.026754,-0.019183,0,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.58456,-0.026839,-0.015408,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.47049,-0.027035,0.060917,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.9686,-0.027087,-0.0029945,0,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.56075,-0.027109,-0.057896,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.55487,-0.027124,-0.019712,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.65234,-0.027231,0.0028653,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.41341,-0.027314,-0.063583,0,0
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.54321,-0.02744,-0.03024,0,0
4,GO GASTRULATION,0.63354,-0.027444,-0.013782,0,0
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.79636,-0.027489,0.040424,0,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.85082,-0.027633,-0.0022425,0,0
4,GO MULTI ORGANISM PROCESS,0.31232,-0.027757,-0.024679,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.92682,-0.027866,0.019943,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.42347,-0.02795,-0.10694,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.84397,-0.027976,-0.0064383,0,0
4,GO SUCKLING BEHAVIOR,0.5726,-0.027992,-0.051205,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.38888,-0.028018,-0.02735,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.69707,-0.02805,-0.054728,0,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.63978,-0.028071,-0.010951,0,0
4,GO TUBE DEVELOPMENT,0.69061,-0.028147,-0.0091664,0,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.67137,-0.028151,-0.033225,0,0
4,GO CELL PROJECTION ORGANIZATION,0.81668,-0.028194,0.028072,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.63978,-0.028304,-0.012309,0,0
4,GO NEUTROPHIL CHEMOTAXIS,0.79636,-0.028463,-0.023348,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.8303,-0.0285,0.021388,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.46512,-0.028564,-0.047473,0,0
4,GO INTERLEUKIN 4 PRODUCTION,0.14048,-0.028578,-0.10365,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.71658,-0.028662,0.016258,0,0
4,GO NIK NF KAPPAB SIGNALING,0.48678,-0.028697,-0.067435,0,0
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.32938,-0.028733,-0.083823,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.17099,-0.028858,-0.072465,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.81668,-0.028914,-0.0096918,0,0
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.64605,-0.029087,0.046738,0,0
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.22568,-0.029145,-0.054013,0,0
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.1313,-0.029199,-0.070242,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.7495,-0.02922,0.00042064,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.87833,-0.029252,-0.0051852,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.53167,-0.029276,0.03272,0,0
4,GO PEPTIDYL SERINE MODIFICATION,0.22235,-0.02929,-0.029849,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.94769,-0.029336,0.039851,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.44402,-0.029429,-0.02468,0,0
4,GO RESPONSE TO NICOTINE,0.94769,-0.029482,0.029615,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.54321,-0.029555,-0.042089,0,0
4,GO REGULATION OF RESPONSE TO WOUNDING,0.64605,-0.029757,-0.0337,0,0
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.51459,-0.029779,-0.017499,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.20621,-0.02979,-0.070872,0,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.89907,-0.029911,-0.0034756,0,0
4,GO PHAGOSOME MATURATION,0.63978,-0.029925,-0.039594,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.69707,-0.029958,-0.032843,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.94073,-0.029961,-0.072445,0,0
4,GO REGULATION OF INTEGRIN ACTIVATION,0.32938,-0.030256,-0.095974,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.59664,-0.030417,0.049969,0,0
4,GO LIPID TRANSLOCATION,0.34256,-0.030483,-0.065044,0,0
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.23589,-0.030484,-0.028896,0,0
4,GO RESPONSE TO BACTERIUM,0.097379,-0.03056,-0.099571,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.80989,-0.0306,0.01407,0,0
4,GO ENDOTHELIUM DEVELOPMENT,0.78289,-0.030763,0.03035,0,0
4,GO NEUTROPHIL MIGRATION,0.30815,-0.030839,-0.056273,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.53167,-0.030853,-0.014876,0,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.62732,-0.03095,-0.022426,0,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.7495,-0.030963,0.011579,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.55487,-0.031206,-0.015836,0,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.96163,-0.031251,0.0017284,0,0
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.34256,-0.03137,-0.067763,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.46512,-0.031388,-0.07533,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.4598,-0.031432,-0.036645,0,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.87833,-0.031522,-0.01748,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.41842,-0.03165,-0.04765,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.85768,-0.031708,-0.010589,0,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.43883,-0.031741,-0.024462,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.78962,-0.031787,0.010242,0,0
4,GO REGULATION OF WOUND HEALING,0.2839,-0.031798,-0.080592,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.72313,-0.031861,-0.017107,0,0
4,GO NEURON CELL CELL ADHESION,0.36526,-0.031881,0.21366,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.98953,-0.03196,0.0080618,0,0
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.3746,-0.032028,-0.15868,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.98953,-0.032085,0.0054254,0,0
4,GO PH REDUCTION,0.70355,-0.032175,-0.021352,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.77618,-0.032222,0.047232,0,0
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.27227,-0.032254,-0.060845,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.53742,-0.032374,-0.03962,0,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.48131,-0.032404,-0.019357,0,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.39858,-0.032463,-0.050165,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.31653,-0.032478,-0.029096,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.47049,-0.032631,-0.02796,0,0
4,GO SPERMATID DIFFERENTIATION,0.65234,-0.032698,0.0043384,0,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.44924,-0.032746,-0.060137,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.51459,-0.032747,0.076537,0,0
4,GO RESPONSE TO RADIATION,0.50337,-0.032806,-0.0095606,0,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.49227,-0.032818,-0.066694,0,0
4,GO CELL GROWTH,0.32077,-0.032836,-0.014546,0,0
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.3746,-0.032838,-0.092756,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.31653,-0.032857,-0.036661,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.55487,-0.032869,-0.015849,0,0
4,GO TUBE MORPHOGENESIS,0.55487,-0.032896,-0.017018,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.61497,-0.033065,-0.053722,0,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.92682,-0.033273,0.031234,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.16032,-0.033287,-0.074488,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.42855,-0.033401,-0.01776,0,0
4,GO REGULATION OF BINDING,0.43367,-0.033426,-0.029329,0,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.39858,-0.033588,-0.031415,0,0
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.52594,-0.033596,-0.048475,0,0
4,GO ACTIN FILAMENT BASED PROCESS,0.36526,-0.033627,-0.027304,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.53167,-0.03369,-0.023382,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.83713,-0.033847,0.033697,0,0
4,GO REGULATION OF HORMONE SECRETION,0.69707,-0.033877,-0.01091,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.56666,-0.033886,0.064625,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.71006,-0.033905,-0.010098,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.51459,-0.033991,-0.035655,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.43883,-0.034058,-0.076011,0,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.24643,-0.034153,-0.092246,0,0
4,GO ORGAN INDUCTION,0.96163,-0.034342,0.045905,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.5726,-0.034442,-0.048387,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.36526,-0.034494,-0.044872,0,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.27611,-0.034517,-0.079316,0,0
4,GO RNA 3 END PROCESSING,0.99651,-0.034533,-0.01432,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.94073,-0.034574,0.0049764,0,0
4,GO REGULATION OF PEPTIDE TRANSPORT,0.23245,-0.034801,-0.035599,0,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.079444,-0.034821,-0.047432,0,0
4,GO REGULATION OF PROTEIN MATURATION,0.39371,-0.034893,-0.059256,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.55487,-0.034963,-0.02454,0,0
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.72969,-0.035027,-0.034607,0,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.53742,-0.03507,0.042656,0,0
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.17934,-0.035195,-0.048615,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.61497,-0.035196,-0.0066979,0,0
4,GO ER NUCLEUS SIGNALING PATHWAY,0.32938,-0.035364,-0.065075,0,0
4,GO RESPONSE TO CYTOKINE,0.14526,-0.035387,-0.080795,0,0
4,GO INTERFERON ALPHA PRODUCTION,0.89215,-0.035494,-0.0054875,0,0
4,GO REGULATION OF DEFENSE RESPONSE,0.27611,-0.035723,-0.051652,0,0
4,GO MITOCHONDRION DISTRIBUTION,0.87144,-0.035727,0.044843,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.27999,-0.035774,-0.06843,0,0
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.21256,-0.035863,-0.042871,0,0
4,GO MRNA TRANSCRIPTION,0.92682,-0.036005,-0.0040798,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.29586,-0.036007,-0.035302,0,0
4,GO ORGANELLE ASSEMBLY,0.56075,-0.036083,-0.013198,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.28785,-0.036094,-0.076063,0,0
4,GO RESPONSE TO GLUCAGON,0.41842,-0.036217,-0.066666,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.60883,-0.036291,-0.032491,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.97557,-0.036371,0.032659,0,0
4,GO PROTEIN STABILIZATION,0.17374,-0.036524,-0.047204,0,0
4,GO T CELL ACTIVATION,0.38888,-0.036561,-0.050134,0,0
4,GO MULTIVESICULAR BODY ORGANIZATION,0.69061,-0.036618,-0.010119,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.70355,-0.036726,-0.010859,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.70355,-0.036871,-0.076064,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.90599,-0.036893,0.0050098,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.4545,-0.036905,-0.057971,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.64605,-0.036924,-0.012897,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.71658,-0.037046,-0.011271,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.64605,-0.03713,-0.016531,0,0
4,GO MEMBRANE HYPERPOLARIZATION,0.41842,-0.037198,-0.044512,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.75615,-0.037221,-0.012419,0,0
4,GO REGULATION OF PEPTIDE SECRETION,0.19393,-0.037223,-0.048818,0,0
4,GO POTASSIUM ION HOMEOSTASIS,0.8303,-0.037233,-0.011391,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.22235,-0.037243,-0.16823,0,0
4,GO UBIQUINONE METABOLIC PROCESS,0.13814,-0.037286,-0.099334,0,0
4,GO LEUKOCYTE HOMEOSTASIS,0.34256,-0.037323,-0.03916,0,0
4,GO COAGULATION,0.11434,-0.037328,-0.090122,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.32506,-0.037356,-0.082405,0,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.26847,-0.037359,-0.037818,0,0
4,GO BONE REMODELING,0.71658,-0.037399,-0.039521,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.90599,-0.037433,0.035454,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.65234,-0.037438,0.013753,0,0
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.46512,-0.037456,-0.043015,0,0
4,GO CELL CELL SIGNALING,0.40349,-0.037578,-0.010168,0,0
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.5726,-0.037606,-0.014779,0,0
4,GO RETROGRADE AXONAL TRANSPORT,0.96163,-0.037667,0.0082694,0,0
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.63978,-0.03767,-0.038258,0,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.36526,-0.037702,-0.037431,0,0
4,GO BASE EXCISION REPAIR,0.12049,-0.037713,-0.081047,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.65866,-0.037721,-0.014399,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.24643,-0.037802,-0.060257,0,0
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.20621,-0.037826,-0.081223,0,0
4,GO POSITIVE REGULATION OF CELL DEATH,0.27999,-0.037893,-0.037059,0,0
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.57857,-0.037904,-0.040753,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.25001,-0.038073,-0.0428,0,0
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.59059,-0.038075,-0.016036,0,0
4,GO VASCULOGENESIS,0.41842,-0.038119,-0.084386,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.78962,-0.038147,-0.0095737,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.80989,-0.038228,0.028257,0,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.16559,-0.038362,-0.016246,0,0
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.83713,-0.038589,-0.037066,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.59664,-0.038614,0.041435,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.188,-0.038638,-0.11439,0,0
4,GO RIG I SIGNALING PATHWAY,0.27999,-0.038752,-0.085388,0,0
4,GO BLASTOCYST DEVELOPMENT,0.15773,-0.038793,-0.045927,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.81668,-0.038829,0.008824,0,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.76948,-0.038872,-0.0059196,0,0
4,GO MEMBRANE DOCKING,0.64605,-0.038894,0.0098716,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.72313,-0.03893,-0.019805,0,0
4,GO NOTOCHORD DEVELOPMENT,0.97557,-0.038954,0.043217,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.94769,-0.038993,0.0096883,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.29992,-0.039016,-0.023798,0,0
4,GO CELLULAR RESPONSE TO FATTY ACID,0.41341,-0.03907,-0.067234,0,0
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.1313,-0.039071,-0.10249,0,0
4,GO SPERM AXONEME ASSEMBLY,0.76948,-0.039132,0.044717,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.47588,-0.039177,-0.063667,0,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.38888,-0.039186,-0.054163,0,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.37932,-0.039187,-0.030729,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.29586,-0.039197,-0.063525,0,0
4,GO TISSUE REGENERATION,0.60883,-0.039209,-0.041273,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.4978,-0.039263,-0.033461,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.87833,-0.0393,-0.012947,0,0
4,GO ACETYL COA METABOLIC PROCESS,0.5726,-0.039374,-0.044824,0,0
4,GO WATER TRANSPORT,0.072231,-0.039375,-0.11126,0,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.24288,-0.039387,-0.031754,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.063042,-0.039398,-0.040672,0,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.50896,-0.039416,-0.0079616,0,0
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.25729,-0.03947,-0.047921,0,0
4,GO LEUKOCYTE DIFFERENTIATION,0.32938,-0.039484,-0.039605,0,0
4,GO DNA CATABOLIC PROCESS,0.52025,-0.039489,-0.014215,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.56666,-0.03949,-0.026292,0,0
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.35607,-0.039499,-0.057018,0,0
4,GO RESPONSE TO VITAMIN A,0.94073,-0.039553,-0.002645,0,0
4,GO AMINO ACID IMPORT,0.30402,-0.039621,-0.079286,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.69061,-0.039644,-0.0096461,0,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.22905,-0.039739,-0.069997,0,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.49227,-0.039787,-0.054671,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.24288,-0.039789,-0.071599,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.26847,-0.039811,-0.077683,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.42347,-0.039821,-0.035783,0,0
4,GO REGULATION OF CELLULAR PH,0.37932,-0.039925,-0.037874,0,0
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.22905,-0.039967,-0.10672,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.40843,-0.039996,-0.054465,0,0
4,GO MIRNA METABOLIC PROCESS,0.34256,-0.040063,-0.042522,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.34256,-0.040117,-0.03383,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.80989,-0.040187,-0.022962,0,0
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.3746,-0.04022,-0.036097,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.87833,-0.040307,0.0060526,0,0
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.066855,-0.040331,-0.065805,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.44924,-0.040407,-0.043426,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.36064,-0.040434,-0.072129,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.44402,-0.040476,-0.041945,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.23589,-0.040548,-0.024755,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42855,-0.040628,-0.052225,0,0
4,GO REGULATION OF CELL DEATH,0.22235,-0.040709,-0.035132,0,0
4,GO SEGMENTATION,0.65866,-0.04071,0.062645,0,0
4,GO REGENERATION,0.25363,-0.04073,-0.056958,0,0
4,GO TOR SIGNALING,0.075049,-0.040752,-0.049231,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.43883,-0.040762,-0.081625,0,0
4,GO SPERM CAPACITATION,0.8303,-0.04077,-0.0050302,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.32077,-0.040819,-0.12397,0,0
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.32506,-0.040923,-0.10508,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.91987,-0.040928,-0.083496,0,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,1,-0.040961,-0.0033499,0,0
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.079444,-0.040974,-0.067316,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.53742,-0.041001,-0.02872,0,0
4,GO AGING,0.12259,-0.041003,-0.065123,0,0
4,GO STRIATUM DEVELOPMENT,0.188,-0.041003,-0.10327,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.14526,-0.041032,-0.045676,0,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.21579,-0.041078,-0.055138,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.25363,-0.041095,-0.071934,0,0
4,GO ATP BIOSYNTHETIC PROCESS,0.40349,-0.041133,-0.056226,0,0
4,GO REGULATION OF CELL CELL ADHESION,0.19393,-0.041163,-0.076283,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.36526,-0.0412,-0.13743,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.17934,-0.041221,-0.080579,0,0
4,GO SUPEROXIDE ANION GENERATION,0.49227,-0.041222,-0.076126,0,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.78962,-0.04123,-0.009788,0,0
4,GO GLYCOSYLATION,0.16559,-0.041406,-0.068819,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.92682,-0.041426,0.04126,0,0
4,GO RNA POLYADENYLATION,0.27999,-0.041498,-0.046889,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.86455,-0.041531,-0.060458,0,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.30815,-0.041537,-0.050445,0,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.15517,-0.041647,-0.096263,0,0
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.188,-0.041776,-0.085014,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.63978,-0.041779,-0.035203,0,0
4,GO CHLORIDE ION HOMEOSTASIS,0.29586,-0.041847,-0.072392,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.099158,-0.041856,-0.069937,0,0
4,GO APOPTOTIC PROCESS,0.17099,-0.041868,-0.041858,0,0
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.7495,-0.04193,-0.017831,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.54321,-0.041949,-0.024566,0,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.20937,-0.041966,-0.051508,0,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.1028,-0.041981,-0.088755,0,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.27999,-0.042136,-0.085959,0,0
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.43367,-0.042206,-0.041517,0,0
4,GO DEVELOPMENTAL CELL GROWTH,0.33812,-0.042249,0.0043411,0,0
4,GO REGULATION OF CELL MATURATION,0.9686,-0.042336,0.0091142,0,0
4,GO VACUOLAR TRANSPORT,0.27227,-0.042429,-0.046332,0,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.17934,-0.042574,-0.097454,0,0
4,GO NEGATIVE REGULATION OF CELL DEATH,0.44402,-0.042599,-0.0211,0,0
4,GO TOXIN TRANSPORT,0.51459,-0.042637,-0.042525,0,0
4,GO FOREBRAIN CELL MIGRATION,0.80312,-0.042722,0.0079332,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.22235,-0.042744,-0.038333,0,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.66501,-0.042784,-0.012816,0,0
4,GO LEUKOCYTE CELL CELL ADHESION,0.17374,-0.042875,-0.077169,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.65234,-0.04296,0.063427,0,0
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.27611,-0.043035,-0.060016,0,0
4,GO PHOTOPERIODISM,0.26471,-0.043238,-0.052713,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.4978,-0.043318,-0.02852,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.72313,-0.043345,-0.00045482,0,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.44402,-0.043472,-0.052058,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.25363,-0.043516,-0.027222,0,0
4,GO RESPONSE TO ANGIOTENSIN,0.27999,-0.043558,-0.1108,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.76948,-0.043826,0.062441,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.54903,-0.04383,-0.047774,0,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.088862,-0.043852,-0.12006,0,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.70355,-0.043873,-0.02843,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.87144,-0.043887,0.0057198,0,0
4,GO TUBULIN DEACETYLATION,0.75615,-0.043913,0.034077,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.85082,-0.043965,0.0021583,0,0
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.17374,-0.044147,-0.067633,0,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.62113,-0.044172,-0.052586,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.26847,-0.044186,-0.056461,0,0
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.40349,-0.044187,-0.074322,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.58456,-0.044204,-0.050775,0,0
4,GO CELL SUBSTRATE ADHESION,0.31232,-0.044304,-0.065408,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.31653,-0.044308,-0.12017,0,0
4,GO RESPONSE TO INTERLEUKIN 6,0.4598,-0.044314,-0.045581,0,0
4,GO VASCULATURE DEVELOPMENT,0.42347,-0.044403,-0.032941,0,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.4598,-0.044444,-0.023965,0,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.61497,-0.044626,-0.13217,0,0
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.32077,-0.044634,-0.10367,0,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.29184,-0.044707,-0.047938,0,0
4,GO RHYTHMIC PROCESS,0.47049,-0.044803,-0.017306,0,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.085627,-0.044862,-0.058613,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.28785,-0.044896,-0.028352,0,0
4,GO GOLGI TO VACUOLE TRANSPORT,0.36526,-0.044919,-0.062945,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.87833,-0.044967,0.013484,0,0
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.29992,-0.04507,-0.047433,0,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.48678,-0.045194,-0.02701,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.62732,-0.045196,0.0094325,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.54321,-0.045241,0.0017658,0,0
4,GO REGULATION OF PLATELET ACTIVATION,0.47049,-0.045284,-0.068436,0,0
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.70355,-0.045395,-0.062947,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.25729,-0.045565,-0.035113,0,0
4,GO APOPTOTIC SIGNALING PATHWAY,0.13814,-0.045576,-0.060125,0,0
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.88523,-0.045645,0.0048932,0,0
4,GO CELLULAR PIGMENTATION,0.19393,-0.04568,-0.061252,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.58456,-0.045687,-0.027422,0,0
4,GO NODAL SIGNALING PATHWAY,0.29184,-0.045726,-0.075643,0,0
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.17934,-0.045819,-0.10331,0,0
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.48131,-0.045961,-0.042182,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.78962,-0.04599,0.083834,0,0
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.188,-0.046006,-0.086816,0,0
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.29586,-0.046027,-0.082651,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.44924,-0.046064,-0.059097,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.54321,-0.046094,-0.055407,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.27611,-0.046193,-0.076948,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.28785,-0.046226,-0.089971,0,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.44402,-0.046227,-0.10906,0,0
4,GO CGMP METABOLIC PROCESS,0.26098,-0.046231,-0.11988,0,0
4,GO VAGINA DEVELOPMENT,0.27999,-0.046304,-0.10406,0,0
4,GO CHOLESTEROL STORAGE,0.36526,-0.046346,-0.066688,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.088862,-0.046414,-0.071519,0,0
4,GO REGULATION OF HYDROLASE ACTIVITY,0.11434,-0.046478,-0.055936,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.56075,-0.046491,-0.059301,0,0
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.42347,-0.046501,-0.030403,0,0
4,GO REGULATION OF ICOSANOID SECRETION,0.4545,-0.046534,-0.047538,0,0
4,GO BONE RESORPTION,0.25363,-0.04654,-0.089257,0,0
4,GO POSITIVE REGULATION OF CELL SIZE,0.64605,-0.046573,-0.042256,0,0
4,GO WATER HOMEOSTASIS,0.7495,-0.046582,0.0015956,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.28785,-0.046592,-0.099459,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.82348,-0.046692,0.0013138,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.44402,-0.046824,-0.050422,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.23245,-0.046825,-0.044001,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.27999,-0.046836,-0.045699,0,0
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.38888,-0.046902,-0.050223,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.95466,-0.046995,-0.0039059,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.59059,-0.04702,0.00015138,0,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.40843,-0.047127,-0.041085,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.67137,-0.047134,-0.032118,0,0
4,GO POSITIVE REGULATION OF CELL ADHESION,0.11841,-0.047163,-0.092646,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.33812,-0.047171,-0.030345,0,0
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.39858,-0.04718,-0.047137,0,0
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.34702,-0.047285,-0.043722,0,0
4,GO REPLICATIVE SENESCENCE,0.38888,-0.047296,-0.093181,0,0
4,GO ACTIN FILAMENT ORGANIZATION,0.21905,-0.047377,-0.043409,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.79636,-0.04742,0.021652,0,0
4,GO RESPONSE TO ACTIVITY,0.38888,-0.047487,-0.025061,0,0
4,GO AMINE BIOSYNTHETIC PROCESS,0.55487,-0.047488,-0.041161,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.78289,-0.047499,0.038667,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.80312,-0.047625,-0.034966,0,0
4,GO REGULATION OF OSSIFICATION,0.49227,-0.047719,-0.045726,0,0
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.090515,-0.047862,-0.09548,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.65866,-0.047911,-0.014165,0,0
4,GO GOLGI RIBBON FORMATION,0.50337,-0.048012,-0.028405,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.54321,-0.048016,-0.024397,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.55487,-0.048067,-0.0034559,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.36526,-0.048112,-0.029764,0,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.77618,-0.048211,-0.012403,0,0
4,GO HEAT GENERATION,0.58456,-0.048225,-0.015671,0,0
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.11434,-0.048376,-0.0779,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.14769,-0.048566,-0.070764,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.72969,-0.048612,-0.030816,0,0
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.15517,-0.048684,-0.042028,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.10654,-0.048713,-0.056056,0,0
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.15015,-0.048715,-0.040547,0,0
4,GO REGULATION OF FATTY ACID TRANSPORT,0.4598,-0.048804,-0.061082,0,0
4,GO HETEROTYPIC CELL CELL ADHESION,0.66501,-0.048842,-0.019693,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.20621,-0.048858,-0.11883,0,0
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.20937,-0.048985,-0.030898,0,0
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.49227,-0.04902,-0.025314,0,0
4,GO LYMPHOCYTE ACTIVATION,0.26847,-0.049104,-0.050974,0,0
4,GO PROTEIN MATURATION,0.095625,-0.049141,-0.07172,0,0
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.32938,-0.049163,-0.053078,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.084046,-0.049193,-0.12208,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.36991,-0.04922,-0.067719,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.17374,-0.049284,-0.12187,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.16828,-0.049292,-0.041132,0,0
4,GO REGULATION OF ACTION POTENTIAL,0.22905,-0.049408,-0.080238,0,0
4,GO ANIMAL ORGAN MATURATION,0.14526,-0.049425,-0.10139,0,0
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.17653,-0.049589,-0.066155,0,0
4,GO PLATELET ACTIVATION,0.20937,-0.049696,-0.063995,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.33812,-0.04976,-0.042422,0,0
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.14526,-0.04977,-0.15337,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.57857,-0.049777,-0.0079906,0,0
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.32077,-0.049813,-0.030936,0,0
4,GO GLUCOSE IMPORT,0.90599,-0.049996,0.0008655,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.20621,-0.050043,-0.018725,0,0
4,GO CELL ACTIVATION,0.099158,-0.050163,-0.083395,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.63354,-0.050212,0.057715,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.80312,-0.050223,-0.026489,0,0
4,GO REGULATION OF SECRETION,0.16828,-0.05029,-0.044301,0,0
4,GO POSTSYNAPSE ORGANIZATION,0.72313,-0.050318,0.0060868,0,0
4,GO T CELL APOPTOTIC PROCESS,0.32938,-0.050347,-0.064122,0,0
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.22905,-0.050373,-0.077884,0,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.20621,-0.050395,-0.048807,0,0
4,GO GRANULOCYTE CHEMOTAXIS,0.3746,-0.050484,-0.060847,0,0
4,GO MYOFIBRIL ASSEMBLY,0.17934,-0.050577,-0.069601,0,0
4,GO MUSCLE CELL DEVELOPMENT,0.20621,-0.050696,-0.06273,0,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.24643,-0.050721,-0.066123,0,0
4,GO POSITIVE REGULATION OF CELL KILLING,0.62732,-0.050747,-0.047377,0,0
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.17934,-0.050757,-0.032781,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.87833,-0.050793,0.021014,0,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.27611,-0.050801,-0.09941,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.87144,-0.050804,0.018374,0,0
4,GO VIRION ASSEMBLY,0.23245,-0.050811,-0.05422,0,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.78962,-0.050833,-0.013382,0,0
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.63354,-0.050893,-0.031803,0,0
4,GO GAP JUNCTION ASSEMBLY,0.70355,-0.050899,-0.035765,0,0
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.81668,-0.050942,-0.019292,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.38408,-0.051009,-0.047535,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.25001,-0.051108,-0.038917,0,0
4,GO CARBOHYDRATE TRANSPORT,0.14526,-0.051226,-0.061784,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.72313,-0.051294,0.01644,0,0
4,GO REGULATION OF PROTEOLYSIS,0.088862,-0.051368,-0.079466,0,0
4,GO TYPE 2 IMMUNE RESPONSE,0.12049,-0.051479,-0.16026,0,0
4,GO IMMATURE T CELL PROLIFERATION,0.69707,-0.051523,-0.025779,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.79636,-0.051525,-0.02094,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.33812,-0.05153,-0.016589,0,0
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.085627,-0.051595,-0.063337,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,1,-0.05161,0.042124,0,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.32938,-0.051806,-0.040993,0,0
4,GO LYMPHOCYTE MIGRATION,0.084046,-0.051877,-0.085023,0,0
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.52594,-0.051904,-0.10453,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.71006,-0.051942,0.0097087,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.2839,-0.051971,-0.068714,0,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.4598,-0.051977,-0.043864,0,0
4,GO REGULATION OF TOR SIGNALING,0.099158,-0.052008,-0.052948,0,0
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.085627,-0.052019,-0.054193,0,0
4,GO LYSOSOMAL TRANSPORT,0.23589,-0.052101,-0.054886,0,0
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.32077,-0.052145,-0.079166,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.23937,-0.052203,-0.073745,0,0
4,GO INOSITOL METABOLIC PROCESS,0.23245,-0.052225,-0.094884,0,0
4,GO NEURON PROJECTION ORGANIZATION,0.50337,-0.052321,-0.04242,0,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.3746,-0.052322,-0.049064,0,0
4,GO RECEPTOR CLUSTERING,0.71006,-0.052404,-0.016319,0,0
4,GO B CELL DIFFERENTIATION,0.28785,-0.05244,-0.0472,0,0
4,GO OVULATION CYCLE PROCESS,0.14526,-0.052489,-0.073364,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.29992,-0.052542,-0.10863,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.65866,-0.052608,-0.011574,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.19695,-0.052627,-0.051505,0,0
4,GO ZYMOGEN ACTIVATION,0.20937,-0.052843,-0.16488,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.8303,-0.052906,-0.01016,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.24288,-0.052914,-0.03895,0,0
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.082489,-0.052962,-0.06443,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.21579,-0.053142,-0.055005,0,0
4,GO CELLULAR RESPONSE TO KETONE,0.20937,-0.053242,-0.068016,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.16294,-0.053248,-0.029143,0,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.15264,-0.053279,-0.083972,0,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.63354,-0.053301,-0.022098,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.85082,-0.053328,-0.056676,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.19095,-0.053367,-0.075175,0,0
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.11039,-0.053394,-0.079618,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.29184,-0.053444,-0.095021,0,0
4,GO REGULATION OF FATTY ACID OXIDATION,0.41341,-0.053573,-0.051574,0,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.23937,-0.053638,-0.051551,0,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.26098,-0.053675,-0.10423,0,0
4,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.21905,-0.053894,-0.13073,0,0
4,GO AMELOGENESIS,0.49227,-0.053997,-0.045185,0,0
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.26847,-0.054006,-0.047215,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.60883,-0.054032,-0.038001,0,0
4,GO COGNITION,0.43367,-0.054065,-0.024076,0,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.73628,-0.054084,-0.013662,0,0
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.29992,-0.054132,-0.044471,0,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.29992,-0.05415,-0.031004,0,0
4,GO REGULATION OF RESPONSE TO FOOD,0.48678,-0.054208,-0.050894,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.82348,-0.05421,0.029323,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.17099,-0.054234,-0.069549,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.23245,-0.054256,-0.09802,0,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.92682,-0.05433,0.020622,0,0
4,GO REGULATION OF BODY FLUID LEVELS,0.092194,-0.054429,-0.081622,0,0
4,GO GLYCINE METABOLIC PROCESS,0.4598,-0.054447,-0.10363,0,0
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.29992,-0.054555,-0.052166,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.5726,-0.054579,-0.020456,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.37932,-0.054688,0.0072785,0,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.2839,-0.054711,-0.064807,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.13814,-0.054772,-0.096595,0,0
4,GO NUCLEOSIDE SALVAGE,0.2839,-0.054784,-0.089395,0,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.23589,-0.054802,-0.090406,0,0
4,GO RESPONSE TO TYPE I INTERFERON,0.85082,-0.054867,-0.072656,0,0
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.15773,-0.054886,-0.080595,0,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.095625,-0.054896,-0.073499,0,0
4,GO CELLULAR RESPONSE TO STARVATION,0.10654,-0.055007,-0.071164,0,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.63978,-0.055015,0.087391,0,0
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.22235,-0.055235,-0.060317,0,0
4,GO METHIONINE METABOLIC PROCESS,0.18219,-0.055314,-0.082084,0,0
4,GO POSITIVE REGULATION OF CELL AGING,0.67137,-0.05542,-0.0033981,0,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.48131,-0.055435,-0.0056568,0,0
4,GO PROTEIN TARGETING TO VACUOLE,0.15773,-0.055454,-0.079832,0,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.15773,-0.055541,-0.054195,0,0
4,GO CAMP BIOSYNTHETIC PROCESS,0.98953,-0.055562,0.011812,0,0
4,GO POSITIVE REGULATION OF WOUND HEALING,0.39371,-0.055589,-0.076271,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.72313,-0.055651,-0.04578,0,0
4,GO NCRNA 3 END PROCESSING,0.15015,-0.055689,-0.10823,0,0
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.44402,-0.055818,-0.049243,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.42347,-0.055819,-0.026427,0,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.59059,-0.055864,-0.035757,0,0
4,GO RESPONSE TO ISCHEMIA,0.38888,-0.055866,-0.055677,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.27227,-0.055923,-0.038606,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.25363,-0.055924,-0.060518,0,0
4,GO DIET INDUCED THERMOGENESIS,0.34256,-0.056106,-0.072381,0,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.21905,-0.056225,-0.039206,0,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.39371,-0.056269,-0.078705,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.36526,-0.056295,-0.028792,0,0
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.30402,-0.056317,-0.065134,0,0
4,GO RESPONSE TO ALCOHOL,0.12049,-0.05635,-0.067334,0,0
4,GO AXO DENDRITIC TRANSPORT,0.24643,-0.056379,-0.040381,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.27611,-0.056382,-0.038119,0,0
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.11841,-0.056431,-0.072058,0,0
4,GO RESPONSE TO LEAD ION,0.56666,-0.056533,-0.037533,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.020205,-0.056541,-0.031678,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.34702,-0.056547,-0.091144,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.093897,-0.05668,-0.052261,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.34702,-0.056687,-0.074351,0,0
4,GO MANGANESE ION TRANSPORT,0.092194,-0.056711,-0.1038,0,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.11434,-0.056742,-0.072442,0,0
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.49227,-0.056816,-0.018163,0,0
4,GO CELL MATURATION,0.43883,-0.05683,-0.018134,0,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.21579,-0.056852,-0.075954,0,0
4,GO HYPOTHALAMUS DEVELOPMENT,0.24643,-0.056878,-0.080357,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.25001,-0.056894,-0.10969,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.78962,-0.05692,0.039566,0,0
4,GO ADAPTIVE IMMUNE RESPONSE,0.17374,-0.056984,-0.09599,0,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.16828,-0.057146,-0.11757,0,0
4,GO LEUKOCYTE MIGRATION,0.11636,-0.057151,-0.079502,0,0
4,GO PROTEOLYSIS,0.055956,-0.057182,-0.060186,0,0
4,GO MISMATCH REPAIR,0.31232,-0.057273,-0.022552,0,0
4,GO FIBROBLAST ACTIVATION,0.37932,-0.057289,-0.084651,0,0
4,GO ENSHEATHMENT OF NEURONS,0.56075,-0.057291,-0.014116,0,0
4,GO DEVELOPMENTAL PIGMENTATION,0.11039,-0.057309,-0.082192,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.54903,-0.057312,-0.018355,0,0
4,GO BIOLOGICAL ADHESION,0.21256,-0.057316,-0.0525,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.69061,-0.05736,0.015108,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.85082,-0.057379,0.040023,0,0
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.11235,-0.057434,-0.061901,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.31653,-0.057469,-0.088369,0,0
4,GO POLYAMINE METABOLIC PROCESS,0.54321,-0.057477,-0.026329,0,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.16294,-0.05764,-0.15722,0,0
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.1313,-0.057672,-0.092041,0,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.59059,-0.057858,-0.0257,0,0
4,GO NCRNA CATABOLIC PROCESS,0.32077,-0.057978,-0.06257,0,0
4,GO RESPONSE TO OSMOTIC STRESS,0.19393,-0.058036,-0.067592,0,0
4,GO TELOMERE ORGANIZATION,0.20309,-0.058086,-0.044673,0,0
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.20309,-0.058171,-0.077482,0,0
4,GO ACUTE PHASE RESPONSE,0.093897,-0.058189,-0.1295,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.4598,-0.058278,-0.051392,0,0
4,GO ALCOHOL CATABOLIC PROCESS,0.21256,-0.058311,-0.052415,0,0
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.10465,-0.058312,-0.065325,0,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.69061,-0.058334,-0.0037695,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.47588,-0.05842,-0.013267,0,0
4,GO PROTEIN DEMANNOSYLATION,0.21256,-0.05848,-0.12613,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.064293,-0.058486,-0.084442,0,0
4,GO SYNAPSE MATURATION,0.29992,-0.058597,-0.16262,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.36526,-0.058606,-0.037754,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.27611,-0.05875,-0.074943,0,0
4,GO SUPEROXIDE METABOLIC PROCESS,0.42347,-0.058802,-0.046109,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.14048,-0.058803,-0.046827,0,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0695,-0.058834,-0.092492,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.32077,-0.058915,-0.026096,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.76948,-0.058942,-0.0044481,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.52025,-0.058993,-0.047941,0,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.087232,-0.059037,-0.035933,0,0
4,GO HAIR FOLLICLE MATURATION,0.44924,-0.059042,-0.081107,0,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.2839,-0.059086,-0.13677,0,0
4,GO STRESS FIBER ASSEMBLY,0.8303,-0.059102,-0.018427,0,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.1313,-0.059109,-0.074239,0,0
4,GO VOCALIZATION BEHAVIOR,0.63354,-0.059138,0.14905,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.36526,-0.059214,-0.035122,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.94769,-0.059221,-0.0113,0,0
4,GO REGULATION OF PROTEIN STABILITY,0.077957,-0.059372,-0.054775,0,0
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.19095,-0.059378,-0.11896,0,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.25001,-0.059475,-0.070573,0,0
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.37932,-0.05952,-0.044347,0,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.2839,-0.059562,-0.055287,0,0
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.22235,-0.059591,-0.060648,0,0
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14285,-0.059681,-0.12267,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.50337,-0.059765,-0.03038,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.59664,-0.059857,-0.024975,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.17374,-0.059881,-0.056649,0,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.47049,-0.059887,-0.037283,0,0
4,GO LIPOPROTEIN METABOLIC PROCESS,0.072231,-0.05993,-0.083733,0,0
4,GO FATTY ACID TRANSPORT,0.080955,-0.059936,-0.07968,0,0
4,GO RRNA TRANSCRIPTION,0.63978,-0.05995,-0.037279,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.15773,-0.060018,-0.031846,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.46512,-0.060112,-0.037863,0,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.42855,-0.060262,-0.038154,0,0
4,GO PIGMENT ACCUMULATION,0.64605,-0.06039,-0.029296,0,0
4,GO DENDRITIC CELL DIFFERENTIATION,0.25729,-0.060426,-0.12398,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.80989,-0.06047,-0.039452,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.9686,-0.060507,0.031638,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.12908,-0.060513,-0.086402,0,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.088862,-0.060523,-0.043344,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.41341,-0.060657,-0.041695,0,0
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.29184,-0.060712,-0.010471,0,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.21905,-0.06078,-0.036617,0,0
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.049546,-0.060814,-0.12202,0,0
4,GO TRABECULA FORMATION,0.79636,-0.060892,-0.0076644,0,0
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.068167,-0.060961,-0.11284,0,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.33812,-0.060995,-0.059213,0,0
4,GO REGULATION OF PH,0.16294,-0.061038,-0.041956,0,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.079444,-0.061046,-0.034682,0,0
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.084046,-0.061219,-0.079319,0,0
4,GO AXONAL TRANSPORT,0.43367,-0.061269,-0.029986,0,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.11841,-0.061289,-0.10963,0,0
4,GO LIPID HOMEOSTASIS,0.14526,-0.061317,-0.068682,0,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.39858,-0.061358,-0.02637,0,0
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.13355,-0.06136,-0.090882,0,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.33812,-0.06142,-0.060154,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.96163,-0.061521,0.020856,0,0
4,GO PROTEIN PALMITOYLATION,0.86455,-0.061569,0.021172,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.43367,-0.061591,-0.026851,0,0
4,GO RETINA HOMEOSTASIS,0.18219,-0.061711,-0.054248,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.29992,-0.061732,-0.052887,0,0
4,GO P38MAPK CASCADE,0.22235,-0.061742,-0.080416,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.65234,-0.061759,0.031869,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.49227,-0.061765,-0.036795,0,0
4,GO LIPID DROPLET ORGANIZATION,0.12259,-0.061794,-0.090307,0,0
4,GO GLIAL CELL MIGRATION,0.33812,-0.061965,-0.063439,0,0
4,GO RESPONSE TO INTERLEUKIN 4,0.23245,-0.06208,-0.062158,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.92682,-0.062143,0.013542,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.072231,-0.062255,-0.092581,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.2839,-0.062268,-0.043891,0,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.38408,-0.062323,-0.018607,0,0
4,GO HORMONE TRANSPORT,0.61497,-0.062384,-0.018003,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.47049,-0.062408,-0.02683,0,0
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.082489,-0.062423,-0.10809,0,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.14048,-0.062441,-0.08812,0,0
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.068167,-0.062448,-0.045294,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.38408,-0.062518,-0.06031,0,0
4,GO CGMP MEDIATED SIGNALING,0.34702,-0.062555,-0.062075,0,0
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.13355,-0.062559,-0.082456,0,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.50337,-0.062693,-0.053036,0,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.073629,-0.062742,-0.10891,0,0
4,GO GENITALIA MORPHOGENESIS,0.78962,-0.062817,0.033679,0,0
4,GO RESPONSE TO INTERLEUKIN 7,0.19695,-0.062833,-0.076513,0,0
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.077957,-0.062893,-0.055886,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.81668,-0.062896,0.013167,0,0
4,GO MITOPHAGY,0.090515,-0.063015,-0.10816,0,0
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.31653,-0.063067,-0.051392,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.36991,-0.063155,-0.051202,0,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.94769,-0.063179,0.012498,0,0
4,GO LYSOSOME LOCALIZATION,0.83713,-0.063224,0.0019566,0,0
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.049546,-0.0633,-0.10588,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.63978,-0.063302,-0.021968,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.35153,-0.06334,-0.08669,0,0
4,GO REGULATION OF PHOSPHORYLATION,0.050569,-0.063442,-0.061072,0,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.24288,-0.063551,-0.058415,0,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.19095,-0.063852,-0.10428,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.96163,-0.063884,-0.021088,0,0
4,GO CERAMIDE METABOLIC PROCESS,0.035393,-0.063964,-0.097013,0,0
4,GO TYPE I INTERFERON PRODUCTION,0.33373,-0.064014,-0.071772,0,0
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.14526,-0.064037,-0.089092,0,0
4,GO AORTA DEVELOPMENT,0.74288,-0.064111,0.0098017,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.88523,-0.064139,-0.0088783,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.13583,-0.064157,-0.11153,0,0
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.17374,-0.064182,-0.09045,0,0
4,GO VESICLE LOCALIZATION,0.082489,-0.064192,-0.048052,0,0
4,GO MEMORY,0.26847,-0.064199,-0.050479,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.97557,-0.064214,0.0041864,0,0
4,GO KIDNEY MORPHOGENESIS,0.83713,-0.064289,0.022766,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.16828,-0.064294,-0.095385,0,0
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.060602,-0.064312,-0.06503,0,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.12259,-0.064378,-0.055443,0,0
4,GO REGULATION OF CELL KILLING,0.55487,-0.064414,-0.043464,0,0
4,GO IMMUNE EFFECTOR PROCESS,0.097379,-0.064556,-0.098044,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.25729,-0.064591,-0.043959,0,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.36064,-0.064635,-0.037902,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.060602,-0.064665,-0.071005,0,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.2839,-0.064879,-0.048906,0,0
4,GO LEUKOCYTE MEDIATED IMMUNITY,0.061812,-0.064967,-0.12072,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.44402,-0.065007,-0.045871,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.50337,-0.065046,-0.0088513,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.24643,-0.065052,-0.064386,0,0
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.14048,-0.065095,-0.10626,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.67137,-0.065198,-0.011818,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.32506,-0.0652,-0.1022,0,0
4,GO REGULATION OF NUCLEASE ACTIVITY,0.17099,-0.06524,-0.097953,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.98953,-0.065279,0.010426,0,0
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.088862,-0.065288,-0.1358,0,0
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.12689,-0.065306,-0.053182,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.47049,-0.065312,-0.1508,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.42855,-0.065322,-0.041817,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.59059,-0.065392,-0.030764,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.34702,-0.065457,-0.041658,0,0
4,GO GENITALIA DEVELOPMENT,0.2,-0.065498,-0.035236,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.93377,-0.065526,0.0026369,0,0
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.077957,-0.065575,-0.059722,0,0
4,GO CELLULAR RESPONSE TO ALKALOID,0.25363,-0.065633,-0.054633,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.10845,-0.06564,-0.13106,0,0
4,GO REGULATION OF MUSCLE ADAPTATION,0.32506,-0.065687,-0.048413,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.40349,-0.065701,-0.031552,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.72313,-0.065842,0.0093024,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.10654,-0.065903,-0.032043,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.21905,-0.066034,-0.09233,0,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.62732,-0.066039,-0.025365,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.71658,-0.06604,0.013728,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.23937,-0.066071,-0.039771,0,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.29586,-0.066079,-0.061817,0,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.077957,-0.066152,-0.16085,0,0
4,GO CELLULAR RESPONSE TO LIPID,0.2839,-0.066153,-0.040838,0,0
4,GO B CELL ACTIVATION,0.05161,-0.066222,-0.080858,0,0
4,GO PHOSPHATE ION TRANSPORT,0.2,-0.066241,-0.062734,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.11039,-0.066312,-0.056147,0,0
4,GO HISTAMINE TRANSPORT,0.21905,-0.066313,-0.1569,0,0
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.11235,-0.066315,-0.095177,0,0
4,GO PRESYNAPSE ORGANIZATION,0.82348,-0.066334,0.02689,0,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.21905,-0.066334,-0.055798,0,0
4,GO PIGMENT GRANULE MATURATION,0.59059,-0.066447,-0.047504,0,0
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0695,-0.06645,-0.11611,0,0
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.10654,-0.066454,-0.069497,0,0
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.068167,-0.066475,-0.054536,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.26847,-0.066487,-0.014648,0,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.22905,-0.0665,-0.082433,0,0
4,GO LUNG ALVEOLUS DEVELOPMENT,0.71658,-0.066563,0.0009496,0,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.53167,-0.066614,-0.060986,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.43367,-0.066634,-0.075848,0,0
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.37932,-0.06668,-0.044376,0,0
4,GO REGULATION OF B CELL PROLIFERATION,0.12259,-0.066794,-0.10029,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.91293,-0.066835,-0.00024721,0,0
4,GO LEUKOCYTE PROLIFERATION,0.073629,-0.066843,-0.1037,0,0
4,GO DEPHOSPHORYLATION,0.18219,-0.066845,-0.032641,0,0
4,GO PHOSPHOLIPID TRANSPORT,0.1028,-0.066884,-0.082157,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.41842,-0.066954,-0.070926,0,0
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.05161,-0.066983,-0.085002,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.19695,-0.066986,-0.14013,0,0
4,GO REGULATION OF CILIUM BEAT FREQUENCY,0.16032,-0.067135,-0.10014,0,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.29992,-0.067156,-0.1072,0,0
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.059411,-0.067341,-0.059815,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.78289,-0.06738,-0.0013994,0,0
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.26471,-0.067436,-0.083731,0,0
4,GO ACTIVATION OF MAPK ACTIVITY,0.15773,-0.067479,-0.054508,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.079444,-0.067508,-0.088023,0,0
4,GO LEUKOTRIENE METABOLIC PROCESS,0.33373,-0.067561,-0.087553,0,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.14048,-0.067592,-0.10062,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.37932,-0.067659,-0.043717,0,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.10654,-0.067768,-0.12424,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.20309,-0.067816,-0.11165,0,0
4,GO BLEB ASSEMBLY,0.47588,-0.067856,-0.1875,0,0
4,GO ACTIN FILAMENT SEVERING,0.2839,-0.067901,-0.15627,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.32506,-0.067954,-0.048248,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.14048,-0.067956,-0.064528,0,0
4,GO MYELOID CELL HOMEOSTASIS,0.26471,-0.068066,-0.053273,0,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.74288,-0.068089,-0.0022538,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.8303,-0.068143,-0.037963,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.21579,-0.068204,-0.05037,0,0
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.15015,-0.068211,-0.088069,0,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.66501,-0.068223,0.0053162,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.13355,-0.068224,-0.076638,0,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.25729,-0.068315,-0.056379,0,0
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.10096,-0.06835,-0.072353,0,0
4,GO PROSTANOID METABOLIC PROCESS,0.28785,-0.068402,-0.15265,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.20937,-0.06857,-0.080281,0,0
4,GO GOLGI ORGANIZATION,0.050569,-0.0686,-0.073104,0,0
4,GO PEPTIDE SECRETION,0.10096,-0.068619,-0.065001,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.29992,-0.06877,-0.036549,0,0
4,GO B CELL APOPTOTIC PROCESS,0.24288,-0.068837,-0.097197,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.30815,-0.068842,-0.045742,0,0
4,GO SIGNAL RELEASE,0.37932,-0.068888,-0.018691,0,0
4,GO AMYLOID BETA METABOLIC PROCESS,0.27999,-0.068967,-0.07158,0,0
4,GO CELLULAR RESPONSE TO PEPTIDE,0.090515,-0.069008,-0.05667,0,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.050569,-0.069034,-0.064465,0,0
4,GO POSITIVE REGULATION OF BINDING,0.32938,-0.069042,-0.036635,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.47049,-0.06907,-0.027798,0,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.084046,-0.069112,-0.10795,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.23589,-0.069123,-0.040047,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.39371,-0.069218,-0.076469,0,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.055956,-0.06923,-0.084025,0,0
4,GO SECRETORY GRANULE LOCALIZATION,0.33812,-0.069259,-0.093158,0,0
4,GO FUCOSE METABOLIC PROCESS,0.35607,-0.069335,-0.082397,0,0
4,GO MESENCHYME DEVELOPMENT,0.97557,-0.069375,0.041506,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.15517,-0.069413,-0.073842,0,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.18508,-0.069463,-0.088749,0,0
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.063042,-0.069636,-0.11266,0,0
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.027803,-0.069642,-0.10732,0,0
4,GO DRUG CATABOLIC PROCESS,0.088862,-0.069719,-0.11458,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.15517,-0.069773,-0.044567,0,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.05824,-0.06979,-0.044016,0,0
4,GO ERAD PATHWAY,0.075049,-0.069872,-0.09187,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.47588,-0.070008,-0.04421,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.11841,-0.07007,-0.040421,0,0
4,GO NUCLEAR MIGRATION,0.48131,-0.070136,-0.033268,0,0
4,GO CELLULAR DEFENSE RESPONSE,0.079444,-0.070168,-0.14494,0,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.22568,-0.070204,-0.079609,0,0
4,GO RESPONSE TO LIPID,0.10465,-0.07022,-0.070193,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.60272,-0.070233,-0.050216,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.63354,-0.070254,0.050036,0,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.075049,-0.070281,-0.048118,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1,-0.070284,0.023852,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.93377,-0.070322,0.021919,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.060602,-0.070402,-0.04135,0,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.4978,-0.070482,-0.11953,0,0
4,GO URONIC ACID METABOLIC PROCESS,0.11039,-0.070489,-0.093058,0,0
4,GO RESPONSE TO DOPAMINE,0.76281,-0.07054,-0.0098018,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.54903,-0.070546,-0.040511,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.20309,-0.070557,-0.058659,0,0
4,GO PREPULSE INHIBITION,0.80989,-0.070564,0.0050233,0,0
4,GO REGULATION OF COAGULATION,0.17374,-0.070583,-0.11961,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.26098,-0.070659,-0.041027,0,0
4,GO RESPONSE TO FATTY ACID,0.15015,-0.07066,-0.08431,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.20621,-0.070666,-0.04973,0,0
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.064293,-0.07073,-0.084218,0,0
4,GO SYNAPSE ASSEMBLY,0.98255,-0.07079,0.038494,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.60883,-0.070846,-0.05658,0,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.94073,-0.070866,0.034148,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.059411,-0.070899,-0.033452,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.83713,-0.070925,0.0077222,0,0
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.27999,-0.071019,-0.085525,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.89907,-0.07102,0.025357,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.27999,-0.071022,-0.053144,0,0
4,GO LEUKOCYTE CHEMOTAXIS,0.15015,-0.071119,-0.077995,0,0
4,GO NEGATIVE REGULATION OF GROWTH,0.13583,-0.071133,-0.065107,0,0
4,GO ASYMMETRIC CELL DIVISION,0.17374,-0.071142,-0.11018,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.55487,-0.071213,-0.025099,0,0
4,GO ALPHA BETA T CELL PROLIFERATION,0.35153,-0.07127,-0.087236,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.12049,-0.071275,-0.090693,0,0
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.27611,-0.071289,-0.076279,0,0
4,GO REGULATION OF GTPASE ACTIVITY,0.17099,-0.071432,-0.045231,0,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.2839,-0.07153,-0.046008,0,0
4,GO ARACHIDONIC ACID SECRETION,0.14769,-0.071552,-0.08076,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.77618,-0.071615,0.014467,0,0
4,GO L GLUTAMATE IMPORT,0.38408,-0.071649,-0.065048,0,0
4,GO NEGATIVE REGULATION OF SECRETION,0.070855,-0.071674,-0.056471,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.56666,-0.07168,-0.026721,0,0
4,GO RESPONSE TO ESTROGEN,0.38408,-0.071723,-0.060041,0,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.85082,-0.071763,-0.037867,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.23589,-0.071794,-0.074949,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.11636,-0.071954,-0.11221,0,0
4,GO PEPTIDE CROSS LINKING,0.17099,-0.072046,-0.14375,0,0
4,GO NEURON PROJECTION EXTENSION,0.54321,-0.072062,0.023808,0,0
4,GO T CELL PROLIFERATION,0.043763,-0.072074,-0.12463,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.21579,-0.072093,-0.17149,0,0
4,GO ENDOSOMAL TRANSPORT,0.15015,-0.072189,-0.031543,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.32938,-0.07219,-0.074859,0,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.56666,-0.07219,-0.0057651,0,0
4,GO RESPONSE TO STEROID HORMONE,0.188,-0.072325,-0.059754,0,0
4,GO PLATELET AGGREGATION,0.12049,-0.072348,-0.11995,0,0
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.10845,-0.072369,-0.11947,0,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.43367,-0.072384,-0.03659,0,0
4,GO LIPID MODIFICATION,0.068167,-0.072443,-0.074598,0,0
4,GO OOCYTE DIFFERENTIATION,0.095625,-0.072458,-0.07223,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.98953,-0.072501,0.024757,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.72313,-0.072542,0.0047492,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.050569,-0.072548,-0.076629,0,0
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.12473,-0.072685,-0.098605,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.23589,-0.072775,-0.059343,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.12689,-0.072849,-0.060662,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.56075,-0.072858,-0.0012887,0,0
4,GO TERPENOID METABOLIC PROCESS,0.11039,-0.07287,-0.10795,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.31232,-0.072904,-0.06372,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.32938,-0.07302,-0.063684,0,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.13814,-0.073024,-0.067501,0,0
4,GO MUSCLE ADAPTATION,0.092194,-0.073077,-0.093174,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.39858,-0.073087,-0.047176,0,0
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.17653,-0.073096,-0.094777,0,0
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.92682,-0.073118,-0.011653,0,0
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.12689,-0.073213,-0.068753,0,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.44402,-0.07322,-0.065403,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.04854,-0.073286,-0.067903,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.27611,-0.073328,-0.060756,0,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.14526,-0.073432,-0.079186,0,0
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.17934,-0.073736,-0.088267,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.23245,-0.073746,-0.043703,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.22568,-0.073838,-0.097904,0,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.15015,-0.073868,-0.09357,0,0
4,GO CELL CYCLE ARREST,0.16559,-0.073873,-0.043092,0,0
4,GO PROTEIN N LINKED GLYCOSYLATION,0.13583,-0.073959,-0.084039,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.13814,-0.074107,-0.053625,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.86455,-0.074111,-0.0018357,0,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.34256,-0.074253,-0.078512,0,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.69707,-0.074363,-0.076522,0,0
4,GO NUCLEUS LOCALIZATION,0.27611,-0.074379,-0.047489,0,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.26847,-0.074428,-0.10504,0,0
4,GO NEUROBLAST DIVISION,0.77618,-0.074473,-0.042596,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.10845,-0.074522,-0.091408,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.05824,-0.074543,-0.054622,0,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.077957,-0.074561,-0.10435,0,0
4,GO BEHAVIOR,0.23589,-0.074602,-0.039676,0,0
4,GO AXONEME ASSEMBLY,0.68418,-0.07473,0.011937,0,0
4,GO POSITIVE REGULATION OF COAGULATION,0.42347,-0.07475,-0.071385,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.20309,-0.07504,-0.094104,0,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.065563,-0.075071,-0.060341,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.48678,-0.075082,-0.037599,0,0
4,GO REGULATION OF PROTEIN FOLDING,0.05824,-0.075096,-0.096881,0,0
4,GO REGULATION OF LIPID TRANSPORT,0.15517,-0.075198,-0.074976,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.14769,-0.075278,-0.15778,0,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.049546,-0.07528,-0.088528,0,0
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.10096,-0.075281,-0.14735,0,0
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.1028,-0.075327,-0.084937,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.33373,-0.075332,-0.097157,0,0
4,GO RESPONSE TO DSRNA,0.18219,-0.075343,-0.080455,0,0
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.27227,-0.075375,-0.10152,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.099158,-0.07542,-0.098947,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.58456,-0.075473,-0.034693,0,0
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.061812,-0.075481,-0.064754,0,0
4,GO NUCLEOTIDE TRANSPORT,0.19695,-0.075493,-0.07006,0,0
4,GO B CELL PROLIFERATION,0.087232,-0.075594,-0.092905,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.040234,-0.075624,-0.050646,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.47588,-0.075632,-0.079587,0,0
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.055956,-0.075719,-0.087116,0,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.11434,-0.075923,-0.12694,0,0
4,GO RESPONSE TO INTERLEUKIN 2,0.41842,-0.075924,-0.050073,0,0
4,GO RESPONSE TO PEPTIDE,0.075049,-0.075949,-0.060415,0,0
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.050569,-0.07603,-0.057437,0,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.68418,-0.076131,0.075985,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.16559,-0.076138,-0.080948,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.66501,-0.076149,-0.076837,0,0
4,GO INTEGRIN ACTIVATION,0.19393,-0.076169,-0.10957,0,0
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.36991,-0.076226,-0.20306,0,0
4,GO REGULATION OF IMMUNE RESPONSE,0.12473,-0.076263,-0.078795,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.13814,-0.07632,-0.095269,0,0
4,GO CELLULAR EXTRAVASATION,0.16828,-0.07671,-0.066931,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.50337,-0.076716,-0.026912,0,0
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.060602,-0.076771,-0.065997,0,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.15264,-0.076813,-0.10366,0,0
4,GO SYMBIOTIC PROCESS,0.063042,-0.07683,-0.082549,0,0
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.072231,-0.076861,-0.11935,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.39371,-0.076902,-0.080306,0,0
4,GO EXPLORATION BEHAVIOR,0.57857,-0.077024,-0.022676,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.050569,-0.077061,-0.23345,0,0
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.063042,-0.077089,-0.1354,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.54321,-0.077097,-0.029314,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.24288,-0.077124,-0.055977,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.4598,-0.077142,-0.032363,0,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.11235,-0.077273,-0.10522,0,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.54321,-0.077299,-0.046925,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.71658,-0.077626,-0.070085,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.37932,-0.077637,-0.031793,0,0
4,GO RESPONSE TO ALKALOID,0.055956,-0.077692,-0.082622,0,0
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.053746,-0.077706,-0.064612,0,0
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.059411,-0.077799,-0.075366,0,0
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.29184,-0.077862,-0.1085,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.14769,-0.077863,-0.085334,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.064293,-0.077955,-0.18451,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.92682,-0.077974,0.06269,0,0
4,GO PROTEIN POLYMERIZATION,0.038561,-0.078076,-0.050968,0,0
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.05161,-0.078102,-0.11422,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.73628,-0.078129,0.025863,0,0
4,GO AUTOPHAGOSOME ORGANIZATION,0.15264,-0.078169,-0.087681,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.15773,-0.07821,-0.08822,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.34702,-0.078216,-0.082081,0,0
4,GO SYNCYTIUM FORMATION,0.36064,-0.078222,-0.06461,0,0
4,GO REGULATION OF TRANSPORT,0.024288,-0.078232,-0.064381,0,0
4,GO PURINE NUCLEOTIDE TRANSPORT,0.23589,-0.078233,-0.068334,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.87833,-0.078241,0.084962,0,0
4,GO REGULATION OF HORMONE LEVELS,0.20309,-0.078297,-0.055934,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.070855,-0.078325,-0.1456,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.057089,-0.078327,-0.085759,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.3746,-0.078375,-0.04817,0,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.99651,-0.078414,0.018634,0,0
4,GO REGULATION OF CELL SIZE,0.16294,-0.078442,-0.020807,0,0
4,GO HISTONE PHOSPHORYLATION,0.04854,-0.078458,-0.096655,0,0
4,GO REGULATION OF AMINO ACID TRANSPORT,0.3746,-0.078461,-0.049764,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.30815,-0.07848,-0.083,0,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.17934,-0.078591,-0.05029,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.98255,-0.078623,0.030052,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.25729,-0.078645,-0.058269,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.20621,-0.078701,-0.085768,0,0
4,GO MULTICELLULAR ORGANISM AGING,0.13583,-0.078715,-0.060849,0,0
4,GO SENSORY PERCEPTION,0.099158,-0.078725,-0.05041,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.12259,-0.078777,-0.11666,0,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.41842,-0.078779,-0.071482,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.16032,-0.078784,-0.10176,0,0
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.23245,-0.078793,-0.051621,0,0
4,GO SERTOLI CELL DIFFERENTIATION,0.26471,-0.078861,-0.097214,0,0
4,GO LIVER MORPHOGENESIS,0.48678,-0.078928,-0.093626,0,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.31653,-0.078937,-0.087678,0,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.27999,-0.079103,-0.11894,0,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.76948,-0.079109,0.0089536,0,0
4,GO GLUTAMATE METABOLIC PROCESS,0.14526,-0.079224,-0.067151,0,0
4,GO REGULATION OF RNA BINDING,0.17653,-0.079229,-0.087341,0,0
4,GO UV PROTECTION,0.29586,-0.079262,-0.096163,0,0
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.075049,-0.079339,-0.1447,0,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.1028,-0.079425,-0.050208,0,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.11636,-0.079575,-0.079801,0,0
4,GO PIGMENT GRANULE ORGANIZATION,0.33812,-0.079663,-0.052342,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.26471,-0.079777,-0.048915,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.34256,-0.079843,-0.045909,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.11841,-0.079873,-0.1036,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.4598,-0.079893,-0.0050559,0,0
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.20937,-0.079897,-0.11839,0,0
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.10654,-0.080002,-0.043324,0,0
4,GO T CELL MEDIATED IMMUNITY,0.097379,-0.080056,-0.15685,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.11235,-0.080063,-0.04649,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.38888,-0.080198,-0.050711,0,0
4,GO ERBB SIGNALING PATHWAY,0.44402,-0.08023,-0.040796,0,0
4,GO RNA INTERFERENCE,0.064293,-0.080326,-0.11409,0,0
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0060989,-0.080568,-0.10802,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.050569,-0.080661,-0.058965,0,0
4,GO REGULATION OF LIPID STORAGE,0.28785,-0.080693,-0.06466,0,0
4,GO EXTRACELLULAR TRANSPORT,0.32938,-0.0807,-0.055057,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.046579,-0.080737,-0.049744,0,0
4,GO NEPHRON MORPHOGENESIS,0.30815,-0.080754,-0.024015,0,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.44924,-0.080792,-0.036493,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.066855,-0.080804,-0.09123,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.057089,-0.081012,-0.070615,0,0
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.16294,-0.081141,-0.07179,0,0
4,GO REGULATION OF TISSUE REMODELING,0.14526,-0.081261,-0.10344,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.33373,-0.081333,-0.037306,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.14526,-0.081375,-0.097998,0,0
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.53167,-0.081564,-0.078005,0,0
4,GO SYNAPTIC SIGNALING,0.4598,-0.081564,-0.010612,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.20309,-0.081635,-0.10898,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.59664,-0.081666,-0.020686,0,0
4,GO NEURAL CREST CELL MIGRATION,0.78289,-0.081799,0.0050337,0,0
4,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.061812,-0.081835,-0.1245,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.037747,-0.08189,-0.034924,0,0
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.32938,-0.081933,-0.094648,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.60272,-0.081955,-0.018068,0,0
4,GO POSTREPLICATION REPAIR,0.11434,-0.082052,-0.047137,0,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.072231,-0.082227,-0.08188,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.26471,-0.082278,-0.011384,0,0
4,GO RESPONSE TO COCAINE,0.29992,-0.08241,-0.041118,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.19095,-0.082438,-0.046081,0,0
4,GO PRIMARY MIRNA PROCESSING,0.11434,-0.082449,-0.11016,0,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.52594,-0.082483,-0.028585,0,0
4,GO RESPONSE TO PEPTIDE HORMONE,0.04854,-0.082503,-0.065195,0,0
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.082489,-0.082542,-0.091873,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.079444,-0.082573,-0.080434,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.14769,-0.082588,-0.10368,0,0
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.19695,-0.082683,-0.18257,0,0
4,GO LOCOMOTORY BEHAVIOR,0.22568,-0.082788,-0.049673,0,0
4,GO CELLULAR RESPONSE TO STEROL,0.26847,-0.082847,-0.088329,0,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.33812,-0.082975,-0.069962,0,0
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.36526,-0.083042,-0.034008,0,0
4,GO NERVE DEVELOPMENT,0.38408,-0.083126,-0.043267,0,0
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.14526,-0.083226,-0.079604,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.99651,-0.083283,0.0089147,0,0
4,GO RESPONSE TO STEROL,0.090515,-0.083377,-0.11683,0,0
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.52594,-0.083407,-0.043909,0,0
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.20309,-0.083531,-0.069757,0,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.60272,-0.083563,-0.027118,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.51459,-0.083586,-0.042057,0,0
4,GO STEROL METABOLIC PROCESS,0.11039,-0.08363,-0.091559,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.67776,-0.083649,-0.051811,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.077957,-0.083722,-0.087564,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.12689,-0.0838,-0.11309,0,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.057089,-0.08389,-0.071309,0,0
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.064293,-0.083939,-0.088733,0,0
4,GO BROWN FAT CELL DIFFERENTIATION,0.35153,-0.08396,-0.064406,0,0
4,GO POSITIVE REGULATION OF MITOPHAGY,0.0695,-0.084011,-0.13533,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.24643,-0.084174,-0.11783,0,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.099158,-0.084195,-0.078934,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.26471,-0.084423,-0.027763,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.059411,-0.084573,-0.053102,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.18219,-0.084651,-0.14406,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.2839,-0.084684,-0.018355,0,0
4,GO REGULATION OF T CELL MIGRATION,0.052669,-0.084858,-0.10981,0,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.077957,-0.085007,-0.10687,0,0
4,GO FEMALE SEX DIFFERENTIATION,0.23937,-0.085064,-0.032658,0,0
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.092194,-0.085091,-0.056707,0,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.24643,-0.085158,-0.06511,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.27611,-0.085192,-0.079037,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.36526,-0.085193,-0.1022,0,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.077957,-0.085398,-0.068308,0,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.31653,-0.085408,-0.11867,0,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.22905,-0.085413,-0.070136,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.070855,-0.085433,-0.043384,0,0
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.19393,-0.085434,-0.076872,0,0
4,GO METANEPHROS DEVELOPMENT,0.87833,-0.085463,0.030153,0,0
4,GO PLATELET DEGRANULATION,0.0695,-0.085502,-0.15044,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.50896,-0.085666,-0.071856,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.20621,-0.085738,-0.13714,0,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.25363,-0.085816,-0.044599,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.068167,-0.085819,-0.076374,0,0
4,GO RHYTHMIC BEHAVIOR,0.014841,-0.085939,-0.10614,0,0
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.4598,-0.086038,-0.096839,0,0
4,GO T CELL CYTOKINE PRODUCTION,0.12259,-0.086122,-0.12046,0,0
4,GO PEPTIDE CATABOLIC PROCESS,0.12473,-0.086299,-0.11211,0,0
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.18508,-0.086314,-0.054779,0,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.050569,-0.086355,-0.068595,0,0
4,GO VASCULAR WOUND HEALING,0.24288,-0.086364,-0.10959,0,0
4,GO LYMPHOCYTE COSTIMULATION,0.3746,-0.086364,-0.034071,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.46512,-0.086485,-0.045486,0,0
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.14285,-0.086509,-0.066994,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.48131,-0.086566,-0.048514,0,0
4,GO NEPHRON DEVELOPMENT,0.78962,-0.086584,0.016138,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.15517,-0.086702,-0.055996,0,0
4,GO B CELL MEDIATED IMMUNITY,0.076492,-0.086754,-0.13126,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.60272,-0.086819,-0.026702,0,0
4,GO LEARNING,0.27999,-0.087007,-0.058882,0,0
4,GO INTERLEUKIN 8 PRODUCTION,0.25001,-0.087032,-0.09766,0,0
4,GO ISOPRENOID METABOLIC PROCESS,0.079444,-0.087063,-0.10898,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.29586,-0.087272,-0.039059,0,0
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.36526,-0.087397,-0.046736,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.2839,-0.087468,-0.031146,0,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.80989,-0.087471,-0.0027206,0,0
4,GO ENDOCYTOSIS,0.04854,-0.087518,-0.076497,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.29992,-0.087588,-0.091842,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.092194,-0.087597,-0.17892,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.0695,-0.087603,-0.08212,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.188,-0.087645,-0.06185,0,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.14285,-0.087733,-0.069446,0,0
4,GO REGULATION OF TUBE SIZE,0.11636,-0.087737,-0.072747,0,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.18508,-0.088009,-0.049399,0,0
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.072231,-0.088065,-0.10214,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.03245,-0.088169,-0.056454,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.85082,-0.088214,0.014042,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.14048,-0.088319,-0.05033,0,0
4,GO VIRAL BUDDING,0.50337,-0.088374,-0.015665,0,0
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.17934,-0.088424,-0.095391,0,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.29992,-0.088426,-0.031567,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.21905,-0.088464,-0.034785,0,0
4,GO RENAL ABSORPTION,0.17653,-0.088498,-0.19483,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.10654,-0.08851,-0.12642,0,0
4,GO RESPONSE TO SALT STRESS,0.22235,-0.088527,-0.09563,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.05824,-0.08854,-0.12199,0,0
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.30815,-0.08857,-0.0645,0,0
4,GO PROTEIN NEDDYLATION,0.092194,-0.088603,-0.11285,0,0
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.7495,-0.088627,0.096448,0,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.11434,-0.088768,-0.17047,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.25001,-0.088788,-0.069356,0,0
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.099158,-0.088823,-0.13959,0,0
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.23589,-0.088879,-0.099062,0,0
4,GO SYNAPSE ORGANIZATION,0.67776,-0.088896,-0.00068379,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.11039,-0.088983,-0.041478,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.33812,-0.089144,-0.039075,0,0
4,GO PIGMENT CELL DIFFERENTIATION,0.11434,-0.089293,-0.091577,0,0
4,GO REGULATION OF MAP KINASE ACTIVITY,0.16828,-0.089337,-0.054558,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.188,-0.089543,-0.10985,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.16828,-0.089563,-0.081233,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.093897,-0.089635,-0.12687,0,0
4,GO EXECUTION PHASE OF APOPTOSIS,0.10654,-0.089701,-0.045019,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.80989,-0.089738,-0.029513,0,0
4,GO RESPONSE TO KETONE,0.11434,-0.089754,-0.0772,0,0
4,GO DIVALENT METAL ION EXPORT,0.23245,-0.089784,-0.11998,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.65234,-0.089806,0.022605,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.26098,-0.089991,-0.12249,0,0
4,GO PHOSPHOLIPID HOMEOSTASIS,0.8303,-0.090008,-0.017019,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.21256,-0.090107,-0.061272,0,0
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.36991,-0.090152,-0.04638,0,0
4,GO SPHINGOLIPID METABOLIC PROCESS,0.024288,-0.090154,-0.11095,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.063042,-0.090201,-0.077493,0,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.043763,-0.090451,-0.064336,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.47049,-0.0905,-0.11961,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.1028,-0.090596,-0.10706,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.14285,-0.090641,-0.041443,0,0
4,GO TISSUE MIGRATION,0.084046,-0.090679,-0.11904,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.47588,-0.090711,-0.051793,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.072231,-0.090893,-0.084104,0,0
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.20309,-0.090906,-0.14929,0,0
4,GO ENDOSOME ORGANIZATION,0.090515,-0.090917,-0.077309,0,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.4545,-0.090945,-0.09808,0,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.14526,-0.090957,-0.10445,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.14048,-0.090974,-0.046165,0,0
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.16559,-0.091057,-0.086906,0,0
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.17934,-0.091196,-0.11536,0,0
4,GO REGULATION OF LIPID LOCALIZATION,0.15264,-0.091269,-0.070931,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.12049,-0.09136,-0.091922,0,0
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.24288,-0.091543,-0.12691,0,0
4,GO INTERLEUKIN 13 PRODUCTION,0.24643,-0.091839,-0.11747,0,0
4,GO BIOLOGICAL PHASE,0.62113,-0.091868,-0.071595,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.080955,-0.091888,-0.049082,0,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.11434,-0.091904,-0.11793,0,0
4,GO CYTIDINE TO URIDINE EDITING,0.74288,-0.092063,-0.072839,0,0
4,GO VESICLE BUDDING FROM MEMBRANE,0.076492,-0.092075,-0.08581,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.50896,-0.092248,-0.04824,0,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.045624,-0.092258,-0.075021,0,0
4,GO PROTEASOME ASSEMBLY,0.1028,-0.092275,-0.11179,0,0
4,GO ANATOMICAL STRUCTURE MATURATION,0.32938,-0.092347,-0.028193,0,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.060602,-0.092397,-0.080327,0,0
4,GO FIBRINOLYSIS,0.15015,-0.092513,-0.16353,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.29184,-0.092538,-0.079475,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.1028,-0.092594,-0.060729,0,0
4,GO REGULATION OF STEROL TRANSPORT,0.14526,-0.092735,-0.095765,0,0
4,GO ORGANELLE INHERITANCE,0.15517,-0.09274,-0.065077,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.057089,-0.092779,-0.16338,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.44924,-0.092798,-0.068754,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.42347,-0.092861,-0.081353,0,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.13814,-0.092978,-0.091394,0,0
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.061812,-0.092997,-0.099232,0,0
4,GO RESPONSE TO CATECHOLAMINE,0.18219,-0.093108,-0.064385,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.27227,-0.093222,-0.093574,0,0
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.17099,-0.093283,-0.10027,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.16032,-0.093426,-0.15632,0,0
4,GO REGULATION OF MACROAUTOPHAGY,0.050569,-0.093459,-0.075535,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.088862,-0.093498,-0.12824,0,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.27611,-0.093506,-0.058853,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.084046,-0.093528,-0.10791,0,0
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.12473,-0.093545,-0.10224,0,0
4,GO ENDODERM DEVELOPMENT,0.52594,-0.093676,-0.034429,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.059411,-0.093683,-0.12461,0,0
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.04854,-0.093694,-0.14686,0,0
4,GO CELL RECOGNITION,0.13814,-0.093743,-0.065856,0,0
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.068167,-0.093747,-0.067355,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.16294,-0.0939,-0.13327,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.10654,-0.093977,-0.18836,0,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.093897,-0.094093,-0.095106,0,0
4,GO RESPONSE TO INTERLEUKIN 15,0.050569,-0.094144,-0.19971,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.14769,-0.094156,-0.11803,0,0
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.17653,-0.0942,-0.088417,0,0
4,GO HOMOTYPIC CELL CELL ADHESION,0.034637,-0.094302,-0.16069,0,0
4,GO HYPOTONIC RESPONSE,0.090515,-0.094303,-0.11855,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.13583,-0.094353,-0.13465,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.55487,-0.094373,-0.051045,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.28785,-0.094397,-0.033129,0,0
4,GO MACROPHAGE CHEMOTAXIS,0.19695,-0.094455,-0.095921,0,0
4,GO AUTOPHAGIC CELL DEATH,0.34256,-0.09446,-0.034107,0,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.36064,-0.094487,-0.075913,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.22568,-0.094501,-0.049045,0,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.059411,-0.094533,-0.068998,0,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.38888,-0.094571,-0.058222,0,0
4,GO AMINO ACID TRANSPORT,0.21579,-0.094596,-0.041055,0,0
4,GO VESICLE ORGANIZATION,0.031059,-0.094641,-0.076075,0,0
4,GO NERVOUS SYSTEM PROCESS,0.14285,-0.094703,-0.04307,0,0
4,GO AMYLOID FIBRIL FORMATION,0.38888,-0.094717,-0.053218,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.46512,-0.094795,-0.058668,0,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.13355,-0.094795,-0.12631,0,0
4,GO RESPONSE TO CADMIUM ION,0.19695,-0.094928,-0.11465,0,0
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.19695,-0.09508,-0.10519,0,0
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.11434,-0.095114,-0.081384,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.4978,-0.095218,-0.026745,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.21256,-0.095269,-0.062957,0,0
4,GO GMP METABOLIC PROCESS,0.44402,-0.095278,-0.055673,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.099158,-0.095284,-0.16158,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.17099,-0.095317,-0.16141,0,0
4,GO RENAL SYSTEM PROCESS,0.17374,-0.09545,-0.080001,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.2,-0.09553,-0.080753,0,0
4,GO PEPTIDE HORMONE SECRETION,0.34702,-0.095608,-0.032846,0,0
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.035393,-0.095613,-0.062913,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.48131,-0.09565,-0.039644,0,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.83713,-0.095675,0.020203,0,0
4,GO GOLGI VESICLE TRANSPORT,0.16559,-0.09587,-0.042538,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.049546,-0.095881,-0.10878,0,0
4,GO CELL ADHESION MEDIATED BY INTEGRIN,0.057089,-0.09593,-0.19263,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.17374,-0.095989,-0.06537,0,0
4,GO MAINTENANCE OF CELL POLARITY,0.3746,-0.095989,-0.058969,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.29992,-0.096076,-0.073992,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.092194,-0.096203,-0.048222,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.27227,-0.096217,-0.058008,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.19695,-0.096244,-0.081613,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.077957,-0.096264,-0.080007,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.23245,-0.096287,-0.091348,0,0
4,GO PROTEIN KINASE A SIGNALING,0.055956,-0.096521,-0.075524,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.15015,-0.096684,-0.15753,0,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.72969,-0.096825,-0.0050431,0,0
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.050569,-0.096924,-0.13099,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.22568,-0.096942,-0.063748,0,0
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.22235,-0.097007,-0.071032,0,0
4,GO OTIC VESICLE MORPHOGENESIS,0.71658,-0.097058,-0.0291,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.19095,-0.097214,-0.070565,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.17374,-0.097295,-0.090051,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.033166,-0.097372,-0.10493,0,0
4,GO CYTOSOLIC TRANSPORT,0.10654,-0.097445,-0.052823,0,0
4,GO CELL CHEMOTAXIS,0.11235,-0.097454,-0.083901,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.47588,-0.097523,-0.028348,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.32077,-0.09764,-0.051162,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.066855,-0.097699,-0.095727,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.85768,-0.097797,0.034123,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.60883,-0.097823,-0.046151,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.32938,-0.09793,-0.071453,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.40843,-0.09821,-0.067534,0,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.4598,-0.098342,-0.050982,0,0
4,GO L AMINO ACID TRANSPORT,0.14285,-0.098501,-0.077372,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0695,-0.09853,-0.1137,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.21579,-0.09855,-0.12365,0,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.21905,-0.098736,-0.087508,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.36064,-0.099145,-0.12603,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.030383,-0.099154,-0.093042,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.72969,-0.09926,-0.012394,0,0
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.19695,-0.099308,-0.068546,0,0
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.053746,-0.099336,-0.089154,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.37932,-0.099446,-0.031636,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.10654,-0.099478,-0.064484,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.17934,-0.099568,-0.10234,0,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.17653,-0.099587,-0.084882,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19393,-0.099594,-0.16097,0,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.25001,-0.099649,-0.0063792,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.94769,-0.099653,0.020848,0,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.69707,-0.0998,-0.030958,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.72313,-0.099815,0.0081137,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.42347,-0.099836,-0.03538,0,0
4,GO AMYLOID BETA FORMATION,0.14048,-0.099855,-0.11102,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.01282,-0.099904,-0.070748,0,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.61497,-0.099946,-0.022282,0,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.063042,-0.099954,-0.14228,0,0
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.087232,-0.10013,-0.08257,0,0
4,GO REGULATION OF MAPK CASCADE,0.095625,-0.10024,-0.070226,0,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.060602,-0.10039,-0.1095,0,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.095625,-0.10051,-0.096688,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.12473,-0.10058,-0.11699,0,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.15773,-0.10059,-0.12921,0,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.14769,-0.10101,-0.083527,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.63978,-0.10103,-0.0088178,0,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.36064,-0.10104,-0.042713,0,0
4,GO DETOXIFICATION,0.054842,-0.10111,-0.11622,0,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.29586,-0.10113,-0.10744,0,0
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.02068,-0.10123,-0.13105,0,0
4,GO TISSUE REMODELING,0.42855,-0.10125,-0.049374,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.5726,-0.10129,-0.017579,0,0
4,GO NEGATIVE REGULATION OF COAGULATION,0.22568,-0.10131,-0.13987,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.052669,-0.10147,-0.10122,0,0
4,GO FIBROBLAST PROLIFERATION,0.2,-0.10158,-0.088163,0,0
4,GO ERYTHROCYTE HOMEOSTASIS,0.14048,-0.10159,-0.066465,0,0
4,GO ENERGY HOMEOSTASIS,0.63354,-0.10172,-0.0098567,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.054842,-0.10187,-0.10284,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.19695,-0.10194,-0.11648,0,0
4,GO HYALURONAN METABOLIC PROCESS,0.072231,-0.102,-0.12773,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.20937,-0.10201,-0.030776,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.25729,-0.10203,-0.046784,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.29992,-0.10205,-0.058431,0,0
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.068167,-0.10205,-0.10277,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.068167,-0.1021,-0.13008,0,0
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.11235,-0.10212,-0.081914,0,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.15015,-0.10219,-0.18246,0,0
4,GO RESPONSE TO LIGHT INTENSITY,0.15517,-0.10228,-0.12012,0,0
4,GO LINOLEIC ACID METABOLIC PROCESS,0.42855,-0.10241,-0.064401,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.14285,-0.10264,-0.099287,0,0
4,GO REGULATION OF CELL MATRIX ADHESION,0.35607,-0.10276,-0.066167,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.36991,-0.10282,-0.03791,0,0
4,GO PANCREATIC JUICE SECRETION,0.33812,-0.10299,-0.053222,0,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.17934,-0.10299,-0.11422,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.16559,-0.10313,-0.12228,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.24288,-0.10314,-0.043777,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.15773,-0.1032,-0.047799,0,0
4,GO ERK1 AND ERK2 CASCADE,0.10845,-0.10325,-0.094877,0,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.16828,-0.10336,-0.3075,0,0
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.092194,-0.10351,-0.067237,0,0
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.023205,-0.10354,-0.1429,0,0
4,GO MONONUCLEAR CELL MIGRATION,0.060602,-0.10357,-0.13868,0,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.084046,-0.10357,-0.13135,0,0
4,GO RESPONSE TO ACID CHEMICAL,0.19095,-0.10367,-0.031947,0,0
4,GO RESPONSE TO POTASSIUM ION,0.19393,-0.10373,-0.12841,0,0
4,GO REGULATION OF SODIUM ION TRANSPORT,0.12259,-0.10375,-0.086587,0,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.82348,-0.10382,0.024462,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.2,-0.10385,-0.0067409,0,0
4,GO RESPONSE TO AXON INJURY,0.36064,-0.10388,-0.038093,0,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.11434,-0.10407,-0.11975,0,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.065563,-0.10418,-0.075513,0,0
4,GO RESPONSE TO FUNGUS,0.22235,-0.10426,-0.051874,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.31232,-0.10429,-0.085562,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.50337,-0.10435,-0.024517,0,0
4,GO DIGESTION,0.064293,-0.10461,-0.0953,0,0
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.075049,-0.10465,-0.12619,0,0
4,GO RESPONSE TO ETHANOL,0.11841,-0.10474,-0.072601,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.29184,-0.10477,-0.041327,0,0
4,GO RESPONSE TO TUMOR CELL,0.079444,-0.10484,-0.1745,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.42347,-0.10486,-0.046474,0,0
4,GO MYOBLAST FUSION,0.29184,-0.1049,-0.092213,0,0
4,GO STEROL HOMEOSTASIS,0.13814,-0.10492,-0.091284,0,0
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.10096,-0.10495,-0.11506,0,0
4,GO SEROTONIN TRANSPORT,0.053746,-0.10496,-0.17508,0,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.15517,-0.1051,-0.05255,0,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.40349,-0.10512,-0.018644,0,0
4,GO REGULATION OF BLOOD PRESSURE,0.054842,-0.10519,-0.084705,0,0
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.079444,-0.10523,-0.10109,0,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.059411,-0.10534,-0.14446,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.05824,-0.10535,-0.1568,0,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.043763,-0.10553,-0.12086,0,0
4,GO REGULATION OF CHEMOTAXIS,0.10654,-0.10594,-0.068569,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.33373,-0.106,-0.11977,0,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.16032,-0.10602,-0.1214,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.52594,-0.1061,-0.2318,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.93377,-0.10617,0.023945,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.065563,-0.10636,-0.20562,0,0
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.049546,-0.10639,-0.066035,0,0
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.42347,-0.10648,-0.065805,0,0
4,GO BLOOD VESSEL REMODELING,0.079444,-0.10672,-0.15254,0,0
4,GO LOCOMOTOR RHYTHM,0.16032,-0.10677,-0.093452,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.60272,-0.1069,-0.059605,0,0
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.05824,-0.10721,-0.084788,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.15264,-0.10728,-0.11683,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.25729,-0.10734,-0.02207,0,0
4,GO ALANINE TRANSPORT,0.19095,-0.10741,-0.10726,0,0
4,GO DEVELOPMENTAL MATURATION,0.26098,-0.10743,-0.048137,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.20309,-0.10749,-0.081674,0,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.055956,-0.1076,-0.12347,0,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.084046,-0.10762,-0.098286,0,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.095625,-0.10767,-0.093613,0,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.084046,-0.10804,-0.13275,0,0
4,GO VESICLE DOCKING,0.11636,-0.10805,-0.070633,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.12689,-0.1081,-0.13206,0,0
4,GO REGULATION OF VASCULOGENESIS,0.02843,-0.10817,-0.30782,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.15517,-0.10821,-0.1001,0,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.4545,-0.10824,-0.037327,0,0
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.12259,-0.10825,-0.11857,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.054842,-0.10835,-0.12152,0,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.23937,-0.10842,-0.077887,0,0
4,GO SHORT TERM MEMORY,0.98255,-0.10849,0.014393,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.13583,-0.10852,-0.1194,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.016734,-0.10868,-0.19877,0,0
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.24643,-0.10868,-0.077323,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.088862,-0.10876,-0.10142,0,0
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.085627,-0.10892,-0.20333,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.61497,-0.10926,-0.019089,0,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.40843,-0.10932,-0.078336,0,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.82348,-0.10937,0.038117,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.052669,-0.10937,-0.16356,0,0
4,GO CELLULAR ANION HOMEOSTASIS,0.96163,-0.10951,0.026855,0,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.10845,-0.10963,-0.078621,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.3746,-0.10969,-0.038316,0,0
4,GO ADIPOSE TISSUE DEVELOPMENT,0.30402,-0.10972,-0.028745,0,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.23937,-0.10978,-0.045668,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.14285,-0.11007,-0.060017,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.34256,-0.11011,-0.044083,0,0
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.11235,-0.11014,-0.18672,0,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.095625,-0.11019,-0.12376,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.11235,-0.11021,-0.064287,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.11434,-0.11035,-0.11833,0,0
4,GO REGULATION OF EXCRETION,0.05824,-0.11036,-0.13224,0,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.18508,-0.11036,-0.080976,0,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0695,-0.11042,-0.067687,0,0
4,GO FEAR RESPONSE,0.097379,-0.11046,-0.069414,0,0
4,GO MICROVILLUS ASSEMBLY,0.34256,-0.11056,-0.083438,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.52025,-0.11058,-0.03395,0,0
4,GO T CELL MIGRATION,0.075049,-0.1107,-0.11507,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.23937,-0.11077,-0.058635,0,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.47588,-0.1108,-0.033457,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.088862,-0.11086,-0.052443,0,0
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.04854,-0.11087,-0.12224,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.037747,-0.11095,-0.1097,0,0
4,GO MACROAUTOPHAGY,0.063042,-0.11095,-0.074989,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.04854,-0.11095,-0.16025,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.17934,-0.11097,-0.19668,0,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.4545,-0.11105,-0.094993,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.18508,-0.1111,-0.087782,0,0
4,GO FERTILIZATION,0.017969,-0.11117,-0.082333,0,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.40843,-0.1112,-0.052322,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.56075,-0.11132,-0.010642,0,0
4,GO OSTEOBLAST PROLIFERATION,0.27227,-0.11151,-0.10719,0,0
4,GO ACTIN CROSSLINK FORMATION,0.67137,-0.11154,0.017077,0,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.36064,-0.11155,-0.049489,0,0
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.092194,-0.11163,-0.11179,0,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.080955,-0.11165,-0.079563,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0695,-0.11173,-0.093861,0,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.033894,-0.11179,-0.080984,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.059411,-0.11182,-0.11419,0,0
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.054842,-0.11199,-0.096038,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.37932,-0.112,-0.052763,0,0
4,GO ADULT LOCOMOTORY BEHAVIOR,0.095625,-0.11204,-0.078175,0,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.082489,-0.11206,-0.15958,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.34702,-0.1121,-0.15289,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.16559,-0.11213,-0.053682,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.29586,-0.11215,-0.026037,0,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.28785,-0.11225,-0.093903,0,0
4,GO SELECTIVE AUTOPHAGY,0.070855,-0.11225,-0.11209,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.29992,-0.11227,-0.061106,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.14285,-0.11247,-0.077986,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.16294,-0.1127,-0.13185,0,0
4,GO KETONE CATABOLIC PROCESS,0.020205,-0.11272,-0.22643,0,0
4,GO TRANSLESION SYNTHESIS,0.050569,-0.11286,-0.076096,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.011904,-0.11298,-0.087826,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.0695,-0.11303,-0.092737,0,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.054842,-0.11303,-0.096489,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.15773,-0.11306,-0.19176,0,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.46512,-0.11315,-0.042833,0,0
4,GO CHYLOMICRON ASSEMBLY,0.12689,-0.11321,-0.10309,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.10465,-0.11346,-0.10694,0,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.050569,-0.11348,-0.071668,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.084046,-0.11353,-0.086392,0,0
4,GO NEGATIVE REGULATION OF CELL SIZE,0.076492,-0.11354,-0.10587,0,0
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.12049,-0.11361,-0.10439,0,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.35153,-0.11362,-0.13365,0,0
4,GO MATING,0.0045306,-0.11362,-0.12641,0,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.077957,-0.11366,-0.15003,0,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.15015,-0.11379,-0.15778,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.060602,-0.11393,-0.15271,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0079323,-0.11397,-0.1293,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.35153,-0.11411,-0.058077,0,0
4,GO REGULATION OF BONE DEVELOPMENT,0.0016129,-0.11418,-0.19063,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.40843,-0.11419,-0.089626,0,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.11434,-0.1143,-0.093056,0,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.079444,-0.11524,-0.12809,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.15015,-0.11533,-0.062904,0,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.25729,-0.11533,-0.049867,0,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.077957,-0.11534,-0.14081,0,0
4,GO REGULATION OF EXOCYTOSIS,0.188,-0.11558,-0.035607,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.49227,-0.11558,-0.11428,0,0
4,GO FOAM CELL DIFFERENTIATION,0.14048,-0.11563,-0.12556,0,0
4,GO RESPONSE TO AMYLOID BETA,0.25363,-0.11574,-0.070064,0,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.14285,-0.11599,-0.084792,0,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.12689,-0.11616,-0.084464,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.51459,-0.11631,-0.034994,0,0
4,GO RESPONSE TO INTERFERON BETA,0.24643,-0.11636,-0.23178,0,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.082489,-0.11651,-0.13416,0,0
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.027803,-0.11656,-0.11336,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.21905,-0.11675,-0.029368,0,0
4,GO ADULT BEHAVIOR,0.32938,-0.11682,-0.02521,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.31232,-0.11688,-0.13962,0,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.16294,-0.11693,-0.063503,0,0
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.11235,-0.11694,-0.12373,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.057089,-0.11735,-0.12675,0,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.11039,-0.11744,-0.083537,0,0
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.066855,-0.11745,-0.12444,0,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.10096,-0.11749,-0.1491,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.30815,-0.11754,-0.06048,0,0
4,GO RECEPTOR RECYCLING,0.075049,-0.11755,-0.075196,0,0
4,GO DIGESTIVE SYSTEM PROCESS,0.052669,-0.11755,-0.094661,0,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0073363,-0.11769,-0.11252,0,0
4,GO AMINE CATABOLIC PROCESS,0.15015,-0.1178,-0.11425,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0695,-0.11781,-0.13243,0,0
4,GO RESPONSE TO IRON ION,0.11235,-0.11807,-0.065774,0,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.13583,-0.11809,-0.14351,0,0
4,GO STEROID CATABOLIC PROCESS,0.17374,-0.11813,-0.092666,0,0
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.1028,-0.11813,-0.15163,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.076492,-0.11819,-0.12163,0,0
4,GO MYOBLAST PROLIFERATION,0.23245,-0.11831,-0.082536,0,0
4,GO GLUTAMATE SECRETION,0.24643,-0.11832,-0.070139,0,0
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.11636,-0.11836,-0.092747,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.12689,-0.11844,-0.088563,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.015953,-0.11894,-0.18713,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.2,-0.11897,-0.08487,0,0
4,GO DETECTION OF BIOTIC STIMULUS,0.053746,-0.11902,-0.19338,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.20621,-0.11913,-0.14318,0,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.079444,-0.11924,-0.092106,0,0
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.05824,-0.11925,-0.12233,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.11434,-0.11936,-0.14016,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.087232,-0.11942,-0.12648,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.18508,-0.11944,-0.11155,0,0
4,GO MEMBRANE INVAGINATION,0.097379,-0.11944,-0.10188,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.17653,-0.11953,-0.091018,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.12049,-0.11957,-0.18831,0,0
4,GO MESONEPHROS DEVELOPMENT,0.27999,-0.11967,-0.050968,0,0
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.16032,-0.11981,-0.10109,0,0
4,GO MUSCLE SYSTEM PROCESS,0.0071468,-0.11991,-0.11099,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.061812,-0.11992,-0.11362,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.033894,-0.11995,-0.11706,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.27999,-0.12033,-0.051991,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.015953,-0.12041,-0.087313,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.80312,-0.12049,-0.0067641,0,0
4,GO PIGMENT GRANULE LOCALIZATION,0.079444,-0.12062,-0.084092,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.075049,-0.12081,-0.077323,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.31653,-0.12091,-0.078253,0,0
4,GO HYALURONAN CATABOLIC PROCESS,0.14048,-0.12121,-0.20503,0,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.03939,-0.12126,-0.08426,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.21905,-0.12131,-0.16824,0,0
4,GO KERATINOCYTE MIGRATION,0.066855,-0.12142,-0.1219,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.75615,-0.12154,-0.025014,0,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.077957,-0.12154,-0.13819,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.11434,-0.12162,-0.062748,0,0
4,GO INTRACELLULAR LIPID TRANSPORT,0.37932,-0.12177,-0.053503,0,0
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.12908,-0.12186,-0.088893,0,0
4,GO OPTIC NERVE DEVELOPMENT,0.1313,-0.1219,-0.15351,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.14285,-0.12206,-0.061878,0,0
4,GO GERMINAL CENTER FORMATION,0.13355,-0.12208,-0.21226,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.054842,-0.12208,-0.082843,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.12689,-0.12215,-0.11169,0,0
4,GO PROTEIN LOCALIZATION TO AXON,0.56075,-0.12229,-0.023346,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.084046,-0.12237,-0.18678,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.001228,-0.12251,-0.12131,0,0
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.25001,-0.12262,-0.074906,0,0
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.11235,-0.12266,-0.13978,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.21579,-0.12269,-0.11244,0,0
4,GO RESPONSE TO INTERLEUKIN 18,0.37932,-0.12285,-0.14351,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.17374,-0.12291,-0.17026,0,0
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.013798,-0.12296,-0.10159,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.13814,-0.12301,-0.14588,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.026586,-0.12304,-0.12675,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.063042,-0.12311,-0.1514,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.04854,-0.12317,-0.090379,0,0
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.038561,-0.12321,-0.14072,0,0
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.10845,-0.1233,-0.10672,0,0
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.025994,-0.12339,-0.11183,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0050528,-0.12343,-0.13682,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.063042,-0.1235,-0.10994,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.05824,-0.12352,-0.1118,0,0
4,GO RESPONSE TO THYROID HORMONE,0.16828,-0.12355,-0.12289,0,0
4,GO METANEPHROS MORPHOGENESIS,0.54321,-0.12365,-0.02677,0,0
4,GO REGULATION OF SYSTEM PROCESS,0.02843,-0.12376,-0.086519,0,0
4,GO SODIUM ION TRANSPORT,0.088862,-0.1238,-0.070898,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.23589,-0.12381,-0.081585,0,0
4,GO RESPONSE TO L GLUTAMATE,0.74288,-0.12405,-0.037756,0,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.24288,-0.12408,-0.077475,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.16828,-0.12409,-0.089586,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.20309,-0.12426,-0.087745,0,0
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.20937,-0.12437,-0.072555,0,0
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.11841,-0.1244,-0.13411,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.12049,-0.12446,-0.082704,0,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.05824,-0.12459,-0.11034,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.52025,-0.1246,-0.040486,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.088862,-0.12467,-0.082301,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.63354,-0.12499,-0.047306,0,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.059411,-0.1252,-0.10938,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.14526,-0.12531,-0.074269,0,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.043763,-0.12539,-0.11955,0,0
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.13355,-0.1254,-0.069492,0,0
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.10096,-0.12544,-0.093693,0,0
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.057089,-0.12546,-0.11788,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.16828,-0.12547,-0.081224,0,0
4,GO MYELIN ASSEMBLY,0.33373,-0.12554,-0.068908,0,0
4,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.15773,-0.12591,-0.16033,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.17374,-0.12601,-0.085258,0,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.35607,-0.12602,-0.07784,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.019739,-0.12603,-0.08489,0,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.38888,-0.12603,-0.069543,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.22905,-0.12617,-0.094282,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.10465,-0.12625,-0.081468,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.040234,-0.12653,-0.078646,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.54321,-0.12662,-0.018071,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.26098,-0.12662,-0.060718,0,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.20621,-0.12662,-0.12344,0,0
4,GO AMYLOID BETA CLEARANCE,0.093897,-0.12671,-0.13666,0,0
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.088862,-0.12686,-0.087838,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.076492,-0.12707,-0.068897,0,0
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.36991,-0.1271,-0.11788,0,0
4,GO PROTEIN HOMOOLIGOMERIZATION,0.001986,-0.12713,-0.10586,0,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.35153,-0.12713,-0.14625,0,0
4,GO INSULIN SECRETION,0.14285,-0.12722,-0.060866,0,0
4,GO TOXIN METABOLIC PROCESS,0.11039,-0.12726,-0.15238,0,0
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.52594,-0.12744,-0.046264,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.084046,-0.12762,-0.14833,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.030383,-0.12768,-0.10756,0,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.31232,-0.12776,-0.030876,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.075049,-0.12789,-0.12248,0,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.36991,-0.12794,-0.066511,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.054842,-0.128,-0.1247,0,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.21256,-0.12843,-0.090104,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.11039,-0.12845,-0.17581,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.47049,-0.12846,-0.10162,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.63354,-0.12859,-0.030473,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.13355,-0.12865,-0.11457,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.090515,-0.1288,-0.10958,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0028957,-0.12902,-0.11913,0,0
4,GO BLASTODERM SEGMENTATION,0.42347,-0.12904,-0.08439,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.2,-0.12942,-0.21823,0,0
4,GO REGULATION OF ION TRANSPORT,0.01282,-0.12948,-0.1069,0,0
4,GO RESPONSE TO OXYGEN RADICAL,0.12259,-0.1299,-0.076985,0,0
4,GO FEVER GENERATION,0.188,-0.12997,-0.10082,0,0
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.073629,-0.13007,-0.086315,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.037747,-0.13036,-0.14056,0,0
4,GO MEMBRANE DISASSEMBLY,0.093897,-0.13074,-0.09287,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.020205,-0.13086,-0.16638,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.065563,-0.13086,-0.073515,0,0
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.017549,-0.13091,-0.13089,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.063042,-0.13093,-0.16619,0,0
4,GO REGULATION OF INSULIN SECRETION,0.082489,-0.131,-0.065681,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.054842,-0.13103,-0.096117,0,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.097379,-0.13109,-0.089109,0,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.090515,-0.13114,-0.12228,0,0
4,GO LIPID STORAGE,0.088862,-0.1314,-0.10315,0,0
4,GO ETHANOL OXIDATION,0.26098,-0.13184,-0.19777,0,0
4,GO ANOIKIS,0.33812,-0.13191,-0.088621,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.60272,-0.13204,-0.031115,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.11039,-0.1322,-0.1265,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.082489,-0.13267,-0.12106,0,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.17374,-0.13291,-0.089006,0,0
4,GO PROGRAMMED NECROTIC CELL DEATH,0.055956,-0.13295,-0.17577,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.26098,-0.13305,-0.07601,0,0
4,GO BIOMINERALIZATION,0.11235,-0.13337,-0.092375,0,0
4,GO PROTEIN DEGLYCOSYLATION,0.061812,-0.13349,-0.17982,0,0
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.21905,-0.13363,-0.14546,0,0
4,GO REGULATION OF METAL ION TRANSPORT,0.0034322,-0.13366,-0.11369,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.054842,-0.13366,-0.081304,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.019739,-0.13367,-0.15698,0,0
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.17099,-0.13375,-0.069247,0,0
4,GO GLIAL CELL ACTIVATION,0.080955,-0.13375,-0.11457,0,0
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.37932,-0.13386,-0.093289,0,0
4,GO RESPONSE TO PEPTIDOGLYCAN,0.054842,-0.13397,-0.12517,0,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.55487,-0.13399,-0.0068165,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.22905,-0.13417,-0.13157,0,0
4,GO PODOSOME ASSEMBLY,0.26471,-0.13417,-0.082128,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.097379,-0.13434,-0.10041,0,0
4,GO RESPONSE TO ZINC ION,0.10096,-0.13441,-0.14369,0,0
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.059411,-0.13442,-0.1755,0,0
4,GO CATECHOLAMINE METABOLIC PROCESS,0.15773,-0.13449,-0.068804,0,0
4,GO CALCIUM ION IMPORT,0.05161,-0.13453,-0.069259,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.11434,-0.13468,-0.20124,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.21905,-0.13484,-0.12231,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.38888,-0.13501,-0.022717,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.010506,-0.13506,-0.13877,0,0
4,GO PLASMA MEMBRANE FUSION,0.099158,-0.13508,-0.13963,0,0
4,GO GOLGI TO ENDOSOME TRANSPORT,0.12689,-0.13518,-0.097125,0,0
4,GO DENDRITE EXTENSION,0.40843,-0.1352,0.032449,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.085627,-0.13536,-0.21869,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.41341,-0.13539,-0.079307,0,0
4,GO VISUAL BEHAVIOR,0.011904,-0.13539,-0.11586,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.061812,-0.13567,-0.11363,0,0
4,GO T CELL MEDIATED CYTOTOXICITY,0.10845,-0.13589,-0.21283,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036948,-0.13594,-0.1059,0,0
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.053746,-0.13613,-0.14101,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.16559,-0.13617,-0.054195,0,0
4,GO EXOCYTIC PROCESS,0.17099,-0.13621,-0.061378,0,0
4,GO MAST CELL MIGRATION,0.26098,-0.13667,-0.10254,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.11434,-0.13668,-0.1439,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0040578,-0.13678,-0.10697,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.10465,-0.13707,-0.093938,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.4598,-0.13712,-0.054774,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.18508,-0.13716,-0.12177,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.27999,-0.13721,-0.071439,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.29184,-0.13731,-0.039581,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.48678,-0.13778,-0.10871,0,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.88523,-0.13779,0.0044702,0,0
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.10465,-0.1378,-0.069545,0,0
4,GO DRUG METABOLIC PROCESS,0.0049174,-0.13805,-0.18801,0,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.11434,-0.1381,-0.15609,0,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.19393,-0.13829,-0.10014,0,0
4,GO SPROUTING ANGIOGENESIS,0.12908,-0.13845,-0.088382,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.079444,-0.13848,-0.11661,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.0029794,-0.13851,-0.11733,0,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.15773,-0.13857,-0.11356,0,0
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.22905,-0.13872,-0.12783,0,0
4,GO INTESTINAL LIPID ABSORPTION,0.0695,-0.13875,-0.19929,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.063042,-0.1388,-0.11599,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.12689,-0.13885,-0.081881,0,0
4,GO RESPONSE TO INTERFERON GAMMA,0.095625,-0.13897,-0.16634,0,0
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.072231,-0.13919,-0.1674,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.036948,-0.13925,-0.14691,0,0
4,GO ASSOCIATIVE LEARNING,0.0054795,-0.13936,-0.1615,0,0
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.87144,-0.13957,-0.012027,0,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.22235,-0.1398,-0.13639,0,0
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.066855,-0.13993,-0.10613,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.25363,-0.13999,-0.045053,0,0
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.099158,-0.14001,-0.080498,0,0
4,GO HEART PROCESS,0.015203,-0.14011,-0.12319,0,0
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.92682,-0.14013,0.073441,0,0
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.21256,-0.14021,-0.12029,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.17934,-0.14037,-0.089607,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.022165,-0.14038,-0.088691,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.30402,-0.14038,-0.069416,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.13814,-0.14061,-0.071078,0,0
4,GO RESPONSE TO TOXIC SUBSTANCE,0.0034322,-0.14064,-0.12886,0,0
4,GO STRIATED MUSCLE ADAPTATION,0.049546,-0.14105,-0.126,0,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.11841,-0.14111,-0.19344,0,0
4,GO PROTEIN ACTIVATION CASCADE,0.054842,-0.14138,-0.15678,0,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.40843,-0.14146,-0.050674,0,0
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.13355,-0.14154,-0.17693,0,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.0033369,-0.14156,-0.13077,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.070855,-0.14161,-0.12351,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.04854,-0.14173,-0.14778,0,0
4,GO ENDODERM FORMATION,0.26098,-0.14189,-0.10894,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.26098,-0.14227,-0.11104,0,0
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.18219,-0.14244,-0.1429,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.061812,-0.14247,-0.15909,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.17374,-0.14263,-0.12969,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.00090094,-0.14279,-0.11929,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.092194,-0.14292,-0.11035,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0060989,-0.14302,-0.12674,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.56075,-0.14309,-0.0069361,0,0
4,GO FEEDING BEHAVIOR,0.049546,-0.14339,-0.081165,0,0
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.30402,-0.14346,-0.11855,0,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.78962,-0.14373,-0.027734,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.055956,-0.14373,-0.12638,0,0
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.04854,-0.14383,-0.10861,0,0
4,GO PROSTAGLANDIN TRANSPORT,0.076492,-0.14388,-0.11463,0,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.063042,-0.14451,-0.18212,0,0
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.077957,-0.14462,-0.11034,0,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.097379,-0.1447,-0.08403,0,0
4,GO HYPEROSMOTIC RESPONSE,0.16032,-0.14473,-0.073973,0,0
4,GO RECEPTOR INTERNALIZATION,0.049546,-0.14474,-0.077402,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.10845,-0.14487,-0.10118,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.188,-0.14488,-0.093674,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.031748,-0.14506,-0.12886,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.13814,-0.14525,-0.15008,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.14285,-0.14531,-0.13961,0,0
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.0099891,-0.14546,-0.10947,0,0
4,GO PRESYNAPTIC ENDOCYTOSIS,0.2,-0.14552,-0.056434,0,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.016734,-0.14554,-0.14166,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.01282,-0.14555,-0.16688,0,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.12473,-0.14565,-0.090478,0,0
4,GO POSITIVE REGULATION OF CELL MATURATION,0.31232,-0.14574,-0.14613,0,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.47049,-0.14583,-0.045166,0,0
4,GO POSTSYNAPSE ASSEMBLY,0.65234,-0.14632,0.014297,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.31232,-0.1465,-0.047882,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.016734,-0.14665,-0.12399,0,0
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.23589,-0.14669,-0.083116,0,0
4,GO EATING BEHAVIOR,0.0094949,-0.14745,-0.12284,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.041967,-0.14751,-0.10833,0,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.076492,-0.14776,-0.098362,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.26471,-0.1479,-0.11472,0,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.12908,-0.14828,-0.11839,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.021165,-0.1484,-0.10278,0,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.11039,-0.14852,-0.08865,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.080955,-0.14895,-0.10492,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.065563,-0.14902,-0.16751,0,0
4,GO REGULATION OF WATER LOSS VIA SKIN,0.54903,-0.14904,-0.073734,0,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.10654,-0.14919,-0.16899,0,0
4,GO NOREPINEPHRINE TRANSPORT,0.16294,-0.14938,-0.08585,0,0
4,GO BONE MINERALIZATION,0.065563,-0.14957,-0.11666,0,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.059411,-0.14961,-0.1303,0,0
4,GO REVERSE CHOLESTEROL TRANSPORT,0.073629,-0.14991,-0.16209,0,0
4,GO RESPONSE TO TESTOSTERONE,0.15773,-0.1501,-0.08167,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.03245,-0.15127,-0.0879,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.00057693,-0.15164,-0.14951,0,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.007729,-0.15167,-0.18223,0,0
4,GO INTERLEUKIN 5 PRODUCTION,0.16828,-0.15237,-0.13658,0,0
4,GO MUSCLE CONTRACTION,0.00353,-0.15242,-0.12454,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.029068,-0.15288,-0.19909,0,0
4,GO AMINOGLYCAN METABOLIC PROCESS,0.022165,-0.15331,-0.13365,0,0
4,GO ANION HOMEOSTASIS,0.054842,-0.15349,-0.1153,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.03245,-0.15353,-0.14458,0,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.10654,-0.15388,-0.076213,0,0
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.010245,-0.15406,-0.1678,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.055956,-0.15407,-0.13074,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.4978,-0.15428,-0.037078,0,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.30402,-0.15462,-0.076545,0,0
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.0017641,-0.15555,-0.10727,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.95466,-0.15557,-0.0012532,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00079435,-0.15572,-0.15979,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.059411,-0.15582,-0.058028,0,0
4,GO NEGATIVE CHEMOTAXIS,0.11039,-0.15588,-0.11453,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.13355,-0.15594,-0.13485,0,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.097379,-0.1561,-0.16239,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.054842,-0.15614,-0.10759,0,0
4,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.32077,-0.15632,-0.070596,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.26847,-0.15634,-0.12846,0,0
4,GO REFLEX,0.22905,-0.15636,-0.13995,0,0
4,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.090515,-0.1564,-0.18449,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.079444,-0.15644,-0.10408,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.055956,-0.15672,-0.13456,0,0
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.17934,-0.15691,-0.2947,0,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.32077,-0.15694,-0.088655,0,0
4,GO NEUROTRANSMITTER SECRETION,0.090515,-0.15711,-0.061212,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.13814,-0.15715,-0.13519,0,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.19095,-0.1572,-0.10826,0,0
4,GO GLOMERULUS DEVELOPMENT,0.54321,-0.15739,-0.015158,0,0
4,GO REGULATION OF BLOOD CIRCULATION,0.014138,-0.15842,-0.11948,0,0
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.02166,-0.1588,-0.14661,0,0
4,GO RESPONSE TO SALT,0.05824,-0.1588,-0.093989,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0099891,-0.15911,-0.18417,0,0
4,GO STRIATED MUSCLE CONTRACTION,0.004408,-0.15926,-0.15836,0,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.033894,-0.1593,-0.09121,0,0
4,GO MICROVILLUS ORGANIZATION,0.099158,-0.15963,-0.16847,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.031748,-0.15965,-0.15352,0,0
4,GO POTASSIUM ION TRANSPORT,0.05161,-0.15971,-0.097573,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.063042,-0.15978,-0.25666,0,0
4,GO PIRNA METABOLIC PROCESS,0.014841,-0.16071,-0.19133,0,0
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.25001,-0.16078,-0.1495,0,0
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.29586,-0.16096,-0.060506,0,0
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.03245,-0.16109,-0.1964,0,0
4,GO RESPONSE TO HISTAMINE,0.11039,-0.16172,-0.18922,0,0
4,GO REGULATION OF PODOSOME ASSEMBLY,0.54903,-0.16174,-0.049794,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.20937,-0.16188,-0.13503,0,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.070855,-0.16211,-0.090359,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.066855,-0.16219,-0.1463,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.10096,-0.16243,-0.08891,0,0
4,GO BILE ACID AND BILE SALT TRANSPORT,0.040234,-0.16245,-0.21194,0,0
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.036948,-0.16262,-0.10555,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.033166,-0.16304,-0.14853,0,0
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.035393,-0.1633,-0.13305,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.093897,-0.16338,-0.11761,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.041093,-0.16353,-0.16216,0,0
4,GO AMMONIUM ION METABOLIC PROCESS,0.0695,-0.1636,-0.16543,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.049546,-0.16367,-0.20407,0,0
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.22235,-0.16372,-0.093197,0,0
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.073629,-0.16375,-0.17303,0,0
4,GO LIPID DROPLET FORMATION,0.40843,-0.16412,-0.077176,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.10654,-0.1642,-0.14053,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.31232,-0.16467,-0.047192,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.20309,-0.16475,-0.12821,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.010245,-0.16479,-0.14896,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.007729,-0.16482,-0.12747,0,0
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.26471,-0.16489,-0.063231,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.23937,-0.16506,-0.08918,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.10654,-0.16545,-0.15043,0,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.11434,-0.16585,-0.17168,0,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.024288,-0.16629,-0.12795,0,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.52594,-0.16639,0.013404,0,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.1313,-0.16651,-0.18259,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.11039,-0.16658,-0.11682,0,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.34702,-0.16679,-0.13469,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0056288,-0.16744,-0.12017,0,0
4,GO RESPIRATORY BURST,0.0081404,-0.16758,-0.20214,0,0
4,GO REGULATION OF TOLERANCE INDUCTION,0.15015,-0.16777,-0.18917,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.076492,-0.16795,-0.14449,0,0
4,GO REGULATION OF NEURON MATURATION,0.29184,-0.16796,-0.076156,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.038561,-0.1681,-0.092654,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.11841,-0.16813,-0.22662,0,0
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.188,-0.16813,-0.085946,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.26471,-0.16829,-0.079823,0,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.40349,-0.16832,-0.11161,0,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.1028,-0.16865,-0.11551,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.2839,-0.16952,-0.015715,0,0
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.054842,-0.16958,-0.14971,0,0
4,GO BLASTOCYST FORMATION,0.0085714,-0.16998,-0.13815,0,0
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.1028,-0.17006,-0.21038,0,0
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.007729,-0.17115,-0.19188,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.12259,-0.17145,-0.23073,0,0
4,GO ZYMOGEN INHIBITION,0.10096,-0.17199,-0.18555,0,0
4,GO BASEMENT MEMBRANE ORGANIZATION,0.42855,-0.17223,-0.080508,0,0
4,GO DOPAMINE METABOLIC PROCESS,0.1313,-0.17231,-0.084816,0,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.10845,-0.17248,-0.12542,0,0
4,GO ACTION POTENTIAL,0.020205,-0.17277,-0.13692,0,0
4,GO ENAMEL MINERALIZATION,0.63354,-0.17305,-0.035079,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0047853,-0.17316,-0.12547,0,0
4,GO NEUROMUSCULAR PROCESS,0.041093,-0.17373,-0.096994,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.12049,-0.17373,-0.16406,0,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.025994,-0.17387,-0.16626,0,0
4,GO ZINC ION HOMEOSTASIS,0.22568,-0.17387,-0.1494,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.8303,-0.17397,0.039775,0,0
4,GO STEROID HORMONE SECRETION,0.22235,-0.17399,-0.10018,0,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.066855,-0.17402,-0.13381,0,0
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.054842,-0.17455,-0.15256,0,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0014738,-0.17458,-0.16085,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.00032948,-0.17493,-0.2197,0,0
4,GO COLLAGEN CATABOLIC PROCESS,0.13583,-0.17561,-0.11992,0,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.029719,-0.17628,-0.15534,0,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.029719,-0.1763,-0.17369,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.11434,-0.17635,-0.069627,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.079444,-0.17652,-0.13291,0,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.12259,-0.17665,-0.16888,0,0
4,GO RESPONSE TO CAFFEINE,0.01282,-0.17666,-0.20407,0,0
4,GO MEMBRANE BIOGENESIS,0.52594,-0.17692,-0.048362,0,0
4,GO FATTY ACID HOMEOSTASIS,0.010245,-0.17723,-0.21628,0,0
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.02843,-0.17739,-0.12514,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.059411,-0.17763,-0.15828,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.05161,-0.17772,-0.1704,0,0
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.20937,-0.1779,-0.10563,0,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.40843,-0.17882,-0.068195,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.004408,-0.17893,-0.15982,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.10654,-0.17893,-0.15582,0,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.072231,-0.17899,-0.145,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.15517,-0.17909,-0.14808,0,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0021689,-0.17928,-0.18276,0,0
4,GO SYNAPTIC VESICLE MATURATION,0.15015,-0.17929,-0.083263,0,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.11434,-0.17951,-0.11096,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,0.00079435,-0.17953,-0.15837,0,0
4,GO LONG TERM MEMORY,0.022165,-0.17978,-0.15403,0,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.21256,-0.1798,-0.15196,0,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.41341,-0.18028,-0.045572,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.48131,-0.18039,-0.096809,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0045306,-0.1805,-0.12827,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.20309,-0.18098,-0.065724,0,0
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.093897,-0.18103,-0.26992,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.072231,-0.1813,-0.21618,0,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011047,-0.18166,-0.12705,0,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.19095,-0.18211,-0.15466,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.03245,-0.18255,-0.22445,0,0
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.088862,-0.18263,-0.14575,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.63354,-0.1828,0.002569,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.057089,-0.18323,-0.17717,0,0
4,GO MEMBRANE REPOLARIZATION,0.016734,-0.18324,-0.13858,0,0
4,GO POLYOL TRANSPORT,0.013139,-0.18371,-0.21485,0,0
4,GO TOLERANCE INDUCTION,0.059411,-0.18378,-0.27674,0,0
4,GO RESPONSE TO AMINE,0.00055855,-0.18389,-0.24441,0,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.007729,-0.18434,-0.12583,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.62113,-0.18472,-0.056079,0,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.1028,-0.18483,-0.095535,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.12259,-0.18494,-0.21741,0,0
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.046579,-0.18524,-0.17409,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.090515,-0.18548,-0.14388,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.16294,-0.18564,-0.15908,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0069616,-0.18574,-0.16846,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0019282,-0.1859,-0.14663,0,0
4,GO RESPONSE TO DIETARY EXCESS,0.2839,-0.18626,-0.094709,0,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.10845,-0.1863,-0.15416,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0094949,-0.18655,-0.14431,0,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.029719,-0.1866,-0.14268,0,0
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0097392,-0.18697,-0.13399,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.0027346,-0.18712,-0.202,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.5726,-0.18718,-0.046789,0,0
4,GO REGULATION OF DENDRITE EXTENSION,0.19695,-0.18725,-0.039742,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.12689,-0.1875,-0.11265,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.059411,-0.18765,-0.12777,0,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.31232,-0.18788,-0.12044,0,0
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.13583,-0.1879,-0.1435,0,0
4,GO REGULATION OF AMYLOID BETA FORMATION,0.03245,-0.18801,-0.16758,0,0
4,GO MONOCYTE CHEMOTAXIS,0.084046,-0.1892,-0.14164,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.19095,-0.18956,-0.10625,0,0
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.095625,-0.1896,-0.18523,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.068167,-0.19001,-0.16445,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0032441,-0.19042,-0.12699,0,0
4,GO PHAGOCYTOSIS RECOGNITION,0.14048,-0.19051,-0.15298,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.23245,-0.19082,-0.12705,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.11434,-0.19143,-0.14657,0,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.3746,-0.1924,-0.0967,0,0
4,GO MALE MEIOSIS I,0.030383,-0.19241,-0.18669,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.023741,-0.19316,-0.19085,0,0
4,GO COENZYME A METABOLIC PROCESS,0.0075304,-0.19357,-0.18966,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.025414,-0.194,-0.20347,0,0
4,GO CARNITINE SHUTTLE,0.097379,-0.19401,-0.13528,0,0
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0695,-0.19577,-0.16247,0,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.36991,-0.1965,-0.037045,0,0
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.053746,-0.1971,-0.15637,0,0
4,GO PROTEIN KINASE C SIGNALING,0.0021689,-0.19726,-0.20191,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0051916,-0.19743,-0.1122,0,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.072231,-0.19778,-0.23413,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.04854,-0.19781,-0.15084,0,0
4,GO CARNITINE METABOLIC PROCESS,0.23937,-0.19837,-0.077283,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.0038387,-0.19869,-0.24147,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0028141,-0.19941,-0.22419,0,0
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.23937,-0.19956,-0.10647,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.085627,-0.19968,-0.11572,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0012662,-0.20072,-0.16972,0,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.17099,-0.20088,-0.15756,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0028141,-0.20097,-0.25176,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0022992,-0.20111,-0.1738,0,0
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.019739,-0.20116,-0.17863,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.010245,-0.20131,-0.1465,0,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.011904,-0.20183,-0.21777,0,0
4,GO MEMBRANE RAFT ORGANIZATION,0.22235,-0.20199,-0.18463,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.00047456,-0.20273,-0.20891,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.042857,-0.20291,-0.13373,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.038561,-0.20302,-0.1555,0,0
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.21579,-0.20302,-0.11194,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.20937,-0.20324,-0.13702,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.070855,-0.20337,-0.21855,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.031748,-0.20419,-0.17994,0,0
4,GO SECRETION BY TISSUE,0.052669,-0.20422,-0.14652,0,0
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,4.8379e-05,-0.20431,-0.23787,0,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.02068,-0.20445,-0.27022,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0007696,-0.20474,-0.1647,0,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.16828,-0.20516,-0.13648,0,0
4,GO NEURON MATURATION,0.10654,-0.20552,-0.12396,0,0
4,GO REGULATION OF ANOIKIS,0.082489,-0.20568,-0.18758,0,0
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.16032,-0.207,-0.094437,0,0
4,GO PROTEIN OXIDATION,0.010506,-0.20749,-0.22581,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.060602,-0.20839,-0.15831,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0020453,-0.20891,-0.16152,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.016339,-0.20924,-0.14095,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.02166,-0.20931,-0.17449,0,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.007729,-0.20953,-0.23658,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0021689,-0.2099,-0.19922,0,0
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.12049,-0.21052,-0.15235,0,0
4,GO IMPORT INTO CELL,0.0064317,-0.21062,-0.129,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00059588,-0.21096,-0.18462,0,0
4,GO RESPONSE TO INSECTICIDE,0.05824,-0.21171,-0.15808,0,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.3746,-0.21175,-0.10476,0,0
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0016129,-0.21256,-0.18693,0,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.084046,-0.21274,-0.1368,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.079444,-0.21347,-0.18948,0,0
4,GO CARDIAC CONDUCTION,0.033166,-0.21387,-0.12558,0,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.013139,-0.21438,-0.2065,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0013054,-0.2144,-0.23943,0,0
4,GO STARTLE RESPONSE,0.47588,-0.21501,-0.053294,0,0
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.11039,-0.2155,-0.18828,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.036948,-0.2156,-0.17392,0,0
4,GO REGULATION OF ACROSOME REACTION,0.007729,-0.21579,-0.25853,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0028141,-0.21681,-0.16558,0,0
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.14285,-0.21722,-0.20812,0,0
4,GO T CELL EXTRAVASATION,0.21256,-0.21751,-0.15987,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0071468,-0.21824,-0.20085,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0079323,-0.21864,-0.18144,0,0
4,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.027803,-0.21937,-0.17619,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.034637,-0.21942,-0.21288,0,0
4,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.12259,-0.21951,-0.15443,0,0
4,GO HEART INDUCTION,0.066855,-0.22111,-0.22055,0,0
4,GO CAMP METABOLIC PROCESS,0.05161,-0.22196,-0.13842,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.053746,-0.22297,-0.18192,0,0
4,GO MACROPHAGE PROLIFERATION,0.10096,-0.22412,-0.18392,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.055956,-0.22508,-0.13774,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.053746,-0.22518,-0.2237,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.15773,-0.22528,-0.21406,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.02166,-0.22552,-0.16329,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.041093,-0.22659,-0.1752,0,0
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.073629,-0.2266,-0.20962,0,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.001228,-0.22667,-0.25659,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0085714,-0.22765,-0.18179,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00049035,-0.22796,-0.19852,0,0
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.038561,-0.2292,-0.21375,0,0
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.073629,-0.2294,-0.13776,0,0
4,GO CHEMOSENSORY BEHAVIOR,0.0039469,-0.22977,-0.16801,0,0
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.33373,-0.23029,-0.089382,0,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.15773,-0.2309,-0.12976,0,0
4,GO DETECTION OF OTHER ORGANISM,0.052669,-0.23123,-0.20312,0,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.10845,-0.23209,-0.22095,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0022332,-0.23229,-0.19301,0,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.10845,-0.23234,-0.16238,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00036427,-0.2326,-0.18215,0,0
4,GO HEMIDESMOSOME ASSEMBLY,0.10465,-0.23272,-0.28253,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.40843,-0.23362,-0.085532,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.018836,-0.23435,-0.15327,0,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.017549,-0.23457,-0.13745,0,0
4,GO MEMBRANE RAFT ASSEMBLY,0.31232,-0.23487,-0.27857,0,0
4,GO LIPOXYGENASE PATHWAY,0.02268,-0.23541,-0.24454,0,0
4,GO REGULATION OF VESICLE FUSION,0.017969,-0.23553,-0.22548,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.054842,-0.23604,-0.20587,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0031536,-0.23605,-0.1608,0,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.001662,-0.2361,-0.23803,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.10654,-0.23694,-0.17259,0,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.047551,-0.23728,-0.16801,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.49227,-0.23776,-0.22875,0,0
4,GO SKELETAL MUSCLE ADAPTATION,0.05161,-0.23881,-0.14911,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00047456,-0.23949,-0.18302,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.029719,-0.24061,-0.15448,0,0
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00038934,-0.241,-0.23435,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.20309,-0.24127,-0.27075,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0019282,-0.24199,-0.20596,0,0
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.082489,-0.2421,-0.16183,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00026903,-0.24365,-0.18945,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.080955,-0.24391,-0.1603,0,0
4,GO RELAXATION OF CARDIAC MUSCLE,0.029068,-0.24575,-0.22227,0,0
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00013917,-0.24606,-0.21728,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.010245,-0.24628,-0.19636,0,0
4,GO DIOL BIOSYNTHETIC PROCESS,0.0026572,-0.2468,-0.20697,0,0
4,GO RESPONSE TO AMPHETAMINE,0.00052342,-0.24853,-0.2947,0,0
4,GO ELASTIC FIBER ASSEMBLY,0.025994,-0.25091,-0.28333,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.007729,-0.25222,-0.19332,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.42855,-0.25364,-0.29969,0,0
4,GO MATING BEHAVIOR,0.00025131,-0.25435,-0.24641,0,0
4,GO NEURONAL ACTION POTENTIAL,0.016734,-0.25483,-0.19103,0,0
4,GO MEMBRANE DEPOLARIZATION,0.0062634,-0.25562,-0.18497,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.047551,-0.25626,-0.18761,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.1313,-0.25662,-0.16841,0,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0037331,-0.25677,-0.26697,0,0
4,GO ZINC ION TRANSPORT,0.0039469,-0.25831,-0.18295,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00095906,-0.25839,-0.22517,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.16032,-0.25943,-0.14798,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.0024367,-0.25999,-0.29972,0,0
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0038387,-0.26016,-0.21743,0,0
4,GO MECHANOSENSORY BEHAVIOR,0.11434,-0.26284,-0.17013,0,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.030383,-0.26384,-0.16995,0,0
4,GO NEGATIVE REGULATION OF ANOIKIS,0.25729,-0.26398,-0.16633,0,0
4,GO INNERVATION,0.30402,-0.26411,-0.059957,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.00087311,-0.26472,-0.24171,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00017186,-0.26531,-0.29568,0,0
4,GO RESPONSE TO MUSCLE STRETCH,0.009256,-0.26552,-0.26651,0,0
4,GO PROTEIN TRIMERIZATION,0.00090094,-0.26599,-0.28147,0,0
4,GO REGULATION OF RESPIRATORY BURST,0.054842,-0.26697,-0.17051,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.093897,-0.26768,-0.16009,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.41341,-0.26833,-0.14507,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.011047,-0.26897,-0.27729,0,0
4,GO EPOXYGENASE P450 PATHWAY,0.035393,-0.26915,-0.20469,0,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.035393,-0.26929,-0.16933,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.095625,-0.27078,-0.25607,0,0
4,GO GTP METABOLIC PROCESS,0.00092958,-0.2725,-0.27483,0,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.046579,-0.2731,-0.203,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.36991,-0.2743,-0.12234,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.025994,-0.27438,-0.18799,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.076492,-0.27556,-0.19018,0,0
4,GO MINERALOCORTICOID METABOLIC PROCESS,0.036948,-0.27763,-0.23276,0,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0025817,-0.27807,-0.25144,0,0
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.082489,-0.27995,-0.17332,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.30815,-0.28086,-0.12323,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00038934,-0.28106,-0.22327,0,0
4,GO ACROSOME REACTION,0.00038934,-0.28131,-0.2479,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00092958,-0.28141,-0.3001,0,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0081404,-0.28205,-0.19635,0,0
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.050569,-0.28264,-0.12805,0,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.049546,-0.2828,-0.24244,0,0
4,GO TRANSMISSION OF NERVE IMPULSE,0.010773,-0.28284,-0.17322,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.044685,-0.28378,-0.20343,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0022992,-0.28513,-0.329,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.014138,-0.2868,-0.24506,0,0
4,GO PLASMA MEMBRANE REPAIR,0.066855,-0.28697,-0.15629,0,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.05824,-0.28736,-0.21572,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00047456,-0.28772,-0.2419,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.031059,-0.28839,-0.18086,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.18219,-0.28911,-0.11914,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.073629,-0.28954,-0.18819,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.065563,-0.29132,-0.21111,0,0
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,2.9532e-05,-0.29258,-0.29141,0,0
4,GO SEROTONIN METABOLIC PROCESS,0.16032,-0.29357,-0.14686,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.095625,-0.29433,-0.17337,0,0
4,GO GASTRIC ACID SECRETION,0.00040247,-0.29721,-0.25591,0,0
4,GO PROTEIN REFOLDING,2.0833e-05,-0.30131,-0.32291,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.47588,-0.30252,-0.031218,0,0
4,GO HEPARIN METABOLIC PROCESS,0.001986,-0.30482,-0.35586,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.033894,-0.30902,-0.21843,0,0
4,GO EOSINOPHIL MIGRATION,0.02166,-0.31456,-0.24516,0,0
4,GO RESPONSE TO COPPER ION,0.02843,-0.31519,-0.25864,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.00072223,-0.31644,-0.26361,0,0
4,GO ACTIN FILAMENT NETWORK FORMATION,0.11841,-0.31817,-0.1321,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.16032,-0.32102,-0.095386,0,0
4,GO RESPONSE TO MAGNESIUM ION,0.00021909,-0.32203,-0.34722,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.044685,-0.32796,-0.24563,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.085627,-0.33085,-0.1849,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00025131,-0.33113,-0.24409,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0031536,-0.33125,-0.23405,0,0
4,GO GROOMING BEHAVIOR,0.00030804,-0.34315,-0.29331,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.066855,-0.34565,-0.20707,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00016023,-0.3459,-0.27483,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00010845,-0.34672,-0.30163,0,0
4,GO EOSINOPHIL CHEMOTAXIS,0.010245,-0.34989,-0.27017,0,0
4,GO DETECTION OF CALCIUM ION,0.038561,-0.35397,-0.21377,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.00017796,-0.36725,-0.33511,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,-0.384,-0.26297,0,0
4,GO NADH METABOLIC PROCESS,7.0571e-06,-0.39546,-0.36051,0,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.057089,-0.39597,-0.22635,0,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.004408,-0.39697,-0.31614,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,1.104e-05,-0.40037,-0.42987,0,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0015653,-0.40062,-0.38459,0,0
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0075304,-0.40847,-0.3263,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00063551,-0.41306,-0.355,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.00020448,-0.41871,-0.31014,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.0011199,-0.42474,-0.4046,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.0021062,-0.43585,-0.35472,0,0
4,GO MUCUS SECRETION,0.077957,-0.44082,-0.27363,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0013872,-0.45129,-0.37062,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.0018173,-0.45905,-0.32859,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.00011241,-0.47371,-0.52192,0,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,1.5816e-05,-0.53409,-0.48947,0,0
